data_1y4e_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1y4e _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.413 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 2.6 mp . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.947 0.403 . . . . 0.0 111.816 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.419 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 4.5 mp -75.46 -55.17 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.709 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.544 ' HG ' ' N ' ' A' ' 172' ' ' ASP . 2.6 pt? -60.04 -51.47 69.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.028 0.442 . . . . 0.0 110.449 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.544 ' N ' ' HG ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -76.23 5.5 6.85 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.288 178.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 170' ' ' ILE . . . -71.75 -71.1 0.29 Allowed 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -108.24 -3.76 33.29 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 1.5 t80 69.74 -61.9 0.43 Allowed 'General case' 0 C--O 1.231 0.113 0 CA-C-O 121.028 0.442 . . . . 0.0 110.348 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 23.1 t80 . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.333 179.278 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.422 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 3.5 tt . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 121.123 0.487 . . . . 0.0 110.315 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.422 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.0 mp -74.1 -45.7 47.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.788 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.41 -53.12 53.38 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -74.77 1.05 13.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.921 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 170' ' ' ILE . . . -72.82 -53.44 11.47 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.143 0.497 . . . . 0.0 109.69 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -105.63 -18.48 11.67 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.294 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.427 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 13.0 t80 76.02 -25.73 0.2 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.882 0.473 . . . . 0.0 112.04 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.7 p90 . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.648 0.261 . . . . 0.0 111.209 179.918 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.492 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--O 1.226 -0.161 0 CA-C-O 120.951 0.405 . . . . 0.0 110.715 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 3.7 mp -80.61 -50.84 16.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.245 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 7.3 mp -65.26 -50.93 63.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.277 0.561 . . . . 0.0 109.949 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -74.0 -4.42 35.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.032 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -71.67 -70.36 0.33 Allowed 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -123.33 -27.73 1.44 Allowed Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.51 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 15.6 t80 79.15 -20.14 0.4 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.443 0.697 . . . . 0.0 112.149 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.331 -0.201 0 CA-C-O 121.368 0.604 . . . . 0.0 109.466 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.517 ' O ' ' N ' ' A' ' 173' ' ' ALA . 7.7 tt . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 120.891 0.377 . . . . 0.0 111.355 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.487 ' HA ' ' HB2' ' A' ' 173' ' ' ALA . 7.4 mm -69.19 -31.42 49.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.356 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.2 mp -70.71 -4.01 21.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.485 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -152.4 13.84 0.57 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.234 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 169' ' ' ILE . . . -81.86 -38.58 25.21 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -130.57 -14.64 1.9 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 114.755 -1.112 . . . . 0.0 112.344 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 73.63 -45.88 0.62 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.651 0.225 . . . . 0.0 111.245 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.402 ' O ' ' CG ' ' A' ' 176' ' ' PHE . 55.4 t80 . . . . . 0 C--N 1.331 -0.239 0 CA-C-O 120.568 0.223 . . . . 0.0 111.141 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.89 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 118.925 -0.56 . . . . 0.0 109.638 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.496 ' H ' ' CG2' ' A' ' 169' ' ' ILE . 2.9 mm 24.19 -64.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.457 0.703 . . . . 0.0 112.714 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.89 ' N ' ' O ' ' A' ' 169' ' ' ILE . 0.1 OUTLIER -67.95 -51.27 49.5 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.916 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 169' ' ' ILE . 1.0 OUTLIER -73.44 -15.7 61.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.546 179.286 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.42 ' CB ' HG13 ' A' ' 169' ' ' ILE . . . -78.14 -59.35 2.82 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.081 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -119.02 -21.85 3.69 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.864 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 70.9 -48.11 0.66 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.787 0.294 . . . . 0.0 111.192 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.231 0 CA-C-O 120.747 0.308 . . . . 0.0 110.962 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.448 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 121.048 0.452 . . . . 0.0 111.058 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.42 ' O ' ' HB1' ' A' ' 173' ' ' ALA . 2.5 mp -83.75 -70.37 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.617 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.97 -48.4 71.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.89 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.04 1.91 9.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.665 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.448 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -73.92 -51.72 15.21 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.195 0.522 . . . . 0.0 109.612 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -118.54 -18.15 4.96 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.785 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 15.6 t80 78.1 -34.11 0.18 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 122.551 0.34 . . . . 0.0 111.881 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.207 0 CA-C-O 120.752 0.311 . . . . 0.0 111.151 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.463 HD13 HG21 ' A' ' 169' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 121.123 0.487 . . . . 0.0 111.294 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 3.4 mp -70.12 -41.54 79.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.61 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 12.9 mt -67.03 -59.13 3.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.263 0.554 . . . . 0.0 109.709 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.93 10.03 1.64 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.462 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -71.74 -48.41 47.2 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -117.88 -28.1 2.34 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 177.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 6.1 t80 74.56 -31.52 0.22 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.178 0.591 . . . . 0.0 112.003 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.411 ' H ' ' C ' ' A' ' 174' ' ' GLY . 1.1 m-85 . . . . . 0 C--N 1.331 -0.196 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.46 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 7.3 tp . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 121.07 0.462 . . . . 0.0 110.635 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.495 ' HA ' ' HB1' ' A' ' 173' ' ' ALA . 4.2 mt -69.38 -35.44 67.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.942 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 0.0 OUTLIER -65.69 -57.94 6.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.673 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.29 -2.79 26.61 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.729 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.495 ' HB1' ' HA ' ' A' ' 170' ' ' ILE . . . -73.57 -69.23 0.44 Allowed 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 121.158 0.504 . . . . 0.0 109.944 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -113.35 -15.14 9.15 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.871 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.504 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 5.8 t80 77.63 -41.7 0.36 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 39.8 p90 . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.656 0.265 . . . . 0.0 111.363 -179.738 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.486 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--O 1.228 -0.03 0 CA-C-O 120.816 0.341 . . . . 0.0 111.508 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 3.4 mp -70.1 -41.99 79.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.578 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 27.9 mt -65.72 -56.65 10.93 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.11 2.26 11.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.231 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.486 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.35 -62.0 1.59 Allowed 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.191 0.519 . . . . 0.0 109.884 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -112.49 -11.85 14.34 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.616 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.479 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 24.5 t80 71.78 -29.96 0.2 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.732 0.413 . . . . 0.0 111.751 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.466 ' H ' ' C ' ' A' ' 174' ' ' GLY . 8.3 t80 . . . . . 0 C--N 1.332 -0.192 0 CA-C-O 120.681 0.277 . . . . 0.0 111.238 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.452 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 9.2 tp . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 121.404 0.621 . . . . 0.0 110.303 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.452 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.1 mp -74.83 -46.7 40.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.157 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.3 mt -65.4 -55.64 16.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.065 0.46 . . . . 0.0 110.223 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.421 ' OD1' ' CZ ' ' A' ' 175' ' ' TYR . 0.9 OUTLIER -76.07 14.46 0.7 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.399 179.209 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.04 -59.37 2.74 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 175' ' ' TYR . . . -113.35 -2.96 24.45 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 177.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.421 ' CZ ' ' OD1' ' A' ' 172' ' ' ASP . 6.2 m-85 68.69 -61.6 0.41 Allowed 'General case' 0 C--N 1.338 0.105 0 C-N-CA 123.029 0.532 . . . . 0.0 110.79 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.6 t80 . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.15 179.674 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.46 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 121.095 0.474 . . . . 0.0 110.234 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.46 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.2 mp -75.35 -38.37 40.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.296 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 63.8 mt -67.18 -57.93 5.8 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.2 4.81 6.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.118 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -71.94 -45.8 59.84 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.257 0.551 . . . . 0.0 109.772 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.538 ' C ' ' CG ' ' A' ' 175' ' ' TYR . . . -122.03 -0.02 10.7 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.775 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.538 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER 59.23 -32.91 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 179.416 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.513 ' H ' ' C ' ' A' ' 174' ' ' GLY . 22.5 t80 . . . . . 0 C--N 1.33 -0.275 0 O-C-N 122.098 -0.376 . . . . 0.0 111.102 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.465 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 120.597 0.236 . . . . 0.0 111.274 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.407 ' O ' ' HB1' ' A' ' 173' ' ' ALA . 1.8 mp -87.69 -67.85 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.091 0.472 . . . . 0.0 110.997 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -41.1 82.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.165 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -72.53 -8.62 56.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.716 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -75.48 -64.37 1.08 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.196 0.522 . . . . 0.0 109.997 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -125.31 -17.64 2.65 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.157 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 77.66 -20.39 0.38 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 122.491 0.316 . . . . 0.0 111.675 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.964 0.411 . . . . 0.0 110.559 179.441 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.471 HG22 HD11 ' A' ' 169' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 121.051 0.453 . . . . 0.0 111.336 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.441 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 2.3 mp -73.81 -54.32 15.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.947 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 3.4 pp -62.76 -50.17 72.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.122 0.487 . . . . 0.0 109.815 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.406 ' N ' ' CD1' ' A' ' 171' ' ' LEU . 7.4 t0 -74.77 0.81 14.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.13 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 170' ' ' ILE . . . -72.46 -70.05 0.37 Allowed 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -109.91 -23.07 6.31 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.499 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 7.6 t80 75.25 -22.92 0.25 Allowed 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 122.891 0.477 . . . . 0.0 111.942 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.374 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.447 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 8.6 pt . . . . . 0 N--CA 1.46 0.053 0 CA-C-O 120.693 0.282 . . . . 0.0 111.754 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 7.2 mt -74.79 -49.8 28.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.493 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 0.8 OUTLIER -65.21 -52.68 53.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.62 2.62 9.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.489 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.16 -68.32 0.47 Allowed 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 121.211 0.529 . . . . 0.0 109.666 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -110.89 -12.95 14.78 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.343 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 4.7 t80 77.44 -12.28 1.09 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.702 0.401 . . . . 0.0 111.829 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 55.6 t80 . . . . . 0 C--N 1.331 -0.217 0 CA-C-O 120.882 0.372 . . . . 0.0 110.679 179.455 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.534 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.5 OUTLIER . . . . . 0 C--O 1.227 -0.099 0 CA-C-O 121.309 0.575 . . . . 0.0 110.543 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.512 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 0.8 OUTLIER -77.54 -43.26 30.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.739 -1.118 . . . . 0.0 111.926 -178.839 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 54.5 tp -63.66 -55.47 23.2 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -73.62 -4.59 35.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.62 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -73.88 -68.2 0.53 Allowed 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.323 0.582 . . . . 0.0 109.526 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -130.7 3.51 5.73 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.683 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 17.0 t80 71.12 -44.04 0.58 Allowed 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.9 p90 . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 120.682 0.277 . . . . 0.0 111.364 179.816 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.531 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 1.3 tt . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.724 0.297 . . . . 0.0 110.66 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.458 ' HA ' ' HB3' ' A' ' 173' ' ' ALA . 2.8 mp -77.8 -39.48 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.743 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 0.4 OUTLIER -63.91 -58.44 6.76 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.249 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -73.66 -3.43 28.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.745 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.85 -73.17 0.21 Allowed 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.351 0.596 . . . . 0.0 109.556 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -120.54 -8.34 8.41 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.624 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 20.4 t80 69.7 -46.73 0.59 Allowed 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 122.676 0.39 . . . . 0.0 111.549 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.772 0.32 . . . . 0.0 111.069 179.865 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.464 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.458 -0.045 0 CA-C-O 121.171 0.51 . . . . 0.0 110.329 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.416 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 11.0 mm -73.2 -46.12 51.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.196 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 3.4 pp -65.26 -49.88 67.92 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.42 ' N ' ' CD1' ' A' ' 171' ' ' LEU . 23.0 t0 -73.92 -5.34 40.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.472 178.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.464 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -74.32 -66.32 0.74 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.122 0.487 . . . . 0.0 110.147 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -119.47 -10.79 7.67 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.275 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.499 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 11.9 t80 79.36 -29.1 0.14 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 122.554 0.342 . . . . 0.0 111.914 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 30.9 p90 . . . . . 0 C--N 1.331 -0.21 0 CA-C-O 120.699 0.285 . . . . 0.0 111.262 179.784 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.51 HG23 ' N ' ' A' ' 170' ' ' ILE . 19.9 tt . . . . . 0 CA--C 1.519 -0.244 0 CA-C-O 121.627 0.727 . . . . 0.0 110.536 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.51 ' N ' HG23 ' A' ' 169' ' ' ILE . 0.9 OUTLIER -73.63 -35.04 43.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.33 -1.305 . . . . 0.0 111.994 -178.609 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.514 ' H ' ' CD2' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -62.56 -64.17 1.0 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.089 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -75.15 4.3 7.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.41 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -71.34 -64.56 0.89 Allowed 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -111.73 -18.49 7.9 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.162 178.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 77.76 -30.5 0.16 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.799 0.44 . . . . 0.0 111.8 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.332 -0.158 0 CA-C-O 120.561 0.22 . . . . 0.0 111.37 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.536 HG13 ' N ' ' A' ' 170' ' ' ILE . 21.8 pt . . . . . 0 CA--C 1.519 -0.217 0 CA-C-O 121.448 0.642 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.536 ' N ' HG13 ' A' ' 169' ' ' ILE . 1.5 pt -76.19 -45.77 34.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.825 -177.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 0.0 OUTLIER -62.72 -56.48 17.25 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -74.09 1.33 11.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.028 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -73.36 -69.45 0.43 Allowed 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 121.238 0.542 . . . . 0.0 109.69 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -113.93 -9.28 16.41 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.612 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 31.3 t80 77.01 -8.97 1.6 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 122.652 0.381 . . . . 0.0 112.019 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 . . . . . 0 C--N 1.323 -0.546 0 CA-C-O 120.806 0.336 . . . . 0.0 110.913 179.754 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.833 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.6 OUTLIER . . . . . 0 CA--C 1.538 0.492 0 CA-C-O 119.3 -0.381 . . . . 0.0 110.337 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.487 ' H ' ' CG2' ' A' ' 169' ' ' ILE . 2.8 mp 27.11 -66.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.893 0.877 . . . . 0.0 112.993 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.833 ' N ' ' O ' ' A' ' 169' ' ' ILE . 3.6 pp -68.99 -48.44 63.08 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.263 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.413 ' N ' ' CD1' ' A' ' 171' ' ' LEU . 28.2 m-20 -70.33 -7.06 39.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.124 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.88 -58.49 3.25 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.917 0.389 . . . . 0.0 110.309 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -110.9 -30.72 3.12 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.39 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER 75.36 -36.92 0.32 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 122.475 0.31 . . . . 0.0 111.6 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.405 ' H ' ' C ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 120.928 0.394 . . . . 0.0 110.232 179.205 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.441 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--O 1.226 -0.146 0 CA-C-O 121.115 0.483 . . . . 0.0 110.642 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.514 ' HA ' ' HB1' ' A' ' 173' ' ' ALA . 2.8 mp -69.33 -36.37 71.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.801 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 10.9 mp -65.62 -53.57 39.81 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.548 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -75.74 -6.07 48.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.514 178.073 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.514 ' HB1' ' HA ' ' A' ' 170' ' ' ILE . . . -74.51 -74.26 0.2 Allowed 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.31 0.576 . . . . 0.0 109.879 179.808 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -115.81 -15.19 7.51 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.687 178.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.424 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER 75.09 -47.34 0.61 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.358 0.263 . . . . 0.0 111.633 179.897 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.173 0 CA-C-O 120.688 0.28 . . . . 0.0 111.24 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.552 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 120.929 0.395 . . . . 0.0 110.849 . . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.444 ' CD1' ' CG2' ' A' ' 169' ' ' ILE . 6.5 mm -78.78 -47.88 22.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.73 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.4 tp -62.75 -55.06 30.04 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -74.47 -2.48 25.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.81 178.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.552 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.86 -67.27 0.58 Allowed 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.114 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -131.47 -4.33 3.99 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.688 178.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 70.16 -47.33 0.62 Allowed 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 122.433 0.293 . . . . 0.0 111.234 -179.755 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.1 t80 . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.846 0.355 . . . . 0.0 110.695 179.458 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.412 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.458 -0.038 0 CA-C-O 120.909 0.385 . . . . 0.0 111.24 . . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 2.8 mp -72.83 -48.85 43.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.561 -179.492 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.98 -49.81 66.55 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.487 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -75.95 1.67 14.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.04 178.564 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.25 -42.12 66.01 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.214 0.53 . . . . 0.0 109.666 179.74 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.53 ' C ' ' CG ' ' A' ' 175' ' ' TYR . . . -119.62 -1.96 13.28 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.826 178.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.53 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER 58.51 -37.32 0.06 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 179.483 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.477 ' H ' ' C ' ' A' ' 174' ' ' GLY . 26.9 p90 . . . . . 0 C--N 1.328 -0.345 0 O-C-N 122.094 -0.378 . . . . 0.0 111.164 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.502 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 12.6 pt . . . . . 0 N--CA 1.457 -0.112 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.453 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 8.4 mm -81.48 -50.84 16.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.962 -179.408 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 0.0 OUTLIER -62.63 -53.38 55.38 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.938 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.43 -1.17 17.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.887 178.715 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.91 -56.84 4.61 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 121.194 0.521 . . . . 0.0 109.787 179.626 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -129.88 -3.5 4.94 Favored Glycine 0 CA--C 1.52 0.38 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.057 179.126 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.3 OUTLIER 70.13 -55.8 0.6 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.64 0.257 . . . . 0.0 111.358 179.974 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 11.4 t80 . . . . . 0 C--N 1.331 -0.224 0 CA-C-O 120.902 0.382 . . . . 0.0 110.572 179.766 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.444 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 5.5 tt . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 121.16 0.505 . . . . 0.0 110.673 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 10.4 mm -71.56 -42.82 72.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.053 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.06 -53.55 36.95 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.795 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -74.82 -0.1 17.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.035 178.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.97 -60.94 2.0 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.159 0.504 . . . . 0.0 109.851 179.757 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -109.67 -19.03 8.5 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.497 178.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 78.83 -29.83 0.15 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.658 0.383 . . . . 0.0 111.953 179.647 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.406 ' O ' ' CG ' ' A' ' 176' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-O 120.747 0.308 . . . . 0.0 110.737 179.696 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 1.9 tp . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 121.009 0.433 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.448 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.5 mp -74.55 -41.57 48.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.216 -179.899 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -65.2 -57.75 7.74 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.82 4.51 6.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.067 178.754 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.97 -56.01 5.74 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.207 0.527 . . . . 0.0 109.826 179.683 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -121.74 -0.03 10.99 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.726 178.695 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.494 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.2 OUTLIER 55.1 -59.79 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.047 0.939 . . . . 0.0 112.154 179.898 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.606 ' N ' ' O ' ' A' ' 174' ' ' GLY . 13.1 m-85 . . . . . 0 C--N 1.323 -0.547 0 CA-C-O 120.782 0.325 . . . . 0.0 111.118 -179.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.495 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 8.4 tp . . . . . 0 CA--C 1.519 -0.242 0 CA-C-O 121.479 0.657 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.495 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 0.8 OUTLIER -74.04 -44.3 50.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 114.683 -1.144 . . . . 0.0 112.507 -178.25 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -65.16 -58.37 6.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.054 0.454 . . . . 0.0 109.845 179.53 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -74.66 5.46 4.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.552 179.105 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -70.79 -56.42 6.37 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.304 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -111.55 -26.36 4.55 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 177.9 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 72.25 -40.68 0.48 Allowed 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 122.633 0.373 . . . . 0.0 111.663 179.641 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.423 ' H ' ' C ' ' A' ' 174' ' ' GLY . 8.6 m-85 . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 120.814 0.34 . . . . 0.0 110.622 179.661 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.46 0.066 0 CA-C-O 121.27 0.557 . . . . 0.0 111.322 . . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.492 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 0.7 OUTLIER -78.98 -44.78 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.938 -1.028 . . . . 0.0 112.968 -178.02 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -64.51 -58.16 7.18 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.1 4.84 4.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.151 178.857 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.22 -56.48 5.46 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.257 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -133.86 2.06 4.37 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.559 178.465 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 70.35 -56.83 0.59 Allowed 'General case' 0 C--O 1.231 0.096 0 C-N-CA 122.543 0.337 . . . . 0.0 111.733 179.75 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 120.619 0.247 . . . . 0.0 111.621 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 3.7 tp . . . . . 0 CA--C 1.521 -0.168 0 CA-C-O 121.393 0.616 . . . . 0.0 110.717 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.477 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 0.7 OUTLIER -79.01 -43.78 24.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.707 -179.277 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 1.2 tp -65.8 -58.91 4.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.114 0.483 . . . . 0.0 109.992 179.557 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -74.24 5.54 4.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.448 179.052 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -71.25 -64.69 0.87 Allowed 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.505 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -112.3 -17.09 8.43 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 178.167 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 6.0 t80 75.58 -11.46 1.1 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.705 0.402 . . . . 0.0 111.81 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 120.986 0.422 . . . . 0.0 110.867 179.672 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.477 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 4.8 tp . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 121.062 0.458 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.406 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 9.0 mm -73.4 -45.89 50.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.447 -179.284 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 34.5 tp -64.33 -54.37 34.12 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.46 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.94 -0.67 16.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.082 178.649 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.42 -61.86 1.65 Allowed 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.25 0.547 . . . . 0.0 109.911 179.779 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -114.15 -13.95 9.55 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.683 178.848 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 24.9 t80 70.91 -51.06 0.68 Allowed 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 122.459 0.304 . . . . 0.0 111.599 179.904 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.209 -179.828 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.464 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 8.2 tp . . . . . 0 N--CA 1.458 -0.031 0 CA-C-O 120.994 0.426 . . . . 0.0 111.299 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.464 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.7 mp -73.82 -36.38 45.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.522 -179.671 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 20.2 mt -64.92 -62.39 1.59 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.658 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -77.43 8.06 4.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.359 178.996 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -71.1 -59.15 2.93 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.328 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 175' ' ' TYR . . . -123.37 -1.64 9.22 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.188 178.024 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.403 ' HB2' ' O ' ' A' ' 174' ' ' GLY . 63.6 m-85 66.36 -57.65 0.37 Allowed 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.02 0.528 . . . . 0.0 111.336 179.679 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 120.761 0.315 . . . . 0.0 110.958 179.552 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.448 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--O 1.227 -0.109 0 CA-C-O 121.047 0.451 . . . . 0.0 110.996 . . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.442 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 2.2 mp -75.46 -53.36 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.315 -179.785 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 12.2 tp -65.33 -49.93 67.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.361 0.601 . . . . 0.0 109.384 179.446 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.06 -1.32 16.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.153 179.102 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.448 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.66 -64.78 0.89 Allowed 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.092 0.472 . . . . 0.0 109.736 179.631 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -116.18 -16.83 6.5 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.688 178.807 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.436 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 24.2 t80 75.89 -10.61 1.25 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.401 0.28 . . . . 0.0 111.753 179.986 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 71.3 t80 . . . . . 0 C--N 1.332 -0.194 0 CA-C-O 120.838 0.351 . . . . 0.0 110.948 179.664 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.491 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.9 OUTLIER . . . . . 0 CA--C 1.534 0.35 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 . . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.474 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 2.7 mp -83.13 -65.56 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.039 0.447 . . . . 0.0 111.236 179.956 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 1.4 pp -65.8 -45.04 83.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.353 0.597 . . . . 0.0 110.252 179.902 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.19 -5.55 32.71 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.947 179.492 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -75.75 -62.2 1.67 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.107 0.48 . . . . 0.0 110.243 179.735 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -130.67 1.48 5.59 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.484 179.584 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.508 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER 57.54 -52.51 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 179.344 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.522 ' N ' ' O ' ' A' ' 174' ' ' GLY . 2.9 m-85 . . . . . 0 C--N 1.327 -0.378 0 CA-C-O 120.75 0.309 . . . . 0.0 111.041 179.941 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.927 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 . . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.479 ' H ' ' CG2' ' A' ' 169' ' ' ILE . 1.9 mt 25.63 -62.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.387 0.675 . . . . 0.0 112.664 178.349 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.927 ' N ' ' O ' ' A' ' 169' ' ' ILE . 13.7 mt -67.05 -51.0 60.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.674 179.824 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -72.31 -6.86 46.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.074 179.575 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.61 -59.55 2.7 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.753 0.311 . . . . 0.0 110.367 179.887 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -100.06 -20.9 14.75 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.636 179.048 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 64.9 t80 69.29 -57.63 0.53 Allowed 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.8 0.333 . . . . 0.0 111.003 -179.953 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 6.5 t80 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.526 179.503 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.467 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 18.4 pt . . . . . 0 N--CA 1.454 -0.234 0 CA-C-O 120.72 0.295 . . . . 0.0 111.336 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.443 ' N ' HG13 ' A' ' 169' ' ' ILE . 3.1 mp -78.71 -43.36 25.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.483 -179.974 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.408 ' N ' ' CD2' ' A' ' 171' ' ' LEU . 2.5 mm? -64.6 -58.93 4.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.104 0.478 . . . . 0.0 109.773 179.852 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -74.32 4.7 5.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.256 179.01 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.08 -52.75 15.37 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.548 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -121.43 -5.82 9.16 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.793 178.76 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.415 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 85.1 t80 68.99 -53.59 0.57 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.547 0.339 . . . . 0.0 111.574 179.981 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.406 ' O ' ' CG ' ' A' ' 176' ' ' PHE . 27.7 t80 . . . . . 0 CA--C 1.532 0.267 0 CA-C-O 120.587 0.232 . . . . 0.0 111.171 -179.802 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.499 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 17.0 tt . . . . . 0 CA--C 1.52 -0.184 0 CA-C-O 121.636 0.732 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.535 ' HA ' ' HB2' ' A' ' 173' ' ' ALA . 3.3 pt -71.82 -43.55 69.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 114.16 -1.382 . . . . 0.0 111.827 -178.524 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 8.9 mt -63.06 -51.6 66.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.975 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -75.02 -8.24 55.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.312 178.227 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.535 ' HB2' ' HA ' ' A' ' 170' ' ' ILE . . . -75.14 -76.15 0.15 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.123 0.487 . . . . 0.0 110.191 179.71 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -114.82 -14.19 8.82 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.914 179.12 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 32.6 t80 77.48 -43.47 0.41 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 179.668 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.211 0 CA-C-O 120.57 0.224 . . . . 0.0 111.595 -179.878 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.513 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.52 -0.207 0 CA-C-O 121.023 0.439 . . . . 0.0 111.517 . . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.513 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.3 pp -76.1 -49.71 24.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.224 -178.271 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 3.4 pp -67.47 -48.58 66.77 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.988 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.95 -2.37 23.73 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.922 178.655 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -71.73 -70.8 0.3 Allowed 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.539 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.467 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -110.86 -23.66 5.8 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.131 -0.787 . . . . 0.0 111.131 178.127 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER 71.25 -13.53 0.52 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.398 0.279 . . . . 0.0 111.199 -179.726 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.467 ' H ' ' C ' ' A' ' 174' ' ' GLY . 36.7 p90 . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.752 0.31 . . . . 0.0 110.256 179.189 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.46 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 5.6 tp . . . . . 0 CA--C 1.523 -0.067 0 CA-C-O 120.964 0.411 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.42 ' O ' ' HB1' ' A' ' 173' ' ' ALA . 7.4 mm -73.94 -49.83 32.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.916 -178.927 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.7 -48.0 76.29 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.609 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -76.5 -1.35 26.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.956 178.488 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.62 -57.35 4.2 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.818 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.47 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -115.02 -15.12 8.03 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.663 178.757 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 68.66 -10.11 0.5 Allowed 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 122.3 0.24 . . . . 0.0 111.567 -179.766 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.47 ' H ' ' C ' ' A' ' 174' ' ' GLY . 7.4 m-85 . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.734 0.302 . . . . 0.0 110.389 179.463 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.453 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 121.047 0.451 . . . . 0.0 111.053 . . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.402 ' CD1' ' CG2' ' A' ' 169' ' ' ILE . 8.1 mm -73.56 -42.35 55.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.523 -179.454 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.64 -56.05 14.24 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.471 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -74.52 0.54 14.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.008 178.701 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -71.64 -57.35 4.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.285 0.564 . . . . 0.0 109.5 179.662 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -112.66 -22.14 5.84 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.309 178.558 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 70.08 -53.07 0.63 Allowed 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 122.476 0.31 . . . . 0.0 111.45 179.815 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.218 0 CA-C-O 120.803 0.335 . . . . 0.0 110.734 179.789 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.477 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.275 0 CA-C-O 120.713 0.292 . . . . 0.0 111.348 . . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.444 ' CD1' ' CG2' ' A' ' 169' ' ' ILE . 7.0 mm -76.95 -50.12 21.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.893 -179.506 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.5 mp -64.08 -52.31 59.89 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.592 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -74.01 0.61 13.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.012 178.48 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.15 -52.26 17.49 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.372 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -126.48 -25.33 1.3 Allowed Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.519 178.782 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 7.8 t80 79.44 -21.63 0.32 Allowed 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.231 0.613 . . . . 0.0 112.275 179.62 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 . . . . . 0 C--N 1.327 -0.39 0 CA-C-O 121.405 0.622 . . . . 0.0 109.341 179.093 . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.424 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 8.4 tt . . . . . 0 N--CA 1.458 -0.046 0 CA-C-O 121.166 0.508 . . . . 0.0 110.796 . . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.446 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 1.9 mp -71.07 -37.37 66.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.94 -179.875 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.39 -55.42 18.22 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.784 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.74 1.3 17.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.04 178.432 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 170' ' ' ILE . . . -73.4 -45.68 53.25 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-O 121.05 0.452 . . . . 0.0 110.157 -179.869 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 175' ' ' TYR . . . -117.99 -20.68 4.41 Favored Glycine 0 N--CA 1.452 -0.281 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 178.688 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.434 ' HB2' ' O ' ' A' ' 174' ' ' GLY . 57.6 m-85 69.44 -12.64 0.42 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 179.0 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 121.455 0.645 . . . . 0.0 109.26 178.638 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.408 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 10.8 pt . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.965 0.412 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 10.7 mm -77.12 -42.56 31.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.41 -179.848 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.97 -57.03 9.79 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.535 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.09 4.55 6.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.119 178.671 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -71.59 -47.27 55.91 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.287 0.565 . . . . 0.0 109.501 179.616 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -121.09 -28.05 1.74 Allowed Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 178.338 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 46.9 t80 77.0 -13.74 0.91 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.314 0.646 . . . . 0.0 112.501 179.184 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.403 ' CD2' ' O ' ' A' ' 176' ' ' PHE . 42.2 p90 . . . . . 0 C--N 1.328 -0.341 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.665 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.527 0.077 0 CA-C-O 120.905 0.383 . . . . 0.0 110.711 . . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.459 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.4 mp -78.35 -42.57 26.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.803 179.504 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.5 mt -64.38 -56.95 10.9 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.429 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -74.45 2.48 9.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.087 178.685 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.77 -60.71 2.1 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-O 121.151 0.501 . . . . 0.0 109.731 179.737 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -115.53 -11.35 10.56 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.626 178.769 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.482 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 64.0 t80 72.47 -17.29 0.39 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.787 0.435 . . . . 0.0 112.119 179.903 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.416 ' H ' ' C ' ' A' ' 174' ' ' GLY . 0.4 OUTLIER . . . . . 0 C--N 1.331 -0.231 0 CA-C-O 120.795 0.331 . . . . 0.0 111.004 179.765 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.471 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--O 1.227 -0.086 0 CA-C-O 120.864 0.364 . . . . 0.0 111.566 . . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.406 ' O ' ' HB1' ' A' ' 173' ' ' ALA . 2.4 mp -74.67 -56.67 8.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.868 -179.27 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -53.25 40.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.907 0.384 . . . . 0.0 110.813 -179.675 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.43 8.75 2.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.979 179.771 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.471 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.31 -67.58 0.54 Allowed 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.357 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.632 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -117.91 8.43 14.61 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 178.034 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.472 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER 53.72 -63.34 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.005 0.922 . . . . 0.0 111.638 179.846 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.632 ' N ' ' O ' ' A' ' 174' ' ' GLY . 11.8 t80 . . . . . 0 C--N 1.321 -0.661 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.293 179.639 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.465 0.311 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 . . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 3.9 mp -81.66 -61.87 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.937 0.398 . . . . 0.0 111.752 -179.616 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.42 ' N ' ' CD2' ' A' ' 171' ' ' LEU . 2.5 mm? -67.5 -51.26 53.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.891 -179.489 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -73.45 4.19 5.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.96 -179.796 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.476 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -73.19 -65.71 0.77 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.33 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -108.45 -24.74 6.05 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 178.113 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 75.43 -25.13 0.21 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.645 0.378 . . . . 0.0 111.537 179.814 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.434 ' H ' ' C ' ' A' ' 174' ' ' GLY . 11.6 m-85 . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 120.702 0.287 . . . . 0.0 110.971 179.728 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.43 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 8.7 pt . . . . . 0 N--CA 1.461 0.086 0 CA-C-O 120.757 0.313 . . . . 0.0 111.533 . . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.421 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 3.8 mp -75.76 -52.78 17.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.729 -179.352 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.86 -51.41 59.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.058 0.456 . . . . 0.0 109.976 179.849 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.63 3.5 7.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.519 179.209 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.43 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.24 -63.71 1.09 Allowed 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.576 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -112.62 -11.49 14.71 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.353 178.368 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 3.8 t80 72.57 -55.6 0.67 Allowed 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.53 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.214 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.276 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.497 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 7.4 tt . . . . . 0 CA--C 1.522 -0.103 0 CA-C-O 121.176 0.512 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.401 ' HA ' ' HB1' ' A' ' 173' ' ' ALA . 10.2 mm -69.65 -38.53 76.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.286 -179.217 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 82.7 mt -64.86 -58.82 5.17 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.102 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.72 0.21 16.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.166 178.597 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.497 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.88 -62.11 1.57 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.162 0.506 . . . . 0.0 109.748 179.737 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -113.27 -12.31 12.2 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.752 178.891 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 8.0 t80 73.11 -53.34 0.7 Allowed 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 122.48 0.312 . . . . 0.0 111.687 179.793 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.68 0.276 . . . . 0.0 110.915 179.882 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.467 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 7.2 tp . . . . . 0 CA--C 1.526 0.026 0 CA-C-O 121.171 0.51 . . . . 0.0 110.645 . . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.464 ' HA ' ' HB1' ' A' ' 173' ' ' ALA . 1.3 mp -71.63 -40.64 71.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.796 179.952 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 0.8 OUTLIER -66.63 -51.01 61.08 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.659 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -73.37 -8.23 54.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.079 178.032 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -74.64 -64.68 0.98 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.141 0.496 . . . . 0.0 110.119 179.667 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -123.64 -14.46 3.89 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.397 179.459 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 6.9 t80 77.87 -11.03 1.26 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 179.858 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 42.0 p90 . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.62 0.248 . . . . 0.0 111.217 179.73 . . . . . . . . 0 0 . 1 . 049 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.421 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 7.3 tp . . . . . 0 CA--C 1.521 -0.151 0 CA-C-O 121.322 0.582 . . . . 0.0 109.814 . . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.421 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.7 mp -68.28 -23.11 28.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.828 178.822 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.37 -65.95 0.61 Allowed 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.385 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -76.69 7.15 4.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.802 178.092 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.408 ' CB ' ' HA ' ' A' ' 170' ' ' ILE . . . -70.21 -51.21 32.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.734 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -104.83 -19.17 11.23 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 177.811 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 16.5 t80 75.66 -10.19 1.3 Allowed 'General case' 0 C--O 1.23 0.075 0 C-N-CA 122.841 0.456 . . . . 0.0 112.005 179.626 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 120.788 0.328 . . . . 0.0 110.72 179.531 . . . . . . . . 0 0 . 1 . 050 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 14.7 tt . . . . . 0 CA--C 1.519 -0.238 0 CA-C-O 121.372 0.606 . . . . 0.0 111.502 . . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.492 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.0 OUTLIER -71.61 -45.19 68.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.487 -177.813 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.74 -55.21 24.97 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.506 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -76.11 3.26 10.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.384 178.797 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -73.01 -52.67 13.51 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.258 0.551 . . . . 0.0 109.894 179.9 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -121.77 -19.8 3.29 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.22 178.738 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.431 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 62.0 t80 74.28 -12.96 0.83 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.101 0.56 . . . . 0.0 112.127 179.628 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 . . . . . 0 C--N 1.33 -0.25 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.729 . . . . . . . . 0 0 . 1 . 051 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.485 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 2.7 tt . . . . . 0 CA--C 1.518 -0.265 0 CA-C-O 121.543 0.687 . . . . 0.0 110.58 . . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.485 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 0.9 OUTLIER -74.66 -43.16 47.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.544 -178.931 . . . . . . . . 3 3 . 1 . 051 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.21 -54.57 27.55 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.105 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.12 1.23 13.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.943 178.575 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.72 -59.57 2.65 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 121.168 0.509 . . . . 0.0 110.005 179.885 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.581 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -111.73 -4.18 26.51 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.698 178.896 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.502 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER 56.07 -54.4 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.87 0.868 . . . . 0.0 112.589 179.818 . . . . . . . . 3 3 . 1 . 051 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.581 ' N ' ' O ' ' A' ' 174' ' ' GLY . 6.5 m-85 . . . . . 0 C--N 1.324 -0.52 0 CA-C-O 120.616 0.246 . . . . 0.0 111.109 179.984 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.48 HG22 ' CD1' ' A' ' 170' ' ' ILE . 5.5 tp . . . . . 0 CA--C 1.517 -0.298 0 CA-C-O 121.253 0.549 . . . . 0.0 111.569 . . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.48 ' CD1' HG22 ' A' ' 169' ' ' ILE . 5.9 mm -62.22 -30.64 49.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.775 -178.582 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 24.6 tp -65.18 -65.23 0.7 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.081 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -77.6 3.83 12.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.449 178.853 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -71.63 -70.27 0.33 Allowed 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.825 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -107.11 -12.69 23.22 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.078 178.244 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.446 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 4.0 m-85 69.47 -48.02 0.6 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.703 0.401 . . . . 0.0 111.323 -179.908 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.419 ' O ' ' CG ' ' A' ' 176' ' ' PHE . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.293 0 CA-C-O 120.718 0.294 . . . . 0.0 110.364 179.358 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.922 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.4 ' C ' ' O ' ' A' ' 169' ' ' ILE . 4.7 mt 26.77 -62.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.567 0.747 . . . . 0.0 112.539 178.655 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.922 ' N ' ' O ' ' A' ' 169' ' ' ILE . 3.1 mm? -66.8 -52.38 44.62 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.699 179.914 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.03 -19.31 60.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.76 179.608 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -78.3 -73.07 0.34 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.118 -179.651 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -109.12 -25.98 5.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.601 -179.988 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.436 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 25.5 t80 74.49 -39.37 0.42 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.659 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.592 0.234 . . . . 0.0 110.87 179.801 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.528 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 4.9 tt . . . . . 0 C--O 1.226 -0.167 0 CA-C-O 121.015 0.436 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.502 ' O ' ' HB1' ' A' ' 173' ' ' ALA . 2.4 mp -80.23 -60.79 2.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.713 -178.859 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 0.2 OUTLIER -63.09 -48.97 76.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.903 0.382 . . . . 0.0 110.444 -179.199 . . . . . . . . 3 3 . 1 . 054 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.14 -2.79 22.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.859 179.088 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -74.3 -66.86 0.68 Allowed 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.179 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -123.54 -11.56 4.98 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.016 178.889 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 20.0 t80 77.64 -30.08 0.16 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 122.624 0.369 . . . . 0.0 111.842 -179.895 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.67 0.271 . . . . 0.0 111.192 179.775 . . . . . . . . 0 0 . 1 . 055 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.563 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 23.0 pt . . . . . 0 N--CA 1.454 -0.244 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 . . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.436 ' N ' HG13 ' A' ' 169' ' ' ILE . 3.3 mp -76.76 -47.31 28.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.01 -179.252 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 38.1 tp -63.86 -54.48 34.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.346 0.593 . . . . 0.0 109.56 179.751 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.22 -3.47 26.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.849 179.014 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.96 -73.7 0.2 Allowed 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.299 0.571 . . . . 0.0 109.555 179.484 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -118.52 -13.54 6.77 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.509 178.647 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 5.5 t80 76.37 -45.51 0.51 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.474 0.31 . . . . 0.0 111.363 179.97 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 . . . . . 0 C--N 1.331 -0.2 0 CA-C-O 120.672 0.272 . . . . 0.0 111.056 179.892 . . . . . . . . 0 0 . 1 . 056 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.557 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--O 1.226 -0.157 0 CA-C-O 120.838 0.351 . . . . 0.0 111.426 . . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.444 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.2 mp -73.4 -47.55 45.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.676 -179.254 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.99 -56.81 9.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.13 0.49 . . . . 0.0 109.874 179.802 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.02 5.11 5.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.693 179.358 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.34 -63.69 1.1 Allowed 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.54 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 175' ' ' TYR . . . -112.05 -11.88 15.21 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.382 178.495 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 174' ' ' GLY . 16.0 m-85 68.3 -50.74 0.55 Allowed 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 122.687 0.395 . . . . 0.0 111.36 179.915 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.801 179.719 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.447 HG21 HD11 ' A' ' 169' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.467 0.375 0 CA-C-O 120.842 0.353 . . . . 0.0 111.295 . . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.461 ' HA ' ' HB1' ' A' ' 173' ' ' ALA . 3.5 mp -73.98 -42.73 52.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.847 179.992 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 10.5 mt -63.43 -54.51 35.45 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.214 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.88 0.48 15.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.824 178.446 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.461 ' HB1' ' HA ' ' A' ' 170' ' ' ILE . . . -73.06 -77.51 0.1 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.893 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -98.46 -3.17 57.55 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.386 178.392 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER 71.55 -61.52 0.49 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.91 0.386 . . . . 0.0 110.838 179.987 . . . . . . . . 3 3 . 1 . 057 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 36.8 p90 . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.231 179.934 . . . . . . . . 0 0 . 1 . 058 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.51 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.23 0 CA-C-O 121.587 0.708 . . . . 0.0 110.832 . . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.525 ' HA ' ' HB3' ' A' ' 173' ' ' ALA . 11.1 pt -68.15 -38.37 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.57 -178.355 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 0.0 OUTLIER -60.73 -57.3 13.29 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.085 . . . . . . . . 3 3 . 1 . 058 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.21 -2.65 35.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.845 178.334 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.525 ' HB3' ' HA ' ' A' ' 170' ' ' ILE . . . -73.03 -67.24 0.58 Allowed 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 121.056 0.455 . . . . 0.0 110.088 -179.93 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -109.34 -16.47 11.1 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.734 178.942 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.525 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.5 OUTLIER 77.33 -12.93 1.0 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 179.924 . . . . . . . . 3 3 . 1 . 058 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 C--N 1.331 -0.207 0 CA-C-O 120.557 0.218 . . . . 0.0 111.327 -179.981 . . . . . . . . 0 0 . 1 . 059 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.501 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 . . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.413 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.3 mp -73.11 -47.13 48.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.882 0.372 . . . . 0.0 111.783 -179.195 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.56 -0.58 5.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.058 -179.873 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -147.05 15.27 1.17 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.468 -179.926 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.501 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -79.93 -47.31 15.22 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.911 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -129.77 -22.64 1.14 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.981 178.684 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 34.9 t80 71.62 -12.59 0.62 Allowed 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 122.507 0.323 . . . . 0.0 111.386 -179.344 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.447 ' H ' ' C ' ' A' ' 174' ' ' GLY . 7.2 t80 . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 120.795 0.331 . . . . 0.0 110.143 178.959 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.575 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 3.5 tp . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 120.713 0.292 . . . . 0.0 111.755 . . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.439 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 8.1 mm -73.79 -51.71 23.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.193 -178.781 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 3.4 mm? -64.14 -49.17 73.21 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.715 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -75.03 -4.08 36.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.955 178.516 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.575 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -73.17 -68.37 0.5 Allowed 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.234 0.54 . . . . 0.0 109.714 179.656 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -121.72 -8.89 7.25 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.939 178.929 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.49 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.2 OUTLIER 55.76 -53.58 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.883 0.873 . . . . 0.0 112.416 -179.994 . . . . . . . . 3 3 . 1 . 060 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.566 ' N ' ' O ' ' A' ' 174' ' ' GLY . 29.0 t80 . . . . . 0 C--N 1.325 -0.469 0 CA-C-O 120.611 0.244 . . . . 0.0 110.744 179.789 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.45 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 2.1 tt . . . . . 0 N--CA 1.459 0.016 0 CA-C-O 121.134 0.492 . . . . 0.0 111.3 . . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.406 ' N ' HG22 ' A' ' 169' ' ' ILE . 4.2 mp -67.58 -35.05 71.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.342 -179.22 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.31 -60.51 2.71 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.897 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -76.29 4.46 8.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.269 178.692 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -71.94 -68.52 0.45 Allowed 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.741 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -103.37 -13.76 27.66 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 178.032 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.452 ' CG ' ' N ' ' A' ' 176' ' ' PHE . 0.0 OUTLIER 72.64 -53.56 0.7 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.53 0.332 . . . . 0.0 111.534 179.48 . . . . . . . . 3 3 . 1 . 061 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.452 ' N ' ' CG ' ' A' ' 175' ' ' TYR . 26.1 t80 . . . . . 0 C--N 1.332 -0.196 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.359 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.889 ' O ' ' N ' ' A' ' 171' ' ' LEU . 2.5 tt . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 . . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.553 ' N ' HG12 ' A' ' 169' ' ' ILE . 14.7 mt 25.62 -63.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 123.676 0.79 . . . . 0.0 112.762 177.863 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.889 ' N ' ' O ' ' A' ' 169' ' ' ILE . 17.4 mt -66.5 -43.63 84.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.246 -179.628 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.59 -15.88 60.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.35 -179.924 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -76.16 -90.34 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.337 179.966 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -105.55 -10.64 30.72 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.642 178.784 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 60.7 t80 68.3 -61.26 0.4 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.925 0.393 . . . . 0.0 110.411 -179.629 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.403 ' O ' ' CG ' ' A' ' 176' ' ' PHE . 21.3 t80 . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.87 179.112 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.878 ' O ' ' N ' ' A' ' 171' ' ' LEU . 3.0 pt . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 . . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 3.2 mp 33.78 -60.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 123.889 0.876 . . . . 0.0 113.139 178.597 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.878 ' N ' ' O ' ' A' ' 169' ' ' ILE . 0.1 OUTLIER -64.07 -44.48 92.27 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.856 -179.587 . . . . . . . . 3 3 . 1 . 063 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 52.7 p30 -71.72 -10.26 59.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.975 179.818 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -78.29 -63.08 1.48 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.844 0.354 . . . . 0.0 110.815 179.925 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -114.63 -21.78 5.31 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.325 179.751 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER 76.79 -10.98 1.24 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.878 . . . . . . . . 3 3 . 1 . 063 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.715 0.293 . . . . 0.0 111.011 179.609 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.539 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 9.4 tt . . . . . 0 C--O 1.225 -0.216 0 CA-C-O 120.811 0.338 . . . . 0.0 111.673 . . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.442 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.3 mp -76.65 -52.26 17.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.226 -179.144 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 0.0 OUTLIER -64.57 -52.72 56.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.085 0.469 . . . . 0.0 109.953 -179.633 . . . . . . . . 3 3 . 1 . 064 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.45 -0.31 17.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.206 179.129 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.539 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.62 -69.79 0.39 Allowed 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.408 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -120.88 -11.21 6.51 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.523 178.571 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.471 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 26.3 t80 70.51 -18.31 0.25 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.729 0.412 . . . . 0.0 111.801 -179.913 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.467 ' H ' ' C ' ' A' ' 174' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.205 0 CA-C-O 120.858 0.361 . . . . 0.0 110.668 179.849 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.583 HG13 ' N ' ' A' ' 170' ' ' ILE . 24.8 pt . . . . . 0 CA--C 1.515 -0.367 0 CA-C-O 121.752 0.787 . . . . 0.0 110.718 . . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.583 ' N ' HG13 ' A' ' 169' ' ' ILE . 2.1 pt -70.28 -41.73 78.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 113.974 -1.466 . . . . 0.0 112.157 -177.777 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 1.0 OUTLIER -61.84 -57.73 10.68 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.096 . . . . . . . . 3 3 . 1 . 065 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -74.8 -1.9 24.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.014 178.44 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -74.1 -73.51 0.22 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.12 0.486 . . . . 0.0 110.362 179.976 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.536 ' C ' ' CG ' ' A' ' 175' ' ' TYR . . . -98.98 -0.68 57.3 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.02 179.276 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.536 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER 57.68 -53.74 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.672 0.789 . . . . 0.0 112.639 179.451 . . . . . . . . 3 3 . 1 . 065 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 174' ' ' GLY . 2.4 m-85 . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 120.649 0.261 . . . . 0.0 111.088 179.912 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.436 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 4.5 tt . . . . . 0 N--CA 1.458 -0.056 0 CA-C-O 121.047 0.451 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.441 ' HA ' ' HB3' ' A' ' 173' ' ' ALA . 2.1 mp -68.73 -31.07 49.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.378 -179.38 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 8.9 tp -64.89 -63.65 1.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.116 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.28 4.07 9.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.033 178.534 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.441 ' HB3' ' HA ' ' A' ' 170' ' ' ILE . . . -71.53 -64.39 0.93 Allowed 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.678 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -108.83 -14.95 14.0 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.25 178.26 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.461 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 46.7 t80 70.63 -14.96 0.39 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.734 0.414 . . . . 0.0 111.744 -179.904 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.456 ' H ' ' C ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.689 0.281 . . . . 0.0 110.914 179.859 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.903 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.4 OUTLIER . . . . . 0 CA--C 1.537 0.453 0 CA-C-O 118.973 -0.537 . . . . 0.0 109.717 . . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.482 ' H ' ' CG2' ' A' ' 169' ' ' ILE . 15.1 mt 33.24 -62.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.435 0.694 . . . . 0.0 112.734 178.956 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.903 ' N ' ' O ' ' A' ' 169' ' ' ILE . 0.1 OUTLIER -65.77 -52.31 52.02 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.803 -179.713 . . . . . . . . 3 3 . 1 . 067 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -72.08 -9.77 58.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.052 179.979 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -77.8 -53.92 6.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.784 0.326 . . . . 0.0 110.964 -179.817 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -114.28 -15.4 8.35 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.577 179.864 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.46 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 10.6 t80 70.89 -44.83 0.6 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.988 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.429 ' CG ' ' O ' ' A' ' 176' ' ' PHE . 79.5 t80 . . . . . 0 CA--C 1.532 0.271 0 CA-C-O 120.621 0.248 . . . . 0.0 111.458 -179.619 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 4.7 tt . . . . . 0 CA--C 1.524 -0.041 0 CA-C-O 121.162 0.506 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.425 ' HA ' ' HB1' ' A' ' 173' ' ' ALA . 3.8 mt -69.79 -30.79 45.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.124 -179.812 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.47 -62.44 1.46 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.886 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.61 3.32 9.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.781 178.499 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.425 ' HB1' ' HA ' ' A' ' 170' ' ' ILE . . . -71.59 -48.11 50.36 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.417 0.627 . . . . 0.0 109.368 179.477 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 175' ' ' TYR . . . -124.12 -4.49 7.77 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.75 178.875 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.419 ' HB2' ' O ' ' A' ' 174' ' ' GLY . 34.9 m-85 67.69 -50.54 0.51 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.743 0.417 . . . . 0.0 111.965 179.664 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 C--N 1.331 -0.196 0 CA-C-O 120.767 0.318 . . . . 0.0 110.998 179.596 . . . . . . . . 0 0 . 1 . 069 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.436 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 5.8 tp . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 121.083 0.468 . . . . 0.0 110.824 . . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.436 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 4.8 mt -73.37 -43.98 55.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.948 179.93 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.46 -55.45 15.63 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.358 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -75.27 5.89 5.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.304 178.869 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -71.49 -52.71 16.9 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.739 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -104.96 -18.6 12.03 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 177.968 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 5.1 t80 76.53 -11.86 1.11 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.8 0.44 . . . . 0.0 111.905 179.651 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 79.5 t80 . . . . . 0 C--N 1.331 -0.234 0 CA-C-O 120.806 0.336 . . . . 0.0 110.717 179.371 . . . . . . . . 0 0 . 1 . 070 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.444 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 5.7 pt . . . . . 0 CA--C 1.521 -0.155 0 CA-C-O 120.927 0.394 . . . . 0.0 111.369 . . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 6.7 mm -73.8 -41.09 54.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.0 -179.856 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 78.5 mt -66.71 -55.66 14.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.919 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -74.1 0.7 13.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.176 178.637 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -70.92 -43.08 69.0 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.366 0.603 . . . . 0.0 109.386 -179.837 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -120.39 -23.98 2.76 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.385 178.586 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 75.37 -41.29 0.45 Allowed 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 122.692 0.397 . . . . 0.0 111.667 179.893 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 . . . . . 0 C--N 1.325 -0.488 0 CA-C-O 120.775 0.321 . . . . 0.0 110.963 179.813 . . . . . . . . 0 0 . 1 . 071 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 1.4 tt . . . . . 0 C--O 1.227 -0.1 0 CA-C-O 121.222 0.534 . . . . 0.0 112.181 . . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.488 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 0.8 OUTLIER -75.81 -53.8 15.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -176.996 . . . . . . . . 3 3 . 1 . 071 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.568 ' HG ' ' N ' ' A' ' 172' ' ' ASP . 2.6 pt? -66.91 -49.47 65.44 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.362 0.601 . . . . 0.0 110.056 -179.789 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.568 ' N ' ' HG ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -74.23 1.96 10.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.311 179.02 . . . . . . . . 3 3 . 1 . 071 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.69 -54.67 8.37 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.307 0.575 . . . . 0.0 109.596 179.5 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -112.49 -18.9 7.3 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.515 178.617 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 70.01 -56.46 0.58 Allowed 'General case' 0 C--O 1.231 0.115 0 C-N-CA 122.502 0.321 . . . . 0.0 111.377 179.824 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.409 ' O ' ' CG ' ' A' ' 176' ' ' PHE . 89.6 t80 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.882 179.824 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.457 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 3.3 tt . . . . . 0 CA--C 1.529 0.136 0 CA-C-O 120.929 0.395 . . . . 0.0 111.817 . . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.493 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 10.3 mt -71.03 -60.22 2.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.625 -178.359 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.556 ' HG ' ' N ' ' A' ' 172' ' ' ASP . 2.6 pt? -63.91 -47.95 78.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.375 0.607 . . . . 0.0 110.007 -179.579 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.556 ' N ' ' HG ' ' A' ' 171' ' ' LEU . 30.9 m-20 -72.48 -0.92 13.93 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.219 179.091 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.493 ' HB2' ' O ' ' A' ' 170' ' ' ILE . . . -73.16 -66.07 0.73 Allowed 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.591 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -119.74 -9.56 8.26 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.767 178.68 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 12.0 t80 68.82 -61.69 0.41 Allowed 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.971 0.415 . . . . 0.0 110.994 -179.885 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 14.4 t80 . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.912 179.735 . . . . . . . . 0 0 . 1 . 073 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.401 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 5.4 tt . . . . . 0 CA--C 1.522 -0.1 0 CA-C-O 121.264 0.554 . . . . 0.0 110.801 . . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 13.3 mm -71.66 -45.13 68.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.447 -179.299 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 0.9 OUTLIER -65.68 -53.15 45.13 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.035 . . . . . . . . 3 3 . 1 . 073 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -73.82 0.53 12.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.053 178.635 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.96 -55.61 6.32 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.584 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -123.28 -27.45 1.49 Allowed Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 178.539 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.3 OUTLIER 78.07 -14.66 0.83 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.109 0.564 . . . . 0.0 112.125 179.506 . . . . . . . . 3 3 . 1 . 073 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.425 ' O ' ' CG ' ' A' ' 176' ' ' PHE . 14.7 t80 . . . . . 0 C--N 1.33 -0.274 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.562 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.528 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 2.4 pt . . . . . 0 CA--C 1.519 -0.212 0 CA-C-O 120.769 0.319 . . . . 0.0 111.619 . . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 3.4 mp -77.4 -49.19 22.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.644 179.425 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 37.5 mt -68.29 -54.93 14.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.342 179.588 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -71.96 -0.34 11.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.502 179.437 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -70.47 -55.91 7.85 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.842 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -126.23 -22.99 1.63 Allowed Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.549 178.54 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 76.72 -30.34 0.18 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 122.637 0.375 . . . . 0.0 111.579 -179.876 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.416 ' H ' ' C ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.204 0 CA-C-O 120.686 0.279 . . . . 0.0 110.998 179.732 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.55 HG23 ' N ' ' A' ' 170' ' ' ILE . 13.4 tt . . . . . 0 CA--C 1.52 -0.177 0 CA-C-O 121.561 0.696 . . . . 0.0 111.841 . . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.55 ' N ' HG23 ' A' ' 169' ' ' ILE . 0.5 OUTLIER -69.2 -31.75 51.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.96 -177.272 . . . . . . . . 3 3 . 1 . 075 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 2.0 mt -66.55 -56.92 8.58 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.201 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -74.48 -4.18 35.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.58 178.158 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.547 ' HB1' ' HA ' ' A' ' 170' ' ' ILE . . . -73.47 -68.22 0.52 Allowed 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 121.226 0.536 . . . . 0.0 110.148 179.911 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -121.73 -2.03 10.6 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.159 179.292 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.501 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 54.1 t80 69.17 -51.8 0.6 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.473 0.309 . . . . 0.0 111.653 -179.994 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.21 0 CA-C-O 120.754 0.311 . . . . 0.0 111.174 -179.77 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.463 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 1.3 tt . . . . . 0 N--CA 1.465 0.293 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 . . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.428 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 3.9 mp -79.61 -59.28 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.916 0.389 . . . . 0.0 111.12 179.903 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 3.3 mm? -67.78 -47.4 69.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.247 0.546 . . . . 0.0 110.013 179.571 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.9 0.13 11.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.487 179.58 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -73.6 -63.02 1.29 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.142 0.496 . . . . 0.0 109.792 179.677 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -116.1 -12.34 9.22 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.749 178.901 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER 72.63 -56.12 0.66 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.35 0.26 . . . . 0.0 111.68 179.715 . . . . . . . . 3 3 . 1 . 076 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 30.5 p90 . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 120.581 0.229 . . . . 0.0 111.51 -179.636 . . . . . . . . 0 0 . 1 . 077 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.433 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 7.0 pt . . . . . 0 CA--C 1.523 -0.095 0 CA-C-O 120.925 0.393 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 2.9 mp -70.01 -43.53 79.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.297 -179.103 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.21 -52.54 47.0 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.801 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.4 0.11 18.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.164 178.685 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.28 -60.26 2.32 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.043 0.449 . . . . 0.0 109.812 179.94 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -107.22 -20.37 8.74 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 178.535 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 27.3 t80 75.14 -11.08 1.12 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.443 0.297 . . . . 0.0 111.572 179.988 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.8 t80 . . . . . 0 CA--C 1.53 0.185 0 CA-C-O 120.791 0.329 . . . . 0.0 110.629 179.623 . . . . . . . . 0 0 . 1 . 078 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.446 ' O ' ' N ' ' A' ' 173' ' ' ALA . 7.3 tt . . . . . 0 C--O 1.227 -0.115 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 . . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.411 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.4 mp -70.64 -43.34 77.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.029 -178.803 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.0 -2.97 11.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.983 0.421 . . . . 0.0 111.789 179.915 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -145.88 17.28 1.43 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.354 179.978 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 169' ' ' ILE . . . -80.81 -39.99 25.74 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.141 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.615 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -134.68 3.48 4.24 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 114.898 -1.047 . . . . 0.0 111.968 179.046 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.508 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER 54.97 -61.42 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 123.819 0.847 . . . . 0.0 112.147 179.799 . . . . . . . . 3 3 . 1 . 078 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.615 ' N ' ' O ' ' A' ' 174' ' ' GLY . 11.6 m-85 . . . . . 0 C--N 1.318 -0.771 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.056 -179.953 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 170' ' ' ILE . 1.3 tt . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 120.816 0.341 . . . . 0.0 111.757 . . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.465 ' O ' ' HB1' ' A' ' 173' ' ' ALA . 4.2 mp -73.63 -34.98 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.136 -179.582 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 43.6 mt -65.59 -59.46 3.93 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.941 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.54 4.09 8.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.868 178.472 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 170' ' ' ILE . . . -71.31 -53.94 12.52 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.746 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -98.53 -18.39 25.93 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 177.887 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 13.5 t80 75.47 -13.38 0.87 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.81 0.444 . . . . 0.0 111.723 179.787 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.22 0 CA-C-O 120.656 0.265 . . . . 0.0 110.644 179.527 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.461 HG23 ' N ' ' A' ' 170' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 120.601 0.238 . . . . 0.0 111.179 . . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.461 ' N ' HG23 ' A' ' 169' ' ' ILE . 2.9 mp -78.24 -56.13 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.019 0.438 . . . . 0.0 110.507 179.44 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.83 -45.32 75.01 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.964 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -73.82 -0.64 16.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.325 179.214 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 170' ' ' ILE . . . -73.26 -45.63 54.66 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.29 0.567 . . . . 0.0 109.84 179.731 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -126.62 -28.25 0.99 Allowed Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.261 179.054 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 35.7 t80 78.75 -12.66 1.06 Allowed 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 122.97 0.508 . . . . 0.0 112.134 179.525 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.426 ' CD2' ' O ' ' A' ' 176' ' ' PHE . 14.8 p90 . . . . . 0 C--N 1.329 -0.301 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.65 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 23.6 mm . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 121.081 0.467 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 081 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.413 ' HA ' ' HB1' ' A' ' 173' ' ' ALA . 3.8 mp -73.26 -29.77 29.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.592 -179.202 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 22.5 tp -64.81 -64.78 0.78 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 179.339 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -77.68 8.43 4.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.181 178.627 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.413 ' HB1' ' HA ' ' A' ' 170' ' ' ILE . . . -71.26 -51.23 25.68 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.403 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -121.69 -28.32 1.6 Allowed Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 178.046 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 77.8 -24.62 0.21 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.404 0.682 . . . . 0.0 112.192 179.202 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 . . . . . 0 C--N 1.331 -0.237 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.954 . . . . . . . . 0 0 . 1 . 082 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.444 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 2.3 pt . . . . . 0 C--O 1.227 -0.116 0 CA-C-O 120.752 0.31 . . . . 0.0 111.621 . . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 3.8 mp -76.6 -54.29 13.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.293 -179.77 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 25.7 mt -67.37 -53.04 32.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.031 0.444 . . . . 0.0 110.488 179.974 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -74.46 5.27 4.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.727 179.764 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -69.75 -56.86 6.02 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.068 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -132.85 30.9 3.02 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 177.394 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.431 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 18.4 t80 68.5 -69.22 0.15 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.366 0.603 . . . . 0.0 109.432 -178.371 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' A' ' 174' ' ' GLY . 15.6 t80 . . . . . 0 C--N 1.313 -1.013 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.961 178.963 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.909 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.223 -0.306 0 CA-C-O 118.943 -0.551 . . . . 0.0 109.526 . . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.487 ' H ' ' CG2' ' A' ' 169' ' ' ILE . 4.2 mt 21.03 -61.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 178.481 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.909 ' N ' ' O ' ' A' ' 169' ' ' ILE . 0.2 OUTLIER -64.72 -52.38 57.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.57 -179.248 . . . . . . . . 3 3 . 1 . 083 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -73.69 -11.2 60.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.725 0.298 . . . . 0.0 111.094 179.855 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -77.01 -56.12 4.86 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.914 0.388 . . . . 0.0 110.638 179.98 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -99.32 -24.8 9.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.855 179.371 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 27.6 t80 77.3 -40.76 0.35 Allowed 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 122.385 0.274 . . . . 0.0 111.681 179.976 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 . . . . . 0 C--N 1.327 -0.387 0 CA-C-O 120.688 0.28 . . . . 0.0 111.277 -179.979 . . . . . . . . 0 0 . 1 . 084 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 12.6 tt . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 121.158 0.504 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.438 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.6 mp -70.35 -45.25 75.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.046 -179.684 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.6 mp -64.56 -52.22 58.76 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.235 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -76.21 1.54 15.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.153 178.529 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.41 -61.94 1.62 Allowed 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.142 0.496 . . . . 0.0 109.672 179.818 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -102.48 -21.39 10.64 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 178.332 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 1.6 t80 75.13 -38.86 0.39 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.569 0.347 . . . . 0.0 111.464 179.896 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.331 -0.221 0 CA-C-O 120.809 0.337 . . . . 0.0 110.74 179.546 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.883 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.5 OUTLIER . . . . . 0 CA--C 1.536 0.413 0 CA-C-O 118.911 -0.566 . . . . 0.0 109.703 . . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.474 ' H ' ' CG2' ' A' ' 169' ' ' ILE . 2.2 mp 21.98 -63.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 178.595 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.883 ' N ' ' O ' ' A' ' 169' ' ' ILE . 4.0 pp -66.37 -50.32 63.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.181 -179.635 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.402 ' N ' ' CD1' ' A' ' 171' ' ' LEU . 0.4 OUTLIER -69.7 -11.68 61.04 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.607 179.611 . . . . . . . . 3 3 . 1 . 085 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -78.22 -62.0 1.82 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.812 179.87 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -113.15 -24.69 4.72 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.348 179.748 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 1.0 OUTLIER 76.66 -11.82 1.13 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.561 0.22 . . . . 0.0 111.455 -179.792 . . . . . . . . 3 3 . 1 . 085 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 27.8 t80 . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 120.684 0.278 . . . . 0.0 110.702 179.377 . . . . . . . . 0 0 . 1 . 086 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.496 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 5.2 tt . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 . . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.457 HD11 ' CG2' ' A' ' 169' ' ' ILE . 0.4 OUTLIER -67.03 -47.86 80.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.992 -179.899 . . . . . . . . 3 3 . 1 . 086 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.85 -50.92 64.73 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.419 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.82 -5.86 43.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.547 178.445 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -73.71 -73.71 0.21 Allowed 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.571 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -113.95 -19.86 6.25 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.44 178.585 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 35.0 t80 73.03 -44.86 0.61 Allowed 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 122.45 0.3 . . . . 0.0 111.59 179.87 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 38.3 p90 . . . . . 0 C--N 1.331 -0.199 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.349 -179.729 . . . . . . . . 0 0 . 1 . 087 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.562 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 2.9 tp . . . . . 0 C--O 1.226 -0.171 0 CA-C-O 120.859 0.361 . . . . 0.0 111.408 . . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.424 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.8 mp -71.33 -47.93 56.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.016 -179.904 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.48 -50.67 64.48 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.13 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.88 -4.66 39.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.998 178.869 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.562 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -73.37 -69.48 0.42 Allowed 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.368 0.604 . . . . 0.0 109.552 179.632 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -122.36 -20.71 2.91 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.213 178.674 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.418 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 11.8 t80 76.35 -31.68 0.19 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.313 0.645 . . . . 0.0 112.349 179.549 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 121.332 0.587 . . . . 0.0 109.694 179.525 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 7.5 tt . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 121.137 0.494 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.426 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.3 mp -76.13 -51.85 19.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.92 -179.282 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -53.13 52.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.981 0.42 . . . . 0.0 110.002 -179.756 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -74.84 4.73 5.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.384 179.053 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 170' ' ' ILE . . . -70.44 -60.57 2.19 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.694 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -109.36 -17.18 10.2 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 178.085 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 29.7 t80 72.33 -12.39 0.72 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.565 0.346 . . . . 0.0 111.316 -179.777 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.419 ' H ' ' C ' ' A' ' 174' ' ' GLY . 76.4 t80 . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 120.937 0.399 . . . . 0.0 110.193 179.506 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.547 HG23 ' N ' ' A' ' 170' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.521 -0.16 0 CA-C-O 121.219 0.533 . . . . 0.0 111.248 . . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.547 ' N ' HG23 ' A' ' 169' ' ' ILE . 0.6 OUTLIER -74.54 -43.67 48.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.361 -177.95 . . . . . . . . 3 3 . 1 . 089 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.35 -56.55 12.01 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.227 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.7 4.41 7.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.4 179.023 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -71.16 -75.34 0.13 Allowed 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.796 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -95.12 -13.03 54.11 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 177.924 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 69.76 -59.59 0.5 Allowed 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 120.862 0.363 . . . . 0.0 110.955 179.875 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 19.0 p90 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.194 179.708 . . . . . . . . 0 0 . 1 . 090 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.477 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.703 0.287 . . . . 0.0 111.313 . . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 6.0 mm -80.84 -44.09 21.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.61 -179.869 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.38 -57.85 8.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.159 0.504 . . . . 0.0 109.792 179.95 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.9 2.81 7.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.066 178.74 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.02 -54.79 8.8 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.432 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -126.39 -10.64 4.04 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.928 178.692 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.415 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 2.6 t80 68.55 -52.67 0.56 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.62 0.368 . . . . 0.0 111.708 179.59 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 50.2 p90 . . . . . 0 C--N 1.329 -0.292 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.403 . . . . . . . . 0 0 . 1 . 091 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.447 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 0.4 OUTLIER . . . . . 0 CA--C 1.528 0.117 0 CA-C-O 120.788 0.328 . . . . 0.0 111.227 . . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.447 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.6 mp -72.65 -39.56 60.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.367 -179.633 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.0 tt -68.82 -2.51 9.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.684 179.922 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -148.14 15.96 1.05 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.064 179.902 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 169' ' ' ILE . . . -81.46 -46.42 14.58 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.015 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.588 ' O ' ' CG ' ' A' ' 175' ' ' TYR . . . -141.61 0.52 1.69 Allowed Glycine 0 CA--C 1.522 0.531 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.818 179.229 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.588 ' CG ' ' O ' ' A' ' 174' ' ' GLY . 45.2 p90 56.61 -52.72 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.904 0.881 . . . . 0.0 113.02 179.926 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.513 ' N ' ' O ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.511 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.312 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.52 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 1.2 tp . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.815 0.34 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.455 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.5 mp -72.45 -42.71 64.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.312 -179.684 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.7 tt -65.02 -56.21 14.43 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.443 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.1 1.0 14.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.118 178.711 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.95 -57.66 3.89 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.201 0.524 . . . . 0.0 109.833 179.723 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -119.98 -3.45 12.05 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.878 178.983 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.44 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 92.6 t80 71.03 -43.51 0.56 Allowed 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.587 0.355 . . . . 0.0 111.719 -179.964 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.168 0 CA-C-O 120.791 0.329 . . . . 0.0 111.01 179.937 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.466 HD13 HG21 ' A' ' 169' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.46 0.054 0 CA-C-O 121.113 0.482 . . . . 0.0 111.134 . . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 3.4 mp -69.07 -38.71 78.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.618 -179.004 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.6 mp -65.17 -60.09 3.38 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.258 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -74.36 3.31 7.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.263 178.55 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.445 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -71.15 -59.31 2.84 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.973 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -104.52 -20.4 10.22 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 178.309 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 36.7 t80 72.91 -11.64 0.85 Allowed 'General case' 0 C--O 1.232 0.157 0 C-N-CA 122.704 0.402 . . . . 0.0 111.845 179.83 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 23.3 p90 . . . . . 0 C--N 1.33 -0.264 0 CA-C-O 120.821 0.343 . . . . 0.0 110.495 179.348 . . . . . . . . 0 0 . 1 . 094 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.522 -0.119 0 CA-C-O 121.283 0.563 . . . . 0.0 110.853 . . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.498 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 0.7 OUTLIER -79.36 -45.34 23.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 114.92 -1.036 . . . . 0.0 112.074 -178.798 . . . . . . . . 3 3 . 1 . 094 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 13.2 mt -66.93 -55.69 13.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.089 0.471 . . . . 0.0 109.891 179.532 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.05 5.84 4.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.276 179.032 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -73.32 -47.75 40.04 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.26 0.552 . . . . 0.0 109.712 179.639 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.51 ' C ' ' CG ' ' A' ' 175' ' ' TYR . . . -120.75 -1.59 11.8 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.841 178.841 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.51 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER 57.25 -50.07 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.963 0.905 . . . . 0.0 113.088 179.732 . . . . . . . . 3 3 . 1 . 094 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.49 ' N ' ' O ' ' A' ' 174' ' ' GLY . 26.6 p90 . . . . . 0 C--N 1.329 -0.284 0 O-C-N 122.217 -0.302 . . . . 0.0 111.152 -179.935 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.492 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 . . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.43 ' N ' HG21 ' A' ' 169' ' ' ILE . 4.0 mp -71.64 -39.69 69.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.673 -179.022 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.418 ' N ' ' CD2' ' A' ' 171' ' ' LEU . 2.0 mm? -64.54 -60.52 3.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.357 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -75.14 4.41 6.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.501 178.973 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -71.82 -69.66 0.38 Allowed 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.59 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -108.25 -16.41 12.31 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.091 178.211 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 53.1 t80 74.51 -15.78 0.6 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.868 0.467 . . . . 0.0 111.898 179.953 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 . . . . . 0 C--N 1.331 -0.215 0 CA-C-O 120.781 0.324 . . . . 0.0 111.02 -179.964 . . . . . . . . 0 0 . 1 . 096 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.529 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 5.7 tp . . . . . 0 C--O 1.226 -0.16 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 . . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.503 ' H ' ' CG2' ' A' ' 169' ' ' ILE . 1.9 mp -73.35 -39.98 56.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.812 -179.015 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 4.7 tp -64.13 -60.89 2.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.274 0.559 . . . . 0.0 109.762 179.754 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -74.12 -0.0 15.24 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.128 179.014 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -70.11 -71.0 0.26 Allowed 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.203 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -125.87 -8.48 5.16 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.119 177.815 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 12.9 t80 70.59 -55.66 0.62 Allowed 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.605 0.362 . . . . 0.0 111.851 179.558 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.531 0.227 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.187 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.57 HG21 ' N ' ' A' ' 170' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 . . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.57 ' N ' HG21 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -69.92 -39.41 77.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.65 -176.899 . . . . . . . . 3 3 . 1 . 097 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.463 ' H ' HG12 ' A' ' 170' ' ' ILE . 46.5 mt -66.08 -55.79 14.76 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.798 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.34 0.4 19.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.307 178.5 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.22 -75.35 0.14 Allowed 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.777 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -86.5 -17.5 60.25 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 178.334 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 12.0 t80 68.99 -57.21 0.52 Allowed 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 122.607 0.363 . . . . 0.0 111.112 179.872 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.435 ' CD1' ' C ' ' A' ' 176' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.12 179.803 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.572 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 1.1 tp . . . . . 0 N--CA 1.462 0.173 0 CA-C-O 120.89 0.376 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.572 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 0.8 OUTLIER -81.27 -32.29 12.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.757 -179.622 . . . . . . . . 3 3 . 1 . 098 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.75 -62.46 1.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.939 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -76.4 7.84 4.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.135 178.613 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -71.08 -60.1 2.42 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.679 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.441 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -102.24 -17.09 21.19 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 177.884 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.415 ' HB2' ' O ' ' A' ' 174' ' ' GLY . 2.0 m-85 69.7 -12.27 0.47 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.827 0.451 . . . . 0.0 111.846 179.913 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.441 ' H ' ' C ' ' A' ' 174' ' ' GLY . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.237 0 CA-C-O 120.892 0.377 . . . . 0.0 110.186 179.196 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.521 -0.145 0 CA-C-O 121.257 0.551 . . . . 0.0 111.326 . . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.498 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 0.7 OUTLIER -73.95 -46.67 45.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.422 -178.076 . . . . . . . . 3 3 . 1 . 099 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 41.0 tp -66.91 -49.26 66.13 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.726 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -73.25 -5.33 38.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.6 178.357 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -73.2 -70.45 0.36 Allowed 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.607 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -117.24 -15.77 6.42 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.78 178.902 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . 0.456 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 23.4 t80 77.52 -37.16 0.24 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 122.501 0.32 . . . . 0.0 111.638 -179.923 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 11.3 p90 . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 120.849 0.357 . . . . 0.0 110.978 -179.975 . . . . . . . . 0 0 . 1 . 100 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.493 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--O 1.227 -0.128 0 CA-C-O 121.207 0.527 . . . . 0.0 110.971 . . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.419 HD11 ' CG2' ' A' ' 169' ' ' ILE . 20.4 mm -68.54 -48.09 73.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.586 -178.898 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.6 mt -65.25 -48.2 74.08 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.224 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -76.11 -5.16 45.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.844 178.609 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.493 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -73.97 -70.19 0.4 Allowed 'General case' 0 CA--C 1.522 -0.134 0 CA-C-O 121.205 0.526 . . . . 0.0 109.788 179.849 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -121.06 -20.64 3.33 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.027 178.637 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 9.9 t80 75.6 -12.44 0.98 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.053 0.541 . . . . 0.0 111.971 179.659 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 52.1 t80 . . . . . 0 C--N 1.331 -0.233 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.794 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.807 0.337 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.403 ' CG ' ' O ' ' A' ' 156' ' ' LEU . 2.0 pp -165.35 98.79 0.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.937 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.09 -31.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.599 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.5 t -73.41 60.98 0.65 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.062 0.458 . . . . 0.0 110.702 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.43 ' O ' ' CB ' ' A' ' 160' ' ' VAL . 0.3 OUTLIER 73.48 -59.47 0.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.829 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' A' ' 164' ' ' PHE . 0.4 OUTLIER 87.73 -44.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.357 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.409 ' N ' HG11 ' A' ' 160' ' ' VAL . 0.3 OUTLIER -68.66 -29.06 67.45 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.074 0.464 . . . . 0.0 110.663 179.84 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -67.59 -61.12 2.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.665 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 19.4 mt -66.58 -4.63 9.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.106 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER -76.71 -70.91 0.43 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.198 -179.237 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.52 -56.81 11.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.907 0.384 . . . . 0.0 110.863 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.98 147.89 11.86 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.889 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.52 116.03 3.54 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.567 2.178 . . . . 0.0 112.324 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.422 ' CA ' ' HB2' ' A' ' 172' ' ' ASP . 89.5 Cg_endo -80.98 39.9 0.92 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.864 2.376 . . . . 0.0 112.963 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.413 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 2.6 mp -79.13 -71.24 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.947 0.403 . . . . 0.0 111.816 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.484 ' O ' ' HG3' ' A' ' 178' ' ' PRO . 4.5 mp -75.46 -55.17 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.709 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.544 ' HG ' ' N ' ' A' ' 172' ' ' ASP . 2.6 pt? -60.04 -51.47 69.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.028 0.442 . . . . 0.0 110.449 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.544 ' N ' ' HG ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -76.23 5.5 6.85 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.288 178.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 170' ' ' ILE . . . -71.75 -71.1 0.29 Allowed 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -108.24 -3.76 33.29 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 1.5 t80 69.74 -61.9 0.43 Allowed 'General case' 0 C--O 1.231 0.113 0 CA-C-O 121.028 0.442 . . . . 0.0 110.348 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -101.95 -26.88 13.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.333 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.533 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 22.0 mt -60.85 -42.69 88.55 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.589 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 76.5 Cg_exo -51.78 -29.86 35.73 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.543 2.162 . . . . 0.0 112.784 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.12 -11.42 60.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 0.0 111.278 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.83 57.76 1.04 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.279 0.561 . . . . 0.0 109.523 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 121.213 0.53 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.3 62.38 0.95 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.386 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 20.3 tp60 -168.97 46.84 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.147 0.499 . . . . 0.0 110.807 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.66 56.3 0.14 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.929 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.431 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.9 OUTLIER 78.88 -51.54 0.45 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.153 -179.475 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 68.7 t 71.14 -54.06 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 120.873 0.368 . . . . 0.0 111.112 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.43 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 5.3 m-85 -73.06 4.92 3.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.223 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.43 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 81.2 m-85 -160.93 11.88 0.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.01 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.8 tt -66.6 -26.11 66.94 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 4.3 t80 69.76 17.56 7.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.941 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.34 -55.3 22.15 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.283 0.563 . . . . 0.0 109.78 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.681 ' N ' ' HD3' ' A' ' 167' ' ' PRO . 0.3 OUTLIER -158.1 41.81 0.12 Allowed Pre-proline 0 N--CA 1.447 -0.601 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.767 -179.29 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.681 ' HD3' ' N ' ' A' ' 166' ' ' LEU . 15.1 Cg_exo -64.49 -52.87 1.23 Allowed 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 121.76 1.64 . . . . 0.0 113.003 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.489 ' CD ' ' HD2' ' A' ' 167' ' ' PRO . 38.0 Cg_endo -92.22 72.24 0.65 Allowed 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.636 2.224 . . . . 0.0 112.639 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.422 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 3.5 tt -73.91 -41.0 53.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.123 0.487 . . . . 0.0 110.315 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.422 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.0 mp -74.1 -45.7 47.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.788 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.41 -53.12 53.38 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -74.77 1.05 13.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.921 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 170' ' ' ILE . . . -72.82 -53.44 11.47 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.143 0.497 . . . . 0.0 109.69 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -105.63 -18.48 11.67 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.294 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.427 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 13.0 t80 76.02 -25.73 0.2 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.882 0.473 . . . . 0.0 112.04 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -97.69 14.41 26.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.648 0.261 . . . . 0.0 111.209 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.491 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 11.4 mt -81.35 -46.94 1.1 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.248 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 71.6 Cg_exo -48.75 90.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.496 2.131 . . . . 0.0 112.706 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.7 -67.51 0.99 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.447 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -87.81 22.36 2.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.5 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.2 t80 . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.83 0.348 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.402 ' CB ' ' CG2' ' A' ' 160' ' ' VAL . 4.1 pp -73.26 176.12 6.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -170.53 -55.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.408 ' HB3' HD11 ' A' ' 163' ' ' LEU . 3.4 t -75.69 59.68 1.2 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.959 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.447 ' O ' HG13 ' A' ' 160' ' ' VAL . 0.3 OUTLIER 72.74 -47.0 0.66 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.655 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.482 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 90.17 -52.52 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 122.873 0.469 . . . . 0.0 111.07 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.495 ' CE1' ' CD2' ' A' ' 162' ' ' PHE . 0.1 OUTLIER -78.53 32.99 0.2 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.812 0.339 . . . . 0.0 111.215 179.338 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.495 ' CD2' ' CE1' ' A' ' 161' ' ' PHE . 2.6 m-85 -169.41 -14.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.509 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.417 HD12 ' CD ' ' A' ' 167' ' ' PRO . 16.1 tp -61.15 -34.79 75.57 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.466 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 1.4 t80 47.07 38.94 7.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.361 178.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.466 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.1 OUTLIER 86.57 -30.79 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.99 -179.501 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.47 136.25 5.39 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.892 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.417 ' CD ' HD12 ' A' ' 163' ' ' LEU . 88.4 Cg_endo -89.89 103.49 0.33 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.328 2.019 . . . . 0.0 113.271 -178.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.441 ' HB2' ' HB2' ' A' ' 171' ' ' LEU . 61.5 Cg_endo -70.69 80.31 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.608 2.205 . . . . 0.0 111.719 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.492 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -71.06 -32.97 49.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.951 0.405 . . . . 0.0 110.715 -179.679 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.43 ' O ' ' HG2' ' A' ' 178' ' ' PRO . 3.7 mp -80.61 -50.84 16.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.245 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.441 ' HB2' ' HB2' ' A' ' 168' ' ' PRO . 7.3 mp -65.26 -50.93 63.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.277 0.561 . . . . 0.0 109.949 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 2.3 t70 -74.0 -4.42 35.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.032 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -71.67 -70.36 0.33 Allowed 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.535 ' H ' ' HG2' ' A' ' 178' ' ' PRO . . . -123.33 -27.73 1.44 Allowed Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.51 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 15.6 t80 79.15 -20.14 0.4 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.443 0.697 . . . . 0.0 112.149 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -94.83 46.52 1.13 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.368 0.604 . . . . 0.0 109.466 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.526 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 2.6 mt 59.13 50.18 2.95 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.156 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.586 ' O ' ' HG3' ' A' ' 181' ' ' HSL . 49.4 Cg_exo -42.68 -27.64 0.89 Allowed 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.286 2.658 . . . . 0.0 113.273 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.8 tp -59.08 -52.24 66.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.357 . . . . 0.0 110.872 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.512 ' HD2' ' N ' ' A' ' 180' ' ' ARG . 0.1 OUTLIER -90.27 24.8 2.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.973 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . 0.586 ' HG3' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.42 ' CG ' HD21 ' A' ' 163' ' ' LEU . 11.6 p90 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.793 0.33 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.6 mp -164.35 -76.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.842 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 80.92 -5.67 1.67 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.803 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.9 p 76.38 -47.18 0.54 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.459 ' C ' ' CG1' ' A' ' 160' ' ' VAL . 7.5 m-20 -75.22 -33.8 61.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.52 0.2 . . . . 0.0 111.341 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.459 ' CG1' ' C ' ' A' ' 159' ' ' ASP . 2.0 m 66.94 -50.6 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 122.722 0.409 . . . . 0.0 112.088 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -63.6 -22.86 67.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.987 0.423 . . . . 0.0 110.132 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -70.38 -61.86 1.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.795 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.436 ' CD1' ' HB3' ' A' ' 167' ' ' PRO . 12.0 tp -65.41 -8.31 18.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.673 178.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.32 -71.74 0.35 Allowed 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.799 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.1 -52.62 47.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.983 0.42 . . . . 0.0 110.866 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -160.79 110.93 1.3 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.544 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.436 ' HB3' ' CD1' ' A' ' 163' ' ' LEU . 60.0 Cg_endo -73.47 111.35 3.27 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.401 2.067 . . . . 0.0 113.155 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -77.22 63.6 7.77 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.672 2.248 . . . . 0.0 111.509 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.517 ' O ' ' N ' ' A' ' 173' ' ' ALA . 7.7 tt -74.71 -39.96 46.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.355 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.487 ' HA ' ' HB2' ' A' ' 173' ' ' ALA . 7.4 mm -69.19 -31.42 49.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.356 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.2 mp -70.71 -4.01 21.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.485 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -152.4 13.84 0.57 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.234 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 169' ' ' ILE . . . -81.86 -38.58 25.21 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -130.57 -14.64 1.9 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 114.755 -1.112 . . . . 0.0 112.344 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 73.63 -45.88 0.62 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.651 0.225 . . . . 0.0 111.245 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.414 ' CZ ' ' HG ' ' A' ' 179' ' ' LEU . 55.4 t80 -93.34 -3.44 53.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.568 0.223 . . . . 0.0 111.141 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.516 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 11.6 mt -58.94 -45.06 99.61 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.102 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 16.6 Cg_exo -68.33 60.83 1.07 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.668 2.245 . . . . 0.0 112.217 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.414 ' HG ' ' CZ ' ' A' ' 176' ' ' PHE . 0.3 OUTLIER -108.65 -56.79 2.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.318 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.3 32.38 0.7 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.275 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . 0.41 ' H ' ' C ' ' A' ' 179' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.836 0.351 . . . . 0.0 111.26 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.3 pp -73.85 116.61 14.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.023 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.87 -39.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.212 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.34 62.8 0.99 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.334 0.588 . . . . 0.0 110.194 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 78.12 -62.18 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.716 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 82.01 -47.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.073 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.411 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 38.2 p90 -75.97 9.34 2.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.519 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -166.23 8.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.345 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 165' ' ' LEU . 0.3 OUTLIER -63.5 -37.28 86.7 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.325 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 59.42 -1.74 0.14 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.004 178.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.479 ' H ' ' C ' ' A' ' 163' ' ' LEU . 0.3 OUTLIER -70.89 -65.22 0.77 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.177 0.513 . . . . 0.0 110.535 179.452 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.7 mt -164.47 56.77 0.51 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.484 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.28 105.82 0.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.537 2.158 . . . . 0.0 112.151 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.24 -1.46 10.62 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.758 2.305 . . . . 0.0 113.154 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.89 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.6 OUTLIER -72.72 -108.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 118.925 -0.56 . . . . 0.0 109.638 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.496 ' H ' ' CG2' ' A' ' 169' ' ' ILE . 2.9 mm 24.19 -64.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.457 0.703 . . . . 0.0 112.714 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.89 ' N ' ' O ' ' A' ' 169' ' ' ILE . 0.1 OUTLIER -67.95 -51.27 49.5 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.916 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 169' ' ' ILE . 1.0 OUTLIER -73.44 -15.7 61.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.546 179.286 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.42 ' CB ' HG13 ' A' ' 169' ' ' ILE . . . -78.14 -59.35 2.82 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.081 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -119.02 -21.85 3.69 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.864 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 70.9 -48.11 0.66 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.787 0.294 . . . . 0.0 111.192 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.0 12.74 20.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.747 0.308 . . . . 0.0 110.962 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.448 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 8.8 mt -70.92 -51.72 10.69 Favored Pre-proline 0 CA--C 1.528 0.116 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.361 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.448 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 73.8 Cg_exo -50.52 86.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.838 2.358 . . . . 0.0 112.317 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -93.81 -60.29 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.619 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -87.63 21.94 2.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.501 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.852 0.358 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.506 ' HA ' ' CG2' ' A' ' 160' ' ' VAL . 0.5 OUTLIER 58.39 30.75 20.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.973 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.429 ' HB3' HD12 ' A' ' 163' ' ' LEU . 0.1 OUTLIER -73.71 -54.24 8.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.881 -179.224 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.417 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 25.7 t -163.46 38.61 0.09 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.083 0.468 . . . . 0.0 111.105 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 161' ' ' PHE . 1.3 m-20 -162.27 -57.01 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.2 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.506 ' CG2' ' HA ' ' A' ' 156' ' ' LEU . 21.5 t 63.46 -63.63 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.43 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.483 ' N ' ' O ' ' A' ' 159' ' ' ASP . 12.7 m-85 -79.02 4.61 13.94 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.854 -1.066 . . . . 0.0 112.187 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -168.94 12.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.507 -0.477 . . . . 0.0 112.096 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.544 ' CD2' ' HD3' ' A' ' 167' ' ' PRO . 4.5 tt -66.56 -38.54 87.32 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.488 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER 49.18 27.35 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.77 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.488 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.2 OUTLIER 90.05 -26.46 0.06 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.638 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.454 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 0.5 OUTLIER -161.56 103.68 1.2 Allowed Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.402 -178.813 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.591 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 55.4 Cg_endo -71.72 -24.17 21.89 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.674 2.249 . . . . 0.0 115.161 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 22.4 Cg_endo -89.14 17.37 1.63 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.675 1.583 . . . . 0.0 113.385 -179.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.448 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.5 OUTLIER -76.52 -40.01 33.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.048 0.452 . . . . 0.0 111.058 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.42 ' O ' ' HB1' ' A' ' 173' ' ' ALA . 2.5 mp -83.75 -70.37 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.617 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.97 -48.4 71.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.89 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.416 ' CB ' ' HB2' ' A' ' 168' ' ' PRO . 0.3 OUTLIER -74.04 1.91 9.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.665 -179.69 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.448 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -73.92 -51.72 15.21 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.195 0.522 . . . . 0.0 109.612 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -118.54 -18.15 4.96 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.785 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 15.6 t80 78.1 -34.11 0.18 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 122.551 0.34 . . . . 0.0 111.881 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -95.5 18.29 13.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.752 0.311 . . . . 0.0 111.151 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.519 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 11.0 mt -81.24 -45.67 1.15 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.927 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.519 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 51.2 Cg_exo -55.05 -156.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.662 2.241 . . . . 0.0 112.505 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 76.7 70.65 0.07 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.13 0.49 . . . . 0.0 110.343 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.25 54.07 0.98 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.719 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.857 0.361 . . . . 0.0 111.324 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.68 -179.85 3.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.771 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -169.65 -79.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.742 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 54.5 p -164.28 27.98 0.07 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.11 0.481 . . . . 0.0 110.665 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -159.64 -53.26 0.06 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.414 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.441 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 83.97 -49.66 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.768 179.473 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.441 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 0.1 OUTLIER -69.22 -31.15 69.54 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.999 0.428 . . . . 0.0 111.11 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.405 ' C ' ' H ' ' A' ' 164' ' ' PHE . 0.5 OUTLIER -69.07 -58.25 4.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.948 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 14.0 mt -65.73 -5.34 8.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.737 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.1 OUTLIER -78.76 -50.06 11.99 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.849 -1.068 . . . . 0.0 111.185 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 8.2 mt -65.47 -51.05 62.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.356 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.435 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 3.7 mt -159.4 126.24 2.56 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.307 -178.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.49 ' HG2' ' HD3' ' A' ' 168' ' ' PRO . 1.9 Cg_endo -47.04 -42.82 25.69 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.837 2.358 . . . . 0.0 113.726 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.49 ' HD3' ' HG2' ' A' ' 167' ' ' PRO . 41.1 Cg_endo -87.25 63.63 4.12 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.225 1.95 . . . . 0.0 113.067 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.463 HD13 HG21 ' A' ' 169' ' ' ILE . 0.3 OUTLIER -78.21 -35.12 19.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.294 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 3.4 mp -70.12 -41.54 79.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.61 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 12.9 mt -67.03 -59.13 3.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.263 0.554 . . . . 0.0 109.709 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.93 10.03 1.64 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.462 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -71.74 -48.41 47.2 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.412 ' H ' ' CG ' ' A' ' 178' ' ' PRO . . . -117.88 -28.1 2.34 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 177.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 6.1 t80 74.56 -31.52 0.22 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.178 0.591 . . . . 0.0 112.003 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.411 ' H ' ' C ' ' A' ' 174' ' ' GLY . 1.1 m-85 -90.14 50.25 1.83 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.436 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 2.5 mt 62.45 67.16 1.22 Allowed Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.859 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.465 ' O ' ' CB ' ' A' ' 179' ' ' LEU . 51.4 Cg_exo -58.98 -140.92 0.0 OUTLIER 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.498 2.798 . . . . 0.0 112.342 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.465 ' CB ' ' O ' ' A' ' 178' ' ' PRO . 0.1 OUTLIER 86.67 76.99 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.019 0.438 . . . . 0.0 110.545 -179.488 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 67.33 49.06 1.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.634 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 12.7 t80 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.618 0.246 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.413 ' O ' ' CG2' ' A' ' 160' ' ' VAL . 0.2 OUTLIER -166.39 -98.09 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.896 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 73.2 75.38 0.14 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.003 0.43 . . . . 0.0 110.465 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 18.2 p 60.86 56.71 2.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.489 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.46 -59.03 0.54 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.306 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 83.74 -51.54 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.904 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.461 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 13.9 t80 -76.4 39.99 0.21 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.932 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.435 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 18.3 m-85 -165.52 -24.11 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 8.3 tp -60.14 -38.94 84.6 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.507 ' C ' ' H ' ' A' ' 166' ' ' LEU . 1.8 t80 43.65 45.97 6.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.529 177.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 164' ' ' PHE . 31.0 mt 74.27 -25.13 0.2 Allowed 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 122.714 0.406 . . . . 0.0 111.438 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.507 ' H ' ' C ' ' A' ' 164' ' ' PHE . 0.1 OUTLIER -162.19 134.01 4.03 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.159 -177.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -44.89 109.54 0.18 Allowed 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.518 2.145 . . . . 0.0 112.316 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.16 79.24 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.573 2.182 . . . . 0.0 112.541 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.46 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 7.3 tp -74.22 -41.94 51.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.635 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.495 ' HA ' ' HB1' ' A' ' 173' ' ' ALA . 4.2 mt -69.38 -35.44 67.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.942 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 0.0 OUTLIER -65.69 -57.94 6.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.673 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.29 -2.79 26.61 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.729 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.495 ' HB1' ' HA ' ' A' ' 170' ' ' ILE . . . -73.57 -69.23 0.44 Allowed 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 121.158 0.504 . . . . 0.0 109.944 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -113.35 -15.14 9.15 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.871 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.504 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 5.8 t80 77.63 -41.7 0.36 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -94.94 -15.55 23.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.656 0.265 . . . . 0.0 111.363 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.502 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 95.6 mt -56.28 -44.31 99.66 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.723 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 76.3 Cg_exo -49.3 -65.53 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.231 1.954 . . . . 0.0 112.466 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.8 mt 60.6 58.78 2.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.136 0.494 . . . . 0.0 110.363 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 21.3 mmt85 65.34 53.15 1.32 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.458 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . 0.475 ' HG3' ' HB3' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.437 ' O ' ' HB2' ' A' ' 156' ' ' LEU . 1.3 m-85 . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.823 0.344 . . . . 0.0 111.773 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.538 ' O ' ' CB ' ' A' ' 157' ' ' GLN . 0.3 OUTLIER 65.29 -74.71 0.05 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.675 179.099 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.538 ' CB ' ' O ' ' A' ' 156' ' ' LEU . 6.3 tt0 96.0 -32.54 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 123.148 0.579 . . . . 0.0 109.733 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 12.6 t -81.04 64.24 5.72 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.177 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.485 ' C ' ' CG1' ' A' ' 160' ' ' VAL . 0.3 OUTLIER 79.64 -46.13 0.34 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.67 -179.119 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.485 ' CG1' ' C ' ' A' ' 159' ' ' ASP . 2.0 m 67.12 -53.1 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 122.928 0.491 . . . . 0.0 111.909 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.421 ' CD1' HG22 ' A' ' 160' ' ' VAL . 6.2 m-85 -60.78 -26.74 67.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.211 0.529 . . . . 0.0 109.736 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.403 ' HB2' ' HB3' ' A' ' 159' ' ' ASP . 0.3 OUTLIER -71.86 -64.56 0.91 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.521 178.634 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.8 tp -67.97 -4.58 13.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.675 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.477 ' CB ' ' O ' ' A' ' 160' ' ' VAL . 1.0 OUTLIER -74.1 -26.53 60.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.892 -179.124 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.05 -52.94 57.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.914 0.388 . . . . 0.0 110.588 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -161.59 88.87 1.54 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.342 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -65.2 109.82 1.42 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.605 2.203 . . . . 0.0 112.992 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.88 64.72 5.95 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.643 2.229 . . . . 0.0 111.878 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.486 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -74.07 -38.72 49.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.508 -179.377 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 3.4 mp -70.1 -41.99 79.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.578 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 27.9 mt -65.72 -56.65 10.93 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.11 2.26 11.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.231 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.486 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.35 -62.0 1.59 Allowed 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.191 0.519 . . . . 0.0 109.884 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -112.49 -11.85 14.34 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.616 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.479 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 24.5 t80 71.78 -29.96 0.2 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.732 0.413 . . . . 0.0 111.751 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.466 ' H ' ' C ' ' A' ' 174' ' ' GLY . 8.3 t80 -95.59 -12.22 26.01 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.681 0.277 . . . . 0.0 111.238 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.503 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 94.2 mt -55.17 -43.98 99.37 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.531 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 99.9 Cg_exo -44.6 93.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.506 2.137 . . . . 0.0 112.741 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.6 mp -82.94 -68.67 0.69 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.614 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.87 20.59 3.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.729 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.814 0.34 . . . . 0.0 111.422 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.5 pp -166.24 117.78 1.02 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.08 89.69 0.11 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.679 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 9.3 t 78.07 -53.66 0.5 Allowed 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.399 0.619 . . . . 0.0 111.636 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -165.49 -33.13 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.277 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.439 ' C ' ' H ' ' A' ' 162' ' ' PHE . 0.5 OUTLIER 80.63 -52.7 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.578 -179.412 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.436 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 2.8 m-30 -76.12 38.39 0.17 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.561 178.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.453 ' C ' ' H ' ' A' ' 164' ' ' PHE . 0.4 OUTLIER -165.44 -48.61 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.142 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 8.8 mt -67.29 -3.07 6.99 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.453 ' H ' ' C ' ' A' ' 162' ' ' PHE . 7.9 t80 -72.85 -34.48 66.8 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.502 -1.227 . . . . 0.0 110.649 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.5 tp -177.06 -52.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.164 0.507 . . . . 0.0 110.643 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -162.11 145.39 9.07 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.431 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.431 ' HD3' ' CD1' ' A' ' 162' ' ' PHE . 42.3 Cg_endo -68.0 110.37 2.16 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.164 1.909 . . . . 0.0 111.874 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.45 55.79 2.08 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.43 2.086 . . . . 0.0 112.913 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.452 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 9.2 tp -77.28 -43.19 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.404 0.621 . . . . 0.0 110.303 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.452 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.1 mp -74.83 -46.7 40.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.157 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.3 mt -65.4 -55.64 16.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.065 0.46 . . . . 0.0 110.223 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.421 ' OD1' ' CZ ' ' A' ' 175' ' ' TYR . 0.9 OUTLIER -76.07 14.46 0.7 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.399 179.209 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.04 -59.37 2.74 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 175' ' ' TYR . . . -113.35 -2.96 24.45 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 177.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.421 ' CZ ' ' OD1' ' A' ' 172' ' ' ASP . 6.2 m-85 68.69 -61.6 0.41 Allowed 'General case' 0 C--N 1.338 0.105 0 C-N-CA 123.029 0.532 . . . . 0.0 110.79 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -106.52 -8.12 17.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.15 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.462 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 8.8 mt -81.5 -46.72 1.08 Allowed Pre-proline 0 CA--C 1.53 0.185 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 10.4 Cg_endo -90.32 22.04 0.81 Allowed 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.07 2.513 . . . . 0.0 112.855 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 29.7 tp -60.12 -53.66 55.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.37 . . . . 0.0 110.625 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -88.24 43.89 1.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.945 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.769 0.319 . . . . 0.0 111.8 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.2 mt 62.59 34.23 15.22 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.984 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 76.89 74.87 0.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.768 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 9.5 t 60.1 49.26 7.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.829 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.421 ' O ' ' CB ' ' A' ' 160' ' ' VAL . 0.3 OUTLIER 73.86 -54.66 0.68 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.015 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.431 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 87.84 -49.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.197 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.431 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 3.9 m-85 -68.69 -31.81 71.18 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.048 0.451 . . . . 0.0 110.523 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.633 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 0.4 OUTLIER -67.37 -58.92 3.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.539 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.416 ' CD2' ' HG3' ' A' ' 168' ' ' PRO . 0.5 OUTLIER -66.78 -1.46 3.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.211 178.867 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.442 ' H ' ' C ' ' A' ' 162' ' ' PHE . 1.1 t80 -74.37 -14.5 60.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.137 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 162' ' ' PHE . 0.3 OUTLIER -62.72 -31.98 73.01 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.345 0.593 . . . . 0.0 109.862 179.135 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.442 ' HA ' ' HD2' ' A' ' 167' ' ' PRO . 0.0 OUTLIER -159.92 97.12 1.53 Allowed Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.768 -178.746 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 166' ' ' LEU . 6.8 Cg_endo -50.14 119.36 4.83 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.586 2.191 . . . . 0.0 112.316 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.426 ' HB2' ' H ' ' A' ' 169' ' ' ILE . 91.5 Cg_endo -79.14 -151.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.806 2.338 . . . . 0.0 112.13 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.46 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 0.7 OUTLIER -161.03 -45.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.095 0.474 . . . . 0.0 110.234 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.46 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.2 mp -75.35 -38.37 40.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.296 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 63.8 mt -67.18 -57.93 5.8 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.2 4.81 6.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.118 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -71.94 -45.8 59.84 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.257 0.551 . . . . 0.0 109.772 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.538 ' C ' ' CG ' ' A' ' 175' ' ' TYR . . . -122.03 -0.02 10.7 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.775 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.538 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER 59.23 -32.91 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 179.416 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.513 ' H ' ' C ' ' A' ' 174' ' ' GLY . 22.5 t80 -93.01 -16.96 24.46 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.098 -0.376 . . . . 0.0 111.102 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.543 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 17.0 mt -57.57 -42.86 97.88 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.362 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 64.7 Cg_exo -51.94 83.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.722 2.281 . . . . 0.0 112.793 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 177' ' ' LEU . 19.9 mt -92.06 -64.45 1.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.939 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.77 41.35 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.908 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.777 0.322 . . . . 0.0 111.25 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.417 ' O ' ' CB ' ' A' ' 157' ' ' GLN . 0.5 OUTLIER -166.21 -163.11 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.056 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.418 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . 0.0 OUTLIER 82.7 60.1 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.165 0.507 . . . . 0.0 110.97 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.423 ' CB ' ' CD1' ' A' ' 163' ' ' LEU . 1.5 m 61.55 45.75 7.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.71 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.474 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.2 OUTLIER 76.5 -53.62 0.59 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.964 179.682 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 45.4 t 70.63 -54.2 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.856 0.36 . . . . 0.0 111.322 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.96 4.3 4.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.625 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -163.5 14.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.973 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.423 ' CD1' ' CB ' ' A' ' 158' ' ' SER . 2.0 tt -67.66 -31.87 72.16 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 13.1 t80 66.95 8.8 6.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.388 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.413 ' CD2' ' CD2' ' A' ' 163' ' ' LEU . 0.3 OUTLIER -66.05 -61.94 1.76 Allowed 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.23 0.538 . . . . 0.0 110.302 179.183 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.589 ' O ' ' CD2' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -161.11 39.85 0.06 OUTLIER Pre-proline 0 N--CA 1.446 -0.658 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.195 -178.525 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 8.5 Cg_endo -50.44 101.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.402 2.068 . . . . 0.0 112.741 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 166' ' ' LEU . 95.6 Cg_endo -74.21 -97.36 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.841 2.36 . . . . 0.0 112.329 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.465 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.1 OUTLIER 82.38 -39.02 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 122.641 0.377 . . . . 0.0 111.274 -179.786 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.407 ' O ' ' HB1' ' A' ' 173' ' ' ALA . 1.8 mp -87.69 -67.85 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.091 0.472 . . . . 0.0 110.997 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -41.1 82.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.165 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.449 ' CB ' ' HB2' ' A' ' 168' ' ' PRO . 44.5 t0 -72.53 -8.62 56.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.716 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -75.48 -64.37 1.08 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.196 0.522 . . . . 0.0 109.997 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -125.31 -17.64 2.65 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.157 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 77.66 -20.39 0.38 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 122.491 0.316 . . . . 0.0 111.675 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -98.23 21.42 10.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.964 0.411 . . . . 0.0 110.559 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.486 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 3.3 mm? -84.67 -48.1 0.65 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.017 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.486 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 27.4 Cg_exo -63.59 69.56 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.758 2.305 . . . . 0.0 112.345 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 177' ' ' LEU . 0.2 OUTLIER -88.86 -67.76 0.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.738 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -87.44 35.72 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.64 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 120.897 0.38 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.1 pp -165.82 124.77 1.63 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.995 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -170.61 -37.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.162 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.5 m -74.0 63.26 0.93 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.078 0.466 . . . . 0.0 110.153 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 76.11 -62.84 0.41 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.414 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 53.9 t 67.85 -46.81 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.151 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -71.13 -6.3 38.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.426 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -165.45 17.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.684 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 15.2 tp -68.15 -7.17 27.64 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -75.57 -23.84 56.58 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.17 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.1 tp -63.6 -51.08 66.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.966 0.413 . . . . 0.0 110.819 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.24 82.69 1.93 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.313 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -62.56 111.2 1.26 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.36 2.04 . . . . 0.0 112.533 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.43 ' O ' ' CB ' ' A' ' 172' ' ' ASP . 95.7 Cg_endo -80.52 40.43 0.98 Allowed 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.977 2.451 . . . . 0.0 112.905 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.471 HG22 HD11 ' A' ' 169' ' ' ILE . 0.2 OUTLIER -77.03 -41.11 31.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.051 0.453 . . . . 0.0 111.336 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.441 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 2.3 mp -73.81 -54.32 15.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.947 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 3.4 pp -62.76 -50.17 72.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.122 0.487 . . . . 0.0 109.815 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.43 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 7.4 t0 -74.77 0.81 14.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.13 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 170' ' ' ILE . . . -72.46 -70.05 0.37 Allowed 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -109.91 -23.07 6.31 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.499 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 7.6 t80 75.25 -22.92 0.25 Allowed 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 122.891 0.477 . . . . 0.0 111.942 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.4 23.01 6.28 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.551 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 4.0 mp -84.66 -47.86 0.66 Allowed Pre-proline 0 N--CA 1.451 -0.382 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.032 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.551 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 94.2 Cg_exo -45.39 -50.97 8.49 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.623 2.215 . . . . 0.0 112.572 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 20.9 mt 61.29 56.85 2.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.6 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 64.01 41.12 6.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.706 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 16.2 t80 . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.797 0.332 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 9.0 mt 64.83 108.38 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.946 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -169.98 83.23 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.113 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.581 ' O ' ' N ' ' A' ' 160' ' ' VAL . 2.4 t 52.0 72.56 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.595 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.41 ' CG ' ' C ' ' A' ' 158' ' ' SER . 0.0 OUTLIER 57.58 -52.3 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.368 0.667 . . . . 0.0 112.611 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' A' ' 158' ' ' SER . 0.5 OUTLIER 82.53 -53.45 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.564 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.448 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 1.6 m-30 -76.0 40.7 0.21 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.841 0.353 . . . . 0.0 110.463 178.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.458 ' CG ' ' HB3' ' A' ' 167' ' ' PRO . 2.9 t80 -168.23 -57.42 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.042 0.448 . . . . 0.0 110.726 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 42.8 tp -66.45 -4.86 9.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.409 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.55 ' CG ' ' O ' ' A' ' 164' ' ' PHE . 55.0 t80 -79.21 43.66 0.54 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.361 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.415 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 1.1 tp 81.22 -40.07 0.14 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -161.05 132.13 3.83 Favored Pre-proline 0 C--N 1.329 -0.314 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.391 -178.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.458 ' HB3' ' CG ' ' A' ' 162' ' ' PHE . 90.3 Cg_endo -88.93 105.55 0.42 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.751 2.301 . . . . 0.0 112.71 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.84 61.63 1.26 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.583 2.189 . . . . 0.0 112.038 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.447 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 8.6 pt -76.54 -35.23 25.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.754 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 7.2 mt -74.79 -49.8 28.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.493 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 0.8 OUTLIER -65.21 -52.68 53.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.62 2.62 9.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.489 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.16 -68.32 0.47 Allowed 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 121.211 0.529 . . . . 0.0 109.666 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -110.89 -12.95 14.78 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.343 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 4.7 t80 77.44 -12.28 1.09 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.702 0.401 . . . . 0.0 111.829 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -98.18 -9.57 25.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.882 0.372 . . . . 0.0 110.679 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.546 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 2.2 mm? -57.24 -41.77 92.71 Favored Pre-proline 0 CA--C 1.53 0.173 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.817 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 50.1 Cg_exo -53.85 -151.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.541 2.161 . . . . 0.0 112.448 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 178' ' ' PRO . 3.8 mm? 72.1 68.79 0.14 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.105 0.478 . . . . 0.0 110.423 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 67.42 53.69 0.73 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.815 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.84 0.352 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.408 ' O ' ' CB ' ' A' ' 157' ' ' GLN . 19.1 mt -74.79 61.79 1.03 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.366 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' A' ' 156' ' ' LEU . 4.1 tt0 78.88 78.62 0.06 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.252 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 51.63 58.96 4.93 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.668 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 71.65 -59.25 0.56 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.528 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.439 HG11 ' N ' ' A' ' 161' ' ' PHE . 0.6 OUTLIER 75.98 -51.43 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.236 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.439 ' N ' HG11 ' A' ' 160' ' ' VAL . 75.3 t80 -73.56 9.85 1.26 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.236 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.426 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 3.4 m-85 -167.84 5.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.404 ' C ' ' H ' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -67.96 -45.38 74.37 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.584 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 56.68 7.81 0.41 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.529 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.404 ' H ' ' C ' ' A' ' 163' ' ' LEU . 0.2 OUTLIER -70.32 -43.28 70.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.894 0.378 . . . . 0.0 110.728 179.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.452 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 0.1 OUTLIER -161.93 49.82 0.27 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.296 -179.333 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 2.9 Cg_exo -37.58 -51.13 1.76 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 123.266 2.644 . . . . 0.0 113.348 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.415 ' HD3' ' CB ' ' A' ' 167' ' ' PRO . 40.7 Cg_endo -90.78 42.62 0.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.657 2.238 . . . . 0.0 113.37 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.534 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.5 OUTLIER -78.56 -49.28 21.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.309 0.575 . . . . 0.0 110.543 179.384 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.512 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 0.8 OUTLIER -77.54 -43.26 30.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.739 -1.118 . . . . 0.0 111.926 -178.839 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 54.5 tp -63.66 -55.47 23.2 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -73.62 -4.59 35.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.62 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -73.88 -68.2 0.53 Allowed 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.323 0.582 . . . . 0.0 109.526 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -130.7 3.51 5.73 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.683 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 17.0 t80 71.12 -44.04 0.58 Allowed 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -97.62 9.86 41.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.682 0.277 . . . . 0.0 111.364 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.649 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 65.5 mt -84.96 -30.32 0.43 Allowed Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.649 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 84.3 Cg_exo -48.89 -12.54 0.22 Allowed 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.531 2.154 . . . . 0.0 113.836 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 33.9 mt -46.52 -36.17 6.47 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.129 0.49 . . . . 0.0 111.045 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.8 mtm180 -90.94 31.68 1.06 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.207 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 155' ' ' PHE . 6.3 m-85 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.833 0.349 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.3 pp -164.72 21.32 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.52 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -75.17 -14.81 60.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.583 0.23 . . . . 0.0 111.2 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.6 p -75.33 58.84 1.0 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.924 0.392 . . . . 0.0 110.936 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.403 ' O ' HG12 ' A' ' 160' ' ' VAL . 0.1 OUTLIER 70.75 -61.08 0.48 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.023 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.409 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 83.33 -46.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.028 -179.765 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.414 ' CE1' HD11 ' A' ' 169' ' ' ILE . 60.6 m-85 -76.27 6.24 5.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.559 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -165.72 12.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.253 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 65.1 tp -67.6 -36.06 80.15 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 28.8 t80 67.02 1.05 2.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.341 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.4 mp -66.18 -64.87 0.76 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.205 0.526 . . . . 0.0 109.85 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.55 ' O ' ' CD ' ' A' ' 168' ' ' PRO . 0.7 OUTLIER -164.88 58.97 0.63 Allowed Pre-proline 0 N--CA 1.443 -0.81 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.359 179.599 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' A' ' 166' ' ' LEU . 94.2 Cg_endo -98.16 78.98 0.06 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.068 2.512 . . . . 0.0 113.184 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.55 ' CD ' ' O ' ' A' ' 166' ' ' LEU . 56.9 Cg_endo -64.6 45.15 0.14 Allowed 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 123.921 3.081 . . . . 0.0 113.2 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.531 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 1.3 tt -77.18 -46.21 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.724 0.297 . . . . 0.0 110.66 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.458 ' HA ' ' HB3' ' A' ' 173' ' ' ALA . 2.8 mp -77.8 -39.48 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.743 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 0.4 OUTLIER -63.91 -58.44 6.76 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.249 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -73.66 -3.43 28.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.745 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.85 -73.17 0.21 Allowed 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.351 0.596 . . . . 0.0 109.556 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -120.54 -8.34 8.41 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.624 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 20.4 t80 69.7 -46.73 0.59 Allowed 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 122.676 0.39 . . . . 0.0 111.549 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -94.32 16.21 15.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.772 0.32 . . . . 0.0 111.069 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.528 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 11.4 mt -79.49 -44.87 1.63 Allowed Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.936 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 51.7 Cg_exo -55.7 -155.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.756 2.304 . . . . 0.0 112.395 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.419 ' CB ' ' O ' ' A' ' 178' ' ' PRO . 0.2 OUTLIER 80.98 73.74 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.018 0.437 . . . . 0.0 110.555 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 17.4 mtm180 66.31 49.37 1.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.824 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.797 0.332 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.9 pp -166.31 146.61 6.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.878 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 -165.79 18.67 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.801 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.457 ' HB3' ' N ' ' A' ' 163' ' ' LEU . 0.2 OUTLIER -169.87 32.83 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.809 0.338 . . . . 0.0 110.45 179.534 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.465 ' HB3' ' CD1' ' A' ' 161' ' ' PHE . 2.4 m-20 70.83 0.4 3.33 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.949 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.483 ' C ' ' H ' ' A' ' 162' ' ' PHE . 0.4 OUTLIER 80.77 -50.25 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.775 0.322 . . . . 0.0 110.949 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.465 ' CD1' ' HB3' ' A' ' 159' ' ' ASP . 0.1 OUTLIER -77.51 24.7 0.2 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.008 0.433 . . . . 0.0 110.571 178.791 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.483 ' H ' ' C ' ' A' ' 160' ' ' VAL . 1.9 m-85 -163.53 -3.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.074 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.457 ' N ' ' HB3' ' A' ' 158' ' ' SER . 3.2 mt -61.83 -23.85 66.51 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 5.4 t80 60.03 17.7 6.96 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.633 178.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.34 -44.28 79.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.928 0.394 . . . . 0.0 110.657 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.488 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 0.2 OUTLIER -161.48 53.71 0.48 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.927 -179.633 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.589 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 36.3 Cg_endo -67.33 -24.55 43.29 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.659 2.239 . . . . 0.0 114.841 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 28.9 Cg_endo -90.7 33.02 0.32 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.732 1.621 . . . . 0.0 113.478 -178.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.464 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -77.47 -35.63 22.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.171 0.51 . . . . 0.0 110.329 179.171 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.416 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 11.0 mm -73.2 -46.12 51.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.196 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 3.4 pp -65.26 -49.88 67.92 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.42 ' N ' ' CD1' ' A' ' 171' ' ' LEU . 23.0 t0 -73.92 -5.34 40.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.472 178.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.464 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -74.32 -66.32 0.74 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.122 0.487 . . . . 0.0 110.147 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -119.47 -10.79 7.67 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.275 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.499 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 11.9 t80 79.36 -29.1 0.14 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 122.554 0.342 . . . . 0.0 111.914 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -97.95 4.65 49.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.699 0.285 . . . . 0.0 111.262 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.687 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 55.4 mt -86.84 -23.13 0.29 Allowed Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 96.8 Cg_exo -45.72 90.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.241 1.96 . . . . 0.0 113.07 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 177' ' ' LEU . 0.4 OUTLIER -107.07 -65.63 1.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.692 179.195 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 180' ' ' ARG . 0.0 OUTLIER -88.38 37.2 0.81 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.829 178.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 6.5 p90 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 121.006 0.431 . . . . 0.0 111.344 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.411 ' HA ' HG21 ' A' ' 160' ' ' VAL . 34.0 mt -74.87 108.62 7.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.868 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -170.35 -55.08 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.494 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.58 58.94 0.81 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.841 0.353 . . . . 0.0 110.96 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.503 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.2 OUTLIER 72.99 -48.19 0.68 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.463 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.63 ' O ' ' HB2' ' A' ' 164' ' ' PHE . 60.5 t 77.57 -60.76 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.141 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -64.22 -23.02 67.16 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.391 0.615 . . . . 0.0 110.083 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.462 ' CE2' ' HB3' ' A' ' 167' ' ' PRO . 8.8 t80 -67.79 -60.59 2.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.727 178.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 32.1 tp -68.85 -7.06 31.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.488 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.63 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 10.9 t80 -78.49 -120.22 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.394 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.38 -48.82 71.59 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.936 0.398 . . . . 0.0 110.996 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.7 169.15 7.26 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.688 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.462 ' HB3' ' CE2' ' A' ' 162' ' ' PHE . 88.7 Cg_endo -81.74 114.37 2.64 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.388 2.058 . . . . 0.0 112.401 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.557 ' HA ' ' CD2' ' A' ' 171' ' ' LEU . 57.7 Cg_endo -85.87 91.42 0.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.872 2.381 . . . . 0.0 112.74 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.51 HG23 ' N ' ' A' ' 170' ' ' ILE . 19.9 tt -160.93 -45.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.627 0.727 . . . . 0.0 110.536 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.51 ' N ' HG23 ' A' ' 169' ' ' ILE . 0.9 OUTLIER -73.63 -35.04 43.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.33 -1.305 . . . . 0.0 111.994 -178.609 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.557 ' CD2' ' HA ' ' A' ' 168' ' ' PRO . 0.0 OUTLIER -62.56 -64.17 1.0 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.089 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -75.15 4.3 7.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.41 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -71.34 -64.56 0.89 Allowed 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -111.73 -18.49 7.9 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.162 178.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 77.76 -30.5 0.16 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.799 0.44 . . . . 0.0 111.8 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -98.05 14.25 28.11 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.561 0.22 . . . . 0.0 111.37 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.501 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 13.7 mt -83.62 -45.13 0.81 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.355 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 48.0 Cg_exo -55.83 87.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.354 2.036 . . . . 0.0 112.266 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.88 -69.16 0.66 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.911 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.16 17.61 4.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.852 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.84 0.352 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.0 pp -74.01 140.48 45.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.033 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -170.65 -81.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.727 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.8 p -77.12 60.82 1.95 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.802 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.452 ' O ' ' CB ' ' A' ' 160' ' ' VAL . 1.9 t0 78.19 -40.69 0.3 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.629 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.452 ' CB ' ' O ' ' A' ' 159' ' ' ASP . 0.3 OUTLIER 92.97 -46.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 122.948 0.499 . . . . 0.0 111.342 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.402 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 4.9 t80 -67.3 -27.29 67.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.31 0.576 . . . . 0.0 110.239 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -70.6 -63.33 1.11 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.81 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.2 tp -66.34 -6.15 13.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.014 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.428 ' CB ' ' O ' ' A' ' 160' ' ' VAL . 6.3 t80 -78.9 -74.64 0.27 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.699 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.436 ' O ' ' CD2' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -64.89 -57.58 8.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.949 179.821 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.436 ' CD2' ' O ' ' A' ' 165' ' ' LEU . 0.3 OUTLIER -157.57 109.18 1.83 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.159 -179.524 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.559 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 19.4 Cg_endo -62.69 -28.73 76.81 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.233 1.955 . . . . 0.0 114.757 -178.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 24.3 Cg_endo -94.89 41.82 0.17 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.16 1.906 . . . . 0.0 113.646 -178.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.536 HG13 ' N ' ' A' ' 170' ' ' ILE . 21.8 pt -78.71 -42.24 25.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.448 0.642 . . . . 0.0 111.156 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.536 ' N ' HG13 ' A' ' 169' ' ' ILE . 1.5 pt -76.19 -45.77 34.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.825 -177.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 0.0 OUTLIER -62.72 -56.48 17.25 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -74.09 1.33 11.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.028 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -73.36 -69.45 0.43 Allowed 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 121.238 0.542 . . . . 0.0 109.69 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -113.93 -9.28 16.41 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.612 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 31.3 t80 77.01 -8.97 1.6 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 122.652 0.381 . . . . 0.0 112.019 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -97.62 1.46 48.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.806 0.336 . . . . 0.0 110.913 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.643 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.3 OUTLIER -79.91 -32.2 0.71 Allowed Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.682 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 85.1 Cg_exo -48.51 87.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.487 2.124 . . . . 0.0 112.776 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 177' ' ' LEU . 0.3 OUTLIER -110.93 -66.62 1.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.745 179.329 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.1 32.68 0.75 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.705 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . 0.404 ' H ' ' C ' ' A' ' 179' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 2.1 t80 . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.854 0.359 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -164.91 91.93 0.57 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.082 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -169.86 -43.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.015 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.5 p -75.52 60.61 1.22 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.662 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.438 ' O ' ' CB ' ' A' ' 160' ' ' VAL . 0.6 OUTLIER 75.06 -53.55 0.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.038 -179.612 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.438 ' CB ' ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 89.1 -47.93 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.516 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.418 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 11.7 m-85 -67.82 -57.48 6.21 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.477 ' C ' ' H ' ' A' ' 164' ' ' PHE . 8.2 m-85 -73.76 -14.89 61.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.951 178.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.401 ' CD1' ' HB3' ' A' ' 167' ' ' PRO . 58.3 tp -64.36 -3.9 3.35 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 121.774 0.797 . . . . 0.0 109.345 178.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.477 ' H ' ' C ' ' A' ' 162' ' ' PHE . 2.4 m-85 -73.12 -58.95 2.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.141 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.34 -71.46 0.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.064 0.459 . . . . 0.0 110.998 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -162.03 118.28 1.3 Allowed Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.665 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.401 ' HB3' ' CD1' ' A' ' 163' ' ' LEU . 16.8 Cg_endo -58.45 118.99 5.96 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.163 1.908 . . . . 0.0 111.771 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.09 32.18 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.654 2.236 . . . . 0.0 113.493 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.833 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.6 OUTLIER -74.98 -100.31 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 119.3 -0.381 . . . . 0.0 110.337 179.432 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.487 ' H ' ' CG2' ' A' ' 169' ' ' ILE . 2.8 mp 27.11 -66.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.893 0.877 . . . . 0.0 112.993 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.833 ' N ' ' O ' ' A' ' 169' ' ' ILE . 3.6 pp -68.99 -48.44 63.08 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.263 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.413 ' N ' ' CD1' ' A' ' 171' ' ' LEU . 28.2 m-20 -70.33 -7.06 39.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.124 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.88 -58.49 3.25 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.917 0.389 . . . . 0.0 110.309 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -110.9 -30.72 3.12 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.39 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER 75.36 -36.92 0.32 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 122.475 0.31 . . . . 0.0 111.6 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.405 ' H ' ' C ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER -91.62 3.65 54.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.928 0.394 . . . . 0.0 110.232 179.205 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.528 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 2.4 mt -58.57 -53.04 70.25 Favored Pre-proline 0 N--CA 1.453 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.365 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.528 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 50.3 Cg_exo -55.01 -173.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.515 2.143 . . . . 0.0 111.792 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 17.9 mt 77.38 72.16 0.06 Allowed 'General case' 0 CA--C 1.521 -0.152 0 CA-C-O 121.09 0.471 . . . . 0.0 110.549 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 66.19 57.01 0.78 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.712 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.805 0.336 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.4 pp -165.76 66.62 0.12 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.581 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -172.65 -20.13 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.1 t -69.08 -38.38 78.98 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.222 0.535 . . . . 0.0 111.62 -179.051 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -168.51 -37.08 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.511 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.447 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 67.98 -50.14 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.532 179.989 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.447 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 1.2 m-85 -72.55 0.27 10.9 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.933 179.436 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.439 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 27.1 m-85 -159.13 11.87 0.14 Allowed 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.193 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 66.2 tp -68.27 -7.22 28.82 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 177.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -75.5 -32.85 60.68 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.185 -179.712 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.38 -36.6 84.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.062 -179.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.41 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 0.2 OUTLIER -162.15 78.56 2.0 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.643 -179.299 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.445 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 3.2 Cg_exo -38.51 -48.22 2.53 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.147 2.564 . . . . 0.0 112.898 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 41.1 Cg_endo -90.1 62.38 1.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.707 2.271 . . . . 0.0 112.422 -179.685 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.441 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 0.9 OUTLIER -73.97 -41.9 52.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.642 179.831 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.514 ' HA ' ' HB1' ' A' ' 173' ' ' ALA . 2.8 mp -69.33 -36.37 71.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.801 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 10.9 mp -65.62 -53.57 39.81 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.548 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -75.74 -6.07 48.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.514 178.073 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.514 ' HB1' ' HA ' ' A' ' 170' ' ' ILE . . . -74.51 -74.26 0.2 Allowed 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.31 0.576 . . . . 0.0 109.879 179.808 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -115.81 -15.19 7.51 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.687 178.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.424 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER 75.09 -47.34 0.61 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.358 0.263 . . . . 0.0 111.633 179.897 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.43 ' CD2' HD12 ' A' ' 179' ' ' LEU . 0.1 OUTLIER -94.14 16.41 14.8 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 120.688 0.28 . . . . 0.0 111.24 -179.937 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.469 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 5.0 mt -92.94 -46.16 0.32 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.713 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.469 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 21.6 Cg_exo -65.4 -4.87 10.19 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.678 2.252 . . . . 0.0 113.201 -179.478 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.43 HD12 ' CD2' ' A' ' 176' ' ' PHE . 52.6 mt -57.46 -18.79 20.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.735 0.302 . . . . 0.0 111.456 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.67 48.59 1.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.179 0.514 . . . . 0.0 109.997 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . 0.415 ' HB3' ' HA ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.409 ' O ' ' HB2' ' A' ' 156' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 120.858 0.361 . . . . 0.0 111.855 . . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 155' ' ' PHE . 5.8 mt 66.71 55.09 0.79 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.269 179.732 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -170.08 -58.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.356 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.95 59.63 0.92 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.82 0.343 . . . . 0.0 110.827 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.559 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.4 OUTLIER 75.58 -48.78 0.61 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.598 179.999 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 61.1 t 82.91 -64.91 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 C-N-CA 122.798 0.439 . . . . 0.0 109.949 -179.388 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -75.62 46.05 0.34 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.346 178.501 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.448 ' C ' ' H ' ' A' ' 164' ' ' PHE . 3.6 t80 -171.95 -53.19 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.145 0.497 . . . . 0.0 110.299 -179.04 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.5 tp -68.08 -0.34 4.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.955 178.024 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.448 ' H ' ' C ' ' A' ' 162' ' ' PHE . 0.1 OUTLIER -71.77 -18.82 62.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.498 -178.115 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 162' ' ' PHE . 0.0 OUTLIER -66.9 -36.8 83.09 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.374 179.581 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -162.12 67.62 2.06 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.568 -179.156 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.418 ' CB ' ' HD3' ' A' ' 168' ' ' PRO . 3.2 Cg_exo -39.09 -50.01 2.76 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.267 2.645 . . . . 0.0 112.967 -179.629 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.418 ' HD3' ' CB ' ' A' ' 167' ' ' PRO . 38.5 Cg_endo -91.1 65.74 1.3 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.886 2.391 . . . . 0.0 112.572 -179.6 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.552 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -77.94 -37.28 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.929 0.395 . . . . 0.0 110.849 179.96 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.444 ' CD1' ' CG2' ' A' ' 169' ' ' ILE . 6.5 mm -78.78 -47.88 22.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.73 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.4 tp -62.75 -55.06 30.04 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 168' ' ' PRO . 21.8 m-20 -74.47 -2.48 25.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.81 178.726 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.552 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.86 -67.27 0.58 Allowed 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.114 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -131.47 -4.33 3.99 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.688 178.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 70.16 -47.33 0.62 Allowed 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 122.433 0.293 . . . . 0.0 111.234 -179.755 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -92.99 -2.11 56.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.846 0.355 . . . . 0.0 110.695 179.458 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.553 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.2 OUTLIER -58.05 -42.97 97.89 Favored Pre-proline 0 CA--C 1.529 0.145 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.251 179.443 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 75.8 Cg_exo -50.69 -161.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.92 2.414 . . . . 0.0 112.915 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.9 mt 80.35 -2.35 1.94 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.996 -179.301 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -152.9 34.75 0.48 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.122 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 7.9 p90 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.908 0.385 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.461 ' HB3' HG21 ' A' ' 160' ' ' VAL . 6.3 mt 58.12 39.73 25.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.351 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -73.23 -1.91 19.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.09 179.164 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.3 t -72.95 -51.29 19.02 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.443 0.639 . . . . 0.0 111.214 -179.635 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.516 ' O ' ' CG1' ' A' ' 160' ' ' VAL . 1.9 p30 -164.17 -38.18 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.729 -179.519 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.518 HG13 ' N ' ' A' ' 161' ' ' PHE . 0.5 OUTLIER 81.4 -38.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 114.825 -1.08 . . . . 0.0 112.315 179.728 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.518 ' N ' HG13 ' A' ' 160' ' ' VAL . 4.2 p90 -69.51 -27.55 65.28 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 121.096 0.474 . . . . 0.0 110.675 179.846 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.411 ' N ' ' CD1' ' A' ' 161' ' ' PHE . 0.6 OUTLIER -68.32 -59.25 3.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.366 179.277 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.436 ' CB ' ' CD2' ' A' ' 156' ' ' LEU . 15.0 tp -67.02 -3.32 6.92 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.122 178.605 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.412 ' HB2' ' HA ' ' A' ' 161' ' ' PHE . 0.3 OUTLIER -73.28 -20.45 60.82 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.133 -0.939 . . . . 0.0 111.213 -179.279 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.56 -34.94 78.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.328 0.585 . . . . 0.0 110.041 179.013 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -160.16 99.64 1.43 Allowed Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.906 -178.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -65.46 113.81 2.63 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.408 2.072 . . . . 0.0 112.804 -179.159 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.89 52.59 4.41 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.849 2.366 . . . . 0.0 112.33 179.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.412 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -74.5 -38.4 46.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.909 0.385 . . . . 0.0 111.24 -179.587 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 2.8 mp -72.83 -48.85 43.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.561 -179.492 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.98 -49.81 66.55 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.487 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -75.95 1.67 14.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.04 178.564 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.25 -42.12 66.01 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.214 0.53 . . . . 0.0 109.666 179.74 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.53 ' C ' ' CG ' ' A' ' 175' ' ' TYR . . . -119.62 -1.96 13.28 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.826 178.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.53 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER 58.51 -37.32 0.06 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 179.483 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.477 ' H ' ' C ' ' A' ' 174' ' ' GLY . 26.9 p90 -94.62 23.08 5.61 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 122.094 -0.378 . . . . 0.0 111.164 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.455 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 7.7 mt -85.63 -51.12 0.51 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.844 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.455 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 32.0 Cg_exo -58.7 -63.94 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.545 2.163 . . . . 0.0 112.289 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 11.9 mt 61.63 55.62 2.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.009 0.433 . . . . 0.0 110.733 -179.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.18 48.96 5.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.824 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.403 ' O ' ' CD1' ' A' ' 163' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.752 0.31 . . . . 0.0 111.182 . . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.48 87.24 1.58 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.907 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.411 ' HB2' ' CD1' ' A' ' 163' ' ' LEU . 5.0 mm-40 -70.08 -83.38 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.744 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 16.7 p -163.15 31.27 0.09 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.176 0.512 . . . . 0.0 110.284 179.543 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -162.09 -54.6 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.279 179.696 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 67.7 t 66.84 -55.84 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.556 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.56 9.9 1.24 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.142 179.6 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -161.07 12.49 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.854 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.411 ' CD1' ' HB2' ' A' ' 157' ' ' GLN . 0.5 OUTLIER -67.55 -30.08 69.62 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 177.74 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 13.9 t80 68.05 12.02 8.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.712 179.45 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.29 -55.14 17.52 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.198 0.523 . . . . 0.0 110.445 179.209 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.412 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 0.1 OUTLIER -161.29 53.52 0.47 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.198 -179.876 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 10.1 Cg_endo -52.13 107.16 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.741 2.294 . . . . 0.0 112.748 -179.439 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.02 6.51 5.23 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 123.174 2.582 . . . . 0.0 112.961 179.741 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.502 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 12.6 pt -75.31 -37.63 39.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.232 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.453 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 8.4 mm -81.48 -50.84 16.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.962 -179.408 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 0.0 OUTLIER -62.63 -53.38 55.38 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.938 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.43 -1.17 17.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.887 178.715 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.91 -56.84 4.61 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 121.194 0.521 . . . . 0.0 109.787 179.626 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -129.88 -3.5 4.94 Favored Glycine 0 CA--C 1.52 0.38 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.057 179.126 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.3 OUTLIER 70.13 -55.8 0.6 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.64 0.257 . . . . 0.0 111.358 179.974 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -92.36 24.88 3.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.902 0.382 . . . . 0.0 110.572 179.766 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.484 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 0.2 OUTLIER -88.26 -51.37 0.4 Allowed Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.996 179.842 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.532 ' O ' ' HB3' ' A' ' 181' ' ' HSL . 96.1 Cg_exo -44.86 -84.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.516 2.144 . . . . 0.0 112.552 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 55.26 55.56 7.38 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.141 0.496 . . . . 0.0 110.501 179.924 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? 64.07 53.39 1.84 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.579 -179.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . 0.532 ' HB3' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.783 0.325 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.62 142.9 46.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.925 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 159' ' ' ASP . 2.2 mt-30 -170.28 72.94 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.764 179.878 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 157' ' ' GLN . 1.2 p 60.99 -59.69 0.09 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.52 0.676 . . . . 0.0 112.106 179.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 157' ' ' GLN . 1.8 p30 -158.2 -31.49 0.07 Allowed 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.382 -179.522 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.445 ' CG1' ' CD1' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 80.46 -51.45 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.936 179.958 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.479 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 20.4 m-30 -76.96 20.25 0.26 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.746 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.479 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 43.0 m-85 -164.35 -4.44 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -64.65 -40.02 94.7 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.453 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER 54.65 40.06 31.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.702 178.532 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.453 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 4.5 tp 84.73 -28.02 0.09 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.467 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.14 131.2 3.82 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.176 -178.84 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.5 118.32 5.18 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.335 2.023 . . . . 0.0 112.444 -179.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -62.63 80.88 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.519 2.146 . . . . 0.0 111.97 179.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.444 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 5.5 tt -74.03 -34.93 40.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.673 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 10.4 mm -71.56 -42.82 72.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.053 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.06 -53.55 36.95 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.795 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -74.82 -0.1 17.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.035 178.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.97 -60.94 2.0 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.159 0.504 . . . . 0.0 109.851 179.757 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -109.67 -19.03 8.5 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.497 178.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 78.83 -29.83 0.15 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.658 0.383 . . . . 0.0 111.953 179.647 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.436 ' CE2' ' CD1' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -94.75 -0.49 54.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.747 0.308 . . . . 0.0 110.737 179.696 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.47 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.5 OUTLIER -59.52 -47.37 97.97 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.141 179.816 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.47 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 23.4 Cg_exo -64.81 68.93 0.26 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.659 2.239 . . . . 0.0 112.383 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.436 ' CD1' ' CE2' ' A' ' 176' ' ' PHE . 1.8 mt -106.34 -50.48 3.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.733 179.762 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.83 9.16 22.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.78 179.774 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 17.2 p90 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.83 0.348 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.438 ' HB2' HD11 ' A' ' 163' ' ' LEU . 4.5 pp -72.77 -178.25 2.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.686 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -167.73 26.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.835 0.35 . . . . 0.0 111.409 179.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.535 ' O ' ' OG ' ' A' ' 158' ' ' SER . 0.3 OUTLIER -168.48 36.43 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.36 0.6 . . . . 0.0 110.004 179.489 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 158' ' ' SER . 2.8 t0 82.42 -30.15 0.1 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.162 -179.998 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.48 ' C ' ' H ' ' A' ' 162' ' ' PHE . 0.4 OUTLIER 81.03 -45.76 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.865 0.364 . . . . 0.0 110.448 -179.477 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.414 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 27.0 t80 -74.65 12.68 0.76 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.777 177.939 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.609 ' HB3' ' HA ' ' A' ' 167' ' ' PRO . 54.5 m-85 -160.29 7.69 0.09 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.781 -179.486 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.438 HD11 ' HB2' ' A' ' 156' ' ' LEU . 1.1 mt -68.62 -4.05 14.07 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.552 -0.906 . . . . 0.0 108.552 176.967 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.44 ' H ' ' C ' ' A' ' 162' ' ' PHE . 0.2 OUTLIER -71.59 -9.2 57.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.789 -178.705 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.5 mt -176.53 -66.2 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.954 0.407 . . . . 0.0 111.08 179.644 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -162.0 124.93 1.79 Allowed Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.473 -179.62 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.609 ' HA ' ' HB3' ' A' ' 162' ' ' PHE . 70.1 Cg_endo -75.1 110.76 3.18 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.118 1.879 . . . . 0.0 112.624 -179.703 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.405 ' HD2' ' CG ' ' A' ' 162' ' ' PHE . 87.8 Cg_endo -75.84 77.41 3.41 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.646 2.23 . . . . 0.0 112.37 179.852 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 1.9 tp -75.34 -44.68 42.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.448 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.5 mp -74.55 -41.57 48.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.216 -179.899 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -65.2 -57.75 7.74 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.82 4.51 6.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.067 178.754 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.97 -56.01 5.74 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.207 0.527 . . . . 0.0 109.826 179.683 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -121.74 -0.03 10.99 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.726 178.695 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.494 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.2 OUTLIER 55.1 -59.79 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.047 0.939 . . . . 0.0 112.154 179.898 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.606 ' N ' ' O ' ' A' ' 174' ' ' GLY . 13.1 m-85 -95.52 22.87 6.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.782 0.325 . . . . 0.0 111.118 -179.903 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.522 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 14.9 mt -90.57 -49.3 0.36 Allowed Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.081 179.758 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.522 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 36.6 Cg_exo -60.37 -29.99 89.99 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.368 2.046 . . . . 0.0 112.054 179.788 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.8 mp -64.97 -57.6 8.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.89 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -87.17 44.03 1.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 -179.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.28 0 CA-C-O 120.85 0.357 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.525 ' N ' ' CD1' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -165.08 124.86 1.85 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.975 -179.757 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.79 80.67 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.009 -179.636 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.1 m 63.81 68.09 0.59 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.326 179.75 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.498 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.5 OUTLIER 76.17 -60.59 0.48 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.717 179.426 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.498 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 95.7 t 76.27 -46.21 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.052 -179.297 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.403 ' O ' ' CD1' ' A' ' 162' ' ' PHE . 1.1 t80 -71.76 -1.33 13.59 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.091 179.641 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.403 ' CD1' ' O ' ' A' ' 161' ' ' PHE . 11.9 m-85 -162.43 13.78 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.151 179.748 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 52.9 tp -66.74 -17.68 64.98 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.143 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.477 ' HA ' ' HG3' ' A' ' 167' ' ' PRO . 15.3 t80 68.29 21.2 8.51 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.378 179.516 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.4 -48.68 66.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.944 179.438 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.503 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 0.2 OUTLIER -159.92 44.41 0.17 Allowed Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.731 -179.293 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.561 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 19.3 Cg_endo -61.66 -28.17 82.17 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.263 1.975 . . . . 0.0 114.113 -179.936 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 13.5 Cg_endo -99.01 118.7 0.11 Allowed 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 122.984 2.456 . . . . 0.0 111.939 -179.635 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.495 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 8.4 tp -70.66 -41.82 77.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.857 -179.914 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.495 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 0.8 OUTLIER -74.04 -44.3 50.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 114.683 -1.144 . . . . 0.0 112.507 -178.25 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.406 ' CD2' ' HG2' ' A' ' 178' ' ' PRO . 2.4 tm? -65.16 -58.37 6.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.054 0.454 . . . . 0.0 109.845 179.53 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.423 ' CB ' ' HG ' ' A' ' 166' ' ' LEU . 12.0 m-20 -74.66 5.46 4.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.552 179.105 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -70.79 -56.42 6.37 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.304 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -111.55 -26.36 4.55 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 177.9 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 72.25 -40.68 0.48 Allowed 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 122.633 0.373 . . . . 0.0 111.663 179.641 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.423 ' H ' ' C ' ' A' ' 174' ' ' GLY . 8.6 m-85 -90.34 6.99 40.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.814 0.34 . . . . 0.0 110.622 179.661 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.519 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 0.4 OUTLIER -62.17 -59.79 12.02 Favored Pre-proline 0 N--CA 1.453 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.076 179.477 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.519 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 52.0 Cg_exo -53.54 -174.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.398 2.066 . . . . 0.0 112.052 179.158 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.3 mp 69.52 71.43 0.25 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.221 0.534 . . . . 0.0 110.272 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 70.76 63.98 0.18 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.206 -179.463 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.6 t80 . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.793 0.33 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 16.1 mt 62.72 16.03 8.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.338 179.847 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.4 -1.73 25.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.802 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.9 55.13 0.53 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.891 0.377 . . . . 0.0 110.857 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.15 -63.78 0.36 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.603 -179.711 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.48 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 68.08 -53.17 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.823 179.613 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.48 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 0.2 OUTLIER -77.14 3.46 12.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.989 -179.723 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -169.08 15.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.738 -179.8 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.44 ' CD2' ' HB2' ' A' ' 165' ' ' LEU . 9.0 tp -65.91 -35.9 81.91 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.898 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 1.6 t80 53.89 8.27 0.15 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.939 178.688 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.44 ' HB2' ' CD2' ' A' ' 163' ' ' LEU . 3.0 tp -70.38 -54.99 10.21 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.024 0.44 . . . . 0.0 110.265 179.449 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.578 ' N ' ' HD3' ' A' ' 167' ' ' PRO . 0.2 OUTLIER -161.18 47.83 0.23 Allowed Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.134 -179.553 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.578 ' HD3' ' N ' ' A' ' 166' ' ' LEU . 23.7 Cg_exo -59.66 -50.2 8.55 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 121.529 1.486 . . . . 0.0 111.704 179.29 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 167' ' ' PRO . 28.8 Cg_endo -94.28 97.36 0.13 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.187 2.591 . . . . 0.0 112.385 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 0.1 OUTLIER -75.82 -44.91 38.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.27 0.557 . . . . 0.0 111.322 -179.888 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.492 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 0.7 OUTLIER -78.98 -44.78 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.938 -1.028 . . . . 0.0 112.968 -178.02 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 168' ' ' PRO . 2.0 tm? -64.51 -58.16 7.18 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.446 ' HB2' ' HG2' ' A' ' 168' ' ' PRO . 1.2 m-20 -74.1 4.84 4.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.151 178.857 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.22 -56.48 5.46 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.257 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.427 ' HA3' ' HG ' ' A' ' 177' ' ' LEU . . . -133.86 2.06 4.37 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.559 178.465 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 70.35 -56.83 0.59 Allowed 'General case' 0 C--O 1.231 0.096 0 C-N-CA 122.543 0.337 . . . . 0.0 111.733 179.75 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -94.93 -10.72 30.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.619 0.247 . . . . 0.0 111.621 -179.638 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.533 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 74.9 mt -53.42 -42.05 89.8 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.529 179.818 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 36.5 Cg_exo -62.05 68.27 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.607 2.205 . . . . 0.0 112.496 -179.847 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -128.86 -66.13 0.84 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.344 179.718 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 10.8 mmt85 -87.66 22.22 2.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.304 179.465 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.461 ' CD1' ' CD1' ' A' ' 165' ' ' LEU . 3.6 m-85 . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.733 0.302 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 155' ' ' PHE . 0.6 OUTLIER 38.97 78.56 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.787 179.836 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -169.01 44.16 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.943 -179.942 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.53 -40.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.415 0.626 . . . . 0.0 111.207 179.784 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -167.24 -35.96 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.534 179.899 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.447 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 78.93 -50.41 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.951 -179.991 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.447 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 57.4 m-85 -76.02 14.13 0.75 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.764 179.706 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.404 ' CD2' ' O ' ' A' ' 161' ' ' PHE . 18.5 m-85 -165.45 2.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.865 0.321 . . . . 0.0 111.865 -179.725 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 10.4 tp -67.21 -30.44 70.37 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.753 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.443 ' O ' ' HB2' ' A' ' 165' ' ' LEU . 4.6 t80 52.61 35.73 18.88 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.682 179.28 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.461 ' CD1' ' CD1' ' A' ' 155' ' ' PHE . 0.1 OUTLIER 84.48 -32.49 0.06 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.862 -179.31 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -164.62 123.87 1.25 Allowed Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.2 -179.217 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.04 112.2 2.43 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.007 1.805 . . . . 0.0 112.463 -179.679 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.409 ' HB2' ' HB2' ' A' ' 172' ' ' ASP . 70.0 Cg_endo -81.92 51.52 3.85 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.896 2.397 . . . . 0.0 112.596 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 3.7 tp -76.07 -46.19 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.393 0.616 . . . . 0.0 110.717 179.844 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.477 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 0.7 OUTLIER -79.01 -43.78 24.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.707 -179.277 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.434 ' HA ' ' HG3' ' A' ' 178' ' ' PRO . 1.2 tp -65.8 -58.91 4.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.114 0.483 . . . . 0.0 109.992 179.557 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.409 ' HB2' ' HB2' ' A' ' 168' ' ' PRO . 4.0 t70 -74.24 5.54 4.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.448 179.052 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -71.25 -64.69 0.87 Allowed 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.505 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -112.3 -17.09 8.43 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 178.167 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 6.0 t80 75.58 -11.46 1.1 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.705 0.402 . . . . 0.0 111.81 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -115.68 -3.15 12.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.986 0.422 . . . . 0.0 110.867 179.672 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.704 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.1 OUTLIER -85.59 -20.77 0.27 Allowed Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.853 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 79.7 Cg_exo -46.92 -18.51 0.57 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.144 1.896 . . . . 0.0 113.414 -179.918 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.9 tt -50.52 -45.9 56.91 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.967 0.413 . . . . 0.0 110.58 -179.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -91.53 31.08 1.21 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.126 179.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . 0.435 ' HG3' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.877 0.37 . . . . 0.0 111.949 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 48.66 -161.47 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.355 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -169.75 92.93 0.24 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.88 0.371 . . . . 0.0 111.022 -179.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 47.74 75.67 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.143 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 160' ' ' VAL . 1.0 OUTLIER 75.26 -60.05 0.52 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.137 -179.971 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 85.88 -49.15 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.903 -179.827 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.536 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 0.1 OUTLIER -76.73 25.52 0.14 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.801 179.535 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.579 ' C ' ' H ' ' A' ' 164' ' ' PHE . 47.1 m-85 -166.78 -22.73 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.871 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 9.6 tp -63.42 0.16 0.76 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.771 0.796 . . . . 0.0 109.788 178.279 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.579 ' H ' ' C ' ' A' ' 162' ' ' PHE . 69.6 t80 -74.24 7.94 2.47 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.046 -179.156 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -172.81 -45.68 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.862 0.363 . . . . 0.0 111.091 179.78 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 1.6 tp -160.75 138.92 7.27 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 -179.574 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.89 116.31 4.62 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.359 2.04 . . . . 0.0 112.248 -179.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.404 ' HG3' ' CG ' ' A' ' 162' ' ' PHE . 72.6 Cg_endo -76.51 81.66 2.45 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.501 2.134 . . . . 0.0 112.426 -179.892 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.477 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 4.8 tp -75.87 -35.84 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.991 179.965 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.406 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 9.0 mm -73.4 -45.89 50.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.447 -179.284 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 34.5 tp -64.33 -54.37 34.12 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.46 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.94 -0.67 16.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.082 178.649 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.42 -61.86 1.65 Allowed 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.25 0.547 . . . . 0.0 109.911 179.779 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -114.15 -13.95 9.55 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.683 178.848 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 24.9 t80 70.91 -51.06 0.68 Allowed 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 122.459 0.304 . . . . 0.0 111.599 179.904 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -95.57 5.7 50.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.209 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.67 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.1 OUTLIER -77.02 -30.59 0.81 Allowed Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.695 179.921 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 51.6 Cg_exo -54.76 -145.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.597 2.198 . . . . 0.0 112.521 -179.8 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.435 ' CB ' ' O ' ' A' ' 178' ' ' PRO . 0.1 OUTLIER 83.61 76.63 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.105 0.478 . . . . 0.0 110.281 -179.495 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.38 55.96 0.38 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.763 -179.739 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.419 ' O ' ' HB2' ' A' ' 156' ' ' LEU . 3.1 t80 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.795 0.331 . . . . 0.0 111.778 . . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 155' ' ' PHE . 1.9 mt 66.64 99.76 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.348 179.558 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.97 -17.71 61.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.609 179.422 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.45 ' O ' ' CG ' ' A' ' 159' ' ' ASP . 0.7 OUTLIER -73.96 62.6 0.88 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.024 179.686 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.507 ' O ' HG12 ' A' ' 160' ' ' VAL . 2.0 p30 63.34 -58.37 0.17 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.607 -179.019 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.684 ' O ' ' HB2' ' A' ' 164' ' ' PHE . 0.3 OUTLIER 80.29 -40.39 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 122.614 0.366 . . . . 0.0 110.537 -179.543 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.495 ' N ' HG12 ' A' ' 160' ' ' VAL . 80.6 m-85 -77.98 34.26 0.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.717 -0.219 . . . . 0.0 110.595 178.55 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.432 ' C ' ' H ' ' A' ' 164' ' ' PHE . 0.2 OUTLIER -170.67 -55.74 0.02 OUTLIER 'General case' 0 N--CA 1.457 -0.085 0 CA-C-O 121.134 0.492 . . . . 0.0 111.679 -178.585 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 16.7 mt -66.49 -2.42 4.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.164 179.297 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.684 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.1 OUTLIER -76.17 50.61 0.63 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.374 -179.378 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 79.83 -40.42 0.21 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.544 179.939 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.42 171.82 6.43 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.863 -178.782 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -74.1 108.4 2.65 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.58 2.187 . . . . 0.0 112.531 -179.792 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -68.09 74.55 0.72 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.405 2.07 . . . . 0.0 112.211 179.74 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.464 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 8.2 tp -75.55 -46.46 36.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.299 -179.782 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.464 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.7 mp -73.82 -36.38 45.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.522 -179.671 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 20.2 mt -64.92 -62.39 1.59 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.658 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -77.43 8.06 4.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.359 178.996 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -71.1 -59.15 2.93 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.328 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 175' ' ' TYR . . . -123.37 -1.64 9.22 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.188 178.024 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.403 ' HB2' ' O ' ' A' ' 174' ' ' GLY . 63.6 m-85 66.36 -57.65 0.37 Allowed 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.02 0.528 . . . . 0.0 111.336 179.679 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -96.78 15.87 20.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.761 0.315 . . . . 0.0 110.958 179.552 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.51 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 22.9 mt -84.84 -42.82 0.69 Allowed Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.621 179.983 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 63.1 Cg_exo -42.02 -28.07 0.75 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.573 2.182 . . . . 0.0 112.818 -179.95 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.15 -43.58 67.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.705 179.566 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -88.43 33.0 0.75 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.961 179.892 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . 0.412 ' HG3' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.822 0.344 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.9 mp -162.94 84.73 0.52 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.471 179.957 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -74.46 -24.38 59.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.924 -179.968 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.425 ' O ' ' CB ' ' A' ' 159' ' ' ASP . 0.3 OUTLIER -163.86 62.18 0.16 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.582 179.915 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 158' ' ' SER . 1.0 OUTLIER 82.23 -27.36 0.12 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.879 -179.918 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.435 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.5 OUTLIER 79.14 -52.58 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.183 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.435 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 1.2 m-85 -75.56 37.92 0.14 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.767 178.761 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.434 ' H ' ' C ' ' A' ' 160' ' ' VAL . 42.7 m-85 -162.39 -22.82 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 179.891 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.415 ' CD1' ' HA ' ' A' ' 167' ' ' PRO . 4.0 mm? -60.09 -34.22 73.16 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.584 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.453 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 2.7 t80 59.85 91.9 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.235 177.414 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.453 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 5.2 tp 87.33 -48.35 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.558 178.809 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.539 ' HB3' ' HD2' ' A' ' 168' ' ' PRO . 0.0 OUTLIER -161.55 148.17 11.34 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.614 -178.549 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.429 ' CB ' ' HD3' ' A' ' 168' ' ' PRO . 2.6 Cg_exo -40.92 -51.69 3.62 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.081 2.521 . . . . 0.0 113.305 -179.474 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.539 ' HD2' ' HB3' ' A' ' 166' ' ' LEU . 37.2 Cg_endo -92.42 -167.38 0.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.725 2.283 . . . . 0.0 112.399 -179.725 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.448 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.2 OUTLIER -170.35 -43.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.996 179.815 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.442 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 2.2 mp -75.46 -53.36 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.315 -179.785 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 12.2 tp -65.33 -49.93 67.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.361 0.601 . . . . 0.0 109.384 179.446 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.06 -1.32 16.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.153 179.102 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.448 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.66 -64.78 0.89 Allowed 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.092 0.472 . . . . 0.0 109.736 179.631 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -116.18 -16.83 6.5 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.688 178.807 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.436 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 24.2 t80 75.89 -10.61 1.25 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.401 0.28 . . . . 0.0 111.753 179.986 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.414 ' CZ ' HD13 ' A' ' 179' ' ' LEU . 71.3 t80 -95.44 -4.0 45.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.838 0.351 . . . . 0.0 110.948 179.664 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.57 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 3.8 mm? -56.46 -41.82 93.14 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.252 179.682 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 63.8 Cg_exo -53.99 -137.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.888 2.392 . . . . 0.0 112.651 -179.865 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.436 ' CB ' ' O ' ' A' ' 178' ' ' PRO . 20.8 mt 84.45 74.83 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.976 0.417 . . . . 0.0 110.591 -179.571 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.97 48.21 3.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.842 -179.933 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 29.1 p90 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.77 0.319 . . . . 0.0 111.287 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -166.29 156.53 12.3 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.325 179.835 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? 64.43 23.11 12.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.807 -179.626 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 50.69 33.06 7.67 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.144 0.497 . . . . 0.0 111.311 -179.862 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.522 ' O ' HG11 ' A' ' 160' ' ' VAL . 4.0 m-20 -163.86 -55.76 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.919 179.681 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.522 HG11 ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 74.93 -47.58 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.485 179.165 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.494 ' HA ' ' HB2' ' A' ' 164' ' ' PHE . 0.1 OUTLIER -61.85 -20.22 63.45 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.935 0.397 . . . . 0.0 110.779 -179.677 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.418 ' CE1' ' HD2' ' A' ' 168' ' ' PRO . 0.1 OUTLIER -70.61 -60.54 2.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.302 0.572 . . . . 0.0 110.19 179.188 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.422 ' HG ' ' HG3' ' A' ' 167' ' ' PRO . 9.0 mp -68.03 -4.08 12.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.015 178.405 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.494 ' HB2' ' HA ' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -82.57 21.67 0.95 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.122 -179.017 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -170.97 -74.81 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.764 0.316 . . . . 0.0 111.334 179.776 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -160.5 83.21 2.08 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.063 -179.421 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.422 ' HG3' ' HG ' ' A' ' 163' ' ' LEU . 37.4 Cg_endo -66.83 111.98 2.33 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.261 1.974 . . . . 0.0 112.353 -179.431 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.42 ' O ' ' CD1' ' A' ' 170' ' ' ILE . 44.5 Cg_endo -87.18 -166.15 0.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.055 2.503 . . . . 0.0 111.791 179.679 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.491 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.9 OUTLIER 79.48 -38.36 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.89 179.622 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.474 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 2.7 mp -83.13 -65.56 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.039 0.447 . . . . 0.0 111.236 179.956 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 1.4 pp -65.8 -45.04 83.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.353 0.597 . . . . 0.0 110.252 179.902 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.19 -5.55 32.71 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.947 179.492 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -75.75 -62.2 1.67 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.107 0.48 . . . . 0.0 110.243 179.735 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -130.67 1.48 5.59 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.484 179.584 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.508 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER 57.54 -52.51 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 179.344 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.522 ' N ' ' O ' ' A' ' 174' ' ' GLY . 2.9 m-85 -92.82 18.55 8.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.75 0.309 . . . . 0.0 111.041 179.941 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.473 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.1 OUTLIER -80.91 -48.33 1.12 Allowed Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.851 179.548 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 80.3 Cg_exo -43.42 -39.97 9.65 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.682 2.255 . . . . 0.0 112.749 179.941 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 63.73 61.73 0.96 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.092 0.473 . . . . 0.0 110.175 -179.69 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? 66.7 39.2 3.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.415 -179.494 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.844 0.354 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.1 mp 60.4 119.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.246 179.675 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.4 ' CB ' HD13 ' A' ' 163' ' ' LEU . 1.6 mm100 -170.34 42.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.59 179.94 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.1 p 74.86 -59.4 0.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.956 -179.751 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -78.16 -48.26 16.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.299 179.647 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' A' ' 164' ' ' PHE . 57.9 t 69.51 -54.59 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.651 179.621 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.484 ' HA ' ' HB2' ' A' ' 164' ' ' PHE . 5.1 p90 -61.97 -23.26 66.29 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.104 0.478 . . . . 0.0 110.26 179.908 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.83 -61.61 1.73 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.468 179.102 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.4 HD13 ' CB ' ' A' ' 157' ' ' GLN . 7.5 mt -67.33 -6.24 17.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.9 178.656 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.484 ' HB2' ' HA ' ' A' ' 161' ' ' PHE . 0.1 OUTLIER -79.35 -47.14 16.3 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.028 -179.414 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.1 tp -62.65 -78.48 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.214 0.53 . . . . 0.0 110.417 179.621 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.517 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 0.7 OUTLIER -88.31 105.56 9.82 Favored Pre-proline 0 N--CA 1.445 -0.703 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.997 -179.535 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.609 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 30.9 Cg_endo -66.77 -25.45 46.07 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.131 1.887 . . . . 0.0 114.244 -179.407 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 22.6 Cg_endo -91.34 87.17 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.972 1.781 . . . . 0.0 113.062 -179.374 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.927 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -72.25 -101.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.739 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.479 ' H ' ' CG2' ' A' ' 169' ' ' ILE . 1.9 mt 25.63 -62.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.387 0.675 . . . . 0.0 112.664 178.349 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.927 ' N ' ' O ' ' A' ' 169' ' ' ILE . 13.7 mt -67.05 -51.0 60.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.674 179.824 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -72.31 -6.86 46.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.074 179.575 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.61 -59.55 2.7 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.753 0.311 . . . . 0.0 110.367 179.887 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -100.06 -20.9 14.75 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.636 179.048 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 64.9 t80 69.29 -57.63 0.53 Allowed 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.8 0.333 . . . . 0.0 111.003 -179.953 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.417 ' CE1' ' HG ' ' A' ' 179' ' ' LEU . 6.5 t80 -93.86 18.73 9.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.526 179.503 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.478 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 13.5 mt -86.53 -46.84 0.54 Allowed Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.312 179.968 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.478 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 12.3 Cg_exo -71.42 -4.18 14.48 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.89 2.393 . . . . 0.0 112.903 -179.684 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.417 ' HG ' ' CE1' ' A' ' 176' ' ' PHE . 4.0 mm? -70.61 -65.23 0.76 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.961 0.41 . . . . 0.0 110.9 -179.941 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.58 35.47 0.83 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.874 179.936 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.559 0.219 . . . . 0.0 111.375 . . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.1 mt -167.68 -71.61 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.027 -179.69 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 14.0 tp60 75.96 56.47 0.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.779 -179.959 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.405 ' HB3' ' CD1' ' A' ' 163' ' ' LEU . 27.6 t 61.16 60.24 1.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.643 -179.935 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.438 ' O ' HG12 ' A' ' 160' ' ' VAL . 1.8 t70 76.09 -59.63 0.51 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.354 179.953 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.438 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 85.13 -46.3 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.927 -179.463 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.421 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 1.3 m-85 -75.49 8.62 2.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.256 179.381 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -164.46 11.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.874 -179.744 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.423 ' CG ' ' HD3' ' A' ' 167' ' ' PRO . 0.9 OUTLIER -69.47 -38.89 77.91 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.542 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.487 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 0.9 OUTLIER 48.94 29.2 2.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.317 179.843 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.487 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.2 OUTLIER 89.7 -30.71 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.209 -179.45 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -165.24 83.77 1.1 Allowed Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.683 -178.804 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.546 ' HG2' ' HD3' ' A' ' 168' ' ' PRO . 8.8 Cg_endo -59.03 -36.62 96.27 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.121 1.881 . . . . 0.0 113.257 -179.975 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.546 ' HD3' ' HG2' ' A' ' 167' ' ' PRO . 25.2 Cg_endo -93.43 84.48 0.17 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.488 2.125 . . . . 0.0 112.848 -179.481 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.467 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 18.4 pt -75.13 -44.4 43.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.336 179.94 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.443 ' N ' HG13 ' A' ' 169' ' ' ILE . 3.1 mp -78.71 -43.36 25.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.483 -179.974 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.408 ' N ' ' CD2' ' A' ' 171' ' ' LEU . 2.5 mm? -64.6 -58.93 4.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.104 0.478 . . . . 0.0 109.773 179.852 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -74.32 4.7 5.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.256 179.01 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.08 -52.75 15.37 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.548 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -121.43 -5.82 9.16 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.793 178.76 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.415 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 85.1 t80 68.99 -53.59 0.57 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.547 0.339 . . . . 0.0 111.574 179.981 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.406 ' O ' ' CG ' ' A' ' 176' ' ' PHE . 27.7 t80 -92.93 -7.18 46.79 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.587 0.232 . . . . 0.0 111.171 -179.802 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.55 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 38.9 mt -55.35 -42.45 96.03 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.265 179.57 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 49.5 Cg_exo -56.51 79.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.74 2.293 . . . . 0.0 112.617 -179.991 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 177' ' ' LEU . 1.0 OUTLIER -82.85 -68.5 0.7 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.291 179.481 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.31 45.05 1.25 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.127 179.118 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.417 ' O ' ' CD2' ' A' ' 156' ' ' LEU . 15.5 p90 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.655 0.264 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.417 ' CD2' ' O ' ' A' ' 155' ' ' PHE . 98.0 mt -160.41 132.23 6.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.517 -179.99 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -171.24 -31.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.399 -179.886 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.1 m -73.38 62.55 0.72 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.13 0.49 . . . . 0.0 110.701 -179.964 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.408 ' OD1' ' CZ ' ' A' ' 161' ' ' PHE . 0.2 OUTLIER 76.92 -63.81 0.36 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.483 -179.743 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.403 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 71.61 -46.63 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.76 179.568 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.42 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 6.8 p90 -71.94 -4.84 30.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.485 -179.743 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.42 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 8.5 m-85 -164.01 15.67 0.06 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.629 179.708 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 18.6 tp -68.84 -6.1 24.94 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.353 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -75.84 -19.93 58.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.654 -179.487 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.3 mt -63.55 -51.16 66.59 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.267 0.555 . . . . 0.0 110.46 179.788 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.417 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 0.9 OUTLIER -161.34 77.54 2.31 Favored Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.973 -178.413 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -63.43 111.57 1.5 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.195 1.93 . . . . 0.0 112.015 -179.489 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -83.46 -166.04 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.95 2.433 . . . . 0.0 112.303 -179.879 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.499 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 17.0 tt -171.85 -44.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.484 179.96 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.535 ' HA ' ' HB2' ' A' ' 173' ' ' ALA . 3.3 pt -71.82 -43.55 69.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 114.16 -1.382 . . . . 0.0 111.827 -178.524 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.401 ' HA ' ' HG2' ' A' ' 178' ' ' PRO . 8.9 mt -63.06 -51.6 66.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.975 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -75.02 -8.24 55.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.312 178.227 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.535 ' HB2' ' HA ' ' A' ' 170' ' ' ILE . . . -75.14 -76.15 0.15 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.123 0.487 . . . . 0.0 110.191 179.71 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -114.82 -14.19 8.82 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.914 179.12 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 32.6 t80 77.48 -43.47 0.41 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 179.668 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -96.29 -8.16 33.48 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.57 0.224 . . . . 0.0 111.595 -179.878 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.625 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 21.3 mt -73.84 -35.59 2.53 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 179.94 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 43.9 Cg_exo -55.63 -154.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.548 2.165 . . . . 0.0 112.812 -179.546 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.4 tp 77.27 68.47 0.05 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.133 0.492 . . . . 0.0 110.202 -179.51 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.57 60.36 1.67 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.438 -179.527 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.406 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 51.0 p90 . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.66 0.266 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 155' ' ' PHE . 81.5 mt -161.6 -179.04 6.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.745 -179.991 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.4 87.59 0.13 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.769 179.966 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.6 p 78.77 -56.0 0.45 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.436 0.636 . . . . 0.0 111.522 179.946 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.561 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 2.0 t0 -167.93 -31.76 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.214 -179.887 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.561 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 83.1 t 82.93 -55.12 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.699 -179.775 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.462 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 2.3 m-85 -75.06 32.34 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.362 179.354 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.462 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 22.2 m-85 -169.96 -17.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.494 179.941 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.522 ' C ' ' H ' ' A' ' 165' ' ' LEU . 20.7 tp -57.78 -44.04 85.95 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.544 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 2.6 t80 61.87 -13.25 0.05 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 177.64 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.522 ' H ' ' C ' ' A' ' 163' ' ' LEU . 0.3 OUTLIER -66.67 -39.99 88.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.855 0.359 . . . . 0.0 111.059 -179.965 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -160.19 95.84 1.53 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.523 -179.37 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.11 113.83 2.77 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.271 1.981 . . . . 0.0 112.947 -179.397 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -83.51 93.73 0.81 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.173 2.582 . . . . 0.0 111.445 179.21 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.513 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 0.1 OUTLIER -159.14 -45.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.517 -179.108 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.513 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.3 pp -76.1 -49.71 24.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.224 -178.271 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 3.4 pp -67.47 -48.58 66.77 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.988 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.95 -2.37 23.73 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.922 178.655 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -71.73 -70.8 0.3 Allowed 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.539 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.467 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -110.86 -23.66 5.8 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.131 -0.787 . . . . 0.0 111.131 178.127 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER 71.25 -13.53 0.52 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.398 0.279 . . . . 0.0 111.199 -179.726 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.467 ' H ' ' C ' ' A' ' 174' ' ' GLY . 36.7 p90 -95.28 -8.72 35.16 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.752 0.31 . . . . 0.0 110.256 179.189 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.572 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 3.5 mm? -46.53 -46.01 46.96 Favored Pre-proline 0 CA--C 1.529 0.156 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.441 179.32 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.572 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 18.9 Cg_exo -68.9 59.11 1.2 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.006 2.471 . . . . 0.0 112.311 179.665 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.59 -4.21 53.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.863 0.363 . . . . 0.0 111.22 179.849 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.44 47.1 0.89 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.542 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.79 0.329 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.2 pp -165.33 77.28 0.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.106 0.479 . . . . 0.0 111.065 -179.91 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -81.5 25.36 0.52 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.176 179.494 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.8 t 76.14 27.66 0.88 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.947 0.403 . . . . 0.0 110.785 -179.509 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.488 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 10.3 m-20 -159.39 -51.87 0.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.796 179.755 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 94.9 t 76.45 -58.58 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.396 179.273 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.428 ' O ' ' HB3' ' A' ' 164' ' ' PHE . 97.5 m-85 -65.61 -30.07 70.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.127 0.489 . . . . 0.0 110.325 179.831 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.09 -61.36 1.84 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.691 178.985 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.435 ' HG ' ' HA ' ' A' ' 167' ' ' PRO . 4.2 tp -67.16 -3.07 6.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.468 179.143 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.471 ' CB ' ' O ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER -75.15 -33.88 61.55 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.476 -178.763 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.41 HD21 ' CD2' ' A' ' 164' ' ' PHE . 3.3 mt -63.08 -41.8 99.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.921 0.391 . . . . 0.0 110.617 179.836 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.468 ' CG ' ' O ' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -160.9 98.66 1.33 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.791 -179.051 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.584 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 59.3 Cg_endo -73.72 -21.64 18.77 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 122.787 2.325 . . . . 0.0 115.85 -178.159 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 23.0 Cg_endo -91.12 22.88 0.67 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.799 1.666 . . . . 0.0 113.853 -178.581 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.46 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 5.6 tp -78.89 -38.07 20.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.964 0.411 . . . . 0.0 111.122 179.656 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.42 ' O ' ' HB1' ' A' ' 173' ' ' ALA . 7.4 mm -73.94 -49.83 32.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.916 -178.927 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.7 -48.0 76.29 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.609 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -76.5 -1.35 26.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.956 178.488 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.62 -57.35 4.2 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.818 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.47 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -115.02 -15.12 8.03 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.663 178.757 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 68.66 -10.11 0.5 Allowed 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 122.3 0.24 . . . . 0.0 111.567 -179.766 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.47 ' H ' ' C ' ' A' ' 174' ' ' GLY . 7.4 m-85 -91.84 -0.9 57.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.734 0.302 . . . . 0.0 110.389 179.463 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.454 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.4 OUTLIER -53.62 -51.84 72.61 Favored Pre-proline 0 N--CA 1.456 -0.156 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.082 179.207 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 31.7 Cg_exo -60.52 81.76 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.866 2.377 . . . . 0.0 111.613 179.167 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 98.8 mt -93.3 -75.63 0.49 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.295 -179.364 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 13.9 mmp_? -86.87 30.59 0.74 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.912 -179.841 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 120.914 0.388 . . . . 0.0 111.511 . . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 9.4 mt 65.37 -179.04 0.19 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.82 -179.882 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.413 ' O ' ' HB3' ' A' ' 158' ' ' SER . 0.9 OUTLIER -170.47 41.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.881 -179.928 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.413 ' HB3' ' O ' ' A' ' 157' ' ' GLN . 1.8 t 68.48 -59.87 0.44 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.366 0.603 . . . . 0.0 111.271 -179.99 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 161' ' ' PHE . 1.0 OUTLIER -148.27 -22.85 0.34 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.577 -179.865 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.553 HG12 ' N ' ' A' ' 161' ' ' PHE . 9.8 p 56.95 -50.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.374 0.67 . . . . 0.0 112.588 179.941 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.553 ' N ' HG12 ' A' ' 160' ' ' VAL . 0.3 OUTLIER -71.24 -1.34 12.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.465 0.174 . . . . 0.0 110.978 179.194 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.433 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 9.7 m-85 -164.82 12.83 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.899 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.435 ' HG ' ' HB2' ' A' ' 165' ' ' LEU . 61.5 tp -69.24 -32.49 71.75 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.451 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.473 ' CG ' ' O ' ' A' ' 164' ' ' PHE . 0.0 OUTLIER 66.13 1.75 2.07 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.101 179.047 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.435 ' HB2' ' HG ' ' A' ' 163' ' ' LEU . 0.1 OUTLIER -67.37 -67.38 0.46 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.87 0.367 . . . . 0.0 110.841 179.424 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.434 ' N ' ' HD3' ' A' ' 167' ' ' PRO . 0.2 OUTLIER -160.76 61.33 1.46 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.874 -179.657 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.462 ' HB2' ' HD3' ' A' ' 168' ' ' PRO . 36.1 Cg_exo -57.97 -47.93 18.48 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.596 2.198 . . . . 0.0 112.622 -179.919 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.462 ' HD3' ' HB2' ' A' ' 167' ' ' PRO . 36.1 Cg_endo -92.28 45.24 0.41 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.879 2.386 . . . . 0.0 112.705 -179.502 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.453 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -75.76 -37.13 35.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.047 0.451 . . . . 0.0 111.053 -179.879 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.402 ' CD1' ' CG2' ' A' ' 169' ' ' ILE . 8.1 mm -73.56 -42.35 55.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.523 -179.454 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.64 -56.05 14.24 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.471 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -74.52 0.54 14.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.008 178.701 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -71.64 -57.35 4.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.285 0.564 . . . . 0.0 109.5 179.662 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -112.66 -22.14 5.84 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.309 178.558 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 70.08 -53.07 0.63 Allowed 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 122.476 0.31 . . . . 0.0 111.45 179.815 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.48 1.8 56.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.803 0.335 . . . . 0.0 110.734 179.789 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.476 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.1 OUTLIER -60.55 -49.4 90.16 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.565 179.547 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 54.7 Cg_exo -52.95 83.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.81 2.34 . . . . 0.0 112.426 179.97 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 177' ' ' LEU . 3.5 mp -130.56 -69.11 0.66 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.369 179.801 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 0.0 OUTLIER -86.95 25.75 1.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.188 179.3 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.462 ' N ' ' CD1' ' A' ' 155' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 120.453 0.168 . . . . 0.0 111.233 . . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.7 pp -165.74 145.41 6.44 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.837 0.351 . . . . 0.0 110.906 -179.927 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.99 61.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.406 0.622 . . . . 0.0 110.927 179.79 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 59.7 p -165.13 45.52 0.09 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.808 179.533 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.469 ' O ' HG13 ' A' ' 160' ' ' VAL . 0.3 OUTLIER 78.25 -56.89 0.47 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.115 -178.42 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 66.23 -56.44 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.351 179.848 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.499 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 5.9 p90 -79.21 17.97 0.73 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.158 179.051 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.419 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 2.9 m-85 -169.68 0.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.563 -179.893 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 30.1 tp -63.03 -20.43 65.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.701 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 1.5 t80 60.42 81.57 0.18 Allowed 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.04 179.098 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.9 tp -170.51 -52.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.038 179.989 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.421 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 0.1 OUTLIER -161.2 54.34 0.54 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.204 -179.806 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 10.7 Cg_endo -54.2 104.83 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.85 2.366 . . . . 0.0 112.842 -179.464 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 166' ' ' LEU . 62.8 Cg_endo -71.41 82.17 1.15 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.721 2.281 . . . . 0.0 111.36 179.084 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.477 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -75.82 -36.93 34.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.348 -179.151 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.444 ' CD1' ' CG2' ' A' ' 169' ' ' ILE . 7.0 mm -76.95 -50.12 21.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.893 -179.506 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.5 mp -64.08 -52.31 59.89 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.592 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -74.01 0.61 13.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.012 178.48 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.15 -52.26 17.49 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.372 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.572 ' N ' ' HG2' ' A' ' 178' ' ' PRO . . . -126.48 -25.33 1.3 Allowed Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.519 178.782 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 7.8 t80 79.44 -21.63 0.32 Allowed 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.231 0.613 . . . . 0.0 112.275 179.62 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -94.7 53.71 1.67 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.405 0.622 . . . . 0.0 109.341 179.093 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.719 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 1.3 mt 48.36 51.81 11.45 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.906 -178.482 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.719 ' HD3' ' N ' ' A' ' 177' ' ' LEU . 11.8 Cg_exo -74.85 72.58 4.5 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 123.604 2.87 . . . . 0.0 112.421 -179.748 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.35 -45.01 6.97 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.227 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.464 ' N ' ' HD2' ' A' ' 180' ' ' ARG . 0.0 OUTLIER -90.21 20.92 4.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.97 179.19 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.842 0.353 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 99.8 mt -72.99 85.61 1.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.751 179.894 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -170.13 -38.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.444 -179.908 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.459 ' O ' ' CB ' ' A' ' 159' ' ' ASP . 53.9 p -74.85 66.32 1.5 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.611 179.215 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.465 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 3.8 t0 87.6 -50.07 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.985 -179.186 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 80.6 t 73.86 -47.87 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.649 0.262 . . . . 0.0 111.203 179.797 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.83 12.69 0.36 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.339 179.502 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.439 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 87.7 t80 -165.16 3.24 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.505 179.799 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.1 tp -61.68 -31.34 71.46 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.647 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.453 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 7.1 t80 44.43 38.36 2.53 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.396 177.671 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.453 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.2 OUTLIER 86.54 -31.7 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.038 -179.676 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.16 131.06 3.04 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.396 -179.242 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.87 112.62 3.44 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.457 2.105 . . . . 0.0 112.511 -179.522 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.18 76.51 0.91 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.489 2.126 . . . . 0.0 112.541 -179.966 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.424 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 8.4 tt -75.51 -41.87 42.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.166 0.508 . . . . 0.0 110.796 179.726 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.446 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 1.9 mp -71.07 -37.37 66.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.94 -179.875 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.39 -55.42 18.22 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.784 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.74 1.3 17.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.04 178.432 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 170' ' ' ILE . . . -73.4 -45.68 53.25 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-O 121.05 0.452 . . . . 0.0 110.157 -179.869 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.583 ' H ' ' HG2' ' A' ' 178' ' ' PRO . . . -117.99 -20.68 4.41 Favored Glycine 0 N--CA 1.452 -0.281 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 178.688 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.434 ' HB2' ' O ' ' A' ' 174' ' ' GLY . 57.6 m-85 69.44 -12.64 0.42 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 179.0 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.427 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 0.6 OUTLIER -94.73 37.67 1.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.455 0.645 . . . . 0.0 109.26 178.638 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.554 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 17.2 mt 62.34 43.34 0.55 Allowed Pre-proline 0 N--CA 1.453 -0.292 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.999 -178.869 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.583 ' HG2' ' H ' ' A' ' 174' ' ' GLY . 32.5 Cg_exo -40.16 -80.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.907 2.405 . . . . 0.0 113.147 179.635 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.403 ' H ' ' HB2' ' A' ' 178' ' ' PRO . 50.0 mt 53.72 48.46 21.45 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.976 0.417 . . . . 0.0 110.728 -179.835 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.45 47.23 5.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.716 -179.767 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . 0.491 ' HB3' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.857 0.361 . . . . 0.0 111.314 . . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.405 ' HA ' HD12 ' A' ' 163' ' ' LEU . 5.3 mp -72.84 -177.2 2.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.034 -179.806 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 80.34 35.27 0.13 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.289 0.566 . . . . 0.0 110.501 -179.879 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -164.72 75.85 0.29 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.711 179.47 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 76.94 -57.18 0.53 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.566 -178.944 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 70.65 -45.17 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 120.742 0.306 . . . . 0.0 111.63 179.649 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.405 ' CE1' ' HB2' ' A' ' 162' ' ' PHE . 0.1 OUTLIER -72.62 -3.19 23.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.988 0.423 . . . . 0.0 110.765 179.663 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.413 ' C ' ' H ' ' A' ' 164' ' ' PHE . 0.1 OUTLIER -162.86 19.81 0.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.201 179.642 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 156' ' ' LEU . 0.8 OUTLIER -68.61 -5.24 18.85 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.815 0.817 . . . . 0.0 109.131 177.59 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.413 ' H ' ' C ' ' A' ' 162' ' ' PHE . 2.0 m-85 -71.07 -67.48 0.51 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.853 -179.481 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -65.27 -74.82 0.1 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.929 0.395 . . . . 0.0 110.908 179.861 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.8 mt -164.44 101.35 0.86 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.946 -179.29 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.62 111.72 2.43 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.223 1.949 . . . . 0.0 112.347 179.981 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.22 48.84 2.82 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.778 2.318 . . . . 0.0 112.83 -179.923 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.408 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 10.8 pt -75.77 -36.09 32.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.965 0.412 . . . . 0.0 110.888 179.695 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 10.7 mm -77.12 -42.56 31.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.41 -179.848 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.97 -57.03 9.79 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.535 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.09 4.55 6.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.119 178.671 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -71.59 -47.27 55.91 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.287 0.565 . . . . 0.0 109.501 179.616 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.518 ' H ' ' HG2' ' A' ' 178' ' ' PRO . . . -121.09 -28.05 1.74 Allowed Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 178.338 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 46.9 t80 77.0 -13.74 0.91 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.314 0.646 . . . . 0.0 112.501 179.184 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.431 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 42.2 p90 -95.36 37.9 1.16 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.665 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.574 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 4.4 mt 62.5 43.05 0.51 Allowed Pre-proline 0 N--CA 1.453 -0.319 0 CA-C-N 115.041 -0.982 . . . . 0.0 111.234 -178.973 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.574 ' HD3' ' N ' ' A' ' 177' ' ' LEU . 36.5 Cg_exo -41.77 -70.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.835 2.357 . . . . 0.0 112.886 179.391 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 56.35 54.67 7.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.13 0.49 . . . . 0.0 110.481 -179.837 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 62.48 57.14 1.93 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.286 -179.306 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . 0.507 ' HB3' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 6.2 p90 . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 121.005 0.431 . . . . 0.0 111.358 . . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.442 ' N ' ' CD2' ' A' ' 156' ' ' LEU . 0.1 OUTLIER -74.66 -41.44 60.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.138 -179.815 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.476 ' HB3' ' HB2' ' A' ' 163' ' ' LEU . 10.2 tp-100 66.91 19.67 10.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.994 0.426 . . . . 0.0 110.921 -179.763 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 32.7 t 45.97 53.91 8.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.763 179.948 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -162.75 -68.2 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.697 179.152 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.418 HG11 ' N ' ' A' ' 161' ' ' PHE . 1.1 t 69.5 -58.95 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.849 179.452 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.418 ' N ' HG11 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -74.24 16.02 0.28 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.194 179.954 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -172.18 -7.14 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 179.958 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.537 ' HG ' ' H ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER -61.14 -42.39 98.45 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.011 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.468 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 0.0 OUTLIER 42.16 36.45 0.71 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.499 176.864 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.537 ' H ' ' HG ' ' A' ' 163' ' ' LEU . 0.2 OUTLIER 88.18 -33.01 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.651 -179.197 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 163' ' ' LEU . 0.7 OUTLIER -166.01 99.49 0.73 Allowed Pre-proline 0 N--CA 1.451 -0.412 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.389 -179.116 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -62.4 117.01 3.87 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.093 1.862 . . . . 0.0 112.36 -179.578 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -89.94 -160.24 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.213 2.609 . . . . 0.0 112.469 -179.828 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 0.1 OUTLIER -166.56 -46.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.711 179.566 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.459 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.4 mp -78.35 -42.57 26.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.803 179.504 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.5 mt -64.38 -56.95 10.9 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.429 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -74.45 2.48 9.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.087 178.685 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.77 -60.71 2.1 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-O 121.151 0.501 . . . . 0.0 109.731 179.737 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -115.53 -11.35 10.56 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.626 178.769 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.482 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 64.0 t80 72.47 -17.29 0.39 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.787 0.435 . . . . 0.0 112.119 179.903 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.416 ' H ' ' C ' ' A' ' 174' ' ' GLY . 0.4 OUTLIER -99.53 -18.23 17.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.795 0.331 . . . . 0.0 111.004 179.765 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.555 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 45.1 mt -61.86 -39.18 57.06 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.884 179.982 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 81.5 Cg_exo -47.11 -179.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.475 2.117 . . . . 0.0 112.856 -179.599 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.521 ' HB2' ' O ' ' A' ' 178' ' ' PRO . 3.2 mm? 74.55 71.85 0.1 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.198 -179.297 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 19.3 mtm180 69.8 57.71 0.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.666 -179.533 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . 0.511 ' HB2' ' O ' ' A' ' 177' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.428 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 64.6 m-85 . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.729 0.299 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 155' ' ' PHE . 38.0 mt -162.32 -170.71 2.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.567 179.999 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -167.66 81.25 0.19 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.916 0.388 . . . . 0.0 110.944 -179.891 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.6 m 58.99 64.08 1.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.542 -179.897 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 71.42 -60.05 0.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.691 -179.586 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 73.39 -49.82 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.323 179.837 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.427 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 3.2 t80 -74.0 1.74 10.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.969 179.503 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.425 ' CD1' ' O ' ' A' ' 161' ' ' PHE . 0.9 OUTLIER -158.9 9.74 0.13 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.14 179.753 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 30.6 tp -69.36 -5.37 22.98 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.748 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.479 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 25.4 t80 -77.22 17.14 0.5 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.618 -179.11 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.479 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.1 OUTLIER 85.64 -23.35 0.16 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 179.394 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.46 146.31 13.68 Favored Pre-proline 0 C--N 1.323 -0.551 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.769 -178.334 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -75.06 117.25 4.83 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.513 2.142 . . . . 0.0 113.2 -179.182 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.409 ' O ' ' CB ' ' A' ' 172' ' ' ASP . 46.1 Cg_endo -88.23 26.89 0.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 123.271 2.647 . . . . 0.0 112.42 179.533 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.471 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -73.73 -37.23 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 111.566 -179.286 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.406 ' O ' ' HB1' ' A' ' 173' ' ' ALA . 2.4 mp -74.67 -56.67 8.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.868 -179.27 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -53.25 40.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.907 0.384 . . . . 0.0 110.813 -179.675 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.409 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 0.7 OUTLIER -75.43 8.75 2.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.979 179.771 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.471 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.31 -67.58 0.54 Allowed 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.357 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.632 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -117.91 8.43 14.61 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 178.034 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.472 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER 53.72 -63.34 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.005 0.922 . . . . 0.0 111.638 179.846 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.632 ' N ' ' O ' ' A' ' 174' ' ' GLY . 11.8 t80 -102.31 0.47 34.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.293 179.639 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.52 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 70.2 mt -83.33 -43.73 0.84 Allowed Pre-proline 0 CA--C 1.53 0.197 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -179.811 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 34.7 Cg_exo -58.02 -154.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.342 2.028 . . . . 0.0 112.222 -179.84 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 71.42 67.24 0.16 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.053 0.454 . . . . 0.0 110.441 -179.694 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 63.68 59.71 1.15 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.492 -179.63 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.447 ' O ' ' O ' ' A' ' 156' ' ' LEU . 21.4 m-85 . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.791 0.329 . . . . 0.0 111.3 . . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 155' ' ' PHE . 3.6 pp 43.28 -178.14 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.289 179.639 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 17.3 tp60 -172.25 -85.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.137 179.963 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.404 ' O ' ' CB ' ' A' ' 159' ' ' ASP . 0.5 OUTLIER -75.87 61.9 1.51 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.928 0.394 . . . . 0.0 110.348 179.691 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.408 ' O ' ' CB ' ' A' ' 160' ' ' VAL . 4.3 t0 79.61 -47.19 0.36 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.363 -179.636 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.444 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 83.82 -51.5 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.882 0.372 . . . . 0.0 110.453 -179.588 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.444 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 63.6 t80 -76.67 35.21 0.15 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.137 179.286 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.424 ' H ' ' C ' ' A' ' 160' ' ' VAL . 2.1 m-85 -172.02 -19.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 179.973 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.1 mt -57.69 -41.94 82.63 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.397 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 44.05 55.13 5.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.008 178.097 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 tp -172.62 -29.49 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -179.297 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.402 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 1.6 mt -156.55 54.63 0.91 Allowed Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.979 0.418 . . . . 0.0 111.188 -178.396 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.408 ' CB ' ' HD3' ' A' ' 168' ' ' PRO . 2.8 Cg_exo -40.45 -49.84 3.9 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.255 2.637 . . . . 0.0 113.083 179.946 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.415 ' O ' HG22 ' A' ' 169' ' ' ILE . 60.9 Cg_endo -88.17 -47.66 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.285 1.99 . . . . 0.0 113.113 -179.258 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.5 OUTLIER 80.94 -33.85 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.811 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 3.9 mp -81.66 -61.87 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.937 0.398 . . . . 0.0 111.752 -179.616 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.42 ' N ' ' CD2' ' A' ' 171' ' ' LEU . 2.5 mm? -67.5 -51.26 53.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.891 -179.489 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -73.45 4.19 5.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.96 -179.796 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.476 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -73.19 -65.71 0.77 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.33 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -108.45 -24.74 6.05 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 178.113 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 75.43 -25.13 0.21 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.645 0.378 . . . . 0.0 111.537 179.814 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.434 ' H ' ' C ' ' A' ' 174' ' ' GLY . 11.6 m-85 -95.37 -2.43 49.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.702 0.287 . . . . 0.0 110.971 179.728 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.56 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 4.9 mt -56.14 -43.28 99.18 Favored Pre-proline 0 CA--C 1.53 0.194 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.767 179.457 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.57 ' O ' ' HB2' ' A' ' 179' ' ' LEU . 55.9 Cg_exo -54.15 -155.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.769 2.313 . . . . 0.0 112.561 179.816 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.57 ' HB2' ' O ' ' A' ' 178' ' ' PRO . 1.2 mt 87.92 80.81 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 122.927 0.491 . . . . 0.0 109.998 -179.285 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER 70.95 28.34 3.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.019 -179.554 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 33.5 p90 . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.75 0.31 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.0 mp -163.91 146.87 9.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.775 179.893 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -172.05 89.57 0.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.683 -179.977 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.8 t 79.67 -53.64 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.372 0.606 . . . . 0.0 111.845 179.832 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.568 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 1.0 OUTLIER -165.73 -29.93 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.784 -179.772 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.568 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 81.3 t 83.16 -53.51 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.627 -179.759 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.452 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 66.4 m-85 -74.91 32.67 0.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.128 179.065 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.487 ' H ' ' C ' ' A' ' 160' ' ' VAL . 8.0 m-85 -167.67 -12.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.443 -179.89 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.407 ' HG ' ' HD3' ' A' ' 167' ' ' PRO . 1.2 tp -61.12 -29.76 69.96 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.853 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.441 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 9.3 t80 51.56 23.38 1.86 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.049 178.714 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.441 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.1 OUTLIER 83.06 -19.82 0.37 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.637 -179.862 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.426 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 0.1 OUTLIER -167.17 83.61 0.86 Allowed Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.526 -178.509 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.454 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 2.7 Cg_exo -39.38 -47.03 3.28 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.09 2.527 . . . . 0.0 112.922 179.78 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 41.3 Cg_endo -90.38 81.44 0.51 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.733 2.289 . . . . 0.0 112.724 -179.346 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.43 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 8.7 pt -76.38 -34.48 25.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.533 -179.967 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.421 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 3.8 mp -75.76 -52.78 17.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.729 -179.352 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.86 -51.41 59.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.058 0.456 . . . . 0.0 109.976 179.849 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.63 3.5 7.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.519 179.209 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.43 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.24 -63.71 1.09 Allowed 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.576 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.44 ' HA3' ' CG ' ' A' ' 177' ' ' LEU . . . -112.62 -11.49 14.71 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.353 178.368 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 3.8 t80 72.57 -55.6 0.67 Allowed 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.53 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.2 21.65 6.7 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.276 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.458 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 5.9 mt -88.43 -48.17 0.44 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.023 179.618 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.458 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 45.2 Cg_exo -57.07 -20.32 36.93 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.417 2.078 . . . . 0.0 112.44 179.983 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 9.1 mp -73.76 -7.22 51.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.428 -179.846 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 45.01 0.94 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.961 0.41 . . . . 0.0 110.306 179.822 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 12.6 p90 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.966 0.412 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.431 ' HG ' ' N ' ' A' ' 157' ' ' GLN . 2.3 pt? -166.8 -37.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.094 -179.854 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.431 ' N ' ' HG ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -74.51 6.77 3.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.787 179.718 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 159' ' ' ASP . 46.9 t -74.01 61.37 0.81 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.997 0.427 . . . . 0.0 111.081 -179.613 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.444 ' C ' ' H ' ' A' ' 161' ' ' PHE . 15.3 m-20 68.87 -64.78 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.84 179.858 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 69.64 -42.74 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.781 179.808 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.444 ' H ' ' C ' ' A' ' 159' ' ' ASP . 1.2 p90 -72.18 -5.31 34.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.957 179.735 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.421 ' CD1' ' O ' ' A' ' 161' ' ' PHE . 21.5 m-85 -162.29 21.9 0.1 Allowed 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.371 179.492 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.3 tp -66.15 -10.73 43.84 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.158 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -82.64 31.92 0.41 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.9 -179.859 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -171.38 -46.78 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.732 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.417 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 0.3 OUTLIER -158.75 91.28 2.04 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.07 -178.124 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.557 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 16.7 Cg_endo -63.91 -31.81 66.73 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.544 2.162 . . . . 0.0 114.162 -179.789 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 29.7 Cg_endo -89.37 47.04 0.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 121.739 1.626 . . . . 0.0 113.206 -179.058 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.497 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 7.4 tt -77.31 -37.37 25.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.176 0.512 . . . . 0.0 110.694 179.393 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.401 ' HA ' ' HB1' ' A' ' 173' ' ' ALA . 10.2 mm -69.65 -38.53 76.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.286 -179.217 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 82.7 mt -64.86 -58.82 5.17 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.102 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.72 0.21 16.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.166 178.597 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.497 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.88 -62.11 1.57 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.162 0.506 . . . . 0.0 109.748 179.737 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -113.27 -12.31 12.2 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.752 178.891 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 8.0 t80 73.11 -53.34 0.7 Allowed 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 122.48 0.312 . . . . 0.0 111.687 179.793 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.62 -7.91 45.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.68 0.276 . . . . 0.0 110.915 179.882 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.522 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 15.3 mt -52.81 -44.6 96.42 Favored Pre-proline 0 CA--C 1.529 0.165 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.255 179.693 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 50.2 Cg_exo -54.89 -162.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.522 2.148 . . . . 0.0 112.237 179.923 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 71.57 69.18 0.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.145 0.497 . . . . 0.0 110.169 -179.677 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 66.16 58.35 0.72 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.561 -179.632 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . 0.404 ' HB3' ' O ' ' A' ' 177' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.9 0.381 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.8 mt 55.15 -92.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.864 -179.866 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.451 ' HB3' ' CD2' ' A' ' 163' ' ' LEU . 8.6 mt-30 52.3 22.87 2.17 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.776 0.322 . . . . 0.0 111.397 179.745 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.1 t 77.93 -11.0 1.26 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 179.838 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -167.49 -38.74 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.557 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.526 ' O ' ' CB ' ' A' ' 164' ' ' PHE . 0.4 OUTLIER 84.08 -51.93 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.583 179.209 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.461 ' O ' ' HB3' ' A' ' 164' ' ' PHE . 0.2 OUTLIER -69.19 -37.37 78.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.35 0.595 . . . . 0.0 110.371 179.824 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.42 ' C ' ' H ' ' A' ' 164' ' ' PHE . 1.2 m-85 -72.84 -62.9 1.29 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.276 179.695 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.451 ' CD2' ' HB3' ' A' ' 157' ' ' GLN . 2.5 tp -66.19 -0.49 2.54 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.164 179.737 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.526 ' CB ' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER -68.83 -13.84 62.66 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.295 -178.974 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.63 -38.87 92.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.456 0.646 . . . . 0.0 109.88 178.857 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.63 97.55 1.25 Allowed Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.704 -179.156 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.55 117.16 3.89 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.51 2.14 . . . . 0.0 112.98 -178.976 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.41 ' HD3' ' HG ' ' A' ' 163' ' ' LEU . 57.3 Cg_endo -86.73 90.16 0.62 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.164 2.576 . . . . 0.0 112.516 179.866 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.467 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 7.2 tp -72.96 -41.15 60.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.171 0.51 . . . . 0.0 110.645 179.792 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.464 ' HA ' ' HB1' ' A' ' 173' ' ' ALA . 1.3 mp -71.63 -40.64 71.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.796 179.952 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 0.8 OUTLIER -66.63 -51.01 61.08 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.659 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -73.37 -8.23 54.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.079 178.032 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -74.64 -64.68 0.98 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.141 0.496 . . . . 0.0 110.119 179.667 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -123.64 -14.46 3.89 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.397 179.459 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 6.9 t80 77.87 -11.03 1.26 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 179.858 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -137.15 9.69 3.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.62 0.248 . . . . 0.0 111.217 179.73 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.552 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 74.4 mt -90.27 -38.15 0.41 Allowed Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.783 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 81.0 Cg_exo -43.17 -78.1 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.366 2.044 . . . . 0.0 113.151 -179.353 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 53.93 50.52 16.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.151 0.501 . . . . 0.0 110.402 -179.648 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.74 47.96 3.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.673 -179.533 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . 0.425 ' HB3' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.809 0.338 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.407 ' HB2' HG21 ' A' ' 160' ' ' VAL . 4.6 pp -163.34 21.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.486 -179.773 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.4 -34.19 54.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.12 0.485 . . . . 0.0 110.414 179.508 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.507 ' O ' ' HB2' ' A' ' 162' ' ' PHE . 0.8 OUTLIER -80.13 35.79 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.382 -179.275 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.581 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.3 OUTLIER 75.25 -14.77 0.73 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 179.652 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.581 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 62.1 t 87.23 -48.67 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 C-N-CA 122.849 0.46 . . . . 0.0 111.983 179.522 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -66.19 -32.83 74.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.911 0.386 . . . . 0.0 111.276 -179.407 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.507 ' HB2' ' O ' ' A' ' 158' ' ' SER . 0.6 OUTLIER -67.87 -57.87 5.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.857 179.758 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 18.5 mt -66.09 -3.68 5.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.465 0.65 . . . . 0.0 109.693 178.432 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.489 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER -76.71 2.21 14.91 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.753 -179.506 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.9 tp -173.6 -38.74 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 120.773 0.32 . . . . 0.0 111.123 179.98 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.503 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 0.7 OUTLIER -159.33 123.28 2.08 Favored Pre-proline 0 N--CA 1.451 -0.396 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.67 -178.626 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.591 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 37.6 Cg_endo -69.06 -25.67 31.63 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.475 2.117 . . . . 0.0 114.549 -179.924 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 23.8 Cg_endo -87.22 -152.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.761 1.641 . . . . 0.0 113.117 -179.252 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.421 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 7.3 tp -157.78 -40.03 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.322 0.582 . . . . 0.0 109.814 -179.37 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.421 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.7 mp -68.28 -23.11 28.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.828 178.822 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.37 -65.95 0.61 Allowed 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.385 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -76.69 7.15 4.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.802 178.092 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.408 ' CB ' ' HA ' ' A' ' 170' ' ' ILE . . . -70.21 -51.21 32.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.734 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -104.83 -19.17 11.23 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 177.811 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 16.5 t80 75.66 -10.19 1.3 Allowed 'General case' 0 C--O 1.23 0.075 0 C-N-CA 122.841 0.456 . . . . 0.0 112.005 179.626 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -96.45 -0.16 49.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.788 0.328 . . . . 0.0 110.72 179.531 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.453 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 1.0 OUTLIER -60.38 -49.31 90.93 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.25 -179.939 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.453 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 82.1 Cg_exo -45.56 -63.36 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.65 2.234 . . . . 0.0 112.669 -179.793 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.94 61.94 0.62 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.177 0.513 . . . . 0.0 110.556 -179.892 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.17 47.81 3.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.785 -179.872 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 120.911 0.386 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.3 pp -164.74 45.73 0.1 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.981 -179.752 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.09 -35.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.517 179.828 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.36 61.51 0.66 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.128 0.489 . . . . 0.0 110.239 179.641 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 73.24 -60.62 0.53 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.589 -179.388 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.3 t 69.28 -58.92 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.368 179.85 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -75.64 8.54 2.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.121 -179.838 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -167.18 9.0 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 179.949 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 165' ' ' LEU . 18.5 tp -64.22 -30.35 71.41 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.083 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' A' ' 163' ' ' LEU . 0.1 OUTLIER 63.47 -9.51 0.13 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.71 -1.132 . . . . 0.0 112.486 178.505 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.49 ' H ' ' C ' ' A' ' 163' ' ' LEU . 8.7 mt -69.76 -76.25 0.1 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.162 0.506 . . . . 0.0 110.71 179.234 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.419 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 0.2 OUTLIER -163.62 53.37 0.36 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.834 -179.5 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 9.5 Cg_endo -53.69 106.93 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.727 2.285 . . . . 0.0 113.025 -179.023 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -78.73 48.63 2.84 Favored 'Trans proline' 0 CA--C 1.527 0.164 0 C-N-CA 122.974 2.45 . . . . 0.0 112.05 179.082 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 14.7 tt -77.35 -43.71 30.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.372 0.606 . . . . 0.0 111.502 -179.486 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.492 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.0 OUTLIER -71.61 -45.19 68.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.487 -177.813 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.74 -55.21 24.97 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.506 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -76.11 3.26 10.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.384 178.797 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -73.01 -52.67 13.51 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.258 0.551 . . . . 0.0 109.894 179.9 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.682 ' H ' ' HG2' ' A' ' 178' ' ' PRO . . . -121.77 -19.8 3.29 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.22 178.738 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.431 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 62.0 t80 74.28 -12.96 0.83 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.101 0.56 . . . . 0.0 112.127 179.628 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -93.96 45.84 1.16 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.729 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.664 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 12.0 mt 53.81 53.38 10.78 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.028 -178.727 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.682 ' HG2' ' H ' ' A' ' 174' ' ' GLY . 27.8 Cg_exo -65.69 64.41 0.4 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.189 2.592 . . . . 0.0 112.153 179.899 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.74 -65.91 0.94 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.936 -179.979 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.84 39.85 0.87 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.651 -179.801 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 051 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.827 0.346 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 051 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.424 ' HA ' ' CD2' ' A' ' 163' ' ' LEU . 33.8 mt 57.01 92.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.16 179.762 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -169.82 45.78 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.163 0.506 . . . . 0.0 111.382 179.676 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.6 m -168.31 -62.54 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.884 179.259 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.824 ' O ' ' N ' ' A' ' 161' ' ' PHE . 86.1 m-20 -89.13 -43.7 10.85 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.509 179.117 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.418 ' H ' ' HB2' ' A' ' 163' ' ' LEU . 13.2 p 44.44 -55.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 O-C-N 124.326 1.016 . . . . 0.0 112.156 -178.988 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.824 ' N ' ' O ' ' A' ' 159' ' ' ASP . 0.5 OUTLIER -73.99 -5.54 41.99 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.44 178.527 . . . . . . . . 3 3 . 1 . 051 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.539 ' HB3' ' HA ' ' A' ' 167' ' ' PRO . 3.7 p90 -164.57 17.7 0.05 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.77 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 159' ' ' ASP . 0.8 OUTLIER -72.54 -6.67 45.59 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.318 0.58 . . . . 0.0 109.437 177.14 . . . . . . . . 3 3 . 1 . 051 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.83 -45.06 62.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.584 -178.643 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -175.42 -42.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.798 0.332 . . . . 0.0 111.329 -179.931 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.8 tp -162.12 141.28 7.24 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.661 -179.122 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.539 ' HA ' ' HB3' ' A' ' 162' ' ' PHE . 56.3 Cg_endo -70.66 116.72 4.78 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.259 1.973 . . . . 0.0 112.411 -179.932 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.36 81.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.457 2.105 . . . . 0.0 112.093 179.922 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.485 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 2.7 tt -73.78 -43.59 53.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.543 0.687 . . . . 0.0 110.58 179.909 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.485 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 0.9 OUTLIER -74.66 -43.16 47.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.544 -178.931 . . . . . . . . 3 3 . 1 . 051 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.411 ' HA ' ' CG ' ' A' ' 178' ' ' PRO . 1.0 OUTLIER -65.21 -54.57 27.55 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.105 . . . . . . . . 3 3 . 1 . 051 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.12 1.23 13.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.943 178.575 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.72 -59.57 2.65 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 121.168 0.509 . . . . 0.0 110.005 179.885 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.581 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -111.73 -4.18 26.51 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.698 178.896 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.502 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER 56.07 -54.4 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.87 0.868 . . . . 0.0 112.589 179.818 . . . . . . . . 3 3 . 1 . 051 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.581 ' N ' ' O ' ' A' ' 174' ' ' GLY . 6.5 m-85 -91.82 15.28 13.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.616 0.246 . . . . 0.0 111.109 179.984 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.552 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 13.9 mt -84.14 -49.38 0.66 Allowed Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.829 179.721 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.552 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 2.7 Cg_endo -82.39 50.72 3.51 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.12 2.547 . . . . 0.0 112.25 -179.902 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.3 tp -85.59 -72.41 0.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.98 46.04 1.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.853 179.857 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 052 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.738 0.304 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 052 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.484 ' O ' ' HB2' ' A' ' 157' ' ' GLN . 0.7 OUTLIER -73.31 -80.24 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 -179.939 . . . . . . . . 3 3 . 1 . 052 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 156' ' ' LEU . 0.4 OUTLIER 71.57 -59.66 0.54 Allowed 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.845 -179.755 . . . . . . . . 3 3 . 1 . 052 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.422 ' O ' ' CB ' ' A' ' 159' ' ' ASP . 37.8 t -162.8 44.25 0.13 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.135 179.355 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.448 ' HB3' ' CE2' ' A' ' 161' ' ' PHE . 2.8 t0 82.62 -5.98 1.32 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.882 -179.825 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.444 ' CB ' ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 88.46 -47.27 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 179.197 . . . . . . . . 3 3 . 1 . 052 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.448 ' CE2' ' HB3' ' A' ' 159' ' ' ASP . 11.5 p90 -68.22 -34.07 75.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.005 0.431 . . . . 0.0 110.943 -179.542 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.456 ' CD1' ' CD1' ' A' ' 169' ' ' ILE . 0.1 OUTLIER -69.83 -55.74 8.98 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.979 179.822 . . . . . . . . 3 3 . 1 . 052 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.7 tp -65.47 -4.13 5.37 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.539 0.685 . . . . 0.0 109.639 178.437 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.449 ' H ' ' C ' ' A' ' 162' ' ' PHE . 0.4 OUTLIER -75.06 -47.52 28.47 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.584 -179.701 . . . . . . . . 3 3 . 1 . 052 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.21 -35.41 80.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.678 179.512 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -161.0 138.23 6.7 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.784 -179.23 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.553 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 18.4 Cg_endo -64.85 -32.57 55.37 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.325 2.017 . . . . 0.0 114.421 -179.169 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 28.5 Cg_endo -87.86 75.38 2.1 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.793 1.662 . . . . 0.0 112.557 -179.362 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.48 HG22 ' CD1' ' A' ' 170' ' ' ILE . 5.5 tp -77.47 -51.15 18.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.569 -179.875 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.48 ' CD1' HG22 ' A' ' 169' ' ' ILE . 5.9 mm -62.22 -30.64 49.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.775 -178.582 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 24.6 tp -65.18 -65.23 0.7 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.081 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -77.6 3.83 12.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.449 178.853 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -71.63 -70.27 0.33 Allowed 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.825 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -107.11 -12.69 23.22 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.078 178.244 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.446 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 4.0 m-85 69.47 -48.02 0.6 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.703 0.401 . . . . 0.0 111.323 -179.908 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.419 ' O ' ' CG ' ' A' ' 176' ' ' PHE . 0.1 OUTLIER -91.98 -6.89 50.39 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.718 0.294 . . . . 0.0 110.364 179.358 . . . . . . . . 3 3 . 1 . 052 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.505 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 0.1 OUTLIER -52.64 -46.83 95.75 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.209 179.594 . . . . . . . . 3 3 . 1 . 052 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.505 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 24.3 Cg_exo -64.67 64.35 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.782 2.321 . . . . 0.0 112.283 179.967 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' A' ' 177' ' ' LEU . 7.6 tp -97.71 -64.97 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.702 179.816 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -87.22 35.53 0.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.591 179.746 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 053 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.884 0.373 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 053 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.5 pp -74.01 127.3 32.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.945 -179.945 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.12 -71.62 0.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.962 0.41 . . . . 0.0 110.699 179.962 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 19.4 p -163.76 33.43 0.08 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.293 179.645 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -162.15 -54.61 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.567 179.912 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 77.29 -45.59 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.315 179.953 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -75.11 10.57 1.45 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.692 179.843 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -162.84 9.03 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.447 -179.983 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.402 ' O ' ' HB3' ' A' ' 164' ' ' PHE . 0.6 OUTLIER -66.12 -35.43 80.47 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.06 . . . . . . . . 3 3 . 1 . 053 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.402 ' HB3' ' O ' ' A' ' 163' ' ' LEU . 36.3 t80 70.26 3.15 4.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.322 179.018 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.54 -56.52 9.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.111 0.481 . . . . 0.0 110.259 179.071 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.479 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 0.6 OUTLIER -161.34 48.08 0.23 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.186 -179.716 . . . . . . . . 3 3 . 1 . 053 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.552 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 18.4 Cg_endo -65.31 -30.36 54.04 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.206 1.937 . . . . 0.0 114.393 -179.482 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 23.1 Cg_endo -92.25 81.41 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.037 1.825 . . . . 0.0 112.881 -179.47 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.922 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -73.31 -109.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.163 . . . . . . . . 3 3 . 1 . 053 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.4 ' C ' ' O ' ' A' ' 169' ' ' ILE . 4.7 mt 26.77 -62.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.567 0.747 . . . . 0.0 112.539 178.655 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.922 ' N ' ' O ' ' A' ' 169' ' ' ILE . 3.1 mm? -66.8 -52.38 44.62 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.699 179.914 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.03 -19.31 60.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.76 179.608 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -78.3 -73.07 0.34 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.118 -179.651 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -109.12 -25.98 5.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.601 -179.988 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.436 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 25.5 t80 74.49 -39.37 0.42 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.659 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.66 -10.02 35.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.592 0.234 . . . . 0.0 110.87 179.801 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.543 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 11.3 mt -49.13 -43.69 69.59 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.063 179.441 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 31.4 Cg_exo -60.07 -10.5 12.79 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.731 2.287 . . . . 0.0 113.012 -179.982 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 41.3 tp -57.97 -55.55 33.44 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.051 0.453 . . . . 0.0 110.616 179.874 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.9 43.82 1.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.939 179.659 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . 0.434 ' HB3' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.414 ' O ' ' CD1' ' A' ' 155' ' ' PHE . 28.0 t80 . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.818 0.342 . . . . 0.0 111.721 . . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 27.3 mt 60.06 29.96 19.48 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.022 179.649 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -170.77 -31.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.235 -179.919 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 92.1 p -73.52 60.85 0.67 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.099 0.476 . . . . 0.0 110.734 179.907 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.446 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.6 OUTLIER 75.53 -60.37 0.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.237 -179.987 . . . . . . . . 3 3 . 1 . 054 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.446 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 75.5 t 73.08 -48.7 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.184 -179.832 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.423 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 0.0 OUTLIER -73.92 5.49 4.14 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.259 179.27 . . . . . . . . 3 3 . 1 . 054 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.423 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 74.6 m-85 -159.83 8.01 0.1 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.667 179.852 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.465 ' O ' ' HG3' ' A' ' 167' ' ' PRO . 30.4 tp -72.1 -2.57 19.01 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.492 0.663 . . . . 0.0 109.432 177.504 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.52 ' HA ' ' HG3' ' A' ' 167' ' ' PRO . 35.7 t80 -62.98 -7.13 4.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.556 -179.09 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.89 -38.57 91.4 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.169 0.509 . . . . 0.0 109.632 177.997 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.5 ' N ' ' HD3' ' A' ' 167' ' ' PRO . 0.2 OUTLIER -164.57 55.79 0.45 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.378 -179.646 . . . . . . . . 3 3 . 1 . 054 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.52 ' HG3' ' HA ' ' A' ' 164' ' ' PHE . 13.5 Cg_exo -63.7 -52.67 1.69 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.226 1.951 . . . . 0.0 113.156 -179.581 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.51 ' HD3' ' HB2' ' A' ' 167' ' ' PRO . 42.1 Cg_endo -91.18 88.04 0.28 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.799 2.333 . . . . 0.0 113.321 -178.702 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.528 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 4.9 tt -79.14 -36.61 18.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.015 0.436 . . . . 0.0 111.231 179.535 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.502 ' O ' ' HB1' ' A' ' 173' ' ' ALA . 2.4 mp -80.23 -60.79 2.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.713 -178.859 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 0.2 OUTLIER -63.09 -48.97 76.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.903 0.382 . . . . 0.0 110.444 -179.199 . . . . . . . . 3 3 . 1 . 054 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.51 ' HB2' ' HG2' ' A' ' 168' ' ' PRO . 0.6 OUTLIER -73.14 -2.79 22.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.859 179.088 . . . . . . . . 3 3 . 1 . 054 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -74.3 -66.86 0.68 Allowed 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.179 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -123.54 -11.56 4.98 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.016 178.889 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 20.0 t80 77.64 -30.08 0.16 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 122.624 0.369 . . . . 0.0 111.842 -179.895 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -99.82 13.97 31.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.67 0.271 . . . . 0.0 111.192 179.775 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.479 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 6.0 mt -87.05 -46.84 0.51 Allowed Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.394 -179.842 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 66.9 Cg_exo -50.3 -22.58 8.68 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.291 1.994 . . . . 0.0 112.473 179.786 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.81 -9.37 43.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.88 -179.689 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -147.66 47.82 1.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.964 0.411 . . . . 0.0 110.487 179.953 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 055 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 66.3 t80 . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 055 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.39 101.83 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.129 179.457 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -169.79 89.67 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.022 -179.992 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.8 t 66.93 61.62 0.5 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.851 179.879 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.568 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.8 OUTLIER 70.81 -57.17 0.6 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.355 179.816 . . . . . . . . 3 3 . 1 . 055 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.568 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 85.2 t 83.53 -65.3 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.22 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.404 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 0.3 OUTLIER -75.67 48.24 0.45 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.263 178.41 . . . . . . . . 3 3 . 1 . 055 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.404 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 3.7 m-85 -169.53 -30.54 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.737 -179.876 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.606 ' C ' ' H ' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -56.33 -60.47 3.47 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 178.156 . . . . . . . . 3 3 . 1 . 055 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 9.2 t80 58.59 -34.36 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.328 175.92 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.606 ' H ' ' C ' ' A' ' 163' ' ' LEU . 7.8 mt -63.06 -43.07 99.62 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.007 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.565 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 0.2 OUTLIER -163.15 78.49 1.73 Allowed Pre-proline 0 N--CA 1.453 -0.279 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.486 -178.994 . . . . . . . . 3 3 . 1 . 055 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.6 105.97 1.0 Allowed 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.2 1.933 . . . . 0.0 111.802 179.47 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.565 ' HD3' ' O ' ' A' ' 166' ' ' LEU . 72.4 Cg_endo -74.02 44.82 1.04 Allowed 'Trans proline' 0 CA--C 1.529 0.232 0 C-N-CA 122.952 2.435 . . . . 0.0 113.149 -179.718 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.563 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 23.0 pt -79.34 -43.72 23.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -179.886 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.436 ' N ' HG13 ' A' ' 169' ' ' ILE . 3.3 mp -76.76 -47.31 28.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.01 -179.252 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 38.1 tp -63.86 -54.48 34.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.346 0.593 . . . . 0.0 109.56 179.751 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.22 -3.47 26.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.849 179.014 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.96 -73.7 0.2 Allowed 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.299 0.571 . . . . 0.0 109.555 179.484 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -118.52 -13.54 6.77 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.509 178.647 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 5.5 t80 76.37 -45.51 0.51 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.474 0.31 . . . . 0.0 111.363 179.97 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -94.4 -9.37 35.91 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.672 0.272 . . . . 0.0 111.056 179.892 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.558 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 22.7 mt -51.44 -41.66 77.76 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.069 179.452 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 52.2 Cg_exo -54.87 -152.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.605 2.203 . . . . 0.0 112.187 179.752 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' A' ' 178' ' ' PRO . 0.9 OUTLIER 74.12 71.85 0.11 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.232 0.539 . . . . 0.0 110.29 -179.693 . . . . . . . . 3 3 . 1 . 055 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 69.95 52.68 0.39 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.927 -179.78 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 056 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.555 0.217 . . . . 0.0 111.159 . . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.1 mt -168.73 169.71 9.83 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.882 0.372 . . . . 0.0 111.234 -179.579 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -170.36 79.4 0.09 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.897 179.873 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 51.66 69.6 0.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.105 179.995 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.579 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER 70.67 -57.27 0.59 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.44 179.876 . . . . . . . . 3 3 . 1 . 056 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.579 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 95.0 t 85.05 -59.88 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 122.827 0.451 . . . . 0.0 110.312 -179.555 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.468 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 0.1 OUTLIER -74.45 41.35 0.14 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.994 179.205 . . . . . . . . 3 3 . 1 . 056 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.458 ' CE1' ' HB2' ' A' ' 159' ' ' ASP . 0.0 OUTLIER -173.43 -21.51 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.552 179.544 . . . . . . . . 3 3 . 1 . 056 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.606 ' C ' ' H ' ' A' ' 165' ' ' LEU . 5.1 tt -53.68 -53.12 56.45 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 178.223 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 3.1 t80 59.66 -29.72 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 114.846 -1.07 . . . . 0.0 113.489 176.412 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.606 ' H ' ' C ' ' A' ' 163' ' ' LEU . 1.4 tp -178.1 -32.29 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.068 0.461 . . . . 0.0 110.582 -179.377 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.581 ' N ' HD23 ' A' ' 163' ' ' LEU . 0.1 OUTLIER -158.02 114.36 1.79 Allowed Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.479 -179.367 . . . . . . . . 3 3 . 1 . 056 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.415 ' HD3' ' CD2' ' A' ' 163' ' ' LEU . 90.2 Cg_endo -83.51 106.76 1.34 Allowed 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.25 1.967 . . . . 0.0 112.789 -179.018 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.79 62.88 1.27 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.381 2.054 . . . . 0.0 111.679 179.406 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.557 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.1 OUTLIER -75.02 -43.97 44.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.426 -179.363 . . . . . . . . 3 3 . 1 . 056 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.444 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.2 mp -73.4 -47.55 45.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.676 -179.254 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.99 -56.81 9.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.13 0.49 . . . . 0.0 109.874 179.802 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.02 5.11 5.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.693 179.358 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.34 -63.69 1.1 Allowed 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.54 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 175' ' ' TYR . . . -112.05 -11.88 15.21 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.382 178.495 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 174' ' ' GLY . 16.0 m-85 68.3 -50.74 0.55 Allowed 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 122.687 0.395 . . . . 0.0 111.36 179.915 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -91.38 -7.26 51.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.801 179.719 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.498 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 12.1 mt -50.26 -47.56 82.24 Favored Pre-proline 0 CA--C 1.529 0.145 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.695 179.44 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 71.1 Cg_exo -50.39 -174.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.76 2.307 . . . . 0.0 112.22 179.483 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.404 ' CB ' ' O ' ' A' ' 178' ' ' PRO . 0.3 OUTLIER 80.02 73.91 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.112 0.482 . . . . 0.0 110.34 -179.767 . . . . . . . . 3 3 . 1 . 056 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 24.9 mtm180 68.87 56.25 0.43 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.758 -179.609 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 057 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.861 0.362 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 057 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.405 ' CD1' ' N ' ' A' ' 157' ' ' GLN . 4.3 pp -165.34 -170.64 1.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.034 -179.592 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.405 ' N ' ' CD1' ' A' ' 156' ' ' LEU . 1.1 mm-40 -169.73 91.19 0.21 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.621 179.933 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.409 ' HB3' ' CD1' ' A' ' 163' ' ' LEU . 0.6 OUTLIER 63.29 32.81 14.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.148 -179.607 . . . . . . . . 3 3 . 1 . 057 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.413 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER 78.43 -51.68 0.48 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.194 -179.693 . . . . . . . . 3 3 . 1 . 057 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.413 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 76.4 t 69.88 -60.38 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 121.129 0.49 . . . . 0.0 110.847 -179.754 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -76.67 10.33 2.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.077 179.088 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -165.05 14.06 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.223 -179.836 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.441 ' CD1' ' HD3' ' A' ' 167' ' ' PRO . 0.9 OUTLIER -67.75 -39.46 84.19 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.196 . . . . . . . . 3 3 . 1 . 057 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.49 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER 47.71 29.2 1.46 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.466 179.886 . . . . . . . . 3 3 . 1 . 057 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.49 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.2 OUTLIER 89.82 -30.39 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.219 -179.379 . . . . . . . . 3 3 . 1 . 057 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.86 83.34 1.52 Allowed Pre-proline 0 N--CA 1.449 -0.478 0 CA-C-O 120.732 0.301 . . . . 0.0 110.749 -178.884 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.441 ' HD3' ' CD1' ' A' ' 163' ' ' LEU . 33.6 Cg_endo -65.32 109.5 1.38 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.536 2.157 . . . . 0.0 112.416 -179.611 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.411 ' O ' HG22 ' A' ' 169' ' ' ILE . 72.6 Cg_endo -74.38 -158.38 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.422 2.081 . . . . 0.0 111.567 179.467 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.447 HG21 HD11 ' A' ' 169' ' ' ILE . 0.5 OUTLIER 80.66 -41.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.295 -179.66 . . . . . . . . 3 3 . 1 . 057 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.461 ' HA ' ' HB1' ' A' ' 173' ' ' ALA . 3.5 mp -73.98 -42.73 52.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.847 179.992 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 10.5 mt -63.43 -54.51 35.45 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.214 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.88 0.48 15.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.824 178.446 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.461 ' HB1' ' HA ' ' A' ' 170' ' ' ILE . . . -73.06 -77.51 0.1 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.893 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.433 ' HA3' ' CG ' ' A' ' 177' ' ' LEU . . . -98.46 -3.17 57.55 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.386 178.392 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER 71.55 -61.52 0.49 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.91 0.386 . . . . 0.0 110.838 179.987 . . . . . . . . 3 3 . 1 . 057 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -107.67 -17.84 13.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.231 179.934 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.51 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 66.3 mt -54.53 -43.8 98.35 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.757 -179.584 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 24.4 Cg_exo -65.23 68.83 0.3 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.657 2.238 . . . . 0.0 112.742 -179.573 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.0 mp -117.24 -16.24 10.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.96 0.41 . . . . 0.0 111.049 179.504 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -149.06 52.97 0.97 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.404 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 058 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 18.2 p90 . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.764 0.316 . . . . 0.0 111.297 . . . . . . . . . 0 0 . 1 . 058 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.435 ' O ' ' CB ' ' A' ' 157' ' ' GLN . 20.9 mt 60.69 179.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.883 179.952 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.435 ' CB ' ' O ' ' A' ' 156' ' ' LEU . 0.1 OUTLIER 84.87 48.68 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.265 0.555 . . . . 0.0 110.35 -179.697 . . . . . . . . 3 3 . 1 . 058 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 31.4 t -164.11 35.83 0.08 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.1 179.773 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.433 ' O ' ' CB ' ' A' ' 160' ' ' VAL . 0.9 OUTLIER 79.02 -41.73 0.28 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.091 -179.475 . . . . . . . . 3 3 . 1 . 058 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.433 ' CB ' ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 88.73 -42.07 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.207 179.963 . . . . . . . . 3 3 . 1 . 058 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.421 ' HA ' ' HB2' ' A' ' 164' ' ' PHE . 0.5 OUTLIER -68.04 -26.84 66.07 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.0 0.428 . . . . 0.0 110.581 179.515 . . . . . . . . 3 3 . 1 . 058 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.409 ' C ' ' H ' ' A' ' 164' ' ' PHE . 1.3 m-85 -67.74 -60.31 2.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.599 179.562 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 17.4 mt -66.26 -4.4 7.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.706 178.534 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.421 ' HB2' ' HA ' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -74.71 -8.28 55.92 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.251 -179.509 . . . . . . . . 3 3 . 1 . 058 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.32 -34.31 78.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.101 0.477 . . . . 0.0 110.275 179.112 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.458 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 0.2 OUTLIER -162.08 63.37 1.51 Allowed Pre-proline 0 N--CA 1.452 -0.33 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.895 -179.535 . . . . . . . . 3 3 . 1 . 058 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -61.32 107.06 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.719 2.279 . . . . 0.0 113.063 -179.005 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.474 ' HA ' HD23 ' A' ' 171' ' ' LEU . 93.4 Cg_endo -76.82 86.17 1.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.865 2.377 . . . . 0.0 111.523 178.983 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.51 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 0.0 OUTLIER -162.01 -42.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.587 0.708 . . . . 0.0 110.832 -179.114 . . . . . . . . 3 3 . 1 . 058 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.525 ' HA ' ' HB3' ' A' ' 173' ' ' ALA . 11.1 pt -68.15 -38.37 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.57 -178.355 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 0.0 OUTLIER -60.73 -57.3 13.29 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.085 . . . . . . . . 3 3 . 1 . 058 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.21 -2.65 35.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.845 178.334 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.525 ' HB3' ' HA ' ' A' ' 170' ' ' ILE . . . -73.03 -67.24 0.58 Allowed 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 121.056 0.455 . . . . 0.0 110.088 -179.93 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -109.34 -16.47 11.1 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.734 178.942 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.525 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.5 OUTLIER 77.33 -12.93 1.0 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 179.924 . . . . . . . . 3 3 . 1 . 058 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -120.86 -12.51 8.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.557 0.218 . . . . 0.0 111.327 -179.981 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.538 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 83.5 mt -55.29 -41.72 92.18 Favored Pre-proline 0 CA--C 1.531 0.233 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.782 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 52.5 Cg_exo -56.18 76.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.501 2.134 . . . . 0.0 112.98 -179.64 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 177' ' ' LEU . 0.4 OUTLIER -115.36 -6.91 12.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.941 0.4 . . . . 0.0 110.931 179.337 . . . . . . . . 3 3 . 1 . 058 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.403 ' HD3' ' CD1' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -150.94 43.42 0.8 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.463 . . . . . . . . 3 3 . 1 . 058 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 059 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.703 0.287 . . . . 0.0 111.111 . . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.401 ' CD1' ' N ' ' A' ' 157' ' ' GLN . 3.6 pp -165.21 -168.47 1.4 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.895 -179.91 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.401 ' N ' ' CD1' ' A' ' 156' ' ' LEU . 0.0 OUTLIER 79.24 82.08 0.06 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.02 0.438 . . . . 0.0 110.85 -179.772 . . . . . . . . 3 3 . 1 . 059 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.3 p 50.95 51.44 17.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.194 179.971 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.475 ' O ' ' CB ' ' A' ' 160' ' ' VAL . 0.4 OUTLIER 74.13 -52.52 0.69 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.471 179.774 . . . . . . . . 3 3 . 1 . 059 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.475 ' CB ' ' O ' ' A' ' 159' ' ' ASP . 0.3 OUTLIER 94.23 -40.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.016 0.527 . . . . 0.0 110.952 -179.698 . . . . . . . . 3 3 . 1 . 059 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.41 ' N ' HG12 ' A' ' 160' ' ' VAL . 52.7 m-85 -70.01 -30.14 67.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.041 0.448 . . . . 0.0 110.55 179.529 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.452 ' C ' ' H ' ' A' ' 164' ' ' PHE . 3.3 m-85 -67.66 -59.26 3.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.747 179.723 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.1 mt -65.68 -3.55 4.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.846 178.593 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.452 ' H ' ' C ' ' A' ' 162' ' ' PHE . 1.6 t80 -74.11 -19.2 60.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.101 -179.584 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.2 -35.38 80.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.059 0.457 . . . . 0.0 110.637 179.544 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.5 mt -162.17 71.32 2.29 Favored Pre-proline 0 N--CA 1.45 -0.442 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.446 -178.884 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.41 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 4.0 Cg_exo -36.71 -49.12 1.42 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.517 2.811 . . . . 0.0 113.609 -179.587 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.426 ' O ' HG21 ' A' ' 169' ' ' ILE . 61.4 Cg_endo -88.64 -52.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.362 2.041 . . . . 0.0 113.077 -179.161 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.501 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.0 OUTLIER 81.02 -45.19 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 179.439 . . . . . . . . 3 3 . 1 . 059 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.413 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.3 mp -73.11 -47.13 48.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.882 0.372 . . . . 0.0 111.783 -179.195 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.56 -0.58 5.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.058 -179.873 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -147.05 15.27 1.17 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.468 -179.926 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.501 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -79.93 -47.31 15.22 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.911 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -129.77 -22.64 1.14 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.981 178.684 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 34.9 t80 71.62 -12.59 0.62 Allowed 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 122.507 0.323 . . . . 0.0 111.386 -179.344 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.447 ' H ' ' C ' ' A' ' 174' ' ' GLY . 7.2 t80 -96.02 -6.42 38.85 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.795 0.331 . . . . 0.0 110.143 178.959 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.441 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 1.4 mm? -47.8 -52.15 41.19 Favored Pre-proline 0 CA--C 1.529 0.142 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.311 179.506 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 49.5 Cg_exo -57.41 -157.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.66 2.24 . . . . 0.0 112.057 179.296 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.406 ' CB ' ' O ' ' A' ' 178' ' ' PRO . 9.5 tp 81.93 -9.8 1.19 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.757 179.961 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.59 31.21 0.52 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.448 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 060 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.417 ' O ' HD22 ' A' ' 156' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.572 0.225 . . . . 0.0 111.181 . . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.417 HD22 ' O ' ' A' ' 155' ' ' PHE . 32.3 mt -161.14 23.64 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.448 -179.88 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.05 -27.56 60.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.052 0.453 . . . . 0.0 110.278 179.245 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.4 ' O ' ' CB ' ' A' ' 159' ' ' ASP . 0.6 OUTLIER -78.3 8.36 5.12 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.012 -179.807 . . . . . . . . 3 3 . 1 . 060 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.405 ' O ' ' CB ' ' A' ' 160' ' ' VAL . 0.3 OUTLIER 79.87 -6.64 1.75 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 179.896 . . . . . . . . 3 3 . 1 . 060 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.485 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 82.99 -54.69 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-O 120.822 0.344 . . . . 0.0 110.513 -179.949 . . . . . . . . 3 3 . 1 . 060 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.501 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 67.5 m-85 -78.24 34.11 0.2 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.092 179.115 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.501 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 53.6 m-85 -166.79 -18.15 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.741 -0.208 . . . . 0.0 111.518 -179.77 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.574 ' C ' ' H ' ' A' ' 165' ' ' LEU . 15.0 tp -59.27 -40.98 87.78 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.311 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.441 ' CE2' ' CD1' ' A' ' 165' ' ' LEU . 0.0 OUTLIER 64.57 -25.29 0.08 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.335 178.065 . . . . . . . . 3 3 . 1 . 060 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.574 ' H ' ' C ' ' A' ' 163' ' ' LEU . 4.5 mp -67.57 -67.98 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.938 0.399 . . . . 0.0 111.115 -179.99 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.505 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 0.2 OUTLIER -162.81 102.85 1.04 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.13 -179.493 . . . . . . . . 3 3 . 1 . 060 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -86.76 98.23 0.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.56 2.173 . . . . 0.0 113.231 -179.115 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 166' ' ' LEU . 42.2 Cg_endo -64.79 72.19 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.678 2.252 . . . . 0.0 111.591 179.032 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.575 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 3.5 tp -76.97 -37.3 26.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.755 -179.276 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.439 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 8.1 mm -73.79 -51.71 23.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.193 -178.781 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 3.4 mm? -64.14 -49.17 73.21 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.715 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -75.03 -4.08 36.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.955 178.516 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.575 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -73.17 -68.37 0.5 Allowed 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.234 0.54 . . . . 0.0 109.714 179.656 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -121.72 -8.89 7.25 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.939 178.929 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.49 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.2 OUTLIER 55.76 -53.58 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.883 0.873 . . . . 0.0 112.416 -179.994 . . . . . . . . 3 3 . 1 . 060 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.566 ' N ' ' O ' ' A' ' 174' ' ' GLY . 29.0 t80 -90.36 -4.94 56.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.611 0.244 . . . . 0.0 110.744 179.789 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 179' ' ' LEU . 16.8 mt -52.54 -49.38 86.17 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.889 179.47 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.469 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 84.2 Cg_exo -46.15 82.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.011 2.474 . . . . 0.0 112.748 179.538 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 177' ' ' LEU . 0.3 OUTLIER -94.34 -61.76 1.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.061 179.568 . . . . . . . . 3 3 . 1 . 060 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.01 38.12 0.79 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.811 179.028 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . 0.406 ' H ' ' C ' ' A' ' 179' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.41 ' O ' HD23 ' A' ' 156' ' ' LEU . 5.2 p90 . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.74 0.305 . . . . 0.0 111.144 . . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.41 HD23 ' O ' ' A' ' 155' ' ' PHE . 20.7 mt -163.32 -177.88 5.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.847 -179.982 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 78.33 65.42 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.782 -179.825 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.87 58.81 3.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.521 -179.928 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 73.7 -58.99 0.57 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.913 -179.64 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.424 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 84.32 -48.33 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.914 -179.843 . . . . . . . . 3 3 . 1 . 061 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.462 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 15.7 t80 -76.47 23.91 0.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.716 179.691 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.462 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 19.6 m-85 -168.63 -10.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.953 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.498 ' C ' ' H ' ' A' ' 165' ' ' LEU . 0.4 OUTLIER -61.9 -48.86 78.57 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.235 . . . . . . . . 3 3 . 1 . 061 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 58.11 -0.61 0.1 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.23 -0.895 . . . . 0.0 112.168 178.473 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.498 ' H ' ' C ' ' A' ' 163' ' ' LEU . 0.6 OUTLIER -71.34 -36.83 71.68 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 120.803 0.335 . . . . 0.0 111.573 179.883 . . . . . . . . 3 3 . 1 . 061 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.62 ' CD2' ' O ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -158.7 95.02 1.84 Allowed Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-O 121.477 0.656 . . . . 0.0 112.644 -176.976 . . . . . . . . 3 3 . 1 . 061 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.585 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 17.7 Cg_endo -65.76 -28.96 51.3 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.246 1.964 . . . . 0.0 113.974 -179.981 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 20.4 Cg_endo -92.59 93.57 0.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.143 1.895 . . . . 0.0 112.764 -179.359 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.45 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 2.1 tt -75.26 -33.28 27.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.3 -179.925 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.406 ' N ' HG22 ' A' ' 169' ' ' ILE . 4.2 mp -67.58 -35.05 71.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.342 -179.22 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.31 -60.51 2.71 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.897 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -76.29 4.46 8.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.269 178.692 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -71.94 -68.52 0.45 Allowed 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.741 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.433 ' HA3' ' CG ' ' A' ' 177' ' ' LEU . . . -103.37 -13.76 27.66 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 178.032 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.452 ' CG ' ' N ' ' A' ' 176' ' ' PHE . 0.0 OUTLIER 72.64 -53.56 0.7 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.53 0.332 . . . . 0.0 111.534 179.48 . . . . . . . . 3 3 . 1 . 061 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.452 ' N ' ' CG ' ' A' ' 175' ' ' TYR . 26.1 t80 -93.84 18.99 9.43 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.359 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.472 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 6.2 mt -88.12 -47.35 0.46 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.715 -0.221 . . . . 0.0 111.227 179.673 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.546 ' O ' ' HG3' ' A' ' 181' ' ' HSL . 32.2 Cg_exo -58.33 -22.16 56.49 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.463 2.108 . . . . 0.0 112.353 -179.955 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.13 -58.77 5.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.763 179.984 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -88.31 29.2 0.99 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.961 179.954 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . 0.546 ' HG3' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 38.5 p90 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.727 0.299 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 062 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.2 mp -164.71 141.66 6.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.925 179.969 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -170.51 78.51 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.069 179.948 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 16.0 m 53.42 69.26 0.72 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.015 179.898 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.44 ' O ' ' CB ' ' A' ' 160' ' ' VAL . 0.4 OUTLIER 72.85 -59.47 0.57 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.816 -179.786 . . . . . . . . 3 3 . 1 . 062 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 164' ' ' PHE . 0.4 OUTLIER 90.47 -46.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.363 179.786 . . . . . . . . 3 3 . 1 . 062 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.413 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 8.6 m-85 -70.36 -34.05 72.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.0 0.429 . . . . 0.0 110.958 179.998 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.424 ' C ' ' H ' ' A' ' 164' ' ' PHE . 0.1 OUTLIER -68.54 -59.37 3.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.159 179.913 . . . . . . . . 3 3 . 1 . 062 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 25.2 mt -66.52 -3.28 5.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.975 178.839 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.519 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.1 OUTLIER -77.66 11.9 1.89 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.944 -179.374 . . . . . . . . 3 3 . 1 . 062 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.497 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.2 OUTLIER 89.6 -25.52 0.07 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.678 0.391 . . . . 0.0 112.002 179.5 . . . . . . . . 3 3 . 1 . 062 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.42 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 0.1 OUTLIER -162.33 129.86 2.68 Favored Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.814 -178.488 . . . . . . . . 3 3 . 1 . 062 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.517 ' HG2' ' HD3' ' A' ' 168' ' ' PRO . 1.3 Cg_endo -48.58 -42.31 35.81 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.885 2.39 . . . . 0.0 113.717 -179.902 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.517 ' HD3' ' HG2' ' A' ' 167' ' ' PRO . 37.7 Cg_endo -87.04 76.6 2.23 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.254 1.969 . . . . 0.0 113.354 -178.834 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.889 ' O ' ' N ' ' A' ' 171' ' ' LEU . 2.5 tt -72.37 -90.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.271 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.553 ' N ' HG12 ' A' ' 169' ' ' ILE . 14.7 mt 25.62 -63.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 123.676 0.79 . . . . 0.0 112.762 177.863 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.889 ' N ' ' O ' ' A' ' 169' ' ' ILE . 17.4 mt -66.5 -43.63 84.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.246 -179.628 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.59 -15.88 60.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.35 -179.924 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -76.16 -90.34 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.337 179.966 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -105.55 -10.64 30.72 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.642 178.784 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 60.7 t80 68.3 -61.26 0.4 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.925 0.393 . . . . 0.0 110.411 -179.629 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.403 ' O ' ' CG ' ' A' ' 176' ' ' PHE . 21.3 t80 -107.81 10.92 28.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.87 179.112 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.625 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 71.6 mt -91.59 -49.91 0.32 Allowed Pre-proline 0 CA--C 1.53 0.174 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -179.673 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.625 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 3.0 Cg_exo -76.23 -68.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.682 2.255 . . . . 0.0 112.317 -179.79 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.1 tp 69.54 63.81 0.26 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.597 -179.854 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? 60.95 47.99 7.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.671 -179.869 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 063 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.467 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.908 0.385 . . . . 0.0 111.301 . . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 155' ' ' PHE . 0.2 OUTLIER 55.06 -177.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.404 179.863 . . . . . . . . 3 3 . 1 . 063 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.418 ' HB2' ' CD2' ' A' ' 163' ' ' LEU . 1.7 mt-30 -169.59 -58.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.677 179.854 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 30.2 t -163.88 29.89 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.047 0.451 . . . . 0.0 111.332 179.618 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -165.8 -54.57 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.875 179.428 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 67.46 -53.43 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.725 179.616 . . . . . . . . 3 3 . 1 . 063 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.476 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 0.1 OUTLIER -74.83 3.01 8.84 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.755 . . . . . . . . 3 3 . 1 . 063 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.534 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 0.0 OUTLIER -167.14 9.56 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.994 . . . . . . . . 3 3 . 1 . 063 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.448 ' CD2' ' HB2' ' A' ' 165' ' ' LEU . 12.1 tp -63.86 -33.82 76.54 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.727 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 10.3 t80 57.64 6.93 0.48 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.631 178.221 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.448 ' HB2' ' CD2' ' A' ' 163' ' ' LEU . 0.2 OUTLIER -70.35 -42.71 71.49 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.131 0.491 . . . . 0.0 110.534 179.252 . . . . . . . . 3 3 . 1 . 063 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.96 129.32 2.93 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.441 -179.496 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -57.6 119.52 6.83 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.376 2.05 . . . . 0.0 112.216 -179.713 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -86.24 29.38 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.927 2.418 . . . . 0.0 113.232 -179.547 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.878 ' O ' ' N ' ' A' ' 171' ' ' LEU . 3.0 pt -75.44 -111.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.304 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.41 ' CG2' ' HG3' ' A' ' 178' ' ' PRO . 3.2 mp 33.78 -60.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 123.889 0.876 . . . . 0.0 113.139 178.597 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.878 ' N ' ' O ' ' A' ' 169' ' ' ILE . 0.1 OUTLIER -64.07 -44.48 92.27 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.856 -179.587 . . . . . . . . 3 3 . 1 . 063 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 52.7 p30 -71.72 -10.26 59.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.975 179.818 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -78.29 -63.08 1.48 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.844 0.354 . . . . 0.0 110.815 179.925 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -114.63 -21.78 5.31 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.325 179.751 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER 76.79 -10.98 1.24 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.878 . . . . . . . . 3 3 . 1 . 063 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.8 7.87 3.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.715 0.293 . . . . 0.0 111.011 179.609 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.551 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 98.0 mt -84.0 -41.79 0.76 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.347 179.856 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 52.7 Cg_exo -53.87 -168.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.447 2.098 . . . . 0.0 112.384 -179.876 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.411 ' O ' ' HG3' ' A' ' 180' ' ' ARG . 0.6 OUTLIER 81.65 -9.7 1.23 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.474 -179.815 . . . . . . . . 3 3 . 1 . 063 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 179' ' ' LEU . 8.2 mtm180 -149.48 29.32 0.78 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.41 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 064 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.791 0.329 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 064 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.4 pp -164.49 -175.12 3.73 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.168 -179.634 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -169.15 -84.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.919 179.813 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.418 ' CB ' ' CD2' ' A' ' 163' ' ' LEU . 0.5 OUTLIER -76.52 60.22 1.59 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.865 0.364 . . . . 0.0 110.648 179.671 . . . . . . . . 3 3 . 1 . 064 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.408 ' CB ' ' O ' ' A' ' 158' ' ' SER . 0.8 OUTLIER 79.91 -45.05 0.3 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.668 -179.813 . . . . . . . . 3 3 . 1 . 064 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.447 ' C ' ' H ' ' A' ' 162' ' ' PHE . 0.4 OUTLIER 82.42 -48.72 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 120.881 0.372 . . . . 0.0 110.942 -179.707 . . . . . . . . 3 3 . 1 . 064 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.445 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 4.2 m-30 -76.95 26.2 0.14 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.174 179.341 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.447 ' H ' ' C ' ' A' ' 160' ' ' VAL . 61.0 m-85 -162.95 -1.4 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.197 -179.892 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.418 ' CD2' ' CB ' ' A' ' 158' ' ' SER . 0.8 OUTLIER -64.31 -37.25 86.84 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.906 . . . . . . . . 3 3 . 1 . 064 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 67.0 10.21 7.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.748 178.922 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -67.57 -56.77 8.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.013 0.435 . . . . 0.0 110.259 179.132 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.499 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -162.88 107.12 1.03 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.876 -179.992 . . . . . . . . 3 3 . 1 . 064 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.15 111.01 2.84 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.25 1.967 . . . . 0.0 112.96 -179.08 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.445 ' O ' ' CB ' ' A' ' 172' ' ' ASP . 61.5 Cg_endo -83.49 37.08 0.63 Allowed 'Trans proline' 0 CA--C 1.527 0.155 0 C-N-CA 123.064 2.509 . . . . 0.0 112.52 179.578 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.539 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 9.4 tt -75.97 -43.55 38.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.811 0.338 . . . . 0.0 111.673 -179.351 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.442 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.3 mp -76.65 -52.26 17.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.226 -179.144 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 0.0 OUTLIER -64.57 -52.72 56.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.085 0.469 . . . . 0.0 109.953 -179.633 . . . . . . . . 3 3 . 1 . 064 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.445 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 0.4 OUTLIER -74.45 -0.31 17.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.206 179.129 . . . . . . . . 3 3 . 1 . 064 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.539 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.62 -69.79 0.39 Allowed 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.408 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -120.88 -11.21 6.51 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.523 178.571 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.471 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 26.3 t80 70.51 -18.31 0.25 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.729 0.412 . . . . 0.0 111.801 -179.913 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.467 ' H ' ' C ' ' A' ' 174' ' ' GLY . 0.3 OUTLIER -97.93 20.61 11.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.858 0.361 . . . . 0.0 110.668 179.849 . . . . . . . . 3 3 . 1 . 064 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.528 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 3.3 mm? -86.47 -46.02 0.56 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.538 -179.749 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.528 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 31.7 Cg_exo -58.49 -77.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.339 2.026 . . . . 0.0 112.361 -179.758 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.433 HD23 ' CE1' ' A' ' 176' ' ' PHE . 0.2 OUTLIER 52.98 51.12 16.46 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.018 0.437 . . . . 0.0 110.716 -179.952 . . . . . . . . 3 3 . 1 . 064 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 179' ' ' LEU . 5.1 mmt180 65.63 43.93 3.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.996 179.969 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . 0.489 ' HB3' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.776 0.322 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 065 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.443 ' O ' ' CB ' ' A' ' 157' ' ' GLN . 0.6 OUTLIER -75.37 -162.89 0.21 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 -179.961 . . . . . . . . 3 3 . 1 . 065 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.443 ' CB ' ' O ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER 83.38 77.95 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.993 0.425 . . . . 0.0 110.985 -179.954 . . . . . . . . 3 3 . 1 . 065 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 12.4 t 67.43 32.48 5.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.215 179.671 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.603 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 1.7 t0 75.75 -45.05 0.53 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.663 179.793 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.603 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 97.0 t 88.22 -47.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 123.061 0.545 . . . . 0.0 111.013 -179.661 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -67.63 -30.88 70.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.109 0.48 . . . . 0.0 110.368 179.507 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.414 ' C ' ' H ' ' A' ' 164' ' ' PHE . 7.4 t80 -69.35 -59.18 3.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.822 179.389 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 16.6 tp -66.15 -4.36 7.38 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.875 178.683 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.1 OUTLIER -75.85 -40.94 53.73 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.904 -179.483 . . . . . . . . 3 3 . 1 . 065 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.6 tp -65.69 -34.59 78.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.786 179.67 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.462 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 0.6 OUTLIER -160.05 119.48 1.63 Allowed Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.144 -178.749 . . . . . . . . 3 3 . 1 . 065 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.581 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 18.6 Cg_endo -63.06 -29.63 75.2 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.275 1.983 . . . . 0.0 114.312 -179.622 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 30.2 Cg_endo -90.5 91.57 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.886 1.724 . . . . 0.0 113.143 -179.21 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.583 HG13 ' N ' ' A' ' 170' ' ' ILE . 24.8 pt -75.6 -42.08 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.752 0.787 . . . . 0.0 110.718 179.35 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.583 ' N ' HG13 ' A' ' 169' ' ' ILE . 2.1 pt -70.28 -41.73 78.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 113.974 -1.466 . . . . 0.0 112.157 -177.777 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 1.0 OUTLIER -61.84 -57.73 10.68 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.096 . . . . . . . . 3 3 . 1 . 065 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -74.8 -1.9 24.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.014 178.44 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -74.1 -73.51 0.22 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.12 0.486 . . . . 0.0 110.362 179.976 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.536 ' C ' ' CG ' ' A' ' 175' ' ' TYR . . . -98.98 -0.68 57.3 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.02 179.276 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.536 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER 57.68 -53.74 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.672 0.789 . . . . 0.0 112.639 179.451 . . . . . . . . 3 3 . 1 . 065 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 174' ' ' GLY . 2.4 m-85 -93.71 19.97 8.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.649 0.261 . . . . 0.0 111.088 179.912 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.507 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 15.7 mt -84.12 -46.24 0.74 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.94 179.782 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 25.7 Cg_exo -64.38 63.34 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.884 2.389 . . . . 0.0 112.598 179.911 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 9.9 mt -90.61 -2.34 57.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.914 0.388 . . . . 0.0 110.951 179.661 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.09 44.35 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.523 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 066 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.405 ' O ' ' CG ' ' A' ' 156' ' ' LEU . 1.1 m-85 . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 . . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.405 ' CG ' ' O ' ' A' ' 155' ' ' PHE . 0.2 OUTLIER 60.56 140.4 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.253 -179.991 . . . . . . . . 3 3 . 1 . 066 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.421 ' HB2' ' CD1' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -170.26 72.25 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.038 0.447 . . . . 0.0 110.991 179.993 . . . . . . . . 3 3 . 1 . 066 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.7 p 80.49 -49.72 0.32 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.204 179.504 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -72.99 -55.31 6.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.04 0.448 . . . . 0.0 110.149 179.908 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.5 OUTLIER 73.51 -58.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.818 -179.828 . . . . . . . . 3 3 . 1 . 066 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.508 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 0.2 OUTLIER -74.32 50.1 0.39 Allowed 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.917 . . . . . . . . 3 3 . 1 . 066 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -168.33 -59.32 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.808 -178.566 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.421 ' CD1' ' HB2' ' A' ' 157' ' ' GLN . 0.2 OUTLIER -68.38 -5.14 17.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.561 178.415 . . . . . . . . 3 3 . 1 . 066 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.498 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.3 OUTLIER -78.08 53.17 1.16 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.367 179.962 . . . . . . . . 3 3 . 1 . 066 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.412 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.1 OUTLIER 82.23 -50.17 0.21 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.333 -179.802 . . . . . . . . 3 3 . 1 . 066 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -168.37 161.52 8.95 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.304 -179.17 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -87.2 112.2 0.88 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.863 2.375 . . . . 0.0 112.085 179.371 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.34 59.5 1.42 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.464 2.109 . . . . 0.0 112.639 -179.748 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.436 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 4.5 tt -77.75 -42.32 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.147 179.832 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.441 ' HA ' ' HB3' ' A' ' 173' ' ' ALA . 2.1 mp -68.73 -31.07 49.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.378 -179.38 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.411 ' CD1' ' CG ' ' A' ' 178' ' ' PRO . 8.9 tp -64.89 -63.65 1.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.116 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.28 4.07 9.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.033 178.534 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.441 ' HB3' ' HA ' ' A' ' 170' ' ' ILE . . . -71.53 -64.39 0.93 Allowed 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.678 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -108.83 -14.95 14.0 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.25 178.26 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.461 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 46.7 t80 70.63 -14.96 0.39 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.734 0.414 . . . . 0.0 111.744 -179.904 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.456 ' H ' ' C ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER -96.4 11.1 36.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.689 0.281 . . . . 0.0 110.914 179.859 . . . . . . . . 3 3 . 1 . 066 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.439 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.4 OUTLIER -71.76 -51.46 8.99 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.675 179.903 . . . . . . . . 3 3 . 1 . 066 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 37.7 Cg_exo -61.25 -48.8 9.05 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.791 2.328 . . . . 0.0 112.75 -179.752 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.39 -10.05 56.21 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.595 -179.506 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -147.57 60.54 1.15 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.125 0.488 . . . . 0.0 109.684 179.561 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 067 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.774 0.321 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 067 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.425 ' HB2' ' CG2' ' A' ' 160' ' ' VAL . 1.0 OUTLIER -164.8 24.52 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.423 -179.853 . . . . . . . . 3 3 . 1 . 067 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -78.39 -45.41 22.47 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.239 0.543 . . . . 0.0 110.168 179.518 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 162' ' ' PHE . 0.0 OUTLIER -81.81 39.65 0.56 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.3 -179.406 . . . . . . . . 3 3 . 1 . 067 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.561 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.6 OUTLIER 76.13 -18.17 0.48 Allowed 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 179.586 . . . . . . . . 3 3 . 1 . 067 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.561 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 50.0 t 87.45 -55.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 C-N-CA 123.013 0.525 . . . . 0.0 111.588 179.659 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -67.53 -35.52 79.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.901 0.381 . . . . 0.0 111.032 -179.557 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.439 ' HB2' ' O ' ' A' ' 158' ' ' SER . 1.7 m-85 -68.49 -57.67 5.47 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.767 179.708 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 158' ' ' SER . 17.6 tp -65.53 -3.11 3.99 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.996 178.654 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.45 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.1 OUTLIER -72.36 -80.4 0.06 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.79 -179.191 . . . . . . . . 3 3 . 1 . 067 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.73 -66.78 0.55 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.319 0.58 . . . . 0.0 110.326 179.259 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -164.18 135.35 3.46 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.338 -179.004 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.6 115.41 3.72 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.075 1.85 . . . . 0.0 112.031 179.822 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.424 ' HD2' ' CD2' ' A' ' 162' ' ' PHE . 66.6 Cg_endo -84.07 20.74 1.16 Allowed 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.892 2.395 . . . . 0.0 113.212 -179.514 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.903 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.4 OUTLIER -72.56 -107.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 118.973 -0.537 . . . . 0.0 109.717 179.754 . . . . . . . . 3 3 . 1 . 067 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.482 ' H ' ' CG2' ' A' ' 169' ' ' ILE . 15.1 mt 33.24 -62.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.435 0.694 . . . . 0.0 112.734 178.956 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.903 ' N ' ' O ' ' A' ' 169' ' ' ILE . 0.1 OUTLIER -65.77 -52.31 52.02 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.803 -179.713 . . . . . . . . 3 3 . 1 . 067 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -72.08 -9.77 58.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.052 179.979 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -77.8 -53.92 6.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.784 0.326 . . . . 0.0 110.964 -179.817 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -114.28 -15.4 8.35 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.577 179.864 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.46 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 10.6 t80 70.89 -44.83 0.6 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.988 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.429 ' CG ' ' O ' ' A' ' 176' ' ' PHE . 79.5 t80 -93.45 1.06 56.97 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.621 0.248 . . . . 0.0 111.458 -179.619 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.522 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 81.4 mt -70.89 -43.86 14.53 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.389 179.69 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 74.9 Cg_exo -49.93 -24.25 10.21 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.467 2.112 . . . . 0.0 112.888 179.982 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.417 HD23 ' CE1' ' A' ' 176' ' ' PHE . 1.1 mp -66.04 -61.34 2.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.969 0.414 . . . . 0.0 110.837 -179.755 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.423 ' NE ' ' CE2' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -90.26 55.86 3.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.826 179.983 . . . . . . . . 3 3 . 1 . 067 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 068 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 18.7 p90 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.722 0.296 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 068 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.2 mt 62.48 -80.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.024 179.964 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -170.23 84.55 0.11 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.359 179.989 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 53.6 p 55.63 70.71 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.404 -179.417 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.444 ' O ' ' CB ' ' A' ' 160' ' ' VAL . 0.4 OUTLIER 75.5 -59.39 0.53 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.97 -179.516 . . . . . . . . 3 3 . 1 . 068 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.444 ' CB ' ' O ' ' A' ' 159' ' ' ASP . 0.3 OUTLIER 90.95 -47.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.911 -179.941 . . . . . . . . 3 3 . 1 . 068 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.421 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 18.5 m-85 -70.73 -32.04 69.08 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.134 0.492 . . . . 0.0 110.391 179.448 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.417 ' C ' ' H ' ' A' ' 164' ' ' PHE . 3.1 m-85 -67.95 -58.22 4.91 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.72 179.493 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.2 tp -65.77 -4.57 6.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.76 178.637 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.417 ' H ' ' C ' ' A' ' 162' ' ' PHE . 0.2 OUTLIER -75.85 -56.88 4.25 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.863 -179.602 . . . . . . . . 3 3 . 1 . 068 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.2 -51.52 60.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.806 179.638 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -160.39 143.15 9.82 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.184 -179.31 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -62.56 119.15 6.12 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.218 1.945 . . . . 0.0 112.542 -179.556 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.412 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 41.0 Cg_endo -91.06 95.22 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.312 2.675 . . . . 0.0 112.296 -179.946 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.41 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 4.7 tt -72.1 -38.52 63.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.162 0.506 . . . . 0.0 110.886 -179.9 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.425 ' HA ' ' HB1' ' A' ' 173' ' ' ALA . 3.8 mt -69.79 -30.79 45.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.124 -179.812 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.434 ' HA ' ' HG3' ' A' ' 178' ' ' PRO . 1.0 OUTLIER -66.47 -62.44 1.46 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.886 . . . . . . . . 3 3 . 1 . 068 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.61 3.32 9.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.781 178.499 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.425 ' HB1' ' HA ' ' A' ' 170' ' ' ILE . . . -71.59 -48.11 50.36 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.417 0.627 . . . . 0.0 109.368 179.477 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 175' ' ' TYR . . . -124.12 -4.49 7.77 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.75 178.875 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.419 ' HB2' ' O ' ' A' ' 174' ' ' GLY . 34.9 m-85 67.69 -50.54 0.51 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.743 0.417 . . . . 0.0 111.965 179.664 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -94.99 7.52 45.8 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.767 0.318 . . . . 0.0 110.998 179.596 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.689 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 88.8 mt -87.11 -22.65 0.28 Allowed Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 179.848 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.689 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 96.4 Cg_exo -45.52 -20.25 0.56 Allowed 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.381 2.054 . . . . 0.0 113.31 -179.636 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -44.7 -31.24 1.11 Allowed 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.192 0.52 . . . . 0.0 111.246 -179.97 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.0 57.31 1.48 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.661 -179.368 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . 0.513 ' HB3' ' HA ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.67 0.271 . . . . 0.0 111.384 . . . . . . . . . 0 0 . 1 . 069 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -164.4 -35.42 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.568 -179.464 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.417 ' HB2' ' CD2' ' A' ' 163' ' ' LEU . 0.3 OUTLIER 54.71 25.56 6.62 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.851 0.358 . . . . 0.0 110.861 -179.768 . . . . . . . . 3 3 . 1 . 069 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.8 m 49.18 36.24 8.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.202 0.525 . . . . 0.0 110.952 -179.79 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -163.01 -57.24 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.963 179.843 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.521 ' O ' ' HB2' ' A' ' 164' ' ' PHE . 0.9 OUTLIER 71.95 -58.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.371 -179.62 . . . . . . . . 3 3 . 1 . 069 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.448 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 36.9 m-85 -70.91 51.53 0.14 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.62 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.488 ' H ' ' C ' ' A' ' 160' ' ' VAL . 0.2 OUTLIER -167.26 -69.17 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.003 -0.998 . . . . 0.0 109.954 -177.886 . . . . . . . . 3 3 . 1 . 069 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.417 ' CD2' ' HB2' ' A' ' 157' ' ' GLN . 4.5 tp -67.66 -15.45 63.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.526 178.489 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.521 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 8.2 t80 -83.26 -33.9 25.92 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.376 -179.212 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.415 ' O ' ' CD ' ' A' ' 167' ' ' PRO . 0.1 OUTLIER -64.59 -74.1 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.907 0.384 . . . . 0.0 110.782 179.841 . . . . . . . . 3 3 . 1 . 069 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.483 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 0.1 OUTLIER -105.09 66.62 0.14 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.456 -179.853 . . . . . . . . 3 3 . 1 . 069 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.599 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 20.9 Cg_endo -63.83 -27.72 67.57 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.344 2.029 . . . . 0.0 114.13 -179.838 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 28.2 Cg_endo -92.12 87.08 0.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 121.931 1.754 . . . . 0.0 113.147 -179.14 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.436 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 5.8 tp -76.58 -43.39 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.824 179.549 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.436 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 4.8 mt -73.37 -43.98 55.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.948 179.93 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.46 -55.45 15.63 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.358 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -75.27 5.89 5.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.304 178.869 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -71.49 -52.71 16.9 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.739 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -104.96 -18.6 12.03 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 177.968 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 5.1 t80 76.53 -11.86 1.11 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.8 0.44 . . . . 0.0 111.905 179.651 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -97.69 -3.08 39.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.806 0.336 . . . . 0.0 110.717 179.371 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.511 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 1.0 OUTLIER -62.97 -45.63 86.92 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.365 179.973 . . . . . . . . 3 3 . 1 . 069 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 36.8 Cg_exo -60.6 79.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.546 2.164 . . . . 0.0 112.394 -179.793 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.2 mt -96.37 -51.86 4.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.516 179.738 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 180' ' ' ARG . 0.0 OUTLIER -87.5 9.92 19.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.6 179.651 . . . . . . . . 3 3 . 1 . 069 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 070 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 14.2 t80 . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.916 0.388 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 070 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.417 ' C ' ' H ' ' A' ' 158' ' ' SER . 3.1 pp -164.33 111.94 1.09 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.125 -179.851 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -79.05 22.83 0.38 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.103 179.378 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 156' ' ' LEU . 3.6 p 78.73 46.13 0.05 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.27 0.557 . . . . 0.0 110.785 -179.476 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.64 ' O ' ' N ' ' A' ' 161' ' ' PHE . 33.1 m-20 -158.82 -63.11 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.299 179.505 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.487 HG11 ' N ' ' A' ' 161' ' ' PHE . 14.8 p 54.66 -51.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 O-C-N 124.196 0.935 . . . . 0.0 112.045 -179.1 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.64 ' N ' ' O ' ' A' ' 159' ' ' ASP . 32.9 m-85 -74.28 1.02 12.41 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.577 0.227 . . . . 0.0 111.397 178.931 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.456 ' O ' ' CD1' ' A' ' 162' ' ' PHE . 2.8 p90 -168.05 14.24 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 179.791 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.469 ' HB2' ' HB2' ' A' ' 159' ' ' ASP . 25.6 tp -67.06 -33.37 75.37 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 178.084 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.481 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 0.2 OUTLIER 49.18 30.12 2.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.002 179.606 . . . . . . . . 3 3 . 1 . 070 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.481 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.6 OUTLIER 87.34 -24.43 0.11 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.021 -179.44 . . . . . . . . 3 3 . 1 . 070 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -158.67 132.18 4.84 Favored Pre-proline 0 N--CA 1.449 -0.516 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.684 -178.674 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.401 ' HD3' ' CD1' ' A' ' 163' ' ' LEU . 38.5 Cg_endo -67.33 119.81 6.84 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.087 1.858 . . . . 0.0 112.882 -178.826 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -85.83 96.15 0.58 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.052 2.502 . . . . 0.0 111.421 179.27 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.444 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 5.7 pt -65.2 -32.77 59.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.369 -179.093 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 6.7 mm -73.8 -41.09 54.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.0 -179.856 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 78.5 mt -66.71 -55.66 14.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.919 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -74.1 0.7 13.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.176 178.637 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -70.92 -43.08 69.0 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.366 0.603 . . . . 0.0 109.386 -179.837 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -120.39 -23.98 2.76 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.385 178.586 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 75.37 -41.29 0.45 Allowed 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 122.692 0.397 . . . . 0.0 111.667 179.893 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -93.85 -7.12 44.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.775 0.321 . . . . 0.0 110.963 179.813 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.525 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.1 OUTLIER -54.15 -44.65 98.79 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.21 179.736 . . . . . . . . 3 3 . 1 . 070 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 31.7 Cg_exo -59.34 69.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.738 2.292 . . . . 0.0 112.652 -179.724 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -113.02 -5.24 13.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.723 179.489 . . . . . . . . 3 3 . 1 . 070 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -147.48 41.62 1.05 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.484 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 071 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 6.9 p90 . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.877 0.37 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 071 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.6 mp -73.94 167.81 20.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 -179.883 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -171.74 95.0 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.496 -179.976 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.553 ' O ' ' CG ' ' A' ' 159' ' ' ASP . 1.6 m 62.75 79.05 0.27 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.557 -179.705 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.553 ' CG ' ' O ' ' A' ' 158' ' ' SER . 2.8 p30 60.36 -56.41 0.08 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.801 0.841 . . . . 0.0 112.203 -179.677 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.548 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 2.5 t 74.57 -62.96 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.043 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -73.66 52.24 0.39 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.686 178.058 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -168.12 -43.94 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.321 -179.477 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.82 -51.03 71.26 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.874 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 46.63 40.31 8.29 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.68 -1.145 . . . . 0.0 112.133 176.209 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -175.52 -61.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.933 0.397 . . . . 0.0 110.963 -179.993 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -161.6 120.12 1.44 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.519 -179.574 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.09 111.54 2.48 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.229 1.953 . . . . 0.0 112.074 179.918 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.483 ' HA ' ' CD2' ' A' ' 171' ' ' LEU . 88.1 Cg_endo -77.8 55.85 5.41 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.676 2.251 . . . . 0.0 112.47 -179.836 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 1.4 tt -80.69 -44.01 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.222 0.534 . . . . 0.0 112.181 -179.583 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.488 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 0.8 OUTLIER -75.81 -53.8 15.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -176.996 . . . . . . . . 3 3 . 1 . 071 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.568 ' HG ' ' N ' ' A' ' 172' ' ' ASP . 2.6 pt? -66.91 -49.47 65.44 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.362 0.601 . . . . 0.0 110.056 -179.789 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.568 ' N ' ' HG ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -74.23 1.96 10.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.311 179.02 . . . . . . . . 3 3 . 1 . 071 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.69 -54.67 8.37 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.307 0.575 . . . . 0.0 109.596 179.5 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -112.49 -18.9 7.3 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.515 178.617 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 70.01 -56.46 0.58 Allowed 'General case' 0 C--O 1.231 0.115 0 C-N-CA 122.502 0.321 . . . . 0.0 111.377 179.824 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.409 ' O ' ' CG ' ' A' ' 176' ' ' PHE . 89.6 t80 -92.92 2.22 56.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.882 179.824 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.494 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.1 OUTLIER -64.2 -46.5 79.48 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.806 179.675 . . . . . . . . 3 3 . 1 . 071 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 75.2 Cg_exo -50.37 88.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.618 2.212 . . . . 0.0 112.554 179.953 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.13 -78.83 0.58 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.371 179.683 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -87.65 35.37 0.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.536 179.462 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 072 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.869 0.366 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 072 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.426 ' CD2' HG23 ' A' ' 160' ' ' VAL . 4.8 mp 50.79 24.74 1.85 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.45 179.72 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.59 -6.46 48.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.412 179.668 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 21.6 p -74.01 -43.82 56.69 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.444 0.64 . . . . 0.0 111.423 -179.397 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.454 ' O ' HG13 ' A' ' 160' ' ' VAL . 1.1 t0 -169.01 -35.75 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.605 -179.956 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.527 ' O ' ' HB2' ' A' ' 164' ' ' PHE . 0.3 OUTLIER 90.88 -42.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.53 179.93 . . . . . . . . 3 3 . 1 . 072 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.448 ' N ' HG13 ' A' ' 160' ' ' VAL . 58.8 m-85 -72.73 -38.34 67.46 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.051 0.453 . . . . 0.0 111.035 179.831 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.429 ' C ' ' H ' ' A' ' 164' ' ' PHE . 0.2 OUTLIER -72.17 -53.79 11.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.766 179.6 . . . . . . . . 3 3 . 1 . 072 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 18.6 mt -66.26 -4.4 7.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.406 178.478 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.527 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER -79.53 19.03 0.66 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.032 179.806 . . . . . . . . 3 3 . 1 . 072 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.505 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.4 OUTLIER 91.6 -39.18 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 122.988 0.515 . . . . 0.0 111.367 -179.943 . . . . . . . . 3 3 . 1 . 072 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.411 HD21 ' HA ' ' A' ' 166' ' ' LEU . 8.0 mt -165.11 169.16 7.72 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.925 -178.018 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.409 ' HD2' HD22 ' A' ' 166' ' ' LEU . 83.2 Cg_endo -84.64 117.26 2.02 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.701 2.267 . . . . 0.0 112.05 179.572 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.519 ' HA ' ' CD2' ' A' ' 171' ' ' LEU . 92.1 Cg_endo -78.91 10.76 2.79 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.539 2.159 . . . . 0.0 113.328 -179.454 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.457 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 3.3 tt -77.24 -29.15 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.929 0.395 . . . . 0.0 111.817 -179.706 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.493 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 10.3 mt -71.03 -60.22 2.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.625 -178.359 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.556 ' HG ' ' N ' ' A' ' 172' ' ' ASP . 2.6 pt? -63.91 -47.95 78.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.375 0.607 . . . . 0.0 110.007 -179.579 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.556 ' N ' ' HG ' ' A' ' 171' ' ' LEU . 30.9 m-20 -72.48 -0.92 13.93 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.219 179.091 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.493 ' HB2' ' O ' ' A' ' 170' ' ' ILE . . . -73.16 -66.07 0.73 Allowed 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.591 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -119.74 -9.56 8.26 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.767 178.68 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 12.0 t80 68.82 -61.69 0.41 Allowed 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.971 0.415 . . . . 0.0 110.994 -179.885 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -100.87 16.49 25.01 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.912 179.735 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.526 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 28.7 mt -93.58 -47.21 0.29 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.742 -179.71 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 3.7 Cg_exo -72.73 -86.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.269 1.98 . . . . 0.0 111.958 -179.829 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 52.2 mt 51.39 49.4 21.07 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 121.044 0.45 . . . . 0.0 110.778 179.906 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? 64.89 45.83 3.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.898 -179.996 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . 0.502 ' HB3' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.414 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 9.8 m-85 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.602 0.239 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 155' ' ' PHE . 72.5 mt -162.11 81.81 0.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.771 -179.909 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -165.15 11.94 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.99 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.415 ' HB3' ' CG ' ' A' ' 163' ' ' LEU . 1.7 t -80.67 -33.93 35.15 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.615 0.721 . . . . 0.0 110.238 178.92 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.446 ' O ' HG13 ' A' ' 160' ' ' VAL . 0.4 OUTLIER -167.75 -37.79 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.043 179.555 . . . . . . . . 3 3 . 1 . 073 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.472 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 65.33 -52.82 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.031 179.566 . . . . . . . . 3 3 . 1 . 073 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.472 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 73.6 m-85 -72.51 -1.26 15.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.527 0.204 . . . . 0.0 111.428 179.737 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.466 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 20.0 m-85 -161.35 14.47 0.1 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.904 -179.994 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.486 ' HB3' ' HG ' ' A' ' 165' ' ' LEU . 1.0 OUTLIER -69.5 -38.07 77.48 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.409 0.623 . . . . 0.0 109.4 178.955 . . . . . . . . 3 3 . 1 . 073 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 14.8 t80 66.58 8.6 5.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.805 179.652 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.486 ' HG ' ' HB3' ' A' ' 163' ' ' LEU . 44.5 mt -67.43 -48.91 65.9 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.248 0.547 . . . . 0.0 110.532 179.439 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.42 128.11 2.51 Favored Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.439 -178.254 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.34 116.75 4.83 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.236 1.957 . . . . 0.0 112.265 -179.927 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.425 ' HA ' HD21 ' A' ' 171' ' ' LEU . 88.8 Cg_endo -80.06 38.52 0.75 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.701 2.267 . . . . 0.0 113.047 -179.726 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.401 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 5.4 tt -77.59 -34.62 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.264 0.554 . . . . 0.0 110.801 179.726 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 13.3 mm -71.66 -45.13 68.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.447 -179.299 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 0.9 OUTLIER -65.68 -53.15 45.13 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.035 . . . . . . . . 3 3 . 1 . 073 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -73.82 0.53 12.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.053 178.635 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.96 -55.61 6.32 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.584 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.568 ' H ' ' HG2' ' A' ' 178' ' ' PRO . . . -123.28 -27.45 1.49 Allowed Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 178.539 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.3 OUTLIER 78.07 -14.66 0.83 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.109 0.564 . . . . 0.0 112.125 179.506 . . . . . . . . 3 3 . 1 . 073 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.425 ' O ' ' CG ' ' A' ' 176' ' ' PHE . 14.7 t80 -96.02 43.91 1.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.562 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.55 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 3.8 mt 57.14 46.61 2.14 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.077 -178.689 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.568 ' HG2' ' H ' ' A' ' 174' ' ' GLY . 39.2 Cg_exo -41.25 -65.05 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.041 2.494 . . . . 0.0 112.963 179.554 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 56.13 53.52 8.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.971 0.415 . . . . 0.0 110.214 -179.689 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? 63.05 56.55 1.77 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.032 -179.134 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . 0.565 ' HB3' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 2.2 p90 . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.843 0.354 . . . . 0.0 111.279 . . . . . . . . . 0 0 . 1 . 074 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.4 pp -166.14 -39.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.202 179.759 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.404 ' OE1' ' N ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -72.29 -14.52 61.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.764 179.542 . . . . . . . . 3 3 . 1 . 074 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.404 ' N ' ' OE1' ' A' ' 157' ' ' GLN . 1.2 t -77.25 1.64 17.97 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.501 179.905 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.415 ' O ' ' CB ' ' A' ' 160' ' ' VAL . 2.0 t0 80.72 -19.21 0.45 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 122.331 0.253 . . . . 0.0 111.537 -179.733 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 164' ' ' PHE . 0.4 OUTLIER 85.5 -50.61 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 122.467 0.307 . . . . 0.0 111.352 179.667 . . . . . . . . 3 3 . 1 . 074 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.447 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 55.6 m-85 -68.79 -32.53 72.32 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.105 0.478 . . . . 0.0 110.676 179.848 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.12 -59.04 3.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.652 179.504 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.6 tp -66.51 -4.33 8.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.017 178.705 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.1 OUTLIER -78.12 -42.78 30.86 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.653 -179.021 . . . . . . . . 3 3 . 1 . 074 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.3 -51.58 59.73 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.155 0.502 . . . . 0.0 110.963 -179.958 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.2 tp -159.98 105.17 1.42 Allowed Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.289 -178.73 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.61 113.84 3.3 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.335 2.023 . . . . 0.0 113.217 -179.327 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.435 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 80.3 Cg_endo -82.57 92.14 0.95 Allowed 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.028 2.485 . . . . 0.0 111.059 178.862 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.528 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 2.4 pt -56.15 -29.83 28.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.619 -178.634 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 3.4 mp -77.4 -49.19 22.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.644 179.425 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 37.5 mt -68.29 -54.93 14.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.342 179.588 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.435 ' CG ' ' O ' ' A' ' 168' ' ' PRO . 4.2 p30 -71.96 -0.34 11.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.502 179.437 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -70.47 -55.91 7.85 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.842 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -126.23 -22.99 1.63 Allowed Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.549 178.54 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 76.72 -30.34 0.18 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 122.637 0.375 . . . . 0.0 111.579 -179.876 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.416 ' H ' ' C ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER -97.42 -8.45 29.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.686 0.279 . . . . 0.0 110.998 179.732 . . . . . . . . 3 3 . 1 . 074 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.496 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 38.8 mt -53.79 -44.92 98.86 Favored Pre-proline 0 CA--C 1.529 0.145 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.404 -179.987 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 82.0 Cg_exo -48.4 87.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.497 2.131 . . . . 0.0 112.62 -179.87 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 177' ' ' LEU . 24.1 mt -138.58 -57.96 0.63 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.758 179.633 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.764 ' N ' ' HD2' ' A' ' 180' ' ' ARG . 0.0 OUTLIER -105.02 27.91 7.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.406 179.918 . . . . . . . . 3 3 . 1 . 074 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 075 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.85 0.357 . . . . 0.0 111.946 . . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.4 HD23 ' CG2' ' A' ' 160' ' ' VAL . 22.7 mt 63.65 73.19 0.45 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.219 179.671 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -170.08 36.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 179.798 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 9.3 t -164.64 90.49 0.54 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.126 179.837 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.441 ' O ' ' CB ' ' A' ' 160' ' ' VAL . 1.2 m-20 71.84 -57.71 0.61 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.636 -179.252 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.466 ' O ' ' CB ' ' A' ' 164' ' ' PHE . 0.4 OUTLIER 91.07 -50.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.588 179.525 . . . . . . . . 3 3 . 1 . 075 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.434 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 0.9 OUTLIER -69.85 -30.14 67.55 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.223 0.535 . . . . 0.0 110.536 179.797 . . . . . . . . 3 3 . 1 . 075 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.6 -61.85 1.63 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.094 179.649 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 17.5 mt -66.27 -5.33 10.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.121 179.251 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.466 ' CB ' ' O ' ' A' ' 160' ' ' VAL . 0.1 OUTLIER -77.36 -43.82 31.52 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.597 -179.538 . . . . . . . . 3 3 . 1 . 075 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.1 -42.05 94.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.793 179.687 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.455 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 2.3 tp -161.65 125.87 2.01 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.123 -179.368 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.585 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 27.5 Cg_endo -64.85 -25.52 60.25 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.516 2.144 . . . . 0.0 114.699 -179.495 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 22.3 Cg_endo -93.93 101.44 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.072 1.848 . . . . 0.0 112.646 -179.38 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.55 HG23 ' N ' ' A' ' 170' ' ' ILE . 13.4 tt -72.77 -44.34 59.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.841 -179.614 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.55 ' N ' HG23 ' A' ' 169' ' ' ILE . 0.5 OUTLIER -69.2 -31.75 51.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.96 -177.272 . . . . . . . . 3 3 . 1 . 075 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 168' ' ' PRO . 2.0 mt -66.55 -56.92 8.58 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.201 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -74.48 -4.18 35.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.58 178.158 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.547 ' HB1' ' HA ' ' A' ' 170' ' ' ILE . . . -73.47 -68.22 0.52 Allowed 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 121.226 0.536 . . . . 0.0 110.148 179.911 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -121.73 -2.03 10.6 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.159 179.292 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.501 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 54.1 t80 69.17 -51.8 0.6 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.473 0.309 . . . . 0.0 111.653 -179.994 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.27 26.69 2.81 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.754 0.311 . . . . 0.0 111.174 -179.77 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.491 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 11.0 mt -91.89 -50.96 0.3 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.908 179.725 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.491 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 53.0 Cg_exo -55.76 -18.82 22.48 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.666 2.244 . . . . 0.0 112.788 179.986 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.36 -5.06 29.66 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 -179.776 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.15 57.61 1.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.163 0.506 . . . . 0.0 110.032 179.707 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 076 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.844 0.354 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 076 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.513 ' O ' ' CB ' ' A' ' 157' ' ' GLN . 0.3 OUTLIER -167.4 -162.47 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.594 -179.814 . . . . . . . . 3 3 . 1 . 076 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.513 ' CB ' ' O ' ' A' ' 156' ' ' LEU . 5.3 tt0 91.83 84.44 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.222 0.534 . . . . 0.0 111.071 -179.936 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.9 t 77.87 -63.76 0.32 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.743 179.444 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.48 ' C ' ' CG1' ' A' ' 160' ' ' VAL . 4.1 m-20 -164.18 -21.7 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.992 -1.004 . . . . 0.0 112.037 -179.539 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.48 ' CG1' ' C ' ' A' ' 159' ' ' ASP . 1.2 m 63.78 -54.43 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 122.674 0.39 . . . . 0.0 111.596 -179.744 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' A' ' 159' ' ' ASP . 6.0 t80 -70.89 2.04 4.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.49 0.186 . . . . 0.0 111.466 179.561 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -165.8 12.1 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.218 -179.942 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.445 ' CD1' ' HD3' ' A' ' 167' ' ' PRO . 15.4 tp -68.93 -33.09 73.17 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 178.748 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.462 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER 48.22 31.91 2.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.708 179.435 . . . . . . . . 3 3 . 1 . 076 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.462 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.1 OUTLIER 85.69 -29.58 0.07 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.821 -179.253 . . . . . . . . 3 3 . 1 . 076 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.429 ' CD1' ' HD2' ' A' ' 167' ' ' PRO . 0.2 OUTLIER -161.8 128.97 2.6 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.926 -178.87 . . . . . . . . 3 3 . 1 . 076 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.445 ' HD3' ' CD1' ' A' ' 163' ' ' LEU . 73.3 Cg_endo -76.13 108.67 2.73 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.141 1.894 . . . . 0.0 112.429 -179.598 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.407 ' O ' HG23 ' A' ' 169' ' ' ILE . 28.4 Cg_endo -64.23 -56.99 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.198 1.932 . . . . 0.0 112.368 -179.953 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.463 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 1.3 tt 83.08 -35.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.761 -179.961 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.428 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 3.9 mp -79.61 -59.28 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.916 0.389 . . . . 0.0 111.12 179.903 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 3.3 mm? -67.78 -47.4 69.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.247 0.546 . . . . 0.0 110.013 179.571 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.9 0.13 11.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.487 179.58 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -73.6 -63.02 1.29 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.142 0.496 . . . . 0.0 109.792 179.677 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.4 ' HA3' ' HG ' ' A' ' 177' ' ' LEU . . . -116.1 -12.34 9.22 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.749 178.901 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER 72.63 -56.12 0.66 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.35 0.26 . . . . 0.0 111.68 179.715 . . . . . . . . 3 3 . 1 . 076 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -94.15 -12.54 28.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.581 0.229 . . . . 0.0 111.51 -179.636 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.532 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 76.8 mt -52.7 -42.98 91.84 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.421 179.905 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 32.5 Cg_exo -57.92 -156.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.392 2.061 . . . . 0.0 112.206 179.931 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 74.89 69.92 0.09 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.2 0.524 . . . . 0.0 110.455 -179.829 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 66.08 47.09 1.99 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.885 -179.866 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 077 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 57.8 t80 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.843 0.354 . . . . 0.0 111.745 . . . . . . . . . 0 0 . 1 . 077 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.4 mt 62.57 50.22 3.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.291 179.555 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.411 ' HB2' ' CD2' ' A' ' 163' ' ' LEU . 11.5 tm0? -77.46 17.21 0.53 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.42 179.261 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 78.45 -61.65 0.36 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.787 0.327 . . . . 0.0 110.437 -179.329 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.442 ' O ' HG11 ' A' ' 160' ' ' VAL . 3.7 t0 -78.85 -48.48 14.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.044 179.143 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.447 HG11 ' CD1' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 83.55 -48.71 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.655 179.588 . . . . . . . . 3 3 . 1 . 077 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.447 ' CD1' HG11 ' A' ' 160' ' ' VAL . 73.1 m-85 -65.35 -27.38 68.55 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.989 0.423 . . . . 0.0 110.592 179.983 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -72.79 -63.68 1.12 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.401 179.037 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.411 ' CD2' ' HB2' ' A' ' 157' ' ' GLN . 14.2 tp -66.8 -4.11 8.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.473 179.11 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.437 ' HB3' ' O ' ' A' ' 161' ' ' PHE . 0.5 OUTLIER -72.06 -14.22 61.8 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.637 -179.571 . . . . . . . . 3 3 . 1 . 077 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.18 -19.81 64.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.813 178.651 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.43 HD23 ' HD2' ' A' ' 168' ' ' PRO . 0.3 OUTLIER -156.85 61.04 2.34 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.069 -176.93 . . . . . . . . 3 3 . 1 . 077 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.517 ' HG2' ' HD3' ' A' ' 168' ' ' PRO . 2.6 Cg_endo -42.81 -47.24 8.16 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.546 2.831 . . . . 0.0 113.847 179.914 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.517 ' HD3' ' HG2' ' A' ' 167' ' ' PRO . 52.1 Cg_endo -82.49 88.97 1.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.154 1.902 . . . . 0.0 113.498 -178.562 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.433 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 7.0 pt -75.23 -32.93 27.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.271 179.466 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.411 HG23 ' CD2' ' A' ' 177' ' ' LEU . 2.9 mp -70.01 -43.53 79.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.297 -179.103 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.21 -52.54 47.0 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.801 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.4 0.11 18.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.164 178.685 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.28 -60.26 2.32 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.043 0.449 . . . . 0.0 109.812 179.94 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -107.22 -20.37 8.74 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 178.535 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 27.3 t80 75.14 -11.08 1.12 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.443 0.297 . . . . 0.0 111.572 179.988 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -97.47 -9.81 26.53 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.791 0.329 . . . . 0.0 110.629 179.623 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.43 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.6 OUTLIER -51.91 -50.15 79.75 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.2 -179.869 . . . . . . . . 3 3 . 1 . 077 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 22.4 Cg_exo -65.05 91.67 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.6 2.2 . . . . 0.0 112.386 -179.829 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.403 ' CD2' ' O ' ' A' ' 177' ' ' LEU . 1.0 OUTLIER -81.02 -70.96 0.49 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.908 0.385 . . . . 0.0 110.714 179.756 . . . . . . . . 3 3 . 1 . 077 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.6 16.7 3.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.634 -179.914 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 078 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.961 0.41 . . . . 0.0 111.177 . . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.28 158.14 33.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.121 -179.823 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -170.23 -92.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.484 179.842 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 77.9 p -161.97 18.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.779 0.323 . . . . 0.0 111.388 179.537 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.421 ' HB3' ' HB2' ' A' ' 162' ' ' PHE . 6.5 t70 -168.9 -44.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.055 0.455 . . . . 0.0 110.176 179.683 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.444 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 87.09 -50.67 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.154 179.95 . . . . . . . . 3 3 . 1 . 078 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.444 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 1.5 m-85 -69.93 -30.42 67.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.226 0.536 . . . . 0.0 110.479 179.599 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.421 ' HB2' ' HB3' ' A' ' 159' ' ' ASP . 0.1 OUTLIER -71.55 -60.42 2.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.146 179.64 . . . . . . . . 3 3 . 1 . 078 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 27.9 tp -65.46 -7.07 12.43 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.721 179.044 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.435 ' CB ' ' O ' ' A' ' 160' ' ' VAL . 1.2 t80 -79.67 -37.71 35.25 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.444 -179.82 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.405 ' O ' ' CD2' ' A' ' 166' ' ' LEU . 0.5 OUTLIER -65.63 -42.13 91.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.841 179.631 . . . . . . . . 3 3 . 1 . 078 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.426 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 0.2 OUTLIER -158.6 119.21 1.85 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.7 -179.345 . . . . . . . . 3 3 . 1 . 078 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.543 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 10.3 Cg_endo -58.38 -32.01 95.24 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.446 2.098 . . . . 0.0 114.303 -179.363 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 26.4 Cg_endo -93.88 100.6 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.448 2.099 . . . . 0.0 112.448 -179.483 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.446 ' O ' ' N ' ' A' ' 173' ' ' ALA . 7.3 tt -73.98 -40.44 52.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.037 -179.305 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.411 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.4 mp -70.64 -43.34 77.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.029 -178.803 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 168' ' ' PRO . 0.4 OUTLIER -69.0 -2.97 11.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.983 0.421 . . . . 0.0 111.789 179.915 . . . . . . . . 3 3 . 1 . 078 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -145.88 17.28 1.43 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.354 179.978 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 169' ' ' ILE . . . -80.81 -39.99 25.74 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.141 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.615 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -134.68 3.48 4.24 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 114.898 -1.047 . . . . 0.0 111.968 179.046 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.508 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER 54.97 -61.42 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 123.819 0.847 . . . . 0.0 112.147 179.799 . . . . . . . . 3 3 . 1 . 078 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.615 ' N ' ' O ' ' A' ' 174' ' ' GLY . 11.6 m-85 -97.05 23.3 7.42 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.056 -179.953 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.515 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 14.1 mt -92.67 -49.63 0.29 Allowed Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.378 -179.968 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 40.7 Cg_exo -57.53 -157.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.374 2.049 . . . . 0.0 112.361 179.921 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 178' ' ' PRO . 2.0 mm? 71.13 68.34 0.17 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.16 0.505 . . . . 0.0 110.732 -179.831 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 63.82 56.11 1.54 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.77 179.872 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 079 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.683 0.278 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 079 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 97.3 mt -161.18 75.94 0.52 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.524 -179.967 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -170.55 -37.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.357 179.981 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.24 62.12 0.92 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.055 0.455 . . . . 0.0 110.405 179.787 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.438 ' O ' ' CB ' ' A' ' 160' ' ' VAL . 2.5 t0 75.88 -60.23 0.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.798 -179.651 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.464 ' O ' ' CB ' ' A' ' 164' ' ' PHE . 0.3 OUTLIER 89.04 -40.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.547 179.748 . . . . . . . . 3 3 . 1 . 079 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.436 ' HA ' ' HB3' ' A' ' 164' ' ' PHE . 48.8 t80 -65.19 -26.1 68.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.109 0.48 . . . . 0.0 110.657 -179.978 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.78 -63.37 1.07 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.052 179.567 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -63.09 -20.11 65.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.877 0.846 . . . . 0.0 109.385 178.888 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.464 ' CB ' ' O ' ' A' ' 160' ' ' VAL . 10.1 t80 -73.65 -60.98 2.0 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.892 -179.488 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.417 HD13 ' CZ ' ' A' ' 161' ' ' PHE . 1.0 OUTLIER -63.99 -63.41 1.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.991 0.424 . . . . 0.0 110.761 179.803 . . . . . . . . 3 3 . 1 . 079 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -161.64 135.86 5.11 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.719 -179.862 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.1 110.26 2.38 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.44 2.093 . . . . 0.0 111.975 179.806 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.43 ' O ' HG23 ' A' ' 169' ' ' ILE . 54.3 Cg_endo -67.65 -94.94 0.0 OUTLIER 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.248 1.965 . . . . 0.0 112.442 -179.638 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 170' ' ' ILE . 1.3 tt 80.23 -35.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.816 0.341 . . . . 0.0 111.757 179.986 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.465 ' O ' ' HB1' ' A' ' 173' ' ' ALA . 4.2 mp -73.63 -34.98 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.136 -179.582 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 43.6 mt -65.59 -59.46 3.93 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.941 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.54 4.09 8.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.868 178.472 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 170' ' ' ILE . . . -71.31 -53.94 12.52 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.746 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -98.53 -18.39 25.93 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 177.887 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 13.5 t80 75.47 -13.38 0.87 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.81 0.444 . . . . 0.0 111.723 179.787 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -99.23 -9.51 23.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.656 0.265 . . . . 0.0 110.644 179.527 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.464 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 11.1 mt -65.58 -48.46 65.2 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.357 -179.764 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 85.9 Cg_exo -47.39 93.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.613 2.209 . . . . 0.0 112.627 -179.926 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.13 -47.29 4.2 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.107 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.438 ' N ' ' HD2' ' A' ' 180' ' ' ARG . 0.0 OUTLIER -89.63 7.12 38.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.953 179.024 . . . . . . . . 3 3 . 1 . 079 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 080 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 32.3 p90 . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.853 0.359 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 080 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.406 ' HA ' ' CD2' ' A' ' 163' ' ' LEU . 0.6 OUTLIER -72.37 176.46 5.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.711 -179.864 . . . . . . . . 3 3 . 1 . 080 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -169.25 -38.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.413 179.939 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.46 37.71 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.975 0.417 . . . . 0.0 111.554 179.835 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.684 ' O ' ' N ' ' A' ' 161' ' ' PHE . 1.7 m-20 -163.76 -57.15 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.353 179.189 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.498 HG11 ' O ' ' A' ' 159' ' ' ASP . 11.1 p 52.14 -52.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 O-C-N 124.17 0.918 . . . . 0.0 112.131 -179.291 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.684 ' N ' ' O ' ' A' ' 159' ' ' ASP . 2.3 t80 -73.79 -2.33 23.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.814 -0.176 . . . . 0.0 111.26 179.071 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.444 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 7.8 m-85 -164.84 14.79 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.988 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.406 ' CD2' ' HA ' ' A' ' 156' ' ' LEU . 5.6 tp -69.81 -30.63 68.2 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.176 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 4.4 t80 67.23 5.03 3.95 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.509 178.957 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -69.21 -64.72 0.82 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.01 0.433 . . . . 0.0 110.93 179.564 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.474 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 0.2 OUTLIER -160.8 92.36 1.56 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.303 -179.546 . . . . . . . . 3 3 . 1 . 080 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.448 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 3.3 Cg_exo -38.89 -45.12 2.55 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.407 2.738 . . . . 0.0 114.018 -179.482 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.474 ' HD2' ' C ' ' A' ' 166' ' ' LEU . 75.5 Cg_endo -86.73 -93.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.979 1.786 . . . . 0.0 113.819 -178.276 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.461 HG23 ' N ' ' A' ' 170' ' ' ILE . 0.2 OUTLIER 88.12 -39.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 122.758 0.423 . . . . 0.0 111.179 -179.049 . . . . . . . . 3 3 . 1 . 080 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.461 ' N ' HG23 ' A' ' 169' ' ' ILE . 2.9 mp -78.24 -56.13 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.019 0.438 . . . . 0.0 110.507 179.44 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.83 -45.32 75.01 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.964 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -73.82 -0.64 16.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.325 179.214 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 170' ' ' ILE . . . -73.26 -45.63 54.66 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.29 0.567 . . . . 0.0 109.84 179.731 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.513 ' H ' ' HG2' ' A' ' 178' ' ' PRO . . . -126.62 -28.25 0.99 Allowed Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.261 179.054 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 35.7 t80 78.75 -12.66 1.06 Allowed 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 122.97 0.508 . . . . 0.0 112.134 179.525 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.473 ' HZ ' ' HG3' ' A' ' 181' ' ' HSL . 14.8 p90 -95.92 37.34 1.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.65 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.534 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 10.1 mt 64.81 46.44 0.56 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.885 -178.856 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.534 ' HD3' ' N ' ' A' ' 177' ' ' LEU . 42.1 Cg_exo -39.87 -69.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.161 2.574 . . . . 0.0 113.021 179.555 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 56.85 52.49 9.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.029 0.442 . . . . 0.0 110.824 179.966 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 65.88 44.95 2.64 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.867 179.965 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . 0.473 ' HG3' ' HZ ' ' A' ' 176' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.869 0.366 . . . . 0.0 111.459 . . . . . . . . . 0 0 . 1 . 081 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 72.2 mt -73.27 73.29 1.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.758 179.85 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -168.21 34.55 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.272 0.558 . . . . 0.0 110.54 179.835 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 159' ' ' ASP . 4.1 t -164.48 88.06 0.49 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.367 179.728 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 158' ' ' SER . 0.7 OUTLIER 74.38 -60.67 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.234 -178.641 . . . . . . . . 3 3 . 1 . 081 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.5 t 68.61 -54.4 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.665 179.593 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.452 ' C ' ' CG ' ' A' ' 162' ' ' PHE . 0.4 OUTLIER -71.59 5.88 2.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.493 179.789 . . . . . . . . 3 3 . 1 . 081 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.452 ' CG ' ' C ' ' A' ' 161' ' ' PHE . 0.1 OUTLIER -160.72 1.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.378 179.728 . . . . . . . . 3 3 . 1 . 081 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 14.3 tp -69.57 -2.84 12.55 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.29 0.567 . . . . 0.0 110.021 177.971 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -68.89 -11.25 60.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.591 -178.985 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.31 -33.02 75.0 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.224 0.535 . . . . 0.0 109.908 178.636 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.417 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 0.2 OUTLIER -160.27 67.97 2.76 Favored Pre-proline 0 N--CA 1.45 -0.461 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.683 -178.902 . . . . . . . . 3 3 . 1 . 081 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.507 ' HG2' ' HD3' ' A' ' 168' ' ' PRO . 4.3 Cg_endo -52.4 -37.68 72.55 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 123.085 2.523 . . . . 0.0 114.293 -179.107 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.507 ' HD3' ' HG2' ' A' ' 167' ' ' PRO . 40.1 Cg_endo -90.17 78.27 0.78 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 121.947 1.765 . . . . 0.0 113.241 -178.732 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 23.6 mm -78.01 -76.71 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.141 179.652 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.435 ' O ' ' HG2' ' A' ' 178' ' ' PRO . 3.8 mp -73.26 -29.77 29.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.592 -179.202 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 22.5 tp -64.81 -64.78 0.78 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 179.339 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -77.68 8.43 4.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.181 178.627 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.413 ' HB1' ' HA ' ' A' ' 170' ' ' ILE . . . -71.26 -51.23 25.68 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.403 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.61 ' H ' ' HG2' ' A' ' 178' ' ' PRO . . . -121.69 -28.32 1.6 Allowed Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 178.046 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 77.8 -24.62 0.21 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.404 0.682 . . . . 0.0 112.192 179.202 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -92.76 50.16 1.54 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.954 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.542 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 5.7 mt 55.23 62.05 8.05 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.449 -178.627 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.61 ' HG2' ' H ' ' A' ' 174' ' ' GLY . 23.6 Cg_exo -67.66 -8.72 23.19 Favored 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 123.68 2.92 . . . . 0.0 112.793 -179.741 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.3 tt -62.27 -57.76 10.21 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.031 0.443 . . . . 0.0 110.963 -179.956 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.55 34.79 0.71 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.853 -179.865 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 082 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.415 ' CE1' HD23 ' A' ' 156' ' ' LEU . 2.4 t80 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.847 0.356 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.415 HD23 ' CE1' ' A' ' 155' ' ' PHE . 0.4 OUTLIER -74.09 145.53 44.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.09 -179.838 . . . . . . . . 3 3 . 1 . 082 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -170.04 52.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.713 -179.967 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.9 p 76.46 0.52 3.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.676 -179.777 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 160' ' ' VAL . 9.9 p30 -161.36 -38.75 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.41 -179.978 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.538 ' O ' ' HB2' ' A' ' 164' ' ' PHE . 0.4 OUTLIER 85.27 -42.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.043 179.434 . . . . . . . . 3 3 . 1 . 082 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.447 ' N ' HG11 ' A' ' 160' ' ' VAL . 60.4 m-85 -67.45 -30.82 70.64 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.071 0.462 . . . . 0.0 110.855 -179.939 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.454 ' CD1' ' HB3' ' A' ' 167' ' ' PRO . 2.4 t80 -67.71 -61.79 1.72 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.474 179.465 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 16.1 tp -67.25 -3.47 7.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.212 178.809 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.538 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.1 OUTLIER -76.39 -36.73 57.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.848 -178.762 . . . . . . . . 3 3 . 1 . 082 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.9 mt -174.8 -44.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.809 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.409 ' CD1' ' HD2' ' A' ' 167' ' ' PRO . 0.2 OUTLIER -158.83 131.08 4.25 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.706 0.289 . . . . 0.0 111.18 -179.084 . . . . . . . . 3 3 . 1 . 082 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.454 ' HB3' ' CD1' ' A' ' 162' ' ' PHE . 18.6 Cg_endo -58.27 116.66 3.4 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.727 2.285 . . . . 0.0 112.441 -179.969 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.79 83.67 0.31 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.457 2.104 . . . . 0.0 111.604 179.522 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.444 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 2.3 pt -69.4 -32.85 54.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.621 -179.326 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 3.8 mp -76.6 -54.29 13.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.293 -179.77 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 25.7 mt -67.37 -53.04 32.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.031 0.444 . . . . 0.0 110.488 179.974 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -74.46 5.27 4.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.727 179.764 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -69.75 -56.86 6.02 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.068 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.588 ' O ' ' HD2' ' A' ' 178' ' ' PRO . . . -132.85 30.9 3.02 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 177.394 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.431 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 18.4 t80 68.5 -69.22 0.15 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.366 0.603 . . . . 0.0 109.432 -178.371 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.447 ' O ' HD23 ' A' ' 177' ' ' LEU . 15.6 t80 -151.69 0.28 0.35 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.961 178.963 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.546 ' O ' ' O ' ' A' ' 178' ' ' PRO . 0.0 OUTLIER -150.97 -68.31 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -178.724 . . . . . . . . 3 3 . 1 . 082 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.588 ' HD2' ' O ' ' A' ' 174' ' ' GLY . 67.6 Cg_exo -34.67 173.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 123.559 2.839 . . . . 0.0 114.308 -179.365 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.44 ' CB ' ' O ' ' A' ' 178' ' ' PRO . 0.2 OUTLIER 86.94 -24.27 0.12 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.369 179.884 . . . . . . . . 3 3 . 1 . 082 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.44 46.68 0.89 Allowed 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.883 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 083 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.879 0.371 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 083 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.416 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 2.5 pt? -165.42 127.06 2.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.944 -179.787 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 43.4 tp60 -170.33 26.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.036 -179.876 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 162' ' ' PHE . 0.3 OUTLIER -167.65 33.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.865 179.95 . . . . . . . . 3 3 . 1 . 083 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.441 ' O ' HG11 ' A' ' 160' ' ' VAL . 0.5 OUTLIER 77.06 -6.59 1.99 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.918 -179.915 . . . . . . . . 3 3 . 1 . 083 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.441 HG11 ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 89.31 -44.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 122.644 0.378 . . . . 0.0 111.56 179.702 . . . . . . . . 3 3 . 1 . 083 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.419 ' O ' ' HB2' ' A' ' 164' ' ' PHE . 46.1 m-85 -68.13 -38.05 81.78 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.203 0.525 . . . . 0.0 110.381 179.806 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.489 ' HB2' ' O ' ' A' ' 158' ' ' SER . 0.1 OUTLIER -72.59 -50.31 26.29 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.643 179.397 . . . . . . . . 3 3 . 1 . 083 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.454 ' HG ' ' HG3' ' A' ' 167' ' ' PRO . 1.4 tt -64.9 -3.47 3.47 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 121.833 0.825 . . . . 0.0 109.856 178.424 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.472 ' H ' ' C ' ' A' ' 162' ' ' PHE . 0.4 OUTLIER -75.46 -72.41 0.31 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.162 -1.381 . . . . 0.0 111.036 -179.343 . . . . . . . . 3 3 . 1 . 083 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.459 ' N ' ' CD1' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -67.11 -68.21 0.4 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.052 0.453 . . . . 0.0 110.684 179.56 . . . . . . . . 3 3 . 1 . 083 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.2 mt -162.28 97.14 1.17 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.692 -179.032 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.454 ' HG3' ' HG ' ' A' ' 163' ' ' LEU . 43.0 Cg_endo -68.35 109.75 2.09 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.467 2.111 . . . . 0.0 112.756 -179.703 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.13 -11.55 19.47 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.583 2.189 . . . . 0.0 112.534 179.663 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.909 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.5 OUTLIER -70.6 -107.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 CA-C-O 118.943 -0.551 . . . . 0.0 109.526 -179.915 . . . . . . . . 3 3 . 1 . 083 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.487 ' H ' ' CG2' ' A' ' 169' ' ' ILE . 4.2 mt 21.03 -61.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 178.481 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.909 ' N ' ' O ' ' A' ' 169' ' ' ILE . 0.2 OUTLIER -64.72 -52.38 57.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.57 -179.248 . . . . . . . . 3 3 . 1 . 083 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -73.69 -11.2 60.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.725 0.298 . . . . 0.0 111.094 179.855 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -77.01 -56.12 4.86 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.914 0.388 . . . . 0.0 110.638 179.98 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -99.32 -24.8 9.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.855 179.371 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 27.6 t80 77.3 -40.76 0.35 Allowed 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 122.385 0.274 . . . . 0.0 111.681 179.976 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -94.13 -7.87 41.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.688 0.28 . . . . 0.0 111.277 -179.979 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.522 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 28.4 mt -56.61 -44.19 99.65 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.343 179.709 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 78.8 Cg_exo -48.22 93.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.496 2.131 . . . . 0.0 112.779 -179.76 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.1 mt -99.1 -71.14 0.7 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.63 179.612 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.26 21.61 4.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.609 179.417 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 084 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 120.909 0.385 . . . . 0.0 111.341 . . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.7 pp -165.74 128.92 2.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.771 -179.265 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -70.05 -46.61 64.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.187 0.518 . . . . 0.0 110.524 179.805 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.494 ' HB3' ' HA ' ' A' ' 163' ' ' LEU . 2.7 t -164.9 51.17 0.11 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.436 179.359 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.461 ' CB ' ' O ' ' A' ' 158' ' ' SER . 0.4 OUTLIER 86.91 -23.91 0.13 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.388 -179.401 . . . . . . . . 3 3 . 1 . 084 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 96.9 t 68.85 -55.16 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.829 0.347 . . . . 0.0 111.614 179.562 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.417 ' O ' ' CD1' ' A' ' 162' ' ' PHE . 96.0 m-85 -72.29 2.33 6.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.018 179.542 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.417 ' CD1' ' O ' ' A' ' 161' ' ' PHE . 0.1 OUTLIER -166.39 16.38 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.847 179.785 . . . . . . . . 3 3 . 1 . 084 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.524 ' O ' ' CD1' ' A' ' 164' ' ' PHE . 0.3 OUTLIER -67.31 -17.98 64.99 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.645 . . . . . . . . 3 3 . 1 . 084 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.584 ' CD2' ' O ' ' A' ' 164' ' ' PHE . 45.1 p90 47.46 57.43 5.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.538 179.784 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -170.6 -19.78 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.961 -179.264 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.465 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 4.3 tp -156.39 94.76 2.35 Favored Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-O 120.833 0.349 . . . . 0.0 111.045 -178.303 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.586 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 20.9 Cg_endo -63.88 -26.12 67.28 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.778 2.319 . . . . 0.0 114.656 -179.414 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 27.4 Cg_endo -93.17 -165.35 0.13 Allowed 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 121.918 1.746 . . . . 0.0 112.582 -179.467 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 12.6 tt -167.44 -42.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.822 -179.851 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.438 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.6 mp -70.35 -45.25 75.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.046 -179.684 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.4 ' HA ' ' HG3' ' A' ' 178' ' ' PRO . 3.6 mp -64.56 -52.22 58.76 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.235 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -76.21 1.54 15.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.153 178.529 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.41 -61.94 1.62 Allowed 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.142 0.496 . . . . 0.0 109.672 179.818 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -102.48 -21.39 10.64 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 178.332 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 1.6 t80 75.13 -38.86 0.39 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.569 0.347 . . . . 0.0 111.464 179.896 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -92.68 1.72 57.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.809 0.337 . . . . 0.0 110.74 179.546 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.487 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.3 OUTLIER -78.57 -46.0 1.97 Allowed Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.149 179.801 . . . . . . . . 3 3 . 1 . 084 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 99.1 Cg_exo -42.55 -68.76 0.09 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.543 2.162 . . . . 0.0 113.0 -179.477 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 8.8 mt 61.01 59.65 1.99 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.023 0.44 . . . . 0.0 110.19 -179.674 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 7.9 mtt-85 68.74 47.17 0.86 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.644 -179.358 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 085 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.404 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.654 0.264 . . . . 0.0 111.275 . . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.408 ' C ' ' H ' ' A' ' 158' ' ' SER . 27.0 mt -162.92 96.28 0.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.577 -179.979 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.79 25.39 0.35 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.986 179.431 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 156' ' ' LEU . 4.4 p 72.97 47.23 0.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.157 0.503 . . . . 0.0 110.982 -179.866 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.42 ' O ' HG11 ' A' ' 160' ' ' VAL . 1.8 m-20 -162.18 -61.74 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.309 179.566 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 164' ' ' PHE . 0.3 OUTLIER 86.1 -38.61 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.703 179.663 . . . . . . . . 3 3 . 1 . 085 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.413 ' N ' HG11 ' A' ' 160' ' ' VAL . 61.7 t80 -66.07 -27.51 68.13 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.976 0.417 . . . . 0.0 110.599 179.901 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.419 ' CE1' ' HB3' ' A' ' 168' ' ' PRO . 0.2 OUTLIER -69.31 -61.45 1.79 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.61 179.324 . . . . . . . . 3 3 . 1 . 085 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.0 tp -66.68 -5.31 11.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.046 178.773 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.2 OUTLIER -77.81 -60.45 2.36 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.288 -179.21 . . . . . . . . 3 3 . 1 . 085 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.82 -51.37 62.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.19 0.519 . . . . 0.0 110.619 179.711 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.404 ' HA ' ' HD2' ' A' ' 167' ' ' PRO . 0.2 OUTLIER -161.9 120.88 1.43 Allowed Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.494 -178.956 . . . . . . . . 3 3 . 1 . 085 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 166' ' ' LEU . 9.9 Cg_endo -53.0 115.55 2.34 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.361 2.041 . . . . 0.0 111.981 179.863 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.419 ' HB3' ' CE1' ' A' ' 162' ' ' PHE . 58.6 Cg_endo -72.38 -3.3 13.14 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.291 1.994 . . . . 0.0 112.979 -179.639 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.883 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.5 OUTLIER -72.11 -107.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 118.911 -0.566 . . . . 0.0 109.703 179.648 . . . . . . . . 3 3 . 1 . 085 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.474 ' H ' ' CG2' ' A' ' 169' ' ' ILE . 2.2 mp 21.98 -63.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 178.595 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.883 ' N ' ' O ' ' A' ' 169' ' ' ILE . 4.0 pp -66.37 -50.32 63.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.181 -179.635 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.402 ' N ' ' CD1' ' A' ' 171' ' ' LEU . 0.4 OUTLIER -69.7 -11.68 61.04 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.607 179.611 . . . . . . . . 3 3 . 1 . 085 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -78.22 -62.0 1.82 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.812 179.87 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -113.15 -24.69 4.72 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.348 179.748 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 1.0 OUTLIER 76.66 -11.82 1.13 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.561 0.22 . . . . 0.0 111.455 -179.792 . . . . . . . . 3 3 . 1 . 085 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.514 ' CD1' HD12 ' A' ' 179' ' ' LEU . 27.8 t80 -122.99 3.94 9.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.684 0.278 . . . . 0.0 110.702 179.377 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.504 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 22.4 mt -75.98 -45.38 3.87 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.209 179.975 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 3.2 Cg_exo -74.0 -85.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.514 2.143 . . . . 0.0 112.055 -179.785 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.514 HD12 ' CD1' ' A' ' 176' ' ' PHE . 4.6 mt 48.88 49.94 18.4 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 121.181 0.515 . . . . 0.0 110.663 -179.911 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 68.87 46.16 0.91 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.628 -179.552 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . 0.483 ' HB3' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.782 0.325 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 086 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 20.1 mt 56.56 70.28 0.66 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.845 179.957 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -78.39 20.54 0.41 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.474 179.572 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 75.57 45.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.098 0.475 . . . . 0.0 110.643 -179.61 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.435 ' O ' ' CB ' ' A' ' 160' ' ' VAL . 44.4 m-20 -158.73 -61.34 0.08 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.199 179.894 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.435 ' CB ' ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 88.37 -41.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.837 179.388 . . . . . . . . 3 3 . 1 . 086 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.428 ' N ' HG11 ' A' ' 160' ' ' VAL . 1.6 m-85 -70.23 -34.5 72.95 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.124 0.488 . . . . 0.0 110.865 -179.843 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.41 ' C ' ' H ' ' A' ' 164' ' ' PHE . 0.3 OUTLIER -68.71 -53.13 23.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.209 -179.848 . . . . . . . . 3 3 . 1 . 086 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 12.8 tp -67.59 -5.44 15.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.329 178.709 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.44 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER -76.83 -4.57 44.29 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.862 179.805 . . . . . . . . 3 3 . 1 . 086 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.44 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.1 OUTLIER 84.2 -20.26 0.32 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.182 -179.643 . . . . . . . . 3 3 . 1 . 086 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.9 tp -168.24 141.57 2.6 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.881 -178.484 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -74.12 109.22 2.84 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.32 2.013 . . . . 0.0 112.345 179.61 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.88 ' O ' ' N ' ' A' ' 170' ' ' ILE . 58.6 Cg_endo -71.72 -17.58 29.32 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.574 2.183 . . . . 0.0 112.508 179.93 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.496 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 5.2 tt 32.0 -62.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.177 0.991 . . . . 0.0 112.647 179.663 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.88 ' N ' ' O ' ' A' ' 168' ' ' PRO . 0.4 OUTLIER -67.03 -47.86 80.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.992 -179.899 . . . . . . . . 3 3 . 1 . 086 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.85 -50.92 64.73 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.419 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.417 ' HB2' ' HG2' ' A' ' 168' ' ' PRO . 0.8 OUTLIER -73.82 -5.86 43.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.547 178.445 . . . . . . . . 3 3 . 1 . 086 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -73.71 -73.71 0.21 Allowed 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.571 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -113.95 -19.86 6.25 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.44 178.585 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 35.0 t80 73.03 -44.86 0.61 Allowed 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 122.45 0.3 . . . . 0.0 111.59 179.87 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -94.08 -13.07 27.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.349 -179.729 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.53 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 8.0 mt -48.55 -43.51 62.23 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 120.522 0.201 . . . . 0.0 111.289 179.797 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 21.6 Cg_exo -65.98 -28.19 50.0 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.565 2.177 . . . . 0.0 112.13 -179.946 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 8.9 mp -77.91 -7.94 57.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.475 -179.913 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.88 62.5 0.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.222 0.534 . . . . 0.0 109.673 179.566 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 087 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.779 0.323 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 087 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -165.72 60.3 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.043 -179.929 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -169.52 -41.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.962 179.975 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.4 p -75.96 57.92 1.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.911 179.873 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.576 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.5 OUTLIER 70.97 -48.6 0.67 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.887 179.871 . . . . . . . . 3 3 . 1 . 087 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.576 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 98.2 t 85.75 -53.38 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 C-N-CA 123.02 0.528 . . . . 0.0 110.719 -179.568 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.419 ' O ' ' CB ' ' A' ' 164' ' ' PHE . 0.1 OUTLIER -68.22 -24.2 64.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.104 0.478 . . . . 0.0 109.868 179.012 . . . . . . . . 3 3 . 1 . 087 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.436 ' C ' ' H ' ' A' ' 164' ' ' PHE . 0.3 OUTLIER -70.93 -51.13 27.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.447 179.152 . . . . . . . . 3 3 . 1 . 087 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.16 -5.89 7.89 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.794 0.807 . . . . 0.0 109.281 178.129 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.436 ' H ' ' C ' ' A' ' 162' ' ' PHE . 0.1 OUTLIER -77.83 -63.46 1.38 Allowed 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.781 -179.733 . . . . . . . . 3 3 . 1 . 087 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.08 -45.84 79.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.175 0.512 . . . . 0.0 110.372 179.403 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.403 HD22 ' N ' ' A' ' 167' ' ' PRO . 0.2 OUTLIER -160.97 122.05 1.65 Allowed Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.323 -178.617 . . . . . . . . 3 3 . 1 . 087 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.403 ' N ' HD22 ' A' ' 166' ' ' LEU . 11.8 Cg_endo -55.54 119.76 7.09 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.582 2.188 . . . . 0.0 112.86 -179.426 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.98 92.94 0.87 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.818 2.345 . . . . 0.0 111.463 179.312 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.562 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 2.9 tp -68.91 -40.67 81.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.408 -179.268 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.424 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.8 mp -71.33 -47.93 56.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.016 -179.904 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.48 -50.67 64.48 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.13 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.88 -4.66 39.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.998 178.869 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.562 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -73.37 -69.48 0.42 Allowed 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.368 0.604 . . . . 0.0 109.552 179.632 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.727 ' H ' ' HG2' ' A' ' 178' ' ' PRO . . . -122.36 -20.71 2.91 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.213 178.674 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.418 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 11.8 t80 76.35 -31.68 0.19 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.313 0.645 . . . . 0.0 112.349 179.549 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -91.63 61.9 4.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.332 0.587 . . . . 0.0 109.694 179.525 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.673 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 2.3 mt 44.16 56.03 13.09 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.029 -178.997 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.727 ' HG2' ' H ' ' A' ' 174' ' ' GLY . 12.5 Cg_exo -73.62 162.79 38.98 Favored 'Trans proline' 0 CA--C 1.528 0.18 0 C-N-CA 123.787 2.992 . . . . 0.0 112.587 -179.652 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.9 mt 167.8 -33.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.041 179.706 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.48 35.47 0.87 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.036 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 088 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.439 ' CE2' ' NE2' ' A' ' 157' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.782 0.325 . . . . 0.0 111.224 . . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.5 pp -165.62 -42.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.201 -179.976 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.446 ' CB ' ' HB2' ' A' ' 163' ' ' LEU . 12.4 mm-40 74.38 67.15 0.09 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.017 0.436 . . . . 0.0 111.188 179.623 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 72.41 -61.22 0.5 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.845 179.943 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.411 ' O ' ' CB ' ' A' ' 160' ' ' VAL . 8.3 m-20 -159.44 12.87 0.14 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.015 -0.538 . . . . 0.0 112.281 179.926 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.418 ' O ' ' HB2' ' A' ' 164' ' ' PHE . 0.4 OUTLIER 83.49 -46.1 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 111.819 0.304 . . . . 0.0 111.819 179.542 . . . . . . . . 3 3 . 1 . 088 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.457 ' HA ' ' HB2' ' A' ' 164' ' ' PHE . 37.8 m-85 -65.0 -24.73 67.6 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.843 0.354 . . . . 0.0 110.876 -179.585 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -68.23 -59.81 2.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.634 179.48 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.446 ' HB2' ' CB ' ' A' ' 157' ' ' GLN . 1.5 tm? -62.8 -16.21 57.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.872 0.844 . . . . 0.0 109.499 178.356 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.457 ' HB2' ' HA ' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -69.08 -12.6 61.83 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.371 -179.472 . . . . . . . . 3 3 . 1 . 088 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.1 tp -64.38 -32.08 73.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.214 0.53 . . . . 0.0 110.058 178.935 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.45 ' O ' ' CD2' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -160.29 78.1 2.6 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.044 -178.544 . . . . . . . . 3 3 . 1 . 088 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.579 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 36.0 Cg_endo -69.38 -25.9 29.92 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.819 2.346 . . . . 0.0 115.302 -178.563 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 33.8 Cg_endo -88.3 49.85 1.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.56 1.507 . . . . 0.0 112.912 -179.294 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 7.5 tt -77.49 -41.23 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.952 179.585 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.426 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.3 mp -76.13 -51.85 19.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.92 -179.282 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -53.13 52.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.981 0.42 . . . . 0.0 110.002 -179.756 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -74.84 4.73 5.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.384 179.053 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 170' ' ' ILE . . . -70.44 -60.57 2.19 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.694 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -109.36 -17.18 10.2 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 178.085 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 29.7 t80 72.33 -12.39 0.72 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.565 0.346 . . . . 0.0 111.316 -179.777 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.439 ' CD1' HD23 ' A' ' 179' ' ' LEU . 76.4 t80 -97.88 19.17 14.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.937 0.399 . . . . 0.0 110.193 179.506 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.412 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 2.4 mt -81.05 -53.44 0.78 Allowed Pre-proline 0 C--O 1.232 0.155 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.918 -179.886 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 74.5 Cg_exo -50.46 -71.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.637 2.225 . . . . 0.0 112.498 -179.764 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.439 HD23 ' CD1' ' A' ' 176' ' ' PHE . 50.3 mt 61.28 57.17 2.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.062 0.458 . . . . 0.0 110.779 -179.981 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 9.4 mmp_? 62.09 46.67 6.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.812 179.926 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 089 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.424 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 82.8 m-85 . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.68 0.276 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 155' ' ' PHE . 84.0 mt -161.97 79.36 0.54 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.787 -179.999 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -169.82 -40.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.413 179.715 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.82 60.78 0.74 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.229 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.459 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.3 OUTLIER 72.41 -58.88 0.58 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.383 -179.053 . . . . . . . . 3 3 . 1 . 089 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.459 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 57.6 t 74.25 -65.23 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.831 -179.842 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.427 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 22.8 m-85 -79.89 35.33 0.31 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.03 178.841 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.427 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 7.4 m-85 -170.06 -26.65 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.809 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 166' ' ' LEU . 0.6 OUTLIER -57.13 -48.84 77.67 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.593 . . . . . . . . 3 3 . 1 . 089 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.491 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 0.5 OUTLIER 43.37 38.53 1.76 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.721 177.352 . . . . . . . . 3 3 . 1 . 089 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.516 ' O ' HD23 ' A' ' 166' ' ' LEU . 0.7 OUTLIER 88.08 -29.69 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.068 -179.43 . . . . . . . . 3 3 . 1 . 089 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.516 HD23 ' O ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER -158.99 132.78 4.99 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.156 -178.859 . . . . . . . . 3 3 . 1 . 089 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.427 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 4.0 Cg_exo -38.4 -46.0 2.32 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.572 2.848 . . . . 0.0 114.355 -178.98 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.479 ' HD2' ' CD1' ' A' ' 166' ' ' LEU . 52.3 Cg_endo -88.78 101.04 0.38 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.74 2.293 . . . . 0.0 112.227 -179.336 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.547 HG23 ' N ' ' A' ' 170' ' ' ILE . 0.0 OUTLIER -71.22 -46.5 65.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.248 -179.455 . . . . . . . . 3 3 . 1 . 089 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.547 ' N ' HG23 ' A' ' 169' ' ' ILE . 0.6 OUTLIER -74.54 -43.67 48.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.361 -177.95 . . . . . . . . 3 3 . 1 . 089 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.411 ' HA ' ' HG2' ' A' ' 178' ' ' PRO . 0.2 OUTLIER -65.35 -56.55 12.01 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.227 . . . . . . . . 3 3 . 1 . 089 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.7 4.41 7.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.4 179.023 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -71.16 -75.34 0.13 Allowed 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.796 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.408 ' HA3' ' HG ' ' A' ' 177' ' ' LEU . . . -95.12 -13.03 54.11 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 177.924 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 69.76 -59.59 0.5 Allowed 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 120.862 0.363 . . . . 0.0 110.955 179.875 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -96.94 -5.5 37.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.194 179.708 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.517 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 62.7 mt -71.61 -45.21 12.81 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.161 179.685 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.517 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 27.5 Cg_exo -62.11 -149.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.466 2.111 . . . . 0.0 111.984 179.812 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.6 tp 81.02 74.1 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.135 0 CA-C-O 121.071 0.462 . . . . 0.0 110.763 -179.894 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 67.17 57.35 0.6 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.832 179.862 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 090 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.619 ' O ' ' O ' ' A' ' 156' ' ' LEU . 9.8 m-85 . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 120.79 0.329 . . . . 0.0 111.392 . . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.619 ' O ' ' O ' ' A' ' 155' ' ' PHE . 3.3 pp 45.15 142.74 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.393 -0.822 . . . . 0.0 112.934 179.29 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -171.13 -80.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.225 179.881 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.7 m -170.1 -40.85 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.374 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -84.31 -52.45 6.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.066 178.819 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.447 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 80.0 -52.39 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.171 179.839 . . . . . . . . 3 3 . 1 . 090 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.447 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 72.6 t80 -69.57 -28.7 66.2 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.051 0.453 . . . . 0.0 110.259 179.393 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.423 ' CD1' ' HG3' ' A' ' 168' ' ' PRO . 0.2 OUTLIER -68.49 -60.05 2.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.782 179.46 . . . . . . . . 3 3 . 1 . 090 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 13.5 mt -65.93 -5.22 8.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.93 178.791 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.1 OUTLIER -75.95 -63.69 1.25 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.869 -179.457 . . . . . . . . 3 3 . 1 . 090 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -55.21 18.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.993 0.425 . . . . 0.0 110.667 179.607 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.4 ' HG ' ' HD2' ' A' ' 167' ' ' PRO . 3.9 tp -161.37 141.56 8.09 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.587 -179.658 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.4 ' HD2' ' HG ' ' A' ' 166' ' ' LEU . 13.6 Cg_endo -57.06 110.17 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.478 2.118 . . . . 0.0 112.901 -179.672 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.423 ' HG3' ' CD1' ' A' ' 162' ' ' PHE . 81.8 Cg_endo -80.94 87.02 1.54 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.102 2.535 . . . . 0.0 112.093 179.45 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.477 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.1 OUTLIER -72.07 -38.17 62.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.313 -179.825 . . . . . . . . 3 3 . 1 . 090 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 6.0 mm -80.84 -44.09 21.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.61 -179.869 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.38 -57.85 8.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.159 0.504 . . . . 0.0 109.792 179.95 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.9 2.81 7.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.066 178.74 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.02 -54.79 8.8 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.432 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.434 ' HA3' ' CG ' ' A' ' 177' ' ' LEU . . . -126.39 -10.64 4.04 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.928 178.692 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.415 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 2.6 t80 68.55 -52.67 0.56 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.62 0.368 . . . . 0.0 111.708 179.59 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -92.49 10.01 31.98 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.403 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.519 ' O ' ' HB3' ' A' ' 181' ' ' HSL . 13.2 mt -71.85 -46.74 12.07 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.509 0.195 . . . . 0.0 110.806 179.352 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 90.2 Cg_exo -44.25 -28.78 2.58 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.512 2.142 . . . . 0.0 112.408 179.718 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.1 mp -81.5 -55.1 4.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.122 179.329 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.76 37.57 0.8 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.424 179.44 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . 0.519 ' HB3' ' O ' ' A' ' 177' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.517 0.199 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 091 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.406 HD21 ' HA ' ' A' ' 156' ' ' LEU . 7.0 mt -167.48 42.08 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.957 0.408 . . . . 0.0 110.683 -179.716 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -168.61 52.0 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.373 0.606 . . . . 0.0 110.731 179.804 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.8 m -164.72 64.38 0.13 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.306 179.684 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.417 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.4 OUTLIER 76.69 -59.51 0.49 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.243 -178.746 . . . . . . . . 3 3 . 1 . 091 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.43 ' C ' ' H ' ' A' ' 162' ' ' PHE . 92.7 t 70.62 -59.23 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.678 179.917 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.47 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 36.0 t80 -74.85 20.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.541 179.351 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.47 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 35.4 m-85 -166.87 -17.14 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 179.978 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.46 -41.97 95.25 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.53 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.45 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 0.6 OUTLIER 48.73 30.25 2.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.358 178.212 . . . . . . . . 3 3 . 1 . 091 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.45 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.1 OUTLIER 85.38 -22.85 0.18 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.436 -179.754 . . . . . . . . 3 3 . 1 . 091 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.423 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 0.5 OUTLIER -161.59 115.01 1.25 Allowed Pre-proline 0 N--CA 1.447 -0.595 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.048 -178.357 . . . . . . . . 3 3 . 1 . 091 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.512 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 1.7 Cg_endo -49.35 -40.04 43.94 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.442 2.095 . . . . 0.0 113.415 -179.474 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.512 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 34.7 Cg_endo -92.25 81.94 0.28 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.452 2.102 . . . . 0.0 113.074 -179.008 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.447 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 0.4 OUTLIER -77.49 -45.93 28.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.227 179.904 . . . . . . . . 3 3 . 1 . 091 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.447 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.6 mp -72.65 -39.56 60.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.367 -179.633 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.0 tt -68.82 -2.51 9.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.684 179.922 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -148.14 15.96 1.05 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.064 179.902 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 169' ' ' ILE . . . -81.46 -46.42 14.58 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.015 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.588 ' O ' ' CG ' ' A' ' 175' ' ' TYR . . . -141.61 0.52 1.69 Allowed Glycine 0 CA--C 1.522 0.531 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.818 179.229 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.588 ' CG ' ' O ' ' A' ' 174' ' ' GLY . 45.2 p90 56.61 -52.72 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.904 0.881 . . . . 0.0 113.02 179.926 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.513 ' N ' ' O ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER -92.11 12.72 21.15 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.312 . . . . . . . . 3 3 . 1 . 091 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.515 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 11.8 mt -72.08 -48.12 10.77 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-O 120.635 0.255 . . . . 0.0 110.415 179.332 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 85.5 Cg_exo -48.52 -25.86 8.2 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.714 2.276 . . . . 0.0 112.395 179.479 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.36 -60.54 2.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.909 -179.853 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.99 44.87 1.21 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.969 -179.881 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 092 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 120.813 0.34 . . . . 0.0 111.293 . . . . . . . . . 0 0 . 1 . 092 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.451 ' N ' ' CD2' ' A' ' 156' ' ' LEU . 0.1 OUTLIER -73.25 -21.71 60.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.011 -179.88 . . . . . . . . 3 3 . 1 . 092 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.19 18.65 6.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.51 179.817 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.4 p 74.91 -10.86 1.14 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.529 -179.925 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.503 ' O ' ' CG1' ' A' ' 160' ' ' VAL . 1.2 m-20 -78.62 -63.79 1.32 Allowed 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.452 0.168 . . . . 0.0 110.668 179.741 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.537 HG12 ' N ' ' A' ' 161' ' ' PHE . 9.9 p 58.39 -44.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 123.978 0.799 . . . . 0.0 112.634 -179.567 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.537 ' N ' HG12 ' A' ' 160' ' ' VAL . 0.3 OUTLIER -71.13 -16.47 62.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.406 0.146 . . . . 0.0 111.273 179.929 . . . . . . . . 3 3 . 1 . 092 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.508 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 56.2 m-85 -161.85 20.65 0.11 Allowed 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 179.777 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.404 ' O ' ' CD1' ' A' ' 163' ' ' LEU . 2.1 tm? -65.97 -18.68 65.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.916 0.865 . . . . 0.0 109.289 177.811 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -70.95 -67.76 0.48 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.354 -1.294 . . . . 0.0 112.022 -178.796 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.452 ' N ' ' CD1' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -63.4 -72.76 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.333 -178.952 . . . . . . . . 3 3 . 1 . 092 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.451 ' CD2' ' O ' ' A' ' 165' ' ' LEU . 0.3 OUTLIER -160.61 120.22 1.59 Allowed Pre-proline 0 N--CA 1.451 -0.395 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.16 -178.348 . . . . . . . . 3 3 . 1 . 092 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.436 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 6.4 Cg_exo -37.7 -48.55 1.99 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.796 2.33 . . . . 0.0 112.587 179.9 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.443 ' HD2' ' CD1' ' A' ' 166' ' ' LEU . 33.2 Cg_endo -92.41 74.16 0.51 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.092 2.528 . . . . 0.0 112.288 179.96 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.52 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 1.2 tp -74.2 -44.25 49.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.224 -179.659 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.455 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.5 mp -72.45 -42.71 64.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.312 -179.684 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . 3.7 tt -65.02 -56.21 14.43 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.443 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.1 1.0 14.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.118 178.711 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.95 -57.66 3.89 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.201 0.524 . . . . 0.0 109.833 179.723 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -119.98 -3.45 12.05 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.878 178.983 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.44 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 92.6 t80 71.03 -43.51 0.56 Allowed 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.587 0.355 . . . . 0.0 111.719 -179.964 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.9 14.11 22.66 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.791 0.329 . . . . 0.0 111.01 179.937 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.562 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 54.4 mt -82.98 -38.61 0.76 Allowed Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.76 179.995 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 86.8 Cg_exo -44.16 -26.34 1.48 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.555 2.17 . . . . 0.0 113.001 -179.771 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.8 -15.62 31.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.13 179.661 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -145.58 46.32 1.29 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.029 0.442 . . . . 0.0 110.133 179.728 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . 0.466 ' HB3' ' HA ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.525 ' O ' ' HB2' ' A' ' 156' ' ' LEU . 16.1 m-85 . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 . . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.525 ' HB2' ' O ' ' A' ' 155' ' ' PHE . 6.5 mt 75.93 -43.97 0.49 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.843 179.952 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -71.46 -14.64 62.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.879 0.371 . . . . 0.0 110.535 179.556 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.2 p -79.7 28.4 0.27 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.978 -179.697 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.542 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.2 OUTLIER 79.59 -25.44 0.18 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.921 . . . . . . . . 3 3 . 1 . 093 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.542 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 58.0 t 81.62 -54.46 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.115 0 C-N-CA 122.613 0.365 . . . . 0.0 111.233 179.946 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.569 ' O ' ' HB2' ' A' ' 164' ' ' PHE . 31.0 t80 -67.36 -35.51 79.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.14 0.495 . . . . 0.0 110.403 179.626 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.505 ' C ' ' H ' ' A' ' 164' ' ' PHE . 0.2 OUTLIER -77.49 -44.88 27.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.413 179.698 . . . . . . . . 3 3 . 1 . 093 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 167' ' ' PRO . 3.4 tp -62.66 -4.24 1.92 Allowed 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 121.894 0.854 . . . . 0.0 109.293 178.783 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.569 ' HB2' ' O ' ' A' ' 161' ' ' PHE . 0.1 OUTLIER -75.6 -67.68 0.64 Allowed 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.41 -179.998 . . . . . . . . 3 3 . 1 . 093 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.38 -70.99 0.22 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.977 0.418 . . . . 0.0 111.246 179.407 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.426 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 5.7 tp -160.48 95.39 1.5 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.694 -178.309 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.567 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 21.7 Cg_endo -66.19 -28.55 48.1 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.746 2.297 . . . . 0.0 115.021 -179.126 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 33.2 Cg_endo -89.49 59.44 2.08 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.789 1.659 . . . . 0.0 113.083 -178.923 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.466 HD13 HG21 ' A' ' 169' ' ' ILE . 0.3 OUTLIER -76.82 -33.75 21.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.134 179.711 . . . . . . . . 3 3 . 1 . 093 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 3.4 mp -69.07 -38.71 78.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.618 -179.004 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.6 mp -65.17 -60.09 3.38 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.258 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -74.36 3.31 7.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.263 178.55 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.445 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -71.15 -59.31 2.84 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.973 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -104.52 -20.4 10.22 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 178.309 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 36.7 t80 72.91 -11.64 0.85 Allowed 'General case' 0 C--O 1.232 0.157 0 C-N-CA 122.704 0.402 . . . . 0.0 111.845 179.83 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -95.41 -3.08 47.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.821 0.343 . . . . 0.0 110.495 179.348 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.425 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 1.3 mm? -53.51 -51.86 72.13 Favored Pre-proline 0 C--N 1.333 -0.139 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.592 179.649 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 35.4 Cg_exo -58.7 -41.08 67.19 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.681 2.254 . . . . 0.0 112.223 179.649 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.6 mt -63.36 -56.08 19.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.839 -179.9 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -87.44 49.1 1.75 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.943 179.982 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 094 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.814 0.34 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 094 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 17.7 mt 51.55 57.4 6.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.177 179.962 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 72.28 27.22 2.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.987 179.952 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 53.35 44.03 30.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.056 179.957 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.491 ' C ' ' CG1' ' A' ' 160' ' ' VAL . 15.7 m-20 -162.28 -57.29 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.598 179.872 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.491 ' CG1' ' C ' ' A' ' 159' ' ' ASP . 1.5 m 67.46 -58.48 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 123.134 0.574 . . . . 0.0 110.072 -179.72 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.512 ' CE1' ' CE2' ' A' ' 162' ' ' PHE . 0.0 OUTLIER -73.6 49.12 0.29 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.438 . . . . . . . . 3 3 . 1 . 094 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.512 ' CE2' ' CE1' ' A' ' 161' ' ' PHE . 5.5 m-85 -166.42 -30.53 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.68 -179.385 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 12.8 mt -58.43 -34.77 71.16 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.204 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.471 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 1.4 t80 46.38 40.6 8.1 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.719 177.649 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.471 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.2 OUTLIER 86.47 -30.08 0.05 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.067 -179.738 . . . . . . . . 3 3 . 1 . 094 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.24 133.97 4.49 Favored Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.422 -178.941 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.98 108.64 0.26 Allowed 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.533 2.155 . . . . 0.0 112.395 -179.703 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.9 82.11 1.29 Allowed 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.646 2.231 . . . . 0.0 112.042 179.75 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 0.1 OUTLIER -74.48 -45.24 46.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.283 0.563 . . . . 0.0 110.853 -179.911 . . . . . . . . 3 3 . 1 . 094 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.498 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 0.7 OUTLIER -79.36 -45.34 23.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 114.92 -1.036 . . . . 0.0 112.074 -178.798 . . . . . . . . 3 3 . 1 . 094 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 13.2 mt -66.93 -55.69 13.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.089 0.471 . . . . 0.0 109.891 179.532 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.05 5.84 4.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.276 179.032 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -73.32 -47.75 40.04 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.26 0.552 . . . . 0.0 109.712 179.639 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.51 ' C ' ' CG ' ' A' ' 175' ' ' TYR . . . -120.75 -1.59 11.8 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.841 178.841 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.51 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER 57.25 -50.07 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.963 0.905 . . . . 0.0 113.088 179.732 . . . . . . . . 3 3 . 1 . 094 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.49 ' N ' ' O ' ' A' ' 174' ' ' GLY . 26.6 p90 -90.57 9.88 27.76 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 122.217 -0.302 . . . . 0.0 111.152 -179.935 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.434 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.1 OUTLIER -69.52 -51.35 16.66 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.651 179.663 . . . . . . . . 3 3 . 1 . 094 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 38.4 Cg_exo -61.22 78.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.627 2.218 . . . . 0.0 112.18 179.923 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.94 -63.85 1.17 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.21 -179.919 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.38 16.02 4.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.836 -179.891 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 095 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.906 0.384 . . . . 0.0 111.881 . . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 9.3 mt 65.38 108.79 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.993 179.873 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.404 ' CB ' ' CD1' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -168.62 -73.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.244 0.545 . . . . 0.0 111.105 -179.963 . . . . . . . . 3 3 . 1 . 095 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 20.6 t -171.06 -35.17 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.505 179.727 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 161' ' ' PHE . 2.1 m-20 -76.85 -57.8 3.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.151 179.321 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 63.4 -51.93 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.184 179.623 . . . . . . . . 3 3 . 1 . 095 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.461 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 10.1 m-85 -72.73 -0.05 12.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.679 0.276 . . . . 0.0 111.082 179.643 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.444 ' CG ' ' C ' ' A' ' 161' ' ' PHE . 0.0 OUTLIER -160.58 14.02 0.11 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.151 -179.956 . . . . . . . . 3 3 . 1 . 095 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.404 ' CD1' ' CB ' ' A' ' 157' ' ' GLN . 3.4 mt -67.56 -10.87 55.84 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.343 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -78.45 -84.03 0.08 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.38 -179.475 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.83 -66.0 0.62 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.951 0.405 . . . . 0.0 111.307 -179.702 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.598 ' HB3' ' HD2' ' A' ' 168' ' ' PRO . 0.0 OUTLIER -160.19 153.06 17.91 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.538 -179.53 . . . . . . . . 3 3 . 1 . 095 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.427 ' CB ' ' HD3' ' A' ' 168' ' ' PRO . 3.0 Cg_exo -37.35 -52.45 1.48 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.517 2.811 . . . . 0.0 113.875 -179.189 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.598 ' HD2' ' HB3' ' A' ' 166' ' ' LEU . 85.6 Cg_endo -83.64 -62.41 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.836 1.69 . . . . 0.0 113.209 -179.198 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.492 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.0 OUTLIER 80.33 -38.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 179.4 . . . . . . . . 3 3 . 1 . 095 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.43 ' N ' HG21 ' A' ' 169' ' ' ILE . 4.0 mp -71.64 -39.69 69.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.673 -179.022 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.418 ' N ' ' CD2' ' A' ' 171' ' ' LEU . 2.0 mm? -64.54 -60.52 3.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.357 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -75.14 4.41 6.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.501 178.973 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -71.82 -69.66 0.38 Allowed 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.59 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -108.25 -16.41 12.31 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.091 178.211 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 53.1 t80 74.51 -15.78 0.6 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.868 0.467 . . . . 0.0 111.898 179.953 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -107.67 -22.41 12.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.781 0.324 . . . . 0.0 111.02 -179.964 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.522 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 47.6 mt -48.29 -42.75 54.84 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.742 -179.946 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 26.0 Cg_exo -63.14 71.67 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.562 2.174 . . . . 0.0 112.408 -179.777 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 177' ' ' LEU . 0.4 OUTLIER -77.39 -66.1 0.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.572 179.675 . . . . . . . . 3 3 . 1 . 095 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.37 40.57 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.578 179.58 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 096 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 1.3 p90 . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.836 0.351 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 096 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.412 ' HB2' ' CG2' ' A' ' 160' ' ' VAL . 1.3 pt? -165.43 170.29 14.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.051 -179.968 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -169.18 -85.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.888 179.904 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.5 t -78.18 53.6 1.25 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.742 0.306 . . . . 0.0 111.204 179.928 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.538 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 6.7 t0 75.87 -34.88 0.25 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 179.913 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.538 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 75.8 t 80.45 -57.02 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 C-N-CA 122.549 0.339 . . . . 0.0 110.486 -179.613 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.518 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 7.3 m-85 -73.71 36.84 0.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.771 179.01 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.543 ' C ' ' H ' ' A' ' 164' ' ' PHE . 93.0 m-85 -165.88 -25.71 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.129 179.845 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 6.0 tp -63.53 -1.89 1.4 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.769 0.795 . . . . 0.0 109.283 178.062 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.543 ' H ' ' C ' ' A' ' 162' ' ' PHE . 10.1 t80 -68.5 -10.03 52.89 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.347 -179.662 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.5 tp -64.44 -31.67 72.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.082 0.468 . . . . 0.0 110.136 178.971 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 1.8 tp -160.61 66.57 2.45 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.588 -179.463 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.67 108.24 0.52 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.954 2.436 . . . . 0.0 113.827 -178.505 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.42 ' HG2' ' HB2' ' A' ' 172' ' ' ASP . 92.5 Cg_endo -79.14 86.1 1.75 Allowed 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.937 2.425 . . . . 0.0 110.932 178.293 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.529 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 5.7 tp -71.45 -63.4 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.414 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.503 ' H ' ' CG2' ' A' ' 169' ' ' ILE . 1.9 mp -73.35 -39.98 56.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.812 -179.015 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 4.7 tp -64.13 -60.89 2.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.274 0.559 . . . . 0.0 109.762 179.754 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.42 ' HB2' ' HG2' ' A' ' 168' ' ' PRO . 4.6 t70 -74.12 -0.0 15.24 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.128 179.014 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -70.11 -71.0 0.26 Allowed 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.203 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.496 ' HA3' ' CG ' ' A' ' 177' ' ' LEU . . . -125.87 -8.48 5.16 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.119 177.815 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 12.9 t80 70.59 -55.66 0.62 Allowed 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.605 0.362 . . . . 0.0 111.851 179.558 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -94.99 16.8 15.27 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.187 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.496 ' CG ' ' HA3' ' A' ' 174' ' ' GLY . 6.2 mt -81.56 -47.89 1.03 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.57 0.224 . . . . 0.0 110.826 179.434 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 73.6 Cg_exo -50.32 166.24 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.418 2.079 . . . . 0.0 112.069 179.718 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.405 ' CB ' ' O ' ' A' ' 178' ' ' PRO . 1.4 tp 81.49 -10.83 1.14 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.557 -179.824 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 180' ' ' ARG . 0.6 OUTLIER -151.66 32.06 0.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.445 . . . . . . . . 3 3 . 1 . 096 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 097 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.436 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 1.9 t80 . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.796 0.331 . . . . 0.0 111.551 . . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.498 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 0.2 OUTLIER 62.59 132.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.477 179.782 . . . . . . . . 3 3 . 1 . 097 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.426 ' HG2' ' N ' ' A' ' 158' ' ' SER . 4.6 pm0 -172.06 -41.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.98 -179.832 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.426 ' N ' ' HG2' ' A' ' 157' ' ' GLN . 37.6 t -78.13 52.19 1.07 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.556 -179.764 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.452 ' O ' ' CB ' ' A' ' 160' ' ' VAL . 0.4 OUTLIER 75.37 -29.03 0.19 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.576 . . . . . . . . 3 3 . 1 . 097 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.452 ' CB ' ' O ' ' A' ' 159' ' ' ASP . 0.3 OUTLIER 92.29 -41.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 122.929 0.492 . . . . 0.0 111.209 -179.806 . . . . . . . . 3 3 . 1 . 097 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.423 ' N ' HG12 ' A' ' 160' ' ' VAL . 82.6 t80 -69.37 -29.27 67.01 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.078 0.466 . . . . 0.0 110.55 179.53 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.428 ' C ' ' H ' ' A' ' 164' ' ' PHE . 1.2 t80 -67.48 -60.1 2.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.942 179.784 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 18.6 mt -66.58 -1.92 4.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.206 178.761 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.428 ' H ' ' C ' ' A' ' 162' ' ' PHE . 1.5 t80 -73.41 -33.63 65.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.274 -179.038 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.5 mt -66.0 -46.1 79.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.036 0.446 . . . . 0.0 110.58 179.5 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -160.61 86.13 1.87 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.125 -179.162 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.84 110.31 1.66 Allowed 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.645 2.23 . . . . 0.0 113.187 -179.017 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.465 ' O ' ' CB ' ' A' ' 169' ' ' ILE . 92.0 Cg_endo -76.12 -146.88 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.873 2.382 . . . . 0.0 111.037 178.912 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.57 HG21 ' N ' ' A' ' 170' ' ' ILE . 0.4 OUTLIER 86.79 -39.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.53 . . . . . . . . 3 3 . 1 . 097 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.57 ' N ' HG21 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -69.92 -39.41 77.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.65 -176.899 . . . . . . . . 3 3 . 1 . 097 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.463 ' H ' HG12 ' A' ' 170' ' ' ILE . 46.5 mt -66.08 -55.79 14.76 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.798 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.34 0.4 19.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.307 178.5 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -72.22 -75.35 0.14 Allowed 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.777 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -86.5 -17.5 60.25 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 178.334 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 12.0 t80 68.99 -57.21 0.52 Allowed 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 122.607 0.363 . . . . 0.0 111.112 179.872 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.435 ' CD1' ' C ' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -93.1 15.98 13.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.12 179.803 . . . . . . . . 3 3 . 1 . 097 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.495 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 13.9 mt -83.01 -47.05 0.84 Allowed Pre-proline 0 CA--C 1.529 0.158 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.74 179.732 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.495 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 8.1 Cg_exo -72.49 96.77 0.83 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.614 2.209 . . . . 0.0 111.982 179.648 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -82.72 -72.91 0.42 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.952 0.406 . . . . 0.0 110.463 179.814 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.56 21.9 3.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.588 179.648 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 098 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.65 0.262 . . . . 0.0 111.327 . . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.2 mt -170.38 80.66 0.1 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.783 -179.828 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -169.27 71.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.252 0.549 . . . . 0.0 111.124 179.842 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.412 ' CB ' ' CD1' ' A' ' 163' ' ' LEU . 13.7 m -166.14 47.66 0.08 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.574 179.666 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.408 ' O ' HG13 ' A' ' 160' ' ' VAL . 0.5 OUTLIER 76.67 -57.66 0.53 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.56 -178.975 . . . . . . . . 3 3 . 1 . 098 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.418 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 71.29 -47.97 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.641 179.722 . . . . . . . . 3 3 . 1 . 098 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.418 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 1.2 m-85 -73.3 -0.0 13.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.933 -179.807 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -166.53 13.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.926 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.412 ' CD1' ' CB ' ' A' ' 158' ' ' SER . 0.7 OUTLIER -66.75 -38.0 85.76 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.487 . . . . . . . . 3 3 . 1 . 098 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 8.6 t80 70.49 2.7 4.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.585 -1.189 . . . . 0.0 112.055 179.245 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.12 -56.33 9.2 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.122 0.487 . . . . 0.0 110.406 179.208 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.594 ' N ' ' HD3' ' A' ' 167' ' ' PRO . 0.1 OUTLIER -159.34 51.7 0.44 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.944 -179.981 . . . . . . . . 3 3 . 1 . 098 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.594 ' HD3' ' N ' ' A' ' 166' ' ' LEU . 25.3 Cg_exo -60.35 -48.39 11.78 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.296 1.997 . . . . 0.0 112.922 -179.867 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.464 ' HD3' ' HB2' ' A' ' 167' ' ' PRO . 58.8 Cg_endo -88.04 -97.41 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.383 2.055 . . . . 0.0 113.127 -179.072 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.572 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 1.1 tp 80.65 -55.39 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-O 120.89 0.376 . . . . 0.0 110.984 -179.539 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.572 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 0.8 OUTLIER -81.27 -32.29 12.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.757 -179.622 . . . . . . . . 3 3 . 1 . 098 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.403 ' CD1' ' HG3' ' A' ' 178' ' ' PRO . 2.1 tm? -66.75 -62.46 1.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.939 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -76.4 7.84 4.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.135 178.613 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -71.08 -60.1 2.42 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.679 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.441 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -102.24 -17.09 21.19 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 177.884 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.415 ' HB2' ' O ' ' A' ' 174' ' ' GLY . 2.0 m-85 69.7 -12.27 0.47 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.827 0.451 . . . . 0.0 111.846 179.913 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.441 ' H ' ' C ' ' A' ' 174' ' ' GLY . 0.6 OUTLIER -94.91 -10.95 29.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.892 0.377 . . . . 0.0 110.186 179.196 . . . . . . . . 3 3 . 1 . 098 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.558 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.8 OUTLIER -54.01 -42.0 91.05 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.992 179.371 . . . . . . . . 3 3 . 1 . 098 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 47.5 Cg_exo -57.06 73.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.804 2.336 . . . . 0.0 112.737 -179.922 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 177' ' ' LEU . 16.6 mt -96.86 -49.79 4.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.102 0.477 . . . . 0.0 109.791 179.233 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.53 23.64 1.59 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.961 179.122 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . 0.421 ' H ' ' C ' ' A' ' 179' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 2.7 t80 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.815 0.34 . . . . 0.0 111.869 . . . . . . . . . 0 0 . 1 . 099 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 11.2 mt 64.47 156.51 0.08 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.92 179.84 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.95 -64.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.888 -179.926 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.96 23.31 0.46 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.899 179.976 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.8 t70 76.62 -1.58 2.85 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 179.886 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.474 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 82.01 -53.91 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.768 0.318 . . . . 0.0 110.514 -179.912 . . . . . . . . 3 3 . 1 . 099 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.474 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 27.1 m-85 -77.25 33.49 0.15 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.9 179.094 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.429 ' H ' ' C ' ' A' ' 160' ' ' VAL . 5.3 m-85 -168.54 -17.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.802 -179.634 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 27.0 tp -59.94 -34.06 72.73 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.23 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.45 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 31.2 t80 45.76 37.81 3.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.84 178.001 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.45 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 4.3 tp 84.6 -26.05 0.12 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.354 -179.577 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.479 ' CD1' ' O ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -158.49 132.9 5.26 Favored Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.172 -178.437 . . . . . . . . 3 3 . 1 . 099 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.41 120.32 8.02 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.146 1.897 . . . . 0.0 112.748 -178.915 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.483 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 41.9 Cg_endo -90.84 106.24 0.3 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 123.582 2.855 . . . . 0.0 111.477 179.437 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 170' ' ' ILE . 0.1 OUTLIER -69.04 -42.53 82.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.326 -179.366 . . . . . . . . 3 3 . 1 . 099 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.498 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 0.7 OUTLIER -73.95 -46.67 45.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.422 -178.076 . . . . . . . . 3 3 . 1 . 099 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.483 ' HB3' ' HB2' ' A' ' 168' ' ' PRO . 41.0 tp -66.91 -49.26 66.13 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.726 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -73.25 -5.33 38.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.6 178.357 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -73.2 -70.45 0.36 Allowed 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.607 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -117.24 -15.77 6.42 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.78 178.902 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . 0.456 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 23.4 t80 77.52 -37.16 0.24 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 122.501 0.32 . . . . 0.0 111.638 -179.923 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -97.39 28.63 3.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.849 0.357 . . . . 0.0 110.978 -179.975 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.574 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 12.1 mt -101.91 -52.81 0.15 Allowed Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.471 -179.88 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.574 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 4.6 Cg_exo -78.32 -28.63 4.47 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.741 2.294 . . . . 0.0 112.571 -179.639 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -66.72 -60.58 2.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.85 -179.741 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.99 49.92 1.71 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.763 179.815 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 100 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.441 ' HA ' ' CG2' ' A' ' 160' ' ' VAL . 1.8 m-85 . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.665 0.269 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.422 HD22 ' O ' ' A' ' 155' ' ' PHE . 14.9 mt -163.89 172.16 14.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.136 179.983 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.4 ' CB ' ' HG ' ' A' ' 163' ' ' LEU . 44.3 tp60 48.53 27.5 1.47 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.779 -179.523 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.4 p 43.72 46.44 6.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.615 -179.933 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.519 ' O ' HG12 ' A' ' 160' ' ' VAL . 1.1 t0 -164.74 -64.16 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.034 179.436 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.519 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 71.8 -36.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.355 -179.764 . . . . . . . . 3 3 . 1 . 100 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.502 ' N ' HG12 ' A' ' 160' ' ' VAL . 0.2 OUTLIER -76.3 16.36 0.47 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.81 178.644 . . . . . . . . 3 3 . 1 . 100 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.429 ' H ' ' C ' ' A' ' 160' ' ' VAL . 43.2 m-85 -162.99 1.15 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.841 -179.758 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.4 ' HG ' ' CB ' ' A' ' 157' ' ' GLN . 0.2 OUTLIER -65.51 -44.09 88.06 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.56 . . . . . . . . 3 3 . 1 . 100 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 62.44 7.86 2.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.847 178.873 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.02 -26.92 65.24 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 120.888 0.375 . . . . 0.0 111.04 179.529 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.431 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 0.2 OUTLIER -159.73 76.94 2.91 Favored Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.018 -178.639 . . . . . . . . 3 3 . 1 . 100 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.455 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 2.7 Cg_exo -40.16 -47.37 4.08 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.113 2.542 . . . . 0.0 112.928 179.903 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 42.8 Cg_endo -88.61 58.76 2.57 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.539 2.159 . . . . 0.0 112.643 -179.424 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.493 ' O ' ' CB ' ' A' ' 173' ' ' ALA . 0.2 OUTLIER -77.31 -32.94 19.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.971 179.726 . . . . . . . . 3 3 . 1 . 100 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.419 HD11 ' CG2' ' A' ' 169' ' ' ILE . 20.4 mm -68.54 -48.09 73.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.586 -178.898 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.6 mt -65.25 -48.2 74.08 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.224 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -76.11 -5.16 45.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.844 178.609 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.493 ' CB ' ' O ' ' A' ' 169' ' ' ILE . . . -73.97 -70.19 0.4 Allowed 'General case' 0 CA--C 1.522 -0.134 0 CA-C-O 121.205 0.526 . . . . 0.0 109.788 179.849 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.699 ' H ' ' HG2' ' A' ' 178' ' ' PRO . . . -121.06 -20.64 3.33 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.027 178.637 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 9.9 t80 75.6 -12.44 0.98 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.053 0.541 . . . . 0.0 111.971 179.659 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -94.3 45.79 1.14 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.794 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.662 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 5.0 mt 54.02 52.41 9.4 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.037 -178.687 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.699 ' HG2' ' H ' ' A' ' 174' ' ' GLY . 24.0 Cg_exo -67.29 56.58 0.6 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.154 2.57 . . . . 0.0 112.578 179.848 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 11.6 mt -101.28 -66.33 0.92 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.921 0.391 . . . . 0.0 110.545 179.8 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 42.84 1.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.607 179.66 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.701 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 2.6 mp . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.947 0.403 . . . . 0.0 111.816 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.514 HD12 ' H ' ' A' ' 170' ' ' ILE . 4.5 mp -75.46 -55.17 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.709 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.57 ' HG ' ' N ' ' A' ' 172' ' ' ASP . 2.6 pt? -60.04 -51.47 69.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.028 0.442 . . . . 0.0 110.449 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.57 ' N ' ' HG ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -76.23 5.5 6.85 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.288 178.898 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.75 -71.1 0.29 Allowed 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -108.24 -3.76 33.29 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 1.5 t80 69.74 -61.9 0.43 Allowed 'General case' 0 C--O 1.231 0.113 0 CA-C-O 121.028 0.442 . . . . 0.0 110.348 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 23.1 t80 . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.333 179.278 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.779 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 3.5 tt . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 121.123 0.487 . . . . 0.0 110.315 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.442 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 2.0 mp -74.1 -45.7 47.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.788 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.432 HD22 ' N ' ' A' ' 171' ' ' LEU . 3.5 mm? -64.41 -53.12 53.38 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -74.77 1.05 13.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.921 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.779 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.82 -53.44 11.47 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.143 0.497 . . . . 0.0 109.69 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -105.63 -18.48 11.67 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.294 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.45 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 13.0 t80 76.02 -25.73 0.2 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.882 0.473 . . . . 0.0 112.04 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.7 p90 . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.648 0.261 . . . . 0.0 111.209 179.918 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.978 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--O 1.226 -0.161 0 CA-C-O 120.951 0.405 . . . . 0.0 110.715 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 3.7 mp -80.61 -50.84 16.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.245 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.473 HD12 ' N ' ' A' ' 171' ' ' LEU . 7.3 mp -65.26 -50.93 63.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.277 0.561 . . . . 0.0 109.949 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -74.0 -4.42 35.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.032 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.978 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.67 -70.36 0.33 Allowed 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -123.33 -27.73 1.44 Allowed Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.51 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 15.6 t80 79.15 -20.14 0.4 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.443 0.697 . . . . 0.0 112.149 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.331 -0.201 0 CA-C-O 121.368 0.604 . . . . 0.0 109.466 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.905 HG23 HD13 ' A' ' 170' ' ' ILE . 7.7 tt . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 120.891 0.377 . . . . 0.0 111.355 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.905 HD13 HG23 ' A' ' 169' ' ' ILE . 7.4 mm -69.19 -31.42 49.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.356 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.2 mp -70.71 -4.01 21.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.485 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -152.4 13.84 0.57 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.234 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -81.86 -38.58 25.21 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -130.57 -14.64 1.9 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 114.755 -1.112 . . . . 0.0 112.344 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 73.63 -45.88 0.62 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.651 0.225 . . . . 0.0 111.245 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.402 ' O ' ' CG ' ' A' ' 176' ' ' PHE . 55.4 t80 . . . . . 0 C--N 1.331 -0.239 0 CA-C-O 120.568 0.223 . . . . 0.0 111.141 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.935 HG13 ' HB2' ' A' ' 173' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 118.925 -0.56 . . . . 0.0 109.638 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.683 ' H ' HG23 ' A' ' 169' ' ' ILE . 2.9 mm 24.19 -64.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.457 0.703 . . . . 0.0 112.714 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.89 ' N ' ' O ' ' A' ' 169' ' ' ILE . 0.1 OUTLIER -67.95 -51.27 49.5 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.916 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 169' ' ' ILE . 1.0 OUTLIER -73.44 -15.7 61.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.546 179.286 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.935 ' HB2' HG13 ' A' ' 169' ' ' ILE . . . -78.14 -59.35 2.82 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.081 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -119.02 -21.85 3.69 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.864 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 70.9 -48.11 0.66 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.787 0.294 . . . . 0.0 111.192 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.231 0 CA-C-O 120.747 0.308 . . . . 0.0 110.962 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.982 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 121.048 0.452 . . . . 0.0 111.058 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.471 HG13 HG23 ' A' ' 169' ' ' ILE . 2.5 mp -83.75 -70.37 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.617 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.97 -48.4 71.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.89 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.04 1.91 9.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.665 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.982 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.92 -51.72 15.21 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.195 0.522 . . . . 0.0 109.612 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -118.54 -18.15 4.96 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.785 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 15.6 t80 78.1 -34.11 0.18 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 122.551 0.34 . . . . 0.0 111.881 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.207 0 CA-C-O 120.752 0.311 . . . . 0.0 111.151 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.749 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 121.123 0.487 . . . . 0.0 111.294 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.451 HD12 ' H ' ' A' ' 170' ' ' ILE . 3.4 mp -70.12 -41.54 79.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.61 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 12.9 mt -67.03 -59.13 3.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.263 0.554 . . . . 0.0 109.709 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.93 10.03 1.64 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.462 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.749 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.74 -48.41 47.2 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -117.88 -28.1 2.34 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 6.1 t80 74.56 -31.52 0.22 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.178 0.591 . . . . 0.0 112.003 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 . . . . . 0 C--N 1.331 -0.196 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.002 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.773 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 7.3 tp . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 121.07 0.462 . . . . 0.0 110.635 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.429 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 4.2 mt -69.38 -35.44 67.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.942 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 0.0 OUTLIER -65.69 -57.94 6.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.673 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.29 -2.79 26.61 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.729 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.773 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.57 -69.23 0.44 Allowed 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 121.158 0.504 . . . . 0.0 109.944 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -113.35 -15.14 9.15 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.871 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 5.8 t80 77.63 -41.7 0.36 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 39.8 p90 . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.656 0.265 . . . . 0.0 111.363 -179.738 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.848 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--O 1.228 -0.03 0 CA-C-O 120.816 0.341 . . . . 0.0 111.508 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.479 HD12 ' H ' ' A' ' 170' ' ' ILE . 3.4 mp -70.1 -41.99 79.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.578 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 27.9 mt -65.72 -56.65 10.93 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.11 2.26 11.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.231 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.848 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.35 -62.0 1.59 Allowed 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.191 0.519 . . . . 0.0 109.884 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -112.49 -11.85 14.34 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.616 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.493 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 24.5 t80 71.78 -29.96 0.2 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.732 0.413 . . . . 0.0 111.751 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.439 ' H ' ' C ' ' A' ' 174' ' ' GLY . 8.3 t80 . . . . . 0 C--N 1.332 -0.192 0 CA-C-O 120.681 0.277 . . . . 0.0 111.238 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.546 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 9.2 tp . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 121.404 0.621 . . . . 0.0 110.303 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.452 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.1 mp -74.83 -46.7 40.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.157 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.3 mt -65.4 -55.64 16.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.065 0.46 . . . . 0.0 110.223 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.421 ' OD1' ' CZ ' ' A' ' 175' ' ' TYR . 0.9 OUTLIER -76.07 14.46 0.7 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.399 179.209 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.04 -59.37 2.74 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 175' ' ' TYR . . . -113.35 -2.96 24.45 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 177.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.421 ' CZ ' ' OD1' ' A' ' 172' ' ' ASP . 6.2 m-85 68.69 -61.6 0.41 Allowed 'General case' 0 C--N 1.338 0.105 0 C-N-CA 123.029 0.532 . . . . 0.0 110.79 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.6 t80 . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.15 179.674 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.847 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 121.095 0.474 . . . . 0.0 110.234 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.46 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.2 mp -75.35 -38.37 40.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.296 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 63.8 mt -67.18 -57.93 5.8 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.2 4.81 6.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.118 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.847 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.94 -45.8 59.84 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.257 0.551 . . . . 0.0 109.772 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.538 ' C ' ' CG ' ' A' ' 175' ' ' TYR . . . -122.03 -0.02 10.7 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.775 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.538 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER 59.23 -32.91 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 179.416 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.471 ' H ' ' C ' ' A' ' 174' ' ' GLY . 22.5 t80 . . . . . 0 C--N 1.33 -0.275 0 O-C-N 122.098 -0.376 . . . . 0.0 111.102 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.943 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 120.597 0.236 . . . . 0.0 111.274 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.598 HD12 ' H ' ' A' ' 170' ' ' ILE . 1.8 mp -87.69 -67.85 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.091 0.472 . . . . 0.0 110.997 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.747 HD23 ' N ' ' A' ' 172' ' ' ASP . 0.0 OUTLIER -68.06 -41.1 82.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.165 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.747 ' N ' HD23 ' A' ' 171' ' ' LEU . 44.5 t0 -72.53 -8.62 56.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.716 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.943 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -75.48 -64.37 1.08 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.196 0.522 . . . . 0.0 109.997 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -125.31 -17.64 2.65 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.157 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 77.66 -20.39 0.38 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 122.491 0.316 . . . . 0.0 111.675 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.964 0.411 . . . . 0.0 110.559 179.441 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.838 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 121.051 0.453 . . . . 0.0 111.336 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.419 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.3 mp -73.81 -54.32 15.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.947 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.755 HD12 ' N ' ' A' ' 172' ' ' ASP . 3.4 pp -62.76 -50.17 72.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.122 0.487 . . . . 0.0 109.815 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.755 ' N ' HD12 ' A' ' 171' ' ' LEU . 7.4 t0 -74.77 0.81 14.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.13 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.838 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.46 -70.05 0.37 Allowed 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -109.91 -23.07 6.31 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 7.6 t80 75.25 -22.92 0.25 Allowed 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 122.891 0.477 . . . . 0.0 111.942 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.374 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.877 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 8.6 pt . . . . . 0 N--CA 1.46 0.053 0 CA-C-O 120.693 0.282 . . . . 0.0 111.754 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 7.2 mt -74.79 -49.8 28.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.493 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.649 ' H ' HD22 ' A' ' 171' ' ' LEU . 0.8 OUTLIER -65.21 -52.68 53.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.62 2.62 9.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.489 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.877 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.16 -68.32 0.47 Allowed 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 121.211 0.529 . . . . 0.0 109.666 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -110.89 -12.95 14.78 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.343 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 4.7 t80 77.44 -12.28 1.09 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.702 0.401 . . . . 0.0 111.829 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 55.6 t80 . . . . . 0 C--N 1.331 -0.217 0 CA-C-O 120.882 0.372 . . . . 0.0 110.679 179.455 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.943 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.5 OUTLIER . . . . . 0 C--O 1.227 -0.099 0 CA-C-O 121.309 0.575 . . . . 0.0 110.543 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.701 HG23 HG22 ' A' ' 169' ' ' ILE . 0.8 OUTLIER -77.54 -43.26 30.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.739 -1.118 . . . . 0.0 111.926 -178.839 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 54.5 tp -63.66 -55.47 23.2 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -73.62 -4.59 35.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.62 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.943 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.88 -68.2 0.53 Allowed 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.323 0.582 . . . . 0.0 109.526 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -130.7 3.51 5.73 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.683 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 17.0 t80 71.12 -44.04 0.58 Allowed 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.9 p90 . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 120.682 0.277 . . . . 0.0 111.364 179.816 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.959 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 1.3 tt . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.724 0.297 . . . . 0.0 110.66 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.446 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.8 mp -77.8 -39.48 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.743 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 0.4 OUTLIER -63.91 -58.44 6.76 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.249 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -73.66 -3.43 28.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.745 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.959 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.85 -73.17 0.21 Allowed 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.351 0.596 . . . . 0.0 109.556 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -120.54 -8.34 8.41 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.624 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 20.4 t80 69.7 -46.73 0.59 Allowed 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 122.676 0.39 . . . . 0.0 111.549 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.772 0.32 . . . . 0.0 111.069 179.865 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.834 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.458 -0.045 0 CA-C-O 121.171 0.51 . . . . 0.0 110.329 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.743 HD13 HG23 ' A' ' 169' ' ' ILE . 11.0 mm -73.2 -46.12 51.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.196 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.776 HD12 ' N ' ' A' ' 172' ' ' ASP . 3.4 pp -65.26 -49.88 67.92 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.776 ' N ' HD12 ' A' ' 171' ' ' LEU . 23.0 t0 -73.92 -5.34 40.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.472 178.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.834 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -74.32 -66.32 0.74 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.122 0.487 . . . . 0.0 110.147 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -119.47 -10.79 7.67 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.275 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.508 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 11.9 t80 79.36 -29.1 0.14 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 122.554 0.342 . . . . 0.0 111.914 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 30.9 p90 . . . . . 0 C--N 1.331 -0.21 0 CA-C-O 120.699 0.285 . . . . 0.0 111.262 179.784 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.821 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 19.9 tt . . . . . 0 CA--C 1.519 -0.244 0 CA-C-O 121.627 0.727 . . . . 0.0 110.536 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.615 ' CD1' HD13 ' A' ' 171' ' ' LEU . 0.9 OUTLIER -73.63 -35.04 43.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.33 -1.305 . . . . 0.0 111.994 -178.609 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.812 ' H ' HD22 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -62.56 -64.17 1.0 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.089 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -75.15 4.3 7.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.41 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.821 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.34 -64.56 0.89 Allowed 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -111.73 -18.49 7.9 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.162 178.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 77.76 -30.5 0.16 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.799 0.44 . . . . 0.0 111.8 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.332 -0.158 0 CA-C-O 120.561 0.22 . . . . 0.0 111.37 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.894 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 21.8 pt . . . . . 0 CA--C 1.519 -0.217 0 CA-C-O 121.448 0.642 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.677 HG23 HG13 ' A' ' 169' ' ' ILE . 1.5 pt -76.19 -45.77 34.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.825 -177.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 0.0 OUTLIER -62.72 -56.48 17.25 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -74.09 1.33 11.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.028 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.894 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.36 -69.45 0.43 Allowed 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 121.238 0.542 . . . . 0.0 109.69 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -113.93 -9.28 16.41 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.612 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.481 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 31.3 t80 77.01 -8.97 1.6 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 122.652 0.381 . . . . 0.0 112.019 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 . . . . . 0 C--N 1.323 -0.546 0 CA-C-O 120.806 0.336 . . . . 0.0 110.913 179.754 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.833 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.6 OUTLIER . . . . . 0 CA--C 1.538 0.492 0 CA-C-O 119.3 -0.381 . . . . 0.0 110.337 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.714 ' H ' HG23 ' A' ' 169' ' ' ILE . 2.8 mp 27.11 -66.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.893 0.877 . . . . 0.0 112.993 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.833 ' N ' ' O ' ' A' ' 169' ' ' ILE . 3.6 pp -68.99 -48.44 63.08 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.263 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.81 ' N ' HD12 ' A' ' 171' ' ' LEU . 28.2 m-20 -70.33 -7.06 39.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.124 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.88 -58.49 3.25 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.917 0.389 . . . . 0.0 110.309 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -110.9 -30.72 3.12 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.39 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER 75.36 -36.92 0.32 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 122.475 0.31 . . . . 0.0 111.6 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 120.928 0.394 . . . . 0.0 110.232 179.205 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.709 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.226 -0.146 0 CA-C-O 121.115 0.483 . . . . 0.0 110.642 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.441 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.8 mp -69.33 -36.37 71.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.801 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 10.9 mp -65.62 -53.57 39.81 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.548 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -75.74 -6.07 48.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.514 178.073 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.709 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -74.51 -74.26 0.2 Allowed 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.31 0.576 . . . . 0.0 109.879 179.808 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -115.81 -15.19 7.51 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.687 178.844 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER 75.09 -47.34 0.61 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.358 0.263 . . . . 0.0 111.633 179.897 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.173 0 CA-C-O 120.688 0.28 . . . . 0.0 111.24 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 1.006 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 120.929 0.395 . . . . 0.0 110.849 . . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.879 HD13 HG23 ' A' ' 169' ' ' ILE . 6.5 mm -78.78 -47.88 22.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.73 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.4 tp -62.75 -55.06 30.04 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -74.47 -2.48 25.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.81 178.726 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 1.006 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.86 -67.27 0.58 Allowed 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.114 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -131.47 -4.33 3.99 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.688 178.492 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 70.16 -47.33 0.62 Allowed 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 122.433 0.293 . . . . 0.0 111.234 -179.755 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.1 t80 . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.846 0.355 . . . . 0.0 110.695 179.458 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.811 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.458 -0.038 0 CA-C-O 120.909 0.385 . . . . 0.0 111.24 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 2.8 mp -72.83 -48.85 43.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.561 -179.492 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.456 HD23 ' H ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -65.98 -49.81 66.55 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.487 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -75.95 1.67 14.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.04 178.564 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.811 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.25 -42.12 66.01 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.214 0.53 . . . . 0.0 109.666 179.74 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.53 ' C ' ' CG ' ' A' ' 175' ' ' TYR . . . -119.62 -1.96 13.28 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.826 178.881 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.53 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER 58.51 -37.32 0.06 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 179.483 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.501 ' N ' ' O ' ' A' ' 174' ' ' GLY . 26.9 p90 . . . . . 0 C--N 1.328 -0.345 0 O-C-N 122.094 -0.378 . . . . 0.0 111.164 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.971 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 12.6 pt . . . . . 0 N--CA 1.457 -0.112 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.461 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 8.4 mm -81.48 -50.84 16.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.962 -179.408 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 0.0 OUTLIER -62.63 -53.38 55.38 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.938 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.43 -1.17 17.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.887 178.715 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.971 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.91 -56.84 4.61 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 121.194 0.521 . . . . 0.0 109.787 179.626 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -129.88 -3.5 4.94 Favored Glycine 0 CA--C 1.52 0.38 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.057 179.126 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.3 OUTLIER 70.13 -55.8 0.6 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.64 0.257 . . . . 0.0 111.358 179.974 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 11.4 t80 . . . . . 0 C--N 1.331 -0.224 0 CA-C-O 120.902 0.382 . . . . 0.0 110.572 179.766 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.797 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 5.5 tt . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 121.16 0.505 . . . . 0.0 110.673 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.776 HD13 HG23 ' A' ' 169' ' ' ILE . 10.4 mm -71.56 -42.82 72.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.053 -179.836 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.465 ' C ' HD12 ' A' ' 171' ' ' LEU . 0.1 OUTLIER -66.06 -53.55 36.95 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.795 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -74.82 -0.1 17.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.035 178.657 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.797 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.97 -60.94 2.0 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.159 0.504 . . . . 0.0 109.851 179.757 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -109.67 -19.03 8.5 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.497 178.835 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 78.83 -29.83 0.15 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.658 0.383 . . . . 0.0 111.953 179.647 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.406 ' O ' ' CG ' ' A' ' 176' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-O 120.747 0.308 . . . . 0.0 110.737 179.696 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.87 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 1.9 tp . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 121.009 0.433 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.531 HD12 HG22 ' A' ' 169' ' ' ILE . 3.5 mp -74.55 -41.57 48.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.216 -179.899 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -65.2 -57.75 7.74 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.518 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.82 4.51 6.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.067 178.754 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.87 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.97 -56.01 5.74 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.207 0.527 . . . . 0.0 109.826 179.683 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -121.74 -0.03 10.99 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.726 178.695 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.494 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.2 OUTLIER 55.1 -59.79 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.047 0.939 . . . . 0.0 112.154 179.898 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.606 ' N ' ' O ' ' A' ' 174' ' ' GLY . 13.1 m-85 . . . . . 0 C--N 1.323 -0.547 0 CA-C-O 120.782 0.325 . . . . 0.0 111.118 -179.903 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.877 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 8.4 tp . . . . . 0 CA--C 1.519 -0.242 0 CA-C-O 121.479 0.657 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.495 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 0.8 OUTLIER -74.04 -44.3 50.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 114.683 -1.144 . . . . 0.0 112.507 -178.25 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.534 HD13 ' C ' ' A' ' 171' ' ' LEU . 2.4 tm? -65.16 -58.37 6.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.054 0.454 . . . . 0.0 109.845 179.53 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.418 ' N ' HD13 ' A' ' 171' ' ' LEU . 12.0 m-20 -74.66 5.46 4.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.552 179.105 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.877 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -70.79 -56.42 6.37 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.304 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -111.55 -26.36 4.55 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 177.9 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 72.25 -40.68 0.48 Allowed 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 122.633 0.373 . . . . 0.0 111.663 179.641 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 120.814 0.34 . . . . 0.0 110.622 179.661 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.911 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.46 0.066 0 CA-C-O 121.27 0.557 . . . . 0.0 111.322 . . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.516 HG23 HG23 ' A' ' 169' ' ' ILE . 0.7 OUTLIER -78.98 -44.78 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.938 -1.028 . . . . 0.0 112.968 -178.02 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.561 HD13 ' C ' ' A' ' 171' ' ' LEU . 2.0 tm? -64.51 -58.16 7.18 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.491 ' N ' HD13 ' A' ' 171' ' ' LEU . 1.2 m-20 -74.1 4.84 4.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.151 178.857 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.911 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.22 -56.48 5.46 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.257 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -133.86 2.06 4.37 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.559 178.465 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 70.35 -56.83 0.59 Allowed 'General case' 0 C--O 1.231 0.096 0 C-N-CA 122.543 0.337 . . . . 0.0 111.733 179.75 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 120.619 0.247 . . . . 0.0 111.621 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.89 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 3.7 tp . . . . . 0 CA--C 1.521 -0.168 0 CA-C-O 121.393 0.616 . . . . 0.0 110.717 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.605 HG23 HG23 ' A' ' 169' ' ' ILE . 0.7 OUTLIER -79.01 -43.78 24.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.707 -179.277 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 1.2 tp -65.8 -58.91 4.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.114 0.483 . . . . 0.0 109.992 179.557 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -74.24 5.54 4.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.448 179.052 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.89 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.25 -64.69 0.87 Allowed 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.505 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -112.3 -17.09 8.43 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 178.167 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 6.0 t80 75.58 -11.46 1.1 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.705 0.402 . . . . 0.0 111.81 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 120.986 0.422 . . . . 0.0 110.867 179.672 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.871 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 4.8 tp . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 121.062 0.458 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.818 HD13 HG23 ' A' ' 169' ' ' ILE . 9.0 mm -73.4 -45.89 50.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.447 -179.284 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 34.5 tp -64.33 -54.37 34.12 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.46 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.94 -0.67 16.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.082 178.649 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.871 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.42 -61.86 1.65 Allowed 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.25 0.547 . . . . 0.0 109.911 179.779 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -114.15 -13.95 9.55 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.683 178.848 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 24.9 t80 70.91 -51.06 0.68 Allowed 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 122.459 0.304 . . . . 0.0 111.599 179.904 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.209 -179.828 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.882 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 8.2 tp . . . . . 0 N--CA 1.458 -0.031 0 CA-C-O 120.994 0.426 . . . . 0.0 111.299 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.564 HD12 HG22 ' A' ' 169' ' ' ILE . 3.7 mp -73.82 -36.38 45.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.522 -179.671 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 20.2 mt -64.92 -62.39 1.59 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.658 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -77.43 8.06 4.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.359 178.996 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.882 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.1 -59.15 2.93 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.328 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 175' ' ' TYR . . . -123.37 -1.64 9.22 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.188 178.024 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.406 ' HB2' ' O ' ' A' ' 174' ' ' GLY . 63.6 m-85 66.36 -57.65 0.37 Allowed 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.02 0.528 . . . . 0.0 111.336 179.679 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 120.761 0.315 . . . . 0.0 110.958 179.552 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.887 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--O 1.227 -0.109 0 CA-C-O 121.047 0.451 . . . . 0.0 110.996 . . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.473 HD12 ' H ' ' A' ' 170' ' ' ILE . 2.2 mp -75.46 -53.36 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.315 -179.785 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 12.2 tp -65.33 -49.93 67.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.361 0.601 . . . . 0.0 109.384 179.446 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.06 -1.32 16.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.153 179.102 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.887 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.66 -64.78 0.89 Allowed 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.092 0.472 . . . . 0.0 109.736 179.631 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -116.18 -16.83 6.5 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.688 178.807 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.441 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 24.2 t80 75.89 -10.61 1.25 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.401 0.28 . . . . 0.0 111.753 179.986 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 71.3 t80 . . . . . 0 C--N 1.332 -0.194 0 CA-C-O 120.838 0.351 . . . . 0.0 110.948 179.664 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.986 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.9 OUTLIER . . . . . 0 CA--C 1.534 0.35 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 . . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.576 HD12 ' H ' ' A' ' 170' ' ' ILE . 2.7 mp -83.13 -65.56 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.039 0.447 . . . . 0.0 111.236 179.956 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 172' ' ' ASP . 1.4 pp -65.8 -45.04 83.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.353 0.597 . . . . 0.0 110.252 179.902 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.453 ' N ' HD12 ' A' ' 171' ' ' LEU . 0.3 OUTLIER -71.19 -5.55 32.71 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.947 179.492 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.986 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -75.75 -62.2 1.67 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.107 0.48 . . . . 0.0 110.243 179.735 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -130.67 1.48 5.59 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.484 179.584 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.508 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER 57.54 -52.51 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 179.344 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.522 ' N ' ' O ' ' A' ' 174' ' ' GLY . 2.9 m-85 . . . . . 0 C--N 1.327 -0.378 0 CA-C-O 120.75 0.309 . . . . 0.0 111.041 179.941 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.927 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 . . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.703 ' H ' HG23 ' A' ' 169' ' ' ILE . 1.9 mt 25.63 -62.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.387 0.675 . . . . 0.0 112.664 178.349 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.927 ' N ' ' O ' ' A' ' 169' ' ' ILE . 13.7 mt -67.05 -51.0 60.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.674 179.824 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -72.31 -6.86 46.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.074 179.575 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.61 -59.55 2.7 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.753 0.311 . . . . 0.0 110.367 179.887 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -100.06 -20.9 14.75 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.636 179.048 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 64.9 t80 69.29 -57.63 0.53 Allowed 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.8 0.333 . . . . 0.0 111.003 -179.953 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 6.5 t80 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.526 179.503 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.927 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 18.4 pt . . . . . 0 N--CA 1.454 -0.234 0 CA-C-O 120.72 0.295 . . . . 0.0 111.336 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.464 ' N ' HG13 ' A' ' 169' ' ' ILE . 3.1 mp -78.71 -43.36 25.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.483 -179.974 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.422 HD22 ' N ' ' A' ' 171' ' ' LEU . 2.5 mm? -64.6 -58.93 4.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.104 0.478 . . . . 0.0 109.773 179.852 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -74.32 4.7 5.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.256 179.01 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.927 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.08 -52.75 15.37 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.548 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -121.43 -5.82 9.16 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.793 178.76 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.428 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 85.1 t80 68.99 -53.59 0.57 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.547 0.339 . . . . 0.0 111.574 179.981 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.406 ' O ' ' CG ' ' A' ' 176' ' ' PHE . 27.7 t80 . . . . . 0 CA--C 1.532 0.267 0 CA-C-O 120.587 0.232 . . . . 0.0 111.171 -179.802 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.825 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 17.0 tt . . . . . 0 CA--C 1.52 -0.184 0 CA-C-O 121.636 0.732 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.523 ' N ' HG23 ' A' ' 169' ' ' ILE . 3.3 pt -71.82 -43.55 69.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 114.16 -1.382 . . . . 0.0 111.827 -178.524 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 8.9 mt -63.06 -51.6 66.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.975 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -75.02 -8.24 55.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.312 178.227 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.825 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -75.14 -76.15 0.15 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.123 0.487 . . . . 0.0 110.191 179.71 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -114.82 -14.19 8.82 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.914 179.12 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 32.6 t80 77.48 -43.47 0.41 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 179.668 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.211 0 CA-C-O 120.57 0.224 . . . . 0.0 111.595 -179.878 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.887 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER . . . . . 0 CA--C 1.52 -0.207 0 CA-C-O 121.023 0.439 . . . . 0.0 111.517 . . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.652 HD12 ' N ' ' A' ' 171' ' ' LEU . 2.3 pp -76.1 -49.71 24.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.224 -178.271 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.732 HD12 ' N ' ' A' ' 172' ' ' ASP . 3.4 pp -67.47 -48.58 66.77 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.988 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.732 ' N ' HD12 ' A' ' 171' ' ' LEU . 1.3 m-20 -73.95 -2.37 23.73 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.922 178.655 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.887 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.73 -70.8 0.3 Allowed 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.539 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.437 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -110.86 -23.66 5.8 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.131 -0.787 . . . . 0.0 111.131 178.127 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER 71.25 -13.53 0.52 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.398 0.279 . . . . 0.0 111.199 -179.726 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.437 ' H ' ' C ' ' A' ' 174' ' ' GLY . 36.7 p90 . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.752 0.31 . . . . 0.0 110.256 179.189 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.873 HG23 HD13 ' A' ' 170' ' ' ILE . 5.6 tp . . . . . 0 CA--C 1.523 -0.067 0 CA-C-O 120.964 0.411 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.873 HD13 HG23 ' A' ' 169' ' ' ILE . 7.4 mm -73.94 -49.83 32.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.916 -178.927 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.589 ' C ' HD12 ' A' ' 171' ' ' LEU . 0.5 OUTLIER -64.7 -48.0 76.29 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.609 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.409 ' N ' ' HG ' ' A' ' 171' ' ' LEU . 3.5 t0 -76.5 -1.35 26.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.956 178.488 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.845 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.62 -57.35 4.2 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.818 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -115.02 -15.12 8.03 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.663 178.757 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.411 ' HB2' ' O ' ' A' ' 174' ' ' GLY . 1.9 m-85 68.66 -10.11 0.5 Allowed 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 122.3 0.24 . . . . 0.0 111.567 -179.766 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.43 ' H ' ' C ' ' A' ' 174' ' ' GLY . 7.4 m-85 . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.734 0.302 . . . . 0.0 110.389 179.463 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.852 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 121.047 0.451 . . . . 0.0 111.053 . . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.843 HD13 HG23 ' A' ' 169' ' ' ILE . 8.1 mm -73.56 -42.35 55.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.523 -179.454 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.448 HD22 ' N ' ' A' ' 171' ' ' LEU . 3.2 mm? -65.64 -56.05 14.24 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.471 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -74.52 0.54 14.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.008 178.701 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.852 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.64 -57.35 4.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.285 0.564 . . . . 0.0 109.5 179.662 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -112.66 -22.14 5.84 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.309 178.558 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 70.08 -53.07 0.63 Allowed 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 122.476 0.31 . . . . 0.0 111.45 179.815 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.218 0 CA-C-O 120.803 0.335 . . . . 0.0 110.734 179.789 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.912 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.275 0 CA-C-O 120.713 0.292 . . . . 0.0 111.348 . . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.897 HD13 HG23 ' A' ' 169' ' ' ILE . 7.0 mm -76.95 -50.12 21.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.893 -179.506 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.559 HD12 ' H ' ' A' ' 171' ' ' LEU . 4.5 mp -64.08 -52.31 59.89 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.592 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -74.01 0.61 13.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.012 178.48 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.912 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.15 -52.26 17.49 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.372 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -126.48 -25.33 1.3 Allowed Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.519 178.782 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.41 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 7.8 t80 79.44 -21.63 0.32 Allowed 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.231 0.613 . . . . 0.0 112.275 179.62 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 . . . . . 0 C--N 1.327 -0.39 0 CA-C-O 121.405 0.622 . . . . 0.0 109.341 179.093 . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.724 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 8.4 tt . . . . . 0 N--CA 1.458 -0.046 0 CA-C-O 121.166 0.508 . . . . 0.0 110.796 . . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.448 HD12 ' H ' ' A' ' 170' ' ' ILE . 1.9 mp -71.07 -37.37 66.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.94 -179.875 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.39 -55.42 18.22 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.784 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.74 1.3 17.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.04 178.432 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.4 -45.68 53.25 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-O 121.05 0.452 . . . . 0.0 110.157 -179.869 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 175' ' ' TYR . . . -117.99 -20.68 4.41 Favored Glycine 0 N--CA 1.452 -0.281 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 178.688 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' A' ' 174' ' ' GLY . 57.6 m-85 69.44 -12.64 0.42 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 179.0 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 121.455 0.645 . . . . 0.0 109.26 178.638 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.854 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 10.8 pt . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.965 0.412 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 10.7 mm -77.12 -42.56 31.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.41 -179.848 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.97 -57.03 9.79 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.535 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.09 4.55 6.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.119 178.671 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.854 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.59 -47.27 55.91 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.287 0.565 . . . . 0.0 109.501 179.616 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -121.09 -28.05 1.74 Allowed Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 178.338 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.41 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 46.9 t80 77.0 -13.74 0.91 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.314 0.646 . . . . 0.0 112.501 179.184 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.403 ' CD2' ' O ' ' A' ' 176' ' ' PHE . 42.2 p90 . . . . . 0 C--N 1.328 -0.341 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.665 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.877 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER . . . . . 0 CA--C 1.527 0.077 0 CA-C-O 120.905 0.383 . . . . 0.0 110.711 . . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.568 HD12 HG22 ' A' ' 169' ' ' ILE . 3.4 mp -78.35 -42.57 26.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.803 179.504 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.5 mt -64.38 -56.95 10.9 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.429 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -74.45 2.48 9.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.087 178.685 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.877 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.77 -60.71 2.1 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-O 121.151 0.501 . . . . 0.0 109.731 179.737 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.497 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -115.53 -11.35 10.56 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.626 178.769 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.497 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 64.0 t80 72.47 -17.29 0.39 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.787 0.435 . . . . 0.0 112.119 179.903 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.331 -0.231 0 CA-C-O 120.795 0.331 . . . . 0.0 111.004 179.765 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.942 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--O 1.227 -0.086 0 CA-C-O 120.864 0.364 . . . . 0.0 111.566 . . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 2.4 mp -74.67 -56.67 8.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.868 -179.27 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -53.25 40.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.907 0.384 . . . . 0.0 110.813 -179.675 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.43 8.75 2.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.979 179.771 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.942 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.31 -67.58 0.54 Allowed 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.357 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.632 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -117.91 8.43 14.61 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 178.034 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.472 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER 53.72 -63.34 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.005 0.922 . . . . 0.0 111.638 179.846 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.632 ' N ' ' O ' ' A' ' 174' ' ' GLY . 11.8 t80 . . . . . 0 C--N 1.321 -0.661 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.293 179.639 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 1.015 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.465 0.311 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 . . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.504 HD12 ' H ' ' A' ' 170' ' ' ILE . 3.9 mp -81.66 -61.87 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.937 0.398 . . . . 0.0 111.752 -179.616 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.469 HD22 ' N ' ' A' ' 171' ' ' LEU . 2.5 mm? -67.5 -51.26 53.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.891 -179.489 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -73.45 4.19 5.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.96 -179.796 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 1.015 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.19 -65.71 0.77 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.33 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -108.45 -24.74 6.05 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 178.113 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 75.43 -25.13 0.21 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.645 0.378 . . . . 0.0 111.537 179.814 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.401 ' H ' ' C ' ' A' ' 174' ' ' GLY . 11.6 m-85 . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 120.702 0.287 . . . . 0.0 110.971 179.728 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.864 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 8.7 pt . . . . . 0 N--CA 1.461 0.086 0 CA-C-O 120.757 0.313 . . . . 0.0 111.533 . . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.442 HD12 HG13 ' A' ' 169' ' ' ILE . 3.8 mp -75.76 -52.78 17.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.729 -179.352 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.86 -51.41 59.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.058 0.456 . . . . 0.0 109.976 179.849 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.63 3.5 7.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.519 179.209 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.864 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.24 -63.71 1.09 Allowed 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.576 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -112.62 -11.49 14.71 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.353 178.368 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 3.8 t80 72.57 -55.6 0.67 Allowed 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.53 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.214 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.276 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.847 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 7.4 tt . . . . . 0 CA--C 1.522 -0.103 0 CA-C-O 121.176 0.512 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.789 HD13 HG23 ' A' ' 169' ' ' ILE . 10.2 mm -69.65 -38.53 76.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.286 -179.217 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 82.7 mt -64.86 -58.82 5.17 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.102 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.72 0.21 16.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.166 178.597 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.847 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.88 -62.11 1.57 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.162 0.506 . . . . 0.0 109.748 179.737 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -113.27 -12.31 12.2 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.752 178.891 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 8.0 t80 73.11 -53.34 0.7 Allowed 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 122.48 0.312 . . . . 0.0 111.687 179.793 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.68 0.276 . . . . 0.0 110.915 179.882 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.772 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 7.2 tp . . . . . 0 CA--C 1.526 0.026 0 CA-C-O 121.171 0.51 . . . . 0.0 110.645 . . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.426 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.3 mp -71.63 -40.64 71.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.796 179.952 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 0.8 OUTLIER -66.63 -51.01 61.08 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.659 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -73.37 -8.23 54.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.079 178.032 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.772 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -74.64 -64.68 0.98 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.141 0.496 . . . . 0.0 110.119 179.667 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -123.64 -14.46 3.89 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.397 179.459 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.428 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 6.9 t80 77.87 -11.03 1.26 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 179.858 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 42.0 p90 . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.62 0.248 . . . . 0.0 111.217 179.73 . . . . . . . . 0 0 . 1 . 049 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.554 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 7.3 tp . . . . . 0 CA--C 1.521 -0.151 0 CA-C-O 121.322 0.582 . . . . 0.0 109.814 . . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.451 ' HA ' ' HB2' ' A' ' 173' ' ' ALA . 2.7 mp -68.28 -23.11 28.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.828 178.822 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.37 -65.95 0.61 Allowed 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.385 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -76.69 7.15 4.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.802 178.092 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -70.21 -51.21 32.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.734 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -104.83 -19.17 11.23 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 177.811 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 16.5 t80 75.66 -10.19 1.3 Allowed 'General case' 0 C--O 1.23 0.075 0 C-N-CA 122.841 0.456 . . . . 0.0 112.005 179.626 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 120.788 0.328 . . . . 0.0 110.72 179.531 . . . . . . . . 0 0 . 1 . 050 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.834 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 14.7 tt . . . . . 0 CA--C 1.519 -0.238 0 CA-C-O 121.372 0.606 . . . . 0.0 111.502 . . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.503 ' N ' HG23 ' A' ' 169' ' ' ILE . 1.0 OUTLIER -71.61 -45.19 68.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.487 -177.813 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.74 -55.21 24.97 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.506 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -76.11 3.26 10.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.384 178.797 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.834 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.01 -52.67 13.51 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.258 0.551 . . . . 0.0 109.894 179.9 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -121.77 -19.8 3.29 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.22 178.738 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.448 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 62.0 t80 74.28 -12.96 0.83 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.101 0.56 . . . . 0.0 112.127 179.628 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 . . . . . 0 C--N 1.33 -0.25 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.729 . . . . . . . . 0 0 . 1 . 051 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.828 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 2.7 tt . . . . . 0 CA--C 1.518 -0.265 0 CA-C-O 121.543 0.687 . . . . 0.0 110.58 . . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.512 ' N ' HG23 ' A' ' 169' ' ' ILE . 0.9 OUTLIER -74.66 -43.16 47.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.544 -178.931 . . . . . . . . 3 3 . 1 . 051 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.21 -54.57 27.55 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.105 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.12 1.23 13.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.943 178.575 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.828 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.72 -59.57 2.65 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 121.168 0.509 . . . . 0.0 110.005 179.885 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.581 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -111.73 -4.18 26.51 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.698 178.896 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.502 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER 56.07 -54.4 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.87 0.868 . . . . 0.0 112.589 179.818 . . . . . . . . 3 3 . 1 . 051 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.581 ' N ' ' O ' ' A' ' 174' ' ' GLY . 6.5 m-85 . . . . . 0 C--N 1.324 -0.52 0 CA-C-O 120.616 0.246 . . . . 0.0 111.109 179.984 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.749 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 5.5 tp . . . . . 0 CA--C 1.517 -0.298 0 CA-C-O 121.253 0.549 . . . . 0.0 111.569 . . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.603 HD13 HG23 ' A' ' 169' ' ' ILE . 5.9 mm -62.22 -30.64 49.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.775 -178.582 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 24.6 tp -65.18 -65.23 0.7 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.081 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -77.6 3.83 12.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.449 178.853 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.749 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.63 -70.27 0.33 Allowed 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.825 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 175' ' ' TYR . . . -107.11 -12.69 23.22 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.078 178.244 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 4.0 m-85 69.47 -48.02 0.6 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.703 0.401 . . . . 0.0 111.323 -179.908 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.419 ' O ' ' CG ' ' A' ' 176' ' ' PHE . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.293 0 CA-C-O 120.718 0.294 . . . . 0.0 110.364 179.358 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.922 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.4 ' C ' ' O ' ' A' ' 169' ' ' ILE . 4.7 mt 26.77 -62.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.567 0.747 . . . . 0.0 112.539 178.655 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.922 ' N ' ' O ' ' A' ' 169' ' ' ILE . 3.1 mm? -66.8 -52.38 44.62 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.699 179.914 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.03 -19.31 60.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.76 179.608 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -78.3 -73.07 0.34 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.118 -179.651 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -109.12 -25.98 5.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.601 -179.988 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.457 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 25.5 t80 74.49 -39.37 0.42 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.659 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.592 0.234 . . . . 0.0 110.87 179.801 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 1.021 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 4.9 tt . . . . . 0 C--O 1.226 -0.167 0 CA-C-O 121.015 0.436 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.426 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 2.4 mp -80.23 -60.79 2.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.713 -178.859 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 0.2 OUTLIER -63.09 -48.97 76.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.903 0.382 . . . . 0.0 110.444 -179.199 . . . . . . . . 3 3 . 1 . 054 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.14 -2.79 22.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.859 179.088 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 1.021 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -74.3 -66.86 0.68 Allowed 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.179 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -123.54 -11.56 4.98 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.016 178.889 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 20.0 t80 77.64 -30.08 0.16 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 122.624 0.369 . . . . 0.0 111.842 -179.895 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.67 0.271 . . . . 0.0 111.192 179.775 . . . . . . . . 0 0 . 1 . 055 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.998 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 23.0 pt . . . . . 0 N--CA 1.454 -0.244 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 . . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.458 HD12 ' H ' ' A' ' 170' ' ' ILE . 3.3 mp -76.76 -47.31 28.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.01 -179.252 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 38.1 tp -63.86 -54.48 34.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.346 0.593 . . . . 0.0 109.56 179.751 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.22 -3.47 26.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.849 179.014 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.998 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.96 -73.7 0.2 Allowed 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.299 0.571 . . . . 0.0 109.555 179.484 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -118.52 -13.54 6.77 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.509 178.647 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 5.5 t80 76.37 -45.51 0.51 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.474 0.31 . . . . 0.0 111.363 179.97 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 . . . . . 0 C--N 1.331 -0.2 0 CA-C-O 120.672 0.272 . . . . 0.0 111.056 179.892 . . . . . . . . 0 0 . 1 . 056 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.989 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--O 1.226 -0.157 0 CA-C-O 120.838 0.351 . . . . 0.0 111.426 . . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.444 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.2 mp -73.4 -47.55 45.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.676 -179.254 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.493 HD23 ' N ' ' A' ' 172' ' ' ASP . 0.3 OUTLIER -65.99 -56.81 9.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.13 0.49 . . . . 0.0 109.874 179.802 . . . . . . . . 3 3 . 1 . 056 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.493 ' N ' HD23 ' A' ' 171' ' ' LEU . 0.3 OUTLIER -75.02 5.11 5.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.693 179.358 . . . . . . . . 3 3 . 1 . 056 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.989 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.34 -63.69 1.1 Allowed 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.54 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 175' ' ' TYR . . . -112.05 -11.88 15.21 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.382 178.495 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.438 ' HB2' ' O ' ' A' ' 174' ' ' GLY . 16.0 m-85 68.3 -50.74 0.55 Allowed 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 122.687 0.395 . . . . 0.0 111.36 179.915 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.801 179.719 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.753 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.467 0.375 0 CA-C-O 120.842 0.353 . . . . 0.0 111.295 . . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.553 HD12 ' H ' ' A' ' 170' ' ' ILE . 3.5 mp -73.98 -42.73 52.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.847 179.992 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 10.5 mt -63.43 -54.51 35.45 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.214 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.88 0.48 15.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.824 178.446 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.753 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.06 -77.51 0.1 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.893 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -98.46 -3.17 57.55 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.386 178.392 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER 71.55 -61.52 0.49 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.91 0.386 . . . . 0.0 110.838 179.987 . . . . . . . . 3 3 . 1 . 057 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 36.8 p90 . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.231 179.934 . . . . . . . . 0 0 . 1 . 058 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.766 HD13 ' O ' ' A' ' 169' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.23 0 CA-C-O 121.587 0.708 . . . . 0.0 110.832 . . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.638 ' CG1' HD13 ' A' ' 171' ' ' LEU . 11.1 pt -68.15 -38.37 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.57 -178.355 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.833 HD13 ' H ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -60.73 -57.3 13.29 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.085 . . . . . . . . 3 3 . 1 . 058 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.21 -2.65 35.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.845 178.334 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.7 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.03 -67.24 0.58 Allowed 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 121.056 0.455 . . . . 0.0 110.088 -179.93 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -109.34 -16.47 11.1 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.734 178.942 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.534 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.5 OUTLIER 77.33 -12.93 1.0 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 179.924 . . . . . . . . 3 3 . 1 . 058 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 C--N 1.331 -0.207 0 CA-C-O 120.557 0.218 . . . . 0.0 111.327 -179.981 . . . . . . . . 0 0 . 1 . 059 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.825 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 . . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.641 HD12 ' H ' ' A' ' 170' ' ' ILE . 2.3 mp -73.11 -47.13 48.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.882 0.372 . . . . 0.0 111.783 -179.195 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.56 -0.58 5.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.058 -179.873 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -147.05 15.27 1.17 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.468 -179.926 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.825 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -79.93 -47.31 15.22 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.911 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.418 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -129.77 -22.64 1.14 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.981 178.684 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 34.9 t80 71.62 -12.59 0.62 Allowed 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 122.507 0.323 . . . . 0.0 111.386 -179.344 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.418 ' H ' ' C ' ' A' ' 174' ' ' GLY . 7.2 t80 . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 120.795 0.331 . . . . 0.0 110.143 178.959 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.966 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 3.5 tp . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 120.713 0.292 . . . . 0.0 111.755 . . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.856 HD13 HG23 ' A' ' 169' ' ' ILE . 8.1 mm -73.79 -51.71 23.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.193 -178.781 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 171' ' ' LEU . 3.4 mm? -64.14 -49.17 73.21 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.715 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -75.03 -4.08 36.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.955 178.516 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.966 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.17 -68.37 0.5 Allowed 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.234 0.54 . . . . 0.0 109.714 179.656 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.615 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -121.72 -8.89 7.25 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.939 178.929 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.49 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.2 OUTLIER 55.76 -53.58 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.883 0.873 . . . . 0.0 112.416 -179.994 . . . . . . . . 3 3 . 1 . 060 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.615 ' N ' ' O ' ' A' ' 174' ' ' GLY . 29.0 t80 . . . . . 0 C--N 1.325 -0.469 0 CA-C-O 120.611 0.244 . . . . 0.0 110.744 179.789 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.784 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 2.1 tt . . . . . 0 N--CA 1.459 0.016 0 CA-C-O 121.134 0.492 . . . . 0.0 111.3 . . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.519 HD12 ' H ' ' A' ' 170' ' ' ILE . 4.2 mp -67.58 -35.05 71.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.342 -179.22 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.31 -60.51 2.71 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.897 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -76.29 4.46 8.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.269 178.692 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.784 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.94 -68.52 0.45 Allowed 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.741 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -103.37 -13.76 27.66 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 178.032 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.452 ' CG ' ' N ' ' A' ' 176' ' ' PHE . 0.0 OUTLIER 72.64 -53.56 0.7 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.53 0.332 . . . . 0.0 111.534 179.48 . . . . . . . . 3 3 . 1 . 061 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.452 ' N ' ' CG ' ' A' ' 175' ' ' TYR . 26.1 t80 . . . . . 0 C--N 1.332 -0.196 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.359 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.889 ' O ' ' N ' ' A' ' 171' ' ' LEU . 2.5 tt . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 . . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.834 ' H ' HG23 ' A' ' 169' ' ' ILE . 14.7 mt 25.62 -63.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 123.676 0.79 . . . . 0.0 112.762 177.863 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.889 ' N ' ' O ' ' A' ' 169' ' ' ILE . 17.4 mt -66.5 -43.63 84.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.246 -179.628 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.59 -15.88 60.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.35 -179.924 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -76.16 -90.34 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.337 179.966 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -105.55 -10.64 30.72 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.642 178.784 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.409 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 60.7 t80 68.3 -61.26 0.4 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.925 0.393 . . . . 0.0 110.411 -179.629 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 174' ' ' GLY . 21.3 t80 . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.87 179.112 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.878 ' O ' ' N ' ' A' ' 171' ' ' LEU . 3.0 pt . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 . . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.572 HD12 HG13 ' A' ' 169' ' ' ILE . 3.2 mp 33.78 -60.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 123.889 0.876 . . . . 0.0 113.139 178.597 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.878 ' N ' ' O ' ' A' ' 169' ' ' ILE . 0.1 OUTLIER -64.07 -44.48 92.27 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.856 -179.587 . . . . . . . . 3 3 . 1 . 063 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 52.7 p30 -71.72 -10.26 59.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.975 179.818 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -78.29 -63.08 1.48 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.844 0.354 . . . . 0.0 110.815 179.925 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -114.63 -21.78 5.31 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.325 179.751 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER 76.79 -10.98 1.24 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.878 . . . . . . . . 3 3 . 1 . 063 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.715 0.293 . . . . 0.0 111.011 179.609 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 1.003 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 9.4 tt . . . . . 0 C--O 1.225 -0.216 0 CA-C-O 120.811 0.338 . . . . 0.0 111.673 . . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.505 HD12 HG22 ' A' ' 169' ' ' ILE . 3.3 mp -76.65 -52.26 17.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.226 -179.144 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.681 HD23 ' H ' ' A' ' 172' ' ' ASP . 0.0 OUTLIER -64.57 -52.72 56.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.085 0.469 . . . . 0.0 109.953 -179.633 . . . . . . . . 3 3 . 1 . 064 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.681 ' H ' HD23 ' A' ' 171' ' ' LEU . 0.4 OUTLIER -74.45 -0.31 17.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.206 179.129 . . . . . . . . 3 3 . 1 . 064 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 1.003 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.62 -69.79 0.39 Allowed 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.408 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -120.88 -11.21 6.51 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.523 178.571 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.479 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 26.3 t80 70.51 -18.31 0.25 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.729 0.412 . . . . 0.0 111.801 -179.913 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.431 ' H ' ' C ' ' A' ' 174' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.205 0 CA-C-O 120.858 0.361 . . . . 0.0 110.668 179.849 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.852 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 24.8 pt . . . . . 0 CA--C 1.515 -0.367 0 CA-C-O 121.752 0.787 . . . . 0.0 110.718 . . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.601 ' N ' HG13 ' A' ' 169' ' ' ILE . 2.1 pt -70.28 -41.73 78.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 113.974 -1.466 . . . . 0.0 112.157 -177.777 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 1.0 OUTLIER -61.84 -57.73 10.68 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.096 . . . . . . . . 3 3 . 1 . 065 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -74.8 -1.9 24.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.014 178.44 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.852 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -74.1 -73.51 0.22 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.12 0.486 . . . . 0.0 110.362 179.976 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.536 ' C ' ' CG ' ' A' ' 175' ' ' TYR . . . -98.98 -0.68 57.3 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.02 179.276 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.536 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER 57.68 -53.74 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.672 0.789 . . . . 0.0 112.639 179.451 . . . . . . . . 3 3 . 1 . 065 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 174' ' ' GLY . 2.4 m-85 . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 120.649 0.261 . . . . 0.0 111.088 179.912 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.751 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 4.5 tt . . . . . 0 N--CA 1.458 -0.056 0 CA-C-O 121.047 0.451 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.436 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.1 mp -68.73 -31.07 49.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.378 -179.38 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 8.9 tp -64.89 -63.65 1.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.116 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.28 4.07 9.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.033 178.534 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.751 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.53 -64.39 0.93 Allowed 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.678 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -108.83 -14.95 14.0 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.25 178.26 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.472 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 46.7 t80 70.63 -14.96 0.39 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.734 0.414 . . . . 0.0 111.744 -179.904 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.424 ' H ' ' C ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.689 0.281 . . . . 0.0 110.914 179.859 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.903 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.4 OUTLIER . . . . . 0 CA--C 1.537 0.453 0 CA-C-O 118.973 -0.537 . . . . 0.0 109.717 . . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.686 ' H ' HG23 ' A' ' 169' ' ' ILE . 15.1 mt 33.24 -62.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.435 0.694 . . . . 0.0 112.734 178.956 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.903 ' N ' ' O ' ' A' ' 169' ' ' ILE . 0.1 OUTLIER -65.77 -52.31 52.02 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.803 -179.713 . . . . . . . . 3 3 . 1 . 067 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -72.08 -9.77 58.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.052 179.979 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -77.8 -53.92 6.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.784 0.326 . . . . 0.0 110.964 -179.817 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -114.28 -15.4 8.35 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.577 179.864 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.476 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 10.6 t80 70.89 -44.83 0.6 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.988 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.429 ' CG ' ' O ' ' A' ' 176' ' ' PHE . 79.5 t80 . . . . . 0 CA--C 1.532 0.271 0 CA-C-O 120.621 0.248 . . . . 0.0 111.458 -179.619 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.774 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 4.7 tt . . . . . 0 CA--C 1.524 -0.041 0 CA-C-O 121.162 0.506 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 3.8 mt -69.79 -30.79 45.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.124 -179.812 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.47 -62.44 1.46 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.886 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.61 3.32 9.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.781 178.499 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.774 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.59 -48.11 50.36 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.417 0.627 . . . . 0.0 109.368 179.477 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 175' ' ' TYR . . . -124.12 -4.49 7.77 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.75 178.875 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.426 ' HB2' ' O ' ' A' ' 174' ' ' GLY . 34.9 m-85 67.69 -50.54 0.51 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.743 0.417 . . . . 0.0 111.965 179.664 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 C--N 1.331 -0.196 0 CA-C-O 120.767 0.318 . . . . 0.0 110.998 179.596 . . . . . . . . 0 0 . 1 . 069 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.776 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 5.8 tp . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 121.083 0.468 . . . . 0.0 110.824 . . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.436 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 4.8 mt -73.37 -43.98 55.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.948 179.93 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.46 -55.45 15.63 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.358 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -75.27 5.89 5.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.304 178.869 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.776 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.49 -52.71 16.9 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.739 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -104.96 -18.6 12.03 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 177.968 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 5.1 t80 76.53 -11.86 1.11 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.8 0.44 . . . . 0.0 111.905 179.651 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 79.5 t80 . . . . . 0 C--N 1.331 -0.234 0 CA-C-O 120.806 0.336 . . . . 0.0 110.717 179.371 . . . . . . . . 0 0 . 1 . 070 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.832 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 5.7 pt . . . . . 0 CA--C 1.521 -0.155 0 CA-C-O 120.927 0.394 . . . . 0.0 111.369 . . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 6.7 mm -73.8 -41.09 54.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.0 -179.856 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 78.5 mt -66.71 -55.66 14.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.919 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -74.1 0.7 13.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.176 178.637 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.832 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -70.92 -43.08 69.0 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.366 0.603 . . . . 0.0 109.386 -179.837 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -120.39 -23.98 2.76 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.385 178.586 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 75.37 -41.29 0.45 Allowed 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 122.692 0.397 . . . . 0.0 111.667 179.893 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 . . . . . 0 C--N 1.325 -0.488 0 CA-C-O 120.775 0.321 . . . . 0.0 110.963 179.813 . . . . . . . . 0 0 . 1 . 071 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.904 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 1.4 tt . . . . . 0 C--O 1.227 -0.1 0 CA-C-O 121.222 0.534 . . . . 0.0 112.181 . . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.502 ' N ' HG23 ' A' ' 169' ' ' ILE . 0.8 OUTLIER -75.81 -53.8 15.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -176.996 . . . . . . . . 3 3 . 1 . 071 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.588 ' HG ' ' N ' ' A' ' 172' ' ' ASP . 2.6 pt? -66.91 -49.47 65.44 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.362 0.601 . . . . 0.0 110.056 -179.789 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.588 ' N ' ' HG ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -74.23 1.96 10.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.311 179.02 . . . . . . . . 3 3 . 1 . 071 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.904 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.69 -54.67 8.37 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.307 0.575 . . . . 0.0 109.596 179.5 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -112.49 -18.9 7.3 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.515 178.617 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 70.01 -56.46 0.58 Allowed 'General case' 0 C--O 1.231 0.115 0 C-N-CA 122.502 0.321 . . . . 0.0 111.377 179.824 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.409 ' O ' ' CG ' ' A' ' 176' ' ' PHE . 89.6 t80 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.882 179.824 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.878 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 3.3 tt . . . . . 0 CA--C 1.529 0.136 0 CA-C-O 120.929 0.395 . . . . 0.0 111.817 . . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 10.3 mt -71.03 -60.22 2.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.625 -178.359 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.579 ' HG ' ' N ' ' A' ' 172' ' ' ASP . 2.6 pt? -63.91 -47.95 78.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.375 0.607 . . . . 0.0 110.007 -179.579 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.579 ' N ' ' HG ' ' A' ' 171' ' ' LEU . 30.9 m-20 -72.48 -0.92 13.93 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.219 179.091 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.878 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.16 -66.07 0.73 Allowed 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.591 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -119.74 -9.56 8.26 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.767 178.68 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 12.0 t80 68.82 -61.69 0.41 Allowed 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.971 0.415 . . . . 0.0 110.994 -179.885 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 14.4 t80 . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.912 179.735 . . . . . . . . 0 0 . 1 . 073 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.765 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 5.4 tt . . . . . 0 CA--C 1.522 -0.1 0 CA-C-O 121.264 0.554 . . . . 0.0 110.801 . . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.714 HD13 HG23 ' A' ' 169' ' ' ILE . 13.3 mm -71.66 -45.13 68.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.447 -179.299 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.661 ' H ' HD22 ' A' ' 171' ' ' LEU . 0.9 OUTLIER -65.68 -53.15 45.13 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.035 . . . . . . . . 3 3 . 1 . 073 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -73.82 0.53 12.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.053 178.635 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.765 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.96 -55.61 6.32 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.584 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -123.28 -27.45 1.49 Allowed Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 178.539 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.3 OUTLIER 78.07 -14.66 0.83 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.109 0.564 . . . . 0.0 112.125 179.506 . . . . . . . . 3 3 . 1 . 073 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.425 ' O ' ' CG ' ' A' ' 176' ' ' PHE . 14.7 t80 . . . . . 0 C--N 1.33 -0.274 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.562 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 1.01 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 2.4 pt . . . . . 0 CA--C 1.519 -0.212 0 CA-C-O 120.769 0.319 . . . . 0.0 111.619 . . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 3.4 mp -77.4 -49.19 22.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.644 179.425 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 37.5 mt -68.29 -54.93 14.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.342 179.588 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -71.96 -0.34 11.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.502 179.437 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 1.01 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -70.47 -55.91 7.85 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.842 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -126.23 -22.99 1.63 Allowed Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.549 178.54 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 76.72 -30.34 0.18 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 122.637 0.375 . . . . 0.0 111.579 -179.876 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.204 0 CA-C-O 120.686 0.279 . . . . 0.0 110.998 179.732 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.684 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 13.4 tt . . . . . 0 CA--C 1.52 -0.177 0 CA-C-O 121.561 0.696 . . . . 0.0 111.841 . . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.608 ' N ' HG23 ' A' ' 169' ' ' ILE . 0.5 OUTLIER -69.2 -31.75 51.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.96 -177.272 . . . . . . . . 3 3 . 1 . 075 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 2.0 mt -66.55 -56.92 8.58 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.201 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -74.48 -4.18 35.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.58 178.158 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.684 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.47 -68.22 0.52 Allowed 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 121.226 0.536 . . . . 0.0 110.148 179.911 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -121.73 -2.03 10.6 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.159 179.292 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 54.1 t80 69.17 -51.8 0.6 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.473 0.309 . . . . 0.0 111.653 -179.994 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.21 0 CA-C-O 120.754 0.311 . . . . 0.0 111.174 -179.77 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.945 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 1.3 tt . . . . . 0 N--CA 1.465 0.293 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 . . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.542 HD12 ' H ' ' A' ' 170' ' ' ILE . 3.9 mp -79.61 -59.28 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.916 0.389 . . . . 0.0 111.12 179.903 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.483 HD22 ' N ' ' A' ' 171' ' ' LEU . 3.3 mm? -67.78 -47.4 69.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.247 0.546 . . . . 0.0 110.013 179.571 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.9 0.13 11.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.487 179.58 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.945 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.6 -63.02 1.29 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.142 0.496 . . . . 0.0 109.792 179.677 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -116.1 -12.34 9.22 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.749 178.901 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER 72.63 -56.12 0.66 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.35 0.26 . . . . 0.0 111.68 179.715 . . . . . . . . 3 3 . 1 . 076 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 30.5 p90 . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 120.581 0.229 . . . . 0.0 111.51 -179.636 . . . . . . . . 0 0 . 1 . 077 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.759 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 7.0 pt . . . . . 0 CA--C 1.523 -0.095 0 CA-C-O 120.925 0.393 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 2.9 mp -70.01 -43.53 79.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.297 -179.103 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.466 ' C ' HD12 ' A' ' 171' ' ' LEU . 0.1 OUTLIER -66.21 -52.54 47.0 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.801 . . . . . . . . 3 3 . 1 . 077 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.4 0.11 18.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.164 178.685 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.759 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.28 -60.26 2.32 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.043 0.449 . . . . 0.0 109.812 179.94 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -107.22 -20.37 8.74 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 178.535 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 27.3 t80 75.14 -11.08 1.12 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.443 0.297 . . . . 0.0 111.572 179.988 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.8 t80 . . . . . 0 CA--C 1.53 0.185 0 CA-C-O 120.791 0.329 . . . . 0.0 110.629 179.623 . . . . . . . . 0 0 . 1 . 078 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.714 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 7.3 tt . . . . . 0 C--O 1.227 -0.115 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 . . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.411 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.4 mp -70.64 -43.34 77.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.029 -178.803 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.0 -2.97 11.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.983 0.421 . . . . 0.0 111.789 179.915 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -145.88 17.28 1.43 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.354 179.978 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -80.81 -39.99 25.74 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.141 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.615 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -134.68 3.48 4.24 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 114.898 -1.047 . . . . 0.0 111.968 179.046 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.508 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER 54.97 -61.42 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 123.819 0.847 . . . . 0.0 112.147 179.799 . . . . . . . . 3 3 . 1 . 078 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.615 ' N ' ' O ' ' A' ' 174' ' ' GLY . 11.6 m-85 . . . . . 0 C--N 1.318 -0.771 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.056 -179.953 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.769 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 1.3 tt . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 120.816 0.341 . . . . 0.0 111.757 . . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.507 HD12 ' H ' ' A' ' 170' ' ' ILE . 4.2 mp -73.63 -34.98 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.136 -179.582 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 43.6 mt -65.59 -59.46 3.93 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.941 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.54 4.09 8.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.868 178.472 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.769 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.31 -53.94 12.52 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.746 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -98.53 -18.39 25.93 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 177.887 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 13.5 t80 75.47 -13.38 0.87 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.81 0.444 . . . . 0.0 111.723 179.787 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.22 0 CA-C-O 120.656 0.265 . . . . 0.0 110.644 179.527 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.851 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 120.601 0.238 . . . . 0.0 111.179 . . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.57 HD12 ' H ' ' A' ' 170' ' ' ILE . 2.9 mp -78.24 -56.13 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.019 0.438 . . . . 0.0 110.507 179.44 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 171' ' ' LEU . 3.5 mm? -67.83 -45.32 75.01 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.964 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -73.82 -0.64 16.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.325 179.214 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.851 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.26 -45.63 54.66 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.29 0.567 . . . . 0.0 109.84 179.731 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -126.62 -28.25 0.99 Allowed Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.261 179.054 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 35.7 t80 78.75 -12.66 1.06 Allowed 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 122.97 0.508 . . . . 0.0 112.134 179.525 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.426 ' CD2' ' O ' ' A' ' 176' ' ' PHE . 14.8 p90 . . . . . 0 C--N 1.329 -0.301 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.65 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.79 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 23.6 mm . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 121.081 0.467 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.418 ' N ' HG22 ' A' ' 169' ' ' ILE . 3.8 mp -73.26 -29.77 29.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.592 -179.202 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 22.5 tp -64.81 -64.78 0.78 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 179.339 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -77.68 8.43 4.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.181 178.627 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.79 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.26 -51.23 25.68 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.403 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -121.69 -28.32 1.6 Allowed Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 178.046 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 77.8 -24.62 0.21 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.404 0.682 . . . . 0.0 112.192 179.202 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 . . . . . 0 C--N 1.331 -0.237 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.954 . . . . . . . . 0 0 . 1 . 082 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.927 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 2.3 pt . . . . . 0 C--O 1.227 -0.116 0 CA-C-O 120.752 0.31 . . . . 0.0 111.621 . . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.495 HD12 HG13 ' A' ' 169' ' ' ILE . 3.8 mp -76.6 -54.29 13.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.293 -179.77 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 25.7 mt -67.37 -53.04 32.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.031 0.444 . . . . 0.0 110.488 179.974 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -74.46 5.27 4.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.727 179.764 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.927 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -69.75 -56.86 6.02 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.068 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -132.85 30.9 3.02 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 177.394 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.443 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 18.4 t80 68.5 -69.22 0.15 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.366 0.603 . . . . 0.0 109.432 -178.371 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' A' ' 174' ' ' GLY . 15.6 t80 . . . . . 0 C--N 1.313 -1.013 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.961 178.963 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.909 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.223 -0.306 0 CA-C-O 118.943 -0.551 . . . . 0.0 109.526 . . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.71 ' H ' HG23 ' A' ' 169' ' ' ILE . 4.2 mt 21.03 -61.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 178.481 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.909 ' N ' ' O ' ' A' ' 169' ' ' ILE . 0.2 OUTLIER -64.72 -52.38 57.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.57 -179.248 . . . . . . . . 3 3 . 1 . 083 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -73.69 -11.2 60.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.725 0.298 . . . . 0.0 111.094 179.855 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.424 ' HB2' HG13 ' A' ' 169' ' ' ILE . . . -77.01 -56.12 4.86 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.914 0.388 . . . . 0.0 110.638 179.98 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -99.32 -24.8 9.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.855 179.371 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 27.6 t80 77.3 -40.76 0.35 Allowed 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 122.385 0.274 . . . . 0.0 111.681 179.976 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 . . . . . 0 C--N 1.327 -0.387 0 CA-C-O 120.688 0.28 . . . . 0.0 111.277 -179.979 . . . . . . . . 0 0 . 1 . 084 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.746 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 12.6 tt . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 121.158 0.504 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.438 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.6 mp -70.35 -45.25 75.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.046 -179.684 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.6 mp -64.56 -52.22 58.76 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.235 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -76.21 1.54 15.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.153 178.529 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.746 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.41 -61.94 1.62 Allowed 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.142 0.496 . . . . 0.0 109.672 179.818 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -102.48 -21.39 10.64 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 178.332 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 1.6 t80 75.13 -38.86 0.39 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.569 0.347 . . . . 0.0 111.464 179.896 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.331 -0.221 0 CA-C-O 120.809 0.337 . . . . 0.0 110.74 179.546 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.883 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.5 OUTLIER . . . . . 0 CA--C 1.536 0.413 0 CA-C-O 118.911 -0.566 . . . . 0.0 109.703 . . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.673 ' H ' HG23 ' A' ' 169' ' ' ILE . 2.2 mp 21.98 -63.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 178.595 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.883 ' N ' ' O ' ' A' ' 169' ' ' ILE . 4.0 pp -66.37 -50.32 63.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.181 -179.635 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.748 ' N ' HD12 ' A' ' 171' ' ' LEU . 0.4 OUTLIER -69.7 -11.68 61.04 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.607 179.611 . . . . . . . . 3 3 . 1 . 085 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -78.22 -62.0 1.82 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.812 179.87 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -113.15 -24.69 4.72 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.348 179.748 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 1.0 OUTLIER 76.66 -11.82 1.13 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.561 0.22 . . . . 0.0 111.455 -179.792 . . . . . . . . 3 3 . 1 . 085 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 27.8 t80 . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 120.684 0.278 . . . . 0.0 110.702 179.377 . . . . . . . . 0 0 . 1 . 086 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.793 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 5.2 tt . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 . . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.643 ' H ' HG23 ' A' ' 169' ' ' ILE . 0.4 OUTLIER -67.03 -47.86 80.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.992 -179.899 . . . . . . . . 3 3 . 1 . 086 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 175' ' ' TYR . 0.1 OUTLIER -64.85 -50.92 64.73 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.419 . . . . . . . . 3 3 . 1 . 086 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.82 -5.86 43.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.547 178.445 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.793 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.71 -73.71 0.21 Allowed 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.571 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -113.95 -19.86 6.25 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.44 178.585 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.402 ' HA ' HD13 ' A' ' 171' ' ' LEU . 35.0 t80 73.03 -44.86 0.61 Allowed 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 122.45 0.3 . . . . 0.0 111.59 179.87 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 38.3 p90 . . . . . 0 C--N 1.331 -0.199 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.349 -179.729 . . . . . . . . 0 0 . 1 . 087 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.89 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 2.9 tp . . . . . 0 C--O 1.226 -0.171 0 CA-C-O 120.859 0.361 . . . . 0.0 111.408 . . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.424 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.8 mp -71.33 -47.93 56.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.016 -179.904 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.48 -50.67 64.48 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.13 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.88 -4.66 39.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.998 178.869 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.89 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.37 -69.48 0.42 Allowed 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.368 0.604 . . . . 0.0 109.552 179.632 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -122.36 -20.71 2.91 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.213 178.674 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.438 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 11.8 t80 76.35 -31.68 0.19 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.313 0.645 . . . . 0.0 112.349 179.549 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 121.332 0.587 . . . . 0.0 109.694 179.525 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.829 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 7.5 tt . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 121.137 0.494 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.482 HD12 ' H ' ' A' ' 170' ' ' ILE . 1.3 mp -76.13 -51.85 19.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.92 -179.282 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.735 HD23 ' N ' ' A' ' 172' ' ' ASP . 0.0 OUTLIER -64.75 -53.13 52.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.981 0.42 . . . . 0.0 110.002 -179.756 . . . . . . . . 3 3 . 1 . 088 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.735 ' N ' HD23 ' A' ' 171' ' ' LEU . 1.1 t70 -74.84 4.73 5.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.384 179.053 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.829 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -70.44 -60.57 2.19 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.694 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -109.36 -17.18 10.2 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 178.085 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 29.7 t80 72.33 -12.39 0.72 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.565 0.346 . . . . 0.0 111.316 -179.777 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.419 ' CD2' ' O ' ' A' ' 176' ' ' PHE . 76.4 t80 . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 120.937 0.399 . . . . 0.0 110.193 179.506 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.86 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.521 -0.16 0 CA-C-O 121.219 0.533 . . . . 0.0 111.248 . . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.612 HG23 HG22 ' A' ' 169' ' ' ILE . 0.6 OUTLIER -74.54 -43.67 48.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.361 -177.95 . . . . . . . . 3 3 . 1 . 089 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.35 -56.55 12.01 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.227 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.7 4.41 7.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.4 179.023 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.86 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.16 -75.34 0.13 Allowed 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.796 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -95.12 -13.03 54.11 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 177.924 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 69.76 -59.59 0.5 Allowed 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 120.862 0.363 . . . . 0.0 110.955 179.875 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 19.0 p90 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.194 179.708 . . . . . . . . 0 0 . 1 . 090 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.948 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.703 0.287 . . . . 0.0 111.313 . . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 6.0 mm -80.84 -44.09 21.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.61 -179.869 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.38 -57.85 8.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.159 0.504 . . . . 0.0 109.792 179.95 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.9 2.81 7.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.066 178.74 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.948 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.02 -54.79 8.8 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.432 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -126.39 -10.64 4.04 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.928 178.692 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.422 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 2.6 t80 68.55 -52.67 0.56 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.62 0.368 . . . . 0.0 111.708 179.59 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 50.2 p90 . . . . . 0 C--N 1.329 -0.292 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.403 . . . . . . . . 0 0 . 1 . 091 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.699 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.4 OUTLIER . . . . . 0 CA--C 1.528 0.117 0 CA-C-O 120.788 0.328 . . . . 0.0 111.227 . . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.447 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.6 mp -72.65 -39.56 60.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.367 -179.633 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.442 ' O ' HD23 ' A' ' 171' ' ' LEU . 4.0 tt -68.82 -2.51 9.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.684 179.922 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -148.14 15.96 1.05 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.064 179.902 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -81.46 -46.42 14.58 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.015 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.588 ' O ' ' CG ' ' A' ' 175' ' ' TYR . . . -141.61 0.52 1.69 Allowed Glycine 0 CA--C 1.522 0.531 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.818 179.229 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.588 ' CG ' ' O ' ' A' ' 174' ' ' GLY . 45.2 p90 56.61 -52.72 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.904 0.881 . . . . 0.0 113.02 179.926 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.562 ' N ' ' O ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.511 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.312 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.906 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 1.2 tp . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.815 0.34 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.455 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.5 mp -72.45 -42.71 64.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.312 -179.684 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.7 tt -65.02 -56.21 14.43 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.443 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.1 1.0 14.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.118 178.711 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.906 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.95 -57.66 3.89 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.201 0.524 . . . . 0.0 109.833 179.723 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -119.98 -3.45 12.05 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.878 178.983 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.457 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 92.6 t80 71.03 -43.51 0.56 Allowed 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.587 0.355 . . . . 0.0 111.719 -179.964 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.168 0 CA-C-O 120.791 0.329 . . . . 0.0 111.01 179.937 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.802 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.46 0.054 0 CA-C-O 121.113 0.482 . . . . 0.0 111.134 . . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 3.4 mp -69.07 -38.71 78.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.618 -179.004 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.6 mp -65.17 -60.09 3.38 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.258 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -74.36 3.31 7.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.263 178.55 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.802 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.15 -59.31 2.84 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.973 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -104.52 -20.4 10.22 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 178.309 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 36.7 t80 72.91 -11.64 0.85 Allowed 'General case' 0 C--O 1.232 0.157 0 C-N-CA 122.704 0.402 . . . . 0.0 111.845 179.83 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 23.3 p90 . . . . . 0 C--N 1.33 -0.264 0 CA-C-O 120.821 0.343 . . . . 0.0 110.495 179.348 . . . . . . . . 0 0 . 1 . 094 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.929 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER . . . . . 0 CA--C 1.522 -0.119 0 CA-C-O 121.283 0.563 . . . . 0.0 110.853 . . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.532 HG23 HG23 ' A' ' 169' ' ' ILE . 0.7 OUTLIER -79.36 -45.34 23.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 114.92 -1.036 . . . . 0.0 112.074 -178.798 . . . . . . . . 3 3 . 1 . 094 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.437 HD23 HG13 ' A' ' 170' ' ' ILE . 13.2 mt -66.93 -55.69 13.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.089 0.471 . . . . 0.0 109.891 179.532 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.05 5.84 4.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.276 179.032 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.929 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.32 -47.75 40.04 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.26 0.552 . . . . 0.0 109.712 179.639 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.51 ' C ' ' CG ' ' A' ' 175' ' ' TYR . . . -120.75 -1.59 11.8 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.841 178.841 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.51 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER 57.25 -50.07 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.963 0.905 . . . . 0.0 113.088 179.732 . . . . . . . . 3 3 . 1 . 094 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.49 ' N ' ' O ' ' A' ' 174' ' ' GLY . 26.6 p90 . . . . . 0 C--N 1.329 -0.284 0 O-C-N 122.217 -0.302 . . . . 0.0 111.152 -179.935 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.877 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 . . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.545 HD12 ' H ' ' A' ' 170' ' ' ILE . 4.0 mp -71.64 -39.69 69.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.673 -179.022 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.418 ' N ' ' CD2' ' A' ' 171' ' ' LEU . 2.0 mm? -64.54 -60.52 3.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.357 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -75.14 4.41 6.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.501 178.973 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.877 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.82 -69.66 0.38 Allowed 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.59 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -108.25 -16.41 12.31 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.091 178.211 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.427 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 53.1 t80 74.51 -15.78 0.6 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.868 0.467 . . . . 0.0 111.898 179.953 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 . . . . . 0 C--N 1.331 -0.215 0 CA-C-O 120.781 0.324 . . . . 0.0 111.02 -179.964 . . . . . . . . 0 0 . 1 . 096 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.946 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 5.7 tp . . . . . 0 C--O 1.226 -0.16 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 . . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.746 ' H ' HG23 ' A' ' 169' ' ' ILE . 1.9 mp -73.35 -39.98 56.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.812 -179.015 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 4.7 tp -64.13 -60.89 2.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.274 0.559 . . . . 0.0 109.762 179.754 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -74.12 -0.0 15.24 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.128 179.014 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.946 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -70.11 -71.0 0.26 Allowed 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.203 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -125.87 -8.48 5.16 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.119 177.815 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 12.9 t80 70.59 -55.66 0.62 Allowed 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.605 0.362 . . . . 0.0 111.851 179.558 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.531 0.227 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.187 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.839 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 . . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.46 HG12 ' H ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -69.92 -39.41 77.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.65 -176.899 . . . . . . . . 3 3 . 1 . 097 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.46 ' H ' HG12 ' A' ' 170' ' ' ILE . 46.5 mt -66.08 -55.79 14.76 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.798 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.34 0.4 19.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.307 178.5 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.839 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.22 -75.35 0.14 Allowed 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.777 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -86.5 -17.5 60.25 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 178.334 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 12.0 t80 68.99 -57.21 0.52 Allowed 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 122.607 0.363 . . . . 0.0 111.112 179.872 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.435 ' CD1' ' C ' ' A' ' 176' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.12 179.803 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.878 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 1.1 tp . . . . . 0 N--CA 1.462 0.173 0 CA-C-O 120.89 0.376 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.609 HG13 HG22 ' A' ' 169' ' ' ILE . 0.8 OUTLIER -81.27 -32.29 12.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.757 -179.622 . . . . . . . . 3 3 . 1 . 098 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.586 ' H ' HD12 ' A' ' 170' ' ' ILE . 2.1 tm? -66.75 -62.46 1.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.939 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -76.4 7.84 4.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.135 178.613 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.878 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.08 -60.1 2.42 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.679 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.429 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -102.24 -17.09 21.19 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 177.884 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.429 ' HB2' ' O ' ' A' ' 174' ' ' GLY . 2.0 m-85 69.7 -12.27 0.47 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.827 0.451 . . . . 0.0 111.846 179.913 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.429 ' H ' ' C ' ' A' ' 174' ' ' GLY . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.237 0 CA-C-O 120.892 0.377 . . . . 0.0 110.186 179.196 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.852 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER . . . . . 0 CA--C 1.521 -0.145 0 CA-C-O 121.257 0.551 . . . . 0.0 111.326 . . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.498 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 0.7 OUTLIER -73.95 -46.67 45.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.422 -178.076 . . . . . . . . 3 3 . 1 . 099 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 41.0 tp -66.91 -49.26 66.13 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.726 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -73.25 -5.33 38.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.6 178.357 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.852 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.2 -70.45 0.36 Allowed 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.607 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -117.24 -15.77 6.42 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.78 178.902 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 23.4 t80 77.52 -37.16 0.24 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 122.501 0.32 . . . . 0.0 111.638 -179.923 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 11.3 p90 . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 120.849 0.357 . . . . 0.0 110.978 -179.975 . . . . . . . . 0 0 . 1 . 100 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.798 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--O 1.227 -0.128 0 CA-C-O 121.207 0.527 . . . . 0.0 110.971 . . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.547 HD13 HG23 ' A' ' 169' ' ' ILE . 20.4 mm -68.54 -48.09 73.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.586 -178.898 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.6 mt -65.25 -48.2 74.08 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.224 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -76.11 -5.16 45.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.844 178.609 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.798 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.97 -70.19 0.4 Allowed 'General case' 0 CA--C 1.522 -0.134 0 CA-C-O 121.205 0.526 . . . . 0.0 109.788 179.849 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -121.06 -20.64 3.33 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.027 178.637 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 9.9 t80 75.6 -12.44 0.98 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.053 0.541 . . . . 0.0 111.971 179.659 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 52.1 t80 . . . . . 0 C--N 1.331 -0.233 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.794 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.807 0.337 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.552 ' O ' HD12 ' A' ' 156' ' ' LEU . 2.0 pp -165.35 98.79 0.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.937 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.09 -31.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.599 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.5 t -73.41 60.98 0.65 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.062 0.458 . . . . 0.0 110.702 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.455 ' O ' HG12 ' A' ' 160' ' ' VAL . 0.3 OUTLIER 73.48 -59.47 0.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.829 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 87.73 -44.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.357 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -68.66 -29.06 67.45 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.074 0.464 . . . . 0.0 110.663 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -67.59 -61.12 2.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.665 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 19.4 mt -66.58 -4.63 9.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.106 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.415 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER -76.71 -70.91 0.43 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.198 -179.237 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.52 -56.81 11.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.907 0.384 . . . . 0.0 110.863 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.558 HD23 ' HD2' ' A' ' 167' ' ' PRO . 0.0 OUTLIER -160.98 147.89 11.86 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.889 -179.635 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.611 ' HB2' HD13 ' A' ' 169' ' ' ILE . 33.0 Cg_endo -64.52 116.03 3.54 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.567 2.178 . . . . 0.0 112.324 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.62 ' HA ' HD21 ' A' ' 171' ' ' LEU . 89.5 Cg_endo -80.98 39.9 0.92 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.864 2.376 . . . . 0.0 112.963 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.701 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 2.6 mp -79.13 -71.24 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.947 0.403 . . . . 0.0 111.816 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.516 ' O ' ' HG3' ' A' ' 178' ' ' PRO . 4.5 mp -75.46 -55.17 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.709 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.62 HD21 ' HA ' ' A' ' 168' ' ' PRO . 2.6 pt? -60.04 -51.47 69.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.028 0.442 . . . . 0.0 110.449 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.57 ' N ' ' HG ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -76.23 5.5 6.85 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.288 178.898 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.75 -71.1 0.29 Allowed 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -108.24 -3.76 33.29 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 1.5 t80 69.74 -61.9 0.43 Allowed 'General case' 0 C--O 1.231 0.113 0 CA-C-O 121.028 0.442 . . . . 0.0 110.348 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -101.95 -26.88 13.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.333 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.533 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 22.0 mt -60.85 -42.69 88.55 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.589 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 76.5 Cg_exo -51.78 -29.86 35.73 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.543 2.162 . . . . 0.0 112.784 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.12 -11.42 60.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 0.0 111.278 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.83 57.76 1.04 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.279 0.561 . . . . 0.0 109.523 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 121.213 0.53 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.475 HD13 ' O ' ' A' ' 156' ' ' LEU . 0.2 OUTLIER -74.3 62.38 0.95 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.386 -179.548 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 20.3 tp60 -168.97 46.84 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.147 0.499 . . . . 0.0 110.807 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.66 56.3 0.14 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.929 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.433 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.9 OUTLIER 78.88 -51.54 0.45 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.153 -179.475 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.433 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 68.7 t 71.14 -54.06 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 120.873 0.368 . . . . 0.0 111.112 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.43 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 5.3 m-85 -73.06 4.92 3.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.223 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.43 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 81.2 m-85 -160.93 11.88 0.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.01 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.691 HD23 ' O ' ' A' ' 163' ' ' LEU . 3.8 tt -66.6 -26.11 66.94 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.417 ' HA ' ' HG2' ' A' ' 167' ' ' PRO . 4.3 t80 69.76 17.56 7.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.941 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.595 HD12 HD13 ' A' ' 163' ' ' LEU . 0.2 OUTLIER -64.34 -55.3 22.15 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.283 0.563 . . . . 0.0 109.78 178.825 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.706 ' N ' ' HD3' ' A' ' 167' ' ' PRO . 0.3 OUTLIER -158.1 41.81 0.12 Allowed Pre-proline 0 N--CA 1.447 -0.601 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.767 -179.29 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.706 ' HD3' ' N ' ' A' ' 166' ' ' LEU . 15.1 Cg_exo -64.49 -52.87 1.23 Allowed 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 121.76 1.64 . . . . 0.0 113.003 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.474 ' HD3' ' HB2' ' A' ' 167' ' ' PRO . 38.0 Cg_endo -92.22 72.24 0.65 Allowed 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.636 2.224 . . . . 0.0 112.639 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.779 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 3.5 tt -73.91 -41.0 53.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.123 0.487 . . . . 0.0 110.315 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.908 ' O ' HD12 ' A' ' 177' ' ' LEU . 2.0 mp -74.1 -45.7 47.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.788 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.432 HD22 ' N ' ' A' ' 171' ' ' LEU . 3.5 mm? -64.41 -53.12 53.38 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -74.77 1.05 13.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.921 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.779 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.82 -53.44 11.47 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.143 0.497 . . . . 0.0 109.69 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -105.63 -18.48 11.67 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.294 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.45 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 13.0 t80 76.02 -25.73 0.2 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.882 0.473 . . . . 0.0 112.04 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -97.69 14.41 26.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.648 0.261 . . . . 0.0 111.209 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.908 HD12 ' O ' ' A' ' 170' ' ' ILE . 11.4 mt -81.35 -46.94 1.1 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.248 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 71.6 Cg_exo -48.75 90.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.496 2.131 . . . . 0.0 112.706 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.7 -67.51 0.99 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.447 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -87.81 22.36 2.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.5 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.2 t80 . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.83 0.348 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.587 ' HB2' HG23 ' A' ' 160' ' ' VAL . 4.1 pp -73.26 176.12 6.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.504 ' N ' HD12 ' A' ' 156' ' ' LEU . 0.1 OUTLIER -170.53 -55.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.129 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.66 ' HB3' HD13 ' A' ' 163' ' ' LEU . 3.4 t -75.69 59.68 1.2 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.959 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.457 ' O ' HG12 ' A' ' 160' ' ' VAL . 0.3 OUTLIER 72.74 -47.0 0.66 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.655 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.587 HG23 ' HB2' ' A' ' 156' ' ' LEU . 0.4 OUTLIER 90.17 -52.52 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 122.873 0.469 . . . . 0.0 111.07 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.495 ' CE1' ' CD2' ' A' ' 162' ' ' PHE . 0.1 OUTLIER -78.53 32.99 0.2 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.812 0.339 . . . . 0.0 111.215 179.338 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.495 ' CD2' ' CE1' ' A' ' 161' ' ' PHE . 2.6 m-85 -169.41 -14.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.509 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.66 HD13 ' HB3' ' A' ' 158' ' ' SER . 16.1 tp -61.15 -34.79 75.57 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.466 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 1.4 t80 47.07 38.94 7.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.361 178.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.466 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.1 OUTLIER 86.57 -30.79 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.99 -179.501 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.413 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 0.0 OUTLIER -161.47 136.25 5.39 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.892 -179.024 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.655 ' HD3' HD11 ' A' ' 163' ' ' LEU . 88.4 Cg_endo -89.89 103.49 0.33 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.328 2.019 . . . . 0.0 113.271 -178.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.475 ' HB2' ' HB2' ' A' ' 171' ' ' LEU . 61.5 Cg_endo -70.69 80.31 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.608 2.205 . . . . 0.0 111.719 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.978 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -71.06 -32.97 49.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.951 0.405 . . . . 0.0 110.715 -179.679 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.422 ' O ' ' HG2' ' A' ' 178' ' ' PRO . 3.7 mp -80.61 -50.84 16.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.245 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 168' ' ' PRO . 7.3 mp -65.26 -50.93 63.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.277 0.561 . . . . 0.0 109.949 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 2.3 t70 -74.0 -4.42 35.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.032 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.978 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.67 -70.36 0.33 Allowed 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.645 ' H ' ' HG2' ' A' ' 178' ' ' PRO . . . -123.33 -27.73 1.44 Allowed Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.51 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 15.6 t80 79.15 -20.14 0.4 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.443 0.697 . . . . 0.0 112.149 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -94.83 46.52 1.13 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.368 0.604 . . . . 0.0 109.466 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.55 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 2.6 mt 59.13 50.18 2.95 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.156 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.645 ' HG2' ' H ' ' A' ' 174' ' ' GLY . 49.4 Cg_exo -42.68 -27.64 0.89 Allowed 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.286 2.658 . . . . 0.0 113.273 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 179' ' ' LEU . 1.8 tp -59.08 -52.24 66.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.357 . . . . 0.0 110.872 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.506 ' HD2' ' N ' ' A' ' 180' ' ' ARG . 0.1 OUTLIER -90.27 24.8 2.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.973 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 181' ' ' HSL . . . . . 0.578 ' HG2' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.565 ' O ' HD12 ' A' ' 156' ' ' LEU . 11.6 p90 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.793 0.33 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.565 HD12 ' O ' ' A' ' 155' ' ' PHE . 1.6 mp -164.35 -76.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.842 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 80.92 -5.67 1.67 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.803 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.9 p 76.38 -47.18 0.54 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.64 ' C ' HG13 ' A' ' 160' ' ' VAL . 7.5 m-20 -75.22 -33.8 61.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.52 0.2 . . . . 0.0 111.341 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.64 HG13 ' C ' ' A' ' 159' ' ' ASP . 2.0 m 66.94 -50.6 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 122.722 0.409 . . . . 0.0 112.088 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.405 ' HA ' ' HB2' ' A' ' 164' ' ' PHE . 12.2 t80 -63.6 -22.86 67.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.987 0.423 . . . . 0.0 110.132 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -70.38 -61.86 1.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.795 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.469 HD21 ' CD1' ' A' ' 155' ' ' PHE . 12.0 tp -65.41 -8.31 18.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.673 178.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.405 ' HB2' ' HA ' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -75.32 -71.74 0.35 Allowed 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.799 -179.407 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.1 -52.62 47.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.983 0.42 . . . . 0.0 110.866 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -160.79 110.93 1.3 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.544 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.458 ' HB3' ' CD1' ' A' ' 163' ' ' LEU . 60.0 Cg_endo -73.47 111.35 3.27 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.401 2.067 . . . . 0.0 113.155 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -77.22 63.6 7.77 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.672 2.248 . . . . 0.0 111.509 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.905 HG23 HD13 ' A' ' 170' ' ' ILE . 7.7 tt -74.71 -39.96 46.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.355 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.905 HD13 HG23 ' A' ' 169' ' ' ILE . 7.4 mm -69.19 -31.42 49.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.356 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.2 mp -70.71 -4.01 21.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.485 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -152.4 13.84 0.57 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.234 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -81.86 -38.58 25.21 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.481 ' HA3' HD21 ' A' ' 177' ' ' LEU . . . -130.57 -14.64 1.9 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 114.755 -1.112 . . . . 0.0 112.344 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 73.63 -45.88 0.62 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.651 0.225 . . . . 0.0 111.245 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.423 ' CZ ' ' HG ' ' A' ' 179' ' ' LEU . 55.4 t80 -93.34 -3.44 53.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.568 0.223 . . . . 0.0 111.141 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.516 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 11.6 mt -58.94 -45.06 99.61 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.102 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 16.6 Cg_exo -68.33 60.83 1.07 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.668 2.245 . . . . 0.0 112.217 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.423 ' HG ' ' CZ ' ' A' ' 176' ' ' PHE . 0.3 OUTLIER -108.65 -56.79 2.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.318 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.3 32.38 0.7 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.275 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.836 0.351 . . . . 0.0 111.26 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.3 pp -73.85 116.61 14.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.023 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.87 -39.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.212 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.839 ' OG ' HD11 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -74.34 62.8 0.99 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.334 0.588 . . . . 0.0 110.194 179.866 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 78.12 -62.18 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.716 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 82.01 -47.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.073 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.411 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 38.2 p90 -75.97 9.34 2.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.519 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -166.23 8.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.345 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.839 HD11 ' OG ' ' A' ' 158' ' ' SER . 0.3 OUTLIER -63.5 -37.28 86.7 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.325 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 59.42 -1.74 0.14 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.004 178.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.754 ' HB2' HD22 ' A' ' 163' ' ' LEU . 0.3 OUTLIER -70.89 -65.22 0.77 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.177 0.513 . . . . 0.0 110.535 179.452 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.7 mt -164.47 56.77 0.51 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.484 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.417 ' HA ' ' HD2' ' A' ' 168' ' ' PRO . 9.7 Cg_endo -51.28 105.82 0.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.537 2.158 . . . . 0.0 112.151 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 167' ' ' PRO . 74.4 Cg_endo -73.24 -1.46 10.62 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.758 2.305 . . . . 0.0 113.154 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.935 HG13 ' HB2' ' A' ' 173' ' ' ALA . 0.6 OUTLIER -72.72 -108.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 118.925 -0.56 . . . . 0.0 109.638 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.683 ' H ' HG23 ' A' ' 169' ' ' ILE . 2.9 mm 24.19 -64.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.457 0.703 . . . . 0.0 112.714 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.89 ' N ' ' O ' ' A' ' 169' ' ' ILE . 0.1 OUTLIER -67.95 -51.27 49.5 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.916 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 169' ' ' ILE . 1.0 OUTLIER -73.44 -15.7 61.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.546 179.286 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.935 ' HB2' HG13 ' A' ' 169' ' ' ILE . . . -78.14 -59.35 2.82 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.081 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -119.02 -21.85 3.69 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.864 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 70.9 -48.11 0.66 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.787 0.294 . . . . 0.0 111.192 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.0 12.74 20.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.747 0.308 . . . . 0.0 110.962 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.479 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 8.8 mt -70.92 -51.72 10.69 Favored Pre-proline 0 CA--C 1.528 0.116 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.361 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.479 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 73.8 Cg_exo -50.52 86.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.838 2.358 . . . . 0.0 112.317 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -93.81 -60.29 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.619 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -87.63 21.94 2.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.501 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.852 0.358 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 1.015 ' HA ' HG22 ' A' ' 160' ' ' VAL . 0.5 OUTLIER 58.39 30.75 20.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.973 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.471 ' H ' ' CD1' ' A' ' 163' ' ' LEU . 0.1 OUTLIER -73.71 -54.24 8.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.881 -179.224 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.417 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 25.7 t -163.46 38.61 0.09 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.083 0.468 . . . . 0.0 111.105 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 161' ' ' PHE . 1.3 m-20 -162.27 -57.01 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.2 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 1.015 HG22 ' HA ' ' A' ' 156' ' ' LEU . 21.5 t 63.46 -63.63 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.43 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.483 ' N ' ' O ' ' A' ' 159' ' ' ASP . 12.7 m-85 -79.02 4.61 13.94 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.854 -1.066 . . . . 0.0 112.187 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -168.94 12.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.507 -0.477 . . . . 0.0 112.096 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.565 ' CD2' ' HD3' ' A' ' 167' ' ' PRO . 4.5 tt -66.56 -38.54 87.32 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.488 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER 49.18 27.35 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.77 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.601 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.2 OUTLIER 90.05 -26.46 0.06 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.638 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 165' ' ' LEU . 0.5 OUTLIER -161.56 103.68 1.2 Allowed Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.402 -178.813 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.591 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 55.4 Cg_endo -71.72 -24.17 21.89 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.674 2.249 . . . . 0.0 115.161 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 22.4 Cg_endo -89.14 17.37 1.63 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.675 1.583 . . . . 0.0 113.385 -179.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.982 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.5 OUTLIER -76.52 -40.01 33.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.048 0.452 . . . . 0.0 111.058 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.676 ' O ' HD12 ' A' ' 177' ' ' LEU . 2.5 mp -83.75 -70.37 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.617 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.97 -48.4 71.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.89 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.425 ' HB2' ' CA ' ' A' ' 168' ' ' PRO . 0.3 OUTLIER -74.04 1.91 9.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.665 -179.69 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.982 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.92 -51.72 15.21 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.195 0.522 . . . . 0.0 109.612 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -118.54 -18.15 4.96 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.785 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 15.6 t80 78.1 -34.11 0.18 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 122.551 0.34 . . . . 0.0 111.881 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -95.5 18.29 13.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.752 0.311 . . . . 0.0 111.151 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.676 HD12 ' O ' ' A' ' 170' ' ' ILE . 11.0 mt -81.24 -45.67 1.15 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.927 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.519 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 51.2 Cg_exo -55.05 -156.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.662 2.241 . . . . 0.0 112.505 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.713 HD23 ' HD2' ' A' ' 180' ' ' ARG . 0.2 OUTLIER 76.7 70.65 0.07 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.13 0.49 . . . . 0.0 110.343 -179.643 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.713 ' HD2' HD23 ' A' ' 179' ' ' LEU . 0.0 OUTLIER 66.25 54.07 0.98 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.719 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.857 0.361 . . . . 0.0 111.324 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.614 ' CD2' HG23 ' A' ' 160' ' ' VAL . 0.5 OUTLIER -73.68 -179.85 3.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.771 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -169.65 -79.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.742 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 54.5 p -164.28 27.98 0.07 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.11 0.481 . . . . 0.0 110.665 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -159.64 -53.26 0.06 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.414 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.614 HG23 ' CD2' ' A' ' 156' ' ' LEU . 0.4 OUTLIER 83.97 -49.66 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.768 179.473 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.441 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 0.1 OUTLIER -69.22 -31.15 69.54 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.999 0.428 . . . . 0.0 111.11 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.07 -58.25 4.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.948 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 163' ' ' LEU . 14.0 mt -65.73 -5.34 8.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.737 178.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.413 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.1 OUTLIER -78.76 -50.06 11.99 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.849 -1.068 . . . . 0.0 111.185 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 8.2 mt -65.47 -51.05 62.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.356 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.757 HD23 ' HD2' ' A' ' 167' ' ' PRO . 3.7 mt -159.4 126.24 2.56 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.307 -178.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.757 ' HD2' HD23 ' A' ' 166' ' ' LEU . 1.9 Cg_endo -47.04 -42.82 25.69 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.837 2.358 . . . . 0.0 113.726 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.492 ' HD3' ' HG2' ' A' ' 167' ' ' PRO . 41.1 Cg_endo -87.25 63.63 4.12 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.225 1.95 . . . . 0.0 113.067 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.749 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -78.21 -35.12 19.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.294 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.451 HD12 ' H ' ' A' ' 170' ' ' ILE . 3.4 mp -70.12 -41.54 79.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.61 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 12.9 mt -67.03 -59.13 3.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.263 0.554 . . . . 0.0 109.709 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.93 10.03 1.64 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.462 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.749 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.74 -48.41 47.2 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.499 ' H ' ' CG ' ' A' ' 178' ' ' PRO . . . -117.88 -28.1 2.34 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 177.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 6.1 t80 74.56 -31.52 0.22 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.178 0.591 . . . . 0.0 112.003 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -90.14 50.25 1.83 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.44 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 2.5 mt 62.45 67.16 1.22 Allowed Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.859 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.499 ' CG ' ' H ' ' A' ' 174' ' ' GLY . 51.4 Cg_exo -58.98 -140.92 0.0 OUTLIER 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.498 2.798 . . . . 0.0 112.342 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.465 ' CB ' ' O ' ' A' ' 178' ' ' PRO . 0.1 OUTLIER 86.67 76.99 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.019 0.438 . . . . 0.0 110.545 -179.488 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 67.33 49.06 1.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.634 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.633 ' O ' HD12 ' A' ' 156' ' ' LEU . 12.7 t80 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.618 0.246 . . . . 0.0 111.246 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.633 HD12 ' O ' ' A' ' 155' ' ' PHE . 0.2 OUTLIER -166.39 -98.09 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.896 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 73.2 75.38 0.14 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.003 0.43 . . . . 0.0 110.465 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 18.2 p 60.86 56.71 2.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.489 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.46 -59.03 0.54 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.306 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 83.74 -51.54 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.904 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.461 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 13.9 t80 -76.4 39.99 0.21 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.932 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.435 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 18.3 m-85 -165.52 -24.11 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.451 ' HA ' HD12 ' A' ' 163' ' ' LEU . 8.3 tp -60.14 -38.94 84.6 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.479 ' C ' ' H ' ' A' ' 166' ' ' LEU . 1.8 t80 43.65 45.97 6.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.529 177.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.538 ' O ' HD12 ' A' ' 166' ' ' LEU . 31.0 mt 74.27 -25.13 0.2 Allowed 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 122.714 0.406 . . . . 0.0 111.438 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.538 HD12 ' O ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER -162.19 134.01 4.03 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.159 -177.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -44.89 109.54 0.18 Allowed 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.518 2.145 . . . . 0.0 112.316 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.16 79.24 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.573 2.182 . . . . 0.0 112.541 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.773 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 7.3 tp -74.22 -41.94 51.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.635 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.429 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 4.2 mt -69.38 -35.44 67.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.942 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.889 HD22 ' CG ' ' A' ' 178' ' ' PRO . 0.0 OUTLIER -65.69 -57.94 6.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.673 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.29 -2.79 26.61 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.729 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.773 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.57 -69.23 0.44 Allowed 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 121.158 0.504 . . . . 0.0 109.944 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -113.35 -15.14 9.15 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.871 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 5.8 t80 77.63 -41.7 0.36 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -94.94 -15.55 23.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.656 0.265 . . . . 0.0 111.363 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.502 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 95.6 mt -56.28 -44.31 99.66 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.723 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.889 ' CG ' HD22 ' A' ' 171' ' ' LEU . 76.3 Cg_exo -49.3 -65.53 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.231 1.954 . . . . 0.0 112.466 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.8 mt 60.6 58.78 2.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.136 0.494 . . . . 0.0 110.363 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 21.3 mmt85 65.34 53.15 1.32 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.458 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' HSL . . . . . 0.448 ' HG2' ' HB3' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.437 ' O ' ' HB2' ' A' ' 156' ' ' LEU . 1.3 m-85 . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.823 0.344 . . . . 0.0 111.773 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.538 ' O ' ' CB ' ' A' ' 157' ' ' GLN . 0.3 OUTLIER 65.29 -74.71 0.05 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.675 179.099 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.538 ' CB ' ' O ' ' A' ' 156' ' ' LEU . 6.3 tt0 96.0 -32.54 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 123.148 0.579 . . . . 0.0 109.733 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 12.6 t -81.04 64.24 5.72 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.177 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.659 ' O ' HG13 ' A' ' 160' ' ' VAL . 0.3 OUTLIER 79.64 -46.13 0.34 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.67 -179.119 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 159' ' ' ASP . 2.0 m 67.12 -53.1 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 122.928 0.491 . . . . 0.0 111.909 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.435 ' CD1' HG22 ' A' ' 160' ' ' VAL . 6.2 m-85 -60.78 -26.74 67.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.211 0.529 . . . . 0.0 109.736 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.432 ' HB2' ' HB3' ' A' ' 159' ' ' ASP . 0.3 OUTLIER -71.86 -64.56 0.91 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.521 178.634 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.505 HD23 HD11 ' A' ' 156' ' ' LEU . 3.8 tp -67.97 -4.58 13.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.675 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.477 ' CB ' ' O ' ' A' ' 160' ' ' VAL . 1.0 OUTLIER -74.1 -26.53 60.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.892 -179.124 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.05 -52.94 57.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.914 0.388 . . . . 0.0 110.588 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -161.59 88.87 1.54 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.342 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -65.2 109.82 1.42 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.605 2.203 . . . . 0.0 112.992 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.88 64.72 5.95 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.643 2.229 . . . . 0.0 111.878 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.848 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -74.07 -38.72 49.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.508 -179.377 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.738 ' O ' HD12 ' A' ' 177' ' ' LEU . 3.4 mp -70.1 -41.99 79.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.578 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 27.9 mt -65.72 -56.65 10.93 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.11 2.26 11.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.231 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.848 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.35 -62.0 1.59 Allowed 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.191 0.519 . . . . 0.0 109.884 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -112.49 -11.85 14.34 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.616 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.493 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 24.5 t80 71.78 -29.96 0.2 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.732 0.413 . . . . 0.0 111.751 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.439 ' H ' ' C ' ' A' ' 174' ' ' GLY . 8.3 t80 -95.59 -12.22 26.01 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.681 0.277 . . . . 0.0 111.238 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.738 HD12 ' O ' ' A' ' 170' ' ' ILE . 94.2 mt -55.17 -43.98 99.37 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.531 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 99.9 Cg_exo -44.6 93.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.506 2.137 . . . . 0.0 112.741 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.425 HD13 ' O ' ' A' ' 177' ' ' LEU . 4.6 mp -82.94 -68.67 0.69 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.614 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.87 20.59 3.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.729 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.685 ' HB3' HG21 ' A' ' 160' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.814 0.34 . . . . 0.0 111.422 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.5 pp -166.24 117.78 1.02 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.789 ' O ' HD12 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -172.08 89.69 0.11 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.679 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 157' ' ' GLN . 9.3 t 78.07 -53.66 0.5 Allowed 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.399 0.619 . . . . 0.0 111.636 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -165.49 -33.13 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.277 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.685 HG21 ' HB3' ' A' ' 155' ' ' PHE . 0.5 OUTLIER 80.63 -52.7 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.578 -179.412 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.47 ' N ' HG12 ' A' ' 160' ' ' VAL . 2.8 m-30 -76.12 38.39 0.17 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.561 178.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.45 ' C ' ' H ' ' A' ' 164' ' ' PHE . 0.4 OUTLIER -165.44 -48.61 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.142 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.789 HD12 ' O ' ' A' ' 157' ' ' GLN . 8.8 mt -67.29 -3.07 6.99 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.45 ' H ' ' C ' ' A' ' 162' ' ' PHE . 7.9 t80 -72.85 -34.48 66.8 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.502 -1.227 . . . . 0.0 110.649 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.5 tp -177.06 -52.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.164 0.507 . . . . 0.0 110.643 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 167' ' ' PRO . 0.2 OUTLIER -162.11 145.39 9.07 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.431 -179.072 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.489 ' N ' HD12 ' A' ' 166' ' ' LEU . 42.3 Cg_endo -68.0 110.37 2.16 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.164 1.909 . . . . 0.0 111.874 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.45 55.79 2.08 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.43 2.086 . . . . 0.0 112.913 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.546 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 9.2 tp -77.28 -43.19 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.404 0.621 . . . . 0.0 110.303 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.452 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.1 mp -74.83 -46.7 40.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.157 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.3 mt -65.4 -55.64 16.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.065 0.46 . . . . 0.0 110.223 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.421 ' OD1' ' CZ ' ' A' ' 175' ' ' TYR . 0.9 OUTLIER -76.07 14.46 0.7 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.399 179.209 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.04 -59.37 2.74 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 175' ' ' TYR . . . -113.35 -2.96 24.45 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 177.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.421 ' CZ ' ' OD1' ' A' ' 172' ' ' ASP . 6.2 m-85 68.69 -61.6 0.41 Allowed 'General case' 0 C--N 1.338 0.105 0 C-N-CA 123.029 0.532 . . . . 0.0 110.79 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -106.52 -8.12 17.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.15 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.462 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 8.8 mt -81.5 -46.72 1.08 Allowed Pre-proline 0 CA--C 1.53 0.185 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 10.4 Cg_endo -90.32 22.04 0.81 Allowed 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.07 2.513 . . . . 0.0 112.855 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 29.7 tp -60.12 -53.66 55.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.37 . . . . 0.0 110.625 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -88.24 43.89 1.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.945 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.769 0.319 . . . . 0.0 111.8 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.2 mt 62.59 34.23 15.22 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.984 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 76.89 74.87 0.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.768 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 9.5 t 60.1 49.26 7.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.829 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.421 ' O ' ' CB ' ' A' ' 160' ' ' VAL . 0.3 OUTLIER 73.86 -54.66 0.68 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.015 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.431 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 87.84 -49.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.197 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.431 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 3.9 m-85 -68.69 -31.81 71.18 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.048 0.451 . . . . 0.0 110.523 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.643 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 0.4 OUTLIER -67.37 -58.92 3.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.539 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.713 HD21 ' HG3' ' A' ' 168' ' ' PRO . 0.5 OUTLIER -66.78 -1.46 3.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.211 178.867 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.436 ' H ' ' C ' ' A' ' 162' ' ' PHE . 1.1 t80 -74.37 -14.5 60.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.137 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 162' ' ' PHE . 0.3 OUTLIER -62.72 -31.98 73.01 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.345 0.593 . . . . 0.0 109.862 179.135 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.645 HD23 ' O ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -159.92 97.12 1.53 Allowed Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.768 -178.746 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.476 ' HD2' ' HA ' ' A' ' 166' ' ' LEU . 6.8 Cg_endo -50.14 119.36 4.83 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.586 2.191 . . . . 0.0 112.316 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.713 ' HG3' HD21 ' A' ' 163' ' ' LEU . 91.5 Cg_endo -79.14 -151.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.806 2.338 . . . . 0.0 112.13 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.847 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.7 OUTLIER -161.03 -45.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.095 0.474 . . . . 0.0 110.234 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.523 ' O ' HD12 ' A' ' 177' ' ' LEU . 3.2 mp -75.35 -38.37 40.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.296 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 63.8 mt -67.18 -57.93 5.8 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.2 4.81 6.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.118 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.847 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.94 -45.8 59.84 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.257 0.551 . . . . 0.0 109.772 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.538 ' C ' ' CG ' ' A' ' 175' ' ' TYR . . . -122.03 -0.02 10.7 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.775 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.538 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER 59.23 -32.91 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 179.416 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.471 ' H ' ' C ' ' A' ' 174' ' ' GLY . 22.5 t80 -93.01 -16.96 24.46 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.098 -0.376 . . . . 0.0 111.102 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.543 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 17.0 mt -57.57 -42.86 97.88 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.362 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 64.7 Cg_exo -51.94 83.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.722 2.281 . . . . 0.0 112.793 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 179' ' ' LEU . 19.9 mt -92.06 -64.45 1.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.939 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.77 41.35 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.908 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.777 0.322 . . . . 0.0 111.25 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.417 ' O ' ' CB ' ' A' ' 157' ' ' GLN . 0.5 OUTLIER -166.21 -163.11 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.056 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.438 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . 0.0 OUTLIER 82.7 60.1 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.165 0.507 . . . . 0.0 110.97 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.423 ' CB ' ' CD1' ' A' ' 163' ' ' LEU . 1.5 m 61.55 45.75 7.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.71 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.484 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.2 OUTLIER 76.5 -53.62 0.59 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.964 179.682 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 45.4 t 70.63 -54.2 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.856 0.36 . . . . 0.0 111.322 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.96 4.3 4.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.625 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -163.5 14.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.973 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.886 ' CD2' HD23 ' A' ' 165' ' ' LEU . 2.0 tt -67.66 -31.87 72.16 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 13.1 t80 66.95 8.8 6.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.388 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.886 HD23 ' CD2' ' A' ' 163' ' ' LEU . 0.3 OUTLIER -66.05 -61.94 1.76 Allowed 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.23 0.538 . . . . 0.0 110.302 179.183 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.933 ' O ' HD22 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -161.11 39.85 0.06 OUTLIER Pre-proline 0 N--CA 1.446 -0.658 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.195 -178.525 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 8.5 Cg_endo -50.44 101.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.402 2.068 . . . . 0.0 112.741 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.793 ' O ' HD12 ' A' ' 170' ' ' ILE . 95.6 Cg_endo -74.21 -97.36 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.841 2.36 . . . . 0.0 112.329 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.943 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER 82.38 -39.02 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 122.641 0.377 . . . . 0.0 111.274 -179.786 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.793 HD12 ' O ' ' A' ' 168' ' ' PRO . 1.8 mp -87.69 -67.85 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.091 0.472 . . . . 0.0 110.997 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.747 HD23 ' N ' ' A' ' 172' ' ' ASP . 0.0 OUTLIER -68.06 -41.1 82.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.165 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.747 ' N ' HD23 ' A' ' 171' ' ' LEU . 44.5 t0 -72.53 -8.62 56.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.716 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.943 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -75.48 -64.37 1.08 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.196 0.522 . . . . 0.0 109.997 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -125.31 -17.64 2.65 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.157 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 77.66 -20.39 0.38 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 122.491 0.316 . . . . 0.0 111.675 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -98.23 21.42 10.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.964 0.411 . . . . 0.0 110.559 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.508 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 3.3 mm? -84.67 -48.1 0.65 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.017 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.508 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 27.4 Cg_exo -63.59 69.56 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.758 2.305 . . . . 0.0 112.345 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 177' ' ' LEU . 0.2 OUTLIER -88.86 -67.76 0.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.738 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -87.44 35.72 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.64 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 120.897 0.38 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.871 ' HB2' HG21 ' A' ' 160' ' ' VAL . 4.1 pp -165.82 124.77 1.63 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.995 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -170.61 -37.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.162 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.63 ' O ' HD13 ' A' ' 163' ' ' LEU . 23.5 m -74.0 63.26 0.93 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.078 0.466 . . . . 0.0 110.153 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 158' ' ' SER . 0.3 OUTLIER 76.11 -62.84 0.41 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.414 -179.313 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.871 HG21 ' HB2' ' A' ' 156' ' ' LEU . 53.9 t 67.85 -46.81 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.151 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -71.13 -6.3 38.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.426 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -165.45 17.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.684 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.834 HD11 ' HD2' ' A' ' 168' ' ' PRO . 15.2 tp -68.15 -7.17 27.64 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 177.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -75.57 -23.84 56.58 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.17 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.1 tp -63.6 -51.08 66.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.966 0.413 . . . . 0.0 110.819 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.24 82.69 1.93 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.313 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -62.56 111.2 1.26 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.36 2.04 . . . . 0.0 112.533 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.834 ' HD2' HD11 ' A' ' 163' ' ' LEU . 95.7 Cg_endo -80.52 40.43 0.98 Allowed 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.977 2.451 . . . . 0.0 112.905 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.838 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.2 OUTLIER -77.03 -41.11 31.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.051 0.453 . . . . 0.0 111.336 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.824 ' O ' HD22 ' A' ' 177' ' ' LEU . 2.3 mp -73.81 -54.32 15.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.947 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.755 HD12 ' N ' ' A' ' 172' ' ' ASP . 3.4 pp -62.76 -50.17 72.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.122 0.487 . . . . 0.0 109.815 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.755 ' N ' HD12 ' A' ' 171' ' ' LEU . 7.4 t0 -74.77 0.81 14.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.13 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.838 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.46 -70.05 0.37 Allowed 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -109.91 -23.07 6.31 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 7.6 t80 75.25 -22.92 0.25 Allowed 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 122.891 0.477 . . . . 0.0 111.942 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.4 23.01 6.28 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.824 HD22 ' O ' ' A' ' 170' ' ' ILE . 4.0 mp -84.66 -47.86 0.66 Allowed Pre-proline 0 N--CA 1.451 -0.382 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.032 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.575 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 94.2 Cg_exo -45.39 -50.97 8.49 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.623 2.215 . . . . 0.0 112.572 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 179' ' ' LEU . 20.9 mt 61.29 56.85 2.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.6 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 64.01 41.12 6.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.706 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 16.2 t80 . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.797 0.332 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 9.0 mt 64.83 108.38 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.946 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -169.98 83.23 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.113 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.581 ' O ' ' N ' ' A' ' 160' ' ' VAL . 2.4 t 52.0 72.56 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.595 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.41 ' CG ' ' C ' ' A' ' 158' ' ' SER . 0.0 OUTLIER 57.58 -52.3 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.368 0.667 . . . . 0.0 112.611 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' A' ' 158' ' ' SER . 0.5 OUTLIER 82.53 -53.45 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.564 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.448 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 1.6 m-30 -76.0 40.7 0.21 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.841 0.353 . . . . 0.0 110.463 178.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.477 ' CG ' ' HB3' ' A' ' 167' ' ' PRO . 2.9 t80 -168.23 -57.42 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.042 0.448 . . . . 0.0 110.726 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 42.8 tp -66.45 -4.86 9.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.409 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.55 ' CG ' ' O ' ' A' ' 164' ' ' PHE . 55.0 t80 -79.21 43.66 0.54 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.361 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.415 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 1.1 tp 81.22 -40.07 0.14 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -161.05 132.13 3.83 Favored Pre-proline 0 C--N 1.329 -0.314 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.391 -178.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.477 ' HB3' ' CG ' ' A' ' 162' ' ' PHE . 90.3 Cg_endo -88.93 105.55 0.42 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.751 2.301 . . . . 0.0 112.71 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 167' ' ' PRO . 56.5 Cg_endo -68.84 61.63 1.26 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.583 2.189 . . . . 0.0 112.038 179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.877 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 8.6 pt -76.54 -35.23 25.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.754 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 7.2 mt -74.79 -49.8 28.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.493 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.649 ' H ' HD22 ' A' ' 171' ' ' LEU . 0.8 OUTLIER -65.21 -52.68 53.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.62 2.62 9.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.489 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.877 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.16 -68.32 0.47 Allowed 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 121.211 0.529 . . . . 0.0 109.666 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -110.89 -12.95 14.78 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.343 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 4.7 t80 77.44 -12.28 1.09 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.702 0.401 . . . . 0.0 111.829 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -98.18 -9.57 25.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.882 0.372 . . . . 0.0 110.679 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.546 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 2.2 mm? -57.24 -41.77 92.71 Favored Pre-proline 0 CA--C 1.53 0.173 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.817 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 50.1 Cg_exo -53.85 -151.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.541 2.161 . . . . 0.0 112.448 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 178' ' ' PRO . 3.8 mm? 72.1 68.79 0.14 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.105 0.478 . . . . 0.0 110.423 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 67.42 53.69 0.73 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.815 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.84 0.352 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.408 ' O ' ' CB ' ' A' ' 157' ' ' GLN . 19.1 mt -74.79 61.79 1.03 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.366 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' A' ' 156' ' ' LEU . 4.1 tt0 78.88 78.62 0.06 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.252 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.42 ' HG ' HD12 ' A' ' 163' ' ' LEU . 0.3 OUTLIER 51.63 58.96 4.93 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.668 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 71.65 -59.25 0.56 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.528 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 161' ' ' PHE . 0.6 OUTLIER 75.98 -51.43 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.236 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.495 ' N ' HG12 ' A' ' 160' ' ' VAL . 75.3 t80 -73.56 9.85 1.26 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.236 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.426 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 3.4 m-85 -167.84 5.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.857 HD22 ' HB2' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -67.96 -45.38 74.37 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.584 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 56.68 7.81 0.41 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.529 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.857 ' HB2' HD22 ' A' ' 163' ' ' LEU . 0.2 OUTLIER -70.32 -43.28 70.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.894 0.378 . . . . 0.0 110.728 179.767 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.615 HD22 ' O ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER -161.93 49.82 0.27 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.296 -179.333 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 2.9 Cg_exo -37.58 -51.13 1.76 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 123.266 2.644 . . . . 0.0 113.348 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.432 ' HD3' ' CB ' ' A' ' 167' ' ' PRO . 40.7 Cg_endo -90.78 42.62 0.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.657 2.238 . . . . 0.0 113.37 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.943 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.5 OUTLIER -78.56 -49.28 21.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.309 0.575 . . . . 0.0 110.543 179.384 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.701 HG23 HG22 ' A' ' 169' ' ' ILE . 0.8 OUTLIER -77.54 -43.26 30.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.739 -1.118 . . . . 0.0 111.926 -178.839 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 54.5 tp -63.66 -55.47 23.2 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -73.62 -4.59 35.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.62 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.943 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.88 -68.2 0.53 Allowed 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.323 0.582 . . . . 0.0 109.526 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -130.7 3.51 5.73 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.683 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 17.0 t80 71.12 -44.04 0.58 Allowed 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -97.62 9.86 41.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.682 0.277 . . . . 0.0 111.364 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.649 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 65.5 mt -84.96 -30.32 0.43 Allowed Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.649 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 84.3 Cg_exo -48.89 -12.54 0.22 Allowed 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.531 2.154 . . . . 0.0 113.836 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 33.9 mt -46.52 -36.17 6.47 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.129 0.49 . . . . 0.0 111.045 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.8 mtm180 -90.94 31.68 1.06 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.207 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 155' ' ' PHE . 6.3 m-85 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.833 0.349 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.703 ' O ' HD12 ' A' ' 156' ' ' LEU . 4.3 pp -164.72 21.32 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.52 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -75.17 -14.81 60.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.583 0.23 . . . . 0.0 111.2 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.892 ' HB2' HD13 ' A' ' 163' ' ' LEU . 2.6 p -75.33 58.84 1.0 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.924 0.392 . . . . 0.0 110.936 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.435 ' O ' HG12 ' A' ' 160' ' ' VAL . 0.1 OUTLIER 70.75 -61.08 0.48 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.023 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 83.33 -46.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.028 -179.765 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.658 ' CE1' HD13 ' A' ' 169' ' ' ILE . 60.6 m-85 -76.27 6.24 5.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.559 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -165.72 12.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.253 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.892 HD13 ' HB2' ' A' ' 158' ' ' SER . 65.1 tp -67.6 -36.06 80.15 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 28.8 t80 67.02 1.05 2.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.341 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.718 HD13 ' HG ' ' A' ' 163' ' ' LEU . 4.4 mp -66.18 -64.87 0.76 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.205 0.526 . . . . 0.0 109.85 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.55 ' O ' ' CD ' ' A' ' 168' ' ' PRO . 0.7 OUTLIER -164.88 58.97 0.63 Allowed Pre-proline 0 N--CA 1.443 -0.81 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.359 179.599 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.53 ' HD3' ' N ' ' A' ' 166' ' ' LEU . 94.2 Cg_endo -98.16 78.98 0.06 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.068 2.512 . . . . 0.0 113.184 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.55 ' CD ' ' O ' ' A' ' 166' ' ' LEU . 56.9 Cg_endo -64.6 45.15 0.14 Allowed 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 123.921 3.081 . . . . 0.0 113.2 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.959 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 1.3 tt -77.18 -46.21 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.724 0.297 . . . . 0.0 110.66 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.446 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.8 mp -77.8 -39.48 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.743 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.493 HD23 ' HA ' ' A' ' 168' ' ' PRO . 0.4 OUTLIER -63.91 -58.44 6.76 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.249 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -73.66 -3.43 28.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.745 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.959 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.85 -73.17 0.21 Allowed 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.351 0.596 . . . . 0.0 109.556 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -120.54 -8.34 8.41 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.624 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 20.4 t80 69.7 -46.73 0.59 Allowed 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 122.676 0.39 . . . . 0.0 111.549 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -94.32 16.21 15.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.772 0.32 . . . . 0.0 111.069 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.528 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 11.4 mt -79.49 -44.87 1.63 Allowed Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.936 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 51.7 Cg_exo -55.7 -155.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.756 2.304 . . . . 0.0 112.395 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.555 HD23 ' NE ' ' A' ' 180' ' ' ARG . 0.2 OUTLIER 80.98 73.74 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.018 0.437 . . . . 0.0 110.555 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.555 ' NE ' HD23 ' A' ' 179' ' ' LEU . 17.4 mtm180 66.31 49.37 1.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.824 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.797 0.332 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.786 ' HA ' HD11 ' A' ' 163' ' ' LEU . 3.9 pp -166.31 146.61 6.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.878 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.581 ' HB3' HD21 ' A' ' 163' ' ' LEU . 52.1 tp60 -165.79 18.67 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.801 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.471 ' HB3' ' N ' ' A' ' 163' ' ' LEU . 0.2 OUTLIER -169.87 32.83 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.809 0.338 . . . . 0.0 110.45 179.534 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.491 ' HB3' ' CD1' ' A' ' 161' ' ' PHE . 2.4 m-20 70.83 0.4 3.33 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.949 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.755 ' HA ' HD12 ' A' ' 163' ' ' LEU . 0.4 OUTLIER 80.77 -50.25 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.775 0.322 . . . . 0.0 110.949 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.491 ' CD1' ' HB3' ' A' ' 159' ' ' ASP . 0.1 OUTLIER -77.51 24.7 0.2 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.008 0.433 . . . . 0.0 110.571 178.791 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.455 ' H ' ' C ' ' A' ' 160' ' ' VAL . 1.9 m-85 -163.53 -3.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.074 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.786 HD11 ' HA ' ' A' ' 156' ' ' LEU . 3.2 mt -61.83 -23.85 66.51 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 5.4 t80 60.03 17.7 6.96 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.633 178.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.34 -44.28 79.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.928 0.394 . . . . 0.0 110.657 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.513 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 0.2 OUTLIER -161.48 53.71 0.48 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.927 -179.633 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.589 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 36.3 Cg_endo -67.33 -24.55 43.29 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.659 2.239 . . . . 0.0 114.841 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 28.9 Cg_endo -90.7 33.02 0.32 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.732 1.621 . . . . 0.0 113.478 -178.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.834 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -77.47 -35.63 22.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.171 0.51 . . . . 0.0 110.329 179.171 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.743 HD13 HG23 ' A' ' 169' ' ' ILE . 11.0 mm -73.2 -46.12 51.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.196 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.776 HD12 ' N ' ' A' ' 172' ' ' ASP . 3.4 pp -65.26 -49.88 67.92 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.776 ' N ' HD12 ' A' ' 171' ' ' LEU . 23.0 t0 -73.92 -5.34 40.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.472 178.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.834 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -74.32 -66.32 0.74 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.122 0.487 . . . . 0.0 110.147 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -119.47 -10.79 7.67 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.275 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.508 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 11.9 t80 79.36 -29.1 0.14 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 122.554 0.342 . . . . 0.0 111.914 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -97.95 4.65 49.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.699 0.285 . . . . 0.0 111.262 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.687 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 55.4 mt -86.84 -23.13 0.29 Allowed Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 96.8 Cg_exo -45.72 90.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.241 1.96 . . . . 0.0 113.07 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.477 ' HA ' HD22 ' A' ' 179' ' ' LEU . 0.4 OUTLIER -107.07 -65.63 1.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.692 179.195 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 180' ' ' ARG . 0.0 OUTLIER -88.38 37.2 0.81 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.829 178.866 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 6.5 p90 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 121.006 0.431 . . . . 0.0 111.344 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.407 ' HA ' ' CG2' ' A' ' 160' ' ' VAL . 34.0 mt -74.87 108.62 7.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.868 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -170.35 -55.08 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.494 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.58 58.94 0.81 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.841 0.353 . . . . 0.0 110.96 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.503 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.2 OUTLIER 72.99 -48.19 0.68 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.463 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.646 ' O ' ' HB2' ' A' ' 164' ' ' PHE . 60.5 t 77.57 -60.76 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.141 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.405 ' O ' ' HB3' ' A' ' 164' ' ' PHE . 3.5 m-85 -64.22 -23.02 67.16 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.391 0.615 . . . . 0.0 110.083 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.484 ' CE2' ' HB3' ' A' ' 167' ' ' PRO . 8.8 t80 -67.79 -60.59 2.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.727 178.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 32.1 tp -68.85 -7.06 31.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.488 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.646 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 10.9 t80 -78.49 -120.22 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.394 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.38 -48.82 71.59 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.936 0.398 . . . . 0.0 110.996 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 166' ' ' LEU . 0.2 OUTLIER -165.7 169.15 7.26 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.688 -179.254 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.484 ' HB3' ' CE2' ' A' ' 162' ' ' PHE . 88.7 Cg_endo -81.74 114.37 2.64 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.388 2.058 . . . . 0.0 112.401 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.996 ' HA ' HD21 ' A' ' 171' ' ' LEU . 57.7 Cg_endo -85.87 91.42 0.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.872 2.381 . . . . 0.0 112.74 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.821 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 19.9 tt -160.93 -45.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.627 0.727 . . . . 0.0 110.536 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.82 ' O ' HD12 ' A' ' 177' ' ' LEU . 0.9 OUTLIER -73.63 -35.04 43.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.33 -1.305 . . . . 0.0 111.994 -178.609 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.996 HD21 ' HA ' ' A' ' 168' ' ' PRO . 0.0 OUTLIER -62.56 -64.17 1.0 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.089 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -75.15 4.3 7.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.41 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.821 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.34 -64.56 0.89 Allowed 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -111.73 -18.49 7.9 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.162 178.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 77.76 -30.5 0.16 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.799 0.44 . . . . 0.0 111.8 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -98.05 14.25 28.11 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.561 0.22 . . . . 0.0 111.37 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.82 HD12 ' O ' ' A' ' 170' ' ' ILE . 13.7 mt -83.62 -45.13 0.81 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.355 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 48.0 Cg_exo -55.83 87.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.354 2.036 . . . . 0.0 112.266 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.88 -69.16 0.66 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.911 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.16 17.61 4.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.852 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.84 0.352 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.452 ' C ' HD12 ' A' ' 156' ' ' LEU . 4.0 pp -74.01 140.48 45.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.033 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -170.65 -81.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.727 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.8 p -77.12 60.82 1.95 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.802 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.484 ' O ' HG12 ' A' ' 160' ' ' VAL . 1.9 t0 78.19 -40.69 0.3 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.629 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.3 OUTLIER 92.97 -46.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 122.948 0.499 . . . . 0.0 111.342 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.402 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 4.9 t80 -67.3 -27.29 67.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.31 0.576 . . . . 0.0 110.239 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.555 ' CE2' HD11 ' A' ' 169' ' ' ILE . 2.2 m-85 -70.6 -63.33 1.11 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.81 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.761 HD12 ' HB3' ' A' ' 167' ' ' PRO . 3.2 tp -66.34 -6.15 13.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.014 179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.818 ' CE2' HD12 ' A' ' 165' ' ' LEU . 6.3 t80 -78.9 -74.64 0.27 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.699 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.818 HD12 ' CE2' ' A' ' 164' ' ' PHE . 0.1 OUTLIER -64.89 -57.58 8.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.949 179.821 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.904 ' O ' HG23 ' A' ' 169' ' ' ILE . 0.3 OUTLIER -157.57 109.18 1.83 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.159 -179.524 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.761 ' HB3' HD12 ' A' ' 163' ' ' LEU . 19.4 Cg_endo -62.69 -28.73 76.81 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.233 1.955 . . . . 0.0 114.757 -178.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.603 ' HD2' HD12 ' A' ' 166' ' ' LEU . 24.3 Cg_endo -94.89 41.82 0.17 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.16 1.906 . . . . 0.0 113.646 -178.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.904 HG23 ' O ' ' A' ' 166' ' ' LEU . 21.8 pt -78.71 -42.24 25.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.448 0.642 . . . . 0.0 111.156 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.677 HG23 HG13 ' A' ' 169' ' ' ILE . 1.5 pt -76.19 -45.77 34.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.825 -177.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.585 HD21 ' HA ' ' A' ' 168' ' ' PRO . 0.0 OUTLIER -62.72 -56.48 17.25 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -74.09 1.33 11.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.028 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.894 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.36 -69.45 0.43 Allowed 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 121.238 0.542 . . . . 0.0 109.69 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -113.93 -9.28 16.41 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.612 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.481 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 31.3 t80 77.01 -8.97 1.6 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 122.652 0.381 . . . . 0.0 112.019 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -97.62 1.46 48.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.806 0.336 . . . . 0.0 110.913 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.662 HD12 ' HB ' ' A' ' 170' ' ' ILE . 0.3 OUTLIER -79.91 -32.2 0.71 Allowed Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.682 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 85.1 Cg_exo -48.51 87.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.487 2.124 . . . . 0.0 112.776 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 177' ' ' LEU . 0.3 OUTLIER -110.93 -66.62 1.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.745 179.329 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.1 32.68 0.75 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.705 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 2.1 t80 . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.854 0.359 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -164.91 91.93 0.57 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.082 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -169.86 -43.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.015 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.577 ' OG ' HD13 ' A' ' 163' ' ' LEU . 2.5 p -75.52 60.61 1.22 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.662 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.438 ' O ' ' CB ' ' A' ' 160' ' ' VAL . 0.6 OUTLIER 75.06 -53.55 0.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.038 -179.612 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.438 ' CB ' ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 89.1 -47.93 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.516 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.418 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 11.7 m-85 -67.82 -57.48 6.21 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.463 ' C ' ' H ' ' A' ' 164' ' ' PHE . 8.2 m-85 -73.76 -14.89 61.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.951 178.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.577 HD13 ' OG ' ' A' ' 158' ' ' SER . 58.3 tp -64.36 -3.9 3.35 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 121.774 0.797 . . . . 0.0 109.345 178.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.463 ' H ' ' C ' ' A' ' 162' ' ' PHE . 2.4 m-85 -73.12 -58.95 2.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.141 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.34 -71.46 0.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.064 0.459 . . . . 0.0 110.998 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.774 ' O ' HD13 ' A' ' 166' ' ' LEU . 0.3 OUTLIER -162.03 118.28 1.3 Allowed Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.665 -178.922 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.624 ' N ' HD22 ' A' ' 166' ' ' LEU . 16.8 Cg_endo -58.45 118.99 5.96 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.163 1.908 . . . . 0.0 111.771 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.09 32.18 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.654 2.236 . . . . 0.0 113.493 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.833 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.6 OUTLIER -74.98 -100.31 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 119.3 -0.381 . . . . 0.0 110.337 179.432 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.714 ' H ' HG23 ' A' ' 169' ' ' ILE . 2.8 mp 27.11 -66.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.893 0.877 . . . . 0.0 112.993 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.833 ' N ' ' O ' ' A' ' 169' ' ' ILE . 3.6 pp -68.99 -48.44 63.08 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.263 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.81 ' N ' HD12 ' A' ' 171' ' ' LEU . 28.2 m-20 -70.33 -7.06 39.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.124 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.88 -58.49 3.25 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.917 0.389 . . . . 0.0 110.309 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -110.9 -30.72 3.12 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.39 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER 75.36 -36.92 0.32 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 122.475 0.31 . . . . 0.0 111.6 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.62 3.65 54.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.928 0.394 . . . . 0.0 110.232 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.553 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 2.4 mt -58.57 -53.04 70.25 Favored Pre-proline 0 N--CA 1.453 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.365 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.553 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 50.3 Cg_exo -55.01 -173.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.515 2.143 . . . . 0.0 111.792 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 17.9 mt 77.38 72.16 0.06 Allowed 'General case' 0 CA--C 1.521 -0.152 0 CA-C-O 121.09 0.471 . . . . 0.0 110.549 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 66.19 57.01 0.78 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.712 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.589 ' N ' HD21 ' A' ' 163' ' ' LEU . 89.6 m-85 . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.805 0.336 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.673 ' O ' HD12 ' A' ' 156' ' ' LEU . 1.4 pp -165.76 66.62 0.12 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.581 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -172.65 -20.13 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.405 ' HB3' HD13 ' A' ' 163' ' ' LEU . 7.1 t -69.08 -38.38 78.98 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.222 0.535 . . . . 0.0 111.62 -179.051 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -168.51 -37.08 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.511 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.447 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 67.98 -50.14 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.532 179.989 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.447 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 1.2 m-85 -72.55 0.27 10.9 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.933 179.436 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.439 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 27.1 m-85 -159.13 11.87 0.14 Allowed 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.193 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.589 HD21 ' N ' ' A' ' 155' ' ' PHE . 66.2 tp -68.27 -7.22 28.82 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 177.35 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -75.5 -32.85 60.68 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.185 -179.712 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.448 ' O ' HD22 ' A' ' 166' ' ' LEU . 0.3 OUTLIER -63.38 -36.6 84.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.062 -179.769 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.49 HD13 ' HD2' ' A' ' 168' ' ' PRO . 0.2 OUTLIER -162.15 78.56 2.0 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.643 -179.299 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.458 ' O ' HD11 ' A' ' 163' ' ' LEU . 3.2 Cg_exo -38.51 -48.22 2.53 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.147 2.564 . . . . 0.0 112.898 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.49 ' HD2' HD13 ' A' ' 166' ' ' LEU . 41.1 Cg_endo -90.1 62.38 1.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.707 2.271 . . . . 0.0 112.422 -179.685 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.709 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.9 OUTLIER -73.97 -41.9 52.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.642 179.831 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.523 HG22 ' HG3' ' A' ' 178' ' ' PRO . 2.8 mp -69.33 -36.37 71.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.801 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.426 ' HA ' ' HG2' ' A' ' 178' ' ' PRO . 10.9 mp -65.62 -53.57 39.81 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.548 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -75.74 -6.07 48.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.514 178.073 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.709 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -74.51 -74.26 0.2 Allowed 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.31 0.576 . . . . 0.0 109.879 179.808 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -115.81 -15.19 7.51 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.687 178.844 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER 75.09 -47.34 0.61 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.358 0.263 . . . . 0.0 111.633 179.897 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.653 ' CD1' HD11 ' A' ' 179' ' ' LEU . 0.1 OUTLIER -94.14 16.41 14.8 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 120.688 0.28 . . . . 0.0 111.24 -179.937 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.469 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 5.0 mt -92.94 -46.16 0.32 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.713 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.523 ' HG3' HG22 ' A' ' 170' ' ' ILE . 21.6 Cg_exo -65.4 -4.87 10.19 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.678 2.252 . . . . 0.0 113.201 -179.478 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.653 HD11 ' CD1' ' A' ' 176' ' ' PHE . 52.6 mt -57.46 -18.79 20.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.735 0.302 . . . . 0.0 111.456 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.67 48.59 1.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.179 0.514 . . . . 0.0 109.997 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 181' ' ' HSL . . . . . 0.446 ' HB2' ' HA ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.415 ' O ' ' HB2' ' A' ' 156' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 120.858 0.361 . . . . 0.0 111.855 . . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 155' ' ' PHE . 5.8 mt 66.71 55.09 0.79 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.269 179.732 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -170.08 -58.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.356 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.629 ' HB2' HD22 ' A' ' 163' ' ' LEU . 0.9 OUTLIER -74.95 59.63 0.92 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.82 0.343 . . . . 0.0 110.827 -179.838 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.556 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.4 OUTLIER 75.58 -48.78 0.61 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.598 179.999 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.556 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 61.1 t 82.91 -64.91 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 C-N-CA 122.798 0.439 . . . . 0.0 109.949 -179.388 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -75.62 46.05 0.34 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.346 178.501 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.433 ' C ' ' H ' ' A' ' 164' ' ' PHE . 3.6 t80 -171.95 -53.19 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.145 0.497 . . . . 0.0 110.299 -179.04 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.629 HD22 ' HB2' ' A' ' 158' ' ' SER . 2.5 tp -68.08 -0.34 4.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.955 178.024 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.433 ' H ' ' C ' ' A' ' 162' ' ' PHE . 0.1 OUTLIER -71.77 -18.82 62.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.498 -178.115 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 162' ' ' PHE . 0.0 OUTLIER -66.9 -36.8 83.09 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.374 179.581 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -162.12 67.62 2.06 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.568 -179.156 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.43 ' CB ' ' HD3' ' A' ' 168' ' ' PRO . 3.2 Cg_exo -39.09 -50.01 2.76 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.267 2.645 . . . . 0.0 112.967 -179.629 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.43 ' HD3' ' CB ' ' A' ' 167' ' ' PRO . 38.5 Cg_endo -91.1 65.74 1.3 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.886 2.391 . . . . 0.0 112.572 -179.6 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 1.006 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -77.94 -37.28 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.929 0.395 . . . . 0.0 110.849 179.96 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.879 HD13 HG23 ' A' ' 169' ' ' ILE . 6.5 mm -78.78 -47.88 22.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.73 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.4 tp -62.75 -55.06 30.04 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 168' ' ' PRO . 21.8 m-20 -74.47 -2.48 25.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.81 178.726 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 1.006 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.86 -67.27 0.58 Allowed 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.114 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.451 ' HA3' HD23 ' A' ' 177' ' ' LEU . . . -131.47 -4.33 3.99 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.688 178.492 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 70.16 -47.33 0.62 Allowed 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 122.433 0.293 . . . . 0.0 111.234 -179.755 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -92.99 -2.11 56.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.846 0.355 . . . . 0.0 110.695 179.458 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.553 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.2 OUTLIER -58.05 -42.97 97.89 Favored Pre-proline 0 CA--C 1.529 0.145 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.251 179.443 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 75.8 Cg_exo -50.69 -161.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.92 2.414 . . . . 0.0 112.915 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.9 mt 80.35 -2.35 1.94 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.996 -179.301 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -152.9 34.75 0.48 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.122 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 7.9 p90 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.908 0.385 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.959 HD21 ' CB ' ' A' ' 163' ' ' LEU . 6.3 mt 58.12 39.73 25.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.351 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -73.23 -1.91 19.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.09 179.164 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.3 t -72.95 -51.29 19.02 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.443 0.639 . . . . 0.0 111.214 -179.635 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.84 ' O ' HG12 ' A' ' 160' ' ' VAL . 1.9 p30 -164.17 -38.18 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.729 -179.519 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.84 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.5 OUTLIER 81.4 -38.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 114.825 -1.08 . . . . 0.0 112.315 179.728 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.499 ' CE2' ' HB2' ' A' ' 159' ' ' ASP . 4.2 p90 -69.51 -27.55 65.28 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 121.096 0.474 . . . . 0.0 110.675 179.846 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.411 ' N ' ' CD1' ' A' ' 161' ' ' PHE . 0.6 OUTLIER -68.32 -59.25 3.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.366 179.277 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.959 ' CB ' HD21 ' A' ' 156' ' ' LEU . 15.0 tp -67.02 -3.32 6.92 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.122 178.605 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.415 ' HB2' ' HA ' ' A' ' 161' ' ' PHE . 0.3 OUTLIER -73.28 -20.45 60.82 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.133 -0.939 . . . . 0.0 111.213 -179.279 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.448 ' HA ' HD22 ' A' ' 165' ' ' LEU . 0.2 OUTLIER -63.56 -34.94 78.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.328 0.585 . . . . 0.0 110.041 179.013 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.509 ' C ' HD12 ' A' ' 166' ' ' LEU . 0.6 OUTLIER -160.16 99.64 1.43 Allowed Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.906 -178.88 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -65.46 113.81 2.63 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.408 2.072 . . . . 0.0 112.804 -179.159 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.747 ' HB3' HD11 ' A' ' 171' ' ' LEU . 96.5 Cg_endo -80.89 52.59 4.41 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.849 2.366 . . . . 0.0 112.33 179.651 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.811 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -74.5 -38.4 46.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.909 0.385 . . . . 0.0 111.24 -179.587 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.493 ' O ' HD12 ' A' ' 177' ' ' LEU . 2.8 mp -72.83 -48.85 43.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.561 -179.492 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.747 HD11 ' HB3' ' A' ' 168' ' ' PRO . 0.1 OUTLIER -65.98 -49.81 66.55 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.487 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -75.95 1.67 14.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.04 178.564 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.811 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.25 -42.12 66.01 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.214 0.53 . . . . 0.0 109.666 179.74 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.53 ' C ' ' CG ' ' A' ' 175' ' ' TYR . . . -119.62 -1.96 13.28 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.826 178.881 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.53 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER 58.51 -37.32 0.06 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 179.483 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.501 ' N ' ' O ' ' A' ' 174' ' ' GLY . 26.9 p90 -94.62 23.08 5.61 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 122.094 -0.378 . . . . 0.0 111.164 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.493 HD12 ' O ' ' A' ' 170' ' ' ILE . 7.7 mt -85.63 -51.12 0.51 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.844 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 32.0 Cg_exo -58.7 -63.94 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.545 2.163 . . . . 0.0 112.289 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 179' ' ' LEU . 11.9 mt 61.63 55.62 2.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.009 0.433 . . . . 0.0 110.733 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.18 48.96 5.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.824 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.403 ' O ' ' CD1' ' A' ' 163' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.752 0.31 . . . . 0.0 111.182 . . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.714 HD23 HG21 ' A' ' 160' ' ' VAL . 0.4 OUTLIER -73.48 87.24 1.58 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.907 -179.963 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.597 ' HG3' HD21 ' A' ' 163' ' ' LEU . 5.0 mm-40 -70.08 -83.38 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.744 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 16.7 p -163.15 31.27 0.09 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.176 0.512 . . . . 0.0 110.284 179.543 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -162.09 -54.6 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.279 179.696 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.714 HG21 HD23 ' A' ' 156' ' ' LEU . 67.7 t 66.84 -55.84 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.556 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.56 9.9 1.24 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.142 179.6 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -161.07 12.49 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.854 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 1.055 HD22 HD23 ' A' ' 165' ' ' LEU . 0.5 OUTLIER -67.55 -30.08 69.62 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 177.74 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 13.9 t80 68.05 12.02 8.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.712 179.45 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 1.055 HD23 HD22 ' A' ' 163' ' ' LEU . 0.5 OUTLIER -66.29 -55.14 17.52 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.198 0.523 . . . . 0.0 110.445 179.209 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.412 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 0.1 OUTLIER -161.29 53.52 0.47 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.198 -179.876 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.536 ' O ' HD21 ' A' ' 171' ' ' LEU . 10.1 Cg_endo -52.13 107.16 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.741 2.294 . . . . 0.0 112.748 -179.439 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.408 ' HA ' ' HG ' ' A' ' 171' ' ' LEU . 86.4 Cg_endo -80.02 6.51 5.23 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 123.174 2.582 . . . . 0.0 112.961 179.741 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.971 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 12.6 pt -75.31 -37.63 39.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.232 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.461 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 8.4 mm -81.48 -50.84 16.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.962 -179.408 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.536 HD21 ' O ' ' A' ' 167' ' ' PRO . 0.0 OUTLIER -62.63 -53.38 55.38 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.938 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.43 -1.17 17.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.887 178.715 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.971 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.91 -56.84 4.61 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 121.194 0.521 . . . . 0.0 109.787 179.626 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -129.88 -3.5 4.94 Favored Glycine 0 CA--C 1.52 0.38 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.057 179.126 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.3 OUTLIER 70.13 -55.8 0.6 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.64 0.257 . . . . 0.0 111.358 179.974 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -92.36 24.88 3.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.902 0.382 . . . . 0.0 110.572 179.766 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.515 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 0.2 OUTLIER -88.26 -51.37 0.4 Allowed Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.996 179.842 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 96.1 Cg_exo -44.86 -84.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.516 2.144 . . . . 0.0 112.552 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 179' ' ' LEU . 0.2 OUTLIER 55.26 55.56 7.38 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.141 0.496 . . . . 0.0 110.501 179.924 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? 64.07 53.39 1.84 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.579 -179.578 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 181' ' ' HSL . . . . . 0.504 ' HB2' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.783 0.325 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.62 142.9 46.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.925 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 159' ' ' ASP . 2.2 mt-30 -170.28 72.94 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.764 179.878 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.838 ' OG ' HD23 ' A' ' 163' ' ' LEU . 1.2 p 60.99 -59.69 0.09 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.52 0.676 . . . . 0.0 112.106 179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 157' ' ' GLN . 1.8 p30 -158.2 -31.49 0.07 Allowed 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.382 -179.522 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.445 ' CG1' ' CD1' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 80.46 -51.45 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.936 179.958 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.479 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 20.4 m-30 -76.96 20.25 0.26 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.746 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.479 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 43.0 m-85 -164.35 -4.44 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.838 HD23 ' OG ' ' A' ' 158' ' ' SER . 1.4 tm? -64.65 -40.02 94.7 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.453 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER 54.65 40.06 31.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.702 178.532 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.453 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 4.5 tp 84.73 -28.02 0.09 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.467 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.76 HD23 ' O ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -160.14 131.2 3.82 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.176 -178.84 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.656 ' HD3' HD21 ' A' ' 163' ' ' LEU . 18.8 Cg_endo -59.5 118.32 5.18 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.335 2.023 . . . . 0.0 112.444 -179.559 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 167' ' ' PRO . 27.4 Cg_endo -62.63 80.88 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.519 2.146 . . . . 0.0 111.97 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.797 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 5.5 tt -74.03 -34.93 40.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.673 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.776 HD13 HG23 ' A' ' 169' ' ' ILE . 10.4 mm -71.56 -42.82 72.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.053 -179.836 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.825 HD13 ' HG2' ' A' ' 178' ' ' PRO . 0.1 OUTLIER -66.06 -53.55 36.95 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.795 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -74.82 -0.1 17.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.035 178.657 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.797 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.97 -60.94 2.0 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.159 0.504 . . . . 0.0 109.851 179.757 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -109.67 -19.03 8.5 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.497 178.835 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 78.83 -29.83 0.15 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.658 0.383 . . . . 0.0 111.953 179.647 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.436 ' CE2' ' CD1' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -94.75 -0.49 54.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.747 0.308 . . . . 0.0 110.737 179.696 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.491 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 0.5 OUTLIER -59.52 -47.37 97.97 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.141 179.816 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.825 ' HG2' HD13 ' A' ' 171' ' ' LEU . 23.4 Cg_exo -64.81 68.93 0.26 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.659 2.239 . . . . 0.0 112.383 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.436 ' CD1' ' CE2' ' A' ' 176' ' ' PHE . 1.8 mt -106.34 -50.48 3.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.733 179.762 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.83 9.16 22.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.78 179.774 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 17.2 p90 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.83 0.348 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.75 HD22 ' HB ' ' A' ' 160' ' ' VAL . 4.5 pp -72.77 -178.25 2.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.686 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.449 ' H ' HD11 ' A' ' 163' ' ' LEU . 5.5 mm-40 -167.73 26.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.835 0.35 . . . . 0.0 111.409 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.535 ' O ' ' OG ' ' A' ' 158' ' ' SER . 0.3 OUTLIER -168.48 36.43 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.36 0.6 . . . . 0.0 110.004 179.489 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.415 ' O ' HG12 ' A' ' 160' ' ' VAL . 2.8 t0 82.42 -30.15 0.1 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.162 -179.998 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.75 ' HB ' HD22 ' A' ' 156' ' ' LEU . 0.4 OUTLIER 81.03 -45.76 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.865 0.364 . . . . 0.0 110.448 -179.477 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.414 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 27.0 t80 -74.65 12.68 0.76 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.777 177.939 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.587 ' HB3' ' HA ' ' A' ' 167' ' ' PRO . 54.5 m-85 -160.29 7.69 0.09 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.781 -179.486 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.679 HD12 ' HA ' ' A' ' 160' ' ' VAL . 1.1 mt -68.62 -4.05 14.07 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.552 -0.906 . . . . 0.0 108.552 176.967 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.416 ' H ' ' C ' ' A' ' 162' ' ' PHE . 0.2 OUTLIER -71.59 -9.2 57.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.789 -178.705 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 164' ' ' PHE . 2.5 mt -176.53 -66.2 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.954 0.407 . . . . 0.0 111.08 179.644 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -162.0 124.93 1.79 Allowed Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.473 -179.62 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.587 ' HA ' ' HB3' ' A' ' 162' ' ' PHE . 70.1 Cg_endo -75.1 110.76 3.18 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.118 1.879 . . . . 0.0 112.624 -179.703 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.432 ' HD2' ' CG ' ' A' ' 162' ' ' PHE . 87.8 Cg_endo -75.84 77.41 3.41 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.646 2.23 . . . . 0.0 112.37 179.852 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.87 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 1.9 tp -75.34 -44.68 42.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.531 HD12 HG22 ' A' ' 169' ' ' ILE . 3.5 mp -74.55 -41.57 48.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.216 -179.899 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.849 HD13 ' HG2' ' A' ' 178' ' ' PRO . 3.4 mm? -65.2 -57.75 7.74 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.518 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.82 4.51 6.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.067 178.754 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.87 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.97 -56.01 5.74 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.207 0.527 . . . . 0.0 109.826 179.683 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -121.74 -0.03 10.99 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.726 178.695 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.494 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.2 OUTLIER 55.1 -59.79 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.047 0.939 . . . . 0.0 112.154 179.898 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.631 ' CD1' HD22 ' A' ' 179' ' ' LEU . 13.1 m-85 -95.52 22.87 6.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.782 0.325 . . . . 0.0 111.118 -179.903 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.554 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 14.9 mt -90.57 -49.3 0.36 Allowed Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.081 179.758 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.849 ' HG2' HD13 ' A' ' 171' ' ' LEU . 36.6 Cg_exo -60.37 -29.99 89.99 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.368 2.046 . . . . 0.0 112.054 179.788 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.631 HD22 ' CD1' ' A' ' 176' ' ' PHE . 6.8 mp -64.97 -57.6 8.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.89 -179.891 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -87.17 44.03 1.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 -179.962 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.28 0 CA-C-O 120.85 0.357 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.841 ' O ' HD22 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -165.08 124.86 1.85 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.975 -179.757 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.756 ' O ' HD22 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -173.79 80.67 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.009 -179.636 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.1 m 63.81 68.09 0.59 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.326 179.75 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.504 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.5 OUTLIER 76.17 -60.59 0.48 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.717 179.426 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.504 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 95.7 t 76.27 -46.21 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.052 -179.297 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.403 ' O ' ' CD1' ' A' ' 162' ' ' PHE . 1.1 t80 -71.76 -1.33 13.59 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.091 179.641 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.403 ' CD1' ' O ' ' A' ' 161' ' ' PHE . 11.9 m-85 -162.43 13.78 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.151 179.748 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.756 HD22 ' O ' ' A' ' 157' ' ' GLN . 52.9 tp -66.74 -17.68 64.98 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.143 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.5 ' HA ' ' HG3' ' A' ' 167' ' ' PRO . 15.3 t80 68.29 21.2 8.51 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.378 179.516 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.493 HD23 ' HG ' ' A' ' 163' ' ' LEU . 0.2 OUTLIER -67.4 -48.68 66.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.944 179.438 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.503 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 0.2 OUTLIER -159.92 44.41 0.17 Allowed Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.731 -179.293 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.565 ' CD ' ' HD3' ' A' ' 168' ' ' PRO . 19.3 Cg_endo -61.66 -28.17 82.17 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.263 1.975 . . . . 0.0 114.113 -179.936 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.565 ' HD3' ' CD ' ' A' ' 167' ' ' PRO . 13.5 Cg_endo -99.01 118.7 0.11 Allowed 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 122.984 2.456 . . . . 0.0 111.939 -179.635 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.877 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 8.4 tp -70.66 -41.82 77.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.857 -179.914 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.495 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 0.8 OUTLIER -74.04 -44.3 50.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 114.683 -1.144 . . . . 0.0 112.507 -178.25 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.534 HD13 ' C ' ' A' ' 171' ' ' LEU . 2.4 tm? -65.16 -58.37 6.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.054 0.454 . . . . 0.0 109.845 179.53 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.423 ' CB ' ' HG ' ' A' ' 166' ' ' LEU . 12.0 m-20 -74.66 5.46 4.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.552 179.105 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.877 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -70.79 -56.42 6.37 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.304 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -111.55 -26.36 4.55 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 177.9 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 72.25 -40.68 0.48 Allowed 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 122.633 0.373 . . . . 0.0 111.663 179.641 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -90.34 6.99 40.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.814 0.34 . . . . 0.0 110.622 179.661 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.56 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 0.4 OUTLIER -62.17 -59.79 12.02 Favored Pre-proline 0 N--CA 1.453 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.076 179.477 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.56 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 52.0 Cg_exo -53.54 -174.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.398 2.066 . . . . 0.0 112.052 179.158 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.3 mp 69.52 71.43 0.25 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.221 0.534 . . . . 0.0 110.272 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 70.76 63.98 0.18 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.206 -179.463 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.6 t80 . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.793 0.33 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 16.1 mt 62.72 16.03 8.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.338 179.847 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.4 -1.73 25.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.802 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.795 ' O ' HD13 ' A' ' 163' ' ' LEU . 0.7 OUTLIER -73.9 55.13 0.53 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.891 0.377 . . . . 0.0 110.857 -179.956 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.15 -63.78 0.36 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.603 -179.711 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.48 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 68.08 -53.17 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.823 179.613 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.48 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 0.2 OUTLIER -77.14 3.46 12.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.989 -179.723 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -169.08 15.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.738 -179.8 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.795 HD13 ' O ' ' A' ' 158' ' ' SER . 9.0 tp -65.91 -35.9 81.91 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.898 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 1.6 t80 53.89 8.27 0.15 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.939 178.688 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.459 ' HB2' ' CD2' ' A' ' 163' ' ' LEU . 3.0 tp -70.38 -54.99 10.21 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.024 0.44 . . . . 0.0 110.265 179.449 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.597 ' N ' ' HD3' ' A' ' 167' ' ' PRO . 0.2 OUTLIER -161.18 47.83 0.23 Allowed Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.134 -179.553 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.597 ' HD3' ' N ' ' A' ' 166' ' ' LEU . 23.7 Cg_exo -59.66 -50.2 8.55 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 121.529 1.486 . . . . 0.0 111.704 179.29 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.486 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 28.8 Cg_endo -94.28 97.36 0.13 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.187 2.591 . . . . 0.0 112.385 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.911 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER -75.82 -44.91 38.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.27 0.557 . . . . 0.0 111.322 -179.888 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.516 HG23 HG23 ' A' ' 169' ' ' ILE . 0.7 OUTLIER -78.98 -44.78 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.938 -1.028 . . . . 0.0 112.968 -178.02 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.561 HD13 ' C ' ' A' ' 171' ' ' LEU . 2.0 tm? -64.51 -58.16 7.18 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.491 ' N ' HD13 ' A' ' 171' ' ' LEU . 1.2 m-20 -74.1 4.84 4.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.151 178.857 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.911 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.22 -56.48 5.46 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.257 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.443 ' N ' HD12 ' A' ' 177' ' ' LEU . . . -133.86 2.06 4.37 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.559 178.465 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 70.35 -56.83 0.59 Allowed 'General case' 0 C--O 1.231 0.096 0 C-N-CA 122.543 0.337 . . . . 0.0 111.733 179.75 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -94.93 -10.72 30.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.619 0.247 . . . . 0.0 111.621 -179.638 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.533 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 74.9 mt -53.42 -42.05 89.8 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.529 179.818 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 36.5 Cg_exo -62.05 68.27 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.607 2.205 . . . . 0.0 112.496 -179.847 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.541 HD12 ' HE ' ' A' ' 180' ' ' ARG . 0.1 OUTLIER -128.86 -66.13 0.84 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.344 179.718 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.541 ' HE ' HD12 ' A' ' 179' ' ' LEU . 10.8 mmt85 -87.66 22.22 2.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.304 179.465 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.461 ' CD1' ' CD1' ' A' ' 165' ' ' LEU . 3.6 m-85 . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.733 0.302 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 155' ' ' PHE . 0.6 OUTLIER 38.97 78.56 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.787 179.836 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.511 ' H ' HD22 ' A' ' 163' ' ' LEU . 0.4 OUTLIER -169.01 44.16 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.943 -179.942 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.524 ' CB ' HD13 ' A' ' 163' ' ' LEU . 0.1 OUTLIER -165.53 -40.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.415 0.626 . . . . 0.0 111.207 179.784 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -167.24 -35.96 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.534 179.899 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.447 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 78.93 -50.41 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.951 -179.991 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.447 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 57.4 m-85 -76.02 14.13 0.75 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.764 179.706 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.404 ' CD2' ' O ' ' A' ' 161' ' ' PHE . 18.5 m-85 -165.45 2.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.865 0.321 . . . . 0.0 111.865 -179.725 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.524 HD13 ' CB ' ' A' ' 158' ' ' SER . 10.4 tp -67.21 -30.44 70.37 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.753 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.456 ' O ' ' HB2' ' A' ' 165' ' ' LEU . 4.6 t80 52.61 35.73 18.88 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.682 179.28 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.461 ' CD1' ' CD1' ' A' ' 155' ' ' PHE . 0.1 OUTLIER 84.48 -32.49 0.06 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.862 -179.31 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.922 HD13 ' HD2' ' A' ' 167' ' ' PRO . 0.2 OUTLIER -164.62 123.87 1.25 Allowed Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.2 -179.217 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.922 ' HD2' HD13 ' A' ' 166' ' ' LEU . 37.3 Cg_endo -67.04 112.2 2.43 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.007 1.805 . . . . 0.0 112.463 -179.679 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.439 ' HB2' ' HB2' ' A' ' 172' ' ' ASP . 70.0 Cg_endo -81.92 51.52 3.85 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.896 2.397 . . . . 0.0 112.596 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.89 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 3.7 tp -76.07 -46.19 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.393 0.616 . . . . 0.0 110.717 179.844 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.605 HG23 HG23 ' A' ' 169' ' ' ILE . 0.7 OUTLIER -79.01 -43.78 24.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.707 -179.277 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.84 HD12 ' CG ' ' A' ' 178' ' ' PRO . 1.2 tp -65.8 -58.91 4.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.114 0.483 . . . . 0.0 109.992 179.557 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 168' ' ' PRO . 4.0 t70 -74.24 5.54 4.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.448 179.052 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.89 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.25 -64.69 0.87 Allowed 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.505 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -112.3 -17.09 8.43 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 178.167 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 6.0 t80 75.58 -11.46 1.1 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.705 0.402 . . . . 0.0 111.81 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.406 ' C ' ' HD2' ' A' ' 178' ' ' PRO . 24.6 m-85 -115.68 -3.15 12.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.986 0.422 . . . . 0.0 110.867 179.672 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.801 ' O ' HD12 ' A' ' 177' ' ' LEU . 0.1 OUTLIER -85.59 -20.77 0.27 Allowed Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.853 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.84 ' CG ' HD12 ' A' ' 171' ' ' LEU . 79.7 Cg_exo -46.92 -18.51 0.57 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.144 1.896 . . . . 0.0 113.414 -179.918 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.607 HD23 ' O ' ' A' ' 179' ' ' LEU . 4.9 tt -50.52 -45.9 56.91 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.967 0.413 . . . . 0.0 110.58 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.54 ' HG2' HD12 ' A' ' 177' ' ' LEU . 4.9 ptp180 -91.53 31.08 1.21 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.126 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 181' ' ' HSL . . . . . 0.456 ' HG2' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.546 ' C ' HD23 ' A' ' 156' ' ' LEU . 1.4 m-85 . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.877 0.37 . . . . 0.0 111.949 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.546 HD23 ' C ' ' A' ' 155' ' ' PHE . 0.5 OUTLIER 48.66 -161.47 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.355 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.499 ' O ' HD22 ' A' ' 163' ' ' LEU . 44.8 tt0 -169.75 92.93 0.24 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.88 0.371 . . . . 0.0 111.022 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.605 ' HB2' HD13 ' A' ' 163' ' ' LEU . 0.1 OUTLIER 47.74 75.67 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.143 179.916 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 160' ' ' VAL . 1.0 OUTLIER 75.26 -60.05 0.52 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.137 -179.971 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 85.88 -49.15 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.903 -179.827 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.536 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 0.1 OUTLIER -76.73 25.52 0.14 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.801 179.535 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.569 ' C ' ' H ' ' A' ' 164' ' ' PHE . 47.1 m-85 -166.78 -22.73 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.871 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.605 HD13 ' HB2' ' A' ' 158' ' ' SER . 9.6 tp -63.42 0.16 0.76 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.771 0.796 . . . . 0.0 109.788 178.279 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.569 ' H ' ' C ' ' A' ' 162' ' ' PHE . 69.6 t80 -74.24 7.94 2.47 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.046 -179.156 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 164' ' ' PHE . 0.7 OUTLIER -172.81 -45.68 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.862 0.363 . . . . 0.0 111.091 179.78 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 1.6 tp -160.75 138.92 7.27 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 -179.574 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.89 116.31 4.62 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.359 2.04 . . . . 0.0 112.248 -179.919 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.434 ' HD3' ' HB3' ' A' ' 162' ' ' PHE . 72.6 Cg_endo -76.51 81.66 2.45 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.501 2.134 . . . . 0.0 112.426 -179.892 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.871 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 4.8 tp -75.87 -35.84 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.991 179.965 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.818 HD13 HG23 ' A' ' 169' ' ' ILE . 9.0 mm -73.4 -45.89 50.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.447 -179.284 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.421 ' CD1' ' HG2' ' A' ' 178' ' ' PRO . 34.5 tp -64.33 -54.37 34.12 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.46 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.94 -0.67 16.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.082 178.649 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.871 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.42 -61.86 1.65 Allowed 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.25 0.547 . . . . 0.0 109.911 179.779 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -114.15 -13.95 9.55 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.683 178.848 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 24.9 t80 70.91 -51.06 0.68 Allowed 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 122.459 0.304 . . . . 0.0 111.599 179.904 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -95.57 5.7 50.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.209 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.793 ' O ' HD12 ' A' ' 177' ' ' LEU . 0.1 OUTLIER -77.02 -30.59 0.81 Allowed Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.695 179.921 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 51.6 Cg_exo -54.76 -145.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.597 2.198 . . . . 0.0 112.521 -179.8 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.435 ' CB ' ' O ' ' A' ' 178' ' ' PRO . 0.1 OUTLIER 83.61 76.63 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.105 0.478 . . . . 0.0 110.281 -179.495 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.38 55.96 0.38 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.763 -179.739 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' A' ' 156' ' ' LEU . 3.1 t80 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.795 0.331 . . . . 0.0 111.778 . . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.582 ' HB2' HG23 ' A' ' 160' ' ' VAL . 1.9 mt 66.64 99.76 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.348 179.558 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.97 -17.71 61.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.609 179.422 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.734 ' CB ' HD12 ' A' ' 163' ' ' LEU . 0.7 OUTLIER -73.96 62.6 0.88 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.024 179.686 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.702 ' O ' HG12 ' A' ' 160' ' ' VAL . 2.0 p30 63.34 -58.37 0.17 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.607 -179.019 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.3 OUTLIER 80.29 -40.39 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 122.614 0.366 . . . . 0.0 110.537 -179.543 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -77.98 34.26 0.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.717 -0.219 . . . . 0.0 110.595 178.55 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.418 ' C ' ' H ' ' A' ' 164' ' ' PHE . 0.2 OUTLIER -170.67 -55.74 0.02 OUTLIER 'General case' 0 N--CA 1.457 -0.085 0 CA-C-O 121.134 0.492 . . . . 0.0 111.679 -178.585 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.734 HD12 ' CB ' ' A' ' 158' ' ' SER . 16.7 mt -66.49 -2.42 4.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.164 179.297 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.682 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.1 OUTLIER -76.17 50.61 0.63 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.374 -179.378 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 79.83 -40.42 0.21 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.544 179.939 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.42 171.82 6.43 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.863 -178.782 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.413 ' HA ' ' HD2' ' A' ' 168' ' ' PRO . 65.7 Cg_endo -74.1 108.4 2.65 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.58 2.187 . . . . 0.0 112.531 -179.792 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.59 ' HB3' HD12 ' A' ' 171' ' ' LEU . 45.0 Cg_endo -68.09 74.55 0.72 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.405 2.07 . . . . 0.0 112.211 179.74 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.882 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 8.2 tp -75.55 -46.46 36.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.299 -179.782 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.564 HD12 HG22 ' A' ' 169' ' ' ILE . 3.7 mp -73.82 -36.38 45.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.522 -179.671 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.59 HD12 ' HB3' ' A' ' 168' ' ' PRO . 20.2 mt -64.92 -62.39 1.59 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.658 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -77.43 8.06 4.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.359 178.996 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.882 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.1 -59.15 2.93 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.328 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 175' ' ' TYR . . . -123.37 -1.64 9.22 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.188 178.024 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.406 ' HB2' ' O ' ' A' ' 174' ' ' GLY . 63.6 m-85 66.36 -57.65 0.37 Allowed 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.02 0.528 . . . . 0.0 111.336 179.679 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -96.78 15.87 20.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.761 0.315 . . . . 0.0 110.958 179.552 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.51 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 22.9 mt -84.84 -42.82 0.69 Allowed Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.621 179.983 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 63.1 Cg_exo -42.02 -28.07 0.75 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.573 2.182 . . . . 0.0 112.818 -179.95 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.15 -43.58 67.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.705 179.566 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -88.43 33.0 0.75 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.961 179.892 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 181' ' ' HSL . . . . . 0.434 ' HG2' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.601 ' C ' HD12 ' A' ' 156' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.822 0.344 . . . . 0.0 111.249 . . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.601 HD12 ' C ' ' A' ' 155' ' ' PHE . 3.9 mp -162.94 84.73 0.52 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.471 179.957 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -74.46 -24.38 59.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.924 -179.968 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.464 ' CA ' HD21 ' A' ' 163' ' ' LEU . 0.3 OUTLIER -163.86 62.18 0.16 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.582 179.915 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 158' ' ' SER . 1.0 OUTLIER 82.23 -27.36 0.12 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.879 -179.918 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.488 HG12 ' N ' ' A' ' 161' ' ' PHE . 0.5 OUTLIER 79.14 -52.58 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.183 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.488 ' N ' HG12 ' A' ' 160' ' ' VAL . 1.2 m-85 -75.56 37.92 0.14 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.767 178.761 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.42 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 42.7 m-85 -162.39 -22.82 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 179.891 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.849 HD12 ' O ' ' A' ' 167' ' ' PRO . 4.0 mm? -60.09 -34.22 73.16 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.584 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.453 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 2.7 t80 59.85 91.9 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.235 177.414 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.453 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 5.2 tp 87.33 -48.35 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.558 178.809 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.552 ' HB3' ' HD2' ' A' ' 168' ' ' PRO . 0.0 OUTLIER -161.55 148.17 11.34 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.614 -178.549 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.849 ' O ' HD12 ' A' ' 163' ' ' LEU . 2.6 Cg_exo -40.92 -51.69 3.62 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.081 2.521 . . . . 0.0 113.305 -179.474 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.552 ' HD2' ' HB3' ' A' ' 166' ' ' LEU . 37.2 Cg_endo -92.42 -167.38 0.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.725 2.283 . . . . 0.0 112.399 -179.725 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.887 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.2 OUTLIER -170.35 -43.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.996 179.815 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.863 HG22 ' HG ' ' A' ' 177' ' ' LEU . 2.2 mp -75.46 -53.36 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.315 -179.785 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.842 HD13 ' HG3' ' A' ' 178' ' ' PRO . 12.2 tp -65.33 -49.93 67.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.361 0.601 . . . . 0.0 109.384 179.446 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.06 -1.32 16.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.153 179.102 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.887 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.66 -64.78 0.89 Allowed 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.092 0.472 . . . . 0.0 109.736 179.631 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -116.18 -16.83 6.5 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.688 178.807 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.441 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 24.2 t80 75.89 -10.61 1.25 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.401 0.28 . . . . 0.0 111.753 179.986 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.546 ' CZ ' HD11 ' A' ' 179' ' ' LEU . 71.3 t80 -95.44 -4.0 45.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.838 0.351 . . . . 0.0 110.948 179.664 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.863 ' HG ' HG22 ' A' ' 170' ' ' ILE . 3.8 mm? -56.46 -41.82 93.14 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.252 179.682 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.842 ' HG3' HD13 ' A' ' 171' ' ' LEU . 63.8 Cg_exo -53.99 -137.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.888 2.392 . . . . 0.0 112.651 -179.865 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.546 HD11 ' CZ ' ' A' ' 176' ' ' PHE . 20.8 mt 84.45 74.83 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.976 0.417 . . . . 0.0 110.591 -179.571 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.97 48.21 3.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.842 -179.933 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 29.1 p90 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.77 0.319 . . . . 0.0 111.287 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.798 ' CD1' HD22 ' A' ' 163' ' ' LEU . 0.7 OUTLIER -166.29 156.53 12.3 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.325 179.835 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? 64.43 23.11 12.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.807 -179.626 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 50.69 33.06 7.67 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.144 0.497 . . . . 0.0 111.311 -179.862 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.545 ' O ' HG12 ' A' ' 160' ' ' VAL . 4.0 m-20 -163.86 -55.76 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.919 179.681 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 74.93 -47.58 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.485 179.165 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.517 ' HA ' ' HB2' ' A' ' 164' ' ' PHE . 0.1 OUTLIER -61.85 -20.22 63.45 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.935 0.397 . . . . 0.0 110.779 -179.677 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.449 ' CE1' ' HD2' ' A' ' 168' ' ' PRO . 0.1 OUTLIER -70.61 -60.54 2.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.302 0.572 . . . . 0.0 110.19 179.188 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.798 HD22 ' CD1' ' A' ' 156' ' ' LEU . 9.0 mp -68.03 -4.08 12.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.015 178.405 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.678 ' O ' HD12 ' A' ' 165' ' ' LEU . 0.2 OUTLIER -82.57 21.67 0.95 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.122 -179.017 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.678 HD12 ' O ' ' A' ' 164' ' ' PHE . 0.2 OUTLIER -170.97 -74.81 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.764 0.316 . . . . 0.0 111.334 179.776 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.546 HD22 ' O ' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -160.5 83.21 2.08 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.063 -179.421 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.435 ' HG3' ' HG ' ' A' ' 163' ' ' LEU . 37.4 Cg_endo -66.83 111.98 2.33 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.261 1.974 . . . . 0.0 112.353 -179.431 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.833 ' O ' HD12 ' A' ' 170' ' ' ILE . 44.5 Cg_endo -87.18 -166.15 0.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.055 2.503 . . . . 0.0 111.791 179.679 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.986 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.9 OUTLIER 79.48 -38.36 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.89 179.622 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.833 HD12 ' O ' ' A' ' 168' ' ' PRO . 2.7 mp -83.13 -65.56 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.039 0.447 . . . . 0.0 111.236 179.956 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 172' ' ' ASP . 1.4 pp -65.8 -45.04 83.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.353 0.597 . . . . 0.0 110.252 179.902 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.453 ' N ' HD12 ' A' ' 171' ' ' LEU . 0.3 OUTLIER -71.19 -5.55 32.71 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.947 179.492 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.986 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -75.75 -62.2 1.67 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.107 0.48 . . . . 0.0 110.243 179.735 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -130.67 1.48 5.59 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.484 179.584 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.508 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER 57.54 -52.51 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 179.344 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.522 ' N ' ' O ' ' A' ' 174' ' ' GLY . 2.9 m-85 -92.82 18.55 8.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.75 0.309 . . . . 0.0 111.041 179.941 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.706 ' O ' HD23 ' A' ' 179' ' ' LEU . 0.1 OUTLIER -80.91 -48.33 1.12 Allowed Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.851 179.548 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 80.3 Cg_exo -43.42 -39.97 9.65 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.682 2.255 . . . . 0.0 112.749 179.941 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.706 HD23 ' O ' ' A' ' 177' ' ' LEU . 3.7 mm? 63.73 61.73 0.96 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.092 0.473 . . . . 0.0 110.175 -179.69 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? 66.7 39.2 3.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.415 -179.494 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.844 0.354 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.1 mp 60.4 119.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.246 179.675 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.719 ' HB2' HD12 ' A' ' 163' ' ' LEU . 1.6 mm100 -170.34 42.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.59 179.94 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.1 p 74.86 -59.4 0.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.956 -179.751 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -78.16 -48.26 16.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.299 179.647 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.624 HG12 ' CD2' ' A' ' 164' ' ' PHE . 57.9 t 69.51 -54.59 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.651 179.621 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.504 ' HA ' ' HB2' ' A' ' 164' ' ' PHE . 5.1 p90 -61.97 -23.26 66.29 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.104 0.478 . . . . 0.0 110.26 179.908 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.83 -61.61 1.73 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.468 179.102 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.719 HD12 ' HB2' ' A' ' 157' ' ' GLN . 7.5 mt -67.33 -6.24 17.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.9 178.656 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.624 ' CD2' HG12 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -79.35 -47.14 16.3 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.028 -179.414 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 165' ' ' LEU . 1.1 tp -62.65 -78.48 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.214 0.53 . . . . 0.0 110.417 179.621 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.541 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 0.7 OUTLIER -88.31 105.56 9.82 Favored Pre-proline 0 N--CA 1.445 -0.703 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.997 -179.535 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.609 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 30.9 Cg_endo -66.77 -25.45 46.07 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.131 1.887 . . . . 0.0 114.244 -179.407 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 22.6 Cg_endo -91.34 87.17 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.972 1.781 . . . . 0.0 113.062 -179.374 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.927 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -72.25 -101.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.739 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.703 ' H ' HG23 ' A' ' 169' ' ' ILE . 1.9 mt 25.63 -62.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.387 0.675 . . . . 0.0 112.664 178.349 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.927 ' N ' ' O ' ' A' ' 169' ' ' ILE . 13.7 mt -67.05 -51.0 60.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.674 179.824 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -72.31 -6.86 46.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.074 179.575 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.61 -59.55 2.7 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.753 0.311 . . . . 0.0 110.367 179.887 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -100.06 -20.9 14.75 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.636 179.048 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 64.9 t80 69.29 -57.63 0.53 Allowed 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.8 0.333 . . . . 0.0 111.003 -179.953 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.865 ' HA ' HD23 ' A' ' 179' ' ' LEU . 6.5 t80 -93.86 18.73 9.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.526 179.503 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.497 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 13.5 mt -86.53 -46.84 0.54 Allowed Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.312 179.968 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 12.3 Cg_exo -71.42 -4.18 14.48 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.89 2.393 . . . . 0.0 112.903 -179.684 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.865 HD23 ' HA ' ' A' ' 176' ' ' PHE . 4.0 mm? -70.61 -65.23 0.76 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.961 0.41 . . . . 0.0 110.9 -179.941 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.58 35.47 0.83 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.874 179.936 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.559 0.219 . . . . 0.0 111.375 . . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 156' ' ' LEU . 6.1 mt -167.68 -71.61 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.027 -179.69 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 14.0 tp60 75.96 56.47 0.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.779 -179.959 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.62 ' HB3' HD13 ' A' ' 163' ' ' LEU . 27.6 t 61.16 60.24 1.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.643 -179.935 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.471 ' O ' HG12 ' A' ' 160' ' ' VAL . 1.8 t70 76.09 -59.63 0.51 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.354 179.953 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 85.13 -46.3 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.927 -179.463 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.421 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 1.3 m-85 -75.49 8.62 2.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.256 179.381 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -164.46 11.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.874 -179.744 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.768 HD12 ' CD ' ' A' ' 167' ' ' PRO . 0.9 OUTLIER -69.47 -38.89 77.91 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.542 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.487 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 0.9 OUTLIER 48.94 29.2 2.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.317 179.843 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.488 ' HA ' HD22 ' A' ' 165' ' ' LEU . 0.2 OUTLIER 89.7 -30.71 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.209 -179.45 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -165.24 83.77 1.1 Allowed Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.683 -178.804 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.768 ' CD ' HD12 ' A' ' 163' ' ' LEU . 8.8 Cg_endo -59.03 -36.62 96.27 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.121 1.881 . . . . 0.0 113.257 -179.975 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 25.2 Cg_endo -93.43 84.48 0.17 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.488 2.125 . . . . 0.0 112.848 -179.481 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.927 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 18.4 pt -75.13 -44.4 43.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.336 179.94 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.464 ' N ' HG13 ' A' ' 169' ' ' ILE . 3.1 mp -78.71 -43.36 25.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.483 -179.974 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.895 HD13 ' HG3' ' A' ' 178' ' ' PRO . 2.5 mm? -64.6 -58.93 4.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.104 0.478 . . . . 0.0 109.773 179.852 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.411 ' HB2' ' HG2' ' A' ' 168' ' ' PRO . 7.0 t70 -74.32 4.7 5.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.256 179.01 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.927 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.08 -52.75 15.37 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.548 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.555 ' N ' HD12 ' A' ' 177' ' ' LEU . . . -121.43 -5.82 9.16 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.793 178.76 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.428 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 85.1 t80 68.99 -53.59 0.57 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.547 0.339 . . . . 0.0 111.574 179.981 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.406 ' O ' ' CG ' ' A' ' 176' ' ' PHE . 27.7 t80 -92.93 -7.18 46.79 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.587 0.232 . . . . 0.0 111.171 -179.802 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.555 HD12 ' N ' ' A' ' 174' ' ' GLY . 38.9 mt -55.35 -42.45 96.03 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.265 179.57 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.895 ' HG3' HD13 ' A' ' 171' ' ' LEU . 49.5 Cg_exo -56.51 79.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.74 2.293 . . . . 0.0 112.617 -179.991 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 177' ' ' LEU . 1.0 OUTLIER -82.85 -68.5 0.7 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.291 179.481 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.31 45.05 1.25 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.127 179.118 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.539 ' O ' HD23 ' A' ' 156' ' ' LEU . 15.5 p90 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.655 0.264 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.861 HD22 ' CG2' ' A' ' 160' ' ' VAL . 98.0 mt -160.41 132.23 6.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.517 -179.99 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -171.24 -31.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.399 -179.886 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.518 ' O ' HD13 ' A' ' 163' ' ' LEU . 3.1 m -73.38 62.55 0.72 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.13 0.49 . . . . 0.0 110.701 -179.964 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.408 ' OD1' ' CZ ' ' A' ' 161' ' ' PHE . 0.2 OUTLIER 76.92 -63.81 0.36 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.483 -179.743 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.861 ' CG2' HD22 ' A' ' 156' ' ' LEU . 0.4 OUTLIER 71.61 -46.63 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.76 179.568 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.42 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 6.8 p90 -71.94 -4.84 30.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.485 -179.743 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.577 ' HB3' HD11 ' A' ' 165' ' ' LEU . 8.5 m-85 -164.01 15.67 0.06 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.629 179.708 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.633 HD11 ' HD2' ' A' ' 168' ' ' PRO . 18.6 tp -68.84 -6.1 24.94 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.353 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -75.84 -19.93 58.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.654 -179.487 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.577 HD11 ' HB3' ' A' ' 162' ' ' PHE . 2.3 mt -63.55 -51.16 66.59 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.267 0.555 . . . . 0.0 110.46 179.788 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.525 ' C ' HD12 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -161.34 77.54 2.31 Favored Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.973 -178.413 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -63.43 111.57 1.5 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.195 1.93 . . . . 0.0 112.015 -179.489 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.633 ' HD2' HD11 ' A' ' 163' ' ' LEU . 70.2 Cg_endo -83.46 -166.04 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.95 2.433 . . . . 0.0 112.303 -179.879 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.825 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 17.0 tt -171.85 -44.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.484 179.96 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.523 ' N ' HG23 ' A' ' 169' ' ' ILE . 3.3 pt -71.82 -43.55 69.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 114.16 -1.382 . . . . 0.0 111.827 -178.524 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.547 HD23 ' HG2' ' A' ' 178' ' ' PRO . 8.9 mt -63.06 -51.6 66.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.975 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -75.02 -8.24 55.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.312 178.227 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.825 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -75.14 -76.15 0.15 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.123 0.487 . . . . 0.0 110.191 179.71 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -114.82 -14.19 8.82 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.914 179.12 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 32.6 t80 77.48 -43.47 0.41 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 179.668 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -96.29 -8.16 33.48 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.57 0.224 . . . . 0.0 111.595 -179.878 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.625 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 21.3 mt -73.84 -35.59 2.53 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 179.94 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 43.9 Cg_exo -55.63 -154.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.548 2.165 . . . . 0.0 112.812 -179.546 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.4 tp 77.27 68.47 0.05 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.133 0.492 . . . . 0.0 110.202 -179.51 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.57 60.36 1.67 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.438 -179.527 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.467 ' O ' HD23 ' A' ' 156' ' ' LEU . 51.0 p90 . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.66 0.266 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.467 HD23 ' O ' ' A' ' 155' ' ' PHE . 81.5 mt -161.6 -179.04 6.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.745 -179.991 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.563 ' HB3' HD22 ' A' ' 163' ' ' LEU . 0.1 OUTLIER -170.4 87.59 0.13 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.769 179.966 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.6 p 78.77 -56.0 0.45 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.436 0.636 . . . . 0.0 111.522 179.946 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.56 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 2.0 t0 -167.93 -31.76 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.214 -179.887 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.56 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 83.1 t 82.93 -55.12 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.699 -179.775 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.462 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 2.3 m-85 -75.06 32.34 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.362 179.354 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.462 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 22.2 m-85 -169.96 -17.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.494 179.941 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.563 HD22 ' HB3' ' A' ' 157' ' ' GLN . 20.7 tp -57.78 -44.04 85.95 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.544 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 2.6 t80 61.87 -13.25 0.05 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 177.64 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.488 ' H ' ' C ' ' A' ' 163' ' ' LEU . 0.3 OUTLIER -66.67 -39.99 88.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.855 0.359 . . . . 0.0 111.059 -179.965 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -160.19 95.84 1.53 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.523 -179.37 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.11 113.83 2.77 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.271 1.981 . . . . 0.0 112.947 -179.397 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.403 ' CD ' HG13 ' A' ' 160' ' ' VAL . 81.5 Cg_endo -83.51 93.73 0.81 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.173 2.582 . . . . 0.0 111.445 179.21 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.887 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER -159.14 -45.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.517 -179.108 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.652 HD12 ' N ' ' A' ' 171' ' ' LEU . 2.3 pp -76.1 -49.71 24.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.224 -178.271 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.732 HD12 ' N ' ' A' ' 172' ' ' ASP . 3.4 pp -67.47 -48.58 66.77 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.988 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.732 ' N ' HD12 ' A' ' 171' ' ' LEU . 1.3 m-20 -73.95 -2.37 23.73 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.922 178.655 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.887 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.73 -70.8 0.3 Allowed 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.539 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.437 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -110.86 -23.66 5.8 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.131 -0.787 . . . . 0.0 111.131 178.127 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER 71.25 -13.53 0.52 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.398 0.279 . . . . 0.0 111.199 -179.726 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.437 ' H ' ' C ' ' A' ' 174' ' ' GLY . 36.7 p90 -95.28 -8.72 35.16 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.752 0.31 . . . . 0.0 110.256 179.189 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.58 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 3.5 mm? -46.53 -46.01 46.96 Favored Pre-proline 0 CA--C 1.529 0.156 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.441 179.32 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 18.9 Cg_exo -68.9 59.11 1.2 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.006 2.471 . . . . 0.0 112.311 179.665 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.59 -4.21 53.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.863 0.363 . . . . 0.0 111.22 179.849 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.44 47.1 0.89 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.542 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.79 0.329 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.552 ' O ' HD12 ' A' ' 156' ' ' LEU . 1.2 pp -165.33 77.28 0.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.106 0.479 . . . . 0.0 111.065 -179.91 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.743 ' HG2' HD13 ' A' ' 163' ' ' LEU . 1.9 tp60 -81.5 25.36 0.52 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.176 179.494 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.8 t 76.14 27.66 0.88 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.947 0.403 . . . . 0.0 110.785 -179.509 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.492 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 10.3 m-20 -159.39 -51.87 0.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.796 179.755 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.492 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 94.9 t 76.45 -58.58 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.396 179.273 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.425 ' O ' ' HB3' ' A' ' 164' ' ' PHE . 97.5 m-85 -65.61 -30.07 70.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.127 0.489 . . . . 0.0 110.325 179.831 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.403 ' HB2' ' CB ' ' A' ' 159' ' ' ASP . 0.2 OUTLIER -73.09 -61.36 1.84 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.691 178.985 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.743 HD13 ' HG2' ' A' ' 157' ' ' GLN . 4.2 tp -67.16 -3.07 6.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.468 179.143 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.471 ' CB ' ' O ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER -75.15 -33.88 61.55 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.476 -178.763 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 mt -63.08 -41.8 99.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.921 0.391 . . . . 0.0 110.617 179.836 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.921 HD11 HD13 ' A' ' 169' ' ' ILE . 0.1 OUTLIER -160.9 98.66 1.33 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.791 -179.051 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.594 ' CD ' ' HD3' ' A' ' 168' ' ' PRO . 59.3 Cg_endo -73.72 -21.64 18.77 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 122.787 2.325 . . . . 0.0 115.85 -178.159 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.594 ' HD3' ' CD ' ' A' ' 167' ' ' PRO . 23.0 Cg_endo -91.12 22.88 0.67 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.799 1.666 . . . . 0.0 113.853 -178.581 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.921 HD13 HD11 ' A' ' 166' ' ' LEU . 5.6 tp -78.89 -38.07 20.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.964 0.411 . . . . 0.0 111.122 179.656 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.873 HD13 HG23 ' A' ' 169' ' ' ILE . 7.4 mm -73.94 -49.83 32.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.916 -178.927 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.589 ' C ' HD12 ' A' ' 171' ' ' LEU . 0.5 OUTLIER -64.7 -48.0 76.29 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.609 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.409 ' N ' ' HG ' ' A' ' 171' ' ' LEU . 3.5 t0 -76.5 -1.35 26.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.956 178.488 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.845 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.62 -57.35 4.2 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.818 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -115.02 -15.12 8.03 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.663 178.757 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.411 ' HB2' ' O ' ' A' ' 174' ' ' GLY . 1.9 m-85 68.66 -10.11 0.5 Allowed 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 122.3 0.24 . . . . 0.0 111.567 -179.766 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.43 ' H ' ' C ' ' A' ' 174' ' ' GLY . 7.4 m-85 -91.84 -0.9 57.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.734 0.302 . . . . 0.0 110.389 179.463 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.454 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.4 OUTLIER -53.62 -51.84 72.61 Favored Pre-proline 0 N--CA 1.456 -0.156 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.082 179.207 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 31.7 Cg_exo -60.52 81.76 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.866 2.377 . . . . 0.0 111.613 179.167 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 98.8 mt -93.3 -75.63 0.49 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.295 -179.364 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 13.9 mmp_? -86.87 30.59 0.74 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.912 -179.841 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 120.914 0.388 . . . . 0.0 111.511 . . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 156' ' ' LEU . 9.4 mt 65.37 -179.04 0.19 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.82 -179.882 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.844 ' O ' HD22 ' A' ' 163' ' ' LEU . 0.9 OUTLIER -170.47 41.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.881 -179.928 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.857 ' HB3' HD13 ' A' ' 163' ' ' LEU . 1.8 t 68.48 -59.87 0.44 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.366 0.603 . . . . 0.0 111.271 -179.99 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.72 ' O ' HG12 ' A' ' 160' ' ' VAL . 1.0 OUTLIER -148.27 -22.85 0.34 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.577 -179.865 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.72 HG12 ' O ' ' A' ' 159' ' ' ASP . 9.8 p 56.95 -50.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.374 0.67 . . . . 0.0 112.588 179.941 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.606 ' N ' ' O ' ' A' ' 159' ' ' ASP . 0.3 OUTLIER -71.24 -1.34 12.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.465 0.174 . . . . 0.0 110.978 179.194 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.433 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 9.7 m-85 -164.82 12.83 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.899 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.857 HD13 ' HB3' ' A' ' 158' ' ' SER . 61.5 tp -69.24 -32.49 71.75 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.451 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.473 ' O ' ' CG ' ' A' ' 164' ' ' PHE . 0.0 OUTLIER 66.13 1.75 2.07 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.101 179.047 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.709 ' O ' HD22 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -67.37 -67.38 0.46 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.87 0.367 . . . . 0.0 110.841 179.424 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.709 HD22 ' O ' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -160.76 61.33 1.46 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.874 -179.657 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.451 ' HB2' ' HD3' ' A' ' 168' ' ' PRO . 36.1 Cg_exo -57.97 -47.93 18.48 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.596 2.198 . . . . 0.0 112.622 -179.919 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.451 ' HD3' ' HB2' ' A' ' 167' ' ' PRO . 36.1 Cg_endo -92.28 45.24 0.41 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.879 2.386 . . . . 0.0 112.705 -179.502 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.852 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -75.76 -37.13 35.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.047 0.451 . . . . 0.0 111.053 -179.879 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.843 HD13 HG23 ' A' ' 169' ' ' ILE . 8.1 mm -73.56 -42.35 55.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.523 -179.454 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.448 HD22 ' N ' ' A' ' 171' ' ' LEU . 3.2 mm? -65.64 -56.05 14.24 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.471 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -74.52 0.54 14.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.008 178.701 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.852 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.64 -57.35 4.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.285 0.564 . . . . 0.0 109.5 179.662 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -112.66 -22.14 5.84 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.309 178.558 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 70.08 -53.07 0.63 Allowed 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 122.476 0.31 . . . . 0.0 111.45 179.815 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.639 ' O ' HD13 ' A' ' 179' ' ' LEU . 0.2 OUTLIER -91.48 1.8 56.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.803 0.335 . . . . 0.0 110.734 179.789 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.501 ' O ' HD12 ' A' ' 177' ' ' LEU . 0.1 OUTLIER -60.55 -49.4 90.16 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.565 179.547 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.58 ' O ' HD12 ' A' ' 179' ' ' LEU . 54.7 Cg_exo -52.95 83.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.81 2.34 . . . . 0.0 112.426 179.97 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.639 HD13 ' O ' ' A' ' 176' ' ' PHE . 3.5 mp -130.56 -69.11 0.66 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.369 179.801 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 180' ' ' ARG . 0.0 OUTLIER -86.95 25.75 1.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.188 179.3 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.462 ' N ' ' CD1' ' A' ' 155' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 120.453 0.168 . . . . 0.0 111.233 . . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.497 ' C ' HD12 ' A' ' 156' ' ' LEU . 3.7 pp -165.74 145.41 6.44 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.837 0.351 . . . . 0.0 110.906 -179.927 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.99 61.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.406 0.622 . . . . 0.0 110.927 179.79 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.576 ' OG ' HD22 ' A' ' 163' ' ' LEU . 59.7 p -165.13 45.52 0.09 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.808 179.533 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.504 ' O ' HG12 ' A' ' 160' ' ' VAL . 0.3 OUTLIER 78.25 -56.89 0.47 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.115 -178.42 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 66.23 -56.44 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.351 179.848 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.499 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 5.9 p90 -79.21 17.97 0.73 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.158 179.051 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.419 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 2.9 m-85 -169.68 0.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.563 -179.893 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.576 HD22 ' OG ' ' A' ' 158' ' ' SER . 30.1 tp -63.03 -20.43 65.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.701 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 1.5 t80 60.42 81.57 0.18 Allowed 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.04 179.098 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.496 ' O ' HD12 ' A' ' 166' ' ' LEU . 1.9 tp -170.51 -52.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.038 179.989 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER -161.2 54.34 0.54 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.204 -179.806 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.441 ' HA ' ' HD2' ' A' ' 168' ' ' PRO . 10.7 Cg_endo -54.2 104.83 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.85 2.366 . . . . 0.0 112.842 -179.464 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 167' ' ' PRO . 62.8 Cg_endo -71.41 82.17 1.15 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.721 2.281 . . . . 0.0 111.36 179.084 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.912 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -75.82 -36.93 34.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.348 -179.151 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.897 HD13 HG23 ' A' ' 169' ' ' ILE . 7.0 mm -76.95 -50.12 21.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.893 -179.506 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.559 ' H ' HD12 ' A' ' 171' ' ' LEU . 4.5 mp -64.08 -52.31 59.89 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.592 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -74.01 0.61 13.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.012 178.48 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.912 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.15 -52.26 17.49 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.372 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.679 ' H ' ' HG2' ' A' ' 178' ' ' PRO . . . -126.48 -25.33 1.3 Allowed Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.519 178.782 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.41 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 7.8 t80 79.44 -21.63 0.32 Allowed 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.231 0.613 . . . . 0.0 112.275 179.62 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -94.7 53.71 1.67 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.405 0.622 . . . . 0.0 109.341 179.093 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.727 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 1.3 mt 48.36 51.81 11.45 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.906 -178.482 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.727 ' HD3' ' N ' ' A' ' 177' ' ' LEU . 11.8 Cg_exo -74.85 72.58 4.5 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 123.604 2.87 . . . . 0.0 112.421 -179.748 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.35 -45.01 6.97 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.227 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.452 ' HD2' ' N ' ' A' ' 180' ' ' ARG . 0.0 OUTLIER -90.21 20.92 4.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.97 179.19 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.842 0.353 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.56 HD22 HG13 ' A' ' 160' ' ' VAL . 99.8 mt -72.99 85.61 1.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.751 179.894 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -170.13 -38.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.444 -179.908 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.459 ' O ' ' CB ' ' A' ' 159' ' ' ASP . 53.9 p -74.85 66.32 1.5 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.611 179.215 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.47 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 3.8 t0 87.6 -50.07 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.985 -179.186 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.56 HG13 HD22 ' A' ' 156' ' ' LEU . 80.6 t 73.86 -47.87 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.649 0.262 . . . . 0.0 111.203 179.797 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.83 12.69 0.36 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.339 179.502 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.439 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 87.7 t80 -165.16 3.24 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.505 179.799 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.1 tp -61.68 -31.34 71.46 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.647 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.453 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 7.1 t80 44.43 38.36 2.53 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.396 177.671 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.453 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.2 OUTLIER 86.54 -31.7 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.038 -179.676 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.752 HD23 ' O ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -162.16 131.06 3.04 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.396 -179.242 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.87 112.62 3.44 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.457 2.105 . . . . 0.0 112.511 -179.522 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.18 76.51 0.91 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.489 2.126 . . . . 0.0 112.541 -179.966 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.724 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 8.4 tt -75.51 -41.87 42.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.166 0.508 . . . . 0.0 110.796 179.726 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.448 HD12 ' H ' ' A' ' 170' ' ' ILE . 1.9 mp -71.07 -37.37 66.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.94 -179.875 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.39 -55.42 18.22 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.784 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.74 1.3 17.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.04 178.432 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.4 -45.68 53.25 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-O 121.05 0.452 . . . . 0.0 110.157 -179.869 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.691 ' H ' ' HG2' ' A' ' 178' ' ' PRO . . . -117.99 -20.68 4.41 Favored Glycine 0 N--CA 1.452 -0.281 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 178.688 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' A' ' 174' ' ' GLY . 57.6 m-85 69.44 -12.64 0.42 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 179.0 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.447 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 0.6 OUTLIER -94.73 37.67 1.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.455 0.645 . . . . 0.0 109.26 178.638 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.58 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 17.2 mt 62.34 43.34 0.55 Allowed Pre-proline 0 N--CA 1.453 -0.292 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.999 -178.869 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.691 ' HG2' ' H ' ' A' ' 174' ' ' GLY . 32.5 Cg_exo -40.16 -80.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.907 2.405 . . . . 0.0 113.147 179.635 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.416 ' H ' HG22 ' A' ' 170' ' ' ILE . 50.0 mt 53.72 48.46 21.45 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.976 0.417 . . . . 0.0 110.728 -179.835 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.45 47.23 5.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.716 -179.767 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 181' ' ' HSL . . . . . 0.486 ' HB2' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.857 0.361 . . . . 0.0 111.314 . . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.484 HD12 ' H ' ' A' ' 156' ' ' LEU . 5.3 mp -72.84 -177.2 2.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.034 -179.806 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 80.34 35.27 0.13 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.289 0.566 . . . . 0.0 110.501 -179.879 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.419 ' O ' HD12 ' A' ' 163' ' ' LEU . 0.8 OUTLIER -164.72 75.85 0.29 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.711 179.47 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 158' ' ' SER . 0.4 OUTLIER 76.94 -57.18 0.53 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.566 -178.944 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.419 ' HA ' ' HB2' ' A' ' 163' ' ' LEU . 0.9 OUTLIER 70.65 -45.17 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 120.742 0.306 . . . . 0.0 111.63 179.649 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.421 ' CE1' ' HB2' ' A' ' 162' ' ' PHE . 0.1 OUTLIER -72.62 -3.19 23.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.988 0.423 . . . . 0.0 110.765 179.663 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.421 ' HB2' ' CE1' ' A' ' 161' ' ' PHE . 0.1 OUTLIER -162.86 19.81 0.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.201 179.642 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 163' ' ' LEU . 0.8 OUTLIER -68.61 -5.24 18.85 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.815 0.817 . . . . 0.0 109.131 177.59 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -71.07 -67.48 0.51 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.853 -179.481 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -65.27 -74.82 0.1 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.929 0.395 . . . . 0.0 110.908 179.861 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 166' ' ' LEU . 2.8 mt -164.44 101.35 0.86 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.946 -179.29 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.62 111.72 2.43 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.223 1.949 . . . . 0.0 112.347 179.981 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.22 48.84 2.82 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.778 2.318 . . . . 0.0 112.83 -179.923 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.854 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 10.8 pt -75.77 -36.09 32.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.965 0.412 . . . . 0.0 110.888 179.695 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 10.7 mm -77.12 -42.56 31.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.41 -179.848 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.97 -57.03 9.79 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.535 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.09 4.55 6.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.119 178.671 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.854 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.59 -47.27 55.91 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.287 0.565 . . . . 0.0 109.501 179.616 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.623 ' H ' ' HG2' ' A' ' 178' ' ' PRO . . . -121.09 -28.05 1.74 Allowed Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 178.338 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.41 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 46.9 t80 77.0 -13.74 0.91 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.314 0.646 . . . . 0.0 112.501 179.184 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.448 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 42.2 p90 -95.36 37.9 1.16 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.665 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.603 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 4.4 mt 62.5 43.05 0.51 Allowed Pre-proline 0 N--CA 1.453 -0.319 0 CA-C-N 115.041 -0.982 . . . . 0.0 111.234 -178.973 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.623 ' HG2' ' H ' ' A' ' 174' ' ' GLY . 36.5 Cg_exo -41.77 -70.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.835 2.357 . . . . 0.0 112.886 179.391 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 56.35 54.67 7.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.13 0.49 . . . . 0.0 110.481 -179.837 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 62.48 57.14 1.93 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.286 -179.306 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 181' ' ' HSL . . . . . 0.476 ' HB2' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 6.2 p90 . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 121.005 0.431 . . . . 0.0 111.358 . . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.536 ' O ' HD22 ' A' ' 163' ' ' LEU . 0.1 OUTLIER -74.66 -41.44 60.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.138 -179.815 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.522 ' HB3' HD22 ' A' ' 163' ' ' LEU . 10.2 tp-100 66.91 19.67 10.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.994 0.426 . . . . 0.0 110.921 -179.763 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 32.7 t 45.97 53.91 8.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.763 179.948 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -162.75 -68.2 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.697 179.152 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.578 HG12 ' N ' ' A' ' 161' ' ' PHE . 1.1 t 69.5 -58.95 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.849 179.452 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.578 ' N ' HG12 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -74.24 16.02 0.28 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.194 179.954 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -172.18 -7.14 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 179.958 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.566 ' HG ' ' H ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER -61.14 -42.39 98.45 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.011 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.468 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 0.0 OUTLIER 42.16 36.45 0.71 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.499 176.864 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.566 ' H ' ' HG ' ' A' ' 163' ' ' LEU . 0.2 OUTLIER 88.18 -33.01 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.651 -179.197 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 163' ' ' LEU . 0.7 OUTLIER -166.01 99.49 0.73 Allowed Pre-proline 0 N--CA 1.451 -0.412 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.389 -179.116 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -62.4 117.01 3.87 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.093 1.862 . . . . 0.0 112.36 -179.578 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -89.94 -160.24 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.213 2.609 . . . . 0.0 112.469 -179.828 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.877 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER -166.56 -46.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.711 179.566 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.568 HD12 HG22 ' A' ' 169' ' ' ILE . 3.4 mp -78.35 -42.57 26.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.803 179.504 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.447 HD22 ' HG3' ' A' ' 178' ' ' PRO . 60.5 mt -64.38 -56.95 10.9 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.429 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -74.45 2.48 9.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.087 178.685 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.877 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.77 -60.71 2.1 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-O 121.151 0.501 . . . . 0.0 109.731 179.737 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.497 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -115.53 -11.35 10.56 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.626 178.769 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.497 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 64.0 t80 72.47 -17.29 0.39 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.787 0.435 . . . . 0.0 112.119 179.903 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -99.53 -18.23 17.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.795 0.331 . . . . 0.0 111.004 179.765 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.555 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 45.1 mt -61.86 -39.18 57.06 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.884 179.982 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 81.5 Cg_exo -47.11 -179.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.475 2.117 . . . . 0.0 112.856 -179.599 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 178' ' ' PRO . 3.2 mm? 74.55 71.85 0.1 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.198 -179.297 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 19.3 mtm180 69.8 57.71 0.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.666 -179.533 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 181' ' ' HSL . . . . . 0.504 ' HB3' ' O ' ' A' ' 177' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.439 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 64.6 m-85 . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.729 0.299 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 155' ' ' PHE . 38.0 mt -162.32 -170.71 2.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.567 179.999 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -167.66 81.25 0.19 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.916 0.388 . . . . 0.0 110.944 -179.891 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.791 ' HB3' HD13 ' A' ' 163' ' ' LEU . 1.6 m 58.99 64.08 1.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.542 -179.897 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 71.42 -60.05 0.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.691 -179.586 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 73.39 -49.82 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.323 179.837 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.427 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 3.2 t80 -74.0 1.74 10.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.969 179.503 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.425 ' CD1' ' O ' ' A' ' 161' ' ' PHE . 0.9 OUTLIER -158.9 9.74 0.13 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.14 179.753 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.791 HD13 ' HB3' ' A' ' 158' ' ' SER . 30.6 tp -69.36 -5.37 22.98 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.748 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.479 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 25.4 t80 -77.22 17.14 0.5 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.618 -179.11 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.479 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.1 OUTLIER 85.64 -23.35 0.16 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 179.394 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.48 HD12 ' N ' ' A' ' 167' ' ' PRO . 0.2 OUTLIER -158.46 146.31 13.68 Favored Pre-proline 0 C--N 1.323 -0.551 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.769 -178.334 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.48 ' N ' HD12 ' A' ' 166' ' ' LEU . 66.6 Cg_endo -75.06 117.25 4.83 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.513 2.142 . . . . 0.0 113.2 -179.182 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.409 ' O ' ' CB ' ' A' ' 172' ' ' ASP . 46.1 Cg_endo -88.23 26.89 0.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 123.271 2.647 . . . . 0.0 112.42 179.533 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.942 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -73.73 -37.23 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 111.566 -179.286 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 2.4 mp -74.67 -56.67 8.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.868 -179.27 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -53.25 40.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.907 0.384 . . . . 0.0 110.813 -179.675 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.409 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 0.7 OUTLIER -75.43 8.75 2.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.979 179.771 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.942 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.31 -67.58 0.54 Allowed 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.357 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.632 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -117.91 8.43 14.61 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 178.034 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.472 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER 53.72 -63.34 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.005 0.922 . . . . 0.0 111.638 179.846 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.632 ' N ' ' O ' ' A' ' 174' ' ' GLY . 11.8 t80 -102.31 0.47 34.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.293 179.639 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.561 HD12 ' HA3' ' A' ' 174' ' ' GLY . 70.2 mt -83.33 -43.73 0.84 Allowed Pre-proline 0 CA--C 1.53 0.197 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -179.811 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.714 ' C ' HD22 ' A' ' 179' ' ' LEU . 34.7 Cg_exo -58.02 -154.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.342 2.028 . . . . 0.0 112.222 -179.84 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.714 HD22 ' C ' ' A' ' 178' ' ' PRO . 0.4 OUTLIER 71.42 67.24 0.16 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.053 0.454 . . . . 0.0 110.441 -179.694 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 63.68 59.71 1.15 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.492 -179.63 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.447 ' O ' ' O ' ' A' ' 156' ' ' LEU . 21.4 m-85 . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.791 0.329 . . . . 0.0 111.3 . . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.566 ' C ' HD12 ' A' ' 156' ' ' LEU . 3.6 pp 43.28 -178.14 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.289 179.639 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 17.3 tp60 -172.25 -85.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.137 179.963 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.697 ' HB2' HD21 ' A' ' 163' ' ' LEU . 0.5 OUTLIER -75.87 61.9 1.51 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.928 0.394 . . . . 0.0 110.348 179.691 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.408 ' O ' ' CB ' ' A' ' 160' ' ' VAL . 4.3 t0 79.61 -47.19 0.36 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.363 -179.636 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.472 HG21 ' HB3' ' A' ' 156' ' ' LEU . 0.4 OUTLIER 83.82 -51.5 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.882 0.372 . . . . 0.0 110.453 -179.588 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.444 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 63.6 t80 -76.67 35.21 0.15 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.137 179.286 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -172.02 -19.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 179.973 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.697 HD21 ' HB2' ' A' ' 158' ' ' SER . 4.1 mt -57.69 -41.94 82.63 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.397 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 44.05 55.13 5.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.008 178.097 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 tp -172.62 -29.49 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -179.297 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.887 HD22 ' HA ' ' A' ' 169' ' ' ILE . 1.6 mt -156.55 54.63 0.91 Allowed Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.979 0.418 . . . . 0.0 111.188 -178.396 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.423 ' CB ' ' HD3' ' A' ' 168' ' ' PRO . 2.8 Cg_exo -40.45 -49.84 3.9 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.255 2.637 . . . . 0.0 113.083 179.946 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.817 ' O ' HD12 ' A' ' 170' ' ' ILE . 60.9 Cg_endo -88.17 -47.66 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.285 1.99 . . . . 0.0 113.113 -179.258 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 1.015 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.5 OUTLIER 80.94 -33.85 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.811 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.817 HD12 ' O ' ' A' ' 168' ' ' PRO . 3.9 mp -81.66 -61.87 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.937 0.398 . . . . 0.0 111.752 -179.616 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.469 HD22 ' N ' ' A' ' 171' ' ' LEU . 2.5 mm? -67.5 -51.26 53.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.891 -179.489 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -73.45 4.19 5.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.96 -179.796 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 1.015 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.19 -65.71 0.77 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.33 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -108.45 -24.74 6.05 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 178.113 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 75.43 -25.13 0.21 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.645 0.378 . . . . 0.0 111.537 179.814 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.401 ' H ' ' C ' ' A' ' 174' ' ' GLY . 11.6 m-85 -95.37 -2.43 49.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.702 0.287 . . . . 0.0 110.971 179.728 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.56 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 4.9 mt -56.14 -43.28 99.18 Favored Pre-proline 0 CA--C 1.53 0.194 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.767 179.457 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.572 ' O ' ' HB2' ' A' ' 179' ' ' LEU . 55.9 Cg_exo -54.15 -155.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.769 2.313 . . . . 0.0 112.561 179.816 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.572 ' HB2' ' O ' ' A' ' 178' ' ' PRO . 1.2 mt 87.92 80.81 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 122.927 0.491 . . . . 0.0 109.998 -179.285 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.466 ' CG ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER 70.95 28.34 3.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.019 -179.554 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.543 ' O ' HD12 ' A' ' 156' ' ' LEU . 33.5 p90 . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.75 0.31 . . . . 0.0 111.137 . . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.543 HD12 ' O ' ' A' ' 155' ' ' PHE . 2.0 mp -163.91 146.87 9.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.775 179.893 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.585 ' HB3' HD13 ' A' ' 163' ' ' LEU . 1.5 mt-30 -172.05 89.57 0.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.683 -179.977 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.8 t 79.67 -53.64 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.372 0.606 . . . . 0.0 111.845 179.832 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.567 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 1.0 OUTLIER -165.73 -29.93 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.784 -179.772 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.567 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 81.3 t 83.16 -53.51 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.627 -179.759 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.452 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 66.4 m-85 -74.91 32.67 0.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.128 179.065 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.455 ' H ' ' C ' ' A' ' 160' ' ' VAL . 8.0 m-85 -167.67 -12.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.443 -179.89 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.585 HD13 ' HB3' ' A' ' 157' ' ' GLN . 1.2 tp -61.12 -29.76 69.96 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.853 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.441 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 9.3 t80 51.56 23.38 1.86 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.049 178.714 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.441 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.1 OUTLIER 83.06 -19.82 0.37 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.637 -179.862 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.441 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 0.1 OUTLIER -167.17 83.61 0.86 Allowed Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.526 -178.509 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.454 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 2.7 Cg_exo -39.38 -47.03 3.28 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.09 2.527 . . . . 0.0 112.922 179.78 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 41.3 Cg_endo -90.38 81.44 0.51 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.733 2.289 . . . . 0.0 112.724 -179.346 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.864 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 8.7 pt -76.38 -34.48 25.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.533 -179.967 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.442 HD12 HG13 ' A' ' 169' ' ' ILE . 3.8 mp -75.76 -52.78 17.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.729 -179.352 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.86 -51.41 59.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.058 0.456 . . . . 0.0 109.976 179.849 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.432 ' CG ' HD21 ' A' ' 166' ' ' LEU . 0.6 OUTLIER -74.63 3.5 7.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.519 179.209 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.864 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.24 -63.71 1.09 Allowed 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.576 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.499 ' HA3' HD11 ' A' ' 177' ' ' LEU . . . -112.62 -11.49 14.71 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.353 178.368 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 3.8 t80 72.57 -55.6 0.67 Allowed 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.53 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.496 ' CD1' HD23 ' A' ' 177' ' ' LEU . 0.1 OUTLIER -94.2 21.65 6.7 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.276 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.499 HD11 ' HA3' ' A' ' 174' ' ' GLY . 5.9 mt -88.43 -48.17 0.44 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.023 179.618 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 45.2 Cg_exo -57.07 -20.32 36.93 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.417 2.078 . . . . 0.0 112.44 179.983 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 179' ' ' LEU . 9.1 mp -73.76 -7.22 51.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.428 -179.846 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 45.01 0.94 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.961 0.41 . . . . 0.0 110.306 179.822 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 12.6 p90 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.966 0.412 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.449 ' HG ' ' N ' ' A' ' 157' ' ' GLN . 2.3 pt? -166.8 -37.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.094 -179.854 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.449 ' N ' ' HG ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -74.51 6.77 3.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.787 179.718 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 159' ' ' ASP . 46.9 t -74.01 61.37 0.81 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.997 0.427 . . . . 0.0 111.081 -179.613 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.578 ' OD2' HG22 ' A' ' 169' ' ' ILE . 15.3 m-20 68.87 -64.78 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.84 179.858 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 69.64 -42.74 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.781 179.808 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.421 ' O ' ' CD1' ' A' ' 162' ' ' PHE . 1.2 p90 -72.18 -5.31 34.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.957 179.735 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.421 ' CD1' ' O ' ' A' ' 161' ' ' PHE . 21.5 m-85 -162.29 21.9 0.1 Allowed 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.371 179.492 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.542 HD12 ' HB3' ' A' ' 167' ' ' PRO . 1.3 tp -66.15 -10.73 43.84 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.158 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -82.64 31.92 0.41 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.9 -179.859 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -171.38 -46.78 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.732 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.438 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 0.3 OUTLIER -158.75 91.28 2.04 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.07 -178.124 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.557 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 16.7 Cg_endo -63.91 -31.81 66.73 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.544 2.162 . . . . 0.0 114.162 -179.789 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 29.7 Cg_endo -89.37 47.04 0.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 121.739 1.626 . . . . 0.0 113.206 -179.058 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.847 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 7.4 tt -77.31 -37.37 25.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.176 0.512 . . . . 0.0 110.694 179.393 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.789 HD13 HG23 ' A' ' 169' ' ' ILE . 10.2 mm -69.65 -38.53 76.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.286 -179.217 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.732 HD23 ' HG3' ' A' ' 178' ' ' PRO . 82.7 mt -64.86 -58.82 5.17 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.102 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.72 0.21 16.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.166 178.597 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.847 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.88 -62.11 1.57 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.162 0.506 . . . . 0.0 109.748 179.737 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -113.27 -12.31 12.2 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.752 178.891 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 8.0 t80 73.11 -53.34 0.7 Allowed 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 122.48 0.312 . . . . 0.0 111.687 179.793 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.62 -7.91 45.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.68 0.276 . . . . 0.0 110.915 179.882 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.522 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 15.3 mt -52.81 -44.6 96.42 Favored Pre-proline 0 CA--C 1.529 0.165 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.255 179.693 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.732 ' HG3' HD23 ' A' ' 171' ' ' LEU . 50.2 Cg_exo -54.89 -162.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.522 2.148 . . . . 0.0 112.237 179.923 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 179' ' ' LEU . 0.5 OUTLIER 71.57 69.18 0.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.145 0.497 . . . . 0.0 110.169 -179.677 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 66.16 58.35 0.72 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.561 -179.632 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 181' ' ' HSL . . . . . 0.416 ' HB2' ' O ' ' A' ' 177' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.9 0.381 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 048 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.8 mt 55.15 -92.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.864 -179.866 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.73 ' HB3' HD23 ' A' ' 163' ' ' LEU . 8.6 mt-30 52.3 22.87 2.17 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.776 0.322 . . . . 0.0 111.397 179.745 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.1 t 77.93 -11.0 1.26 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 179.838 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -167.49 -38.74 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.557 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.526 ' O ' ' CB ' ' A' ' 164' ' ' PHE . 0.4 OUTLIER 84.08 -51.93 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.583 179.209 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.457 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 0.2 OUTLIER -69.19 -37.37 78.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.35 0.595 . . . . 0.0 110.371 179.824 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.408 ' C ' ' H ' ' A' ' 164' ' ' PHE . 1.2 m-85 -72.84 -62.9 1.29 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.276 179.695 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.73 HD23 ' HB3' ' A' ' 157' ' ' GLN . 2.5 tp -66.19 -0.49 2.54 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.164 179.737 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.526 ' CB ' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER -68.83 -13.84 62.66 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.295 -178.974 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.63 -38.87 92.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.456 0.646 . . . . 0.0 109.88 178.857 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.678 HD23 ' O ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -161.63 97.55 1.25 Allowed Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.704 -179.156 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 166' ' ' LEU . 17.8 Cg_endo -60.55 117.16 3.89 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.51 2.14 . . . . 0.0 112.98 -178.976 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.568 ' HG3' HD21 ' A' ' 163' ' ' LEU . 57.3 Cg_endo -86.73 90.16 0.62 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.164 2.576 . . . . 0.0 112.516 179.866 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.772 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 7.2 tp -72.96 -41.15 60.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.171 0.51 . . . . 0.0 110.645 179.792 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.426 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.3 mp -71.63 -40.64 71.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.796 179.952 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.446 ' HA ' ' HG2' ' A' ' 178' ' ' PRO . 0.8 OUTLIER -66.63 -51.01 61.08 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.659 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -73.37 -8.23 54.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.079 178.032 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.772 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -74.64 -64.68 0.98 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.141 0.496 . . . . 0.0 110.119 179.667 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -123.64 -14.46 3.89 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.397 179.459 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.428 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 6.9 t80 77.87 -11.03 1.26 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 179.858 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -137.15 9.69 3.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.62 0.248 . . . . 0.0 111.217 179.73 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.552 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 74.4 mt -90.27 -38.15 0.41 Allowed Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.783 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 81.0 Cg_exo -43.17 -78.1 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.366 2.044 . . . . 0.0 113.151 -179.353 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 53.93 50.52 16.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.151 0.501 . . . . 0.0 110.402 -179.648 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.74 47.96 3.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.673 -179.533 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 181' ' ' HSL . . . . . 0.433 ' HB2' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.809 0.338 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 049 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.629 ' O ' HD12 ' A' ' 156' ' ' LEU . 4.6 pp -163.34 21.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.486 -179.773 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.4 -34.19 54.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.12 0.485 . . . . 0.0 110.414 179.508 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.532 ' O ' ' HB2' ' A' ' 162' ' ' PHE . 0.8 OUTLIER -80.13 35.79 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.382 -179.275 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.58 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.3 OUTLIER 75.25 -14.77 0.73 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 179.652 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.58 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 62.1 t 87.23 -48.67 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 C-N-CA 122.849 0.46 . . . . 0.0 111.983 179.522 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -66.19 -32.83 74.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.911 0.386 . . . . 0.0 111.276 -179.407 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.729 ' CZ ' HD13 ' A' ' 169' ' ' ILE . 0.6 OUTLIER -67.87 -57.87 5.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.857 179.758 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 18.5 mt -66.09 -3.68 5.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.465 0.65 . . . . 0.0 109.693 178.432 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER -76.71 2.21 14.91 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.753 -179.506 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.9 tp -173.6 -38.74 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 120.773 0.32 . . . . 0.0 111.123 179.98 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.529 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 0.7 OUTLIER -159.33 123.28 2.08 Favored Pre-proline 0 N--CA 1.451 -0.396 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.67 -178.626 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.591 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 37.6 Cg_endo -69.06 -25.67 31.63 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.475 2.117 . . . . 0.0 114.549 -179.924 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 23.8 Cg_endo -87.22 -152.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.761 1.641 . . . . 0.0 113.117 -179.252 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.729 HD13 ' CZ ' ' A' ' 162' ' ' PHE . 7.3 tp -157.78 -40.03 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.322 0.582 . . . . 0.0 109.814 -179.37 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.451 ' HA ' ' HB2' ' A' ' 173' ' ' ALA . 2.7 mp -68.28 -23.11 28.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.828 178.822 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.711 HD23 ' HD3' ' A' ' 178' ' ' PRO . 0.2 OUTLIER -65.37 -65.95 0.61 Allowed 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.385 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.525 ' HB2' HD13 ' A' ' 166' ' ' LEU . 25.5 t70 -76.69 7.15 4.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.802 178.092 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -70.21 -51.21 32.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.734 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -104.83 -19.17 11.23 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 177.811 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 16.5 t80 75.66 -10.19 1.3 Allowed 'General case' 0 C--O 1.23 0.075 0 C-N-CA 122.841 0.456 . . . . 0.0 112.005 179.626 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -96.45 -0.16 49.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.788 0.328 . . . . 0.0 110.72 179.531 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.453 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 1.0 OUTLIER -60.38 -49.31 90.93 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.25 -179.939 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.711 ' HD3' HD23 ' A' ' 171' ' ' LEU . 82.1 Cg_exo -45.56 -63.36 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.65 2.234 . . . . 0.0 112.669 -179.793 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.94 61.94 0.62 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.177 0.513 . . . . 0.0 110.556 -179.892 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.17 47.81 3.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.785 -179.872 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 050 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 120.911 0.386 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 050 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.746 ' O ' HD12 ' A' ' 156' ' ' LEU . 2.3 pp -164.74 45.73 0.1 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.981 -179.752 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.09 -35.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.517 179.828 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.691 ' HB2' HD22 ' A' ' 163' ' ' LEU . 0.8 OUTLIER -73.36 61.51 0.66 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.128 0.489 . . . . 0.0 110.239 179.641 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 73.24 -60.62 0.53 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.589 -179.388 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.3 t 69.28 -58.92 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.368 179.85 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -75.64 8.54 2.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.121 -179.838 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -167.18 9.0 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 179.949 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.691 HD22 ' HB2' ' A' ' 158' ' ' SER . 18.5 tp -64.22 -30.35 71.41 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.083 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' A' ' 163' ' ' LEU . 0.1 OUTLIER 63.47 -9.51 0.13 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.71 -1.132 . . . . 0.0 112.486 178.505 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.469 ' H ' ' C ' ' A' ' 163' ' ' LEU . 8.7 mt -69.76 -76.25 0.1 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.162 0.506 . . . . 0.0 110.71 179.234 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.419 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 0.2 OUTLIER -163.62 53.37 0.36 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.834 -179.5 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 9.5 Cg_endo -53.69 106.93 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.727 2.285 . . . . 0.0 113.025 -179.023 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.771 ' CB ' HD11 ' A' ' 171' ' ' LEU . 97.7 Cg_endo -78.73 48.63 2.84 Favored 'Trans proline' 0 CA--C 1.527 0.164 0 C-N-CA 122.974 2.45 . . . . 0.0 112.05 179.082 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.834 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 14.7 tt -77.35 -43.71 30.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.372 0.606 . . . . 0.0 111.502 -179.486 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.503 ' N ' HG23 ' A' ' 169' ' ' ILE . 1.0 OUTLIER -71.61 -45.19 68.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.487 -177.813 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.771 HD11 ' CB ' ' A' ' 168' ' ' PRO . 0.1 OUTLIER -63.74 -55.21 24.97 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.506 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -76.11 3.26 10.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.384 178.797 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.834 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.01 -52.67 13.51 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.258 0.551 . . . . 0.0 109.894 179.9 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.785 ' H ' ' HG2' ' A' ' 178' ' ' PRO . . . -121.77 -19.8 3.29 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.22 178.738 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.448 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 62.0 t80 74.28 -12.96 0.83 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.101 0.56 . . . . 0.0 112.127 179.628 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -93.96 45.84 1.16 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.729 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.675 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 12.0 mt 53.81 53.38 10.78 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.028 -178.727 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.785 ' HG2' ' H ' ' A' ' 174' ' ' GLY . 27.8 Cg_exo -65.69 64.41 0.4 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.189 2.592 . . . . 0.0 112.153 179.899 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.74 -65.91 0.94 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.936 -179.979 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.84 39.85 0.87 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.651 -179.801 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 051 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.827 0.346 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 051 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.935 ' HA ' HD22 ' A' ' 163' ' ' LEU . 33.8 mt 57.01 92.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.16 179.762 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -169.82 45.78 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.163 0.506 . . . . 0.0 111.382 179.676 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.6 m -168.31 -62.54 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.884 179.259 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.824 ' O ' ' N ' ' A' ' 161' ' ' PHE . 86.1 m-20 -89.13 -43.7 10.85 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.509 179.117 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.514 HG13 ' N ' ' A' ' 161' ' ' PHE . 13.2 p 44.44 -55.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 O-C-N 124.326 1.016 . . . . 0.0 112.156 -178.988 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.824 ' N ' ' O ' ' A' ' 159' ' ' ASP . 0.5 OUTLIER -73.99 -5.54 41.99 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.44 178.527 . . . . . . . . 3 3 . 1 . 051 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.5 ' HB3' ' HA ' ' A' ' 167' ' ' PRO . 3.7 p90 -164.57 17.7 0.05 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.77 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.935 HD22 ' HA ' ' A' ' 156' ' ' LEU . 0.8 OUTLIER -72.54 -6.67 45.59 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.318 0.58 . . . . 0.0 109.437 177.14 . . . . . . . . 3 3 . 1 . 051 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.83 -45.06 62.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.584 -178.643 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -175.42 -42.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.798 0.332 . . . . 0.0 111.329 -179.931 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.418 ' HG ' ' HD2' ' A' ' 167' ' ' PRO . 2.8 tp -162.12 141.28 7.24 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.661 -179.122 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.5 ' HA ' ' HB3' ' A' ' 162' ' ' PHE . 56.3 Cg_endo -70.66 116.72 4.78 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.259 1.973 . . . . 0.0 112.411 -179.932 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 167' ' ' PRO . 21.1 Cg_endo -61.36 81.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.457 2.105 . . . . 0.0 112.093 179.922 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.828 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 2.7 tt -73.78 -43.59 53.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.543 0.687 . . . . 0.0 110.58 179.909 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.512 ' N ' HG23 ' A' ' 169' ' ' ILE . 0.9 OUTLIER -74.66 -43.16 47.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.544 -178.931 . . . . . . . . 3 3 . 1 . 051 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.424 ' HA ' ' CG ' ' A' ' 178' ' ' PRO . 1.0 OUTLIER -65.21 -54.57 27.55 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.105 . . . . . . . . 3 3 . 1 . 051 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.12 1.23 13.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.943 178.575 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.828 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.72 -59.57 2.65 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 121.168 0.509 . . . . 0.0 110.005 179.885 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.581 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -111.73 -4.18 26.51 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.698 178.896 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.502 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER 56.07 -54.4 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.87 0.868 . . . . 0.0 112.589 179.818 . . . . . . . . 3 3 . 1 . 051 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.581 ' N ' ' O ' ' A' ' 174' ' ' GLY . 6.5 m-85 -91.82 15.28 13.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.616 0.246 . . . . 0.0 111.109 179.984 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.566 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 13.9 mt -84.14 -49.38 0.66 Allowed Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.829 179.721 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.566 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 2.7 Cg_endo -82.39 50.72 3.51 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.12 2.547 . . . . 0.0 112.25 -179.902 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.598 HD23 ' NH2' ' A' ' 180' ' ' ARG . 1.3 tp -85.59 -72.41 0.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.898 -179.987 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.598 ' NH2' HD23 ' A' ' 179' ' ' LEU . 0.0 OUTLIER -86.98 46.04 1.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.853 179.857 . . . . . . . . 3 3 . 1 . 051 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 052 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.738 0.304 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 052 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.495 ' O ' ' HB2' ' A' ' 157' ' ' GLN . 0.7 OUTLIER -73.31 -80.24 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 -179.939 . . . . . . . . 3 3 . 1 . 052 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' A' ' 156' ' ' LEU . 0.4 OUTLIER 71.57 -59.66 0.54 Allowed 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.845 -179.755 . . . . . . . . 3 3 . 1 . 052 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 162' ' ' PHE . 37.8 t -162.8 44.25 0.13 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.135 179.355 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.46 ' O ' HG12 ' A' ' 160' ' ' VAL . 2.8 t0 82.62 -5.98 1.32 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.882 -179.825 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.46 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 88.46 -47.27 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 179.197 . . . . . . . . 3 3 . 1 . 052 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.455 ' CE2' ' HB3' ' A' ' 159' ' ' ASP . 11.5 p90 -68.22 -34.07 75.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.005 0.431 . . . . 0.0 110.943 -179.542 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.72 ' CD1' HD13 ' A' ' 169' ' ' ILE . 0.1 OUTLIER -69.83 -55.74 8.98 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.979 179.822 . . . . . . . . 3 3 . 1 . 052 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.453 HD22 HE21 ' A' ' 157' ' ' GLN . 3.7 tp -65.47 -4.13 5.37 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.539 0.685 . . . . 0.0 109.639 178.437 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.424 ' H ' ' C ' ' A' ' 162' ' ' PHE . 0.4 OUTLIER -75.06 -47.52 28.47 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.584 -179.701 . . . . . . . . 3 3 . 1 . 052 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.21 -35.41 80.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.678 179.512 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.844 HD23 ' CG ' ' A' ' 168' ' ' PRO . 0.1 OUTLIER -161.0 138.23 6.7 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.784 -179.23 . . . . . . . . 3 3 . 1 . 052 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.553 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 18.4 Cg_endo -64.85 -32.57 55.37 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.325 2.017 . . . . 0.0 114.421 -179.169 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.844 ' CG ' HD23 ' A' ' 166' ' ' LEU . 28.5 Cg_endo -87.86 75.38 2.1 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.793 1.662 . . . . 0.0 112.557 -179.362 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.749 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 5.5 tp -77.47 -51.15 18.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.569 -179.875 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.603 HD13 HG23 ' A' ' 169' ' ' ILE . 5.9 mm -62.22 -30.64 49.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.775 -178.582 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 24.6 tp -65.18 -65.23 0.7 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.081 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -77.6 3.83 12.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.449 178.853 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.749 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.63 -70.27 0.33 Allowed 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.825 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 175' ' ' TYR . . . -107.11 -12.69 23.22 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.078 178.244 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 4.0 m-85 69.47 -48.02 0.6 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.703 0.401 . . . . 0.0 111.323 -179.908 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.419 ' O ' ' CG ' ' A' ' 176' ' ' PHE . 0.1 OUTLIER -91.98 -6.89 50.39 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.718 0.294 . . . . 0.0 110.364 179.358 . . . . . . . . 3 3 . 1 . 052 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.523 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 0.1 OUTLIER -52.64 -46.83 95.75 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.209 179.594 . . . . . . . . 3 3 . 1 . 052 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.523 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 24.3 Cg_exo -64.67 64.35 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.782 2.321 . . . . 0.0 112.283 179.967 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' A' ' 177' ' ' LEU . 7.6 tp -97.71 -64.97 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.702 179.816 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -87.22 35.53 0.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.591 179.746 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 053 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.884 0.373 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 053 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.689 ' HA ' HD12 ' A' ' 163' ' ' LEU . 3.5 pp -74.01 127.3 32.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.945 -179.945 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.411 ' OE1' HD21 ' A' ' 163' ' ' LEU . 0.1 OUTLIER -71.12 -71.62 0.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.962 0.41 . . . . 0.0 110.699 179.962 . . . . . . . . 3 3 . 1 . 053 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 19.4 p -163.76 33.43 0.08 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.293 179.645 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.404 ' O ' HG12 ' A' ' 160' ' ' VAL . 6.2 m-20 -162.15 -54.61 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.567 179.912 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.635 HG23 ' CB ' ' A' ' 156' ' ' LEU . 0.4 OUTLIER 77.29 -45.59 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.315 179.953 . . . . . . . . 3 3 . 1 . 053 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -75.11 10.57 1.45 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.692 179.843 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -162.84 9.03 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.447 -179.983 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.689 HD12 ' HA ' ' A' ' 156' ' ' LEU . 0.6 OUTLIER -66.12 -35.43 80.47 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.06 . . . . . . . . 3 3 . 1 . 053 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.418 ' HB3' ' O ' ' A' ' 163' ' ' LEU . 36.3 t80 70.26 3.15 4.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.322 179.018 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.528 ' HB2' HD22 ' A' ' 163' ' ' LEU . 0.1 OUTLIER -67.54 -56.52 9.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.111 0.481 . . . . 0.0 110.259 179.071 . . . . . . . . 3 3 . 1 . 053 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.479 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 0.6 OUTLIER -161.34 48.08 0.23 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.186 -179.716 . . . . . . . . 3 3 . 1 . 053 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.552 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 18.4 Cg_endo -65.31 -30.36 54.04 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.206 1.937 . . . . 0.0 114.393 -179.482 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 23.1 Cg_endo -92.25 81.41 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.037 1.825 . . . . 0.0 112.881 -179.47 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.922 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -73.31 -109.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.163 . . . . . . . . 3 3 . 1 . 053 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.605 ' HA ' HD12 ' A' ' 177' ' ' LEU . 4.7 mt 26.77 -62.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.567 0.747 . . . . 0.0 112.539 178.655 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.922 ' N ' ' O ' ' A' ' 169' ' ' ILE . 3.1 mm? -66.8 -52.38 44.62 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.699 179.914 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.03 -19.31 60.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.76 179.608 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -78.3 -73.07 0.34 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.118 -179.651 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -109.12 -25.98 5.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.601 -179.988 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.457 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 25.5 t80 74.49 -39.37 0.42 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.659 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.66 -10.02 35.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.592 0.234 . . . . 0.0 110.87 179.801 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.605 HD12 ' HA ' ' A' ' 170' ' ' ILE . 11.3 mt -49.13 -43.69 69.59 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.063 179.441 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 31.4 Cg_exo -60.07 -10.5 12.79 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.731 2.287 . . . . 0.0 113.012 -179.982 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 41.3 tp -57.97 -55.55 33.44 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.051 0.453 . . . . 0.0 110.616 179.874 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.9 43.82 1.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.939 179.659 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 181' ' ' HSL . . . . . 0.408 ' HB2' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.414 ' O ' ' CD1' ' A' ' 155' ' ' PHE . 28.0 t80 . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.818 0.342 . . . . 0.0 111.721 . . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 27.3 mt 60.06 29.96 19.48 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.022 179.649 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -170.77 -31.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.235 -179.919 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.552 ' OG ' HD13 ' A' ' 163' ' ' LEU . 92.1 p -73.52 60.85 0.67 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.099 0.476 . . . . 0.0 110.734 179.907 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.449 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.6 OUTLIER 75.53 -60.37 0.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.237 -179.987 . . . . . . . . 3 3 . 1 . 054 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 75.5 t 73.08 -48.7 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.184 -179.832 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.423 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 0.0 OUTLIER -73.92 5.49 4.14 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.259 179.27 . . . . . . . . 3 3 . 1 . 054 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.423 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 74.6 m-85 -159.83 8.01 0.1 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.667 179.852 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.552 HD13 ' OG ' ' A' ' 158' ' ' SER . 30.4 tp -72.1 -2.57 19.01 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.492 0.663 . . . . 0.0 109.432 177.504 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.576 ' HA ' ' HG3' ' A' ' 167' ' ' PRO . 35.7 t80 -62.98 -7.13 4.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.556 -179.09 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.443 ' HA ' HD22 ' A' ' 165' ' ' LEU . 0.2 OUTLIER -64.89 -38.57 91.4 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.169 0.509 . . . . 0.0 109.632 177.997 . . . . . . . . 3 3 . 1 . 054 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.519 ' N ' ' HD3' ' A' ' 167' ' ' PRO . 0.2 OUTLIER -164.57 55.79 0.45 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.378 -179.646 . . . . . . . . 3 3 . 1 . 054 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.576 ' HG3' ' HA ' ' A' ' 164' ' ' PHE . 13.5 Cg_exo -63.7 -52.67 1.69 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.226 1.951 . . . . 0.0 113.156 -179.581 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.709 ' HB3' HD11 ' A' ' 171' ' ' LEU . 42.1 Cg_endo -91.18 88.04 0.28 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.799 2.333 . . . . 0.0 113.321 -178.702 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 1.021 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 4.9 tt -79.14 -36.61 18.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.015 0.436 . . . . 0.0 111.231 179.535 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.426 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 2.4 mp -80.23 -60.79 2.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.713 -178.859 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.709 HD11 ' HB3' ' A' ' 168' ' ' PRO . 0.2 OUTLIER -63.09 -48.97 76.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.903 0.382 . . . . 0.0 110.444 -179.199 . . . . . . . . 3 3 . 1 . 054 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.528 ' HB2' ' HG2' ' A' ' 168' ' ' PRO . 0.6 OUTLIER -73.14 -2.79 22.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.859 179.088 . . . . . . . . 3 3 . 1 . 054 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 1.021 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -74.3 -66.86 0.68 Allowed 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.179 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -123.54 -11.56 4.98 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.016 178.889 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 20.0 t80 77.64 -30.08 0.16 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 122.624 0.369 . . . . 0.0 111.842 -179.895 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -99.82 13.97 31.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.67 0.271 . . . . 0.0 111.192 179.775 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.554 HD12 ' HB3' ' A' ' 173' ' ' ALA . 6.0 mt -87.05 -46.84 0.51 Allowed Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.394 -179.842 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 66.9 Cg_exo -50.3 -22.58 8.68 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.291 1.994 . . . . 0.0 112.473 179.786 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.81 -9.37 43.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.88 -179.689 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -147.66 47.82 1.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.964 0.411 . . . . 0.0 110.487 179.953 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 055 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 66.3 t80 . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 055 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.39 101.83 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.129 179.457 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -169.79 89.67 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.022 -179.992 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.8 t 66.93 61.62 0.5 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.851 179.879 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.568 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.8 OUTLIER 70.81 -57.17 0.6 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.355 179.816 . . . . . . . . 3 3 . 1 . 055 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.568 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 85.2 t 83.53 -65.3 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.22 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.404 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 0.3 OUTLIER -75.67 48.24 0.45 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.263 178.41 . . . . . . . . 3 3 . 1 . 055 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.404 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 3.7 m-85 -169.53 -30.54 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.737 -179.876 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.589 ' O ' ' N ' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -56.33 -60.47 3.47 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 178.156 . . . . . . . . 3 3 . 1 . 055 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 9.2 t80 58.59 -34.36 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.328 175.92 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.589 ' N ' ' O ' ' A' ' 163' ' ' LEU . 7.8 mt -63.06 -43.07 99.62 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.007 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.574 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 0.2 OUTLIER -163.15 78.49 1.73 Allowed Pre-proline 0 N--CA 1.453 -0.279 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.486 -178.994 . . . . . . . . 3 3 . 1 . 055 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.4 ' HA ' ' HD2' ' A' ' 168' ' ' PRO . 36.9 Cg_endo -66.6 105.97 1.0 Allowed 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.2 1.933 . . . . 0.0 111.802 179.47 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.574 ' HD3' ' O ' ' A' ' 166' ' ' LEU . 72.4 Cg_endo -74.02 44.82 1.04 Allowed 'Trans proline' 0 CA--C 1.529 0.232 0 C-N-CA 122.952 2.435 . . . . 0.0 113.149 -179.718 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.998 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 23.0 pt -79.34 -43.72 23.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -179.886 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.458 HD12 ' H ' ' A' ' 170' ' ' ILE . 3.3 mp -76.76 -47.31 28.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.01 -179.252 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 38.1 tp -63.86 -54.48 34.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.346 0.593 . . . . 0.0 109.56 179.751 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.22 -3.47 26.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.849 179.014 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.998 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.96 -73.7 0.2 Allowed 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.299 0.571 . . . . 0.0 109.555 179.484 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -118.52 -13.54 6.77 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.509 178.647 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 5.5 t80 76.37 -45.51 0.51 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.474 0.31 . . . . 0.0 111.363 179.97 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -94.4 -9.37 35.91 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.672 0.272 . . . . 0.0 111.056 179.892 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.558 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 22.7 mt -51.44 -41.66 77.76 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.069 179.452 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 52.2 Cg_exo -54.87 -152.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.605 2.203 . . . . 0.0 112.187 179.752 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 178' ' ' PRO . 0.9 OUTLIER 74.12 71.85 0.11 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.232 0.539 . . . . 0.0 110.29 -179.693 . . . . . . . . 3 3 . 1 . 055 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 69.95 52.68 0.39 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.927 -179.78 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 056 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.555 0.217 . . . . 0.0 111.159 . . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' A' ' 156' ' ' LEU . 5.1 mt -168.73 169.71 9.83 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.882 0.372 . . . . 0.0 111.234 -179.579 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -170.36 79.4 0.09 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.897 179.873 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 51.66 69.6 0.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.105 179.995 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.578 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER 70.67 -57.27 0.59 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.44 179.876 . . . . . . . . 3 3 . 1 . 056 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.578 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 95.0 t 85.05 -59.88 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 122.827 0.451 . . . . 0.0 110.312 -179.555 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.468 ' O ' ' CG ' ' A' ' 161' ' ' PHE . 0.1 OUTLIER -74.45 41.35 0.14 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.994 179.205 . . . . . . . . 3 3 . 1 . 056 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.477 ' CE1' ' HB2' ' A' ' 159' ' ' ASP . 0.0 OUTLIER -173.43 -21.51 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.552 179.544 . . . . . . . . 3 3 . 1 . 056 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.573 ' C ' ' H ' ' A' ' 165' ' ' LEU . 5.1 tt -53.68 -53.12 56.45 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 178.223 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 3.1 t80 59.66 -29.72 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 114.846 -1.07 . . . . 0.0 113.489 176.412 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.573 ' H ' ' C ' ' A' ' 163' ' ' LEU . 1.4 tp -178.1 -32.29 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.068 0.461 . . . . 0.0 110.582 -179.377 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.53 ' N ' HD23 ' A' ' 163' ' ' LEU . 0.1 OUTLIER -158.02 114.36 1.79 Allowed Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.479 -179.367 . . . . . . . . 3 3 . 1 . 056 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.464 ' HD3' HD21 ' A' ' 163' ' ' LEU . 90.2 Cg_endo -83.51 106.76 1.34 Allowed 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.25 1.967 . . . . 0.0 112.789 -179.018 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 167' ' ' PRO . 55.7 Cg_endo -68.79 62.88 1.27 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.381 2.054 . . . . 0.0 111.679 179.406 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.989 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER -75.02 -43.97 44.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.426 -179.363 . . . . . . . . 3 3 . 1 . 056 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.444 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.2 mp -73.4 -47.55 45.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.676 -179.254 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.493 HD23 ' N ' ' A' ' 172' ' ' ASP . 0.3 OUTLIER -65.99 -56.81 9.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.13 0.49 . . . . 0.0 109.874 179.802 . . . . . . . . 3 3 . 1 . 056 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.493 ' N ' HD23 ' A' ' 171' ' ' LEU . 0.3 OUTLIER -75.02 5.11 5.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.693 179.358 . . . . . . . . 3 3 . 1 . 056 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.989 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.34 -63.69 1.1 Allowed 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.54 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 175' ' ' TYR . . . -112.05 -11.88 15.21 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.382 178.495 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.438 ' HB2' ' O ' ' A' ' 174' ' ' GLY . 16.0 m-85 68.3 -50.74 0.55 Allowed 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 122.687 0.395 . . . . 0.0 111.36 179.915 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -91.38 -7.26 51.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.801 179.719 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.498 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 12.1 mt -50.26 -47.56 82.24 Favored Pre-proline 0 CA--C 1.529 0.145 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.695 179.44 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 71.1 Cg_exo -50.39 -174.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.76 2.307 . . . . 0.0 112.22 179.483 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 178' ' ' PRO . 0.3 OUTLIER 80.02 73.91 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.112 0.482 . . . . 0.0 110.34 -179.767 . . . . . . . . 3 3 . 1 . 056 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 24.9 mtm180 68.87 56.25 0.43 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.758 -179.609 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 057 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.861 0.362 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 057 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 157' ' ' GLN . 4.3 pp -165.34 -170.64 1.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.034 -179.592 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.631 ' N ' HD12 ' A' ' 156' ' ' LEU . 1.1 mm-40 -169.73 91.19 0.21 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.621 179.933 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.785 ' HB3' HD13 ' A' ' 163' ' ' LEU . 0.6 OUTLIER 63.29 32.81 14.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.148 -179.607 . . . . . . . . 3 3 . 1 . 057 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.417 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER 78.43 -51.68 0.48 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.194 -179.693 . . . . . . . . 3 3 . 1 . 057 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 76.4 t 69.88 -60.38 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 121.129 0.49 . . . . 0.0 110.847 -179.754 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -76.67 10.33 2.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.077 179.088 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -165.05 14.06 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.223 -179.836 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.785 HD13 ' HB3' ' A' ' 158' ' ' SER . 0.9 OUTLIER -67.75 -39.46 84.19 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.196 . . . . . . . . 3 3 . 1 . 057 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.49 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER 47.71 29.2 1.46 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.466 179.886 . . . . . . . . 3 3 . 1 . 057 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.49 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.2 OUTLIER 89.82 -30.39 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.219 -179.379 . . . . . . . . 3 3 . 1 . 057 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.86 83.34 1.52 Allowed Pre-proline 0 N--CA 1.449 -0.478 0 CA-C-O 120.732 0.301 . . . . 0.0 110.749 -178.884 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.767 ' CD ' HD12 ' A' ' 163' ' ' LEU . 33.6 Cg_endo -65.32 109.5 1.38 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.536 2.157 . . . . 0.0 112.416 -179.611 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.815 ' O ' HD12 ' A' ' 170' ' ' ILE . 72.6 Cg_endo -74.38 -158.38 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.422 2.081 . . . . 0.0 111.567 179.467 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.753 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.5 OUTLIER 80.66 -41.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.295 -179.66 . . . . . . . . 3 3 . 1 . 057 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.815 HD12 ' O ' ' A' ' 168' ' ' PRO . 3.5 mp -73.98 -42.73 52.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.847 179.992 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 10.5 mt -63.43 -54.51 35.45 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.214 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.88 0.48 15.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.824 178.446 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.753 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.06 -77.51 0.1 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.893 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.491 ' HA3' HD12 ' A' ' 177' ' ' LEU . . . -98.46 -3.17 57.55 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.386 178.392 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER 71.55 -61.52 0.49 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.91 0.386 . . . . 0.0 110.838 179.987 . . . . . . . . 3 3 . 1 . 057 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.897 ' O ' HD13 ' A' ' 179' ' ' LEU . 36.8 p90 -107.67 -17.84 13.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.231 179.934 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.51 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 66.3 mt -54.53 -43.8 98.35 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.757 -179.584 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 24.4 Cg_exo -65.23 68.83 0.3 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.657 2.238 . . . . 0.0 112.742 -179.573 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.897 HD13 ' O ' ' A' ' 176' ' ' PHE . 4.0 mp -117.24 -16.24 10.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.96 0.41 . . . . 0.0 111.049 179.504 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -149.06 52.97 0.97 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.404 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 058 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 18.2 p90 . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.764 0.316 . . . . 0.0 111.297 . . . . . . . . . 0 0 . 1 . 058 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.435 ' O ' ' CB ' ' A' ' 157' ' ' GLN . 20.9 mt 60.69 179.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.883 179.952 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.435 ' CB ' ' O ' ' A' ' 156' ' ' LEU . 0.1 OUTLIER 84.87 48.68 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.265 0.555 . . . . 0.0 110.35 -179.697 . . . . . . . . 3 3 . 1 . 058 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 31.4 t -164.11 35.83 0.08 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.1 179.773 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.527 ' O ' HG12 ' A' ' 160' ' ' VAL . 0.9 OUTLIER 79.02 -41.73 0.28 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.091 -179.475 . . . . . . . . 3 3 . 1 . 058 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 88.73 -42.07 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.207 179.963 . . . . . . . . 3 3 . 1 . 058 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.438 ' HA ' ' HB2' ' A' ' 164' ' ' PHE . 0.5 OUTLIER -68.04 -26.84 66.07 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.0 0.428 . . . . 0.0 110.581 179.515 . . . . . . . . 3 3 . 1 . 058 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -67.74 -60.31 2.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.599 179.562 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 17.4 mt -66.26 -4.4 7.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.706 178.534 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.438 ' HB2' ' HA ' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -74.71 -8.28 55.92 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.251 -179.509 . . . . . . . . 3 3 . 1 . 058 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.32 -34.31 78.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.101 0.477 . . . . 0.0 110.275 179.112 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.461 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 0.2 OUTLIER -162.08 63.37 1.51 Allowed Pre-proline 0 N--CA 1.452 -0.33 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.895 -179.535 . . . . . . . . 3 3 . 1 . 058 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -61.32 107.06 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.719 2.279 . . . . 0.0 113.063 -179.005 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.611 ' HA ' HD21 ' A' ' 171' ' ' LEU . 93.4 Cg_endo -76.82 86.17 1.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.865 2.377 . . . . 0.0 111.523 178.983 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.766 HD13 ' O ' ' A' ' 169' ' ' ILE . 0.0 OUTLIER -162.01 -42.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.587 0.708 . . . . 0.0 110.832 -179.114 . . . . . . . . 3 3 . 1 . 058 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.638 ' CG1' HD13 ' A' ' 171' ' ' LEU . 11.1 pt -68.15 -38.37 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.57 -178.355 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.833 HD13 ' H ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -60.73 -57.3 13.29 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.085 . . . . . . . . 3 3 . 1 . 058 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.21 -2.65 35.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.845 178.334 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.7 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.03 -67.24 0.58 Allowed 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 121.056 0.455 . . . . 0.0 110.088 -179.93 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -109.34 -16.47 11.1 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.734 178.942 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.534 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.5 OUTLIER 77.33 -12.93 1.0 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 179.924 . . . . . . . . 3 3 . 1 . 058 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -120.86 -12.51 8.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.557 0.218 . . . . 0.0 111.327 -179.981 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.541 ' O ' HD23 ' A' ' 179' ' ' LEU . 83.5 mt -55.29 -41.72 92.18 Favored Pre-proline 0 CA--C 1.531 0.233 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.782 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 52.5 Cg_exo -56.18 76.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.501 2.134 . . . . 0.0 112.98 -179.64 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 177' ' ' LEU . 0.4 OUTLIER -115.36 -6.91 12.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.941 0.4 . . . . 0.0 110.931 179.337 . . . . . . . . 3 3 . 1 . 058 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.434 ' HD3' HD12 ' A' ' 179' ' ' LEU . 0.0 OUTLIER -150.94 43.42 0.8 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.463 . . . . . . . . 3 3 . 1 . 058 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 059 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.645 ' CD2' HG21 ' A' ' 160' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.703 0.287 . . . . 0.0 111.111 . . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.729 HD12 ' N ' ' A' ' 157' ' ' GLN . 3.6 pp -165.21 -168.47 1.4 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.895 -179.91 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.729 ' N ' HD12 ' A' ' 156' ' ' LEU . 0.0 OUTLIER 79.24 82.08 0.06 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.02 0.438 . . . . 0.0 110.85 -179.772 . . . . . . . . 3 3 . 1 . 059 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.3 p 50.95 51.44 17.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.194 179.971 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.546 ' O ' HG12 ' A' ' 160' ' ' VAL . 0.4 OUTLIER 74.13 -52.52 0.69 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.471 179.774 . . . . . . . . 3 3 . 1 . 059 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.645 HG21 ' CD2' ' A' ' 155' ' ' PHE . 0.3 OUTLIER 94.23 -40.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.016 0.527 . . . . 0.0 110.952 -179.698 . . . . . . . . 3 3 . 1 . 059 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -70.01 -30.14 67.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.041 0.448 . . . . 0.0 110.55 179.529 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.425 ' C ' ' H ' ' A' ' 164' ' ' PHE . 3.3 m-85 -67.66 -59.26 3.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.747 179.723 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.1 mt -65.68 -3.55 4.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.846 178.593 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.425 ' H ' ' C ' ' A' ' 162' ' ' PHE . 1.6 t80 -74.11 -19.2 60.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.101 -179.584 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.2 -35.38 80.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.059 0.457 . . . . 0.0 110.637 179.544 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' A' ' 166' ' ' LEU . 4.5 mt -162.17 71.32 2.29 Favored Pre-proline 0 N--CA 1.45 -0.442 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.446 -178.884 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.415 ' CB ' ' HD3' ' A' ' 168' ' ' PRO . 4.0 Cg_exo -36.71 -49.12 1.42 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.517 2.811 . . . . 0.0 113.609 -179.587 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.778 ' O ' HD12 ' A' ' 170' ' ' ILE . 61.4 Cg_endo -88.64 -52.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.362 2.041 . . . . 0.0 113.077 -179.161 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.825 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.0 OUTLIER 81.02 -45.19 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 179.439 . . . . . . . . 3 3 . 1 . 059 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.778 HD12 ' O ' ' A' ' 168' ' ' PRO . 2.3 mp -73.11 -47.13 48.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.882 0.372 . . . . 0.0 111.783 -179.195 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.56 -0.58 5.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.058 -179.873 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -147.05 15.27 1.17 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.468 -179.926 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.825 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -79.93 -47.31 15.22 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.911 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.418 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -129.77 -22.64 1.14 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.981 178.684 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 34.9 t80 71.62 -12.59 0.62 Allowed 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 122.507 0.323 . . . . 0.0 111.386 -179.344 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.418 ' H ' ' C ' ' A' ' 174' ' ' GLY . 7.2 t80 -96.02 -6.42 38.85 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.795 0.331 . . . . 0.0 110.143 178.959 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.442 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 1.4 mm? -47.8 -52.15 41.19 Favored Pre-proline 0 CA--C 1.529 0.142 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.311 179.506 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.442 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 49.5 Cg_exo -57.41 -157.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.66 2.24 . . . . 0.0 112.057 179.296 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.406 ' CB ' ' O ' ' A' ' 178' ' ' PRO . 9.5 tp 81.93 -9.8 1.19 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.757 179.961 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.59 31.21 0.52 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.448 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 060 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.408 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.572 0.225 . . . . 0.0 111.181 . . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.827 ' CD2' HG23 ' A' ' 160' ' ' VAL . 32.3 mt -161.14 23.64 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.448 -179.88 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.05 -27.56 60.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.052 0.453 . . . . 0.0 110.278 179.245 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 162' ' ' PHE . 0.6 OUTLIER -78.3 8.36 5.12 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.012 -179.807 . . . . . . . . 3 3 . 1 . 060 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.405 ' O ' ' CB ' ' A' ' 160' ' ' VAL . 0.3 OUTLIER 79.87 -6.64 1.75 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 179.896 . . . . . . . . 3 3 . 1 . 060 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.827 HG23 ' CD2' ' A' ' 156' ' ' LEU . 0.4 OUTLIER 82.99 -54.69 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-O 120.822 0.344 . . . . 0.0 110.513 -179.949 . . . . . . . . 3 3 . 1 . 060 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.501 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 67.5 m-85 -78.24 34.11 0.2 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.092 179.115 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.501 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 53.6 m-85 -166.79 -18.15 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.741 -0.208 . . . . 0.0 111.518 -179.77 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.548 ' C ' ' H ' ' A' ' 165' ' ' LEU . 15.0 tp -59.27 -40.98 87.78 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.311 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.441 ' CE2' ' CD1' ' A' ' 165' ' ' LEU . 0.0 OUTLIER 64.57 -25.29 0.08 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.335 178.065 . . . . . . . . 3 3 . 1 . 060 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.548 ' H ' ' C ' ' A' ' 163' ' ' LEU . 4.5 mp -67.57 -67.98 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.938 0.399 . . . . 0.0 111.115 -179.99 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.536 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 0.2 OUTLIER -162.81 102.85 1.04 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.13 -179.493 . . . . . . . . 3 3 . 1 . 060 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.593 ' CB ' HG22 ' A' ' 160' ' ' VAL . 97.0 Cg_endo -86.76 98.23 0.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.56 2.173 . . . . 0.0 113.231 -179.115 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 166' ' ' LEU . 42.2 Cg_endo -64.79 72.19 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.678 2.252 . . . . 0.0 111.591 179.032 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.966 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 3.5 tp -76.97 -37.3 26.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.755 -179.276 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.856 HD13 HG23 ' A' ' 169' ' ' ILE . 8.1 mm -73.79 -51.71 23.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.193 -178.781 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 171' ' ' LEU . 3.4 mm? -64.14 -49.17 73.21 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.715 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -75.03 -4.08 36.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.955 178.516 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.966 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.17 -68.37 0.5 Allowed 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.234 0.54 . . . . 0.0 109.714 179.656 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.615 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -121.72 -8.89 7.25 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.939 178.929 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.49 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.2 OUTLIER 55.76 -53.58 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.883 0.873 . . . . 0.0 112.416 -179.994 . . . . . . . . 3 3 . 1 . 060 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.615 ' N ' ' O ' ' A' ' 174' ' ' GLY . 29.0 t80 -90.36 -4.94 56.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.611 0.244 . . . . 0.0 110.744 179.789 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 179' ' ' LEU . 16.8 mt -52.54 -49.38 86.17 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.889 179.47 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.498 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 84.2 Cg_exo -46.15 82.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.011 2.474 . . . . 0.0 112.748 179.538 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 177' ' ' LEU . 0.3 OUTLIER -94.34 -61.76 1.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.061 179.568 . . . . . . . . 3 3 . 1 . 060 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.01 38.12 0.79 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.811 179.028 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 061 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.418 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 5.2 p90 . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.74 0.305 . . . . 0.0 111.144 . . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 155' ' ' PHE . 20.7 mt -163.32 -177.88 5.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.847 -179.982 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 78.33 65.42 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.782 -179.825 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.405 ' HB3' ' CD1' ' A' ' 163' ' ' LEU . 0.3 OUTLIER 58.87 58.81 3.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.521 -179.928 . . . . . . . . 3 3 . 1 . 061 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 73.7 -58.99 0.57 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.913 -179.64 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.424 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 84.32 -48.33 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.914 -179.843 . . . . . . . . 3 3 . 1 . 061 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.462 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 15.7 t80 -76.47 23.91 0.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.716 179.691 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.462 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 19.6 m-85 -168.63 -10.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.953 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.929 HD22 ' HB2' ' A' ' 165' ' ' LEU . 0.4 OUTLIER -61.9 -48.86 78.57 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.235 . . . . . . . . 3 3 . 1 . 061 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 58.11 -0.61 0.1 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.23 -0.895 . . . . 0.0 112.168 178.473 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.929 ' HB2' HD22 ' A' ' 163' ' ' LEU . 0.6 OUTLIER -71.34 -36.83 71.68 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 120.803 0.335 . . . . 0.0 111.573 179.883 . . . . . . . . 3 3 . 1 . 061 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.951 ' O ' HD22 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -158.7 95.02 1.84 Allowed Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-O 121.477 0.656 . . . . 0.0 112.644 -176.976 . . . . . . . . 3 3 . 1 . 061 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.585 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 17.7 Cg_endo -65.76 -28.96 51.3 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.246 1.964 . . . . 0.0 113.974 -179.981 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.62 ' HB2' HD13 ' A' ' 171' ' ' LEU . 20.4 Cg_endo -92.59 93.57 0.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.143 1.895 . . . . 0.0 112.764 -179.359 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.784 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 2.1 tt -75.26 -33.28 27.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.3 -179.925 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.519 ' H ' HD12 ' A' ' 170' ' ' ILE . 4.2 mp -67.58 -35.05 71.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.342 -179.22 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.62 HD13 ' HB2' ' A' ' 168' ' ' PRO . 0.9 OUTLIER -66.31 -60.51 2.71 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.897 . . . . . . . . 3 3 . 1 . 061 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.917 ' OD2' HD23 ' A' ' 166' ' ' LEU . 1.6 p30 -76.29 4.46 8.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.269 178.692 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.784 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.94 -68.52 0.45 Allowed 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.741 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.418 ' HA3' ' CG ' ' A' ' 177' ' ' LEU . . . -103.37 -13.76 27.66 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 178.032 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.452 ' CG ' ' N ' ' A' ' 176' ' ' PHE . 0.0 OUTLIER 72.64 -53.56 0.7 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.53 0.332 . . . . 0.0 111.534 179.48 . . . . . . . . 3 3 . 1 . 061 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.452 ' N ' ' CG ' ' A' ' 175' ' ' TYR . 26.1 t80 -93.84 18.99 9.43 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.359 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.472 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 6.2 mt -88.12 -47.35 0.46 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.715 -0.221 . . . . 0.0 111.227 179.673 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.534 ' O ' ' HG2' ' A' ' 181' ' ' HSL . 32.2 Cg_exo -58.33 -22.16 56.49 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.463 2.108 . . . . 0.0 112.353 -179.955 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.13 -58.77 5.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.763 179.984 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -88.31 29.2 0.99 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.961 179.954 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 181' ' ' HSL . . . . . 0.534 ' HG2' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.609 ' HE1' HG21 ' A' ' 160' ' ' VAL . 38.5 p90 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.727 0.299 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.568 HD12 ' O ' ' A' ' 155' ' ' PHE . 1.2 mp -164.71 141.66 6.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.925 179.969 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -170.51 78.51 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.069 179.948 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 16.0 m 53.42 69.26 0.72 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.015 179.898 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.469 ' O ' HG12 ' A' ' 160' ' ' VAL . 0.4 OUTLIER 72.85 -59.47 0.57 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.816 -179.786 . . . . . . . . 3 3 . 1 . 062 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.609 HG21 ' HE1' ' A' ' 155' ' ' PHE . 0.4 OUTLIER 90.47 -46.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.363 179.786 . . . . . . . . 3 3 . 1 . 062 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.423 ' CD1' HG21 ' A' ' 169' ' ' ILE . 8.6 m-85 -70.36 -34.05 72.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.0 0.429 . . . . 0.0 110.958 179.998 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.412 ' C ' ' H ' ' A' ' 164' ' ' PHE . 0.1 OUTLIER -68.54 -59.37 3.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.159 179.913 . . . . . . . . 3 3 . 1 . 062 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 25.2 mt -66.52 -3.28 5.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.975 178.839 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.717 ' CE2' HD12 ' A' ' 169' ' ' ILE . 0.1 OUTLIER -77.66 11.9 1.89 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.944 -179.374 . . . . . . . . 3 3 . 1 . 062 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.547 ' O ' HD13 ' A' ' 165' ' ' LEU . 0.2 OUTLIER 89.6 -25.52 0.07 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.678 0.391 . . . . 0.0 112.002 179.5 . . . . . . . . 3 3 . 1 . 062 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.584 HD23 ' HD2' ' A' ' 168' ' ' PRO . 0.1 OUTLIER -162.33 129.86 2.68 Favored Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.814 -178.488 . . . . . . . . 3 3 . 1 . 062 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.52 ' HG2' ' HD3' ' A' ' 168' ' ' PRO . 1.3 Cg_endo -48.58 -42.31 35.81 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.885 2.39 . . . . 0.0 113.717 -179.902 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.584 ' HD2' HD23 ' A' ' 166' ' ' LEU . 37.7 Cg_endo -87.04 76.6 2.23 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.254 1.969 . . . . 0.0 113.354 -178.834 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.889 ' O ' ' N ' ' A' ' 171' ' ' LEU . 2.5 tt -72.37 -90.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.271 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.834 ' H ' HG23 ' A' ' 169' ' ' ILE . 14.7 mt 25.62 -63.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 123.676 0.79 . . . . 0.0 112.762 177.863 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.889 ' N ' ' O ' ' A' ' 169' ' ' ILE . 17.4 mt -66.5 -43.63 84.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.246 -179.628 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.59 -15.88 60.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.35 -179.924 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -76.16 -90.34 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.337 179.966 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.483 ' HA3' HD12 ' A' ' 177' ' ' LEU . . . -105.55 -10.64 30.72 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.642 178.784 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.409 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 60.7 t80 68.3 -61.26 0.4 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.925 0.393 . . . . 0.0 110.411 -179.629 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 174' ' ' GLY . 21.3 t80 -107.81 10.92 28.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.87 179.112 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.63 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 71.6 mt -91.59 -49.91 0.32 Allowed Pre-proline 0 CA--C 1.53 0.174 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -179.673 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.792 ' HB2' HG23 ' A' ' 170' ' ' ILE . 3.0 Cg_exo -76.23 -68.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.682 2.255 . . . . 0.0 112.317 -179.79 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.1 tp 69.54 63.81 0.26 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.597 -179.854 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.577 HH21 HD21 ' A' ' 171' ' ' LEU . 5.2 mmp_? 60.95 47.99 7.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.671 -179.869 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 063 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.663 ' HD1' HD23 ' A' ' 156' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.908 0.385 . . . . 0.0 111.301 . . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.816 ' CB ' HG23 ' A' ' 160' ' ' VAL . 0.2 OUTLIER 55.06 -177.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.404 179.863 . . . . . . . . 3 3 . 1 . 063 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.419 ' HB2' ' CD2' ' A' ' 163' ' ' LEU . 1.7 mt-30 -169.59 -58.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.677 179.854 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 30.2 t -163.88 29.89 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.047 0.451 . . . . 0.0 111.332 179.618 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -165.8 -54.57 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.875 179.428 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.816 HG23 ' CB ' ' A' ' 156' ' ' LEU . 0.4 OUTLIER 67.46 -53.43 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.725 179.616 . . . . . . . . 3 3 . 1 . 063 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.476 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 0.1 OUTLIER -74.83 3.01 8.84 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.755 . . . . . . . . 3 3 . 1 . 063 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.534 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 0.0 OUTLIER -167.14 9.56 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.994 . . . . . . . . 3 3 . 1 . 063 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.469 ' CD2' ' HB2' ' A' ' 165' ' ' LEU . 12.1 tp -63.86 -33.82 76.54 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.727 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 10.3 t80 57.64 6.93 0.48 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.631 178.221 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.469 ' HB2' ' CD2' ' A' ' 163' ' ' LEU . 0.2 OUTLIER -70.35 -42.71 71.49 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.131 0.491 . . . . 0.0 110.534 179.252 . . . . . . . . 3 3 . 1 . 063 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.96 129.32 2.93 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.441 -179.496 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.411 ' HB2' HG12 ' A' ' 169' ' ' ILE . 14.9 Cg_endo -57.6 119.52 6.83 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.376 2.05 . . . . 0.0 112.216 -179.713 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -86.24 29.38 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.927 2.418 . . . . 0.0 113.232 -179.547 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.878 ' O ' ' N ' ' A' ' 171' ' ' LEU . 3.0 pt -75.44 -111.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.304 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.74 HG22 ' HG3' ' A' ' 178' ' ' PRO . 3.2 mp 33.78 -60.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 123.889 0.876 . . . . 0.0 113.139 178.597 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.878 ' N ' ' O ' ' A' ' 169' ' ' ILE . 0.1 OUTLIER -64.07 -44.48 92.27 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.856 -179.587 . . . . . . . . 3 3 . 1 . 063 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 52.7 p30 -71.72 -10.26 59.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.975 179.818 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -78.29 -63.08 1.48 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.844 0.354 . . . . 0.0 110.815 179.925 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -114.63 -21.78 5.31 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.325 179.751 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER 76.79 -10.98 1.24 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.878 . . . . . . . . 3 3 . 1 . 063 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.8 7.87 3.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.715 0.293 . . . . 0.0 111.011 179.609 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.551 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 98.0 mt -84.0 -41.79 0.76 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.347 179.856 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.74 ' HG3' HG22 ' A' ' 170' ' ' ILE . 52.7 Cg_exo -53.87 -168.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.447 2.098 . . . . 0.0 112.384 -179.876 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.422 ' O ' ' HG3' ' A' ' 180' ' ' ARG . 0.6 OUTLIER 81.65 -9.7 1.23 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.474 -179.815 . . . . . . . . 3 3 . 1 . 063 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 179' ' ' LEU . 8.2 mtm180 -149.48 29.32 0.78 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.41 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 064 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.791 0.329 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 064 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.566 ' C ' HD12 ' A' ' 156' ' ' LEU . 4.4 pp -164.49 -175.12 3.73 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.168 -179.634 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -169.15 -84.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.919 179.813 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.921 ' HB2' HD21 ' A' ' 163' ' ' LEU . 0.5 OUTLIER -76.52 60.22 1.59 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.865 0.364 . . . . 0.0 110.648 179.671 . . . . . . . . 3 3 . 1 . 064 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.408 ' CB ' ' O ' ' A' ' 158' ' ' SER . 0.8 OUTLIER 79.91 -45.05 0.3 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.668 -179.813 . . . . . . . . 3 3 . 1 . 064 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.429 HG21 ' HB3' ' A' ' 156' ' ' LEU . 0.4 OUTLIER 82.42 -48.72 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 120.881 0.372 . . . . 0.0 110.942 -179.707 . . . . . . . . 3 3 . 1 . 064 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.445 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 4.2 m-30 -76.95 26.2 0.14 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.174 179.341 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.445 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 61.0 m-85 -162.95 -1.4 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.197 -179.892 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.921 HD21 ' HB2' ' A' ' 158' ' ' SER . 0.8 OUTLIER -64.31 -37.25 86.84 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.906 . . . . . . . . 3 3 . 1 . 064 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 67.0 10.21 7.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.748 178.922 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -67.57 -56.77 8.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.013 0.435 . . . . 0.0 110.259 179.132 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.586 ' C ' HD12 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -162.88 107.12 1.03 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.876 -179.992 . . . . . . . . 3 3 . 1 . 064 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.15 111.01 2.84 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.25 1.967 . . . . 0.0 112.96 -179.08 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.445 ' O ' ' CB ' ' A' ' 172' ' ' ASP . 61.5 Cg_endo -83.49 37.08 0.63 Allowed 'Trans proline' 0 CA--C 1.527 0.155 0 C-N-CA 123.064 2.509 . . . . 0.0 112.52 179.578 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 1.003 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 9.4 tt -75.97 -43.55 38.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.811 0.338 . . . . 0.0 111.673 -179.351 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.505 HD12 HG22 ' A' ' 169' ' ' ILE . 3.3 mp -76.65 -52.26 17.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.226 -179.144 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.681 HD23 ' H ' ' A' ' 172' ' ' ASP . 0.0 OUTLIER -64.57 -52.72 56.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.085 0.469 . . . . 0.0 109.953 -179.633 . . . . . . . . 3 3 . 1 . 064 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.681 ' H ' HD23 ' A' ' 171' ' ' LEU . 0.4 OUTLIER -74.45 -0.31 17.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.206 179.129 . . . . . . . . 3 3 . 1 . 064 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 1.003 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.62 -69.79 0.39 Allowed 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.408 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -120.88 -11.21 6.51 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.523 178.571 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.479 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 26.3 t80 70.51 -18.31 0.25 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.729 0.412 . . . . 0.0 111.801 -179.913 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.431 ' H ' ' C ' ' A' ' 174' ' ' GLY . 0.3 OUTLIER -97.93 20.61 11.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.858 0.361 . . . . 0.0 110.668 179.849 . . . . . . . . 3 3 . 1 . 064 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.542 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 3.3 mm? -86.47 -46.02 0.56 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.538 -179.749 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.542 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 31.7 Cg_exo -58.49 -77.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.339 2.026 . . . . 0.0 112.361 -179.758 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 180' ' ' ARG . 0.2 OUTLIER 52.98 51.12 16.46 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.018 0.437 . . . . 0.0 110.716 -179.952 . . . . . . . . 3 3 . 1 . 064 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 179' ' ' LEU . 5.1 mmt180 65.63 43.93 3.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.996 179.969 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 181' ' ' HSL . . . . . 0.488 ' HB2' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.776 0.322 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 065 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.443 ' O ' ' CB ' ' A' ' 157' ' ' GLN . 0.6 OUTLIER -75.37 -162.89 0.21 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 -179.961 . . . . . . . . 3 3 . 1 . 065 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.443 ' CB ' ' O ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER 83.38 77.95 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.993 0.425 . . . . 0.0 110.985 -179.954 . . . . . . . . 3 3 . 1 . 065 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 12.4 t 67.43 32.48 5.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.215 179.671 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.607 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 1.7 t0 75.75 -45.05 0.53 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.663 179.793 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.607 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 97.0 t 88.22 -47.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 123.061 0.545 . . . . 0.0 111.013 -179.661 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -67.63 -30.88 70.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.109 0.48 . . . . 0.0 110.368 179.507 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -69.35 -59.18 3.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.822 179.389 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.502 ' CD1' HG23 ' A' ' 169' ' ' ILE . 16.6 tp -66.15 -4.36 7.38 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.875 178.683 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.1 OUTLIER -75.85 -40.94 53.73 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.904 -179.483 . . . . . . . . 3 3 . 1 . 065 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.6 tp -65.69 -34.59 78.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.786 179.67 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.551 HD23 ' O ' ' A' ' 166' ' ' LEU . 0.6 OUTLIER -160.05 119.48 1.63 Allowed Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.144 -178.749 . . . . . . . . 3 3 . 1 . 065 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.581 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 18.6 Cg_endo -63.06 -29.63 75.2 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.275 1.983 . . . . 0.0 114.312 -179.622 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 30.2 Cg_endo -90.5 91.57 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.886 1.724 . . . . 0.0 113.143 -179.21 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.852 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 24.8 pt -75.6 -42.08 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.752 0.787 . . . . 0.0 110.718 179.35 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.601 ' N ' HG13 ' A' ' 169' ' ' ILE . 2.1 pt -70.28 -41.73 78.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 113.974 -1.466 . . . . 0.0 112.157 -177.777 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 1.0 OUTLIER -61.84 -57.73 10.68 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.096 . . . . . . . . 3 3 . 1 . 065 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -74.8 -1.9 24.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.014 178.44 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.852 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -74.1 -73.51 0.22 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.12 0.486 . . . . 0.0 110.362 179.976 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.536 ' C ' ' CG ' ' A' ' 175' ' ' TYR . . . -98.98 -0.68 57.3 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.02 179.276 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.536 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER 57.68 -53.74 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.672 0.789 . . . . 0.0 112.639 179.451 . . . . . . . . 3 3 . 1 . 065 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 174' ' ' GLY . 2.4 m-85 -93.71 19.97 8.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.649 0.261 . . . . 0.0 111.088 179.912 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.507 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 15.7 mt -84.12 -46.24 0.74 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.94 179.782 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 25.7 Cg_exo -64.38 63.34 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.884 2.389 . . . . 0.0 112.598 179.911 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 9.9 mt -90.61 -2.34 57.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.914 0.388 . . . . 0.0 110.951 179.661 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.09 44.35 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.523 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 066 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.504 ' O ' HD23 ' A' ' 156' ' ' LEU . 1.1 m-85 . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 . . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.504 HD23 ' O ' ' A' ' 155' ' ' PHE . 0.2 OUTLIER 60.56 140.4 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.253 -179.991 . . . . . . . . 3 3 . 1 . 066 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.604 ' HB2' HD12 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -170.26 72.25 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.038 0.447 . . . . 0.0 110.991 179.993 . . . . . . . . 3 3 . 1 . 066 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.7 p 80.49 -49.72 0.32 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.204 179.504 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -72.99 -55.31 6.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.04 0.448 . . . . 0.0 110.149 179.908 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.5 OUTLIER 73.51 -58.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.818 -179.828 . . . . . . . . 3 3 . 1 . 066 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.508 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 0.2 OUTLIER -74.32 50.1 0.39 Allowed 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.917 . . . . . . . . 3 3 . 1 . 066 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -168.33 -59.32 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.808 -178.566 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.604 HD12 ' HB2' ' A' ' 157' ' ' GLN . 0.2 OUTLIER -68.38 -5.14 17.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.561 178.415 . . . . . . . . 3 3 . 1 . 066 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.3 OUTLIER -78.08 53.17 1.16 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.367 179.962 . . . . . . . . 3 3 . 1 . 066 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.781 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.1 OUTLIER 82.23 -50.17 0.21 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.333 -179.802 . . . . . . . . 3 3 . 1 . 066 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.781 HD12 ' O ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER -168.37 161.52 8.95 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.304 -179.17 . . . . . . . . 3 3 . 1 . 066 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -87.2 112.2 0.88 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.863 2.375 . . . . 0.0 112.085 179.371 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.34 59.5 1.42 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.464 2.109 . . . . 0.0 112.639 -179.748 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.751 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 4.5 tt -77.75 -42.32 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.147 179.832 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.613 HG22 HD22 ' A' ' 177' ' ' LEU . 2.1 mp -68.73 -31.07 49.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.378 -179.38 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.693 ' HA ' HD23 ' A' ' 177' ' ' LEU . 8.9 tp -64.89 -63.65 1.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.116 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.28 4.07 9.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.033 178.534 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.751 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.53 -64.39 0.93 Allowed 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.678 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -108.83 -14.95 14.0 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.25 178.26 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.472 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 46.7 t80 70.63 -14.96 0.39 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.734 0.414 . . . . 0.0 111.744 -179.904 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.424 ' H ' ' C ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER -96.4 11.1 36.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.689 0.281 . . . . 0.0 110.914 179.859 . . . . . . . . 3 3 . 1 . 066 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.693 HD23 ' HA ' ' A' ' 171' ' ' LEU . 0.4 OUTLIER -71.76 -51.46 8.99 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.675 179.903 . . . . . . . . 3 3 . 1 . 066 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.572 ' HG3' HD13 ' A' ' 171' ' ' LEU . 37.7 Cg_exo -61.25 -48.8 9.05 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.791 2.328 . . . . 0.0 112.75 -179.752 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.39 -10.05 56.21 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.595 -179.506 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -147.57 60.54 1.15 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.125 0.488 . . . . 0.0 109.684 179.561 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 067 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.774 0.321 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 067 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.767 ' HA ' HG22 ' A' ' 160' ' ' VAL . 1.0 OUTLIER -164.8 24.52 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.423 -179.853 . . . . . . . . 3 3 . 1 . 067 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -78.39 -45.41 22.47 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.239 0.543 . . . . 0.0 110.168 179.518 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.553 ' OG ' HD22 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -81.81 39.65 0.56 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.3 -179.406 . . . . . . . . 3 3 . 1 . 067 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.558 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.6 OUTLIER 76.13 -18.17 0.48 Allowed 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 179.586 . . . . . . . . 3 3 . 1 . 067 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.767 HG22 ' HA ' ' A' ' 156' ' ' LEU . 50.0 t 87.45 -55.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 C-N-CA 123.013 0.525 . . . . 0.0 111.588 179.659 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.517 ' CE1' HD11 ' A' ' 165' ' ' LEU . 11.9 t80 -67.53 -35.52 79.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.901 0.381 . . . . 0.0 111.032 -179.557 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.467 ' HB2' ' O ' ' A' ' 158' ' ' SER . 1.7 m-85 -68.49 -57.67 5.47 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.767 179.708 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.553 HD22 ' OG ' ' A' ' 158' ' ' SER . 17.6 tp -65.53 -3.11 3.99 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.996 178.654 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.1 OUTLIER -72.36 -80.4 0.06 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.79 -179.191 . . . . . . . . 3 3 . 1 . 067 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.517 HD11 ' CE1' ' A' ' 161' ' ' PHE . 0.0 OUTLIER -69.73 -66.78 0.55 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.319 0.58 . . . . 0.0 110.326 179.259 . . . . . . . . 3 3 . 1 . 067 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -164.18 135.35 3.46 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.338 -179.004 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.6 115.41 3.72 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.075 1.85 . . . . 0.0 112.031 179.822 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.435 ' HD2' ' CD2' ' A' ' 162' ' ' PHE . 66.6 Cg_endo -84.07 20.74 1.16 Allowed 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.892 2.395 . . . . 0.0 113.212 -179.514 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.903 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.4 OUTLIER -72.56 -107.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 118.973 -0.537 . . . . 0.0 109.717 179.754 . . . . . . . . 3 3 . 1 . 067 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.686 ' H ' HG23 ' A' ' 169' ' ' ILE . 15.1 mt 33.24 -62.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.435 0.694 . . . . 0.0 112.734 178.956 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.903 ' N ' ' O ' ' A' ' 169' ' ' ILE . 0.1 OUTLIER -65.77 -52.31 52.02 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.803 -179.713 . . . . . . . . 3 3 . 1 . 067 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -72.08 -9.77 58.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.052 179.979 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -77.8 -53.92 6.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.784 0.326 . . . . 0.0 110.964 -179.817 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -114.28 -15.4 8.35 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.577 179.864 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.476 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 10.6 t80 70.89 -44.83 0.6 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.988 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.628 ' CE1' HD22 ' A' ' 179' ' ' LEU . 79.5 t80 -93.45 1.06 56.97 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.621 0.248 . . . . 0.0 111.458 -179.619 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.522 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 81.4 mt -70.89 -43.86 14.53 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.389 179.69 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 74.9 Cg_exo -49.93 -24.25 10.21 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.467 2.112 . . . . 0.0 112.888 179.982 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.628 HD22 ' CE1' ' A' ' 176' ' ' PHE . 1.1 mp -66.04 -61.34 2.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.969 0.414 . . . . 0.0 110.837 -179.755 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.423 ' NE ' ' CE2' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -90.26 55.86 3.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.826 179.983 . . . . . . . . 3 3 . 1 . 067 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 068 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.521 ' HD2' HD12 ' A' ' 156' ' ' LEU . 18.7 p90 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.722 0.296 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.77 HD13 HG11 ' A' ' 160' ' ' VAL . 4.2 mt 62.48 -80.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.024 179.964 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.512 ' HG3' HG23 ' A' ' 160' ' ' VAL . 5.7 pt20 -170.23 84.55 0.11 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.359 179.989 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 53.6 p 55.63 70.71 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.404 -179.417 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.488 ' O ' HG12 ' A' ' 160' ' ' VAL . 0.4 OUTLIER 75.5 -59.39 0.53 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.97 -179.516 . . . . . . . . 3 3 . 1 . 068 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.77 HG11 HD13 ' A' ' 156' ' ' LEU . 0.3 OUTLIER 90.95 -47.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.911 -179.941 . . . . . . . . 3 3 . 1 . 068 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.421 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 18.5 m-85 -70.73 -32.04 69.08 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.134 0.492 . . . . 0.0 110.391 179.448 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.404 ' C ' ' H ' ' A' ' 164' ' ' PHE . 3.1 m-85 -67.95 -58.22 4.91 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.72 179.493 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.823 HD12 ' HD2' ' A' ' 168' ' ' PRO . 3.2 tp -65.77 -4.57 6.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.76 178.637 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.404 ' H ' ' C ' ' A' ' 162' ' ' PHE . 0.2 OUTLIER -75.85 -56.88 4.25 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.863 -179.602 . . . . . . . . 3 3 . 1 . 068 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.2 -51.52 60.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.806 179.638 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -160.39 143.15 9.82 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.184 -179.31 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -62.56 119.15 6.12 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.218 1.945 . . . . 0.0 112.542 -179.556 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.823 ' HD2' HD12 ' A' ' 163' ' ' LEU . 41.0 Cg_endo -91.06 95.22 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.312 2.675 . . . . 0.0 112.296 -179.946 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.774 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 4.7 tt -72.1 -38.52 63.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.162 0.506 . . . . 0.0 110.886 -179.9 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 3.8 mt -69.79 -30.79 45.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.124 -179.812 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.79 HD12 ' HB3' ' A' ' 178' ' ' PRO . 1.0 OUTLIER -66.47 -62.44 1.46 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.886 . . . . . . . . 3 3 . 1 . 068 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.61 3.32 9.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.781 178.499 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.774 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.59 -48.11 50.36 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.417 0.627 . . . . 0.0 109.368 179.477 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 175' ' ' TYR . . . -124.12 -4.49 7.77 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.75 178.875 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.426 ' HB2' ' O ' ' A' ' 174' ' ' GLY . 34.9 m-85 67.69 -50.54 0.51 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.743 0.417 . . . . 0.0 111.965 179.664 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -94.99 7.52 45.8 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.767 0.318 . . . . 0.0 110.998 179.596 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.689 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 88.8 mt -87.11 -22.65 0.28 Allowed Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 179.848 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.79 ' HB3' HD12 ' A' ' 171' ' ' LEU . 96.4 Cg_exo -45.52 -20.25 0.56 Allowed 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.381 2.054 . . . . 0.0 113.31 -179.636 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -44.7 -31.24 1.11 Allowed 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.192 0.52 . . . . 0.0 111.246 -179.97 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.0 57.31 1.48 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.661 -179.368 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 181' ' ' HSL . . . . . 0.543 ' HB2' ' HA ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.67 0.271 . . . . 0.0 111.384 . . . . . . . . . 0 0 . 1 . 069 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.728 HD12 ' H ' ' A' ' 158' ' ' SER . 0.6 OUTLIER -164.4 -35.42 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.568 -179.464 . . . . . . . . 3 3 . 1 . 069 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.839 ' HG3' HD13 ' A' ' 163' ' ' LEU . 5.7 tm0? 54.71 25.56 6.62 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.851 0.358 . . . . 0.0 110.861 -179.768 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.728 ' H ' HD12 ' A' ' 156' ' ' LEU . 4.8 m 49.18 36.24 8.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.202 0.525 . . . . 0.0 110.952 -179.79 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -163.01 -57.24 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.963 179.843 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.641 HG23 ' HA ' ' A' ' 156' ' ' LEU . 0.9 OUTLIER 71.95 -58.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.371 -179.62 . . . . . . . . 3 3 . 1 . 069 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.567 ' N ' HG12 ' A' ' 160' ' ' VAL . 36.9 m-85 -70.91 51.53 0.14 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.62 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' A' ' 160' ' ' VAL . 0.2 OUTLIER -167.26 -69.17 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.003 -0.998 . . . . 0.0 109.954 -177.886 . . . . . . . . 3 3 . 1 . 069 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.839 HD13 ' HG3' ' A' ' 157' ' ' GLN . 4.5 tp -67.66 -15.45 63.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.526 178.489 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.547 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 8.2 t80 -83.26 -33.9 25.92 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.376 -179.212 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.417 ' C ' ' HD3' ' A' ' 167' ' ' PRO . 0.1 OUTLIER -64.59 -74.1 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.907 0.384 . . . . 0.0 110.782 179.841 . . . . . . . . 3 3 . 1 . 069 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.803 HD13 ' HD2' ' A' ' 168' ' ' PRO . 0.1 OUTLIER -105.09 66.62 0.14 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.456 -179.853 . . . . . . . . 3 3 . 1 . 069 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.599 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 20.9 Cg_endo -63.83 -27.72 67.57 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.344 2.029 . . . . 0.0 114.13 -179.838 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.803 ' HD2' HD13 ' A' ' 166' ' ' LEU . 28.2 Cg_endo -92.12 87.08 0.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 121.931 1.754 . . . . 0.0 113.147 -179.14 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.776 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 5.8 tp -76.58 -43.39 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.824 179.549 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.436 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 4.8 mt -73.37 -43.98 55.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.948 179.93 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.861 HD13 ' HB3' ' A' ' 177' ' ' LEU . 3.3 mm? -66.46 -55.45 15.63 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.358 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -75.27 5.89 5.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.304 178.869 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.776 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.49 -52.71 16.9 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.739 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -104.96 -18.6 12.03 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 177.968 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 5.1 t80 76.53 -11.86 1.11 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.8 0.44 . . . . 0.0 111.905 179.651 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -97.69 -3.08 39.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.806 0.336 . . . . 0.0 110.717 179.371 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.861 ' HB3' HD13 ' A' ' 171' ' ' LEU . 1.0 OUTLIER -62.97 -45.63 86.92 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.365 179.973 . . . . . . . . 3 3 . 1 . 069 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.716 ' HG3' HD12 ' A' ' 171' ' ' LEU . 36.8 Cg_exo -60.6 79.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.546 2.164 . . . . 0.0 112.394 -179.793 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.2 mt -96.37 -51.86 4.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.516 179.738 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.5 9.92 19.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.6 179.651 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 070 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.617 ' CD2' HD23 ' A' ' 156' ' ' LEU . 14.2 t80 . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.916 0.388 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.677 ' O ' HD12 ' A' ' 156' ' ' LEU . 3.1 pp -164.33 111.94 1.09 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.125 -179.851 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.81 ' HB3' HD13 ' A' ' 163' ' ' LEU . 6.9 tp-100 -79.05 22.83 0.38 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.103 179.378 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.6 p 78.73 46.13 0.05 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.27 0.557 . . . . 0.0 110.785 -179.476 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.663 ' O ' ' N ' ' A' ' 161' ' ' PHE . 33.1 m-20 -158.82 -63.11 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.299 179.505 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.605 HG12 ' O ' ' A' ' 159' ' ' ASP . 14.8 p 54.66 -51.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 O-C-N 124.196 0.935 . . . . 0.0 112.045 -179.1 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.663 ' N ' ' O ' ' A' ' 159' ' ' ASP . 32.9 m-85 -74.28 1.02 12.41 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.577 0.227 . . . . 0.0 111.397 178.931 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.456 ' O ' ' CD1' ' A' ' 162' ' ' PHE . 2.8 p90 -168.05 14.24 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 179.791 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.81 HD13 ' HB3' ' A' ' 157' ' ' GLN . 25.6 tp -67.06 -33.37 75.37 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 178.084 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.481 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 0.2 OUTLIER 49.18 30.12 2.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.002 179.606 . . . . . . . . 3 3 . 1 . 070 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.481 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.6 OUTLIER 87.34 -24.43 0.11 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.021 -179.44 . . . . . . . . 3 3 . 1 . 070 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 167' ' ' PRO . 0.1 OUTLIER -158.67 132.18 4.84 Favored Pre-proline 0 N--CA 1.449 -0.516 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.684 -178.674 . . . . . . . . 3 3 . 1 . 070 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.42 ' N ' HD12 ' A' ' 166' ' ' LEU . 38.5 Cg_endo -67.33 119.81 6.84 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.087 1.858 . . . . 0.0 112.882 -178.826 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.429 ' CB ' HD12 ' A' ' 171' ' ' LEU . 69.7 Cg_endo -85.83 96.15 0.58 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.052 2.502 . . . . 0.0 111.421 179.27 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.832 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 5.7 pt -65.2 -32.77 59.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.369 -179.093 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.681 ' O ' HD23 ' A' ' 177' ' ' LEU . 6.7 mm -73.8 -41.09 54.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.0 -179.856 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.429 HD12 ' CB ' ' A' ' 168' ' ' PRO . 78.5 mt -66.71 -55.66 14.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.919 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -74.1 0.7 13.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.176 178.637 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.832 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -70.92 -43.08 69.0 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.366 0.603 . . . . 0.0 109.386 -179.837 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -120.39 -23.98 2.76 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.385 178.586 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 75.37 -41.29 0.45 Allowed 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 122.692 0.397 . . . . 0.0 111.667 179.893 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -93.85 -7.12 44.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.775 0.321 . . . . 0.0 110.963 179.813 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.681 HD23 ' O ' ' A' ' 170' ' ' ILE . 0.1 OUTLIER -54.15 -44.65 98.79 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.21 179.736 . . . . . . . . 3 3 . 1 . 070 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 31.7 Cg_exo -59.34 69.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.738 2.292 . . . . 0.0 112.652 -179.724 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -113.02 -5.24 13.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.723 179.489 . . . . . . . . 3 3 . 1 . 070 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -147.48 41.62 1.05 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.484 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 071 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 6.9 p90 . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.877 0.37 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 071 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.6 mp -73.94 167.81 20.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 -179.883 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.557 ' H ' HG23 ' A' ' 160' ' ' VAL . 0.3 OUTLIER -171.74 95.0 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.496 -179.976 . . . . . . . . 3 3 . 1 . 071 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.553 ' O ' ' CG ' ' A' ' 159' ' ' ASP . 1.6 m 62.75 79.05 0.27 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.557 -179.705 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.568 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 2.8 p30 60.36 -56.41 0.08 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.801 0.841 . . . . 0.0 112.203 -179.677 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.568 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 2.5 t 74.57 -62.96 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.043 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -73.66 52.24 0.39 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.686 178.058 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.407 ' HB2' ' OD1' ' A' ' 159' ' ' ASP . 0.3 OUTLIER -168.12 -43.94 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.321 -179.477 . . . . . . . . 3 3 . 1 . 071 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.419 HD22 ' O ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -57.82 -51.03 71.26 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.874 . . . . . . . . 3 3 . 1 . 071 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 46.63 40.31 8.29 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.68 -1.145 . . . . 0.0 112.133 176.209 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -175.52 -61.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.933 0.397 . . . . 0.0 110.963 -179.993 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.457 HD12 ' N ' ' A' ' 167' ' ' PRO . 0.1 OUTLIER -161.6 120.12 1.44 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.519 -179.574 . . . . . . . . 3 3 . 1 . 071 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.457 ' N ' HD12 ' A' ' 166' ' ' LEU . 41.6 Cg_endo -68.09 111.54 2.48 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.229 1.953 . . . . 0.0 112.074 179.918 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.488 ' HA ' ' CD2' ' A' ' 171' ' ' LEU . 88.1 Cg_endo -77.8 55.85 5.41 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.676 2.251 . . . . 0.0 112.47 -179.836 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.904 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 1.4 tt -80.69 -44.01 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.222 0.534 . . . . 0.0 112.181 -179.583 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.502 ' N ' HG23 ' A' ' 169' ' ' ILE . 0.8 OUTLIER -75.81 -53.8 15.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -176.996 . . . . . . . . 3 3 . 1 . 071 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.588 ' HG ' ' N ' ' A' ' 172' ' ' ASP . 2.6 pt? -66.91 -49.47 65.44 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.362 0.601 . . . . 0.0 110.056 -179.789 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.588 ' N ' ' HG ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -74.23 1.96 10.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.311 179.02 . . . . . . . . 3 3 . 1 . 071 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.904 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.69 -54.67 8.37 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.307 0.575 . . . . 0.0 109.596 179.5 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -112.49 -18.9 7.3 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.515 178.617 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 70.01 -56.46 0.58 Allowed 'General case' 0 C--O 1.231 0.115 0 C-N-CA 122.502 0.321 . . . . 0.0 111.377 179.824 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.409 ' O ' ' CG ' ' A' ' 176' ' ' PHE . 89.6 t80 -92.92 2.22 56.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.882 179.824 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.494 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.1 OUTLIER -64.2 -46.5 79.48 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.806 179.675 . . . . . . . . 3 3 . 1 . 071 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 75.2 Cg_exo -50.37 88.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.618 2.212 . . . . 0.0 112.554 179.953 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.13 -78.83 0.58 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.371 179.683 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -87.65 35.37 0.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.536 179.462 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 072 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.869 0.366 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 072 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.776 ' HB3' HG23 ' A' ' 160' ' ' VAL . 4.8 mp 50.79 24.74 1.85 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.45 179.72 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.59 -6.46 48.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.412 179.668 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 21.6 p -74.01 -43.82 56.69 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.444 0.64 . . . . 0.0 111.423 -179.397 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.625 ' O ' HG12 ' A' ' 160' ' ' VAL . 1.1 t0 -169.01 -35.75 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.605 -179.956 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.776 HG23 ' HB3' ' A' ' 156' ' ' LEU . 0.3 OUTLIER 90.88 -42.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.53 179.93 . . . . . . . . 3 3 . 1 . 072 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.435 ' O ' ' HB2' ' A' ' 164' ' ' PHE . 58.8 m-85 -72.73 -38.34 67.46 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.051 0.453 . . . . 0.0 111.035 179.831 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.4 ' C ' ' H ' ' A' ' 164' ' ' PHE . 0.2 OUTLIER -72.17 -53.79 11.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.766 179.6 . . . . . . . . 3 3 . 1 . 072 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.617 HD12 ' HA ' ' A' ' 156' ' ' LEU . 18.6 mt -66.26 -4.4 7.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.406 178.478 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.508 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER -79.53 19.03 0.66 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.032 179.806 . . . . . . . . 3 3 . 1 . 072 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.505 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.4 OUTLIER 91.6 -39.18 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 122.988 0.515 . . . . 0.0 111.367 -179.943 . . . . . . . . 3 3 . 1 . 072 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 166' ' ' LEU . 8.0 mt -165.11 169.16 7.72 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.925 -178.018 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.543 ' HG2' HD12 ' A' ' 170' ' ' ILE . 83.2 Cg_endo -84.64 117.26 2.02 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.701 2.267 . . . . 0.0 112.05 179.572 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.559 ' HA ' ' CD2' ' A' ' 171' ' ' LEU . 92.1 Cg_endo -78.91 10.76 2.79 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.539 2.159 . . . . 0.0 113.328 -179.454 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.878 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 3.3 tt -77.24 -29.15 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.929 0.395 . . . . 0.0 111.817 -179.706 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.543 HD12 ' HG2' ' A' ' 167' ' ' PRO . 10.3 mt -71.03 -60.22 2.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.625 -178.359 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.579 ' HG ' ' N ' ' A' ' 172' ' ' ASP . 2.6 pt? -63.91 -47.95 78.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.375 0.607 . . . . 0.0 110.007 -179.579 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.579 ' N ' ' HG ' ' A' ' 171' ' ' LEU . 30.9 m-20 -72.48 -0.92 13.93 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.219 179.091 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.878 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.16 -66.07 0.73 Allowed 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.591 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.518 ' HA3' HD12 ' A' ' 177' ' ' LEU . . . -119.74 -9.56 8.26 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.767 178.68 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 12.0 t80 68.82 -61.69 0.41 Allowed 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.971 0.415 . . . . 0.0 110.994 -179.885 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -100.87 16.49 25.01 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.912 179.735 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.525 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 28.7 mt -93.58 -47.21 0.29 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.742 -179.71 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.525 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 3.7 Cg_exo -72.73 -86.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.269 1.98 . . . . 0.0 111.958 -179.829 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 52.2 mt 51.39 49.4 21.07 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 121.044 0.45 . . . . 0.0 110.778 179.906 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? 64.89 45.83 3.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.898 -179.996 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 181' ' ' HSL . . . . . 0.501 ' HB2' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.465 ' O ' HD23 ' A' ' 156' ' ' LEU . 9.8 m-85 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.602 0.239 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 1.044 HD11 HD22 ' A' ' 166' ' ' LEU . 72.5 mt -162.11 81.81 0.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.771 -179.909 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -165.15 11.94 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.99 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.551 ' HB3' HD21 ' A' ' 163' ' ' LEU . 1.7 t -80.67 -33.93 35.15 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.615 0.721 . . . . 0.0 110.238 178.92 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.468 ' O ' HG12 ' A' ' 160' ' ' VAL . 0.4 OUTLIER -167.75 -37.79 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.043 179.555 . . . . . . . . 3 3 . 1 . 073 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.472 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 65.33 -52.82 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.031 179.566 . . . . . . . . 3 3 . 1 . 073 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.472 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 73.6 m-85 -72.51 -1.26 15.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.527 0.204 . . . . 0.0 111.428 179.737 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.466 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 20.0 m-85 -161.35 14.47 0.1 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.904 -179.994 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.705 HD13 HD12 ' A' ' 165' ' ' LEU . 1.0 OUTLIER -69.5 -38.07 77.48 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.409 0.623 . . . . 0.0 109.4 178.955 . . . . . . . . 3 3 . 1 . 073 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 14.8 t80 66.58 8.6 5.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.805 179.652 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.705 HD12 HD13 ' A' ' 163' ' ' LEU . 44.5 mt -67.43 -48.91 65.9 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.248 0.547 . . . . 0.0 110.532 179.439 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 1.044 HD22 HD11 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -161.42 128.11 2.51 Favored Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.439 -178.254 . . . . . . . . 3 3 . 1 . 073 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.34 116.75 4.83 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.236 1.957 . . . . 0.0 112.265 -179.927 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -80.06 38.52 0.75 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.701 2.267 . . . . 0.0 113.047 -179.726 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.765 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 5.4 tt -77.59 -34.62 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.264 0.554 . . . . 0.0 110.801 179.726 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.714 HD13 HG23 ' A' ' 169' ' ' ILE . 13.3 mm -71.66 -45.13 68.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.447 -179.299 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.661 ' H ' HD22 ' A' ' 171' ' ' LEU . 0.9 OUTLIER -65.68 -53.15 45.13 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.035 . . . . . . . . 3 3 . 1 . 073 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -73.82 0.53 12.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.053 178.635 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.765 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.96 -55.61 6.32 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.584 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.671 ' H ' ' HG2' ' A' ' 178' ' ' PRO . . . -123.28 -27.45 1.49 Allowed Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 178.539 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.3 OUTLIER 78.07 -14.66 0.83 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.109 0.564 . . . . 0.0 112.125 179.506 . . . . . . . . 3 3 . 1 . 073 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.425 ' O ' ' CG ' ' A' ' 176' ' ' PHE . 14.7 t80 -96.02 43.91 1.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.562 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.573 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 3.8 mt 57.14 46.61 2.14 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.077 -178.689 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.671 ' HG2' ' H ' ' A' ' 174' ' ' GLY . 39.2 Cg_exo -41.25 -65.05 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.041 2.494 . . . . 0.0 112.963 179.554 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.482 ' H ' HG22 ' A' ' 170' ' ' ILE . 4.4 mm? 56.13 53.52 8.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.971 0.415 . . . . 0.0 110.214 -179.689 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? 63.05 56.55 1.77 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.032 -179.134 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 181' ' ' HSL . . . . . 0.534 ' HB2' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 2.2 p90 . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.843 0.354 . . . . 0.0 111.279 . . . . . . . . . 0 0 . 1 . 074 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.4 pp -166.14 -39.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.202 179.759 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.404 ' OE1' ' N ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -72.29 -14.52 61.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.764 179.542 . . . . . . . . 3 3 . 1 . 074 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.404 ' N ' ' OE1' ' A' ' 157' ' ' GLN . 1.2 t -77.25 1.64 17.97 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.501 179.905 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.415 ' O ' ' CB ' ' A' ' 160' ' ' VAL . 2.0 t0 80.72 -19.21 0.45 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 122.331 0.253 . . . . 0.0 111.537 -179.733 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' A' ' 164' ' ' PHE . 0.4 OUTLIER 85.5 -50.61 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 122.467 0.307 . . . . 0.0 111.352 179.667 . . . . . . . . 3 3 . 1 . 074 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.447 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 55.6 m-85 -68.79 -32.53 72.32 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.105 0.478 . . . . 0.0 110.676 179.848 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.66 ' O ' HD12 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -68.12 -59.04 3.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.652 179.504 . . . . . . . . 3 3 . 1 . 074 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.729 HD12 ' HD2' ' A' ' 168' ' ' PRO . 2.6 tp -66.51 -4.33 8.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.017 178.705 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.466 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.1 OUTLIER -78.12 -42.78 30.86 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.653 -179.021 . . . . . . . . 3 3 . 1 . 074 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.66 HD12 ' O ' ' A' ' 162' ' ' PHE . 0.3 OUTLIER -65.3 -51.58 59.73 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.155 0.502 . . . . 0.0 110.963 -179.958 . . . . . . . . 3 3 . 1 . 074 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.2 tp -159.98 105.17 1.42 Allowed Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.289 -178.73 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.61 113.84 3.3 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.335 2.023 . . . . 0.0 113.217 -179.327 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.729 ' HD2' HD12 ' A' ' 163' ' ' LEU . 80.3 Cg_endo -82.57 92.14 0.95 Allowed 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.028 2.485 . . . . 0.0 111.059 178.862 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 1.01 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 2.4 pt -56.15 -29.83 28.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.619 -178.634 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.558 ' O ' HD12 ' A' ' 177' ' ' LEU . 3.4 mp -77.4 -49.19 22.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.644 179.425 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 37.5 mt -68.29 -54.93 14.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.342 179.588 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.435 ' CG ' ' O ' ' A' ' 168' ' ' PRO . 4.2 p30 -71.96 -0.34 11.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.502 179.437 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 1.01 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -70.47 -55.91 7.85 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.842 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -126.23 -22.99 1.63 Allowed Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.549 178.54 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 76.72 -30.34 0.18 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 122.637 0.375 . . . . 0.0 111.579 -179.876 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.42 -8.45 29.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.686 0.279 . . . . 0.0 110.998 179.732 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.558 HD12 ' O ' ' A' ' 170' ' ' ILE . 38.8 mt -53.79 -44.92 98.86 Favored Pre-proline 0 CA--C 1.529 0.145 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.404 -179.987 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 82.0 Cg_exo -48.4 87.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.497 2.131 . . . . 0.0 112.62 -179.87 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 177' ' ' LEU . 24.1 mt -138.58 -57.96 0.63 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.758 179.633 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.775 ' N ' ' HD2' ' A' ' 180' ' ' ARG . 0.0 OUTLIER -105.02 27.91 7.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.406 179.918 . . . . . . . . 3 3 . 1 . 074 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 075 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.85 0.357 . . . . 0.0 111.946 . . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 22.7 mt 63.65 73.19 0.45 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.219 179.671 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -170.08 36.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 179.798 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 9.3 t -164.64 90.49 0.54 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.126 179.837 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.445 ' O ' HG12 ' A' ' 160' ' ' VAL . 1.2 m-20 71.84 -57.71 0.61 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.636 -179.252 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.466 ' O ' ' CB ' ' A' ' 164' ' ' PHE . 0.4 OUTLIER 91.07 -50.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.588 179.525 . . . . . . . . 3 3 . 1 . 075 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.434 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 0.9 OUTLIER -69.85 -30.14 67.55 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.223 0.535 . . . . 0.0 110.536 179.797 . . . . . . . . 3 3 . 1 . 075 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.6 -61.85 1.63 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.094 179.649 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 163' ' ' LEU . 17.5 mt -66.27 -5.33 10.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.121 179.251 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.466 ' CB ' ' O ' ' A' ' 160' ' ' VAL . 0.1 OUTLIER -77.36 -43.82 31.52 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.597 -179.538 . . . . . . . . 3 3 . 1 . 075 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.1 -42.05 94.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.793 179.687 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.85 HD23 ' OD2' ' A' ' 172' ' ' ASP . 2.3 tp -161.65 125.87 2.01 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.123 -179.368 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.585 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 27.5 Cg_endo -64.85 -25.52 60.25 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.516 2.144 . . . . 0.0 114.699 -179.495 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.714 ' HB2' HD12 ' A' ' 171' ' ' LEU . 22.3 Cg_endo -93.93 101.44 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.072 1.848 . . . . 0.0 112.646 -179.38 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.684 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 13.4 tt -72.77 -44.34 59.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.841 -179.614 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.608 ' N ' HG23 ' A' ' 169' ' ' ILE . 0.5 OUTLIER -69.2 -31.75 51.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.96 -177.272 . . . . . . . . 3 3 . 1 . 075 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.714 HD12 ' HB2' ' A' ' 168' ' ' PRO . 2.0 mt -66.55 -56.92 8.58 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.201 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.85 ' OD2' HD23 ' A' ' 166' ' ' LEU . 11.8 m-20 -74.48 -4.18 35.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.58 178.158 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.684 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.47 -68.22 0.52 Allowed 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 121.226 0.536 . . . . 0.0 110.148 179.911 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -121.73 -2.03 10.6 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.159 179.292 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 54.1 t80 69.17 -51.8 0.6 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.473 0.309 . . . . 0.0 111.653 -179.994 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.27 26.69 2.81 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.754 0.311 . . . . 0.0 111.174 -179.77 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.512 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 11.0 mt -91.89 -50.96 0.3 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.908 179.725 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.512 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 53.0 Cg_exo -55.76 -18.82 22.48 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.666 2.244 . . . . 0.0 112.788 179.986 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.542 HD13 ' O ' ' A' ' 179' ' ' LEU . 0.2 OUTLIER -71.36 -5.06 29.66 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 -179.776 . . . . . . . . 3 3 . 1 . 075 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.15 57.61 1.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.163 0.506 . . . . 0.0 110.032 179.707 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 076 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.844 0.354 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 076 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.513 ' O ' ' CB ' ' A' ' 157' ' ' GLN . 0.3 OUTLIER -167.4 -162.47 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.594 -179.814 . . . . . . . . 3 3 . 1 . 076 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.629 ' O ' HD22 ' A' ' 163' ' ' LEU . 12.1 tt0 91.83 84.44 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.222 0.534 . . . . 0.0 111.071 -179.936 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.496 ' CB ' HD13 ' A' ' 163' ' ' LEU . 1.9 t 77.87 -63.76 0.32 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.743 179.444 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.687 ' O ' HG13 ' A' ' 160' ' ' VAL . 4.1 m-20 -164.18 -21.7 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.992 -1.004 . . . . 0.0 112.037 -179.539 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.687 HG13 ' O ' ' A' ' 159' ' ' ASP . 1.2 m 63.78 -54.43 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 122.674 0.39 . . . . 0.0 111.596 -179.744 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.486 ' N ' HG22 ' A' ' 160' ' ' VAL . 6.0 t80 -70.89 2.04 4.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.49 0.186 . . . . 0.0 111.466 179.561 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -165.8 12.1 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.218 -179.942 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.629 HD22 ' O ' ' A' ' 157' ' ' GLN . 15.4 tp -68.93 -33.09 73.17 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 178.748 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.462 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER 48.22 31.91 2.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.708 179.435 . . . . . . . . 3 3 . 1 . 076 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.462 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.1 OUTLIER 85.69 -29.58 0.07 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.821 -179.253 . . . . . . . . 3 3 . 1 . 076 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.954 HD13 ' HD2' ' A' ' 167' ' ' PRO . 0.2 OUTLIER -161.8 128.97 2.6 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.926 -178.87 . . . . . . . . 3 3 . 1 . 076 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.954 ' HD2' HD13 ' A' ' 166' ' ' LEU . 73.3 Cg_endo -76.13 108.67 2.73 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.141 1.894 . . . . 0.0 112.429 -179.598 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.74 ' O ' HD12 ' A' ' 170' ' ' ILE . 28.4 Cg_endo -64.23 -56.99 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.198 1.932 . . . . 0.0 112.368 -179.953 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.945 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 1.3 tt 83.08 -35.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.761 -179.961 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.74 HD12 ' O ' ' A' ' 168' ' ' PRO . 3.9 mp -79.61 -59.28 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.916 0.389 . . . . 0.0 111.12 179.903 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.483 HD22 ' N ' ' A' ' 171' ' ' LEU . 3.3 mm? -67.78 -47.4 69.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.247 0.546 . . . . 0.0 110.013 179.571 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.9 0.13 11.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.487 179.58 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.945 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.6 -63.02 1.29 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.142 0.496 . . . . 0.0 109.792 179.677 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.403 ' HA3' ' CD1' ' A' ' 177' ' ' LEU . . . -116.1 -12.34 9.22 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.749 178.901 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER 72.63 -56.12 0.66 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.35 0.26 . . . . 0.0 111.68 179.715 . . . . . . . . 3 3 . 1 . 076 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -94.15 -12.54 28.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.581 0.229 . . . . 0.0 111.51 -179.636 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.532 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 76.8 mt -52.7 -42.98 91.84 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.421 179.905 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 32.5 Cg_exo -57.92 -156.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.392 2.061 . . . . 0.0 112.206 179.931 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 74.89 69.92 0.09 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.2 0.524 . . . . 0.0 110.455 -179.829 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 66.08 47.09 1.99 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.885 -179.866 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 077 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.612 ' HB3' HD23 ' A' ' 163' ' ' LEU . 57.8 t80 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.843 0.354 . . . . 0.0 111.745 . . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.4 mt 62.57 50.22 3.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.291 179.555 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.649 ' HB2' HD22 ' A' ' 163' ' ' LEU . 11.5 tm0? -77.46 17.21 0.53 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.42 179.261 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 78.45 -61.65 0.36 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.787 0.327 . . . . 0.0 110.437 -179.329 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.463 ' O ' HG12 ' A' ' 160' ' ' VAL . 3.7 t0 -78.85 -48.48 14.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.044 179.143 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 83.55 -48.71 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.655 179.588 . . . . . . . . 3 3 . 1 . 077 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.453 ' CD1' HG12 ' A' ' 160' ' ' VAL . 73.1 m-85 -65.35 -27.38 68.55 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.989 0.423 . . . . 0.0 110.592 179.983 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -72.79 -63.68 1.12 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.401 179.037 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.649 HD22 ' HB2' ' A' ' 157' ' ' GLN . 14.2 tp -66.8 -4.11 8.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.473 179.11 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.438 ' HB3' ' O ' ' A' ' 161' ' ' PHE . 0.5 OUTLIER -72.06 -14.22 61.8 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.637 -179.571 . . . . . . . . 3 3 . 1 . 077 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -68.18 -19.81 64.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.813 178.651 . . . . . . . . 3 3 . 1 . 077 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.59 HD22 ' HD2' ' A' ' 168' ' ' PRO . 0.3 OUTLIER -156.85 61.04 2.34 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.069 -176.93 . . . . . . . . 3 3 . 1 . 077 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.535 ' HG2' ' HD3' ' A' ' 168' ' ' PRO . 2.6 Cg_endo -42.81 -47.24 8.16 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.546 2.831 . . . . 0.0 113.847 179.914 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.59 ' HD2' HD22 ' A' ' 166' ' ' LEU . 52.1 Cg_endo -82.49 88.97 1.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.154 1.902 . . . . 0.0 113.498 -178.562 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.759 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 7.0 pt -75.23 -32.93 27.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.271 179.466 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.989 HG22 HD22 ' A' ' 177' ' ' LEU . 2.9 mp -70.01 -43.53 79.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.297 -179.103 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.809 HD13 ' CG ' ' A' ' 178' ' ' PRO . 0.1 OUTLIER -66.21 -52.54 47.0 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.801 . . . . . . . . 3 3 . 1 . 077 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.4 0.11 18.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.164 178.685 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.759 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.28 -60.26 2.32 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.043 0.449 . . . . 0.0 109.812 179.94 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -107.22 -20.37 8.74 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 178.535 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 27.3 t80 75.14 -11.08 1.12 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.443 0.297 . . . . 0.0 111.572 179.988 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -97.47 -9.81 26.53 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.791 0.329 . . . . 0.0 110.629 179.623 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.989 HD22 HG22 ' A' ' 170' ' ' ILE . 0.6 OUTLIER -51.91 -50.15 79.75 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.2 -179.869 . . . . . . . . 3 3 . 1 . 077 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.809 ' CG ' HD13 ' A' ' 171' ' ' LEU . 22.4 Cg_exo -65.05 91.67 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.6 2.2 . . . . 0.0 112.386 -179.829 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.848 HD22 ' O ' ' A' ' 177' ' ' LEU . 1.0 OUTLIER -81.02 -70.96 0.49 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.908 0.385 . . . . 0.0 110.714 179.756 . . . . . . . . 3 3 . 1 . 077 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.6 16.7 3.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.634 -179.914 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 078 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.961 0.41 . . . . 0.0 111.177 . . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.505 HD23 ' H ' ' A' ' 156' ' ' LEU . 0.4 OUTLIER -75.28 158.14 33.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.121 -179.823 . . . . . . . . 3 3 . 1 . 078 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.63 ' HB2' HD22 ' A' ' 163' ' ' LEU . 0.9 OUTLIER -170.23 -92.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.484 179.842 . . . . . . . . 3 3 . 1 . 078 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 77.9 p -161.97 18.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.779 0.323 . . . . 0.0 111.388 179.537 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.451 ' HB3' ' HB2' ' A' ' 162' ' ' PHE . 6.5 t70 -168.9 -44.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.055 0.455 . . . . 0.0 110.176 179.683 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.444 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 87.09 -50.67 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.154 179.95 . . . . . . . . 3 3 . 1 . 078 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.444 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 1.5 m-85 -69.93 -30.42 67.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.226 0.536 . . . . 0.0 110.479 179.599 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.451 ' HB2' ' HB3' ' A' ' 159' ' ' ASP . 0.1 OUTLIER -71.55 -60.42 2.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.146 179.64 . . . . . . . . 3 3 . 1 . 078 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.63 HD22 ' HB2' ' A' ' 157' ' ' GLN . 27.9 tp -65.46 -7.07 12.43 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.721 179.044 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.435 ' CB ' ' O ' ' A' ' 160' ' ' VAL . 1.2 t80 -79.67 -37.71 35.25 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.444 -179.82 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.879 ' O ' HD22 ' A' ' 166' ' ' LEU . 0.5 OUTLIER -65.63 -42.13 91.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.841 179.631 . . . . . . . . 3 3 . 1 . 078 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.879 HD22 ' O ' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -158.6 119.21 1.85 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.7 -179.345 . . . . . . . . 3 3 . 1 . 078 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.543 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 10.3 Cg_endo -58.38 -32.01 95.24 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.446 2.098 . . . . 0.0 114.303 -179.363 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.551 ' HB2' ' HB2' ' A' ' 171' ' ' LEU . 26.4 Cg_endo -93.88 100.6 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.448 2.099 . . . . 0.0 112.448 -179.483 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.714 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 7.3 tt -73.98 -40.44 52.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.037 -179.305 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.411 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.4 mp -70.64 -43.34 77.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.029 -178.803 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 168' ' ' PRO . 0.4 OUTLIER -69.0 -2.97 11.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.983 0.421 . . . . 0.0 111.789 179.915 . . . . . . . . 3 3 . 1 . 078 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -145.88 17.28 1.43 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.354 179.978 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -80.81 -39.99 25.74 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.141 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.615 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -134.68 3.48 4.24 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 114.898 -1.047 . . . . 0.0 111.968 179.046 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.508 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER 54.97 -61.42 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 123.819 0.847 . . . . 0.0 112.147 179.799 . . . . . . . . 3 3 . 1 . 078 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.615 ' N ' ' O ' ' A' ' 174' ' ' GLY . 11.6 m-85 -97.05 23.3 7.42 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.056 -179.953 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.534 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 14.1 mt -92.67 -49.63 0.29 Allowed Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.378 -179.968 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.534 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 40.7 Cg_exo -57.53 -157.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.374 2.049 . . . . 0.0 112.361 179.921 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 178' ' ' PRO . 2.0 mm? 71.13 68.34 0.17 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.16 0.505 . . . . 0.0 110.732 -179.831 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 63.82 56.11 1.54 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.77 179.872 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 079 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.497 ' O ' HD23 ' A' ' 156' ' ' LEU . 37.8 m-85 . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.683 0.278 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 155' ' ' PHE . 97.3 mt -161.18 75.94 0.52 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.524 -179.967 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -170.55 -37.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.357 179.981 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.24 62.12 0.92 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.055 0.455 . . . . 0.0 110.405 179.787 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.536 ' O ' HG12 ' A' ' 160' ' ' VAL . 2.5 t0 75.88 -60.23 0.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.798 -179.651 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.3 OUTLIER 89.04 -40.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.547 179.748 . . . . . . . . 3 3 . 1 . 079 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.615 ' CE2' HD12 ' A' ' 165' ' ' LEU . 48.8 t80 -65.19 -26.1 68.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.109 0.48 . . . . 0.0 110.657 -179.978 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.78 -63.37 1.07 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.052 179.567 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.753 ' O ' HD13 ' A' ' 163' ' ' LEU . 2.4 tm? -63.09 -20.11 65.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.877 0.846 . . . . 0.0 109.385 178.888 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.464 ' CB ' ' O ' ' A' ' 160' ' ' VAL . 10.1 t80 -73.65 -60.98 2.0 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.892 -179.488 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.615 HD12 ' CE2' ' A' ' 161' ' ' PHE . 1.0 OUTLIER -63.99 -63.41 1.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.991 0.424 . . . . 0.0 110.761 179.803 . . . . . . . . 3 3 . 1 . 079 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -161.64 135.86 5.11 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.719 -179.862 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.1 110.26 2.38 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.44 2.093 . . . . 0.0 111.975 179.806 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.82 ' O ' HD12 ' A' ' 170' ' ' ILE . 54.3 Cg_endo -67.65 -94.94 0.0 OUTLIER 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.248 1.965 . . . . 0.0 112.442 -179.638 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.769 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 1.3 tt 80.23 -35.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.816 0.341 . . . . 0.0 111.757 179.986 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.967 ' O ' HD12 ' A' ' 177' ' ' LEU . 4.2 mp -73.63 -34.98 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.136 -179.582 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.478 HD23 ' HB3' ' A' ' 177' ' ' LEU . 43.6 mt -65.59 -59.46 3.93 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.941 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.54 4.09 8.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.868 178.472 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.769 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.31 -53.94 12.52 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.746 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -98.53 -18.39 25.93 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 177.887 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 13.5 t80 75.47 -13.38 0.87 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.81 0.444 . . . . 0.0 111.723 179.787 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -99.23 -9.51 23.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.656 0.265 . . . . 0.0 110.644 179.527 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.967 HD12 ' O ' ' A' ' 170' ' ' ILE . 11.1 mt -65.58 -48.46 65.2 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.357 -179.764 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 85.9 Cg_exo -47.39 93.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.613 2.209 . . . . 0.0 112.627 -179.926 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.13 -47.29 4.2 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.107 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.424 ' HD2' ' N ' ' A' ' 180' ' ' ARG . 0.0 OUTLIER -89.63 7.12 38.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.953 179.024 . . . . . . . . 3 3 . 1 . 079 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 080 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.432 ' HB3' HD11 ' A' ' 169' ' ' ILE . 32.3 p90 . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.853 0.359 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.781 ' HA ' HD22 ' A' ' 163' ' ' LEU . 0.6 OUTLIER -72.37 176.46 5.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.711 -179.864 . . . . . . . . 3 3 . 1 . 080 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.25 -38.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.413 179.939 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.46 37.71 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.975 0.417 . . . . 0.0 111.554 179.835 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.684 ' O ' ' N ' ' A' ' 161' ' ' PHE . 1.7 m-20 -163.76 -57.15 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.353 179.189 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.561 HG12 ' O ' ' A' ' 159' ' ' ASP . 11.1 p 52.14 -52.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 O-C-N 124.17 0.918 . . . . 0.0 112.131 -179.291 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.684 ' N ' ' O ' ' A' ' 159' ' ' ASP . 2.3 t80 -73.79 -2.33 23.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.814 -0.176 . . . . 0.0 111.26 179.071 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.444 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 7.8 m-85 -164.84 14.79 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.988 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.781 HD22 ' HA ' ' A' ' 156' ' ' LEU . 5.6 tp -69.81 -30.63 68.2 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.176 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 4.4 t80 67.23 5.03 3.95 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.509 178.957 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.778 ' HB2' HD23 ' A' ' 163' ' ' LEU . 3.0 mm? -69.21 -64.72 0.82 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.01 0.433 . . . . 0.0 110.93 179.564 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.759 HD23 ' HD2' ' A' ' 168' ' ' PRO . 0.2 OUTLIER -160.8 92.36 1.56 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.303 -179.546 . . . . . . . . 3 3 . 1 . 080 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.448 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 3.3 Cg_exo -38.89 -45.12 2.55 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.407 2.738 . . . . 0.0 114.018 -179.482 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.759 ' HD2' HD23 ' A' ' 166' ' ' LEU . 75.5 Cg_endo -86.73 -93.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.979 1.786 . . . . 0.0 113.819 -178.276 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.851 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.2 OUTLIER 88.12 -39.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 122.758 0.423 . . . . 0.0 111.179 -179.049 . . . . . . . . 3 3 . 1 . 080 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.57 ' H ' HD12 ' A' ' 170' ' ' ILE . 2.9 mp -78.24 -56.13 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.019 0.438 . . . . 0.0 110.507 179.44 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 171' ' ' LEU . 3.5 mm? -67.83 -45.32 75.01 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.964 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -73.82 -0.64 16.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.325 179.214 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.851 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.26 -45.63 54.66 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.29 0.567 . . . . 0.0 109.84 179.731 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.61 ' H ' ' HG2' ' A' ' 178' ' ' PRO . . . -126.62 -28.25 0.99 Allowed Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.261 179.054 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 35.7 t80 78.75 -12.66 1.06 Allowed 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 122.97 0.508 . . . . 0.0 112.134 179.525 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.442 ' HZ ' ' HG2' ' A' ' 181' ' ' HSL . 14.8 p90 -95.92 37.34 1.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.65 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.558 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 10.1 mt 64.81 46.44 0.56 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.885 -178.856 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.61 ' HG2' ' H ' ' A' ' 174' ' ' GLY . 42.1 Cg_exo -39.87 -69.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.161 2.574 . . . . 0.0 113.021 179.555 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 179' ' ' LEU . 3.8 mm? 56.85 52.49 9.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.029 0.442 . . . . 0.0 110.824 179.966 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.405 ' CZ ' ' HA ' ' A' ' 180' ' ' ARG . 0.2 OUTLIER 65.88 44.95 2.64 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.867 179.965 . . . . . . . . 3 3 . 1 . 080 nuclear build full ' A' A ' 181' ' ' HSL . . . . . 0.442 ' HG2' ' HZ ' ' A' ' 176' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.869 0.366 . . . . 0.0 111.459 . . . . . . . . . 0 0 . 1 . 081 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 72.2 mt -73.27 73.29 1.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.758 179.85 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -168.21 34.55 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.272 0.558 . . . . 0.0 110.54 179.835 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 159' ' ' ASP . 4.1 t -164.48 88.06 0.49 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.367 179.728 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 158' ' ' SER . 0.7 OUTLIER 74.38 -60.67 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.234 -178.641 . . . . . . . . 3 3 . 1 . 081 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.5 t 68.61 -54.4 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.665 179.593 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.47 ' HB3' ' CE1' ' A' ' 162' ' ' PHE . 0.4 OUTLIER -71.59 5.88 2.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.493 179.789 . . . . . . . . 3 3 . 1 . 081 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.47 ' CE1' ' HB3' ' A' ' 161' ' ' PHE . 0.1 OUTLIER -160.72 1.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.378 179.728 . . . . . . . . 3 3 . 1 . 081 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 14.3 tp -69.57 -2.84 12.55 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.29 0.567 . . . . 0.0 110.021 177.971 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -68.89 -11.25 60.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.591 -178.985 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.475 ' O ' HD22 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -65.31 -33.02 75.0 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.224 0.535 . . . . 0.0 109.908 178.636 . . . . . . . . 3 3 . 1 . 081 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.475 HD22 ' O ' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -160.27 67.97 2.76 Favored Pre-proline 0 N--CA 1.45 -0.461 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.683 -178.902 . . . . . . . . 3 3 . 1 . 081 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.512 ' HG2' ' HD3' ' A' ' 168' ' ' PRO . 4.3 Cg_endo -52.4 -37.68 72.55 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 123.085 2.523 . . . . 0.0 114.293 -179.107 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.512 ' HD3' ' HG2' ' A' ' 167' ' ' PRO . 40.1 Cg_endo -90.17 78.27 0.78 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 121.947 1.765 . . . . 0.0 113.241 -178.732 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.79 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 23.6 mm -78.01 -76.71 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.141 179.652 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.418 ' N ' HG22 ' A' ' 169' ' ' ILE . 3.8 mp -73.26 -29.77 29.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.592 -179.202 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 22.5 tp -64.81 -64.78 0.78 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 179.339 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 168' ' ' PRO . 21.5 t70 -77.68 8.43 4.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.181 178.627 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.79 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.26 -51.23 25.68 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.403 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.714 ' H ' ' HG2' ' A' ' 178' ' ' PRO . . . -121.69 -28.32 1.6 Allowed Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 178.046 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 77.8 -24.62 0.21 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.404 0.682 . . . . 0.0 112.192 179.202 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -92.76 50.16 1.54 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.954 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.549 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 5.7 mt 55.23 62.05 8.05 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.449 -178.627 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.714 ' HG2' ' H ' ' A' ' 174' ' ' GLY . 23.6 Cg_exo -67.66 -8.72 23.19 Favored 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 123.68 2.92 . . . . 0.0 112.793 -179.741 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.3 tt -62.27 -57.76 10.21 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.031 0.443 . . . . 0.0 110.963 -179.956 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.414 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -87.55 34.79 0.71 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.853 -179.865 . . . . . . . . 3 3 . 1 . 081 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 082 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.551 ' HB3' HD23 ' A' ' 163' ' ' LEU . 2.4 t80 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.847 0.356 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.801 ' HA ' HG23 ' A' ' 160' ' ' VAL . 0.4 OUTLIER -74.09 145.53 44.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.09 -179.838 . . . . . . . . 3 3 . 1 . 082 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.416 ' HB2' HD22 ' A' ' 163' ' ' LEU . 2.2 tp60 -170.04 52.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.713 -179.967 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.9 p 76.46 0.52 3.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.676 -179.777 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.521 ' O ' HG12 ' A' ' 160' ' ' VAL . 9.9 p30 -161.36 -38.75 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.41 -179.978 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.801 HG23 ' HA ' ' A' ' 156' ' ' LEU . 0.4 OUTLIER 85.27 -42.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.043 179.434 . . . . . . . . 3 3 . 1 . 082 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.411 ' HA ' ' HB2' ' A' ' 164' ' ' PHE . 60.4 m-85 -67.45 -30.82 70.64 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.071 0.462 . . . . 0.0 110.855 -179.939 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.431 ' CD1' ' HB3' ' A' ' 167' ' ' PRO . 2.4 t80 -67.71 -61.79 1.72 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.474 179.465 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.551 HD23 ' HB3' ' A' ' 155' ' ' PHE . 16.1 tp -67.25 -3.47 7.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.212 178.809 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.521 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.1 OUTLIER -76.39 -36.73 57.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.848 -178.762 . . . . . . . . 3 3 . 1 . 082 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.9 mt -174.8 -44.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.809 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.796 HD13 ' HD2' ' A' ' 167' ' ' PRO . 0.2 OUTLIER -158.83 131.08 4.25 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.706 0.289 . . . . 0.0 111.18 -179.084 . . . . . . . . 3 3 . 1 . 082 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.796 ' HD2' HD13 ' A' ' 166' ' ' LEU . 18.6 Cg_endo -58.27 116.66 3.4 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.727 2.285 . . . . 0.0 112.441 -179.969 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.79 83.67 0.31 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.457 2.104 . . . . 0.0 111.604 179.522 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.927 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 2.3 pt -69.4 -32.85 54.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.621 -179.326 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.495 HD12 HG13 ' A' ' 169' ' ' ILE . 3.8 mp -76.6 -54.29 13.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.293 -179.77 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 25.7 mt -67.37 -53.04 32.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.031 0.444 . . . . 0.0 110.488 179.974 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -74.46 5.27 4.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.727 179.764 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.927 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -69.75 -56.86 6.02 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.068 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.576 ' O ' ' HD2' ' A' ' 178' ' ' PRO . . . -132.85 30.9 3.02 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 177.394 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.443 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 18.4 t80 68.5 -69.22 0.15 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.366 0.603 . . . . 0.0 109.432 -178.371 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.798 ' O ' HD23 ' A' ' 177' ' ' LEU . 15.6 t80 -151.69 0.28 0.35 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.961 178.963 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.798 HD23 ' O ' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -150.97 -68.31 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -178.724 . . . . . . . . 3 3 . 1 . 082 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.576 ' HD2' ' O ' ' A' ' 174' ' ' GLY . 67.6 Cg_exo -34.67 173.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 123.559 2.839 . . . . 0.0 114.308 -179.365 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.654 ' HG ' ' HB1' ' A' ' 173' ' ' ALA . 0.2 OUTLIER 86.94 -24.27 0.12 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.369 179.884 . . . . . . . . 3 3 . 1 . 082 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.44 46.68 0.89 Allowed 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.883 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 083 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.879 0.371 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 083 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.474 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.5 pt? -165.42 127.06 2.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.944 -179.787 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 43.4 tp60 -170.33 26.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.036 -179.876 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.519 ' O ' ' HB2' ' A' ' 162' ' ' PHE . 0.3 OUTLIER -167.65 33.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.865 179.95 . . . . . . . . 3 3 . 1 . 083 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.517 ' O ' HG12 ' A' ' 160' ' ' VAL . 0.5 OUTLIER 77.06 -6.59 1.99 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.918 -179.915 . . . . . . . . 3 3 . 1 . 083 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 89.31 -44.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 122.644 0.378 . . . . 0.0 111.56 179.702 . . . . . . . . 3 3 . 1 . 083 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.439 ' O ' ' HB2' ' A' ' 164' ' ' PHE . 46.1 m-85 -68.13 -38.05 81.78 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.203 0.525 . . . . 0.0 110.381 179.806 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.519 ' HB2' ' O ' ' A' ' 158' ' ' SER . 0.1 OUTLIER -72.59 -50.31 26.29 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.643 179.397 . . . . . . . . 3 3 . 1 . 083 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.667 HD23 ' O ' ' A' ' 163' ' ' LEU . 1.4 tt -64.9 -3.47 3.47 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 121.833 0.825 . . . . 0.0 109.856 178.424 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.586 ' HB3' HD13 ' A' ' 165' ' ' LEU . 0.4 OUTLIER -75.46 -72.41 0.31 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.162 -1.381 . . . . 0.0 111.036 -179.343 . . . . . . . . 3 3 . 1 . 083 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.711 ' N ' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -67.11 -68.21 0.4 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.052 0.453 . . . . 0.0 110.684 179.56 . . . . . . . . 3 3 . 1 . 083 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.2 mt -162.28 97.14 1.17 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.692 -179.032 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.478 ' HB2' HD12 ' A' ' 170' ' ' ILE . 43.0 Cg_endo -68.35 109.75 2.09 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.467 2.111 . . . . 0.0 112.756 -179.703 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.13 -11.55 19.47 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.583 2.189 . . . . 0.0 112.534 179.663 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.909 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.5 OUTLIER -70.6 -107.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 CA-C-O 118.943 -0.551 . . . . 0.0 109.526 -179.915 . . . . . . . . 3 3 . 1 . 083 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.71 ' H ' HG23 ' A' ' 169' ' ' ILE . 4.2 mt 21.03 -61.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 178.481 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.909 ' N ' ' O ' ' A' ' 169' ' ' ILE . 0.2 OUTLIER -64.72 -52.38 57.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.57 -179.248 . . . . . . . . 3 3 . 1 . 083 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -73.69 -11.2 60.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.725 0.298 . . . . 0.0 111.094 179.855 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.424 ' HB2' HG13 ' A' ' 169' ' ' ILE . . . -77.01 -56.12 4.86 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.914 0.388 . . . . 0.0 110.638 179.98 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -99.32 -24.8 9.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.855 179.371 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 27.6 t80 77.3 -40.76 0.35 Allowed 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 122.385 0.274 . . . . 0.0 111.681 179.976 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -94.13 -7.87 41.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.688 0.28 . . . . 0.0 111.277 -179.979 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.703 HD12 ' O ' ' A' ' 170' ' ' ILE . 28.4 mt -56.61 -44.19 99.65 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.343 179.709 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 78.8 Cg_exo -48.22 93.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.496 2.131 . . . . 0.0 112.779 -179.76 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.1 mt -99.1 -71.14 0.7 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.63 179.612 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.26 21.61 4.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.609 179.417 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 084 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 120.909 0.385 . . . . 0.0 111.341 . . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.48 ' O ' HD12 ' A' ' 156' ' ' LEU . 3.7 pp -165.74 128.92 2.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.771 -179.265 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.671 ' HB3' HD22 ' A' ' 163' ' ' LEU . 9.2 tt0 -70.05 -46.61 64.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.187 0.518 . . . . 0.0 110.524 179.805 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.529 ' HB3' ' HA ' ' A' ' 163' ' ' LEU . 2.7 t -164.9 51.17 0.11 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.436 179.359 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.461 ' CB ' ' O ' ' A' ' 158' ' ' SER . 0.4 OUTLIER 86.91 -23.91 0.13 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.388 -179.401 . . . . . . . . 3 3 . 1 . 084 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 96.9 t 68.85 -55.16 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.829 0.347 . . . . 0.0 111.614 179.562 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.417 ' O ' ' CD1' ' A' ' 162' ' ' PHE . 96.0 m-85 -72.29 2.33 6.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.018 179.542 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.417 ' CD1' ' O ' ' A' ' 161' ' ' PHE . 0.1 OUTLIER -166.39 16.38 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.847 179.785 . . . . . . . . 3 3 . 1 . 084 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.671 HD22 ' HB3' ' A' ' 157' ' ' GLN . 0.3 OUTLIER -67.31 -17.98 64.99 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.645 . . . . . . . . 3 3 . 1 . 084 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.584 ' CD2' ' O ' ' A' ' 164' ' ' PHE . 45.1 p90 47.46 57.43 5.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.538 179.784 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -170.6 -19.78 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.961 -179.264 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.497 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 4.3 tp -156.39 94.76 2.35 Favored Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-O 120.833 0.349 . . . . 0.0 111.045 -178.303 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.586 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 20.9 Cg_endo -63.88 -26.12 67.28 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.778 2.319 . . . . 0.0 114.656 -179.414 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 27.4 Cg_endo -93.17 -165.35 0.13 Allowed 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 121.918 1.746 . . . . 0.0 112.582 -179.467 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.746 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 12.6 tt -167.44 -42.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.822 -179.851 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.966 HG22 HD21 ' A' ' 177' ' ' LEU . 1.6 mp -70.35 -45.25 75.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.046 -179.684 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.438 ' HA ' ' HG3' ' A' ' 178' ' ' PRO . 3.6 mp -64.56 -52.22 58.76 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.235 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -76.21 1.54 15.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.153 178.529 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.746 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.41 -61.94 1.62 Allowed 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.142 0.496 . . . . 0.0 109.672 179.818 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -102.48 -21.39 10.64 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 178.332 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 1.6 t80 75.13 -38.86 0.39 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.569 0.347 . . . . 0.0 111.464 179.896 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -92.68 1.72 57.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.809 0.337 . . . . 0.0 110.74 179.546 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.966 HD21 HG22 ' A' ' 170' ' ' ILE . 0.3 OUTLIER -78.57 -46.0 1.97 Allowed Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.149 179.801 . . . . . . . . 3 3 . 1 . 084 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 99.1 Cg_exo -42.55 -68.76 0.09 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.543 2.162 . . . . 0.0 113.0 -179.477 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 8.8 mt 61.01 59.65 1.99 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.023 0.44 . . . . 0.0 110.19 -179.674 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 7.9 mtt-85 68.74 47.17 0.86 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.644 -179.358 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 085 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.43 ' O ' HD23 ' A' ' 156' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.654 0.264 . . . . 0.0 111.275 . . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.735 ' CD2' HG23 ' A' ' 160' ' ' VAL . 27.0 mt -162.92 96.28 0.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.577 -179.979 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.79 25.39 0.35 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.986 179.431 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.4 p 72.97 47.23 0.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.157 0.503 . . . . 0.0 110.982 -179.866 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.581 ' O ' HG12 ' A' ' 160' ' ' VAL . 1.8 m-20 -162.18 -61.74 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.309 179.566 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.735 HG23 ' CD2' ' A' ' 156' ' ' LEU . 0.3 OUTLIER 86.1 -38.61 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.703 179.663 . . . . . . . . 3 3 . 1 . 085 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.701 ' CE2' HD11 ' A' ' 165' ' ' LEU . 61.7 t80 -66.07 -27.51 68.13 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.976 0.417 . . . . 0.0 110.599 179.901 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' A' ' 168' ' ' PRO . 0.2 OUTLIER -69.31 -61.45 1.79 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.61 179.324 . . . . . . . . 3 3 . 1 . 085 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.0 tp -66.68 -5.31 11.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.046 178.773 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.2 OUTLIER -77.81 -60.45 2.36 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.288 -179.21 . . . . . . . . 3 3 . 1 . 085 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.701 HD11 ' CE2' ' A' ' 161' ' ' PHE . 0.3 OUTLIER -64.82 -51.37 62.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.19 0.519 . . . . 0.0 110.619 179.711 . . . . . . . . 3 3 . 1 . 085 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.784 ' O ' HD13 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -161.9 120.88 1.43 Allowed Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.494 -178.956 . . . . . . . . 3 3 . 1 . 085 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.653 ' CD ' HD22 ' A' ' 166' ' ' LEU . 9.9 Cg_endo -53.0 115.55 2.34 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.361 2.041 . . . . 0.0 111.981 179.863 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.436 ' HB3' ' CE1' ' A' ' 162' ' ' PHE . 58.6 Cg_endo -72.38 -3.3 13.14 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.291 1.994 . . . . 0.0 112.979 -179.639 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.883 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.5 OUTLIER -72.11 -107.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 118.911 -0.566 . . . . 0.0 109.703 179.648 . . . . . . . . 3 3 . 1 . 085 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.673 ' H ' HG23 ' A' ' 169' ' ' ILE . 2.2 mp 21.98 -63.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 178.595 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.883 ' N ' ' O ' ' A' ' 169' ' ' ILE . 4.0 pp -66.37 -50.32 63.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.181 -179.635 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.748 ' N ' HD12 ' A' ' 171' ' ' LEU . 0.4 OUTLIER -69.7 -11.68 61.04 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.607 179.611 . . . . . . . . 3 3 . 1 . 085 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -78.22 -62.0 1.82 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.812 179.87 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -113.15 -24.69 4.72 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.348 179.748 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 1.0 OUTLIER 76.66 -11.82 1.13 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.561 0.22 . . . . 0.0 111.455 -179.792 . . . . . . . . 3 3 . 1 . 085 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.448 ' CD1' HD11 ' A' ' 179' ' ' LEU . 27.8 t80 -122.99 3.94 9.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.684 0.278 . . . . 0.0 110.702 179.377 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.595 HD12 ' O ' ' A' ' 170' ' ' ILE . 22.4 mt -75.98 -45.38 3.87 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.209 179.975 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 3.2 Cg_exo -74.0 -85.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.514 2.143 . . . . 0.0 112.055 -179.785 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.448 HD11 ' CD1' ' A' ' 176' ' ' PHE . 4.6 mt 48.88 49.94 18.4 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 121.181 0.515 . . . . 0.0 110.663 -179.911 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 68.87 46.16 0.91 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.628 -179.552 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 181' ' ' HSL . . . . . 0.485 ' HB2' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.782 0.325 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 086 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 156' ' ' LEU . 20.1 mt 56.56 70.28 0.66 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.845 179.957 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -78.39 20.54 0.41 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.474 179.572 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 75.57 45.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.098 0.475 . . . . 0.0 110.643 -179.61 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.526 ' O ' HG12 ' A' ' 160' ' ' VAL . 44.4 m-20 -158.73 -61.34 0.08 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.199 179.894 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 88.37 -41.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.837 179.388 . . . . . . . . 3 3 . 1 . 086 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.428 ' HB3' ' HD2' ' A' ' 168' ' ' PRO . 1.6 m-85 -70.23 -34.5 72.95 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.124 0.488 . . . . 0.0 110.865 -179.843 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -68.71 -53.13 23.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.209 -179.848 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 12.8 tp -67.59 -5.44 15.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.329 178.709 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.44 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER -76.83 -4.57 44.29 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.862 179.805 . . . . . . . . 3 3 . 1 . 086 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.44 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.1 OUTLIER 84.2 -20.26 0.32 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.182 -179.643 . . . . . . . . 3 3 . 1 . 086 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 166' ' ' LEU . 4.9 tp -168.24 141.57 2.6 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.881 -178.484 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -74.12 109.22 2.84 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.32 2.013 . . . . 0.0 112.345 179.61 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.88 ' O ' ' N ' ' A' ' 170' ' ' ILE . 58.6 Cg_endo -71.72 -17.58 29.32 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.574 2.183 . . . . 0.0 112.508 179.93 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.793 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 5.2 tt 32.0 -62.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.177 0.991 . . . . 0.0 112.647 179.663 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.88 ' N ' ' O ' ' A' ' 168' ' ' PRO . 0.4 OUTLIER -67.03 -47.86 80.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.992 -179.899 . . . . . . . . 3 3 . 1 . 086 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 175' ' ' TYR . 0.1 OUTLIER -64.85 -50.92 64.73 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.419 . . . . . . . . 3 3 . 1 . 086 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.42 ' HB2' ' HG2' ' A' ' 168' ' ' PRO . 0.8 OUTLIER -73.82 -5.86 43.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.547 178.445 . . . . . . . . 3 3 . 1 . 086 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.793 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.71 -73.71 0.21 Allowed 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.571 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.453 ' H ' HD12 ' A' ' 177' ' ' LEU . . . -113.95 -19.86 6.25 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.44 178.585 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.402 ' HA ' HD13 ' A' ' 171' ' ' LEU . 35.0 t80 73.03 -44.86 0.61 Allowed 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 122.45 0.3 . . . . 0.0 111.59 179.87 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -94.08 -13.07 27.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.349 -179.729 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.53 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 8.0 mt -48.55 -43.51 62.23 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 120.522 0.201 . . . . 0.0 111.289 179.797 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 21.6 Cg_exo -65.98 -28.19 50.0 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.565 2.177 . . . . 0.0 112.13 -179.946 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 8.9 mp -77.91 -7.94 57.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.475 -179.913 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.88 62.5 0.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.222 0.534 . . . . 0.0 109.673 179.566 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 087 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.779 0.323 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 087 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.589 ' O ' HD12 ' A' ' 156' ' ' LEU . 1.0 OUTLIER -165.72 60.3 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.043 -179.929 . . . . . . . . 3 3 . 1 . 087 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -169.52 -41.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.962 179.975 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.4 p -75.96 57.92 1.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.911 179.873 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.578 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.5 OUTLIER 70.97 -48.6 0.67 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.887 179.871 . . . . . . . . 3 3 . 1 . 087 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.578 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 98.2 t 85.75 -53.38 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 C-N-CA 123.02 0.528 . . . . 0.0 110.719 -179.568 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.419 ' O ' ' CB ' ' A' ' 164' ' ' PHE . 0.1 OUTLIER -68.22 -24.2 64.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.104 0.478 . . . . 0.0 109.868 179.012 . . . . . . . . 3 3 . 1 . 087 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.419 ' C ' ' H ' ' A' ' 164' ' ' PHE . 0.3 OUTLIER -70.93 -51.13 27.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.447 179.152 . . . . . . . . 3 3 . 1 . 087 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.476 HD23 ' O ' ' A' ' 163' ' ' LEU . 0.7 OUTLIER -65.16 -5.89 7.89 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.794 0.807 . . . . 0.0 109.281 178.129 . . . . . . . . 3 3 . 1 . 087 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.419 ' H ' ' C ' ' A' ' 162' ' ' PHE . 0.1 OUTLIER -77.83 -63.46 1.38 Allowed 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.781 -179.733 . . . . . . . . 3 3 . 1 . 087 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.08 -45.84 79.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.175 0.512 . . . . 0.0 110.372 179.403 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.73 HD13 ' O ' ' A' ' 166' ' ' LEU . 0.2 OUTLIER -160.97 122.05 1.65 Allowed Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.323 -178.617 . . . . . . . . 3 3 . 1 . 087 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.675 ' CD ' HD22 ' A' ' 166' ' ' LEU . 11.8 Cg_endo -55.54 119.76 7.09 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.582 2.188 . . . . 0.0 112.86 -179.426 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.98 92.94 0.87 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.818 2.345 . . . . 0.0 111.463 179.312 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.89 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 2.9 tp -68.91 -40.67 81.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.408 -179.268 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.424 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.8 mp -71.33 -47.93 56.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.016 -179.904 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.48 -50.67 64.48 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.13 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.88 -4.66 39.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.998 178.869 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.89 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.37 -69.48 0.42 Allowed 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.368 0.604 . . . . 0.0 109.552 179.632 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.841 ' H ' ' HG2' ' A' ' 178' ' ' PRO . . . -122.36 -20.71 2.91 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.213 178.674 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.438 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 11.8 t80 76.35 -31.68 0.19 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.313 0.645 . . . . 0.0 112.349 179.549 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -91.63 61.9 4.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.332 0.587 . . . . 0.0 109.694 179.525 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.68 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 2.3 mt 44.16 56.03 13.09 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.029 -178.997 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.841 ' HG2' ' H ' ' A' ' 174' ' ' GLY . 12.5 Cg_exo -73.62 162.79 38.98 Favored 'Trans proline' 0 CA--C 1.528 0.18 0 C-N-CA 123.787 2.992 . . . . 0.0 112.587 -179.652 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.9 mt 167.8 -33.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.041 179.706 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.48 35.47 0.87 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.036 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 088 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.439 ' CE2' ' NE2' ' A' ' 157' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.782 0.325 . . . . 0.0 111.224 . . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 158' ' ' SER . 3.5 pp -165.62 -42.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.201 -179.976 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.465 ' CB ' ' HB2' ' A' ' 163' ' ' LEU . 12.4 mm-40 74.38 67.15 0.09 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.017 0.436 . . . . 0.0 111.188 179.623 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.557 ' N ' HD12 ' A' ' 156' ' ' LEU . 0.4 OUTLIER 72.41 -61.22 0.5 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.845 179.943 . . . . . . . . 3 3 . 1 . 088 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.411 ' O ' ' CB ' ' A' ' 160' ' ' VAL . 8.3 m-20 -159.44 12.87 0.14 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.015 -0.538 . . . . 0.0 112.281 179.926 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.411 ' CB ' ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 83.49 -46.1 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 111.819 0.304 . . . . 0.0 111.819 179.542 . . . . . . . . 3 3 . 1 . 088 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.482 ' HA ' ' HB2' ' A' ' 164' ' ' PHE . 37.8 m-85 -65.0 -24.73 67.6 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.843 0.354 . . . . 0.0 110.876 -179.585 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -68.23 -59.81 2.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.634 179.48 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.715 ' O ' HD13 ' A' ' 163' ' ' LEU . 1.5 tm? -62.8 -16.21 57.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.872 0.844 . . . . 0.0 109.499 178.356 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.482 ' HB2' ' HA ' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -69.08 -12.6 61.83 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.371 -179.472 . . . . . . . . 3 3 . 1 . 088 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 165' ' ' LEU . 5.1 tp -64.38 -32.08 73.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.214 0.53 . . . . 0.0 110.058 178.935 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.667 HD23 ' O ' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -160.29 78.1 2.6 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.044 -178.544 . . . . . . . . 3 3 . 1 . 088 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.579 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 36.0 Cg_endo -69.38 -25.9 29.92 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.819 2.346 . . . . 0.0 115.302 -178.563 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 33.8 Cg_endo -88.3 49.85 1.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.56 1.507 . . . . 0.0 112.912 -179.294 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.829 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 7.5 tt -77.49 -41.23 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.952 179.585 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.859 HG22 ' CD1' ' A' ' 177' ' ' LEU . 1.3 mp -76.13 -51.85 19.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.92 -179.282 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.735 HD23 ' N ' ' A' ' 172' ' ' ASP . 0.0 OUTLIER -64.75 -53.13 52.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.981 0.42 . . . . 0.0 110.002 -179.756 . . . . . . . . 3 3 . 1 . 088 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.735 ' N ' HD23 ' A' ' 171' ' ' LEU . 1.1 t70 -74.84 4.73 5.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.384 179.053 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.829 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -70.44 -60.57 2.19 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.694 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -109.36 -17.18 10.2 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 178.085 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 29.7 t80 72.33 -12.39 0.72 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.565 0.346 . . . . 0.0 111.316 -179.777 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.605 ' CD1' HD21 ' A' ' 179' ' ' LEU . 76.4 t80 -97.88 19.17 14.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.937 0.399 . . . . 0.0 110.193 179.506 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.859 ' CD1' HG22 ' A' ' 170' ' ' ILE . 2.4 mt -81.05 -53.44 0.78 Allowed Pre-proline 0 C--O 1.232 0.155 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.918 -179.886 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 74.5 Cg_exo -50.46 -71.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.637 2.225 . . . . 0.0 112.498 -179.764 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.605 HD21 ' CD1' ' A' ' 176' ' ' PHE . 50.3 mt 61.28 57.17 2.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.062 0.458 . . . . 0.0 110.779 -179.981 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 9.4 mmp_? 62.09 46.67 6.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.812 179.926 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 089 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.451 ' O ' HD23 ' A' ' 156' ' ' LEU . 82.8 m-85 . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.68 0.276 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 155' ' ' PHE . 84.0 mt -161.97 79.36 0.54 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.787 -179.999 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -169.82 -40.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.413 179.715 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.82 60.78 0.74 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.229 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.461 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.3 OUTLIER 72.41 -58.88 0.58 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.383 -179.053 . . . . . . . . 3 3 . 1 . 089 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 57.6 t 74.25 -65.23 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.831 -179.842 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.427 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 22.8 m-85 -79.89 35.33 0.31 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.03 178.841 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.427 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 7.4 m-85 -170.06 -26.65 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.809 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.44 ' HA ' HD22 ' A' ' 163' ' ' LEU . 0.6 OUTLIER -57.13 -48.84 77.67 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.593 . . . . . . . . 3 3 . 1 . 089 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.585 ' HB2' HD11 ' A' ' 169' ' ' ILE . 0.5 OUTLIER 43.37 38.53 1.76 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.721 177.352 . . . . . . . . 3 3 . 1 . 089 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.491 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.7 OUTLIER 88.08 -29.69 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.068 -179.43 . . . . . . . . 3 3 . 1 . 089 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.533 HD22 ' HD2' ' A' ' 167' ' ' PRO . 0.1 OUTLIER -158.99 132.78 4.99 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.156 -178.859 . . . . . . . . 3 3 . 1 . 089 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.533 ' HD2' HD22 ' A' ' 166' ' ' LEU . 4.0 Cg_exo -38.4 -46.0 2.32 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.572 2.848 . . . . 0.0 114.355 -178.98 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.503 ' HD2' ' CD1' ' A' ' 166' ' ' LEU . 52.3 Cg_endo -88.78 101.04 0.38 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.74 2.293 . . . . 0.0 112.227 -179.336 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.86 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.0 OUTLIER -71.22 -46.5 65.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.248 -179.455 . . . . . . . . 3 3 . 1 . 089 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.612 HG23 HG22 ' A' ' 169' ' ' ILE . 0.6 OUTLIER -74.54 -43.67 48.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.361 -177.95 . . . . . . . . 3 3 . 1 . 089 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.445 ' HA ' ' HG2' ' A' ' 178' ' ' PRO . 0.2 OUTLIER -65.35 -56.55 12.01 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.227 . . . . . . . . 3 3 . 1 . 089 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.7 4.41 7.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.4 179.023 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.86 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.16 -75.34 0.13 Allowed 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.796 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.45 ' HA3' HD12 ' A' ' 177' ' ' LEU . . . -95.12 -13.03 54.11 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 177.924 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 69.76 -59.59 0.5 Allowed 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 120.862 0.363 . . . . 0.0 110.955 179.875 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -96.94 -5.5 37.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.194 179.708 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.525 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 62.7 mt -71.61 -45.21 12.81 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.161 179.685 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.525 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 27.5 Cg_exo -62.11 -149.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.466 2.111 . . . . 0.0 111.984 179.812 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.464 HD12 ' HA ' ' A' ' 179' ' ' LEU . 2.6 tp 81.02 74.1 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.135 0 CA-C-O 121.071 0.462 . . . . 0.0 110.763 -179.894 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 67.17 57.35 0.6 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.832 179.862 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 090 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.619 ' O ' ' O ' ' A' ' 156' ' ' LEU . 9.8 m-85 . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 120.79 0.329 . . . . 0.0 111.392 . . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.855 ' O ' HD12 ' A' ' 156' ' ' LEU . 3.3 pp 45.15 142.74 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.393 -0.822 . . . . 0.0 112.934 179.29 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.549 ' HB2' HD12 ' A' ' 163' ' ' LEU . 3.1 tp-100 -171.13 -80.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.225 179.881 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.7 m -170.1 -40.85 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.374 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.404 ' O ' HG12 ' A' ' 160' ' ' VAL . 74.6 m-20 -84.31 -52.45 6.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.066 178.819 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.447 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 80.0 -52.39 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.171 179.839 . . . . . . . . 3 3 . 1 . 090 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.447 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 72.6 t80 -69.57 -28.7 66.2 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.051 0.453 . . . . 0.0 110.259 179.393 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.422 ' HB3' ' HG3' ' A' ' 168' ' ' PRO . 0.2 OUTLIER -68.49 -60.05 2.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.782 179.46 . . . . . . . . 3 3 . 1 . 090 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.58 HD23 ' HA ' ' A' ' 167' ' ' PRO . 13.5 mt -65.93 -5.22 8.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.93 178.791 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.95 -63.69 1.25 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.869 -179.457 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -55.21 18.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.993 0.425 . . . . 0.0 110.667 179.607 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 166' ' ' LEU . 3.9 tp -161.37 141.56 8.09 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.587 -179.658 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.58 ' HA ' HD23 ' A' ' 163' ' ' LEU . 13.6 Cg_endo -57.06 110.17 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.478 2.118 . . . . 0.0 112.901 -179.672 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.422 ' HG3' ' HB3' ' A' ' 162' ' ' PHE . 81.8 Cg_endo -80.94 87.02 1.54 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.102 2.535 . . . . 0.0 112.093 179.45 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.948 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER -72.07 -38.17 62.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.313 -179.825 . . . . . . . . 3 3 . 1 . 090 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 6.0 mm -80.84 -44.09 21.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.61 -179.869 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.483 HD13 ' HG2' ' A' ' 178' ' ' PRO . 0.7 OUTLIER -64.38 -57.85 8.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.159 0.504 . . . . 0.0 109.792 179.95 . . . . . . . . 3 3 . 1 . 090 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.9 2.81 7.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.066 178.74 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.948 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.02 -54.79 8.8 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.432 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.468 ' HA3' HD21 ' A' ' 177' ' ' LEU . . . -126.39 -10.64 4.04 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.928 178.692 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.422 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 2.6 t80 68.55 -52.67 0.56 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.62 0.368 . . . . 0.0 111.708 179.59 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -92.49 10.01 31.98 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.403 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.491 ' O ' ' HB2' ' A' ' 181' ' ' HSL . 13.2 mt -71.85 -46.74 12.07 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.509 0.195 . . . . 0.0 110.806 179.352 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.483 ' HG2' HD13 ' A' ' 171' ' ' LEU . 90.2 Cg_exo -44.25 -28.78 2.58 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.512 2.142 . . . . 0.0 112.408 179.718 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.1 mp -81.5 -55.1 4.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.122 179.329 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.76 37.57 0.8 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.424 179.44 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 181' ' ' HSL . . . . . 0.491 ' HB2' ' O ' ' A' ' 177' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.4 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 41.9 m-85 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.517 0.199 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.409 ' HA ' HD23 ' A' ' 156' ' ' LEU . 7.0 mt -167.48 42.08 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.957 0.408 . . . . 0.0 110.683 -179.716 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -168.61 52.0 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.373 0.606 . . . . 0.0 110.731 179.804 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.529 ' O ' HD23 ' A' ' 163' ' ' LEU . 1.8 m -164.72 64.38 0.13 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.306 179.684 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.422 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.4 OUTLIER 76.69 -59.51 0.49 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.243 -178.746 . . . . . . . . 3 3 . 1 . 091 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.422 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 92.7 t 70.62 -59.23 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.678 179.917 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.47 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 36.0 t80 -74.85 20.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.541 179.351 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.47 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 35.4 m-85 -166.87 -17.14 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 179.978 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 158' ' ' SER . 0.3 OUTLIER -60.46 -41.97 95.25 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.53 . . . . . . . . 3 3 . 1 . 091 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.45 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 0.6 OUTLIER 48.73 30.25 2.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.358 178.212 . . . . . . . . 3 3 . 1 . 091 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.45 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.1 OUTLIER 85.38 -22.85 0.18 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.436 -179.754 . . . . . . . . 3 3 . 1 . 091 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.556 HD23 ' O ' ' A' ' 166' ' ' LEU . 0.5 OUTLIER -161.59 115.01 1.25 Allowed Pre-proline 0 N--CA 1.447 -0.595 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.048 -178.357 . . . . . . . . 3 3 . 1 . 091 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.512 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 1.7 Cg_endo -49.35 -40.04 43.94 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.442 2.095 . . . . 0.0 113.415 -179.474 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.512 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 34.7 Cg_endo -92.25 81.94 0.28 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.452 2.102 . . . . 0.0 113.074 -179.008 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.699 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.4 OUTLIER -77.49 -45.93 28.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.227 179.904 . . . . . . . . 3 3 . 1 . 091 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.447 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.6 mp -72.65 -39.56 60.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.367 -179.633 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 171' ' ' LEU . 4.0 tt -68.82 -2.51 9.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.684 179.922 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -148.14 15.96 1.05 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.064 179.902 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -81.46 -46.42 14.58 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.015 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.588 ' O ' ' CG ' ' A' ' 175' ' ' TYR . . . -141.61 0.52 1.69 Allowed Glycine 0 CA--C 1.522 0.531 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.818 179.229 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.588 ' CG ' ' O ' ' A' ' 174' ' ' GLY . 45.2 p90 56.61 -52.72 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.904 0.881 . . . . 0.0 113.02 179.926 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.562 ' N ' ' O ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER -92.11 12.72 21.15 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.312 . . . . . . . . 3 3 . 1 . 091 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.555 HD11 ' N ' ' A' ' 174' ' ' GLY . 11.8 mt -72.08 -48.12 10.77 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-O 120.635 0.255 . . . . 0.0 110.415 179.332 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.517 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 85.5 Cg_exo -48.52 -25.86 8.2 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.714 2.276 . . . . 0.0 112.395 179.479 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.413 ' N ' HD22 ' A' ' 179' ' ' LEU . 3.6 mm? -68.36 -60.54 2.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.909 -179.853 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.99 44.87 1.21 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.969 -179.881 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 092 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 120.813 0.34 . . . . 0.0 111.293 . . . . . . . . . 0 0 . 1 . 092 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.65 ' CD1' HG23 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -73.25 -21.71 60.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.011 -179.88 . . . . . . . . 3 3 . 1 . 092 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.19 18.65 6.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.51 179.817 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.4 p 74.91 -10.86 1.14 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.529 -179.925 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.772 ' O ' HG12 ' A' ' 160' ' ' VAL . 1.2 m-20 -78.62 -63.79 1.32 Allowed 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.452 0.168 . . . . 0.0 110.668 179.741 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.772 HG12 ' O ' ' A' ' 159' ' ' ASP . 9.9 p 58.39 -44.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 123.978 0.799 . . . . 0.0 112.634 -179.567 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.508 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 0.3 OUTLIER -71.13 -16.47 62.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.406 0.146 . . . . 0.0 111.273 179.929 . . . . . . . . 3 3 . 1 . 092 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.508 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 56.2 m-85 -161.85 20.65 0.11 Allowed 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 179.777 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.784 ' O ' HD13 ' A' ' 163' ' ' LEU . 2.1 tm? -65.97 -18.68 65.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.916 0.865 . . . . 0.0 109.289 177.811 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -70.95 -67.76 0.48 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.354 -1.294 . . . . 0.0 112.022 -178.796 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.718 ' N ' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -63.4 -72.76 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.333 -178.952 . . . . . . . . 3 3 . 1 . 092 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.461 HD12 ' HD2' ' A' ' 168' ' ' PRO . 0.3 OUTLIER -160.61 120.22 1.59 Allowed Pre-proline 0 N--CA 1.451 -0.395 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.16 -178.348 . . . . . . . . 3 3 . 1 . 092 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.436 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 6.4 Cg_exo -37.7 -48.55 1.99 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.796 2.33 . . . . 0.0 112.587 179.9 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.461 ' HD2' HD12 ' A' ' 166' ' ' LEU . 33.2 Cg_endo -92.41 74.16 0.51 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.092 2.528 . . . . 0.0 112.288 179.96 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.906 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 1.2 tp -74.2 -44.25 49.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.224 -179.659 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.551 ' O ' HD12 ' A' ' 177' ' ' LEU . 2.5 mp -72.45 -42.71 64.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.312 -179.684 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.413 ' HA ' ' HG3' ' A' ' 178' ' ' PRO . 3.7 tt -65.02 -56.21 14.43 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.443 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.1 1.0 14.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.118 178.711 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.906 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.95 -57.66 3.89 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.201 0.524 . . . . 0.0 109.833 179.723 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -119.98 -3.45 12.05 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.878 178.983 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.457 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 92.6 t80 71.03 -43.51 0.56 Allowed 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.587 0.355 . . . . 0.0 111.719 -179.964 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.9 14.11 22.66 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.791 0.329 . . . . 0.0 111.01 179.937 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.676 HD12 ' HB3' ' A' ' 173' ' ' ALA . 54.4 mt -82.98 -38.61 0.76 Allowed Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.76 179.995 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 86.8 Cg_exo -44.16 -26.34 1.48 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.555 2.17 . . . . 0.0 113.001 -179.771 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 179' ' ' LEU . 0.9 OUTLIER -60.8 -15.62 31.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.13 179.661 . . . . . . . . 3 3 . 1 . 092 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -145.58 46.32 1.29 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.029 0.442 . . . . 0.0 110.133 179.728 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 181' ' ' HSL . . . . . 0.518 ' HB2' ' HA ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.536 ' O ' ' HB2' ' A' ' 156' ' ' LEU . 16.1 m-85 . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 . . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.566 HD23 HG22 ' A' ' 160' ' ' VAL . 6.5 mt 75.93 -43.97 0.49 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.843 179.952 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -71.46 -14.64 62.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.879 0.371 . . . . 0.0 110.535 179.556 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.7 ' OG ' HD13 ' A' ' 163' ' ' LEU . 1.2 p -79.7 28.4 0.27 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.978 -179.697 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.542 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.2 OUTLIER 79.59 -25.44 0.18 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.921 . . . . . . . . 3 3 . 1 . 093 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.566 HG22 HD23 ' A' ' 156' ' ' LEU . 58.0 t 81.62 -54.46 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.115 0 C-N-CA 122.613 0.365 . . . . 0.0 111.233 179.946 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.593 ' O ' ' HB2' ' A' ' 164' ' ' PHE . 31.0 t80 -67.36 -35.51 79.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.14 0.495 . . . . 0.0 110.403 179.626 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.495 ' C ' ' H ' ' A' ' 164' ' ' PHE . 0.2 OUTLIER -77.49 -44.88 27.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.413 179.698 . . . . . . . . 3 3 . 1 . 093 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.7 HD13 ' OG ' ' A' ' 158' ' ' SER . 3.4 tp -62.66 -4.24 1.92 Allowed 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 121.894 0.854 . . . . 0.0 109.293 178.783 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.593 ' HB2' ' O ' ' A' ' 161' ' ' PHE . 0.1 OUTLIER -75.6 -67.68 0.64 Allowed 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.41 -179.998 . . . . . . . . 3 3 . 1 . 093 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.38 -70.99 0.22 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.977 0.418 . . . . 0.0 111.246 179.407 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.446 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 5.7 tp -160.48 95.39 1.5 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.694 -178.309 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.586 ' HG3' HD12 ' A' ' 163' ' ' LEU . 21.7 Cg_endo -66.19 -28.55 48.1 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.746 2.297 . . . . 0.0 115.021 -179.126 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.58 ' CB ' HD13 ' A' ' 171' ' ' LEU . 33.2 Cg_endo -89.49 59.44 2.08 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.789 1.659 . . . . 0.0 113.083 -178.923 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.802 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -76.82 -33.75 21.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.134 179.711 . . . . . . . . 3 3 . 1 . 093 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 3.4 mp -69.07 -38.71 78.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.618 -179.004 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.58 HD13 ' CB ' ' A' ' 168' ' ' PRO . 2.6 mp -65.17 -60.09 3.38 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.258 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -74.36 3.31 7.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.263 178.55 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.802 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.15 -59.31 2.84 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.973 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -104.52 -20.4 10.22 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 178.309 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 36.7 t80 72.91 -11.64 0.85 Allowed 'General case' 0 C--O 1.232 0.157 0 C-N-CA 122.704 0.402 . . . . 0.0 111.845 179.83 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.406 ' HA ' HD12 ' A' ' 179' ' ' LEU . 23.3 p90 -95.41 -3.08 47.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.821 0.343 . . . . 0.0 110.495 179.348 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.443 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 1.3 mm? -53.51 -51.86 72.13 Favored Pre-proline 0 C--N 1.333 -0.139 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.592 179.649 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.443 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 35.4 Cg_exo -58.7 -41.08 67.19 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.681 2.254 . . . . 0.0 112.223 179.649 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 176' ' ' PHE . 2.6 mt -63.36 -56.08 19.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.839 -179.9 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -87.44 49.1 1.75 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.943 179.982 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 094 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.494 ' O ' HG12 ' A' ' 160' ' ' VAL . 32.3 m-85 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.814 0.34 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.538 ' HB3' HD12 ' A' ' 163' ' ' LEU . 17.7 mt 51.55 57.4 6.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.177 179.962 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 72.28 27.22 2.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.987 179.952 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 53.35 44.03 30.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.056 179.957 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.737 ' O ' HG13 ' A' ' 160' ' ' VAL . 15.7 m-20 -162.28 -57.29 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.598 179.872 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.737 HG13 ' O ' ' A' ' 159' ' ' ASP . 1.5 m 67.46 -58.48 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 123.134 0.574 . . . . 0.0 110.072 -179.72 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.512 ' CE1' ' CE2' ' A' ' 162' ' ' PHE . 0.0 OUTLIER -73.6 49.12 0.29 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.438 . . . . . . . . 3 3 . 1 . 094 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.512 ' CE2' ' CE1' ' A' ' 161' ' ' PHE . 5.5 m-85 -166.42 -30.53 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.68 -179.385 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.538 HD12 ' HB3' ' A' ' 156' ' ' LEU . 12.8 mt -58.43 -34.77 71.16 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.204 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.471 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 1.4 t80 46.38 40.6 8.1 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.719 177.649 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.531 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.2 OUTLIER 86.47 -30.08 0.05 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.067 -179.738 . . . . . . . . 3 3 . 1 . 094 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -161.24 133.97 4.49 Favored Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.422 -178.941 . . . . . . . . 3 3 . 1 . 094 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.409 ' HA ' ' HD2' ' A' ' 168' ' ' PRO . 9.9 Cg_endo -51.98 108.64 0.26 Allowed 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.533 2.155 . . . . 0.0 112.395 -179.703 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 167' ' ' PRO . 61.5 Cg_endo -71.9 82.11 1.29 Allowed 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.646 2.231 . . . . 0.0 112.042 179.75 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.929 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER -74.48 -45.24 46.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.283 0.563 . . . . 0.0 110.853 -179.911 . . . . . . . . 3 3 . 1 . 094 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.722 ' O ' HD23 ' A' ' 177' ' ' LEU . 0.7 OUTLIER -79.36 -45.34 23.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 114.92 -1.036 . . . . 0.0 112.074 -178.798 . . . . . . . . 3 3 . 1 . 094 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.437 HD23 HG13 ' A' ' 170' ' ' ILE . 13.2 mt -66.93 -55.69 13.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.089 0.471 . . . . 0.0 109.891 179.532 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.05 5.84 4.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.276 179.032 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.929 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.32 -47.75 40.04 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.26 0.552 . . . . 0.0 109.712 179.639 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.51 ' C ' ' CG ' ' A' ' 175' ' ' TYR . . . -120.75 -1.59 11.8 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.841 178.841 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.51 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER 57.25 -50.07 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.963 0.905 . . . . 0.0 113.088 179.732 . . . . . . . . 3 3 . 1 . 094 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.49 ' N ' ' O ' ' A' ' 174' ' ' GLY . 26.6 p90 -90.57 9.88 27.76 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 122.217 -0.302 . . . . 0.0 111.152 -179.935 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.722 HD23 ' O ' ' A' ' 170' ' ' ILE . 0.1 OUTLIER -69.52 -51.35 16.66 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.651 179.663 . . . . . . . . 3 3 . 1 . 094 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 38.4 Cg_exo -61.22 78.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.627 2.218 . . . . 0.0 112.18 179.923 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.94 -63.85 1.17 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.21 -179.919 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.38 16.02 4.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.836 -179.891 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 095 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.906 0.384 . . . . 0.0 111.881 . . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.405 ' N ' HD13 ' A' ' 163' ' ' LEU . 9.3 mt 65.38 108.79 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.993 179.873 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.814 ' CB ' HD11 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -168.62 -73.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.244 0.545 . . . . 0.0 111.105 -179.963 . . . . . . . . 3 3 . 1 . 095 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 20.6 t -171.06 -35.17 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.505 179.727 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 161' ' ' PHE . 2.1 m-20 -76.85 -57.8 3.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.151 179.321 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 63.4 -51.93 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.184 179.623 . . . . . . . . 3 3 . 1 . 095 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.461 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 10.1 m-85 -72.73 -0.05 12.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.679 0.276 . . . . 0.0 111.082 179.643 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.444 ' CG ' ' C ' ' A' ' 161' ' ' PHE . 0.0 OUTLIER -160.58 14.02 0.11 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.151 -179.956 . . . . . . . . 3 3 . 1 . 095 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.814 HD11 ' CB ' ' A' ' 157' ' ' GLN . 3.4 mt -67.56 -10.87 55.84 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.343 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -78.45 -84.03 0.08 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.38 -179.475 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.537 ' HB2' HD11 ' A' ' 169' ' ' ILE . 0.1 OUTLIER -67.83 -66.0 0.62 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.951 0.405 . . . . 0.0 111.307 -179.702 . . . . . . . . 3 3 . 1 . 095 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.613 ' HB3' ' HD2' ' A' ' 168' ' ' PRO . 0.0 OUTLIER -160.19 153.06 17.91 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.538 -179.53 . . . . . . . . 3 3 . 1 . 095 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.447 ' CB ' ' HD3' ' A' ' 168' ' ' PRO . 3.0 Cg_exo -37.35 -52.45 1.48 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.517 2.811 . . . . 0.0 113.875 -179.189 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.807 ' O ' HD12 ' A' ' 170' ' ' ILE . 85.6 Cg_endo -83.64 -62.41 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.836 1.69 . . . . 0.0 113.209 -179.198 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.877 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.0 OUTLIER 80.33 -38.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 179.4 . . . . . . . . 3 3 . 1 . 095 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.807 HD12 ' O ' ' A' ' 168' ' ' PRO . 4.0 mp -71.64 -39.69 69.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.673 -179.022 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.928 HD13 ' HG3' ' A' ' 178' ' ' PRO . 2.0 mm? -64.54 -60.52 3.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.357 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -75.14 4.41 6.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.501 178.973 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.877 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.82 -69.66 0.38 Allowed 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.59 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -108.25 -16.41 12.31 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.091 178.211 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.427 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 53.1 t80 74.51 -15.78 0.6 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.868 0.467 . . . . 0.0 111.898 179.953 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -107.67 -22.41 12.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.781 0.324 . . . . 0.0 111.02 -179.964 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.522 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 47.6 mt -48.29 -42.75 54.84 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.742 -179.946 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.928 ' HG3' HD13 ' A' ' 171' ' ' LEU . 26.0 Cg_exo -63.14 71.67 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.562 2.174 . . . . 0.0 112.408 -179.777 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 177' ' ' LEU . 0.4 OUTLIER -77.39 -66.1 0.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.572 179.675 . . . . . . . . 3 3 . 1 . 095 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.37 40.57 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.578 179.58 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 096 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 1.3 p90 . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.836 0.351 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 096 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.423 ' HB2' ' CG2' ' A' ' 160' ' ' VAL . 1.3 pt? -165.43 170.29 14.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.051 -179.968 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -169.18 -85.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.888 179.904 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.631 ' HB3' HD13 ' A' ' 163' ' ' LEU . 8.5 t -78.18 53.6 1.25 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.742 0.306 . . . . 0.0 111.204 179.928 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.538 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 6.7 t0 75.87 -34.88 0.25 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 179.913 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.538 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 75.8 t 80.45 -57.02 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 C-N-CA 122.549 0.339 . . . . 0.0 110.486 -179.613 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.518 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 7.3 m-85 -73.71 36.84 0.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.771 179.01 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.518 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 93.0 m-85 -165.88 -25.71 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.129 179.845 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.631 HD13 ' HB3' ' A' ' 158' ' ' SER . 6.0 tp -63.53 -1.89 1.4 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.769 0.795 . . . . 0.0 109.283 178.062 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.514 ' H ' ' C ' ' A' ' 162' ' ' PHE . 10.1 t80 -68.5 -10.03 52.89 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.347 -179.662 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.5 tp -64.44 -31.67 72.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.082 0.468 . . . . 0.0 110.136 178.971 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 1.8 tp -160.61 66.57 2.45 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.588 -179.463 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.67 108.24 0.52 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.954 2.436 . . . . 0.0 113.827 -178.505 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.453 ' HG2' ' HB2' ' A' ' 172' ' ' ASP . 92.5 Cg_endo -79.14 86.1 1.75 Allowed 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.937 2.425 . . . . 0.0 110.932 178.293 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.946 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 5.7 tp -71.45 -63.4 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.414 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.746 ' H ' HG23 ' A' ' 169' ' ' ILE . 1.9 mp -73.35 -39.98 56.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.812 -179.015 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 4.7 tp -64.13 -60.89 2.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.274 0.559 . . . . 0.0 109.762 179.754 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.453 ' HB2' ' HG2' ' A' ' 168' ' ' PRO . 4.6 t70 -74.12 -0.0 15.24 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.128 179.014 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.946 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -70.11 -71.0 0.26 Allowed 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.203 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.486 ' HA3' ' CG ' ' A' ' 177' ' ' LEU . . . -125.87 -8.48 5.16 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.119 177.815 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 12.9 t80 70.59 -55.66 0.62 Allowed 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.605 0.362 . . . . 0.0 111.851 179.558 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -94.99 16.8 15.27 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.187 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.486 ' CG ' ' HA3' ' A' ' 174' ' ' GLY . 6.2 mt -81.56 -47.89 1.03 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.57 0.224 . . . . 0.0 110.826 179.434 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.674 ' HG3' HG22 ' A' ' 170' ' ' ILE . 73.6 Cg_exo -50.32 166.24 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.418 2.079 . . . . 0.0 112.069 179.718 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.405 ' CB ' ' O ' ' A' ' 178' ' ' PRO . 1.4 tp 81.49 -10.83 1.14 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.557 -179.824 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 180' ' ' ARG . 0.6 OUTLIER -151.66 32.06 0.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.445 . . . . . . . . 3 3 . 1 . 096 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 097 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.455 ' O ' HD23 ' A' ' 156' ' ' LEU . 1.9 t80 . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.796 0.331 . . . . 0.0 111.551 . . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 156' ' ' LEU . 0.2 OUTLIER 62.59 132.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.477 179.782 . . . . . . . . 3 3 . 1 . 097 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.416 ' HG2' ' N ' ' A' ' 158' ' ' SER . 4.6 pm0 -172.06 -41.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.98 -179.832 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.416 ' N ' ' HG2' ' A' ' 157' ' ' GLN . 37.6 t -78.13 52.19 1.07 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.556 -179.764 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.569 ' O ' HG12 ' A' ' 160' ' ' VAL . 0.4 OUTLIER 75.37 -29.03 0.19 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.576 . . . . . . . . 3 3 . 1 . 097 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.569 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.3 OUTLIER 92.29 -41.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 122.929 0.492 . . . . 0.0 111.209 -179.806 . . . . . . . . 3 3 . 1 . 097 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -69.37 -29.27 67.01 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.078 0.466 . . . . 0.0 110.55 179.53 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.422 ' C ' ' H ' ' A' ' 164' ' ' PHE . 1.2 t80 -67.48 -60.1 2.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.942 179.784 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.888 HD22 ' HD2' ' A' ' 168' ' ' PRO . 18.6 mt -66.58 -1.92 4.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.206 178.761 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.422 ' H ' ' C ' ' A' ' 162' ' ' PHE . 1.5 t80 -73.41 -33.63 65.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.274 -179.038 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.552 ' O ' HD22 ' A' ' 166' ' ' LEU . 2.5 mt -66.0 -46.1 79.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.036 0.446 . . . . 0.0 110.58 179.5 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.552 HD22 ' O ' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -160.61 86.13 1.87 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.125 -179.162 . . . . . . . . 3 3 . 1 . 097 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.84 110.31 1.66 Allowed 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.645 2.23 . . . . 0.0 113.187 -179.017 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.888 ' HD2' HD22 ' A' ' 163' ' ' LEU . 92.0 Cg_endo -76.12 -146.88 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.873 2.382 . . . . 0.0 111.037 178.912 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.839 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.4 OUTLIER 86.79 -39.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.53 . . . . . . . . 3 3 . 1 . 097 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.46 HG12 ' H ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -69.92 -39.41 77.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.65 -176.899 . . . . . . . . 3 3 . 1 . 097 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.46 ' H ' HG12 ' A' ' 170' ' ' ILE . 46.5 mt -66.08 -55.79 14.76 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.798 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.34 0.4 19.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.307 178.5 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.839 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.22 -75.35 0.14 Allowed 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.777 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -86.5 -17.5 60.25 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 178.334 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 12.0 t80 68.99 -57.21 0.52 Allowed 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 122.607 0.363 . . . . 0.0 111.112 179.872 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.435 ' CD1' ' C ' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -93.1 15.98 13.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.12 179.803 . . . . . . . . 3 3 . 1 . 097 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.641 ' O ' HD22 ' A' ' 179' ' ' LEU . 13.9 mt -83.01 -47.05 0.84 Allowed Pre-proline 0 CA--C 1.529 0.158 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.74 179.732 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.508 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 8.1 Cg_exo -72.49 96.77 0.83 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.614 2.209 . . . . 0.0 111.982 179.648 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.641 HD22 ' O ' ' A' ' 177' ' ' LEU . 3.2 mm? -82.72 -72.91 0.42 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.952 0.406 . . . . 0.0 110.463 179.814 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.56 21.9 3.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.588 179.648 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 181' ' ' HSL . . . . . 0.406 ' HG2' ' HB3' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.65 0.262 . . . . 0.0 111.327 . . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.2 mt -170.38 80.66 0.1 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.783 -179.828 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -169.27 71.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.252 0.549 . . . . 0.0 111.124 179.842 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.503 ' HB2' HD12 ' A' ' 163' ' ' LEU . 13.7 m -166.14 47.66 0.08 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.574 179.666 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.418 ' O ' HG12 ' A' ' 160' ' ' VAL . 0.5 OUTLIER 76.67 -57.66 0.53 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.56 -178.975 . . . . . . . . 3 3 . 1 . 098 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 71.29 -47.97 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.641 179.722 . . . . . . . . 3 3 . 1 . 098 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.418 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 1.2 m-85 -73.3 -0.0 13.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.933 -179.807 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -166.53 13.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.926 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.67 HD22 ' HB2' ' A' ' 165' ' ' LEU . 0.7 OUTLIER -66.75 -38.0 85.76 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.487 . . . . . . . . 3 3 . 1 . 098 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 8.6 t80 70.49 2.7 4.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.585 -1.189 . . . . 0.0 112.055 179.245 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.67 ' HB2' HD22 ' A' ' 163' ' ' LEU . 0.2 OUTLIER -68.12 -56.33 9.2 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.122 0.487 . . . . 0.0 110.406 179.208 . . . . . . . . 3 3 . 1 . 098 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.651 HD12 ' O ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER -159.34 51.7 0.44 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.944 -179.981 . . . . . . . . 3 3 . 1 . 098 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.613 ' HD3' ' N ' ' A' ' 166' ' ' LEU . 25.3 Cg_exo -60.35 -48.39 11.78 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.296 1.997 . . . . 0.0 112.922 -179.867 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.444 ' HD3' ' HB2' ' A' ' 167' ' ' PRO . 58.8 Cg_endo -88.04 -97.41 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.383 2.055 . . . . 0.0 113.127 -179.072 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.878 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 1.1 tp 80.65 -55.39 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-O 120.89 0.376 . . . . 0.0 110.984 -179.539 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.609 HG13 HG22 ' A' ' 169' ' ' ILE . 0.8 OUTLIER -81.27 -32.29 12.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.757 -179.622 . . . . . . . . 3 3 . 1 . 098 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.868 ' HA ' HD23 ' A' ' 177' ' ' LEU . 2.1 tm? -66.75 -62.46 1.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.939 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -76.4 7.84 4.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.135 178.613 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.878 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.08 -60.1 2.42 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.679 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.429 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -102.24 -17.09 21.19 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 177.884 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.429 ' HB2' ' O ' ' A' ' 174' ' ' GLY . 2.0 m-85 69.7 -12.27 0.47 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.827 0.451 . . . . 0.0 111.846 179.913 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.429 ' H ' ' C ' ' A' ' 174' ' ' GLY . 0.6 OUTLIER -94.91 -10.95 29.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.892 0.377 . . . . 0.0 110.186 179.196 . . . . . . . . 3 3 . 1 . 098 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.868 HD23 ' HA ' ' A' ' 171' ' ' LEU . 0.8 OUTLIER -54.01 -42.0 91.05 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.992 179.371 . . . . . . . . 3 3 . 1 . 098 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 47.5 Cg_exo -57.06 73.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.804 2.336 . . . . 0.0 112.737 -179.922 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 177' ' ' LEU . 16.6 mt -96.86 -49.79 4.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.102 0.477 . . . . 0.0 109.791 179.233 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.53 23.64 1.59 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.961 179.122 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 099 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 2.7 t80 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.815 0.34 . . . . 0.0 111.869 . . . . . . . . . 0 0 . 1 . 099 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.529 HD21 ' CG2' ' A' ' 160' ' ' VAL . 11.2 mt 64.47 156.51 0.08 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.92 179.84 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.95 -64.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.888 -179.926 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 162' ' ' PHE . 0.6 OUTLIER -79.96 23.31 0.46 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.899 179.976 . . . . . . . . 3 3 . 1 . 099 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.8 t70 76.62 -1.58 2.85 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 179.886 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.529 ' CG2' HD21 ' A' ' 156' ' ' LEU . 0.4 OUTLIER 82.01 -53.91 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.768 0.318 . . . . 0.0 110.514 -179.912 . . . . . . . . 3 3 . 1 . 099 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.474 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 27.1 m-85 -77.25 33.49 0.15 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.9 179.094 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.413 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 5.3 m-85 -168.54 -17.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.802 -179.634 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.401 HD11 ' HD3' ' A' ' 167' ' ' PRO . 27.0 tp -59.94 -34.06 72.73 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.23 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.45 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 31.2 t80 45.76 37.81 3.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.84 178.001 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 165' ' ' LEU . 4.3 tp 84.6 -26.05 0.12 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.354 -179.577 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.895 ' O ' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -158.49 132.9 5.26 Favored Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.172 -178.437 . . . . . . . . 3 3 . 1 . 099 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.401 ' HD3' HD11 ' A' ' 163' ' ' LEU . 11.2 Cg_endo -55.41 120.32 8.02 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.146 1.897 . . . . 0.0 112.748 -178.915 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.523 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 41.9 Cg_endo -90.84 106.24 0.3 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 123.582 2.855 . . . . 0.0 111.477 179.437 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.852 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER -69.04 -42.53 82.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.326 -179.366 . . . . . . . . 3 3 . 1 . 099 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.498 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 0.7 OUTLIER -73.95 -46.67 45.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.422 -178.076 . . . . . . . . 3 3 . 1 . 099 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 168' ' ' PRO . 41.0 tp -66.91 -49.26 66.13 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.726 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -73.25 -5.33 38.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.6 178.357 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.852 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.2 -70.45 0.36 Allowed 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.607 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -117.24 -15.77 6.42 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.78 178.902 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 23.4 t80 77.52 -37.16 0.24 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 122.501 0.32 . . . . 0.0 111.638 -179.923 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.41 ' HB2' ' HD3' ' A' ' 180' ' ' ARG . 11.3 p90 -97.39 28.63 3.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.849 0.357 . . . . 0.0 110.978 -179.975 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.582 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 12.1 mt -101.91 -52.81 0.15 Allowed Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.471 -179.88 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 4.6 Cg_exo -78.32 -28.63 4.47 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.741 2.294 . . . . 0.0 112.571 -179.639 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -66.72 -60.58 2.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.85 -179.741 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.41 ' HD3' ' HB2' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -90.99 49.92 1.71 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.763 179.815 . . . . . . . . 3 3 . 1 . 099 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 100 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.46 ' HA ' ' CG2' ' A' ' 160' ' ' VAL . 1.8 m-85 . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.665 0.269 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.694 ' HB2' HD12 ' A' ' 163' ' ' LEU . 14.9 mt -163.89 172.16 14.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.136 179.983 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.419 ' HB2' ' HG ' ' A' ' 163' ' ' LEU . 44.3 tp60 48.53 27.5 1.47 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.779 -179.523 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.4 p 43.72 46.44 6.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.615 -179.933 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.806 ' O ' HG12 ' A' ' 160' ' ' VAL . 1.1 t0 -164.74 -64.16 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.034 179.436 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.806 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 71.8 -36.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.355 -179.764 . . . . . . . . 3 3 . 1 . 100 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.449 ' H ' ' C ' ' A' ' 159' ' ' ASP . 0.2 OUTLIER -76.3 16.36 0.47 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.81 178.644 . . . . . . . . 3 3 . 1 . 100 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.405 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 43.2 m-85 -162.99 1.15 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.841 -179.758 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.718 HD22 ' HB2' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -65.51 -44.09 88.06 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.56 . . . . . . . . 3 3 . 1 . 100 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 62.44 7.86 2.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.847 178.873 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.718 ' HB2' HD22 ' A' ' 163' ' ' LEU . 0.2 OUTLIER -69.02 -26.92 65.24 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 120.888 0.375 . . . . 0.0 111.04 179.529 . . . . . . . . 3 3 . 1 . 100 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.443 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 0.2 OUTLIER -159.73 76.94 2.91 Favored Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.018 -178.639 . . . . . . . . 3 3 . 1 . 100 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.455 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 2.7 Cg_exo -40.16 -47.37 4.08 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.113 2.542 . . . . 0.0 112.928 179.903 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 42.8 Cg_endo -88.61 58.76 2.57 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.539 2.159 . . . . 0.0 112.643 -179.424 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.798 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.2 OUTLIER -77.31 -32.94 19.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.971 179.726 . . . . . . . . 3 3 . 1 . 100 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.785 HG23 ' O ' ' A' ' 178' ' ' PRO . 20.4 mm -68.54 -48.09 73.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.586 -178.898 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.6 mt -65.25 -48.2 74.08 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.224 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -76.11 -5.16 45.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.844 178.609 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.798 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.97 -70.19 0.4 Allowed 'General case' 0 CA--C 1.522 -0.134 0 CA-C-O 121.205 0.526 . . . . 0.0 109.788 179.849 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.804 ' H ' ' HG2' ' A' ' 178' ' ' PRO . . . -121.06 -20.64 3.33 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.027 178.637 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 9.9 t80 75.6 -12.44 0.98 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.053 0.541 . . . . 0.0 111.971 179.659 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -94.3 45.79 1.14 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.794 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.678 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 5.0 mt 54.02 52.41 9.4 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.037 -178.687 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.804 ' HG2' ' H ' ' A' ' 174' ' ' GLY . 24.0 Cg_exo -67.29 56.58 0.6 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.154 2.57 . . . . 0.0 112.578 179.848 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.78 ' HG ' HG21 ' A' ' 170' ' ' ILE . 11.6 mt -101.28 -66.33 0.92 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.921 0.391 . . . . 0.0 110.545 179.8 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 42.84 1.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.607 179.66 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.701 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 2.6 mp . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.947 0.403 . . . . 0.0 111.816 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.514 HD12 ' H ' ' A' ' 170' ' ' ILE . 4.5 mp -75.46 -55.17 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.709 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.57 ' HG ' ' N ' ' A' ' 172' ' ' ASP . 2.6 pt? -60.04 -51.47 69.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.028 0.442 . . . . 0.0 110.449 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.57 ' N ' ' HG ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -76.23 5.5 6.85 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.288 178.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.75 -71.1 0.29 Allowed 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -108.24 -3.76 33.29 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 1.5 t80 69.74 -61.9 0.43 Allowed 'General case' 0 C--O 1.231 0.113 0 CA-C-O 121.028 0.442 . . . . 0.0 110.348 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 23.1 t80 . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.333 179.278 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.779 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 3.5 tt . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 121.123 0.487 . . . . 0.0 110.315 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.442 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 2.0 mp -74.1 -45.7 47.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.788 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.432 HD22 ' N ' ' A' ' 171' ' ' LEU . 3.5 mm? -64.41 -53.12 53.38 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -74.77 1.05 13.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.921 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.779 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.82 -53.44 11.47 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.143 0.497 . . . . 0.0 109.69 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -105.63 -18.48 11.67 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.294 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.45 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 13.0 t80 76.02 -25.73 0.2 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.882 0.473 . . . . 0.0 112.04 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.7 p90 . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.648 0.261 . . . . 0.0 111.209 179.918 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.978 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--O 1.226 -0.161 0 CA-C-O 120.951 0.405 . . . . 0.0 110.715 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 3.7 mp -80.61 -50.84 16.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.245 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.473 HD12 ' N ' ' A' ' 171' ' ' LEU . 7.3 mp -65.26 -50.93 63.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.277 0.561 . . . . 0.0 109.949 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -74.0 -4.42 35.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.032 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.978 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.67 -70.36 0.33 Allowed 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -123.33 -27.73 1.44 Allowed Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.51 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 15.6 t80 79.15 -20.14 0.4 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.443 0.697 . . . . 0.0 112.149 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.331 -0.201 0 CA-C-O 121.368 0.604 . . . . 0.0 109.466 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.905 HG23 HD13 ' A' ' 170' ' ' ILE . 7.7 tt . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 120.891 0.377 . . . . 0.0 111.355 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.905 HD13 HG23 ' A' ' 169' ' ' ILE . 7.4 mm -69.19 -31.42 49.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.356 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.2 mp -70.71 -4.01 21.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.485 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -152.4 13.84 0.57 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.234 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -81.86 -38.58 25.21 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -130.57 -14.64 1.9 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 114.755 -1.112 . . . . 0.0 112.344 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 73.63 -45.88 0.62 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.651 0.225 . . . . 0.0 111.245 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.402 ' O ' ' CG ' ' A' ' 176' ' ' PHE . 55.4 t80 . . . . . 0 C--N 1.331 -0.239 0 CA-C-O 120.568 0.223 . . . . 0.0 111.141 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.935 HG13 ' HB2' ' A' ' 173' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 118.925 -0.56 . . . . 0.0 109.638 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.683 ' H ' HG23 ' A' ' 169' ' ' ILE . 2.9 mm 24.19 -64.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.457 0.703 . . . . 0.0 112.714 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.89 ' N ' ' O ' ' A' ' 169' ' ' ILE . 0.1 OUTLIER -67.95 -51.27 49.5 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.916 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 169' ' ' ILE . 1.0 OUTLIER -73.44 -15.7 61.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.546 179.286 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.935 ' HB2' HG13 ' A' ' 169' ' ' ILE . . . -78.14 -59.35 2.82 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.081 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -119.02 -21.85 3.69 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.864 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 70.9 -48.11 0.66 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.787 0.294 . . . . 0.0 111.192 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.231 0 CA-C-O 120.747 0.308 . . . . 0.0 110.962 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.982 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 121.048 0.452 . . . . 0.0 111.058 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.471 HG13 HG23 ' A' ' 169' ' ' ILE . 2.5 mp -83.75 -70.37 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.617 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.97 -48.4 71.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.89 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.04 1.91 9.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.665 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.982 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.92 -51.72 15.21 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.195 0.522 . . . . 0.0 109.612 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -118.54 -18.15 4.96 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.785 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 15.6 t80 78.1 -34.11 0.18 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 122.551 0.34 . . . . 0.0 111.881 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.207 0 CA-C-O 120.752 0.311 . . . . 0.0 111.151 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.749 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 121.123 0.487 . . . . 0.0 111.294 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.451 HD12 ' H ' ' A' ' 170' ' ' ILE . 3.4 mp -70.12 -41.54 79.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.61 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 12.9 mt -67.03 -59.13 3.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.263 0.554 . . . . 0.0 109.709 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.93 10.03 1.64 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.462 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.749 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.74 -48.41 47.2 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -117.88 -28.1 2.34 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 6.1 t80 74.56 -31.52 0.22 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.178 0.591 . . . . 0.0 112.003 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 . . . . . 0 C--N 1.331 -0.196 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.002 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.773 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 7.3 tp . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 121.07 0.462 . . . . 0.0 110.635 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.429 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 4.2 mt -69.38 -35.44 67.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.942 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 0.0 OUTLIER -65.69 -57.94 6.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.29 -2.79 26.61 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.729 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.773 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.57 -69.23 0.44 Allowed 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 121.158 0.504 . . . . 0.0 109.944 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -113.35 -15.14 9.15 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.871 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 5.8 t80 77.63 -41.7 0.36 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 39.8 p90 . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.656 0.265 . . . . 0.0 111.363 -179.738 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.848 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--O 1.228 -0.03 0 CA-C-O 120.816 0.341 . . . . 0.0 111.508 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.479 HD12 ' H ' ' A' ' 170' ' ' ILE . 3.4 mp -70.1 -41.99 79.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.578 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 27.9 mt -65.72 -56.65 10.93 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.11 2.26 11.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.231 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.848 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.35 -62.0 1.59 Allowed 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.191 0.519 . . . . 0.0 109.884 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -112.49 -11.85 14.34 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.616 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.493 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 24.5 t80 71.78 -29.96 0.2 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.732 0.413 . . . . 0.0 111.751 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.439 ' H ' ' C ' ' A' ' 174' ' ' GLY . 8.3 t80 . . . . . 0 C--N 1.332 -0.192 0 CA-C-O 120.681 0.277 . . . . 0.0 111.238 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.546 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 9.2 tp . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 121.404 0.621 . . . . 0.0 110.303 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.452 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.1 mp -74.83 -46.7 40.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.157 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.3 mt -65.4 -55.64 16.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.065 0.46 . . . . 0.0 110.223 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.421 ' OD1' ' CZ ' ' A' ' 175' ' ' TYR . 0.9 OUTLIER -76.07 14.46 0.7 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.399 179.209 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.04 -59.37 2.74 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 175' ' ' TYR . . . -113.35 -2.96 24.45 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 177.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.421 ' CZ ' ' OD1' ' A' ' 172' ' ' ASP . 6.2 m-85 68.69 -61.6 0.41 Allowed 'General case' 0 C--N 1.338 0.105 0 C-N-CA 123.029 0.532 . . . . 0.0 110.79 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.6 t80 . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.15 179.674 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.847 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 121.095 0.474 . . . . 0.0 110.234 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.46 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.2 mp -75.35 -38.37 40.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.296 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 63.8 mt -67.18 -57.93 5.8 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.2 4.81 6.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.118 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.847 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.94 -45.8 59.84 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.257 0.551 . . . . 0.0 109.772 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.538 ' C ' ' CG ' ' A' ' 175' ' ' TYR . . . -122.03 -0.02 10.7 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.775 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.538 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER 59.23 -32.91 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 179.416 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.471 ' H ' ' C ' ' A' ' 174' ' ' GLY . 22.5 t80 . . . . . 0 C--N 1.33 -0.275 0 O-C-N 122.098 -0.376 . . . . 0.0 111.102 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.943 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 120.597 0.236 . . . . 0.0 111.274 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.598 HD12 ' H ' ' A' ' 170' ' ' ILE . 1.8 mp -87.69 -67.85 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.091 0.472 . . . . 0.0 110.997 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.747 HD23 ' N ' ' A' ' 172' ' ' ASP . 0.0 OUTLIER -68.06 -41.1 82.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.165 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.747 ' N ' HD23 ' A' ' 171' ' ' LEU . 44.5 t0 -72.53 -8.62 56.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.716 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.943 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -75.48 -64.37 1.08 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.196 0.522 . . . . 0.0 109.997 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -125.31 -17.64 2.65 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.157 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 77.66 -20.39 0.38 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 122.491 0.316 . . . . 0.0 111.675 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.964 0.411 . . . . 0.0 110.559 179.441 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.838 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 121.051 0.453 . . . . 0.0 111.336 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.419 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.3 mp -73.81 -54.32 15.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.947 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.755 HD12 ' N ' ' A' ' 172' ' ' ASP . 3.4 pp -62.76 -50.17 72.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.122 0.487 . . . . 0.0 109.815 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.755 ' N ' HD12 ' A' ' 171' ' ' LEU . 7.4 t0 -74.77 0.81 14.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.13 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.838 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.46 -70.05 0.37 Allowed 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -109.91 -23.07 6.31 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 7.6 t80 75.25 -22.92 0.25 Allowed 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 122.891 0.477 . . . . 0.0 111.942 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.374 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.877 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 8.6 pt . . . . . 0 N--CA 1.46 0.053 0 CA-C-O 120.693 0.282 . . . . 0.0 111.754 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 7.2 mt -74.79 -49.8 28.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.493 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.649 ' H ' HD22 ' A' ' 171' ' ' LEU . 0.8 OUTLIER -65.21 -52.68 53.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.62 2.62 9.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.489 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.877 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.16 -68.32 0.47 Allowed 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 121.211 0.529 . . . . 0.0 109.666 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -110.89 -12.95 14.78 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.343 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 4.7 t80 77.44 -12.28 1.09 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.702 0.401 . . . . 0.0 111.829 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 55.6 t80 . . . . . 0 C--N 1.331 -0.217 0 CA-C-O 120.882 0.372 . . . . 0.0 110.679 179.455 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.943 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.5 OUTLIER . . . . . 0 C--O 1.227 -0.099 0 CA-C-O 121.309 0.575 . . . . 0.0 110.543 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.701 HG23 HG22 ' A' ' 169' ' ' ILE . 0.8 OUTLIER -77.54 -43.26 30.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.739 -1.118 . . . . 0.0 111.926 -178.839 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 54.5 tp -63.66 -55.47 23.2 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -73.62 -4.59 35.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.62 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.943 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.88 -68.2 0.53 Allowed 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.323 0.582 . . . . 0.0 109.526 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -130.7 3.51 5.73 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.683 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 17.0 t80 71.12 -44.04 0.58 Allowed 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.9 p90 . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 120.682 0.277 . . . . 0.0 111.364 179.816 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.959 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 1.3 tt . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.724 0.297 . . . . 0.0 110.66 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.446 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.8 mp -77.8 -39.48 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.743 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 0.4 OUTLIER -63.91 -58.44 6.76 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.249 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -73.66 -3.43 28.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.745 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.959 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.85 -73.17 0.21 Allowed 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.351 0.596 . . . . 0.0 109.556 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -120.54 -8.34 8.41 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.624 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 20.4 t80 69.7 -46.73 0.59 Allowed 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 122.676 0.39 . . . . 0.0 111.549 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.772 0.32 . . . . 0.0 111.069 179.865 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.834 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.458 -0.045 0 CA-C-O 121.171 0.51 . . . . 0.0 110.329 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.743 HD13 HG23 ' A' ' 169' ' ' ILE . 11.0 mm -73.2 -46.12 51.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.196 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.776 HD12 ' N ' ' A' ' 172' ' ' ASP . 3.4 pp -65.26 -49.88 67.92 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.776 ' N ' HD12 ' A' ' 171' ' ' LEU . 23.0 t0 -73.92 -5.34 40.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.472 178.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.834 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -74.32 -66.32 0.74 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.122 0.487 . . . . 0.0 110.147 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -119.47 -10.79 7.67 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.275 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.508 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 11.9 t80 79.36 -29.1 0.14 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 122.554 0.342 . . . . 0.0 111.914 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 30.9 p90 . . . . . 0 C--N 1.331 -0.21 0 CA-C-O 120.699 0.285 . . . . 0.0 111.262 179.784 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.821 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 19.9 tt . . . . . 0 CA--C 1.519 -0.244 0 CA-C-O 121.627 0.727 . . . . 0.0 110.536 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.615 ' CD1' HD13 ' A' ' 171' ' ' LEU . 0.9 OUTLIER -73.63 -35.04 43.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.33 -1.305 . . . . 0.0 111.994 -178.609 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.812 ' H ' HD22 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -62.56 -64.17 1.0 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.089 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -75.15 4.3 7.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.41 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.821 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.34 -64.56 0.89 Allowed 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -111.73 -18.49 7.9 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.162 178.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 77.76 -30.5 0.16 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.799 0.44 . . . . 0.0 111.8 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.332 -0.158 0 CA-C-O 120.561 0.22 . . . . 0.0 111.37 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.894 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 21.8 pt . . . . . 0 CA--C 1.519 -0.217 0 CA-C-O 121.448 0.642 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.677 HG23 HG13 ' A' ' 169' ' ' ILE . 1.5 pt -76.19 -45.77 34.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.825 -177.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 0.0 OUTLIER -62.72 -56.48 17.25 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -74.09 1.33 11.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.028 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.894 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.36 -69.45 0.43 Allowed 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 121.238 0.542 . . . . 0.0 109.69 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -113.93 -9.28 16.41 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.612 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.481 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 31.3 t80 77.01 -8.97 1.6 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 122.652 0.381 . . . . 0.0 112.019 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 . . . . . 0 C--N 1.323 -0.546 0 CA-C-O 120.806 0.336 . . . . 0.0 110.913 179.754 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.833 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.6 OUTLIER . . . . . 0 CA--C 1.538 0.492 0 CA-C-O 119.3 -0.381 . . . . 0.0 110.337 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.714 ' H ' HG23 ' A' ' 169' ' ' ILE . 2.8 mp 27.11 -66.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.893 0.877 . . . . 0.0 112.993 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.833 ' N ' ' O ' ' A' ' 169' ' ' ILE . 3.6 pp -68.99 -48.44 63.08 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.263 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.81 ' N ' HD12 ' A' ' 171' ' ' LEU . 28.2 m-20 -70.33 -7.06 39.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.124 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.88 -58.49 3.25 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.917 0.389 . . . . 0.0 110.309 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -110.9 -30.72 3.12 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.39 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER 75.36 -36.92 0.32 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 122.475 0.31 . . . . 0.0 111.6 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 120.928 0.394 . . . . 0.0 110.232 179.205 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.709 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.226 -0.146 0 CA-C-O 121.115 0.483 . . . . 0.0 110.642 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.441 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.8 mp -69.33 -36.37 71.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.801 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 10.9 mp -65.62 -53.57 39.81 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.548 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -75.74 -6.07 48.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.514 178.073 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.709 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -74.51 -74.26 0.2 Allowed 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.31 0.576 . . . . 0.0 109.879 179.808 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -115.81 -15.19 7.51 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.687 178.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER 75.09 -47.34 0.61 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.358 0.263 . . . . 0.0 111.633 179.897 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.173 0 CA-C-O 120.688 0.28 . . . . 0.0 111.24 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 1.006 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 120.929 0.395 . . . . 0.0 110.849 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.879 HD13 HG23 ' A' ' 169' ' ' ILE . 6.5 mm -78.78 -47.88 22.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.73 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.4 tp -62.75 -55.06 30.04 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -74.47 -2.48 25.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.81 178.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 1.006 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.86 -67.27 0.58 Allowed 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.114 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -131.47 -4.33 3.99 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.688 178.492 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 70.16 -47.33 0.62 Allowed 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 122.433 0.293 . . . . 0.0 111.234 -179.755 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.1 t80 . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.846 0.355 . . . . 0.0 110.695 179.458 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.811 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.458 -0.038 0 CA-C-O 120.909 0.385 . . . . 0.0 111.24 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 2.8 mp -72.83 -48.85 43.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.561 -179.492 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.456 HD23 ' H ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -65.98 -49.81 66.55 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.487 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -75.95 1.67 14.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.04 178.564 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.811 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.25 -42.12 66.01 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.214 0.53 . . . . 0.0 109.666 179.74 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.53 ' C ' ' CG ' ' A' ' 175' ' ' TYR . . . -119.62 -1.96 13.28 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.826 178.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.53 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER 58.51 -37.32 0.06 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 179.483 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.501 ' N ' ' O ' ' A' ' 174' ' ' GLY . 26.9 p90 . . . . . 0 C--N 1.328 -0.345 0 O-C-N 122.094 -0.378 . . . . 0.0 111.164 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.971 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 12.6 pt . . . . . 0 N--CA 1.457 -0.112 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.461 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 8.4 mm -81.48 -50.84 16.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.962 -179.408 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 0.0 OUTLIER -62.63 -53.38 55.38 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.938 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.43 -1.17 17.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.887 178.715 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.971 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.91 -56.84 4.61 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 121.194 0.521 . . . . 0.0 109.787 179.626 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -129.88 -3.5 4.94 Favored Glycine 0 CA--C 1.52 0.38 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.057 179.126 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.3 OUTLIER 70.13 -55.8 0.6 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.64 0.257 . . . . 0.0 111.358 179.974 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 11.4 t80 . . . . . 0 C--N 1.331 -0.224 0 CA-C-O 120.902 0.382 . . . . 0.0 110.572 179.766 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.797 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 5.5 tt . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 121.16 0.505 . . . . 0.0 110.673 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.776 HD13 HG23 ' A' ' 169' ' ' ILE . 10.4 mm -71.56 -42.82 72.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.053 -179.836 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.465 ' C ' HD12 ' A' ' 171' ' ' LEU . 0.1 OUTLIER -66.06 -53.55 36.95 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.795 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -74.82 -0.1 17.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.035 178.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.797 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.97 -60.94 2.0 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.159 0.504 . . . . 0.0 109.851 179.757 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -109.67 -19.03 8.5 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.497 178.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 78.83 -29.83 0.15 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.658 0.383 . . . . 0.0 111.953 179.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.406 ' O ' ' CG ' ' A' ' 176' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-O 120.747 0.308 . . . . 0.0 110.737 179.696 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.87 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 1.9 tp . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 121.009 0.433 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.531 HD12 HG22 ' A' ' 169' ' ' ILE . 3.5 mp -74.55 -41.57 48.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.216 -179.899 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -65.2 -57.75 7.74 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.518 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.82 4.51 6.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.067 178.754 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.87 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.97 -56.01 5.74 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.207 0.527 . . . . 0.0 109.826 179.683 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -121.74 -0.03 10.99 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.726 178.695 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.494 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.2 OUTLIER 55.1 -59.79 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.047 0.939 . . . . 0.0 112.154 179.898 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.606 ' N ' ' O ' ' A' ' 174' ' ' GLY . 13.1 m-85 . . . . . 0 C--N 1.323 -0.547 0 CA-C-O 120.782 0.325 . . . . 0.0 111.118 -179.903 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.877 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 8.4 tp . . . . . 0 CA--C 1.519 -0.242 0 CA-C-O 121.479 0.657 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.495 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 0.8 OUTLIER -74.04 -44.3 50.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 114.683 -1.144 . . . . 0.0 112.507 -178.25 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.534 HD13 ' C ' ' A' ' 171' ' ' LEU . 2.4 tm? -65.16 -58.37 6.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.054 0.454 . . . . 0.0 109.845 179.53 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.418 ' N ' HD13 ' A' ' 171' ' ' LEU . 12.0 m-20 -74.66 5.46 4.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.552 179.105 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.877 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -70.79 -56.42 6.37 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.304 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -111.55 -26.36 4.55 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 177.9 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 72.25 -40.68 0.48 Allowed 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 122.633 0.373 . . . . 0.0 111.663 179.641 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 120.814 0.34 . . . . 0.0 110.622 179.661 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.911 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.46 0.066 0 CA-C-O 121.27 0.557 . . . . 0.0 111.322 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.516 HG23 HG23 ' A' ' 169' ' ' ILE . 0.7 OUTLIER -78.98 -44.78 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.938 -1.028 . . . . 0.0 112.968 -178.02 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.561 HD13 ' C ' ' A' ' 171' ' ' LEU . 2.0 tm? -64.51 -58.16 7.18 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.491 ' N ' HD13 ' A' ' 171' ' ' LEU . 1.2 m-20 -74.1 4.84 4.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.151 178.857 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.911 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.22 -56.48 5.46 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.257 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -133.86 2.06 4.37 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.559 178.465 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 70.35 -56.83 0.59 Allowed 'General case' 0 C--O 1.231 0.096 0 C-N-CA 122.543 0.337 . . . . 0.0 111.733 179.75 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 120.619 0.247 . . . . 0.0 111.621 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.89 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 3.7 tp . . . . . 0 CA--C 1.521 -0.168 0 CA-C-O 121.393 0.616 . . . . 0.0 110.717 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.605 HG23 HG23 ' A' ' 169' ' ' ILE . 0.7 OUTLIER -79.01 -43.78 24.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.707 -179.277 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 1.2 tp -65.8 -58.91 4.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.114 0.483 . . . . 0.0 109.992 179.557 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -74.24 5.54 4.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.448 179.052 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.89 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.25 -64.69 0.87 Allowed 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.505 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -112.3 -17.09 8.43 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 178.167 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 6.0 t80 75.58 -11.46 1.1 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.705 0.402 . . . . 0.0 111.81 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 120.986 0.422 . . . . 0.0 110.867 179.672 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.871 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 4.8 tp . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 121.062 0.458 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.818 HD13 HG23 ' A' ' 169' ' ' ILE . 9.0 mm -73.4 -45.89 50.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.447 -179.284 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 34.5 tp -64.33 -54.37 34.12 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.46 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.94 -0.67 16.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.082 178.649 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.871 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.42 -61.86 1.65 Allowed 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.25 0.547 . . . . 0.0 109.911 179.779 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -114.15 -13.95 9.55 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.683 178.848 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 24.9 t80 70.91 -51.06 0.68 Allowed 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 122.459 0.304 . . . . 0.0 111.599 179.904 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.209 -179.828 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.882 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 8.2 tp . . . . . 0 N--CA 1.458 -0.031 0 CA-C-O 120.994 0.426 . . . . 0.0 111.299 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.564 HD12 HG22 ' A' ' 169' ' ' ILE . 3.7 mp -73.82 -36.38 45.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.522 -179.671 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 20.2 mt -64.92 -62.39 1.59 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.658 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -77.43 8.06 4.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.359 178.996 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.882 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.1 -59.15 2.93 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.328 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 175' ' ' TYR . . . -123.37 -1.64 9.22 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.188 178.024 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.406 ' HB2' ' O ' ' A' ' 174' ' ' GLY . 63.6 m-85 66.36 -57.65 0.37 Allowed 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.02 0.528 . . . . 0.0 111.336 179.679 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 120.761 0.315 . . . . 0.0 110.958 179.552 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.887 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--O 1.227 -0.109 0 CA-C-O 121.047 0.451 . . . . 0.0 110.996 . . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.473 HD12 ' H ' ' A' ' 170' ' ' ILE . 2.2 mp -75.46 -53.36 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.315 -179.785 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 12.2 tp -65.33 -49.93 67.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.361 0.601 . . . . 0.0 109.384 179.446 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.06 -1.32 16.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.153 179.102 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.887 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.66 -64.78 0.89 Allowed 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.092 0.472 . . . . 0.0 109.736 179.631 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -116.18 -16.83 6.5 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.688 178.807 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.441 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 24.2 t80 75.89 -10.61 1.25 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.401 0.28 . . . . 0.0 111.753 179.986 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 71.3 t80 . . . . . 0 C--N 1.332 -0.194 0 CA-C-O 120.838 0.351 . . . . 0.0 110.948 179.664 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.986 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.9 OUTLIER . . . . . 0 CA--C 1.534 0.35 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 . . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.576 HD12 ' H ' ' A' ' 170' ' ' ILE . 2.7 mp -83.13 -65.56 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.039 0.447 . . . . 0.0 111.236 179.956 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 172' ' ' ASP . 1.4 pp -65.8 -45.04 83.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.353 0.597 . . . . 0.0 110.252 179.902 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.453 ' N ' HD12 ' A' ' 171' ' ' LEU . 0.3 OUTLIER -71.19 -5.55 32.71 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.947 179.492 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.986 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -75.75 -62.2 1.67 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.107 0.48 . . . . 0.0 110.243 179.735 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -130.67 1.48 5.59 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.484 179.584 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.508 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER 57.54 -52.51 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 179.344 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.522 ' N ' ' O ' ' A' ' 174' ' ' GLY . 2.9 m-85 . . . . . 0 C--N 1.327 -0.378 0 CA-C-O 120.75 0.309 . . . . 0.0 111.041 179.941 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.927 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 . . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.703 ' H ' HG23 ' A' ' 169' ' ' ILE . 1.9 mt 25.63 -62.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.387 0.675 . . . . 0.0 112.664 178.349 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.927 ' N ' ' O ' ' A' ' 169' ' ' ILE . 13.7 mt -67.05 -51.0 60.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.674 179.824 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -72.31 -6.86 46.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.074 179.575 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.61 -59.55 2.7 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.753 0.311 . . . . 0.0 110.367 179.887 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -100.06 -20.9 14.75 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.636 179.048 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 64.9 t80 69.29 -57.63 0.53 Allowed 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.8 0.333 . . . . 0.0 111.003 -179.953 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 6.5 t80 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.526 179.503 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.927 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 18.4 pt . . . . . 0 N--CA 1.454 -0.234 0 CA-C-O 120.72 0.295 . . . . 0.0 111.336 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.464 ' N ' HG13 ' A' ' 169' ' ' ILE . 3.1 mp -78.71 -43.36 25.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.483 -179.974 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.422 HD22 ' N ' ' A' ' 171' ' ' LEU . 2.5 mm? -64.6 -58.93 4.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.104 0.478 . . . . 0.0 109.773 179.852 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -74.32 4.7 5.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.256 179.01 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.927 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.08 -52.75 15.37 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.548 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -121.43 -5.82 9.16 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.793 178.76 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.428 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 85.1 t80 68.99 -53.59 0.57 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.547 0.339 . . . . 0.0 111.574 179.981 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.406 ' O ' ' CG ' ' A' ' 176' ' ' PHE . 27.7 t80 . . . . . 0 CA--C 1.532 0.267 0 CA-C-O 120.587 0.232 . . . . 0.0 111.171 -179.802 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.825 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 17.0 tt . . . . . 0 CA--C 1.52 -0.184 0 CA-C-O 121.636 0.732 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.523 ' N ' HG23 ' A' ' 169' ' ' ILE . 3.3 pt -71.82 -43.55 69.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 114.16 -1.382 . . . . 0.0 111.827 -178.524 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 8.9 mt -63.06 -51.6 66.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.975 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -75.02 -8.24 55.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.312 178.227 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.825 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -75.14 -76.15 0.15 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.123 0.487 . . . . 0.0 110.191 179.71 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -114.82 -14.19 8.82 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.914 179.12 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 32.6 t80 77.48 -43.47 0.41 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 179.668 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.211 0 CA-C-O 120.57 0.224 . . . . 0.0 111.595 -179.878 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.887 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER . . . . . 0 CA--C 1.52 -0.207 0 CA-C-O 121.023 0.439 . . . . 0.0 111.517 . . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.652 HD12 ' N ' ' A' ' 171' ' ' LEU . 2.3 pp -76.1 -49.71 24.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.224 -178.271 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.732 HD12 ' N ' ' A' ' 172' ' ' ASP . 3.4 pp -67.47 -48.58 66.77 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.988 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.732 ' N ' HD12 ' A' ' 171' ' ' LEU . 1.3 m-20 -73.95 -2.37 23.73 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.922 178.655 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.887 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.73 -70.8 0.3 Allowed 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.539 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.437 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -110.86 -23.66 5.8 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.131 -0.787 . . . . 0.0 111.131 178.127 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER 71.25 -13.53 0.52 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.398 0.279 . . . . 0.0 111.199 -179.726 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.437 ' H ' ' C ' ' A' ' 174' ' ' GLY . 36.7 p90 . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.752 0.31 . . . . 0.0 110.256 179.189 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.873 HG23 HD13 ' A' ' 170' ' ' ILE . 5.6 tp . . . . . 0 CA--C 1.523 -0.067 0 CA-C-O 120.964 0.411 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.873 HD13 HG23 ' A' ' 169' ' ' ILE . 7.4 mm -73.94 -49.83 32.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.916 -178.927 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.589 ' C ' HD12 ' A' ' 171' ' ' LEU . 0.5 OUTLIER -64.7 -48.0 76.29 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.609 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.409 ' N ' ' HG ' ' A' ' 171' ' ' LEU . 3.5 t0 -76.5 -1.35 26.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.956 178.488 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.845 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.62 -57.35 4.2 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.818 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -115.02 -15.12 8.03 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.663 178.757 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.411 ' HB2' ' O ' ' A' ' 174' ' ' GLY . 1.9 m-85 68.66 -10.11 0.5 Allowed 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 122.3 0.24 . . . . 0.0 111.567 -179.766 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.43 ' H ' ' C ' ' A' ' 174' ' ' GLY . 7.4 m-85 . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.734 0.302 . . . . 0.0 110.389 179.463 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.852 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 121.047 0.451 . . . . 0.0 111.053 . . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.843 HD13 HG23 ' A' ' 169' ' ' ILE . 8.1 mm -73.56 -42.35 55.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.523 -179.454 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.448 HD22 ' N ' ' A' ' 171' ' ' LEU . 3.2 mm? -65.64 -56.05 14.24 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.471 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -74.52 0.54 14.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.008 178.701 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.852 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.64 -57.35 4.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.285 0.564 . . . . 0.0 109.5 179.662 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -112.66 -22.14 5.84 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.309 178.558 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 70.08 -53.07 0.63 Allowed 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 122.476 0.31 . . . . 0.0 111.45 179.815 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.218 0 CA-C-O 120.803 0.335 . . . . 0.0 110.734 179.789 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.912 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.275 0 CA-C-O 120.713 0.292 . . . . 0.0 111.348 . . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.897 HD13 HG23 ' A' ' 169' ' ' ILE . 7.0 mm -76.95 -50.12 21.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.893 -179.506 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.559 HD12 ' H ' ' A' ' 171' ' ' LEU . 4.5 mp -64.08 -52.31 59.89 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.592 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -74.01 0.61 13.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.012 178.48 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.912 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.15 -52.26 17.49 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.372 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -126.48 -25.33 1.3 Allowed Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.519 178.782 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.41 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 7.8 t80 79.44 -21.63 0.32 Allowed 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.231 0.613 . . . . 0.0 112.275 179.62 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 . . . . . 0 C--N 1.327 -0.39 0 CA-C-O 121.405 0.622 . . . . 0.0 109.341 179.093 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.724 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 8.4 tt . . . . . 0 N--CA 1.458 -0.046 0 CA-C-O 121.166 0.508 . . . . 0.0 110.796 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.448 HD12 ' H ' ' A' ' 170' ' ' ILE . 1.9 mp -71.07 -37.37 66.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.94 -179.875 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.39 -55.42 18.22 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.784 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.74 1.3 17.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.04 178.432 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.4 -45.68 53.25 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-O 121.05 0.452 . . . . 0.0 110.157 -179.869 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 175' ' ' TYR . . . -117.99 -20.68 4.41 Favored Glycine 0 N--CA 1.452 -0.281 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 178.688 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' A' ' 174' ' ' GLY . 57.6 m-85 69.44 -12.64 0.42 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 179.0 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 121.455 0.645 . . . . 0.0 109.26 178.638 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.854 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 10.8 pt . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.965 0.412 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 10.7 mm -77.12 -42.56 31.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.41 -179.848 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.97 -57.03 9.79 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.535 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.09 4.55 6.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.119 178.671 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.854 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.59 -47.27 55.91 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.287 0.565 . . . . 0.0 109.501 179.616 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -121.09 -28.05 1.74 Allowed Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 178.338 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.41 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 46.9 t80 77.0 -13.74 0.91 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.314 0.646 . . . . 0.0 112.501 179.184 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.403 ' CD2' ' O ' ' A' ' 176' ' ' PHE . 42.2 p90 . . . . . 0 C--N 1.328 -0.341 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.665 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.877 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER . . . . . 0 CA--C 1.527 0.077 0 CA-C-O 120.905 0.383 . . . . 0.0 110.711 . . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.568 HD12 HG22 ' A' ' 169' ' ' ILE . 3.4 mp -78.35 -42.57 26.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.803 179.504 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.5 mt -64.38 -56.95 10.9 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.429 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -74.45 2.48 9.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.087 178.685 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.877 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.77 -60.71 2.1 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-O 121.151 0.501 . . . . 0.0 109.731 179.737 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.497 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -115.53 -11.35 10.56 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.626 178.769 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.497 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 64.0 t80 72.47 -17.29 0.39 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.787 0.435 . . . . 0.0 112.119 179.903 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.331 -0.231 0 CA-C-O 120.795 0.331 . . . . 0.0 111.004 179.765 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.942 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--O 1.227 -0.086 0 CA-C-O 120.864 0.364 . . . . 0.0 111.566 . . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 2.4 mp -74.67 -56.67 8.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.868 -179.27 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -53.25 40.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.907 0.384 . . . . 0.0 110.813 -179.675 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.43 8.75 2.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.979 179.771 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.942 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.31 -67.58 0.54 Allowed 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.357 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.632 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -117.91 8.43 14.61 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 178.034 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.472 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER 53.72 -63.34 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.005 0.922 . . . . 0.0 111.638 179.846 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.632 ' N ' ' O ' ' A' ' 174' ' ' GLY . 11.8 t80 . . . . . 0 C--N 1.321 -0.661 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.293 179.639 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 1.015 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.465 0.311 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 . . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.504 HD12 ' H ' ' A' ' 170' ' ' ILE . 3.9 mp -81.66 -61.87 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.937 0.398 . . . . 0.0 111.752 -179.616 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.469 HD22 ' N ' ' A' ' 171' ' ' LEU . 2.5 mm? -67.5 -51.26 53.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.891 -179.489 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -73.45 4.19 5.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.96 -179.796 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 1.015 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.19 -65.71 0.77 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.33 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -108.45 -24.74 6.05 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 178.113 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 75.43 -25.13 0.21 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.645 0.378 . . . . 0.0 111.537 179.814 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.401 ' H ' ' C ' ' A' ' 174' ' ' GLY . 11.6 m-85 . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 120.702 0.287 . . . . 0.0 110.971 179.728 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.864 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 8.7 pt . . . . . 0 N--CA 1.461 0.086 0 CA-C-O 120.757 0.313 . . . . 0.0 111.533 . . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.442 HD12 HG13 ' A' ' 169' ' ' ILE . 3.8 mp -75.76 -52.78 17.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.729 -179.352 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.86 -51.41 59.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.058 0.456 . . . . 0.0 109.976 179.849 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.63 3.5 7.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.519 179.209 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.864 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.24 -63.71 1.09 Allowed 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.576 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -112.62 -11.49 14.71 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.353 178.368 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 3.8 t80 72.57 -55.6 0.67 Allowed 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.53 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.214 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.276 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.847 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 7.4 tt . . . . . 0 CA--C 1.522 -0.103 0 CA-C-O 121.176 0.512 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.789 HD13 HG23 ' A' ' 169' ' ' ILE . 10.2 mm -69.65 -38.53 76.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.286 -179.217 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 82.7 mt -64.86 -58.82 5.17 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.102 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.72 0.21 16.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.166 178.597 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.847 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.88 -62.11 1.57 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.162 0.506 . . . . 0.0 109.748 179.737 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -113.27 -12.31 12.2 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.752 178.891 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 8.0 t80 73.11 -53.34 0.7 Allowed 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 122.48 0.312 . . . . 0.0 111.687 179.793 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.68 0.276 . . . . 0.0 110.915 179.882 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.772 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 7.2 tp . . . . . 0 CA--C 1.526 0.026 0 CA-C-O 121.171 0.51 . . . . 0.0 110.645 . . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.426 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.3 mp -71.63 -40.64 71.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.796 179.952 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 0.8 OUTLIER -66.63 -51.01 61.08 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.659 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -73.37 -8.23 54.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.079 178.032 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.772 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -74.64 -64.68 0.98 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.141 0.496 . . . . 0.0 110.119 179.667 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -123.64 -14.46 3.89 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.397 179.459 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.428 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 6.9 t80 77.87 -11.03 1.26 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 179.858 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 42.0 p90 . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.62 0.248 . . . . 0.0 111.217 179.73 . . . . . . . . 0 0 . 1 . 049 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.554 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 7.3 tp . . . . . 0 CA--C 1.521 -0.151 0 CA-C-O 121.322 0.582 . . . . 0.0 109.814 . . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.451 ' HA ' ' HB2' ' A' ' 173' ' ' ALA . 2.7 mp -68.28 -23.11 28.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.828 178.822 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.37 -65.95 0.61 Allowed 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.385 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -76.69 7.15 4.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.802 178.092 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -70.21 -51.21 32.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.734 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -104.83 -19.17 11.23 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 177.811 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 16.5 t80 75.66 -10.19 1.3 Allowed 'General case' 0 C--O 1.23 0.075 0 C-N-CA 122.841 0.456 . . . . 0.0 112.005 179.626 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 120.788 0.328 . . . . 0.0 110.72 179.531 . . . . . . . . 0 0 . 1 . 050 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.834 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 14.7 tt . . . . . 0 CA--C 1.519 -0.238 0 CA-C-O 121.372 0.606 . . . . 0.0 111.502 . . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.503 ' N ' HG23 ' A' ' 169' ' ' ILE . 1.0 OUTLIER -71.61 -45.19 68.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.487 -177.813 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.74 -55.21 24.97 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.506 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -76.11 3.26 10.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.384 178.797 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.834 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.01 -52.67 13.51 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.258 0.551 . . . . 0.0 109.894 179.9 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -121.77 -19.8 3.29 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.22 178.738 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.448 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 62.0 t80 74.28 -12.96 0.83 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.101 0.56 . . . . 0.0 112.127 179.628 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 . . . . . 0 C--N 1.33 -0.25 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.729 . . . . . . . . 0 0 . 1 . 051 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.828 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 2.7 tt . . . . . 0 CA--C 1.518 -0.265 0 CA-C-O 121.543 0.687 . . . . 0.0 110.58 . . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.512 ' N ' HG23 ' A' ' 169' ' ' ILE . 0.9 OUTLIER -74.66 -43.16 47.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.544 -178.931 . . . . . . . . 3 3 . 1 . 051 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.21 -54.57 27.55 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.105 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.12 1.23 13.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.943 178.575 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.828 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.72 -59.57 2.65 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 121.168 0.509 . . . . 0.0 110.005 179.885 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.581 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -111.73 -4.18 26.51 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.698 178.896 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.502 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER 56.07 -54.4 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.87 0.868 . . . . 0.0 112.589 179.818 . . . . . . . . 3 3 . 1 . 051 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.581 ' N ' ' O ' ' A' ' 174' ' ' GLY . 6.5 m-85 . . . . . 0 C--N 1.324 -0.52 0 CA-C-O 120.616 0.246 . . . . 0.0 111.109 179.984 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.749 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 5.5 tp . . . . . 0 CA--C 1.517 -0.298 0 CA-C-O 121.253 0.549 . . . . 0.0 111.569 . . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.603 HD13 HG23 ' A' ' 169' ' ' ILE . 5.9 mm -62.22 -30.64 49.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.775 -178.582 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 24.6 tp -65.18 -65.23 0.7 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.081 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -77.6 3.83 12.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.449 178.853 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.749 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.63 -70.27 0.33 Allowed 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.825 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 175' ' ' TYR . . . -107.11 -12.69 23.22 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.078 178.244 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 4.0 m-85 69.47 -48.02 0.6 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.703 0.401 . . . . 0.0 111.323 -179.908 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.419 ' O ' ' CG ' ' A' ' 176' ' ' PHE . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.293 0 CA-C-O 120.718 0.294 . . . . 0.0 110.364 179.358 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.922 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.4 ' C ' ' O ' ' A' ' 169' ' ' ILE . 4.7 mt 26.77 -62.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.567 0.747 . . . . 0.0 112.539 178.655 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.922 ' N ' ' O ' ' A' ' 169' ' ' ILE . 3.1 mm? -66.8 -52.38 44.62 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.699 179.914 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.03 -19.31 60.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.76 179.608 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -78.3 -73.07 0.34 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.118 -179.651 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -109.12 -25.98 5.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.601 -179.988 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.457 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 25.5 t80 74.49 -39.37 0.42 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.659 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.592 0.234 . . . . 0.0 110.87 179.801 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 1.021 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 4.9 tt . . . . . 0 C--O 1.226 -0.167 0 CA-C-O 121.015 0.436 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.426 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 2.4 mp -80.23 -60.79 2.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.713 -178.859 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 0.2 OUTLIER -63.09 -48.97 76.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.903 0.382 . . . . 0.0 110.444 -179.199 . . . . . . . . 3 3 . 1 . 054 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.14 -2.79 22.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.859 179.088 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 1.021 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -74.3 -66.86 0.68 Allowed 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.179 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -123.54 -11.56 4.98 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.016 178.889 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 20.0 t80 77.64 -30.08 0.16 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 122.624 0.369 . . . . 0.0 111.842 -179.895 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.67 0.271 . . . . 0.0 111.192 179.775 . . . . . . . . 0 0 . 1 . 055 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.998 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 23.0 pt . . . . . 0 N--CA 1.454 -0.244 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 . . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.458 HD12 ' H ' ' A' ' 170' ' ' ILE . 3.3 mp -76.76 -47.31 28.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.01 -179.252 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 38.1 tp -63.86 -54.48 34.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.346 0.593 . . . . 0.0 109.56 179.751 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.22 -3.47 26.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.849 179.014 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.998 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.96 -73.7 0.2 Allowed 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.299 0.571 . . . . 0.0 109.555 179.484 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -118.52 -13.54 6.77 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.509 178.647 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 5.5 t80 76.37 -45.51 0.51 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.474 0.31 . . . . 0.0 111.363 179.97 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 . . . . . 0 C--N 1.331 -0.2 0 CA-C-O 120.672 0.272 . . . . 0.0 111.056 179.892 . . . . . . . . 0 0 . 1 . 056 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.989 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--O 1.226 -0.157 0 CA-C-O 120.838 0.351 . . . . 0.0 111.426 . . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.444 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.2 mp -73.4 -47.55 45.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.676 -179.254 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.493 HD23 ' N ' ' A' ' 172' ' ' ASP . 0.3 OUTLIER -65.99 -56.81 9.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.13 0.49 . . . . 0.0 109.874 179.802 . . . . . . . . 3 3 . 1 . 056 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.493 ' N ' HD23 ' A' ' 171' ' ' LEU . 0.3 OUTLIER -75.02 5.11 5.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.693 179.358 . . . . . . . . 3 3 . 1 . 056 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.989 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.34 -63.69 1.1 Allowed 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.54 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 175' ' ' TYR . . . -112.05 -11.88 15.21 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.382 178.495 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.438 ' HB2' ' O ' ' A' ' 174' ' ' GLY . 16.0 m-85 68.3 -50.74 0.55 Allowed 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 122.687 0.395 . . . . 0.0 111.36 179.915 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.801 179.719 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.753 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.467 0.375 0 CA-C-O 120.842 0.353 . . . . 0.0 111.295 . . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.553 HD12 ' H ' ' A' ' 170' ' ' ILE . 3.5 mp -73.98 -42.73 52.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.847 179.992 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 10.5 mt -63.43 -54.51 35.45 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.214 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.88 0.48 15.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.824 178.446 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.753 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.06 -77.51 0.1 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.893 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -98.46 -3.17 57.55 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.386 178.392 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER 71.55 -61.52 0.49 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.91 0.386 . . . . 0.0 110.838 179.987 . . . . . . . . 3 3 . 1 . 057 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 36.8 p90 . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.231 179.934 . . . . . . . . 0 0 . 1 . 058 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.766 HD13 ' O ' ' A' ' 169' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.23 0 CA-C-O 121.587 0.708 . . . . 0.0 110.832 . . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.638 ' CG1' HD13 ' A' ' 171' ' ' LEU . 11.1 pt -68.15 -38.37 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.57 -178.355 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.833 HD13 ' H ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -60.73 -57.3 13.29 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.085 . . . . . . . . 3 3 . 1 . 058 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.21 -2.65 35.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.845 178.334 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.7 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.03 -67.24 0.58 Allowed 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 121.056 0.455 . . . . 0.0 110.088 -179.93 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -109.34 -16.47 11.1 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.734 178.942 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.534 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.5 OUTLIER 77.33 -12.93 1.0 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 179.924 . . . . . . . . 3 3 . 1 . 058 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 C--N 1.331 -0.207 0 CA-C-O 120.557 0.218 . . . . 0.0 111.327 -179.981 . . . . . . . . 0 0 . 1 . 059 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.825 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 . . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.641 HD12 ' H ' ' A' ' 170' ' ' ILE . 2.3 mp -73.11 -47.13 48.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.882 0.372 . . . . 0.0 111.783 -179.195 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.56 -0.58 5.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.058 -179.873 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -147.05 15.27 1.17 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.468 -179.926 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.825 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -79.93 -47.31 15.22 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.911 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.418 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -129.77 -22.64 1.14 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.981 178.684 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 34.9 t80 71.62 -12.59 0.62 Allowed 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 122.507 0.323 . . . . 0.0 111.386 -179.344 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.418 ' H ' ' C ' ' A' ' 174' ' ' GLY . 7.2 t80 . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 120.795 0.331 . . . . 0.0 110.143 178.959 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.966 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 3.5 tp . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 120.713 0.292 . . . . 0.0 111.755 . . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.856 HD13 HG23 ' A' ' 169' ' ' ILE . 8.1 mm -73.79 -51.71 23.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.193 -178.781 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 171' ' ' LEU . 3.4 mm? -64.14 -49.17 73.21 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.715 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -75.03 -4.08 36.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.955 178.516 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.966 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.17 -68.37 0.5 Allowed 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.234 0.54 . . . . 0.0 109.714 179.656 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.615 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -121.72 -8.89 7.25 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.939 178.929 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.49 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.2 OUTLIER 55.76 -53.58 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.883 0.873 . . . . 0.0 112.416 -179.994 . . . . . . . . 3 3 . 1 . 060 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.615 ' N ' ' O ' ' A' ' 174' ' ' GLY . 29.0 t80 . . . . . 0 C--N 1.325 -0.469 0 CA-C-O 120.611 0.244 . . . . 0.0 110.744 179.789 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.784 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 2.1 tt . . . . . 0 N--CA 1.459 0.016 0 CA-C-O 121.134 0.492 . . . . 0.0 111.3 . . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.519 HD12 ' H ' ' A' ' 170' ' ' ILE . 4.2 mp -67.58 -35.05 71.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.342 -179.22 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.31 -60.51 2.71 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.897 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -76.29 4.46 8.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.269 178.692 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.784 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.94 -68.52 0.45 Allowed 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.741 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -103.37 -13.76 27.66 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 178.032 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.452 ' CG ' ' N ' ' A' ' 176' ' ' PHE . 0.0 OUTLIER 72.64 -53.56 0.7 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.53 0.332 . . . . 0.0 111.534 179.48 . . . . . . . . 3 3 . 1 . 061 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.452 ' N ' ' CG ' ' A' ' 175' ' ' TYR . 26.1 t80 . . . . . 0 C--N 1.332 -0.196 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.359 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.889 ' O ' ' N ' ' A' ' 171' ' ' LEU . 2.5 tt . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 . . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.834 ' H ' HG23 ' A' ' 169' ' ' ILE . 14.7 mt 25.62 -63.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 123.676 0.79 . . . . 0.0 112.762 177.863 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.889 ' N ' ' O ' ' A' ' 169' ' ' ILE . 17.4 mt -66.5 -43.63 84.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.246 -179.628 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.59 -15.88 60.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.35 -179.924 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -76.16 -90.34 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.337 179.966 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -105.55 -10.64 30.72 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.642 178.784 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.409 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 60.7 t80 68.3 -61.26 0.4 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.925 0.393 . . . . 0.0 110.411 -179.629 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 174' ' ' GLY . 21.3 t80 . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.87 179.112 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.878 ' O ' ' N ' ' A' ' 171' ' ' LEU . 3.0 pt . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 . . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.572 HD12 HG13 ' A' ' 169' ' ' ILE . 3.2 mp 33.78 -60.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 123.889 0.876 . . . . 0.0 113.139 178.597 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.878 ' N ' ' O ' ' A' ' 169' ' ' ILE . 0.1 OUTLIER -64.07 -44.48 92.27 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.856 -179.587 . . . . . . . . 3 3 . 1 . 063 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 52.7 p30 -71.72 -10.26 59.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.975 179.818 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -78.29 -63.08 1.48 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.844 0.354 . . . . 0.0 110.815 179.925 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -114.63 -21.78 5.31 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.325 179.751 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER 76.79 -10.98 1.24 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.878 . . . . . . . . 3 3 . 1 . 063 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.715 0.293 . . . . 0.0 111.011 179.609 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 1.003 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 9.4 tt . . . . . 0 C--O 1.225 -0.216 0 CA-C-O 120.811 0.338 . . . . 0.0 111.673 . . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.505 HD12 HG22 ' A' ' 169' ' ' ILE . 3.3 mp -76.65 -52.26 17.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.226 -179.144 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.681 HD23 ' H ' ' A' ' 172' ' ' ASP . 0.0 OUTLIER -64.57 -52.72 56.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.085 0.469 . . . . 0.0 109.953 -179.633 . . . . . . . . 3 3 . 1 . 064 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.681 ' H ' HD23 ' A' ' 171' ' ' LEU . 0.4 OUTLIER -74.45 -0.31 17.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.206 179.129 . . . . . . . . 3 3 . 1 . 064 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 1.003 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.62 -69.79 0.39 Allowed 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.408 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -120.88 -11.21 6.51 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.523 178.571 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.479 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 26.3 t80 70.51 -18.31 0.25 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.729 0.412 . . . . 0.0 111.801 -179.913 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.431 ' H ' ' C ' ' A' ' 174' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.205 0 CA-C-O 120.858 0.361 . . . . 0.0 110.668 179.849 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.852 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 24.8 pt . . . . . 0 CA--C 1.515 -0.367 0 CA-C-O 121.752 0.787 . . . . 0.0 110.718 . . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.601 ' N ' HG13 ' A' ' 169' ' ' ILE . 2.1 pt -70.28 -41.73 78.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 113.974 -1.466 . . . . 0.0 112.157 -177.777 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 1.0 OUTLIER -61.84 -57.73 10.68 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.096 . . . . . . . . 3 3 . 1 . 065 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -74.8 -1.9 24.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.014 178.44 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.852 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -74.1 -73.51 0.22 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.12 0.486 . . . . 0.0 110.362 179.976 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.536 ' C ' ' CG ' ' A' ' 175' ' ' TYR . . . -98.98 -0.68 57.3 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.02 179.276 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.536 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER 57.68 -53.74 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.672 0.789 . . . . 0.0 112.639 179.451 . . . . . . . . 3 3 . 1 . 065 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 174' ' ' GLY . 2.4 m-85 . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 120.649 0.261 . . . . 0.0 111.088 179.912 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.751 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 4.5 tt . . . . . 0 N--CA 1.458 -0.056 0 CA-C-O 121.047 0.451 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.436 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.1 mp -68.73 -31.07 49.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.378 -179.38 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 8.9 tp -64.89 -63.65 1.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.116 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.28 4.07 9.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.033 178.534 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.751 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.53 -64.39 0.93 Allowed 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.678 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -108.83 -14.95 14.0 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.25 178.26 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.472 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 46.7 t80 70.63 -14.96 0.39 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.734 0.414 . . . . 0.0 111.744 -179.904 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.424 ' H ' ' C ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.689 0.281 . . . . 0.0 110.914 179.859 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.903 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.4 OUTLIER . . . . . 0 CA--C 1.537 0.453 0 CA-C-O 118.973 -0.537 . . . . 0.0 109.717 . . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.686 ' H ' HG23 ' A' ' 169' ' ' ILE . 15.1 mt 33.24 -62.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.435 0.694 . . . . 0.0 112.734 178.956 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.903 ' N ' ' O ' ' A' ' 169' ' ' ILE . 0.1 OUTLIER -65.77 -52.31 52.02 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.803 -179.713 . . . . . . . . 3 3 . 1 . 067 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -72.08 -9.77 58.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.052 179.979 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -77.8 -53.92 6.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.784 0.326 . . . . 0.0 110.964 -179.817 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -114.28 -15.4 8.35 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.577 179.864 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.476 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 10.6 t80 70.89 -44.83 0.6 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.988 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.429 ' CG ' ' O ' ' A' ' 176' ' ' PHE . 79.5 t80 . . . . . 0 CA--C 1.532 0.271 0 CA-C-O 120.621 0.248 . . . . 0.0 111.458 -179.619 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.774 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 4.7 tt . . . . . 0 CA--C 1.524 -0.041 0 CA-C-O 121.162 0.506 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 3.8 mt -69.79 -30.79 45.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.124 -179.812 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.47 -62.44 1.46 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.886 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.61 3.32 9.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.781 178.499 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.774 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.59 -48.11 50.36 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.417 0.627 . . . . 0.0 109.368 179.477 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 175' ' ' TYR . . . -124.12 -4.49 7.77 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.75 178.875 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.426 ' HB2' ' O ' ' A' ' 174' ' ' GLY . 34.9 m-85 67.69 -50.54 0.51 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.743 0.417 . . . . 0.0 111.965 179.664 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 C--N 1.331 -0.196 0 CA-C-O 120.767 0.318 . . . . 0.0 110.998 179.596 . . . . . . . . 0 0 . 1 . 069 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.776 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 5.8 tp . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 121.083 0.468 . . . . 0.0 110.824 . . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.436 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 4.8 mt -73.37 -43.98 55.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.948 179.93 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.46 -55.45 15.63 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.358 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -75.27 5.89 5.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.304 178.869 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.776 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.49 -52.71 16.9 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.739 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -104.96 -18.6 12.03 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 177.968 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 5.1 t80 76.53 -11.86 1.11 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.8 0.44 . . . . 0.0 111.905 179.651 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 79.5 t80 . . . . . 0 C--N 1.331 -0.234 0 CA-C-O 120.806 0.336 . . . . 0.0 110.717 179.371 . . . . . . . . 0 0 . 1 . 070 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.832 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 5.7 pt . . . . . 0 CA--C 1.521 -0.155 0 CA-C-O 120.927 0.394 . . . . 0.0 111.369 . . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 6.7 mm -73.8 -41.09 54.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.0 -179.856 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 78.5 mt -66.71 -55.66 14.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.919 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -74.1 0.7 13.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.176 178.637 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.832 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -70.92 -43.08 69.0 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.366 0.603 . . . . 0.0 109.386 -179.837 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -120.39 -23.98 2.76 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.385 178.586 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 75.37 -41.29 0.45 Allowed 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 122.692 0.397 . . . . 0.0 111.667 179.893 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 . . . . . 0 C--N 1.325 -0.488 0 CA-C-O 120.775 0.321 . . . . 0.0 110.963 179.813 . . . . . . . . 0 0 . 1 . 071 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.904 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 1.4 tt . . . . . 0 C--O 1.227 -0.1 0 CA-C-O 121.222 0.534 . . . . 0.0 112.181 . . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.502 ' N ' HG23 ' A' ' 169' ' ' ILE . 0.8 OUTLIER -75.81 -53.8 15.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -176.996 . . . . . . . . 3 3 . 1 . 071 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.588 ' HG ' ' N ' ' A' ' 172' ' ' ASP . 2.6 pt? -66.91 -49.47 65.44 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.362 0.601 . . . . 0.0 110.056 -179.789 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.588 ' N ' ' HG ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -74.23 1.96 10.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.311 179.02 . . . . . . . . 3 3 . 1 . 071 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.904 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.69 -54.67 8.37 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.307 0.575 . . . . 0.0 109.596 179.5 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -112.49 -18.9 7.3 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.515 178.617 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 70.01 -56.46 0.58 Allowed 'General case' 0 C--O 1.231 0.115 0 C-N-CA 122.502 0.321 . . . . 0.0 111.377 179.824 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.409 ' O ' ' CG ' ' A' ' 176' ' ' PHE . 89.6 t80 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.882 179.824 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.878 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 3.3 tt . . . . . 0 CA--C 1.529 0.136 0 CA-C-O 120.929 0.395 . . . . 0.0 111.817 . . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 10.3 mt -71.03 -60.22 2.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.625 -178.359 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.579 ' HG ' ' N ' ' A' ' 172' ' ' ASP . 2.6 pt? -63.91 -47.95 78.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.375 0.607 . . . . 0.0 110.007 -179.579 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.579 ' N ' ' HG ' ' A' ' 171' ' ' LEU . 30.9 m-20 -72.48 -0.92 13.93 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.219 179.091 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.878 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.16 -66.07 0.73 Allowed 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.591 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -119.74 -9.56 8.26 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.767 178.68 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 12.0 t80 68.82 -61.69 0.41 Allowed 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.971 0.415 . . . . 0.0 110.994 -179.885 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 14.4 t80 . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.912 179.735 . . . . . . . . 0 0 . 1 . 073 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.765 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 5.4 tt . . . . . 0 CA--C 1.522 -0.1 0 CA-C-O 121.264 0.554 . . . . 0.0 110.801 . . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.714 HD13 HG23 ' A' ' 169' ' ' ILE . 13.3 mm -71.66 -45.13 68.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.447 -179.299 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.661 ' H ' HD22 ' A' ' 171' ' ' LEU . 0.9 OUTLIER -65.68 -53.15 45.13 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.035 . . . . . . . . 3 3 . 1 . 073 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -73.82 0.53 12.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.053 178.635 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.765 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.96 -55.61 6.32 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.584 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -123.28 -27.45 1.49 Allowed Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 178.539 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.3 OUTLIER 78.07 -14.66 0.83 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.109 0.564 . . . . 0.0 112.125 179.506 . . . . . . . . 3 3 . 1 . 073 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.425 ' O ' ' CG ' ' A' ' 176' ' ' PHE . 14.7 t80 . . . . . 0 C--N 1.33 -0.274 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.562 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 1.01 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 2.4 pt . . . . . 0 CA--C 1.519 -0.212 0 CA-C-O 120.769 0.319 . . . . 0.0 111.619 . . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 3.4 mp -77.4 -49.19 22.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.644 179.425 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 37.5 mt -68.29 -54.93 14.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.342 179.588 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -71.96 -0.34 11.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.502 179.437 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 1.01 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -70.47 -55.91 7.85 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.842 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -126.23 -22.99 1.63 Allowed Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.549 178.54 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 76.72 -30.34 0.18 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 122.637 0.375 . . . . 0.0 111.579 -179.876 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.204 0 CA-C-O 120.686 0.279 . . . . 0.0 110.998 179.732 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.684 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 13.4 tt . . . . . 0 CA--C 1.52 -0.177 0 CA-C-O 121.561 0.696 . . . . 0.0 111.841 . . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.608 ' N ' HG23 ' A' ' 169' ' ' ILE . 0.5 OUTLIER -69.2 -31.75 51.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.96 -177.272 . . . . . . . . 3 3 . 1 . 075 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 2.0 mt -66.55 -56.92 8.58 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.201 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -74.48 -4.18 35.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.58 178.158 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.684 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.47 -68.22 0.52 Allowed 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 121.226 0.536 . . . . 0.0 110.148 179.911 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -121.73 -2.03 10.6 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.159 179.292 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 54.1 t80 69.17 -51.8 0.6 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.473 0.309 . . . . 0.0 111.653 -179.994 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.21 0 CA-C-O 120.754 0.311 . . . . 0.0 111.174 -179.77 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.945 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 1.3 tt . . . . . 0 N--CA 1.465 0.293 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 . . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.542 HD12 ' H ' ' A' ' 170' ' ' ILE . 3.9 mp -79.61 -59.28 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.916 0.389 . . . . 0.0 111.12 179.903 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.483 HD22 ' N ' ' A' ' 171' ' ' LEU . 3.3 mm? -67.78 -47.4 69.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.247 0.546 . . . . 0.0 110.013 179.571 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.9 0.13 11.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.487 179.58 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.945 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.6 -63.02 1.29 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.142 0.496 . . . . 0.0 109.792 179.677 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -116.1 -12.34 9.22 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.749 178.901 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER 72.63 -56.12 0.66 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.35 0.26 . . . . 0.0 111.68 179.715 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 30.5 p90 . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 120.581 0.229 . . . . 0.0 111.51 -179.636 . . . . . . . . 0 0 . 1 . 077 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.759 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 7.0 pt . . . . . 0 CA--C 1.523 -0.095 0 CA-C-O 120.925 0.393 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 2.9 mp -70.01 -43.53 79.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.297 -179.103 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.466 ' C ' HD12 ' A' ' 171' ' ' LEU . 0.1 OUTLIER -66.21 -52.54 47.0 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.801 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.4 0.11 18.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.164 178.685 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.759 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.28 -60.26 2.32 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.043 0.449 . . . . 0.0 109.812 179.94 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -107.22 -20.37 8.74 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 178.535 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 27.3 t80 75.14 -11.08 1.12 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.443 0.297 . . . . 0.0 111.572 179.988 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.8 t80 . . . . . 0 CA--C 1.53 0.185 0 CA-C-O 120.791 0.329 . . . . 0.0 110.629 179.623 . . . . . . . . 0 0 . 1 . 078 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.714 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 7.3 tt . . . . . 0 C--O 1.227 -0.115 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 . . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.411 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.4 mp -70.64 -43.34 77.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.029 -178.803 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.0 -2.97 11.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.983 0.421 . . . . 0.0 111.789 179.915 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -145.88 17.28 1.43 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.354 179.978 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -80.81 -39.99 25.74 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.141 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.615 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -134.68 3.48 4.24 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 114.898 -1.047 . . . . 0.0 111.968 179.046 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.508 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER 54.97 -61.42 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 123.819 0.847 . . . . 0.0 112.147 179.799 . . . . . . . . 3 3 . 1 . 078 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.615 ' N ' ' O ' ' A' ' 174' ' ' GLY . 11.6 m-85 . . . . . 0 C--N 1.318 -0.771 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.056 -179.953 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.769 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 1.3 tt . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 120.816 0.341 . . . . 0.0 111.757 . . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.507 HD12 ' H ' ' A' ' 170' ' ' ILE . 4.2 mp -73.63 -34.98 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.136 -179.582 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 43.6 mt -65.59 -59.46 3.93 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.941 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.54 4.09 8.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.868 178.472 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.769 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.31 -53.94 12.52 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.746 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -98.53 -18.39 25.93 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 177.887 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 13.5 t80 75.47 -13.38 0.87 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.81 0.444 . . . . 0.0 111.723 179.787 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.22 0 CA-C-O 120.656 0.265 . . . . 0.0 110.644 179.527 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.851 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 120.601 0.238 . . . . 0.0 111.179 . . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.57 HD12 ' H ' ' A' ' 170' ' ' ILE . 2.9 mp -78.24 -56.13 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.019 0.438 . . . . 0.0 110.507 179.44 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 171' ' ' LEU . 3.5 mm? -67.83 -45.32 75.01 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.964 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -73.82 -0.64 16.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.325 179.214 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.851 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.26 -45.63 54.66 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.29 0.567 . . . . 0.0 109.84 179.731 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -126.62 -28.25 0.99 Allowed Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.261 179.054 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 35.7 t80 78.75 -12.66 1.06 Allowed 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 122.97 0.508 . . . . 0.0 112.134 179.525 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.426 ' CD2' ' O ' ' A' ' 176' ' ' PHE . 14.8 p90 . . . . . 0 C--N 1.329 -0.301 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.65 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.79 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 23.6 mm . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 121.081 0.467 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.418 ' N ' HG22 ' A' ' 169' ' ' ILE . 3.8 mp -73.26 -29.77 29.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.592 -179.202 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 22.5 tp -64.81 -64.78 0.78 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 179.339 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -77.68 8.43 4.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.181 178.627 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.79 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.26 -51.23 25.68 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.403 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -121.69 -28.32 1.6 Allowed Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 178.046 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 77.8 -24.62 0.21 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.404 0.682 . . . . 0.0 112.192 179.202 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 . . . . . 0 C--N 1.331 -0.237 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.954 . . . . . . . . 0 0 . 1 . 082 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.927 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 2.3 pt . . . . . 0 C--O 1.227 -0.116 0 CA-C-O 120.752 0.31 . . . . 0.0 111.621 . . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.495 HD12 HG13 ' A' ' 169' ' ' ILE . 3.8 mp -76.6 -54.29 13.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.293 -179.77 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 25.7 mt -67.37 -53.04 32.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.031 0.444 . . . . 0.0 110.488 179.974 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -74.46 5.27 4.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.727 179.764 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.927 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -69.75 -56.86 6.02 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.068 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -132.85 30.9 3.02 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 177.394 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.443 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 18.4 t80 68.5 -69.22 0.15 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.366 0.603 . . . . 0.0 109.432 -178.371 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' A' ' 174' ' ' GLY . 15.6 t80 . . . . . 0 C--N 1.313 -1.013 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.961 178.963 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.909 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.223 -0.306 0 CA-C-O 118.943 -0.551 . . . . 0.0 109.526 . . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.71 ' H ' HG23 ' A' ' 169' ' ' ILE . 4.2 mt 21.03 -61.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 178.481 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.909 ' N ' ' O ' ' A' ' 169' ' ' ILE . 0.2 OUTLIER -64.72 -52.38 57.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.57 -179.248 . . . . . . . . 3 3 . 1 . 083 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -73.69 -11.2 60.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.725 0.298 . . . . 0.0 111.094 179.855 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.424 ' HB2' HG13 ' A' ' 169' ' ' ILE . . . -77.01 -56.12 4.86 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.914 0.388 . . . . 0.0 110.638 179.98 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -99.32 -24.8 9.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.855 179.371 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 27.6 t80 77.3 -40.76 0.35 Allowed 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 122.385 0.274 . . . . 0.0 111.681 179.976 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 . . . . . 0 C--N 1.327 -0.387 0 CA-C-O 120.688 0.28 . . . . 0.0 111.277 -179.979 . . . . . . . . 0 0 . 1 . 084 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.746 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 12.6 tt . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 121.158 0.504 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.438 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.6 mp -70.35 -45.25 75.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.046 -179.684 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.6 mp -64.56 -52.22 58.76 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.235 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -76.21 1.54 15.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.153 178.529 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.746 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.41 -61.94 1.62 Allowed 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.142 0.496 . . . . 0.0 109.672 179.818 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -102.48 -21.39 10.64 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 178.332 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 1.6 t80 75.13 -38.86 0.39 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.569 0.347 . . . . 0.0 111.464 179.896 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.331 -0.221 0 CA-C-O 120.809 0.337 . . . . 0.0 110.74 179.546 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.883 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.5 OUTLIER . . . . . 0 CA--C 1.536 0.413 0 CA-C-O 118.911 -0.566 . . . . 0.0 109.703 . . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.673 ' H ' HG23 ' A' ' 169' ' ' ILE . 2.2 mp 21.98 -63.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 178.595 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.883 ' N ' ' O ' ' A' ' 169' ' ' ILE . 4.0 pp -66.37 -50.32 63.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.181 -179.635 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.748 ' N ' HD12 ' A' ' 171' ' ' LEU . 0.4 OUTLIER -69.7 -11.68 61.04 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.607 179.611 . . . . . . . . 3 3 . 1 . 085 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -78.22 -62.0 1.82 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.812 179.87 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -113.15 -24.69 4.72 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.348 179.748 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 1.0 OUTLIER 76.66 -11.82 1.13 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.561 0.22 . . . . 0.0 111.455 -179.792 . . . . . . . . 3 3 . 1 . 085 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 27.8 t80 . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 120.684 0.278 . . . . 0.0 110.702 179.377 . . . . . . . . 0 0 . 1 . 086 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.793 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 5.2 tt . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 . . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.643 ' H ' HG23 ' A' ' 169' ' ' ILE . 0.4 OUTLIER -67.03 -47.86 80.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.992 -179.899 . . . . . . . . 3 3 . 1 . 086 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 175' ' ' TYR . 0.1 OUTLIER -64.85 -50.92 64.73 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.419 . . . . . . . . 3 3 . 1 . 086 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.82 -5.86 43.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.547 178.445 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.793 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.71 -73.71 0.21 Allowed 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.571 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -113.95 -19.86 6.25 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.44 178.585 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.402 ' HA ' HD13 ' A' ' 171' ' ' LEU . 35.0 t80 73.03 -44.86 0.61 Allowed 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 122.45 0.3 . . . . 0.0 111.59 179.87 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 38.3 p90 . . . . . 0 C--N 1.331 -0.199 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.349 -179.729 . . . . . . . . 0 0 . 1 . 087 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.89 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 2.9 tp . . . . . 0 C--O 1.226 -0.171 0 CA-C-O 120.859 0.361 . . . . 0.0 111.408 . . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.424 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.8 mp -71.33 -47.93 56.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.016 -179.904 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.48 -50.67 64.48 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.13 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.88 -4.66 39.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.998 178.869 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.89 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.37 -69.48 0.42 Allowed 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.368 0.604 . . . . 0.0 109.552 179.632 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -122.36 -20.71 2.91 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.213 178.674 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.438 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 11.8 t80 76.35 -31.68 0.19 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.313 0.645 . . . . 0.0 112.349 179.549 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 121.332 0.587 . . . . 0.0 109.694 179.525 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.829 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 7.5 tt . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 121.137 0.494 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.482 HD12 ' H ' ' A' ' 170' ' ' ILE . 1.3 mp -76.13 -51.85 19.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.92 -179.282 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.735 HD23 ' N ' ' A' ' 172' ' ' ASP . 0.0 OUTLIER -64.75 -53.13 52.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.981 0.42 . . . . 0.0 110.002 -179.756 . . . . . . . . 3 3 . 1 . 088 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.735 ' N ' HD23 ' A' ' 171' ' ' LEU . 1.1 t70 -74.84 4.73 5.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.384 179.053 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.829 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -70.44 -60.57 2.19 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.694 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -109.36 -17.18 10.2 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 178.085 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 29.7 t80 72.33 -12.39 0.72 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.565 0.346 . . . . 0.0 111.316 -179.777 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.419 ' CD2' ' O ' ' A' ' 176' ' ' PHE . 76.4 t80 . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 120.937 0.399 . . . . 0.0 110.193 179.506 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.86 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.521 -0.16 0 CA-C-O 121.219 0.533 . . . . 0.0 111.248 . . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.612 HG23 HG22 ' A' ' 169' ' ' ILE . 0.6 OUTLIER -74.54 -43.67 48.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.361 -177.95 . . . . . . . . 3 3 . 1 . 089 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.35 -56.55 12.01 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.227 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.7 4.41 7.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.4 179.023 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.86 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.16 -75.34 0.13 Allowed 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.796 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -95.12 -13.03 54.11 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 177.924 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 69.76 -59.59 0.5 Allowed 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 120.862 0.363 . . . . 0.0 110.955 179.875 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 19.0 p90 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.194 179.708 . . . . . . . . 0 0 . 1 . 090 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.948 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.703 0.287 . . . . 0.0 111.313 . . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 6.0 mm -80.84 -44.09 21.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.61 -179.869 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.38 -57.85 8.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.159 0.504 . . . . 0.0 109.792 179.95 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.9 2.81 7.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.066 178.74 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.948 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.02 -54.79 8.8 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.432 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -126.39 -10.64 4.04 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.928 178.692 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.422 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 2.6 t80 68.55 -52.67 0.56 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.62 0.368 . . . . 0.0 111.708 179.59 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 50.2 p90 . . . . . 0 C--N 1.329 -0.292 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.403 . . . . . . . . 0 0 . 1 . 091 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.699 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.4 OUTLIER . . . . . 0 CA--C 1.528 0.117 0 CA-C-O 120.788 0.328 . . . . 0.0 111.227 . . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.447 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.6 mp -72.65 -39.56 60.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.367 -179.633 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.442 ' O ' HD23 ' A' ' 171' ' ' LEU . 4.0 tt -68.82 -2.51 9.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.684 179.922 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -148.14 15.96 1.05 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.064 179.902 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -81.46 -46.42 14.58 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.015 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.588 ' O ' ' CG ' ' A' ' 175' ' ' TYR . . . -141.61 0.52 1.69 Allowed Glycine 0 CA--C 1.522 0.531 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.818 179.229 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.588 ' CG ' ' O ' ' A' ' 174' ' ' GLY . 45.2 p90 56.61 -52.72 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.904 0.881 . . . . 0.0 113.02 179.926 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.562 ' N ' ' O ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.511 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.312 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.906 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 1.2 tp . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.815 0.34 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.455 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.5 mp -72.45 -42.71 64.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.312 -179.684 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.7 tt -65.02 -56.21 14.43 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.443 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.1 1.0 14.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.118 178.711 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.906 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.95 -57.66 3.89 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.201 0.524 . . . . 0.0 109.833 179.723 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -119.98 -3.45 12.05 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.878 178.983 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.457 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 92.6 t80 71.03 -43.51 0.56 Allowed 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.587 0.355 . . . . 0.0 111.719 -179.964 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.168 0 CA-C-O 120.791 0.329 . . . . 0.0 111.01 179.937 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.802 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.46 0.054 0 CA-C-O 121.113 0.482 . . . . 0.0 111.134 . . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 3.4 mp -69.07 -38.71 78.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.618 -179.004 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.6 mp -65.17 -60.09 3.38 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.258 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -74.36 3.31 7.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.263 178.55 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.802 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.15 -59.31 2.84 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.973 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -104.52 -20.4 10.22 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 178.309 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 36.7 t80 72.91 -11.64 0.85 Allowed 'General case' 0 C--O 1.232 0.157 0 C-N-CA 122.704 0.402 . . . . 0.0 111.845 179.83 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 23.3 p90 . . . . . 0 C--N 1.33 -0.264 0 CA-C-O 120.821 0.343 . . . . 0.0 110.495 179.348 . . . . . . . . 0 0 . 1 . 094 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.929 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER . . . . . 0 CA--C 1.522 -0.119 0 CA-C-O 121.283 0.563 . . . . 0.0 110.853 . . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.532 HG23 HG23 ' A' ' 169' ' ' ILE . 0.7 OUTLIER -79.36 -45.34 23.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 114.92 -1.036 . . . . 0.0 112.074 -178.798 . . . . . . . . 3 3 . 1 . 094 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.437 HD23 HG13 ' A' ' 170' ' ' ILE . 13.2 mt -66.93 -55.69 13.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.089 0.471 . . . . 0.0 109.891 179.532 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.05 5.84 4.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.276 179.032 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.929 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.32 -47.75 40.04 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.26 0.552 . . . . 0.0 109.712 179.639 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.51 ' C ' ' CG ' ' A' ' 175' ' ' TYR . . . -120.75 -1.59 11.8 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.841 178.841 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.51 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER 57.25 -50.07 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.963 0.905 . . . . 0.0 113.088 179.732 . . . . . . . . 3 3 . 1 . 094 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.49 ' N ' ' O ' ' A' ' 174' ' ' GLY . 26.6 p90 . . . . . 0 C--N 1.329 -0.284 0 O-C-N 122.217 -0.302 . . . . 0.0 111.152 -179.935 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.877 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 . . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.545 HD12 ' H ' ' A' ' 170' ' ' ILE . 4.0 mp -71.64 -39.69 69.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.673 -179.022 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.418 ' N ' ' CD2' ' A' ' 171' ' ' LEU . 2.0 mm? -64.54 -60.52 3.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.357 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -75.14 4.41 6.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.501 178.973 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.877 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.82 -69.66 0.38 Allowed 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.59 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -108.25 -16.41 12.31 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.091 178.211 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.427 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 53.1 t80 74.51 -15.78 0.6 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.868 0.467 . . . . 0.0 111.898 179.953 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 . . . . . 0 C--N 1.331 -0.215 0 CA-C-O 120.781 0.324 . . . . 0.0 111.02 -179.964 . . . . . . . . 0 0 . 1 . 096 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.946 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 5.7 tp . . . . . 0 C--O 1.226 -0.16 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 . . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.746 ' H ' HG23 ' A' ' 169' ' ' ILE . 1.9 mp -73.35 -39.98 56.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.812 -179.015 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 4.7 tp -64.13 -60.89 2.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.274 0.559 . . . . 0.0 109.762 179.754 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -74.12 -0.0 15.24 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.128 179.014 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.946 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -70.11 -71.0 0.26 Allowed 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.203 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -125.87 -8.48 5.16 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.119 177.815 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 12.9 t80 70.59 -55.66 0.62 Allowed 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.605 0.362 . . . . 0.0 111.851 179.558 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.531 0.227 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.187 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.839 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 . . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.46 HG12 ' H ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -69.92 -39.41 77.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.65 -176.899 . . . . . . . . 3 3 . 1 . 097 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.46 ' H ' HG12 ' A' ' 170' ' ' ILE . 46.5 mt -66.08 -55.79 14.76 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.798 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.34 0.4 19.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.307 178.5 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.839 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.22 -75.35 0.14 Allowed 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.777 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -86.5 -17.5 60.25 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 178.334 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 12.0 t80 68.99 -57.21 0.52 Allowed 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 122.607 0.363 . . . . 0.0 111.112 179.872 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.435 ' CD1' ' C ' ' A' ' 176' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.12 179.803 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.878 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 1.1 tp . . . . . 0 N--CA 1.462 0.173 0 CA-C-O 120.89 0.376 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.609 HG13 HG22 ' A' ' 169' ' ' ILE . 0.8 OUTLIER -81.27 -32.29 12.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.757 -179.622 . . . . . . . . 3 3 . 1 . 098 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.586 ' H ' HD12 ' A' ' 170' ' ' ILE . 2.1 tm? -66.75 -62.46 1.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.939 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -76.4 7.84 4.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.135 178.613 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.878 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.08 -60.1 2.42 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.679 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.429 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -102.24 -17.09 21.19 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 177.884 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.429 ' HB2' ' O ' ' A' ' 174' ' ' GLY . 2.0 m-85 69.7 -12.27 0.47 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.827 0.451 . . . . 0.0 111.846 179.913 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.429 ' H ' ' C ' ' A' ' 174' ' ' GLY . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.237 0 CA-C-O 120.892 0.377 . . . . 0.0 110.186 179.196 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.852 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER . . . . . 0 CA--C 1.521 -0.145 0 CA-C-O 121.257 0.551 . . . . 0.0 111.326 . . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.498 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 0.7 OUTLIER -73.95 -46.67 45.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.422 -178.076 . . . . . . . . 3 3 . 1 . 099 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 41.0 tp -66.91 -49.26 66.13 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.726 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -73.25 -5.33 38.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.6 178.357 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.852 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.2 -70.45 0.36 Allowed 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.607 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -117.24 -15.77 6.42 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.78 178.902 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 23.4 t80 77.52 -37.16 0.24 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 122.501 0.32 . . . . 0.0 111.638 -179.923 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 11.3 p90 . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 120.849 0.357 . . . . 0.0 110.978 -179.975 . . . . . . . . 0 0 . 1 . 100 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.798 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--O 1.227 -0.128 0 CA-C-O 121.207 0.527 . . . . 0.0 110.971 . . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.547 HD13 HG23 ' A' ' 169' ' ' ILE . 20.4 mm -68.54 -48.09 73.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.586 -178.898 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.6 mt -65.25 -48.2 74.08 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.224 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -76.11 -5.16 45.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.844 178.609 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.798 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.97 -70.19 0.4 Allowed 'General case' 0 CA--C 1.522 -0.134 0 CA-C-O 121.205 0.526 . . . . 0.0 109.788 179.849 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -121.06 -20.64 3.33 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.027 178.637 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 9.9 t80 75.6 -12.44 0.98 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.053 0.541 . . . . 0.0 111.971 179.659 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 52.1 t80 . . . . . 0 C--N 1.331 -0.233 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.794 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.807 0.337 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.552 ' O ' HD12 ' A' ' 156' ' ' LEU . 2.0 pp -165.35 98.79 0.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.937 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.09 -31.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.599 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.5 t -73.41 60.98 0.65 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.062 0.458 . . . . 0.0 110.702 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.455 ' O ' HG12 ' A' ' 160' ' ' VAL . 0.3 OUTLIER 73.48 -59.47 0.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.829 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 87.73 -44.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.357 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -68.66 -29.06 67.45 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.074 0.464 . . . . 0.0 110.663 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -67.59 -61.12 2.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.665 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 19.4 mt -66.58 -4.63 9.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.106 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.415 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER -76.71 -70.91 0.43 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.198 -179.237 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.52 -56.81 11.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.907 0.384 . . . . 0.0 110.863 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.558 HD23 ' HD2' ' A' ' 167' ' ' PRO . 0.0 OUTLIER -160.98 147.89 11.86 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.889 -179.635 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.611 ' HB2' HD13 ' A' ' 169' ' ' ILE . 33.0 Cg_endo -64.52 116.03 3.54 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.567 2.178 . . . . 0.0 112.324 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.62 ' HA ' HD21 ' A' ' 171' ' ' LEU . 89.5 Cg_endo -80.98 39.9 0.92 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.864 2.376 . . . . 0.0 112.963 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.701 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 2.6 mp -79.13 -71.24 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.947 0.403 . . . . 0.0 111.816 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.516 ' O ' ' HG3' ' A' ' 178' ' ' PRO . 4.5 mp -75.46 -55.17 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.709 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.62 HD21 ' HA ' ' A' ' 168' ' ' PRO . 2.6 pt? -60.04 -51.47 69.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.028 0.442 . . . . 0.0 110.449 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.57 ' N ' ' HG ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -76.23 5.5 6.85 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.288 178.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.75 -71.1 0.29 Allowed 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -108.24 -3.76 33.29 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 1.5 t80 69.74 -61.9 0.43 Allowed 'General case' 0 C--O 1.231 0.113 0 CA-C-O 121.028 0.442 . . . . 0.0 110.348 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -101.95 -26.88 13.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.333 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.533 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 22.0 mt -60.85 -42.69 88.55 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.589 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 76.5 Cg_exo -51.78 -29.86 35.73 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.543 2.162 . . . . 0.0 112.784 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.12 -11.42 60.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 0.0 111.278 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.83 57.76 1.04 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.279 0.561 . . . . 0.0 109.523 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 121.213 0.53 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.475 HD13 ' O ' ' A' ' 156' ' ' LEU . 0.2 OUTLIER -74.3 62.38 0.95 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.386 -179.548 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 20.3 tp60 -168.97 46.84 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.147 0.499 . . . . 0.0 110.807 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.66 56.3 0.14 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.929 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.433 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.9 OUTLIER 78.88 -51.54 0.45 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.153 -179.475 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.433 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 68.7 t 71.14 -54.06 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 120.873 0.368 . . . . 0.0 111.112 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.43 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 5.3 m-85 -73.06 4.92 3.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.223 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.43 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 81.2 m-85 -160.93 11.88 0.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.01 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.691 HD23 ' O ' ' A' ' 163' ' ' LEU . 3.8 tt -66.6 -26.11 66.94 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.417 ' HA ' ' HG2' ' A' ' 167' ' ' PRO . 4.3 t80 69.76 17.56 7.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.941 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.595 HD12 HD13 ' A' ' 163' ' ' LEU . 0.2 OUTLIER -64.34 -55.3 22.15 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.283 0.563 . . . . 0.0 109.78 178.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.706 ' N ' ' HD3' ' A' ' 167' ' ' PRO . 0.3 OUTLIER -158.1 41.81 0.12 Allowed Pre-proline 0 N--CA 1.447 -0.601 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.767 -179.29 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.706 ' HD3' ' N ' ' A' ' 166' ' ' LEU . 15.1 Cg_exo -64.49 -52.87 1.23 Allowed 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 121.76 1.64 . . . . 0.0 113.003 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.474 ' HD3' ' HB2' ' A' ' 167' ' ' PRO . 38.0 Cg_endo -92.22 72.24 0.65 Allowed 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.636 2.224 . . . . 0.0 112.639 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.779 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 3.5 tt -73.91 -41.0 53.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.123 0.487 . . . . 0.0 110.315 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.908 ' O ' HD12 ' A' ' 177' ' ' LEU . 2.0 mp -74.1 -45.7 47.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.788 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.432 HD22 ' N ' ' A' ' 171' ' ' LEU . 3.5 mm? -64.41 -53.12 53.38 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -74.77 1.05 13.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.921 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.779 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.82 -53.44 11.47 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.143 0.497 . . . . 0.0 109.69 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -105.63 -18.48 11.67 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.294 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.45 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 13.0 t80 76.02 -25.73 0.2 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.882 0.473 . . . . 0.0 112.04 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -97.69 14.41 26.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.648 0.261 . . . . 0.0 111.209 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.908 HD12 ' O ' ' A' ' 170' ' ' ILE . 11.4 mt -81.35 -46.94 1.1 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.248 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 71.6 Cg_exo -48.75 90.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.496 2.131 . . . . 0.0 112.706 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.7 -67.51 0.99 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.447 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -87.81 22.36 2.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.5 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.2 t80 . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.83 0.348 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.587 ' HB2' HG23 ' A' ' 160' ' ' VAL . 4.1 pp -73.26 176.12 6.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.504 ' N ' HD12 ' A' ' 156' ' ' LEU . 0.1 OUTLIER -170.53 -55.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.129 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.66 ' HB3' HD13 ' A' ' 163' ' ' LEU . 3.4 t -75.69 59.68 1.2 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.959 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.457 ' O ' HG12 ' A' ' 160' ' ' VAL . 0.3 OUTLIER 72.74 -47.0 0.66 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.655 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.587 HG23 ' HB2' ' A' ' 156' ' ' LEU . 0.4 OUTLIER 90.17 -52.52 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 122.873 0.469 . . . . 0.0 111.07 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.495 ' CE1' ' CD2' ' A' ' 162' ' ' PHE . 0.1 OUTLIER -78.53 32.99 0.2 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.812 0.339 . . . . 0.0 111.215 179.338 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.495 ' CD2' ' CE1' ' A' ' 161' ' ' PHE . 2.6 m-85 -169.41 -14.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.509 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.66 HD13 ' HB3' ' A' ' 158' ' ' SER . 16.1 tp -61.15 -34.79 75.57 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.466 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 1.4 t80 47.07 38.94 7.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.361 178.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.466 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.1 OUTLIER 86.57 -30.79 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.99 -179.501 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.413 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 0.0 OUTLIER -161.47 136.25 5.39 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.892 -179.024 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.655 ' HD3' HD11 ' A' ' 163' ' ' LEU . 88.4 Cg_endo -89.89 103.49 0.33 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.328 2.019 . . . . 0.0 113.271 -178.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.475 ' HB2' ' HB2' ' A' ' 171' ' ' LEU . 61.5 Cg_endo -70.69 80.31 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.608 2.205 . . . . 0.0 111.719 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.978 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -71.06 -32.97 49.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.951 0.405 . . . . 0.0 110.715 -179.679 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.422 ' O ' ' HG2' ' A' ' 178' ' ' PRO . 3.7 mp -80.61 -50.84 16.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.245 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 168' ' ' PRO . 7.3 mp -65.26 -50.93 63.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.277 0.561 . . . . 0.0 109.949 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 2.3 t70 -74.0 -4.42 35.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.032 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.978 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.67 -70.36 0.33 Allowed 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.645 ' H ' ' HG2' ' A' ' 178' ' ' PRO . . . -123.33 -27.73 1.44 Allowed Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.51 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 15.6 t80 79.15 -20.14 0.4 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.443 0.697 . . . . 0.0 112.149 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -94.83 46.52 1.13 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.368 0.604 . . . . 0.0 109.466 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.55 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 2.6 mt 59.13 50.18 2.95 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.156 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.645 ' HG2' ' H ' ' A' ' 174' ' ' GLY . 49.4 Cg_exo -42.68 -27.64 0.89 Allowed 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.286 2.658 . . . . 0.0 113.273 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 179' ' ' LEU . 1.8 tp -59.08 -52.24 66.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.357 . . . . 0.0 110.872 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.506 ' HD2' ' N ' ' A' ' 180' ' ' ARG . 0.1 OUTLIER -90.27 24.8 2.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.973 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . 0.578 ' HG2' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.565 ' O ' HD12 ' A' ' 156' ' ' LEU . 11.6 p90 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.793 0.33 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.565 HD12 ' O ' ' A' ' 155' ' ' PHE . 1.6 mp -164.35 -76.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.842 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 80.92 -5.67 1.67 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.803 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.9 p 76.38 -47.18 0.54 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.64 ' C ' HG13 ' A' ' 160' ' ' VAL . 7.5 m-20 -75.22 -33.8 61.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.52 0.2 . . . . 0.0 111.341 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.64 HG13 ' C ' ' A' ' 159' ' ' ASP . 2.0 m 66.94 -50.6 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 122.722 0.409 . . . . 0.0 112.088 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.405 ' HA ' ' HB2' ' A' ' 164' ' ' PHE . 12.2 t80 -63.6 -22.86 67.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.987 0.423 . . . . 0.0 110.132 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -70.38 -61.86 1.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.795 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.469 HD21 ' CD1' ' A' ' 155' ' ' PHE . 12.0 tp -65.41 -8.31 18.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.673 178.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.405 ' HB2' ' HA ' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -75.32 -71.74 0.35 Allowed 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.799 -179.407 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.1 -52.62 47.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.983 0.42 . . . . 0.0 110.866 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -160.79 110.93 1.3 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.544 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.458 ' HB3' ' CD1' ' A' ' 163' ' ' LEU . 60.0 Cg_endo -73.47 111.35 3.27 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.401 2.067 . . . . 0.0 113.155 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -77.22 63.6 7.77 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.672 2.248 . . . . 0.0 111.509 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.905 HG23 HD13 ' A' ' 170' ' ' ILE . 7.7 tt -74.71 -39.96 46.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.355 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.905 HD13 HG23 ' A' ' 169' ' ' ILE . 7.4 mm -69.19 -31.42 49.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.356 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.2 mp -70.71 -4.01 21.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.485 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -152.4 13.84 0.57 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.234 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -81.86 -38.58 25.21 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.481 ' HA3' HD21 ' A' ' 177' ' ' LEU . . . -130.57 -14.64 1.9 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 114.755 -1.112 . . . . 0.0 112.344 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 73.63 -45.88 0.62 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.651 0.225 . . . . 0.0 111.245 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.423 ' CZ ' ' HG ' ' A' ' 179' ' ' LEU . 55.4 t80 -93.34 -3.44 53.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.568 0.223 . . . . 0.0 111.141 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.516 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 11.6 mt -58.94 -45.06 99.61 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.102 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 16.6 Cg_exo -68.33 60.83 1.07 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.668 2.245 . . . . 0.0 112.217 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.423 ' HG ' ' CZ ' ' A' ' 176' ' ' PHE . 0.3 OUTLIER -108.65 -56.79 2.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.318 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.3 32.38 0.7 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.275 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.836 0.351 . . . . 0.0 111.26 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.3 pp -73.85 116.61 14.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.023 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.87 -39.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.212 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.839 ' OG ' HD11 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -74.34 62.8 0.99 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.334 0.588 . . . . 0.0 110.194 179.866 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 78.12 -62.18 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.716 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 82.01 -47.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.073 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.411 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 38.2 p90 -75.97 9.34 2.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.519 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -166.23 8.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.345 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.839 HD11 ' OG ' ' A' ' 158' ' ' SER . 0.3 OUTLIER -63.5 -37.28 86.7 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.325 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 59.42 -1.74 0.14 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.004 178.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.754 ' HB2' HD22 ' A' ' 163' ' ' LEU . 0.3 OUTLIER -70.89 -65.22 0.77 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.177 0.513 . . . . 0.0 110.535 179.452 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.7 mt -164.47 56.77 0.51 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.484 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.417 ' HA ' ' HD2' ' A' ' 168' ' ' PRO . 9.7 Cg_endo -51.28 105.82 0.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.537 2.158 . . . . 0.0 112.151 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 167' ' ' PRO . 74.4 Cg_endo -73.24 -1.46 10.62 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.758 2.305 . . . . 0.0 113.154 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.935 HG13 ' HB2' ' A' ' 173' ' ' ALA . 0.6 OUTLIER -72.72 -108.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 118.925 -0.56 . . . . 0.0 109.638 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.683 ' H ' HG23 ' A' ' 169' ' ' ILE . 2.9 mm 24.19 -64.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.457 0.703 . . . . 0.0 112.714 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.89 ' N ' ' O ' ' A' ' 169' ' ' ILE . 0.1 OUTLIER -67.95 -51.27 49.5 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.916 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 169' ' ' ILE . 1.0 OUTLIER -73.44 -15.7 61.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.546 179.286 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.935 ' HB2' HG13 ' A' ' 169' ' ' ILE . . . -78.14 -59.35 2.82 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.081 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -119.02 -21.85 3.69 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.864 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 70.9 -48.11 0.66 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.787 0.294 . . . . 0.0 111.192 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.0 12.74 20.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.747 0.308 . . . . 0.0 110.962 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.479 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 8.8 mt -70.92 -51.72 10.69 Favored Pre-proline 0 CA--C 1.528 0.116 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.361 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.479 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 73.8 Cg_exo -50.52 86.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.838 2.358 . . . . 0.0 112.317 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -93.81 -60.29 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.619 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -87.63 21.94 2.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.501 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.852 0.358 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 1.015 ' HA ' HG22 ' A' ' 160' ' ' VAL . 0.5 OUTLIER 58.39 30.75 20.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.973 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.471 ' H ' ' CD1' ' A' ' 163' ' ' LEU . 0.1 OUTLIER -73.71 -54.24 8.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.881 -179.224 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.417 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 25.7 t -163.46 38.61 0.09 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.083 0.468 . . . . 0.0 111.105 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 161' ' ' PHE . 1.3 m-20 -162.27 -57.01 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.2 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 1.015 HG22 ' HA ' ' A' ' 156' ' ' LEU . 21.5 t 63.46 -63.63 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.43 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.483 ' N ' ' O ' ' A' ' 159' ' ' ASP . 12.7 m-85 -79.02 4.61 13.94 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.854 -1.066 . . . . 0.0 112.187 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -168.94 12.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.507 -0.477 . . . . 0.0 112.096 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.565 ' CD2' ' HD3' ' A' ' 167' ' ' PRO . 4.5 tt -66.56 -38.54 87.32 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.488 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER 49.18 27.35 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.77 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.601 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.2 OUTLIER 90.05 -26.46 0.06 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.638 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 165' ' ' LEU . 0.5 OUTLIER -161.56 103.68 1.2 Allowed Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.402 -178.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.591 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 55.4 Cg_endo -71.72 -24.17 21.89 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.674 2.249 . . . . 0.0 115.161 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 22.4 Cg_endo -89.14 17.37 1.63 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.675 1.583 . . . . 0.0 113.385 -179.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.982 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.5 OUTLIER -76.52 -40.01 33.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.048 0.452 . . . . 0.0 111.058 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.676 ' O ' HD12 ' A' ' 177' ' ' LEU . 2.5 mp -83.75 -70.37 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.617 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.97 -48.4 71.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.89 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.425 ' HB2' ' CA ' ' A' ' 168' ' ' PRO . 0.3 OUTLIER -74.04 1.91 9.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.665 -179.69 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.982 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.92 -51.72 15.21 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.195 0.522 . . . . 0.0 109.612 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -118.54 -18.15 4.96 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.785 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 15.6 t80 78.1 -34.11 0.18 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 122.551 0.34 . . . . 0.0 111.881 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -95.5 18.29 13.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.752 0.311 . . . . 0.0 111.151 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.676 HD12 ' O ' ' A' ' 170' ' ' ILE . 11.0 mt -81.24 -45.67 1.15 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.927 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.519 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 51.2 Cg_exo -55.05 -156.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.662 2.241 . . . . 0.0 112.505 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.713 HD23 ' HD2' ' A' ' 180' ' ' ARG . 0.2 OUTLIER 76.7 70.65 0.07 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.13 0.49 . . . . 0.0 110.343 -179.643 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.713 ' HD2' HD23 ' A' ' 179' ' ' LEU . 0.0 OUTLIER 66.25 54.07 0.98 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.719 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.857 0.361 . . . . 0.0 111.324 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.614 ' CD2' HG23 ' A' ' 160' ' ' VAL . 0.5 OUTLIER -73.68 -179.85 3.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.771 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -169.65 -79.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.742 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 54.5 p -164.28 27.98 0.07 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.11 0.481 . . . . 0.0 110.665 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -159.64 -53.26 0.06 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.414 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.614 HG23 ' CD2' ' A' ' 156' ' ' LEU . 0.4 OUTLIER 83.97 -49.66 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.768 179.473 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.441 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 0.1 OUTLIER -69.22 -31.15 69.54 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.999 0.428 . . . . 0.0 111.11 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.07 -58.25 4.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.948 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 163' ' ' LEU . 14.0 mt -65.73 -5.34 8.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.737 178.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.413 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.1 OUTLIER -78.76 -50.06 11.99 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.849 -1.068 . . . . 0.0 111.185 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 8.2 mt -65.47 -51.05 62.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.356 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.757 HD23 ' HD2' ' A' ' 167' ' ' PRO . 3.7 mt -159.4 126.24 2.56 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.307 -178.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.757 ' HD2' HD23 ' A' ' 166' ' ' LEU . 1.9 Cg_endo -47.04 -42.82 25.69 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.837 2.358 . . . . 0.0 113.726 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.492 ' HD3' ' HG2' ' A' ' 167' ' ' PRO . 41.1 Cg_endo -87.25 63.63 4.12 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.225 1.95 . . . . 0.0 113.067 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.749 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -78.21 -35.12 19.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.294 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.451 HD12 ' H ' ' A' ' 170' ' ' ILE . 3.4 mp -70.12 -41.54 79.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.61 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 12.9 mt -67.03 -59.13 3.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.263 0.554 . . . . 0.0 109.709 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.93 10.03 1.64 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.462 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.749 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.74 -48.41 47.2 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.499 ' H ' ' CG ' ' A' ' 178' ' ' PRO . . . -117.88 -28.1 2.34 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 177.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 6.1 t80 74.56 -31.52 0.22 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.178 0.591 . . . . 0.0 112.003 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -90.14 50.25 1.83 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.44 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 2.5 mt 62.45 67.16 1.22 Allowed Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.859 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.499 ' CG ' ' H ' ' A' ' 174' ' ' GLY . 51.4 Cg_exo -58.98 -140.92 0.0 OUTLIER 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.498 2.798 . . . . 0.0 112.342 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.465 ' CB ' ' O ' ' A' ' 178' ' ' PRO . 0.1 OUTLIER 86.67 76.99 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.019 0.438 . . . . 0.0 110.545 -179.488 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 67.33 49.06 1.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.634 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.633 ' O ' HD12 ' A' ' 156' ' ' LEU . 12.7 t80 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.618 0.246 . . . . 0.0 111.246 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.633 HD12 ' O ' ' A' ' 155' ' ' PHE . 0.2 OUTLIER -166.39 -98.09 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.896 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 73.2 75.38 0.14 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.003 0.43 . . . . 0.0 110.465 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 18.2 p 60.86 56.71 2.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.489 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.46 -59.03 0.54 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.306 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 83.74 -51.54 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.904 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.461 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 13.9 t80 -76.4 39.99 0.21 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.932 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.435 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 18.3 m-85 -165.52 -24.11 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.451 ' HA ' HD12 ' A' ' 163' ' ' LEU . 8.3 tp -60.14 -38.94 84.6 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.479 ' C ' ' H ' ' A' ' 166' ' ' LEU . 1.8 t80 43.65 45.97 6.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.529 177.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.538 ' O ' HD12 ' A' ' 166' ' ' LEU . 31.0 mt 74.27 -25.13 0.2 Allowed 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 122.714 0.406 . . . . 0.0 111.438 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.538 HD12 ' O ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER -162.19 134.01 4.03 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.159 -177.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -44.89 109.54 0.18 Allowed 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.518 2.145 . . . . 0.0 112.316 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.16 79.24 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.573 2.182 . . . . 0.0 112.541 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.773 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 7.3 tp -74.22 -41.94 51.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.635 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.429 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 4.2 mt -69.38 -35.44 67.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.942 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.889 HD22 ' CG ' ' A' ' 178' ' ' PRO . 0.0 OUTLIER -65.69 -57.94 6.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.29 -2.79 26.61 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.729 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.773 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.57 -69.23 0.44 Allowed 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 121.158 0.504 . . . . 0.0 109.944 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -113.35 -15.14 9.15 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.871 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 5.8 t80 77.63 -41.7 0.36 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -94.94 -15.55 23.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.656 0.265 . . . . 0.0 111.363 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.502 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 95.6 mt -56.28 -44.31 99.66 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.723 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.889 ' CG ' HD22 ' A' ' 171' ' ' LEU . 76.3 Cg_exo -49.3 -65.53 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.231 1.954 . . . . 0.0 112.466 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.8 mt 60.6 58.78 2.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.136 0.494 . . . . 0.0 110.363 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 21.3 mmt85 65.34 53.15 1.32 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.458 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . 0.448 ' HG2' ' HB3' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.437 ' O ' ' HB2' ' A' ' 156' ' ' LEU . 1.3 m-85 . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.823 0.344 . . . . 0.0 111.773 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.538 ' O ' ' CB ' ' A' ' 157' ' ' GLN . 0.3 OUTLIER 65.29 -74.71 0.05 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.675 179.099 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.538 ' CB ' ' O ' ' A' ' 156' ' ' LEU . 6.3 tt0 96.0 -32.54 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 123.148 0.579 . . . . 0.0 109.733 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 12.6 t -81.04 64.24 5.72 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.177 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.659 ' O ' HG13 ' A' ' 160' ' ' VAL . 0.3 OUTLIER 79.64 -46.13 0.34 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.67 -179.119 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 159' ' ' ASP . 2.0 m 67.12 -53.1 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 122.928 0.491 . . . . 0.0 111.909 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.435 ' CD1' HG22 ' A' ' 160' ' ' VAL . 6.2 m-85 -60.78 -26.74 67.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.211 0.529 . . . . 0.0 109.736 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.432 ' HB2' ' HB3' ' A' ' 159' ' ' ASP . 0.3 OUTLIER -71.86 -64.56 0.91 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.521 178.634 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.505 HD23 HD11 ' A' ' 156' ' ' LEU . 3.8 tp -67.97 -4.58 13.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.675 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.477 ' CB ' ' O ' ' A' ' 160' ' ' VAL . 1.0 OUTLIER -74.1 -26.53 60.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.892 -179.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.05 -52.94 57.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.914 0.388 . . . . 0.0 110.588 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -161.59 88.87 1.54 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.342 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -65.2 109.82 1.42 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.605 2.203 . . . . 0.0 112.992 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.88 64.72 5.95 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.643 2.229 . . . . 0.0 111.878 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.848 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -74.07 -38.72 49.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.508 -179.377 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.738 ' O ' HD12 ' A' ' 177' ' ' LEU . 3.4 mp -70.1 -41.99 79.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.578 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 27.9 mt -65.72 -56.65 10.93 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.11 2.26 11.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.231 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.848 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.35 -62.0 1.59 Allowed 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.191 0.519 . . . . 0.0 109.884 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -112.49 -11.85 14.34 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.616 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.493 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 24.5 t80 71.78 -29.96 0.2 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.732 0.413 . . . . 0.0 111.751 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.439 ' H ' ' C ' ' A' ' 174' ' ' GLY . 8.3 t80 -95.59 -12.22 26.01 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.681 0.277 . . . . 0.0 111.238 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.738 HD12 ' O ' ' A' ' 170' ' ' ILE . 94.2 mt -55.17 -43.98 99.37 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.531 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 99.9 Cg_exo -44.6 93.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.506 2.137 . . . . 0.0 112.741 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.425 HD13 ' O ' ' A' ' 177' ' ' LEU . 4.6 mp -82.94 -68.67 0.69 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.614 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.87 20.59 3.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.729 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.685 ' HB3' HG21 ' A' ' 160' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.814 0.34 . . . . 0.0 111.422 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.5 pp -166.24 117.78 1.02 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.789 ' O ' HD12 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -172.08 89.69 0.11 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.679 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 157' ' ' GLN . 9.3 t 78.07 -53.66 0.5 Allowed 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.399 0.619 . . . . 0.0 111.636 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -165.49 -33.13 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.277 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.685 HG21 ' HB3' ' A' ' 155' ' ' PHE . 0.5 OUTLIER 80.63 -52.7 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.578 -179.412 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.47 ' N ' HG12 ' A' ' 160' ' ' VAL . 2.8 m-30 -76.12 38.39 0.17 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.561 178.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.45 ' C ' ' H ' ' A' ' 164' ' ' PHE . 0.4 OUTLIER -165.44 -48.61 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.142 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.789 HD12 ' O ' ' A' ' 157' ' ' GLN . 8.8 mt -67.29 -3.07 6.99 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.45 ' H ' ' C ' ' A' ' 162' ' ' PHE . 7.9 t80 -72.85 -34.48 66.8 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.502 -1.227 . . . . 0.0 110.649 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.5 tp -177.06 -52.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.164 0.507 . . . . 0.0 110.643 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 167' ' ' PRO . 0.2 OUTLIER -162.11 145.39 9.07 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.431 -179.072 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.489 ' N ' HD12 ' A' ' 166' ' ' LEU . 42.3 Cg_endo -68.0 110.37 2.16 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.164 1.909 . . . . 0.0 111.874 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.45 55.79 2.08 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.43 2.086 . . . . 0.0 112.913 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.546 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 9.2 tp -77.28 -43.19 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.404 0.621 . . . . 0.0 110.303 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.452 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.1 mp -74.83 -46.7 40.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.157 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.3 mt -65.4 -55.64 16.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.065 0.46 . . . . 0.0 110.223 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.421 ' OD1' ' CZ ' ' A' ' 175' ' ' TYR . 0.9 OUTLIER -76.07 14.46 0.7 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.399 179.209 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.04 -59.37 2.74 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 175' ' ' TYR . . . -113.35 -2.96 24.45 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 177.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.421 ' CZ ' ' OD1' ' A' ' 172' ' ' ASP . 6.2 m-85 68.69 -61.6 0.41 Allowed 'General case' 0 C--N 1.338 0.105 0 C-N-CA 123.029 0.532 . . . . 0.0 110.79 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -106.52 -8.12 17.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.15 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.462 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 8.8 mt -81.5 -46.72 1.08 Allowed Pre-proline 0 CA--C 1.53 0.185 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 10.4 Cg_endo -90.32 22.04 0.81 Allowed 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.07 2.513 . . . . 0.0 112.855 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 29.7 tp -60.12 -53.66 55.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.37 . . . . 0.0 110.625 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -88.24 43.89 1.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.945 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.769 0.319 . . . . 0.0 111.8 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.2 mt 62.59 34.23 15.22 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.984 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 76.89 74.87 0.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.768 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 9.5 t 60.1 49.26 7.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.829 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.421 ' O ' ' CB ' ' A' ' 160' ' ' VAL . 0.3 OUTLIER 73.86 -54.66 0.68 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.015 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.431 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 87.84 -49.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.197 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.431 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 3.9 m-85 -68.69 -31.81 71.18 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.048 0.451 . . . . 0.0 110.523 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.643 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 0.4 OUTLIER -67.37 -58.92 3.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.539 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.713 HD21 ' HG3' ' A' ' 168' ' ' PRO . 0.5 OUTLIER -66.78 -1.46 3.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.211 178.867 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.436 ' H ' ' C ' ' A' ' 162' ' ' PHE . 1.1 t80 -74.37 -14.5 60.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.137 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 162' ' ' PHE . 0.3 OUTLIER -62.72 -31.98 73.01 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.345 0.593 . . . . 0.0 109.862 179.135 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.645 HD23 ' O ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -159.92 97.12 1.53 Allowed Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.768 -178.746 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.476 ' HD2' ' HA ' ' A' ' 166' ' ' LEU . 6.8 Cg_endo -50.14 119.36 4.83 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.586 2.191 . . . . 0.0 112.316 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.713 ' HG3' HD21 ' A' ' 163' ' ' LEU . 91.5 Cg_endo -79.14 -151.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.806 2.338 . . . . 0.0 112.13 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.847 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.7 OUTLIER -161.03 -45.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.095 0.474 . . . . 0.0 110.234 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.523 ' O ' HD12 ' A' ' 177' ' ' LEU . 3.2 mp -75.35 -38.37 40.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.296 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 63.8 mt -67.18 -57.93 5.8 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.2 4.81 6.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.118 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.847 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.94 -45.8 59.84 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.257 0.551 . . . . 0.0 109.772 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.538 ' C ' ' CG ' ' A' ' 175' ' ' TYR . . . -122.03 -0.02 10.7 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.775 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.538 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER 59.23 -32.91 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 179.416 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.471 ' H ' ' C ' ' A' ' 174' ' ' GLY . 22.5 t80 -93.01 -16.96 24.46 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.098 -0.376 . . . . 0.0 111.102 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.543 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 17.0 mt -57.57 -42.86 97.88 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.362 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 64.7 Cg_exo -51.94 83.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.722 2.281 . . . . 0.0 112.793 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 179' ' ' LEU . 19.9 mt -92.06 -64.45 1.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.939 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.77 41.35 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.908 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.777 0.322 . . . . 0.0 111.25 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.417 ' O ' ' CB ' ' A' ' 157' ' ' GLN . 0.5 OUTLIER -166.21 -163.11 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.056 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.438 ' HB3' ' CG2' ' A' ' 160' ' ' VAL . 0.0 OUTLIER 82.7 60.1 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.165 0.507 . . . . 0.0 110.97 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.423 ' CB ' ' CD1' ' A' ' 163' ' ' LEU . 1.5 m 61.55 45.75 7.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.71 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.484 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.2 OUTLIER 76.5 -53.62 0.59 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.964 179.682 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 45.4 t 70.63 -54.2 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.856 0.36 . . . . 0.0 111.322 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.96 4.3 4.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.625 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -163.5 14.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.973 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.886 ' CD2' HD23 ' A' ' 165' ' ' LEU . 2.0 tt -67.66 -31.87 72.16 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 13.1 t80 66.95 8.8 6.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.388 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.886 HD23 ' CD2' ' A' ' 163' ' ' LEU . 0.3 OUTLIER -66.05 -61.94 1.76 Allowed 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.23 0.538 . . . . 0.0 110.302 179.183 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.933 ' O ' HD22 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -161.11 39.85 0.06 OUTLIER Pre-proline 0 N--CA 1.446 -0.658 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.195 -178.525 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 8.5 Cg_endo -50.44 101.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.402 2.068 . . . . 0.0 112.741 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.793 ' O ' HD12 ' A' ' 170' ' ' ILE . 95.6 Cg_endo -74.21 -97.36 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.841 2.36 . . . . 0.0 112.329 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.943 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER 82.38 -39.02 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 122.641 0.377 . . . . 0.0 111.274 -179.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.793 HD12 ' O ' ' A' ' 168' ' ' PRO . 1.8 mp -87.69 -67.85 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.091 0.472 . . . . 0.0 110.997 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.747 HD23 ' N ' ' A' ' 172' ' ' ASP . 0.0 OUTLIER -68.06 -41.1 82.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.165 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.747 ' N ' HD23 ' A' ' 171' ' ' LEU . 44.5 t0 -72.53 -8.62 56.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.716 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.943 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -75.48 -64.37 1.08 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.196 0.522 . . . . 0.0 109.997 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -125.31 -17.64 2.65 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.157 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 77.66 -20.39 0.38 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 122.491 0.316 . . . . 0.0 111.675 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -98.23 21.42 10.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.964 0.411 . . . . 0.0 110.559 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.508 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 3.3 mm? -84.67 -48.1 0.65 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.017 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.508 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 27.4 Cg_exo -63.59 69.56 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.758 2.305 . . . . 0.0 112.345 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 177' ' ' LEU . 0.2 OUTLIER -88.86 -67.76 0.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.738 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -87.44 35.72 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.64 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 120.897 0.38 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.871 ' HB2' HG21 ' A' ' 160' ' ' VAL . 4.1 pp -165.82 124.77 1.63 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.995 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -170.61 -37.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.162 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.63 ' O ' HD13 ' A' ' 163' ' ' LEU . 23.5 m -74.0 63.26 0.93 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.078 0.466 . . . . 0.0 110.153 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 158' ' ' SER . 0.3 OUTLIER 76.11 -62.84 0.41 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.414 -179.313 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.871 HG21 ' HB2' ' A' ' 156' ' ' LEU . 53.9 t 67.85 -46.81 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.151 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -71.13 -6.3 38.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.426 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -165.45 17.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.684 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.834 HD11 ' HD2' ' A' ' 168' ' ' PRO . 15.2 tp -68.15 -7.17 27.64 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 177.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -75.57 -23.84 56.58 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.17 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.1 tp -63.6 -51.08 66.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.966 0.413 . . . . 0.0 110.819 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.24 82.69 1.93 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.313 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -62.56 111.2 1.26 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.36 2.04 . . . . 0.0 112.533 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.834 ' HD2' HD11 ' A' ' 163' ' ' LEU . 95.7 Cg_endo -80.52 40.43 0.98 Allowed 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.977 2.451 . . . . 0.0 112.905 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.838 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.2 OUTLIER -77.03 -41.11 31.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.051 0.453 . . . . 0.0 111.336 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.824 ' O ' HD22 ' A' ' 177' ' ' LEU . 2.3 mp -73.81 -54.32 15.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.947 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.755 HD12 ' N ' ' A' ' 172' ' ' ASP . 3.4 pp -62.76 -50.17 72.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.122 0.487 . . . . 0.0 109.815 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.755 ' N ' HD12 ' A' ' 171' ' ' LEU . 7.4 t0 -74.77 0.81 14.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.13 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.838 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.46 -70.05 0.37 Allowed 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -109.91 -23.07 6.31 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 7.6 t80 75.25 -22.92 0.25 Allowed 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 122.891 0.477 . . . . 0.0 111.942 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.4 23.01 6.28 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.824 HD22 ' O ' ' A' ' 170' ' ' ILE . 4.0 mp -84.66 -47.86 0.66 Allowed Pre-proline 0 N--CA 1.451 -0.382 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.032 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.575 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 94.2 Cg_exo -45.39 -50.97 8.49 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.623 2.215 . . . . 0.0 112.572 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 179' ' ' LEU . 20.9 mt 61.29 56.85 2.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.6 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 64.01 41.12 6.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.706 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 16.2 t80 . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.797 0.332 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 9.0 mt 64.83 108.38 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.946 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -169.98 83.23 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.113 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.581 ' O ' ' N ' ' A' ' 160' ' ' VAL . 2.4 t 52.0 72.56 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.595 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.41 ' CG ' ' C ' ' A' ' 158' ' ' SER . 0.0 OUTLIER 57.58 -52.3 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.368 0.667 . . . . 0.0 112.611 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' A' ' 158' ' ' SER . 0.5 OUTLIER 82.53 -53.45 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.564 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.448 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 1.6 m-30 -76.0 40.7 0.21 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.841 0.353 . . . . 0.0 110.463 178.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.477 ' CG ' ' HB3' ' A' ' 167' ' ' PRO . 2.9 t80 -168.23 -57.42 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.042 0.448 . . . . 0.0 110.726 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 42.8 tp -66.45 -4.86 9.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.409 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.55 ' CG ' ' O ' ' A' ' 164' ' ' PHE . 55.0 t80 -79.21 43.66 0.54 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.361 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.415 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 1.1 tp 81.22 -40.07 0.14 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -161.05 132.13 3.83 Favored Pre-proline 0 C--N 1.329 -0.314 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.391 -178.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.477 ' HB3' ' CG ' ' A' ' 162' ' ' PHE . 90.3 Cg_endo -88.93 105.55 0.42 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.751 2.301 . . . . 0.0 112.71 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 167' ' ' PRO . 56.5 Cg_endo -68.84 61.63 1.26 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.583 2.189 . . . . 0.0 112.038 179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.877 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 8.6 pt -76.54 -35.23 25.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.754 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 7.2 mt -74.79 -49.8 28.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.493 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.649 ' H ' HD22 ' A' ' 171' ' ' LEU . 0.8 OUTLIER -65.21 -52.68 53.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.62 2.62 9.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.489 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.877 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.16 -68.32 0.47 Allowed 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 121.211 0.529 . . . . 0.0 109.666 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -110.89 -12.95 14.78 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.343 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 4.7 t80 77.44 -12.28 1.09 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.702 0.401 . . . . 0.0 111.829 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -98.18 -9.57 25.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.882 0.372 . . . . 0.0 110.679 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.546 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 2.2 mm? -57.24 -41.77 92.71 Favored Pre-proline 0 CA--C 1.53 0.173 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.817 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 50.1 Cg_exo -53.85 -151.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.541 2.161 . . . . 0.0 112.448 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 178' ' ' PRO . 3.8 mm? 72.1 68.79 0.14 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.105 0.478 . . . . 0.0 110.423 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 67.42 53.69 0.73 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.815 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.84 0.352 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.408 ' O ' ' CB ' ' A' ' 157' ' ' GLN . 19.1 mt -74.79 61.79 1.03 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.366 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' A' ' 156' ' ' LEU . 4.1 tt0 78.88 78.62 0.06 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.252 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.42 ' HG ' HD12 ' A' ' 163' ' ' LEU . 0.3 OUTLIER 51.63 58.96 4.93 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.668 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 71.65 -59.25 0.56 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.528 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 161' ' ' PHE . 0.6 OUTLIER 75.98 -51.43 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.236 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.495 ' N ' HG12 ' A' ' 160' ' ' VAL . 75.3 t80 -73.56 9.85 1.26 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.236 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.426 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 3.4 m-85 -167.84 5.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.857 HD22 ' HB2' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -67.96 -45.38 74.37 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.584 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 56.68 7.81 0.41 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.529 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.857 ' HB2' HD22 ' A' ' 163' ' ' LEU . 0.2 OUTLIER -70.32 -43.28 70.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.894 0.378 . . . . 0.0 110.728 179.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.615 HD22 ' O ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER -161.93 49.82 0.27 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.296 -179.333 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 2.9 Cg_exo -37.58 -51.13 1.76 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 123.266 2.644 . . . . 0.0 113.348 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.432 ' HD3' ' CB ' ' A' ' 167' ' ' PRO . 40.7 Cg_endo -90.78 42.62 0.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.657 2.238 . . . . 0.0 113.37 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.943 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.5 OUTLIER -78.56 -49.28 21.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.309 0.575 . . . . 0.0 110.543 179.384 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.701 HG23 HG22 ' A' ' 169' ' ' ILE . 0.8 OUTLIER -77.54 -43.26 30.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.739 -1.118 . . . . 0.0 111.926 -178.839 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 54.5 tp -63.66 -55.47 23.2 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -73.62 -4.59 35.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.62 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.943 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.88 -68.2 0.53 Allowed 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.323 0.582 . . . . 0.0 109.526 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -130.7 3.51 5.73 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.683 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 17.0 t80 71.12 -44.04 0.58 Allowed 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -97.62 9.86 41.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.682 0.277 . . . . 0.0 111.364 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.649 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 65.5 mt -84.96 -30.32 0.43 Allowed Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.649 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 84.3 Cg_exo -48.89 -12.54 0.22 Allowed 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.531 2.154 . . . . 0.0 113.836 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 33.9 mt -46.52 -36.17 6.47 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.129 0.49 . . . . 0.0 111.045 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 5.8 mtm180 -90.94 31.68 1.06 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.207 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 155' ' ' PHE . 6.3 m-85 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.833 0.349 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.703 ' O ' HD12 ' A' ' 156' ' ' LEU . 4.3 pp -164.72 21.32 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.52 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -75.17 -14.81 60.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.583 0.23 . . . . 0.0 111.2 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.892 ' HB2' HD13 ' A' ' 163' ' ' LEU . 2.6 p -75.33 58.84 1.0 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.924 0.392 . . . . 0.0 110.936 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.435 ' O ' HG12 ' A' ' 160' ' ' VAL . 0.1 OUTLIER 70.75 -61.08 0.48 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.023 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 83.33 -46.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.028 -179.765 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.658 ' CE1' HD13 ' A' ' 169' ' ' ILE . 60.6 m-85 -76.27 6.24 5.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.559 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -165.72 12.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.253 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.892 HD13 ' HB2' ' A' ' 158' ' ' SER . 65.1 tp -67.6 -36.06 80.15 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 28.8 t80 67.02 1.05 2.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.341 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.718 HD13 ' HG ' ' A' ' 163' ' ' LEU . 4.4 mp -66.18 -64.87 0.76 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.205 0.526 . . . . 0.0 109.85 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.55 ' O ' ' CD ' ' A' ' 168' ' ' PRO . 0.7 OUTLIER -164.88 58.97 0.63 Allowed Pre-proline 0 N--CA 1.443 -0.81 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.359 179.599 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.53 ' HD3' ' N ' ' A' ' 166' ' ' LEU . 94.2 Cg_endo -98.16 78.98 0.06 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.068 2.512 . . . . 0.0 113.184 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.55 ' CD ' ' O ' ' A' ' 166' ' ' LEU . 56.9 Cg_endo -64.6 45.15 0.14 Allowed 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 123.921 3.081 . . . . 0.0 113.2 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.959 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 1.3 tt -77.18 -46.21 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.724 0.297 . . . . 0.0 110.66 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.446 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.8 mp -77.8 -39.48 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.743 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.493 HD23 ' HA ' ' A' ' 168' ' ' PRO . 0.4 OUTLIER -63.91 -58.44 6.76 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.249 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -73.66 -3.43 28.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.745 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.959 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.85 -73.17 0.21 Allowed 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.351 0.596 . . . . 0.0 109.556 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -120.54 -8.34 8.41 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.624 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 20.4 t80 69.7 -46.73 0.59 Allowed 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 122.676 0.39 . . . . 0.0 111.549 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -94.32 16.21 15.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.772 0.32 . . . . 0.0 111.069 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.528 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 11.4 mt -79.49 -44.87 1.63 Allowed Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.936 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 51.7 Cg_exo -55.7 -155.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.756 2.304 . . . . 0.0 112.395 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.555 HD23 ' NE ' ' A' ' 180' ' ' ARG . 0.2 OUTLIER 80.98 73.74 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.018 0.437 . . . . 0.0 110.555 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.555 ' NE ' HD23 ' A' ' 179' ' ' LEU . 17.4 mtm180 66.31 49.37 1.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.824 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.797 0.332 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.786 ' HA ' HD11 ' A' ' 163' ' ' LEU . 3.9 pp -166.31 146.61 6.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.878 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.581 ' HB3' HD21 ' A' ' 163' ' ' LEU . 52.1 tp60 -165.79 18.67 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.801 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.471 ' HB3' ' N ' ' A' ' 163' ' ' LEU . 0.2 OUTLIER -169.87 32.83 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.809 0.338 . . . . 0.0 110.45 179.534 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.491 ' HB3' ' CD1' ' A' ' 161' ' ' PHE . 2.4 m-20 70.83 0.4 3.33 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.949 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.755 ' HA ' HD12 ' A' ' 163' ' ' LEU . 0.4 OUTLIER 80.77 -50.25 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.775 0.322 . . . . 0.0 110.949 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.491 ' CD1' ' HB3' ' A' ' 159' ' ' ASP . 0.1 OUTLIER -77.51 24.7 0.2 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.008 0.433 . . . . 0.0 110.571 178.791 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.455 ' H ' ' C ' ' A' ' 160' ' ' VAL . 1.9 m-85 -163.53 -3.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.074 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.786 HD11 ' HA ' ' A' ' 156' ' ' LEU . 3.2 mt -61.83 -23.85 66.51 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 5.4 t80 60.03 17.7 6.96 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.633 178.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.34 -44.28 79.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.928 0.394 . . . . 0.0 110.657 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.513 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 0.2 OUTLIER -161.48 53.71 0.48 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.927 -179.633 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.589 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 36.3 Cg_endo -67.33 -24.55 43.29 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.659 2.239 . . . . 0.0 114.841 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 28.9 Cg_endo -90.7 33.02 0.32 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.732 1.621 . . . . 0.0 113.478 -178.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.834 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -77.47 -35.63 22.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.171 0.51 . . . . 0.0 110.329 179.171 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.743 HD13 HG23 ' A' ' 169' ' ' ILE . 11.0 mm -73.2 -46.12 51.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.196 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.776 HD12 ' N ' ' A' ' 172' ' ' ASP . 3.4 pp -65.26 -49.88 67.92 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.776 ' N ' HD12 ' A' ' 171' ' ' LEU . 23.0 t0 -73.92 -5.34 40.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.472 178.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.834 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -74.32 -66.32 0.74 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.122 0.487 . . . . 0.0 110.147 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -119.47 -10.79 7.67 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.275 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.508 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 11.9 t80 79.36 -29.1 0.14 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 122.554 0.342 . . . . 0.0 111.914 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -97.95 4.65 49.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.699 0.285 . . . . 0.0 111.262 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.687 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 55.4 mt -86.84 -23.13 0.29 Allowed Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 96.8 Cg_exo -45.72 90.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.241 1.96 . . . . 0.0 113.07 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.477 ' HA ' HD22 ' A' ' 179' ' ' LEU . 0.4 OUTLIER -107.07 -65.63 1.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.692 179.195 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 180' ' ' ARG . 0.0 OUTLIER -88.38 37.2 0.81 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.829 178.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 6.5 p90 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 121.006 0.431 . . . . 0.0 111.344 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.407 ' HA ' ' CG2' ' A' ' 160' ' ' VAL . 34.0 mt -74.87 108.62 7.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.868 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -170.35 -55.08 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.494 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.58 58.94 0.81 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.841 0.353 . . . . 0.0 110.96 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.503 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.2 OUTLIER 72.99 -48.19 0.68 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.463 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.646 ' O ' ' HB2' ' A' ' 164' ' ' PHE . 60.5 t 77.57 -60.76 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.141 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.405 ' O ' ' HB3' ' A' ' 164' ' ' PHE . 3.5 m-85 -64.22 -23.02 67.16 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.391 0.615 . . . . 0.0 110.083 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.484 ' CE2' ' HB3' ' A' ' 167' ' ' PRO . 8.8 t80 -67.79 -60.59 2.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.727 178.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 32.1 tp -68.85 -7.06 31.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.488 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.646 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 10.9 t80 -78.49 -120.22 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.394 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.38 -48.82 71.59 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.936 0.398 . . . . 0.0 110.996 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 166' ' ' LEU . 0.2 OUTLIER -165.7 169.15 7.26 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.688 -179.254 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.484 ' HB3' ' CE2' ' A' ' 162' ' ' PHE . 88.7 Cg_endo -81.74 114.37 2.64 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.388 2.058 . . . . 0.0 112.401 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.996 ' HA ' HD21 ' A' ' 171' ' ' LEU . 57.7 Cg_endo -85.87 91.42 0.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.872 2.381 . . . . 0.0 112.74 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.821 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 19.9 tt -160.93 -45.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.627 0.727 . . . . 0.0 110.536 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.82 ' O ' HD12 ' A' ' 177' ' ' LEU . 0.9 OUTLIER -73.63 -35.04 43.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.33 -1.305 . . . . 0.0 111.994 -178.609 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.996 HD21 ' HA ' ' A' ' 168' ' ' PRO . 0.0 OUTLIER -62.56 -64.17 1.0 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.089 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -75.15 4.3 7.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.41 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.821 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.34 -64.56 0.89 Allowed 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -111.73 -18.49 7.9 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.162 178.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 77.76 -30.5 0.16 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.799 0.44 . . . . 0.0 111.8 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -98.05 14.25 28.11 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.561 0.22 . . . . 0.0 111.37 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.82 HD12 ' O ' ' A' ' 170' ' ' ILE . 13.7 mt -83.62 -45.13 0.81 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.355 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 48.0 Cg_exo -55.83 87.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.354 2.036 . . . . 0.0 112.266 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.88 -69.16 0.66 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.911 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.16 17.61 4.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.852 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.84 0.352 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.452 ' C ' HD12 ' A' ' 156' ' ' LEU . 4.0 pp -74.01 140.48 45.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.033 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -170.65 -81.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.727 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.8 p -77.12 60.82 1.95 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.802 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.484 ' O ' HG12 ' A' ' 160' ' ' VAL . 1.9 t0 78.19 -40.69 0.3 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.629 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.3 OUTLIER 92.97 -46.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 122.948 0.499 . . . . 0.0 111.342 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.402 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 4.9 t80 -67.3 -27.29 67.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.31 0.576 . . . . 0.0 110.239 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.555 ' CE2' HD11 ' A' ' 169' ' ' ILE . 2.2 m-85 -70.6 -63.33 1.11 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.81 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.761 HD12 ' HB3' ' A' ' 167' ' ' PRO . 3.2 tp -66.34 -6.15 13.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.014 179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.818 ' CE2' HD12 ' A' ' 165' ' ' LEU . 6.3 t80 -78.9 -74.64 0.27 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.699 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.818 HD12 ' CE2' ' A' ' 164' ' ' PHE . 0.1 OUTLIER -64.89 -57.58 8.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.949 179.821 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.904 ' O ' HG23 ' A' ' 169' ' ' ILE . 0.3 OUTLIER -157.57 109.18 1.83 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.159 -179.524 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.761 ' HB3' HD12 ' A' ' 163' ' ' LEU . 19.4 Cg_endo -62.69 -28.73 76.81 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.233 1.955 . . . . 0.0 114.757 -178.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.603 ' HD2' HD12 ' A' ' 166' ' ' LEU . 24.3 Cg_endo -94.89 41.82 0.17 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.16 1.906 . . . . 0.0 113.646 -178.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.904 HG23 ' O ' ' A' ' 166' ' ' LEU . 21.8 pt -78.71 -42.24 25.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.448 0.642 . . . . 0.0 111.156 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.677 HG23 HG13 ' A' ' 169' ' ' ILE . 1.5 pt -76.19 -45.77 34.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.825 -177.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.585 HD21 ' HA ' ' A' ' 168' ' ' PRO . 0.0 OUTLIER -62.72 -56.48 17.25 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -74.09 1.33 11.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.028 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.894 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.36 -69.45 0.43 Allowed 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 121.238 0.542 . . . . 0.0 109.69 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -113.93 -9.28 16.41 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.612 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.481 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 31.3 t80 77.01 -8.97 1.6 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 122.652 0.381 . . . . 0.0 112.019 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -97.62 1.46 48.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.806 0.336 . . . . 0.0 110.913 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.662 HD12 ' HB ' ' A' ' 170' ' ' ILE . 0.3 OUTLIER -79.91 -32.2 0.71 Allowed Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.682 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 85.1 Cg_exo -48.51 87.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.487 2.124 . . . . 0.0 112.776 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 177' ' ' LEU . 0.3 OUTLIER -110.93 -66.62 1.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.745 179.329 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.1 32.68 0.75 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.705 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 2.1 t80 . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.854 0.359 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -164.91 91.93 0.57 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.082 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -169.86 -43.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.015 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.577 ' OG ' HD13 ' A' ' 163' ' ' LEU . 2.5 p -75.52 60.61 1.22 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.662 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.438 ' O ' ' CB ' ' A' ' 160' ' ' VAL . 0.6 OUTLIER 75.06 -53.55 0.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.038 -179.612 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.438 ' CB ' ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 89.1 -47.93 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.516 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.418 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 11.7 m-85 -67.82 -57.48 6.21 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.463 ' C ' ' H ' ' A' ' 164' ' ' PHE . 8.2 m-85 -73.76 -14.89 61.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.951 178.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.577 HD13 ' OG ' ' A' ' 158' ' ' SER . 58.3 tp -64.36 -3.9 3.35 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 121.774 0.797 . . . . 0.0 109.345 178.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.463 ' H ' ' C ' ' A' ' 162' ' ' PHE . 2.4 m-85 -73.12 -58.95 2.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.141 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.34 -71.46 0.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.064 0.459 . . . . 0.0 110.998 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.774 ' O ' HD13 ' A' ' 166' ' ' LEU . 0.3 OUTLIER -162.03 118.28 1.3 Allowed Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.665 -178.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.624 ' N ' HD22 ' A' ' 166' ' ' LEU . 16.8 Cg_endo -58.45 118.99 5.96 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.163 1.908 . . . . 0.0 111.771 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.09 32.18 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.654 2.236 . . . . 0.0 113.493 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.833 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.6 OUTLIER -74.98 -100.31 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 119.3 -0.381 . . . . 0.0 110.337 179.432 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.714 ' H ' HG23 ' A' ' 169' ' ' ILE . 2.8 mp 27.11 -66.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.893 0.877 . . . . 0.0 112.993 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.833 ' N ' ' O ' ' A' ' 169' ' ' ILE . 3.6 pp -68.99 -48.44 63.08 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.263 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.81 ' N ' HD12 ' A' ' 171' ' ' LEU . 28.2 m-20 -70.33 -7.06 39.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.124 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.88 -58.49 3.25 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.917 0.389 . . . . 0.0 110.309 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -110.9 -30.72 3.12 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.39 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER 75.36 -36.92 0.32 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 122.475 0.31 . . . . 0.0 111.6 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.62 3.65 54.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.928 0.394 . . . . 0.0 110.232 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.553 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 2.4 mt -58.57 -53.04 70.25 Favored Pre-proline 0 N--CA 1.453 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.365 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.553 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 50.3 Cg_exo -55.01 -173.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.515 2.143 . . . . 0.0 111.792 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 17.9 mt 77.38 72.16 0.06 Allowed 'General case' 0 CA--C 1.521 -0.152 0 CA-C-O 121.09 0.471 . . . . 0.0 110.549 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 66.19 57.01 0.78 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.712 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.589 ' N ' HD21 ' A' ' 163' ' ' LEU . 89.6 m-85 . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.805 0.336 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.673 ' O ' HD12 ' A' ' 156' ' ' LEU . 1.4 pp -165.76 66.62 0.12 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.581 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -172.65 -20.13 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.405 ' HB3' HD13 ' A' ' 163' ' ' LEU . 7.1 t -69.08 -38.38 78.98 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.222 0.535 . . . . 0.0 111.62 -179.051 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -168.51 -37.08 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.511 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.447 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 67.98 -50.14 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.532 179.989 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.447 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 1.2 m-85 -72.55 0.27 10.9 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.933 179.436 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.439 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 27.1 m-85 -159.13 11.87 0.14 Allowed 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.193 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.589 HD21 ' N ' ' A' ' 155' ' ' PHE . 66.2 tp -68.27 -7.22 28.82 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 177.35 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -75.5 -32.85 60.68 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.185 -179.712 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.448 ' O ' HD22 ' A' ' 166' ' ' LEU . 0.3 OUTLIER -63.38 -36.6 84.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.062 -179.769 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.49 HD13 ' HD2' ' A' ' 168' ' ' PRO . 0.2 OUTLIER -162.15 78.56 2.0 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.643 -179.299 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.458 ' O ' HD11 ' A' ' 163' ' ' LEU . 3.2 Cg_exo -38.51 -48.22 2.53 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.147 2.564 . . . . 0.0 112.898 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.49 ' HD2' HD13 ' A' ' 166' ' ' LEU . 41.1 Cg_endo -90.1 62.38 1.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.707 2.271 . . . . 0.0 112.422 -179.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.709 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.9 OUTLIER -73.97 -41.9 52.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.642 179.831 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.523 HG22 ' HG3' ' A' ' 178' ' ' PRO . 2.8 mp -69.33 -36.37 71.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.801 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.426 ' HA ' ' HG2' ' A' ' 178' ' ' PRO . 10.9 mp -65.62 -53.57 39.81 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.548 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -75.74 -6.07 48.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.514 178.073 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.709 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -74.51 -74.26 0.2 Allowed 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.31 0.576 . . . . 0.0 109.879 179.808 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -115.81 -15.19 7.51 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.687 178.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER 75.09 -47.34 0.61 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.358 0.263 . . . . 0.0 111.633 179.897 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.653 ' CD1' HD11 ' A' ' 179' ' ' LEU . 0.1 OUTLIER -94.14 16.41 14.8 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 120.688 0.28 . . . . 0.0 111.24 -179.937 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.469 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 5.0 mt -92.94 -46.16 0.32 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.713 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.523 ' HG3' HG22 ' A' ' 170' ' ' ILE . 21.6 Cg_exo -65.4 -4.87 10.19 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.678 2.252 . . . . 0.0 113.201 -179.478 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.653 HD11 ' CD1' ' A' ' 176' ' ' PHE . 52.6 mt -57.46 -18.79 20.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.735 0.302 . . . . 0.0 111.456 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.67 48.59 1.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.179 0.514 . . . . 0.0 109.997 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . 0.446 ' HB2' ' HA ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.415 ' O ' ' HB2' ' A' ' 156' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 120.858 0.361 . . . . 0.0 111.855 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 155' ' ' PHE . 5.8 mt 66.71 55.09 0.79 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.269 179.732 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -170.08 -58.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.356 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.629 ' HB2' HD22 ' A' ' 163' ' ' LEU . 0.9 OUTLIER -74.95 59.63 0.92 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.82 0.343 . . . . 0.0 110.827 -179.838 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.556 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.4 OUTLIER 75.58 -48.78 0.61 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.598 179.999 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.556 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 61.1 t 82.91 -64.91 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 C-N-CA 122.798 0.439 . . . . 0.0 109.949 -179.388 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -75.62 46.05 0.34 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.346 178.501 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.433 ' C ' ' H ' ' A' ' 164' ' ' PHE . 3.6 t80 -171.95 -53.19 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.145 0.497 . . . . 0.0 110.299 -179.04 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.629 HD22 ' HB2' ' A' ' 158' ' ' SER . 2.5 tp -68.08 -0.34 4.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.955 178.024 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.433 ' H ' ' C ' ' A' ' 162' ' ' PHE . 0.1 OUTLIER -71.77 -18.82 62.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.498 -178.115 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 162' ' ' PHE . 0.0 OUTLIER -66.9 -36.8 83.09 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.374 179.581 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -162.12 67.62 2.06 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.568 -179.156 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.43 ' CB ' ' HD3' ' A' ' 168' ' ' PRO . 3.2 Cg_exo -39.09 -50.01 2.76 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.267 2.645 . . . . 0.0 112.967 -179.629 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.43 ' HD3' ' CB ' ' A' ' 167' ' ' PRO . 38.5 Cg_endo -91.1 65.74 1.3 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.886 2.391 . . . . 0.0 112.572 -179.6 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 1.006 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -77.94 -37.28 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.929 0.395 . . . . 0.0 110.849 179.96 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.879 HD13 HG23 ' A' ' 169' ' ' ILE . 6.5 mm -78.78 -47.88 22.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.73 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.4 tp -62.75 -55.06 30.04 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 168' ' ' PRO . 21.8 m-20 -74.47 -2.48 25.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.81 178.726 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 1.006 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.86 -67.27 0.58 Allowed 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.114 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.451 ' HA3' HD23 ' A' ' 177' ' ' LEU . . . -131.47 -4.33 3.99 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.688 178.492 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 70.16 -47.33 0.62 Allowed 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 122.433 0.293 . . . . 0.0 111.234 -179.755 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -92.99 -2.11 56.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.846 0.355 . . . . 0.0 110.695 179.458 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.553 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.2 OUTLIER -58.05 -42.97 97.89 Favored Pre-proline 0 CA--C 1.529 0.145 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.251 179.443 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 75.8 Cg_exo -50.69 -161.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.92 2.414 . . . . 0.0 112.915 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.9 mt 80.35 -2.35 1.94 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.996 -179.301 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -152.9 34.75 0.48 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.122 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 7.9 p90 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.908 0.385 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.959 HD21 ' CB ' ' A' ' 163' ' ' LEU . 6.3 mt 58.12 39.73 25.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.351 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -73.23 -1.91 19.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.09 179.164 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.3 t -72.95 -51.29 19.02 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.443 0.639 . . . . 0.0 111.214 -179.635 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.84 ' O ' HG12 ' A' ' 160' ' ' VAL . 1.9 p30 -164.17 -38.18 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.729 -179.519 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.84 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.5 OUTLIER 81.4 -38.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 114.825 -1.08 . . . . 0.0 112.315 179.728 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.499 ' CE2' ' HB2' ' A' ' 159' ' ' ASP . 4.2 p90 -69.51 -27.55 65.28 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 121.096 0.474 . . . . 0.0 110.675 179.846 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.411 ' N ' ' CD1' ' A' ' 161' ' ' PHE . 0.6 OUTLIER -68.32 -59.25 3.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.366 179.277 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.959 ' CB ' HD21 ' A' ' 156' ' ' LEU . 15.0 tp -67.02 -3.32 6.92 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.122 178.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.415 ' HB2' ' HA ' ' A' ' 161' ' ' PHE . 0.3 OUTLIER -73.28 -20.45 60.82 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.133 -0.939 . . . . 0.0 111.213 -179.279 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.448 ' HA ' HD22 ' A' ' 165' ' ' LEU . 0.2 OUTLIER -63.56 -34.94 78.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.328 0.585 . . . . 0.0 110.041 179.013 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.509 ' C ' HD12 ' A' ' 166' ' ' LEU . 0.6 OUTLIER -160.16 99.64 1.43 Allowed Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.906 -178.88 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -65.46 113.81 2.63 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.408 2.072 . . . . 0.0 112.804 -179.159 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.747 ' HB3' HD11 ' A' ' 171' ' ' LEU . 96.5 Cg_endo -80.89 52.59 4.41 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.849 2.366 . . . . 0.0 112.33 179.651 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.811 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -74.5 -38.4 46.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.909 0.385 . . . . 0.0 111.24 -179.587 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.493 ' O ' HD12 ' A' ' 177' ' ' LEU . 2.8 mp -72.83 -48.85 43.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.561 -179.492 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.747 HD11 ' HB3' ' A' ' 168' ' ' PRO . 0.1 OUTLIER -65.98 -49.81 66.55 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.487 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -75.95 1.67 14.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.04 178.564 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.811 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.25 -42.12 66.01 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.214 0.53 . . . . 0.0 109.666 179.74 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.53 ' C ' ' CG ' ' A' ' 175' ' ' TYR . . . -119.62 -1.96 13.28 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.826 178.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.53 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER 58.51 -37.32 0.06 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 179.483 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.501 ' N ' ' O ' ' A' ' 174' ' ' GLY . 26.9 p90 -94.62 23.08 5.61 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 122.094 -0.378 . . . . 0.0 111.164 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.493 HD12 ' O ' ' A' ' 170' ' ' ILE . 7.7 mt -85.63 -51.12 0.51 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.844 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 32.0 Cg_exo -58.7 -63.94 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.545 2.163 . . . . 0.0 112.289 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 179' ' ' LEU . 11.9 mt 61.63 55.62 2.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.009 0.433 . . . . 0.0 110.733 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.18 48.96 5.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.824 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.403 ' O ' ' CD1' ' A' ' 163' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.752 0.31 . . . . 0.0 111.182 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.714 HD23 HG21 ' A' ' 160' ' ' VAL . 0.4 OUTLIER -73.48 87.24 1.58 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.907 -179.963 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.597 ' HG3' HD21 ' A' ' 163' ' ' LEU . 5.0 mm-40 -70.08 -83.38 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.744 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 16.7 p -163.15 31.27 0.09 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.176 0.512 . . . . 0.0 110.284 179.543 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -162.09 -54.6 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.279 179.696 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.714 HG21 HD23 ' A' ' 156' ' ' LEU . 67.7 t 66.84 -55.84 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.556 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.56 9.9 1.24 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.142 179.6 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -161.07 12.49 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.854 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 1.055 HD22 HD23 ' A' ' 165' ' ' LEU . 0.5 OUTLIER -67.55 -30.08 69.62 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 177.74 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 13.9 t80 68.05 12.02 8.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.712 179.45 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 1.055 HD23 HD22 ' A' ' 163' ' ' LEU . 0.5 OUTLIER -66.29 -55.14 17.52 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.198 0.523 . . . . 0.0 110.445 179.209 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.412 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 0.1 OUTLIER -161.29 53.52 0.47 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.198 -179.876 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.536 ' O ' HD21 ' A' ' 171' ' ' LEU . 10.1 Cg_endo -52.13 107.16 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.741 2.294 . . . . 0.0 112.748 -179.439 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.408 ' HA ' ' HG ' ' A' ' 171' ' ' LEU . 86.4 Cg_endo -80.02 6.51 5.23 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 123.174 2.582 . . . . 0.0 112.961 179.741 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.971 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 12.6 pt -75.31 -37.63 39.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.232 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.461 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 8.4 mm -81.48 -50.84 16.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.962 -179.408 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.536 HD21 ' O ' ' A' ' 167' ' ' PRO . 0.0 OUTLIER -62.63 -53.38 55.38 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.938 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.43 -1.17 17.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.887 178.715 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.971 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.91 -56.84 4.61 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 121.194 0.521 . . . . 0.0 109.787 179.626 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -129.88 -3.5 4.94 Favored Glycine 0 CA--C 1.52 0.38 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.057 179.126 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.3 OUTLIER 70.13 -55.8 0.6 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.64 0.257 . . . . 0.0 111.358 179.974 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -92.36 24.88 3.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.902 0.382 . . . . 0.0 110.572 179.766 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.515 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 0.2 OUTLIER -88.26 -51.37 0.4 Allowed Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.996 179.842 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 96.1 Cg_exo -44.86 -84.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.516 2.144 . . . . 0.0 112.552 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 179' ' ' LEU . 0.2 OUTLIER 55.26 55.56 7.38 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.141 0.496 . . . . 0.0 110.501 179.924 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? 64.07 53.39 1.84 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.579 -179.578 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . 0.504 ' HB2' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.783 0.325 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.62 142.9 46.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.925 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 159' ' ' ASP . 2.2 mt-30 -170.28 72.94 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.764 179.878 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.838 ' OG ' HD23 ' A' ' 163' ' ' LEU . 1.2 p 60.99 -59.69 0.09 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.52 0.676 . . . . 0.0 112.106 179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 157' ' ' GLN . 1.8 p30 -158.2 -31.49 0.07 Allowed 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.382 -179.522 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.445 ' CG1' ' CD1' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 80.46 -51.45 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.936 179.958 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.479 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 20.4 m-30 -76.96 20.25 0.26 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.746 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.479 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 43.0 m-85 -164.35 -4.44 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.838 HD23 ' OG ' ' A' ' 158' ' ' SER . 1.4 tm? -64.65 -40.02 94.7 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.453 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER 54.65 40.06 31.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.702 178.532 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.453 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 4.5 tp 84.73 -28.02 0.09 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.467 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.76 HD23 ' O ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -160.14 131.2 3.82 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.176 -178.84 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.656 ' HD3' HD21 ' A' ' 163' ' ' LEU . 18.8 Cg_endo -59.5 118.32 5.18 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.335 2.023 . . . . 0.0 112.444 -179.559 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 167' ' ' PRO . 27.4 Cg_endo -62.63 80.88 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.519 2.146 . . . . 0.0 111.97 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.797 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 5.5 tt -74.03 -34.93 40.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.673 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.776 HD13 HG23 ' A' ' 169' ' ' ILE . 10.4 mm -71.56 -42.82 72.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.053 -179.836 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.825 HD13 ' HG2' ' A' ' 178' ' ' PRO . 0.1 OUTLIER -66.06 -53.55 36.95 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.795 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -74.82 -0.1 17.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.035 178.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.797 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.97 -60.94 2.0 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.159 0.504 . . . . 0.0 109.851 179.757 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -109.67 -19.03 8.5 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.497 178.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 78.83 -29.83 0.15 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.658 0.383 . . . . 0.0 111.953 179.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.436 ' CE2' ' CD1' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -94.75 -0.49 54.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.747 0.308 . . . . 0.0 110.737 179.696 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.491 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 0.5 OUTLIER -59.52 -47.37 97.97 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.141 179.816 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.825 ' HG2' HD13 ' A' ' 171' ' ' LEU . 23.4 Cg_exo -64.81 68.93 0.26 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.659 2.239 . . . . 0.0 112.383 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.436 ' CD1' ' CE2' ' A' ' 176' ' ' PHE . 1.8 mt -106.34 -50.48 3.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.733 179.762 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.83 9.16 22.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.78 179.774 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 17.2 p90 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.83 0.348 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.75 HD22 ' HB ' ' A' ' 160' ' ' VAL . 4.5 pp -72.77 -178.25 2.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.686 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.449 ' H ' HD11 ' A' ' 163' ' ' LEU . 5.5 mm-40 -167.73 26.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.835 0.35 . . . . 0.0 111.409 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.535 ' O ' ' OG ' ' A' ' 158' ' ' SER . 0.3 OUTLIER -168.48 36.43 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.36 0.6 . . . . 0.0 110.004 179.489 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.415 ' O ' HG12 ' A' ' 160' ' ' VAL . 2.8 t0 82.42 -30.15 0.1 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.162 -179.998 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.75 ' HB ' HD22 ' A' ' 156' ' ' LEU . 0.4 OUTLIER 81.03 -45.76 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.865 0.364 . . . . 0.0 110.448 -179.477 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.414 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 27.0 t80 -74.65 12.68 0.76 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.777 177.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.587 ' HB3' ' HA ' ' A' ' 167' ' ' PRO . 54.5 m-85 -160.29 7.69 0.09 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.781 -179.486 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.679 HD12 ' HA ' ' A' ' 160' ' ' VAL . 1.1 mt -68.62 -4.05 14.07 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.552 -0.906 . . . . 0.0 108.552 176.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.416 ' H ' ' C ' ' A' ' 162' ' ' PHE . 0.2 OUTLIER -71.59 -9.2 57.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.789 -178.705 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 164' ' ' PHE . 2.5 mt -176.53 -66.2 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.954 0.407 . . . . 0.0 111.08 179.644 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -162.0 124.93 1.79 Allowed Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.473 -179.62 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.587 ' HA ' ' HB3' ' A' ' 162' ' ' PHE . 70.1 Cg_endo -75.1 110.76 3.18 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.118 1.879 . . . . 0.0 112.624 -179.703 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.432 ' HD2' ' CG ' ' A' ' 162' ' ' PHE . 87.8 Cg_endo -75.84 77.41 3.41 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.646 2.23 . . . . 0.0 112.37 179.852 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.87 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 1.9 tp -75.34 -44.68 42.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.531 HD12 HG22 ' A' ' 169' ' ' ILE . 3.5 mp -74.55 -41.57 48.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.216 -179.899 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.849 HD13 ' HG2' ' A' ' 178' ' ' PRO . 3.4 mm? -65.2 -57.75 7.74 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.518 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.82 4.51 6.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.067 178.754 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.87 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.97 -56.01 5.74 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.207 0.527 . . . . 0.0 109.826 179.683 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -121.74 -0.03 10.99 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.726 178.695 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.494 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.2 OUTLIER 55.1 -59.79 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.047 0.939 . . . . 0.0 112.154 179.898 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.631 ' CD1' HD22 ' A' ' 179' ' ' LEU . 13.1 m-85 -95.52 22.87 6.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.782 0.325 . . . . 0.0 111.118 -179.903 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.554 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 14.9 mt -90.57 -49.3 0.36 Allowed Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.081 179.758 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.849 ' HG2' HD13 ' A' ' 171' ' ' LEU . 36.6 Cg_exo -60.37 -29.99 89.99 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.368 2.046 . . . . 0.0 112.054 179.788 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.631 HD22 ' CD1' ' A' ' 176' ' ' PHE . 6.8 mp -64.97 -57.6 8.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.89 -179.891 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -87.17 44.03 1.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 -179.962 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.28 0 CA-C-O 120.85 0.357 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.841 ' O ' HD22 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -165.08 124.86 1.85 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.975 -179.757 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.756 ' O ' HD22 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -173.79 80.67 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.009 -179.636 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.1 m 63.81 68.09 0.59 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.326 179.75 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.504 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.5 OUTLIER 76.17 -60.59 0.48 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.717 179.426 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.504 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 95.7 t 76.27 -46.21 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.052 -179.297 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.403 ' O ' ' CD1' ' A' ' 162' ' ' PHE . 1.1 t80 -71.76 -1.33 13.59 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.091 179.641 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.403 ' CD1' ' O ' ' A' ' 161' ' ' PHE . 11.9 m-85 -162.43 13.78 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.151 179.748 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.756 HD22 ' O ' ' A' ' 157' ' ' GLN . 52.9 tp -66.74 -17.68 64.98 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.143 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.5 ' HA ' ' HG3' ' A' ' 167' ' ' PRO . 15.3 t80 68.29 21.2 8.51 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.378 179.516 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.493 HD23 ' HG ' ' A' ' 163' ' ' LEU . 0.2 OUTLIER -67.4 -48.68 66.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.944 179.438 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.503 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 0.2 OUTLIER -159.92 44.41 0.17 Allowed Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.731 -179.293 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.565 ' CD ' ' HD3' ' A' ' 168' ' ' PRO . 19.3 Cg_endo -61.66 -28.17 82.17 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.263 1.975 . . . . 0.0 114.113 -179.936 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.565 ' HD3' ' CD ' ' A' ' 167' ' ' PRO . 13.5 Cg_endo -99.01 118.7 0.11 Allowed 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 122.984 2.456 . . . . 0.0 111.939 -179.635 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.877 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 8.4 tp -70.66 -41.82 77.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.857 -179.914 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.495 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 0.8 OUTLIER -74.04 -44.3 50.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 114.683 -1.144 . . . . 0.0 112.507 -178.25 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.534 HD13 ' C ' ' A' ' 171' ' ' LEU . 2.4 tm? -65.16 -58.37 6.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.054 0.454 . . . . 0.0 109.845 179.53 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.423 ' CB ' ' HG ' ' A' ' 166' ' ' LEU . 12.0 m-20 -74.66 5.46 4.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.552 179.105 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.877 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -70.79 -56.42 6.37 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.304 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -111.55 -26.36 4.55 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 177.9 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 72.25 -40.68 0.48 Allowed 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 122.633 0.373 . . . . 0.0 111.663 179.641 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -90.34 6.99 40.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.814 0.34 . . . . 0.0 110.622 179.661 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.56 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 0.4 OUTLIER -62.17 -59.79 12.02 Favored Pre-proline 0 N--CA 1.453 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.076 179.477 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.56 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 52.0 Cg_exo -53.54 -174.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.398 2.066 . . . . 0.0 112.052 179.158 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.3 mp 69.52 71.43 0.25 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.221 0.534 . . . . 0.0 110.272 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 70.76 63.98 0.18 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.206 -179.463 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.6 t80 . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.793 0.33 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 16.1 mt 62.72 16.03 8.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.338 179.847 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.4 -1.73 25.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.802 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.795 ' O ' HD13 ' A' ' 163' ' ' LEU . 0.7 OUTLIER -73.9 55.13 0.53 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.891 0.377 . . . . 0.0 110.857 -179.956 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.15 -63.78 0.36 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.603 -179.711 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.48 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 68.08 -53.17 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.823 179.613 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.48 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 0.2 OUTLIER -77.14 3.46 12.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.989 -179.723 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -169.08 15.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.738 -179.8 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.795 HD13 ' O ' ' A' ' 158' ' ' SER . 9.0 tp -65.91 -35.9 81.91 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.898 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 1.6 t80 53.89 8.27 0.15 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.939 178.688 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.459 ' HB2' ' CD2' ' A' ' 163' ' ' LEU . 3.0 tp -70.38 -54.99 10.21 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.024 0.44 . . . . 0.0 110.265 179.449 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.597 ' N ' ' HD3' ' A' ' 167' ' ' PRO . 0.2 OUTLIER -161.18 47.83 0.23 Allowed Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.134 -179.553 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.597 ' HD3' ' N ' ' A' ' 166' ' ' LEU . 23.7 Cg_exo -59.66 -50.2 8.55 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 121.529 1.486 . . . . 0.0 111.704 179.29 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.486 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 28.8 Cg_endo -94.28 97.36 0.13 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.187 2.591 . . . . 0.0 112.385 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.911 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER -75.82 -44.91 38.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.27 0.557 . . . . 0.0 111.322 -179.888 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.516 HG23 HG23 ' A' ' 169' ' ' ILE . 0.7 OUTLIER -78.98 -44.78 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.938 -1.028 . . . . 0.0 112.968 -178.02 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.561 HD13 ' C ' ' A' ' 171' ' ' LEU . 2.0 tm? -64.51 -58.16 7.18 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.491 ' N ' HD13 ' A' ' 171' ' ' LEU . 1.2 m-20 -74.1 4.84 4.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.151 178.857 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.911 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.22 -56.48 5.46 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.257 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.443 ' N ' HD12 ' A' ' 177' ' ' LEU . . . -133.86 2.06 4.37 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.559 178.465 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 70.35 -56.83 0.59 Allowed 'General case' 0 C--O 1.231 0.096 0 C-N-CA 122.543 0.337 . . . . 0.0 111.733 179.75 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -94.93 -10.72 30.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.619 0.247 . . . . 0.0 111.621 -179.638 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.533 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 74.9 mt -53.42 -42.05 89.8 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.529 179.818 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 36.5 Cg_exo -62.05 68.27 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.607 2.205 . . . . 0.0 112.496 -179.847 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.541 HD12 ' HE ' ' A' ' 180' ' ' ARG . 0.1 OUTLIER -128.86 -66.13 0.84 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.344 179.718 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.541 ' HE ' HD12 ' A' ' 179' ' ' LEU . 10.8 mmt85 -87.66 22.22 2.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.304 179.465 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.461 ' CD1' ' CD1' ' A' ' 165' ' ' LEU . 3.6 m-85 . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.733 0.302 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 155' ' ' PHE . 0.6 OUTLIER 38.97 78.56 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.787 179.836 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.511 ' H ' HD22 ' A' ' 163' ' ' LEU . 0.4 OUTLIER -169.01 44.16 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.943 -179.942 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.524 ' CB ' HD13 ' A' ' 163' ' ' LEU . 0.1 OUTLIER -165.53 -40.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.415 0.626 . . . . 0.0 111.207 179.784 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -167.24 -35.96 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.534 179.899 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.447 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 78.93 -50.41 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.951 -179.991 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.447 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 57.4 m-85 -76.02 14.13 0.75 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.764 179.706 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.404 ' CD2' ' O ' ' A' ' 161' ' ' PHE . 18.5 m-85 -165.45 2.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.865 0.321 . . . . 0.0 111.865 -179.725 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.524 HD13 ' CB ' ' A' ' 158' ' ' SER . 10.4 tp -67.21 -30.44 70.37 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.753 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.456 ' O ' ' HB2' ' A' ' 165' ' ' LEU . 4.6 t80 52.61 35.73 18.88 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.682 179.28 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.461 ' CD1' ' CD1' ' A' ' 155' ' ' PHE . 0.1 OUTLIER 84.48 -32.49 0.06 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.862 -179.31 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.922 HD13 ' HD2' ' A' ' 167' ' ' PRO . 0.2 OUTLIER -164.62 123.87 1.25 Allowed Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.2 -179.217 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.922 ' HD2' HD13 ' A' ' 166' ' ' LEU . 37.3 Cg_endo -67.04 112.2 2.43 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.007 1.805 . . . . 0.0 112.463 -179.679 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.439 ' HB2' ' HB2' ' A' ' 172' ' ' ASP . 70.0 Cg_endo -81.92 51.52 3.85 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.896 2.397 . . . . 0.0 112.596 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.89 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 3.7 tp -76.07 -46.19 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.393 0.616 . . . . 0.0 110.717 179.844 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.605 HG23 HG23 ' A' ' 169' ' ' ILE . 0.7 OUTLIER -79.01 -43.78 24.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.707 -179.277 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.84 HD12 ' CG ' ' A' ' 178' ' ' PRO . 1.2 tp -65.8 -58.91 4.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.114 0.483 . . . . 0.0 109.992 179.557 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 168' ' ' PRO . 4.0 t70 -74.24 5.54 4.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.448 179.052 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.89 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.25 -64.69 0.87 Allowed 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.505 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -112.3 -17.09 8.43 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 178.167 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 6.0 t80 75.58 -11.46 1.1 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 122.705 0.402 . . . . 0.0 111.81 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.406 ' C ' ' HD2' ' A' ' 178' ' ' PRO . 24.6 m-85 -115.68 -3.15 12.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.986 0.422 . . . . 0.0 110.867 179.672 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.801 ' O ' HD12 ' A' ' 177' ' ' LEU . 0.1 OUTLIER -85.59 -20.77 0.27 Allowed Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.853 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.84 ' CG ' HD12 ' A' ' 171' ' ' LEU . 79.7 Cg_exo -46.92 -18.51 0.57 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.144 1.896 . . . . 0.0 113.414 -179.918 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.607 HD23 ' O ' ' A' ' 179' ' ' LEU . 4.9 tt -50.52 -45.9 56.91 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.967 0.413 . . . . 0.0 110.58 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.54 ' HG2' HD12 ' A' ' 177' ' ' LEU . 4.9 ptp180 -91.53 31.08 1.21 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.126 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . 0.456 ' HG2' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.546 ' C ' HD23 ' A' ' 156' ' ' LEU . 1.4 m-85 . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.877 0.37 . . . . 0.0 111.949 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.546 HD23 ' C ' ' A' ' 155' ' ' PHE . 0.5 OUTLIER 48.66 -161.47 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.355 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.576 ' NE2' HD23 ' A' ' 163' ' ' LEU . 8.8 tt0 -169.75 92.93 0.24 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.88 0.371 . . . . 0.0 111.022 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.605 ' HB2' HD13 ' A' ' 163' ' ' LEU . 0.1 OUTLIER 47.74 75.67 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.143 179.916 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 160' ' ' VAL . 1.0 OUTLIER 75.26 -60.05 0.52 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.137 -179.971 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 85.88 -49.15 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.903 -179.827 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.536 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 0.1 OUTLIER -76.73 25.52 0.14 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.801 179.535 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.569 ' C ' ' H ' ' A' ' 164' ' ' PHE . 47.1 m-85 -166.78 -22.73 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.871 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.605 HD13 ' HB2' ' A' ' 158' ' ' SER . 9.6 tp -63.42 0.16 0.76 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.771 0.796 . . . . 0.0 109.788 178.279 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.569 ' H ' ' C ' ' A' ' 162' ' ' PHE . 69.6 t80 -74.24 7.94 2.47 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.046 -179.156 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 164' ' ' PHE . 0.7 OUTLIER -172.81 -45.68 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.862 0.363 . . . . 0.0 111.091 179.78 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 1.6 tp -160.75 138.92 7.27 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 -179.574 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.89 116.31 4.62 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.359 2.04 . . . . 0.0 112.248 -179.919 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.434 ' HD3' ' HB3' ' A' ' 162' ' ' PHE . 72.6 Cg_endo -76.51 81.66 2.45 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.501 2.134 . . . . 0.0 112.426 -179.892 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.871 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 4.8 tp -75.87 -35.84 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.991 179.965 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.818 HD13 HG23 ' A' ' 169' ' ' ILE . 9.0 mm -73.4 -45.89 50.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.447 -179.284 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.421 ' CD1' ' HG2' ' A' ' 178' ' ' PRO . 34.5 tp -64.33 -54.37 34.12 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.46 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.94 -0.67 16.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.082 178.649 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.871 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.42 -61.86 1.65 Allowed 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.25 0.547 . . . . 0.0 109.911 179.779 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -114.15 -13.95 9.55 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.683 178.848 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 24.9 t80 70.91 -51.06 0.68 Allowed 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 122.459 0.304 . . . . 0.0 111.599 179.904 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -95.57 5.7 50.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.209 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.793 ' O ' HD12 ' A' ' 177' ' ' LEU . 0.1 OUTLIER -77.02 -30.59 0.81 Allowed Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.695 179.921 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 51.6 Cg_exo -54.76 -145.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.597 2.198 . . . . 0.0 112.521 -179.8 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.435 ' CB ' ' O ' ' A' ' 178' ' ' PRO . 0.1 OUTLIER 83.61 76.63 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.105 0.478 . . . . 0.0 110.281 -179.495 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.38 55.96 0.38 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.763 -179.739 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' A' ' 156' ' ' LEU . 3.1 t80 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.795 0.331 . . . . 0.0 111.778 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.582 ' HB2' HG23 ' A' ' 160' ' ' VAL . 1.9 mt 66.64 99.76 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.348 179.558 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.97 -17.71 61.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.609 179.422 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.734 ' CB ' HD12 ' A' ' 163' ' ' LEU . 0.7 OUTLIER -73.96 62.6 0.88 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.024 179.686 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.702 ' O ' HG12 ' A' ' 160' ' ' VAL . 2.0 p30 63.34 -58.37 0.17 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.607 -179.019 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.3 OUTLIER 80.29 -40.39 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 122.614 0.366 . . . . 0.0 110.537 -179.543 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -77.98 34.26 0.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.717 -0.219 . . . . 0.0 110.595 178.55 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.418 ' C ' ' H ' ' A' ' 164' ' ' PHE . 0.2 OUTLIER -170.67 -55.74 0.02 OUTLIER 'General case' 0 N--CA 1.457 -0.085 0 CA-C-O 121.134 0.492 . . . . 0.0 111.679 -178.585 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.734 HD12 ' CB ' ' A' ' 158' ' ' SER . 16.7 mt -66.49 -2.42 4.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.164 179.297 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.682 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.1 OUTLIER -76.17 50.61 0.63 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.374 -179.378 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 79.83 -40.42 0.21 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.544 179.939 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.42 171.82 6.43 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.863 -178.782 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.413 ' HA ' ' HD2' ' A' ' 168' ' ' PRO . 65.7 Cg_endo -74.1 108.4 2.65 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.58 2.187 . . . . 0.0 112.531 -179.792 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.59 ' HB3' HD12 ' A' ' 171' ' ' LEU . 45.0 Cg_endo -68.09 74.55 0.72 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.405 2.07 . . . . 0.0 112.211 179.74 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.882 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 8.2 tp -75.55 -46.46 36.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.299 -179.782 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.564 HD12 HG22 ' A' ' 169' ' ' ILE . 3.7 mp -73.82 -36.38 45.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.522 -179.671 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.59 HD12 ' HB3' ' A' ' 168' ' ' PRO . 20.2 mt -64.92 -62.39 1.59 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.658 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -77.43 8.06 4.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.359 178.996 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.882 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.1 -59.15 2.93 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.328 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 175' ' ' TYR . . . -123.37 -1.64 9.22 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.188 178.024 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.406 ' HB2' ' O ' ' A' ' 174' ' ' GLY . 63.6 m-85 66.36 -57.65 0.37 Allowed 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.02 0.528 . . . . 0.0 111.336 179.679 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -96.78 15.87 20.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.761 0.315 . . . . 0.0 110.958 179.552 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.51 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 22.9 mt -84.84 -42.82 0.69 Allowed Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.621 179.983 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 63.1 Cg_exo -42.02 -28.07 0.75 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.573 2.182 . . . . 0.0 112.818 -179.95 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.15 -43.58 67.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.705 179.566 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -88.43 33.0 0.75 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.961 179.892 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . 0.434 ' HG2' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.601 ' C ' HD12 ' A' ' 156' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.822 0.344 . . . . 0.0 111.249 . . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.601 HD12 ' C ' ' A' ' 155' ' ' PHE . 3.9 mp -162.94 84.73 0.52 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.471 179.957 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -74.46 -24.38 59.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.924 -179.968 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.464 ' CA ' HD21 ' A' ' 163' ' ' LEU . 0.3 OUTLIER -163.86 62.18 0.16 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.582 179.915 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 158' ' ' SER . 1.0 OUTLIER 82.23 -27.36 0.12 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.879 -179.918 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.488 HG12 ' N ' ' A' ' 161' ' ' PHE . 0.5 OUTLIER 79.14 -52.58 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.183 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.488 ' N ' HG12 ' A' ' 160' ' ' VAL . 1.2 m-85 -75.56 37.92 0.14 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.767 178.761 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.42 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 42.7 m-85 -162.39 -22.82 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 179.891 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.849 HD12 ' O ' ' A' ' 167' ' ' PRO . 4.0 mm? -60.09 -34.22 73.16 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.584 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.453 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 2.7 t80 59.85 91.9 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.235 177.414 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.453 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 5.2 tp 87.33 -48.35 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.558 178.809 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.552 ' HB3' ' HD2' ' A' ' 168' ' ' PRO . 0.0 OUTLIER -161.55 148.17 11.34 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.614 -178.549 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.849 ' O ' HD12 ' A' ' 163' ' ' LEU . 2.6 Cg_exo -40.92 -51.69 3.62 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.081 2.521 . . . . 0.0 113.305 -179.474 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.552 ' HD2' ' HB3' ' A' ' 166' ' ' LEU . 37.2 Cg_endo -92.42 -167.38 0.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.725 2.283 . . . . 0.0 112.399 -179.725 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.887 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.2 OUTLIER -170.35 -43.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.996 179.815 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.863 HG22 ' HG ' ' A' ' 177' ' ' LEU . 2.2 mp -75.46 -53.36 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.315 -179.785 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.842 HD13 ' HG3' ' A' ' 178' ' ' PRO . 12.2 tp -65.33 -49.93 67.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.361 0.601 . . . . 0.0 109.384 179.446 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.06 -1.32 16.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.153 179.102 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.887 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.66 -64.78 0.89 Allowed 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.092 0.472 . . . . 0.0 109.736 179.631 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -116.18 -16.83 6.5 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.688 178.807 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.441 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 24.2 t80 75.89 -10.61 1.25 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.401 0.28 . . . . 0.0 111.753 179.986 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.546 ' CZ ' HD11 ' A' ' 179' ' ' LEU . 71.3 t80 -95.44 -4.0 45.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.838 0.351 . . . . 0.0 110.948 179.664 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.863 ' HG ' HG22 ' A' ' 170' ' ' ILE . 3.8 mm? -56.46 -41.82 93.14 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.252 179.682 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.842 ' HG3' HD13 ' A' ' 171' ' ' LEU . 63.8 Cg_exo -53.99 -137.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.888 2.392 . . . . 0.0 112.651 -179.865 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.546 HD11 ' CZ ' ' A' ' 176' ' ' PHE . 20.8 mt 84.45 74.83 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.976 0.417 . . . . 0.0 110.591 -179.571 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.97 48.21 3.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.842 -179.933 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 29.1 p90 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.77 0.319 . . . . 0.0 111.287 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.798 ' CD1' HD22 ' A' ' 163' ' ' LEU . 0.7 OUTLIER -166.29 156.53 12.3 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.325 179.835 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? 64.43 23.11 12.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.807 -179.626 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 50.69 33.06 7.67 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.144 0.497 . . . . 0.0 111.311 -179.862 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.545 ' O ' HG12 ' A' ' 160' ' ' VAL . 4.0 m-20 -163.86 -55.76 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.919 179.681 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 74.93 -47.58 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.485 179.165 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.517 ' HA ' ' HB2' ' A' ' 164' ' ' PHE . 0.1 OUTLIER -61.85 -20.22 63.45 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.935 0.397 . . . . 0.0 110.779 -179.677 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.449 ' CE1' ' HD2' ' A' ' 168' ' ' PRO . 0.1 OUTLIER -70.61 -60.54 2.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.302 0.572 . . . . 0.0 110.19 179.188 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.798 HD22 ' CD1' ' A' ' 156' ' ' LEU . 9.0 mp -68.03 -4.08 12.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.015 178.405 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.678 ' O ' HD12 ' A' ' 165' ' ' LEU . 0.2 OUTLIER -82.57 21.67 0.95 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.122 -179.017 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.678 HD12 ' O ' ' A' ' 164' ' ' PHE . 0.2 OUTLIER -170.97 -74.81 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.764 0.316 . . . . 0.0 111.334 179.776 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.546 HD22 ' O ' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -160.5 83.21 2.08 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.063 -179.421 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.435 ' HG3' ' HG ' ' A' ' 163' ' ' LEU . 37.4 Cg_endo -66.83 111.98 2.33 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.261 1.974 . . . . 0.0 112.353 -179.431 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.833 ' O ' HD12 ' A' ' 170' ' ' ILE . 44.5 Cg_endo -87.18 -166.15 0.28 Allowed 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.055 2.503 . . . . 0.0 111.791 179.679 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.986 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.9 OUTLIER 79.48 -38.36 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.89 179.622 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.833 HD12 ' O ' ' A' ' 168' ' ' PRO . 2.7 mp -83.13 -65.56 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.039 0.447 . . . . 0.0 111.236 179.956 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 172' ' ' ASP . 1.4 pp -65.8 -45.04 83.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.353 0.597 . . . . 0.0 110.252 179.902 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.453 ' N ' HD12 ' A' ' 171' ' ' LEU . 0.3 OUTLIER -71.19 -5.55 32.71 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.947 179.492 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.986 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -75.75 -62.2 1.67 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.107 0.48 . . . . 0.0 110.243 179.735 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -130.67 1.48 5.59 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.484 179.584 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.508 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER 57.54 -52.51 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 179.344 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.522 ' N ' ' O ' ' A' ' 174' ' ' GLY . 2.9 m-85 -92.82 18.55 8.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.75 0.309 . . . . 0.0 111.041 179.941 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.706 ' O ' HD23 ' A' ' 179' ' ' LEU . 0.1 OUTLIER -80.91 -48.33 1.12 Allowed Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.851 179.548 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 80.3 Cg_exo -43.42 -39.97 9.65 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.682 2.255 . . . . 0.0 112.749 179.941 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.706 HD23 ' O ' ' A' ' 177' ' ' LEU . 3.7 mm? 63.73 61.73 0.96 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.092 0.473 . . . . 0.0 110.175 -179.69 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? 66.7 39.2 3.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.415 -179.494 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.844 0.354 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.1 mp 60.4 119.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.246 179.675 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.719 ' HB2' HD12 ' A' ' 163' ' ' LEU . 1.6 mm100 -170.34 42.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.59 179.94 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.1 p 74.86 -59.4 0.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.956 -179.751 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -78.16 -48.26 16.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.299 179.647 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.624 HG12 ' CD2' ' A' ' 164' ' ' PHE . 57.9 t 69.51 -54.59 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.651 179.621 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.504 ' HA ' ' HB2' ' A' ' 164' ' ' PHE . 5.1 p90 -61.97 -23.26 66.29 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.104 0.478 . . . . 0.0 110.26 179.908 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.83 -61.61 1.73 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.468 179.102 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.719 HD12 ' HB2' ' A' ' 157' ' ' GLN . 7.5 mt -67.33 -6.24 17.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.9 178.656 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.624 ' CD2' HG12 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -79.35 -47.14 16.3 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.028 -179.414 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 165' ' ' LEU . 1.1 tp -62.65 -78.48 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.214 0.53 . . . . 0.0 110.417 179.621 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.541 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 0.7 OUTLIER -88.31 105.56 9.82 Favored Pre-proline 0 N--CA 1.445 -0.703 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.997 -179.535 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.609 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 30.9 Cg_endo -66.77 -25.45 46.07 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.131 1.887 . . . . 0.0 114.244 -179.407 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 22.6 Cg_endo -91.34 87.17 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.972 1.781 . . . . 0.0 113.062 -179.374 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.927 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -72.25 -101.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.739 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.703 ' H ' HG23 ' A' ' 169' ' ' ILE . 1.9 mt 25.63 -62.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.387 0.675 . . . . 0.0 112.664 178.349 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.927 ' N ' ' O ' ' A' ' 169' ' ' ILE . 13.7 mt -67.05 -51.0 60.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.674 179.824 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -72.31 -6.86 46.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.074 179.575 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.61 -59.55 2.7 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.753 0.311 . . . . 0.0 110.367 179.887 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -100.06 -20.9 14.75 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.636 179.048 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 64.9 t80 69.29 -57.63 0.53 Allowed 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.8 0.333 . . . . 0.0 111.003 -179.953 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.865 ' HA ' HD23 ' A' ' 179' ' ' LEU . 6.5 t80 -93.86 18.73 9.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.526 179.503 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.497 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 13.5 mt -86.53 -46.84 0.54 Allowed Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.312 179.968 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 12.3 Cg_exo -71.42 -4.18 14.48 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.89 2.393 . . . . 0.0 112.903 -179.684 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.865 HD23 ' HA ' ' A' ' 176' ' ' PHE . 4.0 mm? -70.61 -65.23 0.76 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.961 0.41 . . . . 0.0 110.9 -179.941 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.58 35.47 0.83 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.874 179.936 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.559 0.219 . . . . 0.0 111.375 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 156' ' ' LEU . 6.1 mt -167.68 -71.61 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.027 -179.69 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 14.0 tp60 75.96 56.47 0.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.779 -179.959 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.62 ' HB3' HD13 ' A' ' 163' ' ' LEU . 27.6 t 61.16 60.24 1.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.643 -179.935 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.471 ' O ' HG12 ' A' ' 160' ' ' VAL . 1.8 t70 76.09 -59.63 0.51 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.354 179.953 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 85.13 -46.3 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.927 -179.463 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.421 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 1.3 m-85 -75.49 8.62 2.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.256 179.381 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -164.46 11.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.874 -179.744 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.768 HD12 ' CD ' ' A' ' 167' ' ' PRO . 0.9 OUTLIER -69.47 -38.89 77.91 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.542 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.487 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 0.9 OUTLIER 48.94 29.2 2.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.317 179.843 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.488 ' HA ' HD22 ' A' ' 165' ' ' LEU . 0.2 OUTLIER 89.7 -30.71 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.209 -179.45 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -165.24 83.77 1.1 Allowed Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.683 -178.804 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.768 ' CD ' HD12 ' A' ' 163' ' ' LEU . 8.8 Cg_endo -59.03 -36.62 96.27 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.121 1.881 . . . . 0.0 113.257 -179.975 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 25.2 Cg_endo -93.43 84.48 0.17 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.488 2.125 . . . . 0.0 112.848 -179.481 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.927 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 18.4 pt -75.13 -44.4 43.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.336 179.94 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.464 ' N ' HG13 ' A' ' 169' ' ' ILE . 3.1 mp -78.71 -43.36 25.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.483 -179.974 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.895 HD13 ' HG3' ' A' ' 178' ' ' PRO . 2.5 mm? -64.6 -58.93 4.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.104 0.478 . . . . 0.0 109.773 179.852 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.411 ' HB2' ' HG2' ' A' ' 168' ' ' PRO . 7.0 t70 -74.32 4.7 5.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.256 179.01 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.927 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.08 -52.75 15.37 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.548 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.555 ' N ' HD12 ' A' ' 177' ' ' LEU . . . -121.43 -5.82 9.16 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.793 178.76 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.428 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 85.1 t80 68.99 -53.59 0.57 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.547 0.339 . . . . 0.0 111.574 179.981 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.406 ' O ' ' CG ' ' A' ' 176' ' ' PHE . 27.7 t80 -92.93 -7.18 46.79 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.587 0.232 . . . . 0.0 111.171 -179.802 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.555 HD12 ' N ' ' A' ' 174' ' ' GLY . 38.9 mt -55.35 -42.45 96.03 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.265 179.57 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.895 ' HG3' HD13 ' A' ' 171' ' ' LEU . 49.5 Cg_exo -56.51 79.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.74 2.293 . . . . 0.0 112.617 -179.991 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 177' ' ' LEU . 1.0 OUTLIER -82.85 -68.5 0.7 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.291 179.481 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.31 45.05 1.25 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.127 179.118 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.539 ' O ' HD23 ' A' ' 156' ' ' LEU . 15.5 p90 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.655 0.264 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.861 HD22 ' CG2' ' A' ' 160' ' ' VAL . 98.0 mt -160.41 132.23 6.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.517 -179.99 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -171.24 -31.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.399 -179.886 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.518 ' O ' HD13 ' A' ' 163' ' ' LEU . 3.1 m -73.38 62.55 0.72 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.13 0.49 . . . . 0.0 110.701 -179.964 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.408 ' OD1' ' CZ ' ' A' ' 161' ' ' PHE . 0.2 OUTLIER 76.92 -63.81 0.36 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.483 -179.743 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.861 ' CG2' HD22 ' A' ' 156' ' ' LEU . 0.4 OUTLIER 71.61 -46.63 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.76 179.568 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.42 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 6.8 p90 -71.94 -4.84 30.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.485 -179.743 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.577 ' HB3' HD11 ' A' ' 165' ' ' LEU . 8.5 m-85 -164.01 15.67 0.06 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.629 179.708 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.633 HD11 ' HD2' ' A' ' 168' ' ' PRO . 18.6 tp -68.84 -6.1 24.94 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.353 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -75.84 -19.93 58.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.654 -179.487 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.577 HD11 ' HB3' ' A' ' 162' ' ' PHE . 2.3 mt -63.55 -51.16 66.59 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.267 0.555 . . . . 0.0 110.46 179.788 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.525 ' C ' HD12 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -161.34 77.54 2.31 Favored Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.973 -178.413 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -63.43 111.57 1.5 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.195 1.93 . . . . 0.0 112.015 -179.489 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.633 ' HD2' HD11 ' A' ' 163' ' ' LEU . 70.2 Cg_endo -83.46 -166.04 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.95 2.433 . . . . 0.0 112.303 -179.879 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.825 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 17.0 tt -171.85 -44.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.484 179.96 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.523 ' N ' HG23 ' A' ' 169' ' ' ILE . 3.3 pt -71.82 -43.55 69.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 114.16 -1.382 . . . . 0.0 111.827 -178.524 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.547 HD23 ' HG2' ' A' ' 178' ' ' PRO . 8.9 mt -63.06 -51.6 66.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.975 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -75.02 -8.24 55.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.312 178.227 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.825 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -75.14 -76.15 0.15 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.123 0.487 . . . . 0.0 110.191 179.71 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -114.82 -14.19 8.82 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.914 179.12 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 32.6 t80 77.48 -43.47 0.41 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 179.668 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -96.29 -8.16 33.48 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.57 0.224 . . . . 0.0 111.595 -179.878 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.625 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 21.3 mt -73.84 -35.59 2.53 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 179.94 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 43.9 Cg_exo -55.63 -154.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.548 2.165 . . . . 0.0 112.812 -179.546 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.4 tp 77.27 68.47 0.05 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.133 0.492 . . . . 0.0 110.202 -179.51 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.57 60.36 1.67 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.438 -179.527 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.467 ' O ' HD23 ' A' ' 156' ' ' LEU . 51.0 p90 . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.66 0.266 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.467 HD23 ' O ' ' A' ' 155' ' ' PHE . 81.5 mt -161.6 -179.04 6.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.745 -179.991 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.563 ' HB3' HD22 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -170.4 87.59 0.13 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.769 179.966 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.6 p 78.77 -56.0 0.45 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.436 0.636 . . . . 0.0 111.522 179.946 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.56 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 2.0 t0 -167.93 -31.76 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.214 -179.887 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.56 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 83.1 t 82.93 -55.12 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.699 -179.775 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.462 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 2.3 m-85 -75.06 32.34 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.362 179.354 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.462 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 22.2 m-85 -169.96 -17.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.494 179.941 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.563 HD22 ' HB3' ' A' ' 157' ' ' GLN . 20.7 tp -57.78 -44.04 85.95 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.544 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 2.6 t80 61.87 -13.25 0.05 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 177.64 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.488 ' H ' ' C ' ' A' ' 163' ' ' LEU . 0.3 OUTLIER -66.67 -39.99 88.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.855 0.359 . . . . 0.0 111.059 -179.965 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -160.19 95.84 1.53 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.523 -179.37 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.11 113.83 2.77 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.271 1.981 . . . . 0.0 112.947 -179.397 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.403 ' CD ' HG13 ' A' ' 160' ' ' VAL . 81.5 Cg_endo -83.51 93.73 0.81 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.173 2.582 . . . . 0.0 111.445 179.21 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.887 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER -159.14 -45.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.517 -179.108 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.652 HD12 ' N ' ' A' ' 171' ' ' LEU . 2.3 pp -76.1 -49.71 24.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.224 -178.271 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.732 HD12 ' N ' ' A' ' 172' ' ' ASP . 3.4 pp -67.47 -48.58 66.77 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.988 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.732 ' N ' HD12 ' A' ' 171' ' ' LEU . 1.3 m-20 -73.95 -2.37 23.73 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.922 178.655 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.887 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.73 -70.8 0.3 Allowed 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.539 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.437 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -110.86 -23.66 5.8 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.131 -0.787 . . . . 0.0 111.131 178.127 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER 71.25 -13.53 0.52 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.398 0.279 . . . . 0.0 111.199 -179.726 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.437 ' H ' ' C ' ' A' ' 174' ' ' GLY . 36.7 p90 -95.28 -8.72 35.16 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.752 0.31 . . . . 0.0 110.256 179.189 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.58 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 3.5 mm? -46.53 -46.01 46.96 Favored Pre-proline 0 CA--C 1.529 0.156 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.441 179.32 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 18.9 Cg_exo -68.9 59.11 1.2 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.006 2.471 . . . . 0.0 112.311 179.665 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.59 -4.21 53.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.863 0.363 . . . . 0.0 111.22 179.849 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.44 47.1 0.89 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.542 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.79 0.329 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.552 ' O ' HD12 ' A' ' 156' ' ' LEU . 1.2 pp -165.33 77.28 0.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.106 0.479 . . . . 0.0 111.065 -179.91 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.743 ' HG2' HD13 ' A' ' 163' ' ' LEU . 1.9 tp60 -81.5 25.36 0.52 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.176 179.494 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.8 t 76.14 27.66 0.88 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.947 0.403 . . . . 0.0 110.785 -179.509 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.492 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 10.3 m-20 -159.39 -51.87 0.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.796 179.755 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.492 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 94.9 t 76.45 -58.58 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.396 179.273 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.425 ' O ' ' HB3' ' A' ' 164' ' ' PHE . 97.5 m-85 -65.61 -30.07 70.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.127 0.489 . . . . 0.0 110.325 179.831 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.403 ' HB2' ' CB ' ' A' ' 159' ' ' ASP . 0.2 OUTLIER -73.09 -61.36 1.84 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.691 178.985 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.743 HD13 ' HG2' ' A' ' 157' ' ' GLN . 4.2 tp -67.16 -3.07 6.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.468 179.143 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.471 ' CB ' ' O ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER -75.15 -33.88 61.55 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.476 -178.763 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 mt -63.08 -41.8 99.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.921 0.391 . . . . 0.0 110.617 179.836 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.921 HD11 HD13 ' A' ' 169' ' ' ILE . 0.1 OUTLIER -160.9 98.66 1.33 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.791 -179.051 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.594 ' CD ' ' HD3' ' A' ' 168' ' ' PRO . 59.3 Cg_endo -73.72 -21.64 18.77 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 122.787 2.325 . . . . 0.0 115.85 -178.159 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.594 ' HD3' ' CD ' ' A' ' 167' ' ' PRO . 23.0 Cg_endo -91.12 22.88 0.67 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.799 1.666 . . . . 0.0 113.853 -178.581 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.921 HD13 HD11 ' A' ' 166' ' ' LEU . 5.6 tp -78.89 -38.07 20.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.964 0.411 . . . . 0.0 111.122 179.656 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.873 HD13 HG23 ' A' ' 169' ' ' ILE . 7.4 mm -73.94 -49.83 32.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.916 -178.927 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.589 ' C ' HD12 ' A' ' 171' ' ' LEU . 0.5 OUTLIER -64.7 -48.0 76.29 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.609 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.409 ' N ' ' HG ' ' A' ' 171' ' ' LEU . 3.5 t0 -76.5 -1.35 26.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.956 178.488 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.845 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.62 -57.35 4.2 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.818 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -115.02 -15.12 8.03 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.663 178.757 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.411 ' HB2' ' O ' ' A' ' 174' ' ' GLY . 1.9 m-85 68.66 -10.11 0.5 Allowed 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 122.3 0.24 . . . . 0.0 111.567 -179.766 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.43 ' H ' ' C ' ' A' ' 174' ' ' GLY . 7.4 m-85 -91.84 -0.9 57.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.734 0.302 . . . . 0.0 110.389 179.463 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.454 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.4 OUTLIER -53.62 -51.84 72.61 Favored Pre-proline 0 N--CA 1.456 -0.156 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.082 179.207 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 31.7 Cg_exo -60.52 81.76 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.866 2.377 . . . . 0.0 111.613 179.167 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 98.8 mt -93.3 -75.63 0.49 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.295 -179.364 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 13.9 mmp_? -86.87 30.59 0.74 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.912 -179.841 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 120.914 0.388 . . . . 0.0 111.511 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 156' ' ' LEU . 9.4 mt 65.37 -179.04 0.19 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.82 -179.882 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.844 ' O ' HD22 ' A' ' 163' ' ' LEU . 0.9 OUTLIER -170.47 41.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.881 -179.928 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.857 ' HB3' HD13 ' A' ' 163' ' ' LEU . 1.8 t 68.48 -59.87 0.44 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.366 0.603 . . . . 0.0 111.271 -179.99 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.72 ' O ' HG12 ' A' ' 160' ' ' VAL . 1.0 OUTLIER -148.27 -22.85 0.34 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.577 -179.865 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.72 HG12 ' O ' ' A' ' 159' ' ' ASP . 9.8 p 56.95 -50.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.374 0.67 . . . . 0.0 112.588 179.941 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.606 ' N ' ' O ' ' A' ' 159' ' ' ASP . 0.3 OUTLIER -71.24 -1.34 12.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.465 0.174 . . . . 0.0 110.978 179.194 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.433 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 9.7 m-85 -164.82 12.83 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.899 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.857 HD13 ' HB3' ' A' ' 158' ' ' SER . 61.5 tp -69.24 -32.49 71.75 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.451 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.473 ' O ' ' CG ' ' A' ' 164' ' ' PHE . 0.0 OUTLIER 66.13 1.75 2.07 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.101 179.047 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.709 ' O ' HD22 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -67.37 -67.38 0.46 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.87 0.367 . . . . 0.0 110.841 179.424 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.709 HD22 ' O ' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -160.76 61.33 1.46 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.874 -179.657 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.451 ' HB2' ' HD3' ' A' ' 168' ' ' PRO . 36.1 Cg_exo -57.97 -47.93 18.48 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.596 2.198 . . . . 0.0 112.622 -179.919 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.451 ' HD3' ' HB2' ' A' ' 167' ' ' PRO . 36.1 Cg_endo -92.28 45.24 0.41 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.879 2.386 . . . . 0.0 112.705 -179.502 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.852 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -75.76 -37.13 35.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.047 0.451 . . . . 0.0 111.053 -179.879 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.843 HD13 HG23 ' A' ' 169' ' ' ILE . 8.1 mm -73.56 -42.35 55.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.523 -179.454 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.448 HD22 ' N ' ' A' ' 171' ' ' LEU . 3.2 mm? -65.64 -56.05 14.24 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.471 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -74.52 0.54 14.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.008 178.701 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.852 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.64 -57.35 4.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.285 0.564 . . . . 0.0 109.5 179.662 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -112.66 -22.14 5.84 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.309 178.558 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 70.08 -53.07 0.63 Allowed 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 122.476 0.31 . . . . 0.0 111.45 179.815 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.639 ' O ' HD13 ' A' ' 179' ' ' LEU . 0.2 OUTLIER -91.48 1.8 56.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.803 0.335 . . . . 0.0 110.734 179.789 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.501 ' O ' HD12 ' A' ' 177' ' ' LEU . 0.1 OUTLIER -60.55 -49.4 90.16 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.565 179.547 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.58 ' O ' HD12 ' A' ' 179' ' ' LEU . 54.7 Cg_exo -52.95 83.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.81 2.34 . . . . 0.0 112.426 179.97 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.639 HD13 ' O ' ' A' ' 176' ' ' PHE . 3.5 mp -130.56 -69.11 0.66 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.369 179.801 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 180' ' ' ARG . 0.0 OUTLIER -86.95 25.75 1.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.188 179.3 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.462 ' N ' ' CD1' ' A' ' 155' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 120.453 0.168 . . . . 0.0 111.233 . . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.497 ' C ' HD12 ' A' ' 156' ' ' LEU . 3.7 pp -165.74 145.41 6.44 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.837 0.351 . . . . 0.0 110.906 -179.927 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.99 61.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.406 0.622 . . . . 0.0 110.927 179.79 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.576 ' OG ' HD22 ' A' ' 163' ' ' LEU . 59.7 p -165.13 45.52 0.09 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.808 179.533 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.504 ' O ' HG12 ' A' ' 160' ' ' VAL . 0.3 OUTLIER 78.25 -56.89 0.47 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.115 -178.42 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 66.23 -56.44 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.351 179.848 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.499 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 5.9 p90 -79.21 17.97 0.73 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.158 179.051 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.419 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 2.9 m-85 -169.68 0.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.563 -179.893 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.576 HD22 ' OG ' ' A' ' 158' ' ' SER . 30.1 tp -63.03 -20.43 65.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.701 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 1.5 t80 60.42 81.57 0.18 Allowed 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.04 179.098 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.496 ' O ' HD12 ' A' ' 166' ' ' LEU . 1.9 tp -170.51 -52.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.038 179.989 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER -161.2 54.34 0.54 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.204 -179.806 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.441 ' HA ' ' HD2' ' A' ' 168' ' ' PRO . 10.7 Cg_endo -54.2 104.83 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.85 2.366 . . . . 0.0 112.842 -179.464 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 167' ' ' PRO . 62.8 Cg_endo -71.41 82.17 1.15 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.721 2.281 . . . . 0.0 111.36 179.084 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.912 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -75.82 -36.93 34.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.348 -179.151 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.897 HD13 HG23 ' A' ' 169' ' ' ILE . 7.0 mm -76.95 -50.12 21.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.893 -179.506 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.559 ' H ' HD12 ' A' ' 171' ' ' LEU . 4.5 mp -64.08 -52.31 59.89 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.592 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -74.01 0.61 13.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.012 178.48 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.912 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.15 -52.26 17.49 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.372 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.679 ' H ' ' HG2' ' A' ' 178' ' ' PRO . . . -126.48 -25.33 1.3 Allowed Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.519 178.782 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.41 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 7.8 t80 79.44 -21.63 0.32 Allowed 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.231 0.613 . . . . 0.0 112.275 179.62 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -94.7 53.71 1.67 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.405 0.622 . . . . 0.0 109.341 179.093 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.727 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 1.3 mt 48.36 51.81 11.45 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.906 -178.482 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.727 ' HD3' ' N ' ' A' ' 177' ' ' LEU . 11.8 Cg_exo -74.85 72.58 4.5 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 123.604 2.87 . . . . 0.0 112.421 -179.748 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.35 -45.01 6.97 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.227 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.452 ' HD2' ' N ' ' A' ' 180' ' ' ARG . 0.0 OUTLIER -90.21 20.92 4.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.97 179.19 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.842 0.353 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.56 HD22 HG13 ' A' ' 160' ' ' VAL . 99.8 mt -72.99 85.61 1.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.751 179.894 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -170.13 -38.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.444 -179.908 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.459 ' O ' ' CB ' ' A' ' 159' ' ' ASP . 53.9 p -74.85 66.32 1.5 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.611 179.215 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.47 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 3.8 t0 87.6 -50.07 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.985 -179.186 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.56 HG13 HD22 ' A' ' 156' ' ' LEU . 80.6 t 73.86 -47.87 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.649 0.262 . . . . 0.0 111.203 179.797 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.83 12.69 0.36 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.339 179.502 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.439 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 87.7 t80 -165.16 3.24 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.505 179.799 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.1 tp -61.68 -31.34 71.46 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.647 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.453 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 7.1 t80 44.43 38.36 2.53 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.396 177.671 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.453 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.2 OUTLIER 86.54 -31.7 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.038 -179.676 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.752 HD23 ' O ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -162.16 131.06 3.04 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.396 -179.242 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.87 112.62 3.44 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.457 2.105 . . . . 0.0 112.511 -179.522 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.18 76.51 0.91 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.489 2.126 . . . . 0.0 112.541 -179.966 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.724 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 8.4 tt -75.51 -41.87 42.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.166 0.508 . . . . 0.0 110.796 179.726 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.448 HD12 ' H ' ' A' ' 170' ' ' ILE . 1.9 mp -71.07 -37.37 66.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.94 -179.875 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.39 -55.42 18.22 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.784 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.74 1.3 17.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.04 178.432 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.4 -45.68 53.25 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-O 121.05 0.452 . . . . 0.0 110.157 -179.869 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.691 ' H ' ' HG2' ' A' ' 178' ' ' PRO . . . -117.99 -20.68 4.41 Favored Glycine 0 N--CA 1.452 -0.281 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 178.688 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' A' ' 174' ' ' GLY . 57.6 m-85 69.44 -12.64 0.42 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 179.0 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.447 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 0.6 OUTLIER -94.73 37.67 1.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.455 0.645 . . . . 0.0 109.26 178.638 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.58 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 17.2 mt 62.34 43.34 0.55 Allowed Pre-proline 0 N--CA 1.453 -0.292 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.999 -178.869 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.691 ' HG2' ' H ' ' A' ' 174' ' ' GLY . 32.5 Cg_exo -40.16 -80.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.907 2.405 . . . . 0.0 113.147 179.635 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.416 ' H ' HG22 ' A' ' 170' ' ' ILE . 50.0 mt 53.72 48.46 21.45 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.976 0.417 . . . . 0.0 110.728 -179.835 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.45 47.23 5.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.716 -179.767 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . 0.486 ' HB2' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.857 0.361 . . . . 0.0 111.314 . . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.484 HD12 ' H ' ' A' ' 156' ' ' LEU . 5.3 mp -72.84 -177.2 2.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.034 -179.806 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 80.34 35.27 0.13 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.289 0.566 . . . . 0.0 110.501 -179.879 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.419 ' O ' HD12 ' A' ' 163' ' ' LEU . 0.8 OUTLIER -164.72 75.85 0.29 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.711 179.47 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 158' ' ' SER . 0.4 OUTLIER 76.94 -57.18 0.53 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.566 -178.944 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.419 ' HA ' ' HB2' ' A' ' 163' ' ' LEU . 0.9 OUTLIER 70.65 -45.17 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 120.742 0.306 . . . . 0.0 111.63 179.649 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.421 ' CE1' ' HB2' ' A' ' 162' ' ' PHE . 0.1 OUTLIER -72.62 -3.19 23.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.988 0.423 . . . . 0.0 110.765 179.663 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.421 ' HB2' ' CE1' ' A' ' 161' ' ' PHE . 0.1 OUTLIER -162.86 19.81 0.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.201 179.642 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 163' ' ' LEU . 0.8 OUTLIER -68.61 -5.24 18.85 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.815 0.817 . . . . 0.0 109.131 177.59 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -71.07 -67.48 0.51 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.853 -179.481 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -65.27 -74.82 0.1 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.929 0.395 . . . . 0.0 110.908 179.861 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 166' ' ' LEU . 2.8 mt -164.44 101.35 0.86 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.946 -179.29 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.62 111.72 2.43 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.223 1.949 . . . . 0.0 112.347 179.981 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.22 48.84 2.82 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.778 2.318 . . . . 0.0 112.83 -179.923 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.854 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 10.8 pt -75.77 -36.09 32.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.965 0.412 . . . . 0.0 110.888 179.695 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 10.7 mm -77.12 -42.56 31.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.41 -179.848 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.97 -57.03 9.79 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.535 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.09 4.55 6.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.119 178.671 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.854 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.59 -47.27 55.91 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.287 0.565 . . . . 0.0 109.501 179.616 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.623 ' H ' ' HG2' ' A' ' 178' ' ' PRO . . . -121.09 -28.05 1.74 Allowed Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 178.338 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.41 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 46.9 t80 77.0 -13.74 0.91 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.314 0.646 . . . . 0.0 112.501 179.184 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.448 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 42.2 p90 -95.36 37.9 1.16 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.665 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.603 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 4.4 mt 62.5 43.05 0.51 Allowed Pre-proline 0 N--CA 1.453 -0.319 0 CA-C-N 115.041 -0.982 . . . . 0.0 111.234 -178.973 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.623 ' HG2' ' H ' ' A' ' 174' ' ' GLY . 36.5 Cg_exo -41.77 -70.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.835 2.357 . . . . 0.0 112.886 179.391 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 56.35 54.67 7.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.13 0.49 . . . . 0.0 110.481 -179.837 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 62.48 57.14 1.93 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.286 -179.306 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . 0.476 ' HB2' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 6.2 p90 . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 121.005 0.431 . . . . 0.0 111.358 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.536 ' O ' HD22 ' A' ' 163' ' ' LEU . 0.1 OUTLIER -74.66 -41.44 60.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.138 -179.815 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.522 ' HB3' HD22 ' A' ' 163' ' ' LEU . 10.2 tp-100 66.91 19.67 10.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.994 0.426 . . . . 0.0 110.921 -179.763 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 32.7 t 45.97 53.91 8.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.763 179.948 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -162.75 -68.2 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.697 179.152 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.578 HG12 ' N ' ' A' ' 161' ' ' PHE . 1.1 t 69.5 -58.95 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.849 179.452 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.578 ' N ' HG12 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -74.24 16.02 0.28 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.194 179.954 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -172.18 -7.14 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 179.958 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.566 ' HG ' ' H ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER -61.14 -42.39 98.45 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.011 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.468 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 0.0 OUTLIER 42.16 36.45 0.71 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.499 176.864 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.566 ' H ' ' HG ' ' A' ' 163' ' ' LEU . 0.2 OUTLIER 88.18 -33.01 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.651 -179.197 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 163' ' ' LEU . 0.7 OUTLIER -166.01 99.49 0.73 Allowed Pre-proline 0 N--CA 1.451 -0.412 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.389 -179.116 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -62.4 117.01 3.87 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.093 1.862 . . . . 0.0 112.36 -179.578 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -89.94 -160.24 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.213 2.609 . . . . 0.0 112.469 -179.828 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.877 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER -166.56 -46.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.711 179.566 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.568 HD12 HG22 ' A' ' 169' ' ' ILE . 3.4 mp -78.35 -42.57 26.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.803 179.504 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.447 HD22 ' HG3' ' A' ' 178' ' ' PRO . 60.5 mt -64.38 -56.95 10.9 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.429 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -74.45 2.48 9.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.087 178.685 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.877 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.77 -60.71 2.1 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-O 121.151 0.501 . . . . 0.0 109.731 179.737 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.497 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -115.53 -11.35 10.56 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.626 178.769 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.497 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 64.0 t80 72.47 -17.29 0.39 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.787 0.435 . . . . 0.0 112.119 179.903 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -99.53 -18.23 17.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.795 0.331 . . . . 0.0 111.004 179.765 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.555 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 45.1 mt -61.86 -39.18 57.06 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.884 179.982 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 81.5 Cg_exo -47.11 -179.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.475 2.117 . . . . 0.0 112.856 -179.599 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 178' ' ' PRO . 3.2 mm? 74.55 71.85 0.1 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.198 -179.297 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 19.3 mtm180 69.8 57.71 0.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.666 -179.533 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . 0.504 ' HB3' ' O ' ' A' ' 177' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.439 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 64.6 m-85 . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.729 0.299 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 155' ' ' PHE . 38.0 mt -162.32 -170.71 2.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.567 179.999 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -167.66 81.25 0.19 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.916 0.388 . . . . 0.0 110.944 -179.891 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.791 ' HB3' HD13 ' A' ' 163' ' ' LEU . 1.6 m 58.99 64.08 1.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.542 -179.897 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 71.42 -60.05 0.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.691 -179.586 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 73.39 -49.82 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.323 179.837 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.427 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 3.2 t80 -74.0 1.74 10.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.969 179.503 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.425 ' CD1' ' O ' ' A' ' 161' ' ' PHE . 0.9 OUTLIER -158.9 9.74 0.13 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.14 179.753 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.791 HD13 ' HB3' ' A' ' 158' ' ' SER . 30.6 tp -69.36 -5.37 22.98 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.748 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.479 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 25.4 t80 -77.22 17.14 0.5 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.618 -179.11 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.479 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.1 OUTLIER 85.64 -23.35 0.16 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 179.394 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.48 HD12 ' N ' ' A' ' 167' ' ' PRO . 0.2 OUTLIER -158.46 146.31 13.68 Favored Pre-proline 0 C--N 1.323 -0.551 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.769 -178.334 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.48 ' N ' HD12 ' A' ' 166' ' ' LEU . 66.6 Cg_endo -75.06 117.25 4.83 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.513 2.142 . . . . 0.0 113.2 -179.182 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.409 ' O ' ' CB ' ' A' ' 172' ' ' ASP . 46.1 Cg_endo -88.23 26.89 0.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 123.271 2.647 . . . . 0.0 112.42 179.533 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.942 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -73.73 -37.23 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 111.566 -179.286 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 2.4 mp -74.67 -56.67 8.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.868 -179.27 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -53.25 40.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.907 0.384 . . . . 0.0 110.813 -179.675 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.409 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 0.7 OUTLIER -75.43 8.75 2.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.979 179.771 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.942 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.31 -67.58 0.54 Allowed 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.357 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.632 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -117.91 8.43 14.61 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 178.034 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.472 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER 53.72 -63.34 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.005 0.922 . . . . 0.0 111.638 179.846 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.632 ' N ' ' O ' ' A' ' 174' ' ' GLY . 11.8 t80 -102.31 0.47 34.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.293 179.639 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.561 HD12 ' HA3' ' A' ' 174' ' ' GLY . 70.2 mt -83.33 -43.73 0.84 Allowed Pre-proline 0 CA--C 1.53 0.197 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -179.811 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.714 ' C ' HD22 ' A' ' 179' ' ' LEU . 34.7 Cg_exo -58.02 -154.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.342 2.028 . . . . 0.0 112.222 -179.84 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.714 HD22 ' C ' ' A' ' 178' ' ' PRO . 0.4 OUTLIER 71.42 67.24 0.16 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.053 0.454 . . . . 0.0 110.441 -179.694 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 63.68 59.71 1.15 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.492 -179.63 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.447 ' O ' ' O ' ' A' ' 156' ' ' LEU . 21.4 m-85 . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.791 0.329 . . . . 0.0 111.3 . . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.566 ' C ' HD12 ' A' ' 156' ' ' LEU . 3.6 pp 43.28 -178.14 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.289 179.639 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 17.3 tp60 -172.25 -85.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.137 179.963 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.697 ' HB2' HD21 ' A' ' 163' ' ' LEU . 0.5 OUTLIER -75.87 61.9 1.51 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.928 0.394 . . . . 0.0 110.348 179.691 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.408 ' O ' ' CB ' ' A' ' 160' ' ' VAL . 4.3 t0 79.61 -47.19 0.36 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.363 -179.636 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.472 HG21 ' HB3' ' A' ' 156' ' ' LEU . 0.4 OUTLIER 83.82 -51.5 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.882 0.372 . . . . 0.0 110.453 -179.588 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.444 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 63.6 t80 -76.67 35.21 0.15 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.137 179.286 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -172.02 -19.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 179.973 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.697 HD21 ' HB2' ' A' ' 158' ' ' SER . 4.1 mt -57.69 -41.94 82.63 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.397 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 44.05 55.13 5.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.008 178.097 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 tp -172.62 -29.49 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -179.297 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.887 HD22 ' HA ' ' A' ' 169' ' ' ILE . 1.6 mt -156.55 54.63 0.91 Allowed Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.979 0.418 . . . . 0.0 111.188 -178.396 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.423 ' CB ' ' HD3' ' A' ' 168' ' ' PRO . 2.8 Cg_exo -40.45 -49.84 3.9 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.255 2.637 . . . . 0.0 113.083 179.946 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.817 ' O ' HD12 ' A' ' 170' ' ' ILE . 60.9 Cg_endo -88.17 -47.66 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.285 1.99 . . . . 0.0 113.113 -179.258 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 1.015 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.5 OUTLIER 80.94 -33.85 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.811 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.817 HD12 ' O ' ' A' ' 168' ' ' PRO . 3.9 mp -81.66 -61.87 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.937 0.398 . . . . 0.0 111.752 -179.616 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.469 HD22 ' N ' ' A' ' 171' ' ' LEU . 2.5 mm? -67.5 -51.26 53.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.891 -179.489 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -73.45 4.19 5.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.96 -179.796 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 1.015 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.19 -65.71 0.77 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.33 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -108.45 -24.74 6.05 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 178.113 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 75.43 -25.13 0.21 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.645 0.378 . . . . 0.0 111.537 179.814 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.401 ' H ' ' C ' ' A' ' 174' ' ' GLY . 11.6 m-85 -95.37 -2.43 49.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.702 0.287 . . . . 0.0 110.971 179.728 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.56 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 4.9 mt -56.14 -43.28 99.18 Favored Pre-proline 0 CA--C 1.53 0.194 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.767 179.457 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.572 ' O ' ' HB2' ' A' ' 179' ' ' LEU . 55.9 Cg_exo -54.15 -155.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.769 2.313 . . . . 0.0 112.561 179.816 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.572 ' HB2' ' O ' ' A' ' 178' ' ' PRO . 1.2 mt 87.92 80.81 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 122.927 0.491 . . . . 0.0 109.998 -179.285 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.466 ' CG ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER 70.95 28.34 3.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.019 -179.554 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.543 ' O ' HD12 ' A' ' 156' ' ' LEU . 33.5 p90 . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.75 0.31 . . . . 0.0 111.137 . . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.543 HD12 ' O ' ' A' ' 155' ' ' PHE . 2.0 mp -163.91 146.87 9.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.775 179.893 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.585 ' HB3' HD13 ' A' ' 163' ' ' LEU . 1.5 mt-30 -172.05 89.57 0.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.683 -179.977 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.8 t 79.67 -53.64 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.372 0.606 . . . . 0.0 111.845 179.832 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.567 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 1.0 OUTLIER -165.73 -29.93 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.784 -179.772 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.567 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 81.3 t 83.16 -53.51 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.627 -179.759 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.452 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 66.4 m-85 -74.91 32.67 0.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.128 179.065 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.455 ' H ' ' C ' ' A' ' 160' ' ' VAL . 8.0 m-85 -167.67 -12.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.443 -179.89 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.585 HD13 ' HB3' ' A' ' 157' ' ' GLN . 1.2 tp -61.12 -29.76 69.96 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.853 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.441 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 9.3 t80 51.56 23.38 1.86 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.049 178.714 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.441 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.1 OUTLIER 83.06 -19.82 0.37 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.637 -179.862 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.441 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 0.1 OUTLIER -167.17 83.61 0.86 Allowed Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.526 -178.509 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.454 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 2.7 Cg_exo -39.38 -47.03 3.28 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.09 2.527 . . . . 0.0 112.922 179.78 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 41.3 Cg_endo -90.38 81.44 0.51 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.733 2.289 . . . . 0.0 112.724 -179.346 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.864 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 8.7 pt -76.38 -34.48 25.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.533 -179.967 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.442 HD12 HG13 ' A' ' 169' ' ' ILE . 3.8 mp -75.76 -52.78 17.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.729 -179.352 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.86 -51.41 59.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.058 0.456 . . . . 0.0 109.976 179.849 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.432 ' CG ' HD21 ' A' ' 166' ' ' LEU . 0.6 OUTLIER -74.63 3.5 7.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.519 179.209 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.864 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.24 -63.71 1.09 Allowed 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.576 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.499 ' HA3' HD11 ' A' ' 177' ' ' LEU . . . -112.62 -11.49 14.71 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.353 178.368 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 3.8 t80 72.57 -55.6 0.67 Allowed 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.53 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.496 ' CD1' HD23 ' A' ' 177' ' ' LEU . 0.1 OUTLIER -94.2 21.65 6.7 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.276 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.499 HD11 ' HA3' ' A' ' 174' ' ' GLY . 5.9 mt -88.43 -48.17 0.44 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.023 179.618 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 45.2 Cg_exo -57.07 -20.32 36.93 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.417 2.078 . . . . 0.0 112.44 179.983 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 179' ' ' LEU . 9.1 mp -73.76 -7.22 51.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.428 -179.846 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 45.01 0.94 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.961 0.41 . . . . 0.0 110.306 179.822 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 12.6 p90 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.966 0.412 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.449 ' HG ' ' N ' ' A' ' 157' ' ' GLN . 2.3 pt? -166.8 -37.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.094 -179.854 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.449 ' N ' ' HG ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -74.51 6.77 3.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.787 179.718 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 159' ' ' ASP . 46.9 t -74.01 61.37 0.81 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.997 0.427 . . . . 0.0 111.081 -179.613 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.578 ' OD2' HG22 ' A' ' 169' ' ' ILE . 15.3 m-20 68.87 -64.78 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.84 179.858 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 69.64 -42.74 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.781 179.808 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.421 ' O ' ' CD1' ' A' ' 162' ' ' PHE . 1.2 p90 -72.18 -5.31 34.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.957 179.735 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.421 ' CD1' ' O ' ' A' ' 161' ' ' PHE . 21.5 m-85 -162.29 21.9 0.1 Allowed 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.371 179.492 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.542 HD12 ' HB3' ' A' ' 167' ' ' PRO . 1.3 tp -66.15 -10.73 43.84 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.158 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -82.64 31.92 0.41 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.9 -179.859 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -171.38 -46.78 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.732 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.438 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 0.3 OUTLIER -158.75 91.28 2.04 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.07 -178.124 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.557 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 16.7 Cg_endo -63.91 -31.81 66.73 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.544 2.162 . . . . 0.0 114.162 -179.789 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 29.7 Cg_endo -89.37 47.04 0.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 121.739 1.626 . . . . 0.0 113.206 -179.058 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.847 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 7.4 tt -77.31 -37.37 25.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.176 0.512 . . . . 0.0 110.694 179.393 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.789 HD13 HG23 ' A' ' 169' ' ' ILE . 10.2 mm -69.65 -38.53 76.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.286 -179.217 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.732 HD23 ' HG3' ' A' ' 178' ' ' PRO . 82.7 mt -64.86 -58.82 5.17 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.102 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.72 0.21 16.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.166 178.597 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.847 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.88 -62.11 1.57 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.162 0.506 . . . . 0.0 109.748 179.737 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -113.27 -12.31 12.2 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.752 178.891 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 8.0 t80 73.11 -53.34 0.7 Allowed 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 122.48 0.312 . . . . 0.0 111.687 179.793 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.62 -7.91 45.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.68 0.276 . . . . 0.0 110.915 179.882 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.522 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 15.3 mt -52.81 -44.6 96.42 Favored Pre-proline 0 CA--C 1.529 0.165 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.255 179.693 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.732 ' HG3' HD23 ' A' ' 171' ' ' LEU . 50.2 Cg_exo -54.89 -162.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.522 2.148 . . . . 0.0 112.237 179.923 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 179' ' ' LEU . 0.5 OUTLIER 71.57 69.18 0.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.145 0.497 . . . . 0.0 110.169 -179.677 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 66.16 58.35 0.72 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.561 -179.632 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . 0.416 ' HB2' ' O ' ' A' ' 177' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.9 0.381 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.8 mt 55.15 -92.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.864 -179.866 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.73 ' HB3' HD23 ' A' ' 163' ' ' LEU . 8.6 mt-30 52.3 22.87 2.17 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.776 0.322 . . . . 0.0 111.397 179.745 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.1 t 77.93 -11.0 1.26 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 179.838 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -167.49 -38.74 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.557 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.526 ' O ' ' CB ' ' A' ' 164' ' ' PHE . 0.4 OUTLIER 84.08 -51.93 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.583 179.209 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.457 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 0.2 OUTLIER -69.19 -37.37 78.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.35 0.595 . . . . 0.0 110.371 179.824 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.408 ' C ' ' H ' ' A' ' 164' ' ' PHE . 1.2 m-85 -72.84 -62.9 1.29 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.276 179.695 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.73 HD23 ' HB3' ' A' ' 157' ' ' GLN . 2.5 tp -66.19 -0.49 2.54 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.164 179.737 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.526 ' CB ' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER -68.83 -13.84 62.66 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.295 -178.974 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.63 -38.87 92.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.456 0.646 . . . . 0.0 109.88 178.857 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.678 HD23 ' O ' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -161.63 97.55 1.25 Allowed Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.704 -179.156 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 166' ' ' LEU . 17.8 Cg_endo -60.55 117.16 3.89 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.51 2.14 . . . . 0.0 112.98 -178.976 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.568 ' HG3' HD21 ' A' ' 163' ' ' LEU . 57.3 Cg_endo -86.73 90.16 0.62 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.164 2.576 . . . . 0.0 112.516 179.866 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.772 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 7.2 tp -72.96 -41.15 60.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.171 0.51 . . . . 0.0 110.645 179.792 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.426 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.3 mp -71.63 -40.64 71.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.796 179.952 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.446 ' HA ' ' HG2' ' A' ' 178' ' ' PRO . 0.8 OUTLIER -66.63 -51.01 61.08 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.659 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -73.37 -8.23 54.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.079 178.032 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.772 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -74.64 -64.68 0.98 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.141 0.496 . . . . 0.0 110.119 179.667 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -123.64 -14.46 3.89 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.397 179.459 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.428 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 6.9 t80 77.87 -11.03 1.26 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 179.858 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -137.15 9.69 3.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.62 0.248 . . . . 0.0 111.217 179.73 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.552 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 74.4 mt -90.27 -38.15 0.41 Allowed Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.783 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 81.0 Cg_exo -43.17 -78.1 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.366 2.044 . . . . 0.0 113.151 -179.353 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 53.93 50.52 16.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.151 0.501 . . . . 0.0 110.402 -179.648 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.74 47.96 3.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.673 -179.533 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . 0.433 ' HB2' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.809 0.338 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.629 ' O ' HD12 ' A' ' 156' ' ' LEU . 4.6 pp -163.34 21.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.486 -179.773 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.4 -34.19 54.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.12 0.485 . . . . 0.0 110.414 179.508 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.532 ' O ' ' HB2' ' A' ' 162' ' ' PHE . 0.8 OUTLIER -80.13 35.79 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.382 -179.275 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.58 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.3 OUTLIER 75.25 -14.77 0.73 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 179.652 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.58 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 62.1 t 87.23 -48.67 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 C-N-CA 122.849 0.46 . . . . 0.0 111.983 179.522 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -66.19 -32.83 74.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.911 0.386 . . . . 0.0 111.276 -179.407 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.729 ' CZ ' HD13 ' A' ' 169' ' ' ILE . 0.6 OUTLIER -67.87 -57.87 5.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.857 179.758 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 18.5 mt -66.09 -3.68 5.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.465 0.65 . . . . 0.0 109.693 178.432 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER -76.71 2.21 14.91 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.753 -179.506 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.9 tp -173.6 -38.74 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 120.773 0.32 . . . . 0.0 111.123 179.98 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.529 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 0.7 OUTLIER -159.33 123.28 2.08 Favored Pre-proline 0 N--CA 1.451 -0.396 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.67 -178.626 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.591 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 37.6 Cg_endo -69.06 -25.67 31.63 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.475 2.117 . . . . 0.0 114.549 -179.924 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 23.8 Cg_endo -87.22 -152.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.761 1.641 . . . . 0.0 113.117 -179.252 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.729 HD13 ' CZ ' ' A' ' 162' ' ' PHE . 7.3 tp -157.78 -40.03 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.322 0.582 . . . . 0.0 109.814 -179.37 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.451 ' HA ' ' HB2' ' A' ' 173' ' ' ALA . 2.7 mp -68.28 -23.11 28.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.828 178.822 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.711 HD23 ' HD3' ' A' ' 178' ' ' PRO . 0.2 OUTLIER -65.37 -65.95 0.61 Allowed 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.385 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.525 ' HB2' HD13 ' A' ' 166' ' ' LEU . 25.5 t70 -76.69 7.15 4.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.802 178.092 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -70.21 -51.21 32.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.734 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -104.83 -19.17 11.23 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 177.811 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 16.5 t80 75.66 -10.19 1.3 Allowed 'General case' 0 C--O 1.23 0.075 0 C-N-CA 122.841 0.456 . . . . 0.0 112.005 179.626 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -96.45 -0.16 49.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.788 0.328 . . . . 0.0 110.72 179.531 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.453 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 1.0 OUTLIER -60.38 -49.31 90.93 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.25 -179.939 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.711 ' HD3' HD23 ' A' ' 171' ' ' LEU . 82.1 Cg_exo -45.56 -63.36 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.65 2.234 . . . . 0.0 112.669 -179.793 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.94 61.94 0.62 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.177 0.513 . . . . 0.0 110.556 -179.892 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.17 47.81 3.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.785 -179.872 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 120.911 0.386 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.746 ' O ' HD12 ' A' ' 156' ' ' LEU . 2.3 pp -164.74 45.73 0.1 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.981 -179.752 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.09 -35.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.517 179.828 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.691 ' HB2' HD22 ' A' ' 163' ' ' LEU . 0.8 OUTLIER -73.36 61.51 0.66 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.128 0.489 . . . . 0.0 110.239 179.641 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 73.24 -60.62 0.53 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.589 -179.388 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 61.3 t 69.28 -58.92 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.368 179.85 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -75.64 8.54 2.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.121 -179.838 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -167.18 9.0 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 179.949 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.691 HD22 ' HB2' ' A' ' 158' ' ' SER . 18.5 tp -64.22 -30.35 71.41 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.083 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' A' ' 163' ' ' LEU . 0.1 OUTLIER 63.47 -9.51 0.13 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.71 -1.132 . . . . 0.0 112.486 178.505 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.469 ' H ' ' C ' ' A' ' 163' ' ' LEU . 8.7 mt -69.76 -76.25 0.1 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.162 0.506 . . . . 0.0 110.71 179.234 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.419 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 0.2 OUTLIER -163.62 53.37 0.36 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.834 -179.5 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 166' ' ' LEU . 9.5 Cg_endo -53.69 106.93 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.727 2.285 . . . . 0.0 113.025 -179.023 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.771 ' CB ' HD11 ' A' ' 171' ' ' LEU . 97.7 Cg_endo -78.73 48.63 2.84 Favored 'Trans proline' 0 CA--C 1.527 0.164 0 C-N-CA 122.974 2.45 . . . . 0.0 112.05 179.082 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.834 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 14.7 tt -77.35 -43.71 30.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.372 0.606 . . . . 0.0 111.502 -179.486 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.503 ' N ' HG23 ' A' ' 169' ' ' ILE . 1.0 OUTLIER -71.61 -45.19 68.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.487 -177.813 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.771 HD11 ' CB ' ' A' ' 168' ' ' PRO . 0.1 OUTLIER -63.74 -55.21 24.97 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.506 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -76.11 3.26 10.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.384 178.797 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.834 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.01 -52.67 13.51 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.258 0.551 . . . . 0.0 109.894 179.9 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.785 ' H ' ' HG2' ' A' ' 178' ' ' PRO . . . -121.77 -19.8 3.29 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.22 178.738 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.448 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 62.0 t80 74.28 -12.96 0.83 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.101 0.56 . . . . 0.0 112.127 179.628 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -93.96 45.84 1.16 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.729 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.675 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 12.0 mt 53.81 53.38 10.78 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.028 -178.727 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.785 ' HG2' ' H ' ' A' ' 174' ' ' GLY . 27.8 Cg_exo -65.69 64.41 0.4 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.189 2.592 . . . . 0.0 112.153 179.899 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.74 -65.91 0.94 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.936 -179.979 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.84 39.85 0.87 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.651 -179.801 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 051 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.827 0.346 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 051 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.935 ' HA ' HD22 ' A' ' 163' ' ' LEU . 33.8 mt 57.01 92.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.16 179.762 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -169.82 45.78 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.163 0.506 . . . . 0.0 111.382 179.676 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.6 m -168.31 -62.54 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.884 179.259 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.824 ' O ' ' N ' ' A' ' 161' ' ' PHE . 86.1 m-20 -89.13 -43.7 10.85 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.509 179.117 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.514 HG13 ' N ' ' A' ' 161' ' ' PHE . 13.2 p 44.44 -55.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 O-C-N 124.326 1.016 . . . . 0.0 112.156 -178.988 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.824 ' N ' ' O ' ' A' ' 159' ' ' ASP . 0.5 OUTLIER -73.99 -5.54 41.99 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.44 178.527 . . . . . . . . 3 3 . 1 . 051 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.5 ' HB3' ' HA ' ' A' ' 167' ' ' PRO . 3.7 p90 -164.57 17.7 0.05 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.77 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.935 HD22 ' HA ' ' A' ' 156' ' ' LEU . 0.8 OUTLIER -72.54 -6.67 45.59 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.318 0.58 . . . . 0.0 109.437 177.14 . . . . . . . . 3 3 . 1 . 051 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.83 -45.06 62.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.584 -178.643 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -175.42 -42.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.798 0.332 . . . . 0.0 111.329 -179.931 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.418 ' HG ' ' HD2' ' A' ' 167' ' ' PRO . 2.8 tp -162.12 141.28 7.24 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.661 -179.122 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.5 ' HA ' ' HB3' ' A' ' 162' ' ' PHE . 56.3 Cg_endo -70.66 116.72 4.78 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.259 1.973 . . . . 0.0 112.411 -179.932 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 167' ' ' PRO . 21.1 Cg_endo -61.36 81.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.457 2.105 . . . . 0.0 112.093 179.922 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.828 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 2.7 tt -73.78 -43.59 53.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.543 0.687 . . . . 0.0 110.58 179.909 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.512 ' N ' HG23 ' A' ' 169' ' ' ILE . 0.9 OUTLIER -74.66 -43.16 47.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.544 -178.931 . . . . . . . . 3 3 . 1 . 051 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.424 ' HA ' ' CG ' ' A' ' 178' ' ' PRO . 1.0 OUTLIER -65.21 -54.57 27.55 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.105 . . . . . . . . 3 3 . 1 . 051 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.12 1.23 13.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.943 178.575 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.828 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.72 -59.57 2.65 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 121.168 0.509 . . . . 0.0 110.005 179.885 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.581 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -111.73 -4.18 26.51 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.698 178.896 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.502 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER 56.07 -54.4 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.87 0.868 . . . . 0.0 112.589 179.818 . . . . . . . . 3 3 . 1 . 051 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.581 ' N ' ' O ' ' A' ' 174' ' ' GLY . 6.5 m-85 -91.82 15.28 13.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.616 0.246 . . . . 0.0 111.109 179.984 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.566 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 13.9 mt -84.14 -49.38 0.66 Allowed Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.829 179.721 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.566 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 2.7 Cg_endo -82.39 50.72 3.51 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.12 2.547 . . . . 0.0 112.25 -179.902 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.598 HD23 ' NH2' ' A' ' 180' ' ' ARG . 1.3 tp -85.59 -72.41 0.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.898 -179.987 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.598 ' NH2' HD23 ' A' ' 179' ' ' LEU . 0.0 OUTLIER -86.98 46.04 1.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.853 179.857 . . . . . . . . 3 3 . 1 . 051 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 052 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.738 0.304 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 052 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.495 ' O ' ' HB2' ' A' ' 157' ' ' GLN . 0.7 OUTLIER -73.31 -80.24 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 -179.939 . . . . . . . . 3 3 . 1 . 052 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' A' ' 156' ' ' LEU . 0.4 OUTLIER 71.57 -59.66 0.54 Allowed 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.845 -179.755 . . . . . . . . 3 3 . 1 . 052 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 162' ' ' PHE . 37.8 t -162.8 44.25 0.13 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.135 179.355 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.46 ' O ' HG12 ' A' ' 160' ' ' VAL . 2.8 t0 82.62 -5.98 1.32 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.882 -179.825 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.46 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 88.46 -47.27 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 179.197 . . . . . . . . 3 3 . 1 . 052 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.455 ' CE2' ' HB3' ' A' ' 159' ' ' ASP . 11.5 p90 -68.22 -34.07 75.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.005 0.431 . . . . 0.0 110.943 -179.542 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.72 ' CD1' HD13 ' A' ' 169' ' ' ILE . 0.1 OUTLIER -69.83 -55.74 8.98 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.979 179.822 . . . . . . . . 3 3 . 1 . 052 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.453 HD22 HE21 ' A' ' 157' ' ' GLN . 3.7 tp -65.47 -4.13 5.37 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.539 0.685 . . . . 0.0 109.639 178.437 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.424 ' H ' ' C ' ' A' ' 162' ' ' PHE . 0.4 OUTLIER -75.06 -47.52 28.47 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.584 -179.701 . . . . . . . . 3 3 . 1 . 052 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.21 -35.41 80.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.678 179.512 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.844 HD23 ' CG ' ' A' ' 168' ' ' PRO . 0.1 OUTLIER -161.0 138.23 6.7 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.784 -179.23 . . . . . . . . 3 3 . 1 . 052 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.553 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 18.4 Cg_endo -64.85 -32.57 55.37 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.325 2.017 . . . . 0.0 114.421 -179.169 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.844 ' CG ' HD23 ' A' ' 166' ' ' LEU . 28.5 Cg_endo -87.86 75.38 2.1 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.793 1.662 . . . . 0.0 112.557 -179.362 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.749 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 5.5 tp -77.47 -51.15 18.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.569 -179.875 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.603 HD13 HG23 ' A' ' 169' ' ' ILE . 5.9 mm -62.22 -30.64 49.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.775 -178.582 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 24.6 tp -65.18 -65.23 0.7 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.081 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -77.6 3.83 12.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.449 178.853 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.749 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.63 -70.27 0.33 Allowed 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.825 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 175' ' ' TYR . . . -107.11 -12.69 23.22 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.078 178.244 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 4.0 m-85 69.47 -48.02 0.6 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.703 0.401 . . . . 0.0 111.323 -179.908 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.419 ' O ' ' CG ' ' A' ' 176' ' ' PHE . 0.1 OUTLIER -91.98 -6.89 50.39 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.718 0.294 . . . . 0.0 110.364 179.358 . . . . . . . . 3 3 . 1 . 052 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.523 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 0.1 OUTLIER -52.64 -46.83 95.75 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.209 179.594 . . . . . . . . 3 3 . 1 . 052 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.523 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 24.3 Cg_exo -64.67 64.35 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.782 2.321 . . . . 0.0 112.283 179.967 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' A' ' 177' ' ' LEU . 7.6 tp -97.71 -64.97 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.702 179.816 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -87.22 35.53 0.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.591 179.746 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 053 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.884 0.373 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 053 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.689 ' HA ' HD12 ' A' ' 163' ' ' LEU . 3.5 pp -74.01 127.3 32.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.945 -179.945 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.411 ' OE1' HD21 ' A' ' 163' ' ' LEU . 0.1 OUTLIER -71.12 -71.62 0.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.962 0.41 . . . . 0.0 110.699 179.962 . . . . . . . . 3 3 . 1 . 053 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 19.4 p -163.76 33.43 0.08 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.293 179.645 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.404 ' O ' HG12 ' A' ' 160' ' ' VAL . 6.2 m-20 -162.15 -54.61 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.567 179.912 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.635 HG23 ' CB ' ' A' ' 156' ' ' LEU . 0.4 OUTLIER 77.29 -45.59 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.315 179.953 . . . . . . . . 3 3 . 1 . 053 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -75.11 10.57 1.45 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.692 179.843 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -162.84 9.03 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.447 -179.983 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.689 HD12 ' HA ' ' A' ' 156' ' ' LEU . 0.6 OUTLIER -66.12 -35.43 80.47 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.06 . . . . . . . . 3 3 . 1 . 053 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.418 ' HB3' ' O ' ' A' ' 163' ' ' LEU . 36.3 t80 70.26 3.15 4.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.322 179.018 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.528 ' HB2' HD22 ' A' ' 163' ' ' LEU . 0.1 OUTLIER -67.54 -56.52 9.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.111 0.481 . . . . 0.0 110.259 179.071 . . . . . . . . 3 3 . 1 . 053 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.479 ' N ' ' CD ' ' A' ' 167' ' ' PRO . 0.6 OUTLIER -161.34 48.08 0.23 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.186 -179.716 . . . . . . . . 3 3 . 1 . 053 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.552 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 18.4 Cg_endo -65.31 -30.36 54.04 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.206 1.937 . . . . 0.0 114.393 -179.482 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 23.1 Cg_endo -92.25 81.41 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.037 1.825 . . . . 0.0 112.881 -179.47 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.922 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -73.31 -109.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.163 . . . . . . . . 3 3 . 1 . 053 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.605 ' HA ' HD12 ' A' ' 177' ' ' LEU . 4.7 mt 26.77 -62.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.567 0.747 . . . . 0.0 112.539 178.655 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.922 ' N ' ' O ' ' A' ' 169' ' ' ILE . 3.1 mm? -66.8 -52.38 44.62 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.699 179.914 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.03 -19.31 60.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.76 179.608 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -78.3 -73.07 0.34 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.118 -179.651 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -109.12 -25.98 5.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.601 -179.988 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.457 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 25.5 t80 74.49 -39.37 0.42 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.659 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.66 -10.02 35.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.592 0.234 . . . . 0.0 110.87 179.801 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.605 HD12 ' HA ' ' A' ' 170' ' ' ILE . 11.3 mt -49.13 -43.69 69.59 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.063 179.441 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 31.4 Cg_exo -60.07 -10.5 12.79 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.731 2.287 . . . . 0.0 113.012 -179.982 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 41.3 tp -57.97 -55.55 33.44 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.051 0.453 . . . . 0.0 110.616 179.874 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.9 43.82 1.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.939 179.659 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . 0.408 ' HB2' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.414 ' O ' ' CD1' ' A' ' 155' ' ' PHE . 28.0 t80 . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.818 0.342 . . . . 0.0 111.721 . . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 27.3 mt 60.06 29.96 19.48 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.022 179.649 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -170.77 -31.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.235 -179.919 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.552 ' OG ' HD13 ' A' ' 163' ' ' LEU . 92.1 p -73.52 60.85 0.67 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.099 0.476 . . . . 0.0 110.734 179.907 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.449 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.6 OUTLIER 75.53 -60.37 0.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.237 -179.987 . . . . . . . . 3 3 . 1 . 054 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 75.5 t 73.08 -48.7 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.184 -179.832 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.423 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 0.0 OUTLIER -73.92 5.49 4.14 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.259 179.27 . . . . . . . . 3 3 . 1 . 054 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.423 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 74.6 m-85 -159.83 8.01 0.1 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.667 179.852 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.552 HD13 ' OG ' ' A' ' 158' ' ' SER . 30.4 tp -72.1 -2.57 19.01 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.492 0.663 . . . . 0.0 109.432 177.504 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.576 ' HA ' ' HG3' ' A' ' 167' ' ' PRO . 35.7 t80 -62.98 -7.13 4.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.556 -179.09 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.443 ' HA ' HD22 ' A' ' 165' ' ' LEU . 0.2 OUTLIER -64.89 -38.57 91.4 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.169 0.509 . . . . 0.0 109.632 177.997 . . . . . . . . 3 3 . 1 . 054 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.519 ' N ' ' HD3' ' A' ' 167' ' ' PRO . 0.2 OUTLIER -164.57 55.79 0.45 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.378 -179.646 . . . . . . . . 3 3 . 1 . 054 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.576 ' HG3' ' HA ' ' A' ' 164' ' ' PHE . 13.5 Cg_exo -63.7 -52.67 1.69 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.226 1.951 . . . . 0.0 113.156 -179.581 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.709 ' HB3' HD11 ' A' ' 171' ' ' LEU . 42.1 Cg_endo -91.18 88.04 0.28 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.799 2.333 . . . . 0.0 113.321 -178.702 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 1.021 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 4.9 tt -79.14 -36.61 18.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.015 0.436 . . . . 0.0 111.231 179.535 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.426 ' O ' ' HB3' ' A' ' 173' ' ' ALA . 2.4 mp -80.23 -60.79 2.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.713 -178.859 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.709 HD11 ' HB3' ' A' ' 168' ' ' PRO . 0.2 OUTLIER -63.09 -48.97 76.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.903 0.382 . . . . 0.0 110.444 -179.199 . . . . . . . . 3 3 . 1 . 054 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.528 ' HB2' ' HG2' ' A' ' 168' ' ' PRO . 0.6 OUTLIER -73.14 -2.79 22.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.859 179.088 . . . . . . . . 3 3 . 1 . 054 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 1.021 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -74.3 -66.86 0.68 Allowed 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.179 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -123.54 -11.56 4.98 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.016 178.889 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 20.0 t80 77.64 -30.08 0.16 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 122.624 0.369 . . . . 0.0 111.842 -179.895 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -99.82 13.97 31.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.67 0.271 . . . . 0.0 111.192 179.775 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.554 HD12 ' HB3' ' A' ' 173' ' ' ALA . 6.0 mt -87.05 -46.84 0.51 Allowed Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.394 -179.842 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 66.9 Cg_exo -50.3 -22.58 8.68 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.291 1.994 . . . . 0.0 112.473 179.786 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.81 -9.37 43.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.88 -179.689 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -147.66 47.82 1.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.964 0.411 . . . . 0.0 110.487 179.953 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 055 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 66.3 t80 . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 055 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.39 101.83 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.129 179.457 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -169.79 89.67 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.022 -179.992 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.8 t 66.93 61.62 0.5 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.851 179.879 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.568 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.8 OUTLIER 70.81 -57.17 0.6 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.355 179.816 . . . . . . . . 3 3 . 1 . 055 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.568 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 85.2 t 83.53 -65.3 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.22 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.404 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 0.3 OUTLIER -75.67 48.24 0.45 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.263 178.41 . . . . . . . . 3 3 . 1 . 055 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.404 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 3.7 m-85 -169.53 -30.54 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.737 -179.876 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.589 ' O ' ' N ' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -56.33 -60.47 3.47 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 178.156 . . . . . . . . 3 3 . 1 . 055 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 9.2 t80 58.59 -34.36 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.328 175.92 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.589 ' N ' ' O ' ' A' ' 163' ' ' LEU . 7.8 mt -63.06 -43.07 99.62 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.007 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.574 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 0.2 OUTLIER -163.15 78.49 1.73 Allowed Pre-proline 0 N--CA 1.453 -0.279 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.486 -178.994 . . . . . . . . 3 3 . 1 . 055 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.4 ' HA ' ' HD2' ' A' ' 168' ' ' PRO . 36.9 Cg_endo -66.6 105.97 1.0 Allowed 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.2 1.933 . . . . 0.0 111.802 179.47 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.574 ' HD3' ' O ' ' A' ' 166' ' ' LEU . 72.4 Cg_endo -74.02 44.82 1.04 Allowed 'Trans proline' 0 CA--C 1.529 0.232 0 C-N-CA 122.952 2.435 . . . . 0.0 113.149 -179.718 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.998 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 23.0 pt -79.34 -43.72 23.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -179.886 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.458 HD12 ' H ' ' A' ' 170' ' ' ILE . 3.3 mp -76.76 -47.31 28.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.01 -179.252 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 38.1 tp -63.86 -54.48 34.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.346 0.593 . . . . 0.0 109.56 179.751 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.22 -3.47 26.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.849 179.014 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.998 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.96 -73.7 0.2 Allowed 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.299 0.571 . . . . 0.0 109.555 179.484 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -118.52 -13.54 6.77 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.509 178.647 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 5.5 t80 76.37 -45.51 0.51 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.474 0.31 . . . . 0.0 111.363 179.97 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -94.4 -9.37 35.91 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.672 0.272 . . . . 0.0 111.056 179.892 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.558 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 22.7 mt -51.44 -41.66 77.76 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.069 179.452 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 52.2 Cg_exo -54.87 -152.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.605 2.203 . . . . 0.0 112.187 179.752 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 178' ' ' PRO . 0.9 OUTLIER 74.12 71.85 0.11 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.232 0.539 . . . . 0.0 110.29 -179.693 . . . . . . . . 3 3 . 1 . 055 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 69.95 52.68 0.39 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.927 -179.78 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 056 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.555 0.217 . . . . 0.0 111.159 . . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' A' ' 156' ' ' LEU . 5.1 mt -168.73 169.71 9.83 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.882 0.372 . . . . 0.0 111.234 -179.579 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -170.36 79.4 0.09 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.897 179.873 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 51.66 69.6 0.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.105 179.995 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.578 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER 70.67 -57.27 0.59 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.44 179.876 . . . . . . . . 3 3 . 1 . 056 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.578 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 95.0 t 85.05 -59.88 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 122.827 0.451 . . . . 0.0 110.312 -179.555 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.468 ' O ' ' CG ' ' A' ' 161' ' ' PHE . 0.1 OUTLIER -74.45 41.35 0.14 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.994 179.205 . . . . . . . . 3 3 . 1 . 056 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.477 ' CE1' ' HB2' ' A' ' 159' ' ' ASP . 0.0 OUTLIER -173.43 -21.51 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.552 179.544 . . . . . . . . 3 3 . 1 . 056 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.573 ' C ' ' H ' ' A' ' 165' ' ' LEU . 5.1 tt -53.68 -53.12 56.45 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 178.223 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 3.1 t80 59.66 -29.72 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 114.846 -1.07 . . . . 0.0 113.489 176.412 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.573 ' H ' ' C ' ' A' ' 163' ' ' LEU . 1.4 tp -178.1 -32.29 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.068 0.461 . . . . 0.0 110.582 -179.377 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.53 ' N ' HD23 ' A' ' 163' ' ' LEU . 0.1 OUTLIER -158.02 114.36 1.79 Allowed Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.479 -179.367 . . . . . . . . 3 3 . 1 . 056 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.464 ' HD3' HD21 ' A' ' 163' ' ' LEU . 90.2 Cg_endo -83.51 106.76 1.34 Allowed 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.25 1.967 . . . . 0.0 112.789 -179.018 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 167' ' ' PRO . 55.7 Cg_endo -68.79 62.88 1.27 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.381 2.054 . . . . 0.0 111.679 179.406 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.989 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER -75.02 -43.97 44.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.426 -179.363 . . . . . . . . 3 3 . 1 . 056 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.444 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.2 mp -73.4 -47.55 45.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.676 -179.254 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.493 HD23 ' N ' ' A' ' 172' ' ' ASP . 0.3 OUTLIER -65.99 -56.81 9.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.13 0.49 . . . . 0.0 109.874 179.802 . . . . . . . . 3 3 . 1 . 056 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.493 ' N ' HD23 ' A' ' 171' ' ' LEU . 0.3 OUTLIER -75.02 5.11 5.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.693 179.358 . . . . . . . . 3 3 . 1 . 056 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.989 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.34 -63.69 1.1 Allowed 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.54 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 175' ' ' TYR . . . -112.05 -11.88 15.21 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.382 178.495 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.438 ' HB2' ' O ' ' A' ' 174' ' ' GLY . 16.0 m-85 68.3 -50.74 0.55 Allowed 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 122.687 0.395 . . . . 0.0 111.36 179.915 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -91.38 -7.26 51.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.801 179.719 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.498 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 12.1 mt -50.26 -47.56 82.24 Favored Pre-proline 0 CA--C 1.529 0.145 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.695 179.44 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 71.1 Cg_exo -50.39 -174.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.76 2.307 . . . . 0.0 112.22 179.483 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 178' ' ' PRO . 0.3 OUTLIER 80.02 73.91 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.112 0.482 . . . . 0.0 110.34 -179.767 . . . . . . . . 3 3 . 1 . 056 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 24.9 mtm180 68.87 56.25 0.43 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.758 -179.609 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 057 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.861 0.362 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 057 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 157' ' ' GLN . 4.3 pp -165.34 -170.64 1.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.034 -179.592 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.631 ' N ' HD12 ' A' ' 156' ' ' LEU . 1.1 mm-40 -169.73 91.19 0.21 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.621 179.933 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.785 ' HB3' HD13 ' A' ' 163' ' ' LEU . 0.6 OUTLIER 63.29 32.81 14.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.148 -179.607 . . . . . . . . 3 3 . 1 . 057 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.417 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER 78.43 -51.68 0.48 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.194 -179.693 . . . . . . . . 3 3 . 1 . 057 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 76.4 t 69.88 -60.38 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 121.129 0.49 . . . . 0.0 110.847 -179.754 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -76.67 10.33 2.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.077 179.088 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -165.05 14.06 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.223 -179.836 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.785 HD13 ' HB3' ' A' ' 158' ' ' SER . 0.9 OUTLIER -67.75 -39.46 84.19 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.196 . . . . . . . . 3 3 . 1 . 057 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.49 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER 47.71 29.2 1.46 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.466 179.886 . . . . . . . . 3 3 . 1 . 057 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.49 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.2 OUTLIER 89.82 -30.39 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.219 -179.379 . . . . . . . . 3 3 . 1 . 057 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.86 83.34 1.52 Allowed Pre-proline 0 N--CA 1.449 -0.478 0 CA-C-O 120.732 0.301 . . . . 0.0 110.749 -178.884 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.767 ' CD ' HD12 ' A' ' 163' ' ' LEU . 33.6 Cg_endo -65.32 109.5 1.38 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.536 2.157 . . . . 0.0 112.416 -179.611 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.815 ' O ' HD12 ' A' ' 170' ' ' ILE . 72.6 Cg_endo -74.38 -158.38 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.422 2.081 . . . . 0.0 111.567 179.467 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.753 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.5 OUTLIER 80.66 -41.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.295 -179.66 . . . . . . . . 3 3 . 1 . 057 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.815 HD12 ' O ' ' A' ' 168' ' ' PRO . 3.5 mp -73.98 -42.73 52.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.847 179.992 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 10.5 mt -63.43 -54.51 35.45 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.214 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.88 0.48 15.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.824 178.446 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.753 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.06 -77.51 0.1 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.893 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.491 ' HA3' HD12 ' A' ' 177' ' ' LEU . . . -98.46 -3.17 57.55 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.386 178.392 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER 71.55 -61.52 0.49 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.91 0.386 . . . . 0.0 110.838 179.987 . . . . . . . . 3 3 . 1 . 057 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.897 ' O ' HD13 ' A' ' 179' ' ' LEU . 36.8 p90 -107.67 -17.84 13.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.231 179.934 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.51 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 66.3 mt -54.53 -43.8 98.35 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.757 -179.584 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 24.4 Cg_exo -65.23 68.83 0.3 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.657 2.238 . . . . 0.0 112.742 -179.573 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.897 HD13 ' O ' ' A' ' 176' ' ' PHE . 4.0 mp -117.24 -16.24 10.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.96 0.41 . . . . 0.0 111.049 179.504 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -149.06 52.97 0.97 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.404 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 058 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 18.2 p90 . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.764 0.316 . . . . 0.0 111.297 . . . . . . . . . 0 0 . 1 . 058 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.435 ' O ' ' CB ' ' A' ' 157' ' ' GLN . 20.9 mt 60.69 179.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.883 179.952 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.435 ' CB ' ' O ' ' A' ' 156' ' ' LEU . 0.1 OUTLIER 84.87 48.68 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.265 0.555 . . . . 0.0 110.35 -179.697 . . . . . . . . 3 3 . 1 . 058 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 31.4 t -164.11 35.83 0.08 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.1 179.773 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.527 ' O ' HG12 ' A' ' 160' ' ' VAL . 0.9 OUTLIER 79.02 -41.73 0.28 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.091 -179.475 . . . . . . . . 3 3 . 1 . 058 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 88.73 -42.07 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.207 179.963 . . . . . . . . 3 3 . 1 . 058 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.438 ' HA ' ' HB2' ' A' ' 164' ' ' PHE . 0.5 OUTLIER -68.04 -26.84 66.07 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.0 0.428 . . . . 0.0 110.581 179.515 . . . . . . . . 3 3 . 1 . 058 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -67.74 -60.31 2.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.599 179.562 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 17.4 mt -66.26 -4.4 7.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.706 178.534 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.438 ' HB2' ' HA ' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -74.71 -8.28 55.92 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.251 -179.509 . . . . . . . . 3 3 . 1 . 058 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.32 -34.31 78.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.101 0.477 . . . . 0.0 110.275 179.112 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.461 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 0.2 OUTLIER -162.08 63.37 1.51 Allowed Pre-proline 0 N--CA 1.452 -0.33 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.895 -179.535 . . . . . . . . 3 3 . 1 . 058 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -61.32 107.06 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.719 2.279 . . . . 0.0 113.063 -179.005 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.611 ' HA ' HD21 ' A' ' 171' ' ' LEU . 93.4 Cg_endo -76.82 86.17 1.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.865 2.377 . . . . 0.0 111.523 178.983 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.766 HD13 ' O ' ' A' ' 169' ' ' ILE . 0.0 OUTLIER -162.01 -42.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.587 0.708 . . . . 0.0 110.832 -179.114 . . . . . . . . 3 3 . 1 . 058 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.638 ' CG1' HD13 ' A' ' 171' ' ' LEU . 11.1 pt -68.15 -38.37 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.57 -178.355 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.833 HD13 ' H ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -60.73 -57.3 13.29 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.085 . . . . . . . . 3 3 . 1 . 058 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.21 -2.65 35.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.845 178.334 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.7 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.03 -67.24 0.58 Allowed 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 121.056 0.455 . . . . 0.0 110.088 -179.93 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -109.34 -16.47 11.1 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.734 178.942 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.534 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.5 OUTLIER 77.33 -12.93 1.0 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 179.924 . . . . . . . . 3 3 . 1 . 058 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -120.86 -12.51 8.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.557 0.218 . . . . 0.0 111.327 -179.981 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.541 ' O ' HD23 ' A' ' 179' ' ' LEU . 83.5 mt -55.29 -41.72 92.18 Favored Pre-proline 0 CA--C 1.531 0.233 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.782 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 52.5 Cg_exo -56.18 76.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.501 2.134 . . . . 0.0 112.98 -179.64 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 177' ' ' LEU . 0.4 OUTLIER -115.36 -6.91 12.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.941 0.4 . . . . 0.0 110.931 179.337 . . . . . . . . 3 3 . 1 . 058 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.434 ' HD3' HD12 ' A' ' 179' ' ' LEU . 0.0 OUTLIER -150.94 43.42 0.8 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.463 . . . . . . . . 3 3 . 1 . 058 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 059 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.645 ' CD2' HG21 ' A' ' 160' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.703 0.287 . . . . 0.0 111.111 . . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.729 HD12 ' N ' ' A' ' 157' ' ' GLN . 3.6 pp -165.21 -168.47 1.4 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.895 -179.91 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.729 ' N ' HD12 ' A' ' 156' ' ' LEU . 0.0 OUTLIER 79.24 82.08 0.06 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.02 0.438 . . . . 0.0 110.85 -179.772 . . . . . . . . 3 3 . 1 . 059 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.3 p 50.95 51.44 17.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.194 179.971 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.546 ' O ' HG12 ' A' ' 160' ' ' VAL . 0.4 OUTLIER 74.13 -52.52 0.69 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.471 179.774 . . . . . . . . 3 3 . 1 . 059 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.645 HG21 ' CD2' ' A' ' 155' ' ' PHE . 0.3 OUTLIER 94.23 -40.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.016 0.527 . . . . 0.0 110.952 -179.698 . . . . . . . . 3 3 . 1 . 059 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -70.01 -30.14 67.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.041 0.448 . . . . 0.0 110.55 179.529 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.425 ' C ' ' H ' ' A' ' 164' ' ' PHE . 3.3 m-85 -67.66 -59.26 3.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.747 179.723 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.1 mt -65.68 -3.55 4.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.846 178.593 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.425 ' H ' ' C ' ' A' ' 162' ' ' PHE . 1.6 t80 -74.11 -19.2 60.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.101 -179.584 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.2 -35.38 80.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.059 0.457 . . . . 0.0 110.637 179.544 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' A' ' 166' ' ' LEU . 4.5 mt -162.17 71.32 2.29 Favored Pre-proline 0 N--CA 1.45 -0.442 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.446 -178.884 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.415 ' CB ' ' HD3' ' A' ' 168' ' ' PRO . 4.0 Cg_exo -36.71 -49.12 1.42 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.517 2.811 . . . . 0.0 113.609 -179.587 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.778 ' O ' HD12 ' A' ' 170' ' ' ILE . 61.4 Cg_endo -88.64 -52.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.362 2.041 . . . . 0.0 113.077 -179.161 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.825 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.0 OUTLIER 81.02 -45.19 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 179.439 . . . . . . . . 3 3 . 1 . 059 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.778 HD12 ' O ' ' A' ' 168' ' ' PRO . 2.3 mp -73.11 -47.13 48.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.882 0.372 . . . . 0.0 111.783 -179.195 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.56 -0.58 5.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.058 -179.873 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -147.05 15.27 1.17 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.468 -179.926 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.825 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -79.93 -47.31 15.22 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.911 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.418 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -129.77 -22.64 1.14 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.981 178.684 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 34.9 t80 71.62 -12.59 0.62 Allowed 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 122.507 0.323 . . . . 0.0 111.386 -179.344 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.418 ' H ' ' C ' ' A' ' 174' ' ' GLY . 7.2 t80 -96.02 -6.42 38.85 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.795 0.331 . . . . 0.0 110.143 178.959 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.442 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 1.4 mm? -47.8 -52.15 41.19 Favored Pre-proline 0 CA--C 1.529 0.142 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.311 179.506 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.442 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 49.5 Cg_exo -57.41 -157.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.66 2.24 . . . . 0.0 112.057 179.296 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.406 ' CB ' ' O ' ' A' ' 178' ' ' PRO . 9.5 tp 81.93 -9.8 1.19 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.757 179.961 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.59 31.21 0.52 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.448 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 060 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.408 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.572 0.225 . . . . 0.0 111.181 . . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.827 ' CD2' HG23 ' A' ' 160' ' ' VAL . 32.3 mt -161.14 23.64 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.448 -179.88 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.05 -27.56 60.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.052 0.453 . . . . 0.0 110.278 179.245 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 162' ' ' PHE . 0.6 OUTLIER -78.3 8.36 5.12 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.012 -179.807 . . . . . . . . 3 3 . 1 . 060 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.405 ' O ' ' CB ' ' A' ' 160' ' ' VAL . 0.3 OUTLIER 79.87 -6.64 1.75 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 179.896 . . . . . . . . 3 3 . 1 . 060 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.827 HG23 ' CD2' ' A' ' 156' ' ' LEU . 0.4 OUTLIER 82.99 -54.69 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-O 120.822 0.344 . . . . 0.0 110.513 -179.949 . . . . . . . . 3 3 . 1 . 060 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.501 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 67.5 m-85 -78.24 34.11 0.2 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.092 179.115 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.501 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 53.6 m-85 -166.79 -18.15 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.741 -0.208 . . . . 0.0 111.518 -179.77 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.548 ' C ' ' H ' ' A' ' 165' ' ' LEU . 15.0 tp -59.27 -40.98 87.78 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.311 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.441 ' CE2' ' CD1' ' A' ' 165' ' ' LEU . 0.0 OUTLIER 64.57 -25.29 0.08 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.335 178.065 . . . . . . . . 3 3 . 1 . 060 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.548 ' H ' ' C ' ' A' ' 163' ' ' LEU . 4.5 mp -67.57 -67.98 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.938 0.399 . . . . 0.0 111.115 -179.99 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.536 ' O ' ' HD3' ' A' ' 168' ' ' PRO . 0.2 OUTLIER -162.81 102.85 1.04 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.13 -179.493 . . . . . . . . 3 3 . 1 . 060 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.593 ' CB ' HG22 ' A' ' 160' ' ' VAL . 97.0 Cg_endo -86.76 98.23 0.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.56 2.173 . . . . 0.0 113.231 -179.115 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 166' ' ' LEU . 42.2 Cg_endo -64.79 72.19 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.678 2.252 . . . . 0.0 111.591 179.032 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.966 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 3.5 tp -76.97 -37.3 26.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.755 -179.276 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.856 HD13 HG23 ' A' ' 169' ' ' ILE . 8.1 mm -73.79 -51.71 23.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.193 -178.781 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 171' ' ' LEU . 3.4 mm? -64.14 -49.17 73.21 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.715 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -75.03 -4.08 36.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.955 178.516 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.966 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.17 -68.37 0.5 Allowed 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.234 0.54 . . . . 0.0 109.714 179.656 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.615 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -121.72 -8.89 7.25 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.939 178.929 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.49 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.2 OUTLIER 55.76 -53.58 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.883 0.873 . . . . 0.0 112.416 -179.994 . . . . . . . . 3 3 . 1 . 060 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.615 ' N ' ' O ' ' A' ' 174' ' ' GLY . 29.0 t80 -90.36 -4.94 56.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.611 0.244 . . . . 0.0 110.744 179.789 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 179' ' ' LEU . 16.8 mt -52.54 -49.38 86.17 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.889 179.47 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.498 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 84.2 Cg_exo -46.15 82.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.011 2.474 . . . . 0.0 112.748 179.538 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 177' ' ' LEU . 0.3 OUTLIER -94.34 -61.76 1.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.061 179.568 . . . . . . . . 3 3 . 1 . 060 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.01 38.12 0.79 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.811 179.028 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 061 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.418 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 5.2 p90 . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.74 0.305 . . . . 0.0 111.144 . . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 155' ' ' PHE . 20.7 mt -163.32 -177.88 5.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.847 -179.982 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.76 HE21 HD11 ' A' ' 169' ' ' ILE . 5.7 tp-100 78.33 65.42 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.782 -179.825 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.405 ' HB3' ' CD1' ' A' ' 163' ' ' LEU . 0.3 OUTLIER 58.87 58.81 3.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.521 -179.928 . . . . . . . . 3 3 . 1 . 061 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 73.7 -58.99 0.57 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.913 -179.64 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.424 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 84.32 -48.33 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.914 -179.843 . . . . . . . . 3 3 . 1 . 061 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.462 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 15.7 t80 -76.47 23.91 0.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.716 179.691 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.462 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 19.6 m-85 -168.63 -10.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.953 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.929 HD22 ' HB2' ' A' ' 165' ' ' LEU . 0.4 OUTLIER -61.9 -48.86 78.57 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.235 . . . . . . . . 3 3 . 1 . 061 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 58.11 -0.61 0.1 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.23 -0.895 . . . . 0.0 112.168 178.473 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.929 ' HB2' HD22 ' A' ' 163' ' ' LEU . 0.6 OUTLIER -71.34 -36.83 71.68 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 120.803 0.335 . . . . 0.0 111.573 179.883 . . . . . . . . 3 3 . 1 . 061 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.951 ' O ' HD22 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -158.7 95.02 1.84 Allowed Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-O 121.477 0.656 . . . . 0.0 112.644 -176.976 . . . . . . . . 3 3 . 1 . 061 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.585 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 17.7 Cg_endo -65.76 -28.96 51.3 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.246 1.964 . . . . 0.0 113.974 -179.981 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.62 ' HB2' HD13 ' A' ' 171' ' ' LEU . 20.4 Cg_endo -92.59 93.57 0.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.143 1.895 . . . . 0.0 112.764 -179.359 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.784 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 2.1 tt -75.26 -33.28 27.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.3 -179.925 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.519 ' H ' HD12 ' A' ' 170' ' ' ILE . 4.2 mp -67.58 -35.05 71.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.342 -179.22 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.62 HD13 ' HB2' ' A' ' 168' ' ' PRO . 0.9 OUTLIER -66.31 -60.51 2.71 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.897 . . . . . . . . 3 3 . 1 . 061 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.917 ' OD2' HD23 ' A' ' 166' ' ' LEU . 1.6 p30 -76.29 4.46 8.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.269 178.692 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.784 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.94 -68.52 0.45 Allowed 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.741 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.418 ' HA3' ' CG ' ' A' ' 177' ' ' LEU . . . -103.37 -13.76 27.66 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 178.032 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.452 ' CG ' ' N ' ' A' ' 176' ' ' PHE . 0.0 OUTLIER 72.64 -53.56 0.7 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.53 0.332 . . . . 0.0 111.534 179.48 . . . . . . . . 3 3 . 1 . 061 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.452 ' N ' ' CG ' ' A' ' 175' ' ' TYR . 26.1 t80 -93.84 18.99 9.43 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.359 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.472 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 6.2 mt -88.12 -47.35 0.46 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.715 -0.221 . . . . 0.0 111.227 179.673 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.534 ' O ' ' HG2' ' A' ' 181' ' ' HSL . 32.2 Cg_exo -58.33 -22.16 56.49 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.463 2.108 . . . . 0.0 112.353 -179.955 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.13 -58.77 5.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.763 179.984 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -88.31 29.2 0.99 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.961 179.954 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . 0.534 ' HG2' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.609 ' HE1' HG21 ' A' ' 160' ' ' VAL . 38.5 p90 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.727 0.299 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.568 HD12 ' O ' ' A' ' 155' ' ' PHE . 1.2 mp -164.71 141.66 6.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.925 179.969 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -170.51 78.51 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.069 179.948 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 16.0 m 53.42 69.26 0.72 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.015 179.898 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.469 ' O ' HG12 ' A' ' 160' ' ' VAL . 0.4 OUTLIER 72.85 -59.47 0.57 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.816 -179.786 . . . . . . . . 3 3 . 1 . 062 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.609 HG21 ' HE1' ' A' ' 155' ' ' PHE . 0.4 OUTLIER 90.47 -46.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.363 179.786 . . . . . . . . 3 3 . 1 . 062 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.423 ' CD1' HG21 ' A' ' 169' ' ' ILE . 8.6 m-85 -70.36 -34.05 72.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.0 0.429 . . . . 0.0 110.958 179.998 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.412 ' C ' ' H ' ' A' ' 164' ' ' PHE . 0.1 OUTLIER -68.54 -59.37 3.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.159 179.913 . . . . . . . . 3 3 . 1 . 062 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 25.2 mt -66.52 -3.28 5.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.975 178.839 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.717 ' CE2' HD12 ' A' ' 169' ' ' ILE . 0.1 OUTLIER -77.66 11.9 1.89 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.944 -179.374 . . . . . . . . 3 3 . 1 . 062 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.547 ' O ' HD13 ' A' ' 165' ' ' LEU . 0.2 OUTLIER 89.6 -25.52 0.07 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.678 0.391 . . . . 0.0 112.002 179.5 . . . . . . . . 3 3 . 1 . 062 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.584 HD23 ' HD2' ' A' ' 168' ' ' PRO . 0.1 OUTLIER -162.33 129.86 2.68 Favored Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.814 -178.488 . . . . . . . . 3 3 . 1 . 062 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.52 ' HG2' ' HD3' ' A' ' 168' ' ' PRO . 1.3 Cg_endo -48.58 -42.31 35.81 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.885 2.39 . . . . 0.0 113.717 -179.902 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.584 ' HD2' HD23 ' A' ' 166' ' ' LEU . 37.7 Cg_endo -87.04 76.6 2.23 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.254 1.969 . . . . 0.0 113.354 -178.834 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.889 ' O ' ' N ' ' A' ' 171' ' ' LEU . 2.5 tt -72.37 -90.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.271 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.834 ' H ' HG23 ' A' ' 169' ' ' ILE . 14.7 mt 25.62 -63.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 123.676 0.79 . . . . 0.0 112.762 177.863 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.889 ' N ' ' O ' ' A' ' 169' ' ' ILE . 17.4 mt -66.5 -43.63 84.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.246 -179.628 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.59 -15.88 60.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.35 -179.924 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -76.16 -90.34 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.337 179.966 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.483 ' HA3' HD12 ' A' ' 177' ' ' LEU . . . -105.55 -10.64 30.72 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.642 178.784 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.409 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 60.7 t80 68.3 -61.26 0.4 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.925 0.393 . . . . 0.0 110.411 -179.629 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 174' ' ' GLY . 21.3 t80 -107.81 10.92 28.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.87 179.112 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.63 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 71.6 mt -91.59 -49.91 0.32 Allowed Pre-proline 0 CA--C 1.53 0.174 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -179.673 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.792 ' HB2' HG23 ' A' ' 170' ' ' ILE . 3.0 Cg_exo -76.23 -68.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.682 2.255 . . . . 0.0 112.317 -179.79 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.1 tp 69.54 63.81 0.26 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.597 -179.854 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.577 HH21 HD21 ' A' ' 171' ' ' LEU . 5.2 mmp_? 60.95 47.99 7.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.671 -179.869 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 063 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.663 ' HD1' HD23 ' A' ' 156' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.908 0.385 . . . . 0.0 111.301 . . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.816 ' CB ' HG23 ' A' ' 160' ' ' VAL . 0.2 OUTLIER 55.06 -177.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.404 179.863 . . . . . . . . 3 3 . 1 . 063 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.419 ' HB2' ' CD2' ' A' ' 163' ' ' LEU . 1.7 mt-30 -169.59 -58.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.677 179.854 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 30.2 t -163.88 29.89 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.047 0.451 . . . . 0.0 111.332 179.618 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -165.8 -54.57 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.875 179.428 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.816 HG23 ' CB ' ' A' ' 156' ' ' LEU . 0.4 OUTLIER 67.46 -53.43 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.725 179.616 . . . . . . . . 3 3 . 1 . 063 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.476 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 0.1 OUTLIER -74.83 3.01 8.84 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.755 . . . . . . . . 3 3 . 1 . 063 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.534 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 0.0 OUTLIER -167.14 9.56 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.994 . . . . . . . . 3 3 . 1 . 063 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.469 ' CD2' ' HB2' ' A' ' 165' ' ' LEU . 12.1 tp -63.86 -33.82 76.54 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.727 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 10.3 t80 57.64 6.93 0.48 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.631 178.221 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.469 ' HB2' ' CD2' ' A' ' 163' ' ' LEU . 0.2 OUTLIER -70.35 -42.71 71.49 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.131 0.491 . . . . 0.0 110.534 179.252 . . . . . . . . 3 3 . 1 . 063 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.96 129.32 2.93 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.441 -179.496 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.411 ' HB2' HG12 ' A' ' 169' ' ' ILE . 14.9 Cg_endo -57.6 119.52 6.83 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.376 2.05 . . . . 0.0 112.216 -179.713 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -86.24 29.38 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.927 2.418 . . . . 0.0 113.232 -179.547 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.878 ' O ' ' N ' ' A' ' 171' ' ' LEU . 3.0 pt -75.44 -111.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.304 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.74 HG22 ' HG3' ' A' ' 178' ' ' PRO . 3.2 mp 33.78 -60.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 123.889 0.876 . . . . 0.0 113.139 178.597 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.878 ' N ' ' O ' ' A' ' 169' ' ' ILE . 0.1 OUTLIER -64.07 -44.48 92.27 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.856 -179.587 . . . . . . . . 3 3 . 1 . 063 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 52.7 p30 -71.72 -10.26 59.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.975 179.818 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -78.29 -63.08 1.48 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.844 0.354 . . . . 0.0 110.815 179.925 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -114.63 -21.78 5.31 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.325 179.751 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER 76.79 -10.98 1.24 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.878 . . . . . . . . 3 3 . 1 . 063 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.8 7.87 3.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.715 0.293 . . . . 0.0 111.011 179.609 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.551 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 98.0 mt -84.0 -41.79 0.76 Allowed Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.347 179.856 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.74 ' HG3' HG22 ' A' ' 170' ' ' ILE . 52.7 Cg_exo -53.87 -168.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.447 2.098 . . . . 0.0 112.384 -179.876 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.422 ' O ' ' HG3' ' A' ' 180' ' ' ARG . 0.6 OUTLIER 81.65 -9.7 1.23 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.474 -179.815 . . . . . . . . 3 3 . 1 . 063 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 179' ' ' LEU . 8.2 mtm180 -149.48 29.32 0.78 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.41 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 064 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.791 0.329 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 064 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.566 ' C ' HD12 ' A' ' 156' ' ' LEU . 4.4 pp -164.49 -175.12 3.73 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.168 -179.634 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -169.15 -84.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.919 179.813 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.921 ' HB2' HD21 ' A' ' 163' ' ' LEU . 0.5 OUTLIER -76.52 60.22 1.59 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.865 0.364 . . . . 0.0 110.648 179.671 . . . . . . . . 3 3 . 1 . 064 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.408 ' CB ' ' O ' ' A' ' 158' ' ' SER . 0.8 OUTLIER 79.91 -45.05 0.3 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.668 -179.813 . . . . . . . . 3 3 . 1 . 064 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.429 HG21 ' HB3' ' A' ' 156' ' ' LEU . 0.4 OUTLIER 82.42 -48.72 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 120.881 0.372 . . . . 0.0 110.942 -179.707 . . . . . . . . 3 3 . 1 . 064 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.445 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 4.2 m-30 -76.95 26.2 0.14 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.174 179.341 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.445 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 61.0 m-85 -162.95 -1.4 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.197 -179.892 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.921 HD21 ' HB2' ' A' ' 158' ' ' SER . 0.8 OUTLIER -64.31 -37.25 86.84 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.906 . . . . . . . . 3 3 . 1 . 064 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 67.0 10.21 7.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.748 178.922 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -67.57 -56.77 8.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.013 0.435 . . . . 0.0 110.259 179.132 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.586 ' C ' HD12 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -162.88 107.12 1.03 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.876 -179.992 . . . . . . . . 3 3 . 1 . 064 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.15 111.01 2.84 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.25 1.967 . . . . 0.0 112.96 -179.08 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.445 ' O ' ' CB ' ' A' ' 172' ' ' ASP . 61.5 Cg_endo -83.49 37.08 0.63 Allowed 'Trans proline' 0 CA--C 1.527 0.155 0 C-N-CA 123.064 2.509 . . . . 0.0 112.52 179.578 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 1.003 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 9.4 tt -75.97 -43.55 38.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.811 0.338 . . . . 0.0 111.673 -179.351 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.505 HD12 HG22 ' A' ' 169' ' ' ILE . 3.3 mp -76.65 -52.26 17.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.226 -179.144 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.681 HD23 ' H ' ' A' ' 172' ' ' ASP . 0.0 OUTLIER -64.57 -52.72 56.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.085 0.469 . . . . 0.0 109.953 -179.633 . . . . . . . . 3 3 . 1 . 064 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.681 ' H ' HD23 ' A' ' 171' ' ' LEU . 0.4 OUTLIER -74.45 -0.31 17.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.206 179.129 . . . . . . . . 3 3 . 1 . 064 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 1.003 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.62 -69.79 0.39 Allowed 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.408 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -120.88 -11.21 6.51 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.523 178.571 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.479 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 26.3 t80 70.51 -18.31 0.25 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.729 0.412 . . . . 0.0 111.801 -179.913 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.431 ' H ' ' C ' ' A' ' 174' ' ' GLY . 0.3 OUTLIER -97.93 20.61 11.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.858 0.361 . . . . 0.0 110.668 179.849 . . . . . . . . 3 3 . 1 . 064 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.542 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 3.3 mm? -86.47 -46.02 0.56 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.538 -179.749 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.542 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 31.7 Cg_exo -58.49 -77.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.339 2.026 . . . . 0.0 112.361 -179.758 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 180' ' ' ARG . 0.2 OUTLIER 52.98 51.12 16.46 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.018 0.437 . . . . 0.0 110.716 -179.952 . . . . . . . . 3 3 . 1 . 064 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 179' ' ' LEU . 5.1 mmt180 65.63 43.93 3.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.996 179.969 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . 0.488 ' HB2' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.776 0.322 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 065 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.443 ' O ' ' CB ' ' A' ' 157' ' ' GLN . 0.6 OUTLIER -75.37 -162.89 0.21 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 -179.961 . . . . . . . . 3 3 . 1 . 065 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.443 ' CB ' ' O ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER 83.38 77.95 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.993 0.425 . . . . 0.0 110.985 -179.954 . . . . . . . . 3 3 . 1 . 065 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 12.4 t 67.43 32.48 5.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.215 179.671 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.607 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 1.7 t0 75.75 -45.05 0.53 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.663 179.793 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.607 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 97.0 t 88.22 -47.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 123.061 0.545 . . . . 0.0 111.013 -179.661 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -67.63 -30.88 70.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.109 0.48 . . . . 0.0 110.368 179.507 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -69.35 -59.18 3.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.822 179.389 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.502 ' CD1' HG23 ' A' ' 169' ' ' ILE . 16.6 tp -66.15 -4.36 7.38 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.875 178.683 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.1 OUTLIER -75.85 -40.94 53.73 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.904 -179.483 . . . . . . . . 3 3 . 1 . 065 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.6 tp -65.69 -34.59 78.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.786 179.67 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.551 HD23 ' O ' ' A' ' 166' ' ' LEU . 0.6 OUTLIER -160.05 119.48 1.63 Allowed Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.144 -178.749 . . . . . . . . 3 3 . 1 . 065 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.581 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 18.6 Cg_endo -63.06 -29.63 75.2 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.275 1.983 . . . . 0.0 114.312 -179.622 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 30.2 Cg_endo -90.5 91.57 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.886 1.724 . . . . 0.0 113.143 -179.21 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.852 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 24.8 pt -75.6 -42.08 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.752 0.787 . . . . 0.0 110.718 179.35 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.601 ' N ' HG13 ' A' ' 169' ' ' ILE . 2.1 pt -70.28 -41.73 78.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 113.974 -1.466 . . . . 0.0 112.157 -177.777 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 1.0 OUTLIER -61.84 -57.73 10.68 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.096 . . . . . . . . 3 3 . 1 . 065 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -74.8 -1.9 24.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.014 178.44 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.852 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -74.1 -73.51 0.22 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.12 0.486 . . . . 0.0 110.362 179.976 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.536 ' C ' ' CG ' ' A' ' 175' ' ' TYR . . . -98.98 -0.68 57.3 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.02 179.276 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.536 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER 57.68 -53.74 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.672 0.789 . . . . 0.0 112.639 179.451 . . . . . . . . 3 3 . 1 . 065 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 174' ' ' GLY . 2.4 m-85 -93.71 19.97 8.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.649 0.261 . . . . 0.0 111.088 179.912 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.507 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 15.7 mt -84.12 -46.24 0.74 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.94 179.782 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 25.7 Cg_exo -64.38 63.34 0.25 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.884 2.389 . . . . 0.0 112.598 179.911 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 9.9 mt -90.61 -2.34 57.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.914 0.388 . . . . 0.0 110.951 179.661 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.09 44.35 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.523 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 066 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.504 ' O ' HD23 ' A' ' 156' ' ' LEU . 1.1 m-85 . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 . . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.504 HD23 ' O ' ' A' ' 155' ' ' PHE . 0.2 OUTLIER 60.56 140.4 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.253 -179.991 . . . . . . . . 3 3 . 1 . 066 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.604 ' HB2' HD12 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -170.26 72.25 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.038 0.447 . . . . 0.0 110.991 179.993 . . . . . . . . 3 3 . 1 . 066 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.7 p 80.49 -49.72 0.32 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.204 179.504 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -72.99 -55.31 6.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.04 0.448 . . . . 0.0 110.149 179.908 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.5 OUTLIER 73.51 -58.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.818 -179.828 . . . . . . . . 3 3 . 1 . 066 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.508 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 0.2 OUTLIER -74.32 50.1 0.39 Allowed 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.917 . . . . . . . . 3 3 . 1 . 066 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -168.33 -59.32 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.808 -178.566 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.604 HD12 ' HB2' ' A' ' 157' ' ' GLN . 0.2 OUTLIER -68.38 -5.14 17.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.561 178.415 . . . . . . . . 3 3 . 1 . 066 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.3 OUTLIER -78.08 53.17 1.16 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.367 179.962 . . . . . . . . 3 3 . 1 . 066 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.781 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.1 OUTLIER 82.23 -50.17 0.21 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.333 -179.802 . . . . . . . . 3 3 . 1 . 066 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.781 HD12 ' O ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER -168.37 161.52 8.95 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.304 -179.17 . . . . . . . . 3 3 . 1 . 066 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -87.2 112.2 0.88 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.863 2.375 . . . . 0.0 112.085 179.371 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.34 59.5 1.42 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.464 2.109 . . . . 0.0 112.639 -179.748 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.751 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 4.5 tt -77.75 -42.32 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.147 179.832 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.613 HG22 HD22 ' A' ' 177' ' ' LEU . 2.1 mp -68.73 -31.07 49.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.378 -179.38 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.693 ' HA ' HD23 ' A' ' 177' ' ' LEU . 8.9 tp -64.89 -63.65 1.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.116 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.28 4.07 9.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.033 178.534 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.751 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.53 -64.39 0.93 Allowed 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.678 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -108.83 -14.95 14.0 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.25 178.26 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.472 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 46.7 t80 70.63 -14.96 0.39 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.734 0.414 . . . . 0.0 111.744 -179.904 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.424 ' H ' ' C ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER -96.4 11.1 36.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.689 0.281 . . . . 0.0 110.914 179.859 . . . . . . . . 3 3 . 1 . 066 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.693 HD23 ' HA ' ' A' ' 171' ' ' LEU . 0.4 OUTLIER -71.76 -51.46 8.99 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.675 179.903 . . . . . . . . 3 3 . 1 . 066 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.572 ' HG3' HD13 ' A' ' 171' ' ' LEU . 37.7 Cg_exo -61.25 -48.8 9.05 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.791 2.328 . . . . 0.0 112.75 -179.752 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.39 -10.05 56.21 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.595 -179.506 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -147.57 60.54 1.15 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.125 0.488 . . . . 0.0 109.684 179.561 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 067 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.774 0.321 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 067 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.767 ' HA ' HG22 ' A' ' 160' ' ' VAL . 1.0 OUTLIER -164.8 24.52 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.423 -179.853 . . . . . . . . 3 3 . 1 . 067 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -78.39 -45.41 22.47 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.239 0.543 . . . . 0.0 110.168 179.518 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.553 ' OG ' HD22 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -81.81 39.65 0.56 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.3 -179.406 . . . . . . . . 3 3 . 1 . 067 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.558 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.6 OUTLIER 76.13 -18.17 0.48 Allowed 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 179.586 . . . . . . . . 3 3 . 1 . 067 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.767 HG22 ' HA ' ' A' ' 156' ' ' LEU . 50.0 t 87.45 -55.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 C-N-CA 123.013 0.525 . . . . 0.0 111.588 179.659 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.517 ' CE1' HD11 ' A' ' 165' ' ' LEU . 11.9 t80 -67.53 -35.52 79.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.901 0.381 . . . . 0.0 111.032 -179.557 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.467 ' HB2' ' O ' ' A' ' 158' ' ' SER . 1.7 m-85 -68.49 -57.67 5.47 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.767 179.708 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.553 HD22 ' OG ' ' A' ' 158' ' ' SER . 17.6 tp -65.53 -3.11 3.99 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.996 178.654 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.1 OUTLIER -72.36 -80.4 0.06 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.79 -179.191 . . . . . . . . 3 3 . 1 . 067 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.517 HD11 ' CE1' ' A' ' 161' ' ' PHE . 0.0 OUTLIER -69.73 -66.78 0.55 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.319 0.58 . . . . 0.0 110.326 179.259 . . . . . . . . 3 3 . 1 . 067 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -164.18 135.35 3.46 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.338 -179.004 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.6 115.41 3.72 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.075 1.85 . . . . 0.0 112.031 179.822 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.435 ' HD2' ' CD2' ' A' ' 162' ' ' PHE . 66.6 Cg_endo -84.07 20.74 1.16 Allowed 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.892 2.395 . . . . 0.0 113.212 -179.514 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.903 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.4 OUTLIER -72.56 -107.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 118.973 -0.537 . . . . 0.0 109.717 179.754 . . . . . . . . 3 3 . 1 . 067 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.686 ' H ' HG23 ' A' ' 169' ' ' ILE . 15.1 mt 33.24 -62.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.435 0.694 . . . . 0.0 112.734 178.956 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.903 ' N ' ' O ' ' A' ' 169' ' ' ILE . 0.1 OUTLIER -65.77 -52.31 52.02 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.803 -179.713 . . . . . . . . 3 3 . 1 . 067 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -72.08 -9.77 58.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.052 179.979 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -77.8 -53.92 6.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.784 0.326 . . . . 0.0 110.964 -179.817 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -114.28 -15.4 8.35 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.577 179.864 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.476 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 10.6 t80 70.89 -44.83 0.6 Allowed 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.988 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.628 ' CE1' HD22 ' A' ' 179' ' ' LEU . 79.5 t80 -93.45 1.06 56.97 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.621 0.248 . . . . 0.0 111.458 -179.619 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.522 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 81.4 mt -70.89 -43.86 14.53 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.389 179.69 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 74.9 Cg_exo -49.93 -24.25 10.21 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.467 2.112 . . . . 0.0 112.888 179.982 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.628 HD22 ' CE1' ' A' ' 176' ' ' PHE . 1.1 mp -66.04 -61.34 2.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.969 0.414 . . . . 0.0 110.837 -179.755 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.423 ' NE ' ' CE2' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -90.26 55.86 3.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.826 179.983 . . . . . . . . 3 3 . 1 . 067 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 068 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.521 ' HD2' HD12 ' A' ' 156' ' ' LEU . 18.7 p90 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.722 0.296 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.77 HD13 HG11 ' A' ' 160' ' ' VAL . 4.2 mt 62.48 -80.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.024 179.964 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.512 ' HG3' HG23 ' A' ' 160' ' ' VAL . 0.3 OUTLIER -170.23 84.55 0.11 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.359 179.989 . . . . . . . . 3 3 . 1 . 068 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 53.6 p 55.63 70.71 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.404 -179.417 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.488 ' O ' HG12 ' A' ' 160' ' ' VAL . 0.4 OUTLIER 75.5 -59.39 0.53 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.97 -179.516 . . . . . . . . 3 3 . 1 . 068 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.77 HG11 HD13 ' A' ' 156' ' ' LEU . 0.3 OUTLIER 90.95 -47.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.911 -179.941 . . . . . . . . 3 3 . 1 . 068 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.421 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 18.5 m-85 -70.73 -32.04 69.08 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.134 0.492 . . . . 0.0 110.391 179.448 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.404 ' C ' ' H ' ' A' ' 164' ' ' PHE . 3.1 m-85 -67.95 -58.22 4.91 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.72 179.493 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.823 HD12 ' HD2' ' A' ' 168' ' ' PRO . 3.2 tp -65.77 -4.57 6.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.76 178.637 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.404 ' H ' ' C ' ' A' ' 162' ' ' PHE . 0.2 OUTLIER -75.85 -56.88 4.25 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.863 -179.602 . . . . . . . . 3 3 . 1 . 068 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.2 -51.52 60.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.806 179.638 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -160.39 143.15 9.82 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.184 -179.31 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -62.56 119.15 6.12 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.218 1.945 . . . . 0.0 112.542 -179.556 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.823 ' HD2' HD12 ' A' ' 163' ' ' LEU . 41.0 Cg_endo -91.06 95.22 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.312 2.675 . . . . 0.0 112.296 -179.946 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.774 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 4.7 tt -72.1 -38.52 63.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.162 0.506 . . . . 0.0 110.886 -179.9 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 3.8 mt -69.79 -30.79 45.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.124 -179.812 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.79 HD12 ' HB3' ' A' ' 178' ' ' PRO . 1.0 OUTLIER -66.47 -62.44 1.46 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.886 . . . . . . . . 3 3 . 1 . 068 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.61 3.32 9.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.781 178.499 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.774 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.59 -48.11 50.36 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.417 0.627 . . . . 0.0 109.368 179.477 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 175' ' ' TYR . . . -124.12 -4.49 7.77 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.75 178.875 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.426 ' HB2' ' O ' ' A' ' 174' ' ' GLY . 34.9 m-85 67.69 -50.54 0.51 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.743 0.417 . . . . 0.0 111.965 179.664 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -94.99 7.52 45.8 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.767 0.318 . . . . 0.0 110.998 179.596 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.689 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 88.8 mt -87.11 -22.65 0.28 Allowed Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 179.848 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.79 ' HB3' HD12 ' A' ' 171' ' ' LEU . 96.4 Cg_exo -45.52 -20.25 0.56 Allowed 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.381 2.054 . . . . 0.0 113.31 -179.636 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -44.7 -31.24 1.11 Allowed 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.192 0.52 . . . . 0.0 111.246 -179.97 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.0 57.31 1.48 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.661 -179.368 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . 0.543 ' HB2' ' HA ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.67 0.271 . . . . 0.0 111.384 . . . . . . . . . 0 0 . 1 . 069 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.728 HD12 ' H ' ' A' ' 158' ' ' SER . 0.6 OUTLIER -164.4 -35.42 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.568 -179.464 . . . . . . . . 3 3 . 1 . 069 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.839 ' HG3' HD13 ' A' ' 163' ' ' LEU . 0.3 OUTLIER 54.71 25.56 6.62 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.851 0.358 . . . . 0.0 110.861 -179.768 . . . . . . . . 3 3 . 1 . 069 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.728 ' H ' HD12 ' A' ' 156' ' ' LEU . 4.8 m 49.18 36.24 8.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.202 0.525 . . . . 0.0 110.952 -179.79 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -163.01 -57.24 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.963 179.843 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.641 HG23 ' HA ' ' A' ' 156' ' ' LEU . 0.9 OUTLIER 71.95 -58.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.371 -179.62 . . . . . . . . 3 3 . 1 . 069 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.567 ' N ' HG12 ' A' ' 160' ' ' VAL . 36.9 m-85 -70.91 51.53 0.14 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.62 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' A' ' 160' ' ' VAL . 0.2 OUTLIER -167.26 -69.17 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.003 -0.998 . . . . 0.0 109.954 -177.886 . . . . . . . . 3 3 . 1 . 069 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.839 HD13 ' HG3' ' A' ' 157' ' ' GLN . 4.5 tp -67.66 -15.45 63.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.526 178.489 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.547 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 8.2 t80 -83.26 -33.9 25.92 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.376 -179.212 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.417 ' C ' ' HD3' ' A' ' 167' ' ' PRO . 0.1 OUTLIER -64.59 -74.1 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.907 0.384 . . . . 0.0 110.782 179.841 . . . . . . . . 3 3 . 1 . 069 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.803 HD13 ' HD2' ' A' ' 168' ' ' PRO . 0.1 OUTLIER -105.09 66.62 0.14 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.456 -179.853 . . . . . . . . 3 3 . 1 . 069 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.599 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 20.9 Cg_endo -63.83 -27.72 67.57 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.344 2.029 . . . . 0.0 114.13 -179.838 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.803 ' HD2' HD13 ' A' ' 166' ' ' LEU . 28.2 Cg_endo -92.12 87.08 0.23 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 121.931 1.754 . . . . 0.0 113.147 -179.14 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.776 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 5.8 tp -76.58 -43.39 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.824 179.549 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.436 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 4.8 mt -73.37 -43.98 55.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.948 179.93 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.861 HD13 ' HB3' ' A' ' 177' ' ' LEU . 3.3 mm? -66.46 -55.45 15.63 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.358 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -75.27 5.89 5.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.304 178.869 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.776 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.49 -52.71 16.9 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.739 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -104.96 -18.6 12.03 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 177.968 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 5.1 t80 76.53 -11.86 1.11 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.8 0.44 . . . . 0.0 111.905 179.651 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -97.69 -3.08 39.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.806 0.336 . . . . 0.0 110.717 179.371 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.861 ' HB3' HD13 ' A' ' 171' ' ' LEU . 1.0 OUTLIER -62.97 -45.63 86.92 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.365 179.973 . . . . . . . . 3 3 . 1 . 069 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.716 ' HG3' HD12 ' A' ' 171' ' ' LEU . 36.8 Cg_exo -60.6 79.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.546 2.164 . . . . 0.0 112.394 -179.793 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.2 mt -96.37 -51.86 4.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.516 179.738 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.5 9.92 19.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.6 179.651 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 070 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.617 ' CD2' HD23 ' A' ' 156' ' ' LEU . 14.2 t80 . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.916 0.388 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.677 ' O ' HD12 ' A' ' 156' ' ' LEU . 3.1 pp -164.33 111.94 1.09 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.125 -179.851 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.81 ' HB3' HD13 ' A' ' 163' ' ' LEU . 6.9 tp-100 -79.05 22.83 0.38 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.103 179.378 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.6 p 78.73 46.13 0.05 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.27 0.557 . . . . 0.0 110.785 -179.476 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.663 ' O ' ' N ' ' A' ' 161' ' ' PHE . 33.1 m-20 -158.82 -63.11 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.299 179.505 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.605 HG12 ' O ' ' A' ' 159' ' ' ASP . 14.8 p 54.66 -51.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 O-C-N 124.196 0.935 . . . . 0.0 112.045 -179.1 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.663 ' N ' ' O ' ' A' ' 159' ' ' ASP . 32.9 m-85 -74.28 1.02 12.41 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.577 0.227 . . . . 0.0 111.397 178.931 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.456 ' O ' ' CD1' ' A' ' 162' ' ' PHE . 2.8 p90 -168.05 14.24 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 179.791 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.81 HD13 ' HB3' ' A' ' 157' ' ' GLN . 25.6 tp -67.06 -33.37 75.37 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 178.084 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.481 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 0.2 OUTLIER 49.18 30.12 2.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.002 179.606 . . . . . . . . 3 3 . 1 . 070 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.481 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.6 OUTLIER 87.34 -24.43 0.11 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.021 -179.44 . . . . . . . . 3 3 . 1 . 070 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 167' ' ' PRO . 0.1 OUTLIER -158.67 132.18 4.84 Favored Pre-proline 0 N--CA 1.449 -0.516 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.684 -178.674 . . . . . . . . 3 3 . 1 . 070 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.42 ' N ' HD12 ' A' ' 166' ' ' LEU . 38.5 Cg_endo -67.33 119.81 6.84 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.087 1.858 . . . . 0.0 112.882 -178.826 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.429 ' CB ' HD12 ' A' ' 171' ' ' LEU . 69.7 Cg_endo -85.83 96.15 0.58 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.052 2.502 . . . . 0.0 111.421 179.27 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.832 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 5.7 pt -65.2 -32.77 59.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.369 -179.093 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.681 ' O ' HD23 ' A' ' 177' ' ' LEU . 6.7 mm -73.8 -41.09 54.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.0 -179.856 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.429 HD12 ' CB ' ' A' ' 168' ' ' PRO . 78.5 mt -66.71 -55.66 14.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.919 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -74.1 0.7 13.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.176 178.637 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.832 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -70.92 -43.08 69.0 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.366 0.603 . . . . 0.0 109.386 -179.837 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -120.39 -23.98 2.76 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.385 178.586 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 75.37 -41.29 0.45 Allowed 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 122.692 0.397 . . . . 0.0 111.667 179.893 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -93.85 -7.12 44.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.775 0.321 . . . . 0.0 110.963 179.813 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.681 HD23 ' O ' ' A' ' 170' ' ' ILE . 0.1 OUTLIER -54.15 -44.65 98.79 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.21 179.736 . . . . . . . . 3 3 . 1 . 070 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 31.7 Cg_exo -59.34 69.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.738 2.292 . . . . 0.0 112.652 -179.724 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -113.02 -5.24 13.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.723 179.489 . . . . . . . . 3 3 . 1 . 070 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -147.48 41.62 1.05 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.484 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 071 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 6.9 p90 . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.877 0.37 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 071 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.6 mp -73.94 167.81 20.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 -179.883 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.557 ' H ' HG23 ' A' ' 160' ' ' VAL . 0.3 OUTLIER -171.74 95.0 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.496 -179.976 . . . . . . . . 3 3 . 1 . 071 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.553 ' O ' ' CG ' ' A' ' 159' ' ' ASP . 1.6 m 62.75 79.05 0.27 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.557 -179.705 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.568 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 2.8 p30 60.36 -56.41 0.08 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.801 0.841 . . . . 0.0 112.203 -179.677 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.568 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 2.5 t 74.57 -62.96 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.043 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -73.66 52.24 0.39 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.686 178.058 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.407 ' HB2' ' OD1' ' A' ' 159' ' ' ASP . 0.3 OUTLIER -168.12 -43.94 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.321 -179.477 . . . . . . . . 3 3 . 1 . 071 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.419 HD22 ' O ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -57.82 -51.03 71.26 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.874 . . . . . . . . 3 3 . 1 . 071 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 46.63 40.31 8.29 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.68 -1.145 . . . . 0.0 112.133 176.209 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -175.52 -61.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.933 0.397 . . . . 0.0 110.963 -179.993 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.457 HD12 ' N ' ' A' ' 167' ' ' PRO . 0.1 OUTLIER -161.6 120.12 1.44 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.519 -179.574 . . . . . . . . 3 3 . 1 . 071 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.457 ' N ' HD12 ' A' ' 166' ' ' LEU . 41.6 Cg_endo -68.09 111.54 2.48 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.229 1.953 . . . . 0.0 112.074 179.918 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.488 ' HA ' ' CD2' ' A' ' 171' ' ' LEU . 88.1 Cg_endo -77.8 55.85 5.41 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.676 2.251 . . . . 0.0 112.47 -179.836 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.904 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 1.4 tt -80.69 -44.01 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.222 0.534 . . . . 0.0 112.181 -179.583 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.502 ' N ' HG23 ' A' ' 169' ' ' ILE . 0.8 OUTLIER -75.81 -53.8 15.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -176.996 . . . . . . . . 3 3 . 1 . 071 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.588 ' HG ' ' N ' ' A' ' 172' ' ' ASP . 2.6 pt? -66.91 -49.47 65.44 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.362 0.601 . . . . 0.0 110.056 -179.789 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.588 ' N ' ' HG ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -74.23 1.96 10.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.311 179.02 . . . . . . . . 3 3 . 1 . 071 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.904 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.69 -54.67 8.37 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.307 0.575 . . . . 0.0 109.596 179.5 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -112.49 -18.9 7.3 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.515 178.617 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 70.01 -56.46 0.58 Allowed 'General case' 0 C--O 1.231 0.115 0 C-N-CA 122.502 0.321 . . . . 0.0 111.377 179.824 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.409 ' O ' ' CG ' ' A' ' 176' ' ' PHE . 89.6 t80 -92.92 2.22 56.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.882 179.824 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.494 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 0.1 OUTLIER -64.2 -46.5 79.48 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.806 179.675 . . . . . . . . 3 3 . 1 . 071 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 75.2 Cg_exo -50.37 88.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.618 2.212 . . . . 0.0 112.554 179.953 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.13 -78.83 0.58 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.371 179.683 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -87.65 35.37 0.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.536 179.462 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 072 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.869 0.366 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 072 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.776 ' HB3' HG23 ' A' ' 160' ' ' VAL . 4.8 mp 50.79 24.74 1.85 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.45 179.72 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.59 -6.46 48.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.412 179.668 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 21.6 p -74.01 -43.82 56.69 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.444 0.64 . . . . 0.0 111.423 -179.397 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.625 ' O ' HG12 ' A' ' 160' ' ' VAL . 1.1 t0 -169.01 -35.75 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.605 -179.956 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.776 HG23 ' HB3' ' A' ' 156' ' ' LEU . 0.3 OUTLIER 90.88 -42.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.53 179.93 . . . . . . . . 3 3 . 1 . 072 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.435 ' O ' ' HB2' ' A' ' 164' ' ' PHE . 58.8 m-85 -72.73 -38.34 67.46 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.051 0.453 . . . . 0.0 111.035 179.831 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.4 ' C ' ' H ' ' A' ' 164' ' ' PHE . 0.2 OUTLIER -72.17 -53.79 11.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.766 179.6 . . . . . . . . 3 3 . 1 . 072 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.617 HD12 ' HA ' ' A' ' 156' ' ' LEU . 18.6 mt -66.26 -4.4 7.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.406 178.478 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.508 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER -79.53 19.03 0.66 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.665 -1.152 . . . . 0.0 111.032 179.806 . . . . . . . . 3 3 . 1 . 072 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.505 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.4 OUTLIER 91.6 -39.18 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 122.988 0.515 . . . . 0.0 111.367 -179.943 . . . . . . . . 3 3 . 1 . 072 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 166' ' ' LEU . 8.0 mt -165.11 169.16 7.72 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.925 -178.018 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.543 ' HG2' HD12 ' A' ' 170' ' ' ILE . 83.2 Cg_endo -84.64 117.26 2.02 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.701 2.267 . . . . 0.0 112.05 179.572 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.559 ' HA ' ' CD2' ' A' ' 171' ' ' LEU . 92.1 Cg_endo -78.91 10.76 2.79 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.539 2.159 . . . . 0.0 113.328 -179.454 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.878 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 3.3 tt -77.24 -29.15 16.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.929 0.395 . . . . 0.0 111.817 -179.706 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.543 HD12 ' HG2' ' A' ' 167' ' ' PRO . 10.3 mt -71.03 -60.22 2.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.625 -178.359 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.579 ' HG ' ' N ' ' A' ' 172' ' ' ASP . 2.6 pt? -63.91 -47.95 78.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.375 0.607 . . . . 0.0 110.007 -179.579 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.579 ' N ' ' HG ' ' A' ' 171' ' ' LEU . 30.9 m-20 -72.48 -0.92 13.93 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.219 179.091 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.878 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.16 -66.07 0.73 Allowed 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.591 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.518 ' HA3' HD12 ' A' ' 177' ' ' LEU . . . -119.74 -9.56 8.26 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.767 178.68 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 12.0 t80 68.82 -61.69 0.41 Allowed 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.971 0.415 . . . . 0.0 110.994 -179.885 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -100.87 16.49 25.01 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.912 179.735 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.525 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 28.7 mt -93.58 -47.21 0.29 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.742 -179.71 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.525 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 3.7 Cg_exo -72.73 -86.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.269 1.98 . . . . 0.0 111.958 -179.829 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 52.2 mt 51.39 49.4 21.07 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 121.044 0.45 . . . . 0.0 110.778 179.906 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? 64.89 45.83 3.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.898 -179.996 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . 0.501 ' HB2' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.465 ' O ' HD23 ' A' ' 156' ' ' LEU . 9.8 m-85 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.602 0.239 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 1.044 HD11 HD22 ' A' ' 166' ' ' LEU . 72.5 mt -162.11 81.81 0.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.771 -179.909 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -165.15 11.94 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.99 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.551 ' HB3' HD21 ' A' ' 163' ' ' LEU . 1.7 t -80.67 -33.93 35.15 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.615 0.721 . . . . 0.0 110.238 178.92 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.468 ' O ' HG12 ' A' ' 160' ' ' VAL . 0.4 OUTLIER -167.75 -37.79 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.043 179.555 . . . . . . . . 3 3 . 1 . 073 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.472 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 65.33 -52.82 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.031 179.566 . . . . . . . . 3 3 . 1 . 073 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.472 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 73.6 m-85 -72.51 -1.26 15.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.527 0.204 . . . . 0.0 111.428 179.737 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.466 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 20.0 m-85 -161.35 14.47 0.1 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.904 -179.994 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.705 HD13 HD12 ' A' ' 165' ' ' LEU . 1.0 OUTLIER -69.5 -38.07 77.48 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.409 0.623 . . . . 0.0 109.4 178.955 . . . . . . . . 3 3 . 1 . 073 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 14.8 t80 66.58 8.6 5.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.805 179.652 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.705 HD12 HD13 ' A' ' 163' ' ' LEU . 44.5 mt -67.43 -48.91 65.9 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.248 0.547 . . . . 0.0 110.532 179.439 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 1.044 HD22 HD11 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -161.42 128.11 2.51 Favored Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.439 -178.254 . . . . . . . . 3 3 . 1 . 073 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.34 116.75 4.83 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.236 1.957 . . . . 0.0 112.265 -179.927 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -80.06 38.52 0.75 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.701 2.267 . . . . 0.0 113.047 -179.726 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.765 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 5.4 tt -77.59 -34.62 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.264 0.554 . . . . 0.0 110.801 179.726 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.714 HD13 HG23 ' A' ' 169' ' ' ILE . 13.3 mm -71.66 -45.13 68.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.447 -179.299 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.661 ' H ' HD22 ' A' ' 171' ' ' LEU . 0.9 OUTLIER -65.68 -53.15 45.13 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.035 . . . . . . . . 3 3 . 1 . 073 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -73.82 0.53 12.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.053 178.635 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.765 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.96 -55.61 6.32 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.584 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.671 ' H ' ' HG2' ' A' ' 178' ' ' PRO . . . -123.28 -27.45 1.49 Allowed Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 178.539 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.3 OUTLIER 78.07 -14.66 0.83 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.109 0.564 . . . . 0.0 112.125 179.506 . . . . . . . . 3 3 . 1 . 073 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.425 ' O ' ' CG ' ' A' ' 176' ' ' PHE . 14.7 t80 -96.02 43.91 1.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.562 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.573 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 3.8 mt 57.14 46.61 2.14 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.077 -178.689 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.671 ' HG2' ' H ' ' A' ' 174' ' ' GLY . 39.2 Cg_exo -41.25 -65.05 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.041 2.494 . . . . 0.0 112.963 179.554 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.482 ' H ' HG22 ' A' ' 170' ' ' ILE . 4.4 mm? 56.13 53.52 8.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.971 0.415 . . . . 0.0 110.214 -179.689 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? 63.05 56.55 1.77 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.032 -179.134 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . 0.534 ' HB2' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 2.2 p90 . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.843 0.354 . . . . 0.0 111.279 . . . . . . . . . 0 0 . 1 . 074 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.4 pp -166.14 -39.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.202 179.759 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.404 ' OE1' ' N ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -72.29 -14.52 61.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.764 179.542 . . . . . . . . 3 3 . 1 . 074 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.404 ' N ' ' OE1' ' A' ' 157' ' ' GLN . 1.2 t -77.25 1.64 17.97 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.501 179.905 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.415 ' O ' ' CB ' ' A' ' 160' ' ' VAL . 2.0 t0 80.72 -19.21 0.45 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 122.331 0.253 . . . . 0.0 111.537 -179.733 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' A' ' 164' ' ' PHE . 0.4 OUTLIER 85.5 -50.61 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 122.467 0.307 . . . . 0.0 111.352 179.667 . . . . . . . . 3 3 . 1 . 074 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.447 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 55.6 m-85 -68.79 -32.53 72.32 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.105 0.478 . . . . 0.0 110.676 179.848 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.66 ' O ' HD12 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -68.12 -59.04 3.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.652 179.504 . . . . . . . . 3 3 . 1 . 074 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.729 HD12 ' HD2' ' A' ' 168' ' ' PRO . 2.6 tp -66.51 -4.33 8.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.017 178.705 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.466 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.1 OUTLIER -78.12 -42.78 30.86 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.653 -179.021 . . . . . . . . 3 3 . 1 . 074 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.66 HD12 ' O ' ' A' ' 162' ' ' PHE . 0.3 OUTLIER -65.3 -51.58 59.73 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.155 0.502 . . . . 0.0 110.963 -179.958 . . . . . . . . 3 3 . 1 . 074 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.2 tp -159.98 105.17 1.42 Allowed Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.289 -178.73 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.61 113.84 3.3 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.335 2.023 . . . . 0.0 113.217 -179.327 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.729 ' HD2' HD12 ' A' ' 163' ' ' LEU . 80.3 Cg_endo -82.57 92.14 0.95 Allowed 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.028 2.485 . . . . 0.0 111.059 178.862 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 1.01 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 2.4 pt -56.15 -29.83 28.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.619 -178.634 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.558 ' O ' HD12 ' A' ' 177' ' ' LEU . 3.4 mp -77.4 -49.19 22.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.644 179.425 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 37.5 mt -68.29 -54.93 14.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.342 179.588 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.435 ' CG ' ' O ' ' A' ' 168' ' ' PRO . 4.2 p30 -71.96 -0.34 11.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.502 179.437 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 1.01 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -70.47 -55.91 7.85 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.842 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -126.23 -22.99 1.63 Allowed Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.549 178.54 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 76.72 -30.34 0.18 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 122.637 0.375 . . . . 0.0 111.579 -179.876 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.42 -8.45 29.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.686 0.279 . . . . 0.0 110.998 179.732 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.558 HD12 ' O ' ' A' ' 170' ' ' ILE . 38.8 mt -53.79 -44.92 98.86 Favored Pre-proline 0 CA--C 1.529 0.145 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.404 -179.987 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 82.0 Cg_exo -48.4 87.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.497 2.131 . . . . 0.0 112.62 -179.87 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 177' ' ' LEU . 24.1 mt -138.58 -57.96 0.63 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.758 179.633 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.775 ' N ' ' HD2' ' A' ' 180' ' ' ARG . 0.0 OUTLIER -105.02 27.91 7.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.406 179.918 . . . . . . . . 3 3 . 1 . 074 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 075 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.85 0.357 . . . . 0.0 111.946 . . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 22.7 mt 63.65 73.19 0.45 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.219 179.671 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -170.08 36.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 179.798 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 9.3 t -164.64 90.49 0.54 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.126 179.837 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.445 ' O ' HG12 ' A' ' 160' ' ' VAL . 1.2 m-20 71.84 -57.71 0.61 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.636 -179.252 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.466 ' O ' ' CB ' ' A' ' 164' ' ' PHE . 0.4 OUTLIER 91.07 -50.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.588 179.525 . . . . . . . . 3 3 . 1 . 075 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.434 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 0.9 OUTLIER -69.85 -30.14 67.55 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.223 0.535 . . . . 0.0 110.536 179.797 . . . . . . . . 3 3 . 1 . 075 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.6 -61.85 1.63 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.094 179.649 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 163' ' ' LEU . 17.5 mt -66.27 -5.33 10.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.121 179.251 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.466 ' CB ' ' O ' ' A' ' 160' ' ' VAL . 0.1 OUTLIER -77.36 -43.82 31.52 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.597 -179.538 . . . . . . . . 3 3 . 1 . 075 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.1 -42.05 94.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.793 179.687 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.85 HD23 ' OD2' ' A' ' 172' ' ' ASP . 2.3 tp -161.65 125.87 2.01 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.123 -179.368 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.585 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 27.5 Cg_endo -64.85 -25.52 60.25 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.516 2.144 . . . . 0.0 114.699 -179.495 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.714 ' HB2' HD12 ' A' ' 171' ' ' LEU . 22.3 Cg_endo -93.93 101.44 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.072 1.848 . . . . 0.0 112.646 -179.38 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.684 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 13.4 tt -72.77 -44.34 59.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.841 -179.614 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.608 ' N ' HG23 ' A' ' 169' ' ' ILE . 0.5 OUTLIER -69.2 -31.75 51.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.96 -177.272 . . . . . . . . 3 3 . 1 . 075 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.714 HD12 ' HB2' ' A' ' 168' ' ' PRO . 2.0 mt -66.55 -56.92 8.58 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.201 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.85 ' OD2' HD23 ' A' ' 166' ' ' LEU . 11.8 m-20 -74.48 -4.18 35.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.58 178.158 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.684 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.47 -68.22 0.52 Allowed 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 121.226 0.536 . . . . 0.0 110.148 179.911 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -121.73 -2.03 10.6 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.159 179.292 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 54.1 t80 69.17 -51.8 0.6 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.473 0.309 . . . . 0.0 111.653 -179.994 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.27 26.69 2.81 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.754 0.311 . . . . 0.0 111.174 -179.77 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.512 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 11.0 mt -91.89 -50.96 0.3 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.908 179.725 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.512 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 53.0 Cg_exo -55.76 -18.82 22.48 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.666 2.244 . . . . 0.0 112.788 179.986 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.542 HD13 ' O ' ' A' ' 179' ' ' LEU . 0.2 OUTLIER -71.36 -5.06 29.66 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 -179.776 . . . . . . . . 3 3 . 1 . 075 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.15 57.61 1.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.163 0.506 . . . . 0.0 110.032 179.707 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 076 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.844 0.354 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 076 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.513 ' O ' ' CB ' ' A' ' 157' ' ' GLN . 0.3 OUTLIER -167.4 -162.47 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.594 -179.814 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.629 ' O ' HD22 ' A' ' 163' ' ' LEU . 5.3 tt0 91.83 84.44 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.222 0.534 . . . . 0.0 111.071 -179.936 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.496 ' CB ' HD13 ' A' ' 163' ' ' LEU . 1.9 t 77.87 -63.76 0.32 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.743 179.444 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.687 ' O ' HG13 ' A' ' 160' ' ' VAL . 4.1 m-20 -164.18 -21.7 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.992 -1.004 . . . . 0.0 112.037 -179.539 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.687 HG13 ' O ' ' A' ' 159' ' ' ASP . 1.2 m 63.78 -54.43 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 122.674 0.39 . . . . 0.0 111.596 -179.744 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.486 ' N ' HG22 ' A' ' 160' ' ' VAL . 6.0 t80 -70.89 2.04 4.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.49 0.186 . . . . 0.0 111.466 179.561 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -165.8 12.1 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.218 -179.942 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.629 HD22 ' O ' ' A' ' 157' ' ' GLN . 15.4 tp -68.93 -33.09 73.17 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 178.748 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.462 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER 48.22 31.91 2.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.708 179.435 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.462 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.1 OUTLIER 85.69 -29.58 0.07 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.821 -179.253 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.954 HD13 ' HD2' ' A' ' 167' ' ' PRO . 0.2 OUTLIER -161.8 128.97 2.6 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.926 -178.87 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.954 ' HD2' HD13 ' A' ' 166' ' ' LEU . 73.3 Cg_endo -76.13 108.67 2.73 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.141 1.894 . . . . 0.0 112.429 -179.598 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.74 ' O ' HD12 ' A' ' 170' ' ' ILE . 28.4 Cg_endo -64.23 -56.99 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.198 1.932 . . . . 0.0 112.368 -179.953 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.945 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 1.3 tt 83.08 -35.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.761 -179.961 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.74 HD12 ' O ' ' A' ' 168' ' ' PRO . 3.9 mp -79.61 -59.28 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.916 0.389 . . . . 0.0 111.12 179.903 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.483 HD22 ' N ' ' A' ' 171' ' ' LEU . 3.3 mm? -67.78 -47.4 69.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.247 0.546 . . . . 0.0 110.013 179.571 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.9 0.13 11.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.487 179.58 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.945 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.6 -63.02 1.29 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.142 0.496 . . . . 0.0 109.792 179.677 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.403 ' HA3' ' CD1' ' A' ' 177' ' ' LEU . . . -116.1 -12.34 9.22 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.749 178.901 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER 72.63 -56.12 0.66 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.35 0.26 . . . . 0.0 111.68 179.715 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -94.15 -12.54 28.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.581 0.229 . . . . 0.0 111.51 -179.636 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.532 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 76.8 mt -52.7 -42.98 91.84 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.421 179.905 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 32.5 Cg_exo -57.92 -156.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.392 2.061 . . . . 0.0 112.206 179.931 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 74.89 69.92 0.09 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.2 0.524 . . . . 0.0 110.455 -179.829 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 66.08 47.09 1.99 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.885 -179.866 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 077 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.612 ' HB3' HD23 ' A' ' 163' ' ' LEU . 57.8 t80 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.843 0.354 . . . . 0.0 111.745 . . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.4 mt 62.57 50.22 3.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.291 179.555 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.649 ' HB2' HD22 ' A' ' 163' ' ' LEU . 11.5 tm0? -77.46 17.21 0.53 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.42 179.261 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 78.45 -61.65 0.36 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.787 0.327 . . . . 0.0 110.437 -179.329 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.463 ' O ' HG12 ' A' ' 160' ' ' VAL . 3.7 t0 -78.85 -48.48 14.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.044 179.143 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 83.55 -48.71 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.655 179.588 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.453 ' CD1' HG12 ' A' ' 160' ' ' VAL . 73.1 m-85 -65.35 -27.38 68.55 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.989 0.423 . . . . 0.0 110.592 179.983 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -72.79 -63.68 1.12 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.401 179.037 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.649 HD22 ' HB2' ' A' ' 157' ' ' GLN . 14.2 tp -66.8 -4.11 8.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.473 179.11 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.438 ' HB3' ' O ' ' A' ' 161' ' ' PHE . 0.5 OUTLIER -72.06 -14.22 61.8 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.637 -179.571 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -68.18 -19.81 64.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.813 178.651 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.59 HD22 ' HD2' ' A' ' 168' ' ' PRO . 0.3 OUTLIER -156.85 61.04 2.34 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.069 -176.93 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.535 ' HG2' ' HD3' ' A' ' 168' ' ' PRO . 2.6 Cg_endo -42.81 -47.24 8.16 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.546 2.831 . . . . 0.0 113.847 179.914 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.59 ' HD2' HD22 ' A' ' 166' ' ' LEU . 52.1 Cg_endo -82.49 88.97 1.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.154 1.902 . . . . 0.0 113.498 -178.562 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.759 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 7.0 pt -75.23 -32.93 27.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.271 179.466 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.989 HG22 HD22 ' A' ' 177' ' ' LEU . 2.9 mp -70.01 -43.53 79.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.297 -179.103 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.809 HD13 ' CG ' ' A' ' 178' ' ' PRO . 0.1 OUTLIER -66.21 -52.54 47.0 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.801 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.4 0.11 18.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.164 178.685 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.759 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.28 -60.26 2.32 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.043 0.449 . . . . 0.0 109.812 179.94 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -107.22 -20.37 8.74 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 178.535 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 27.3 t80 75.14 -11.08 1.12 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.443 0.297 . . . . 0.0 111.572 179.988 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -97.47 -9.81 26.53 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.791 0.329 . . . . 0.0 110.629 179.623 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.989 HD22 HG22 ' A' ' 170' ' ' ILE . 0.6 OUTLIER -51.91 -50.15 79.75 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.2 -179.869 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.809 ' CG ' HD13 ' A' ' 171' ' ' LEU . 22.4 Cg_exo -65.05 91.67 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.6 2.2 . . . . 0.0 112.386 -179.829 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.848 HD22 ' O ' ' A' ' 177' ' ' LEU . 1.0 OUTLIER -81.02 -70.96 0.49 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.908 0.385 . . . . 0.0 110.714 179.756 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.6 16.7 3.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.634 -179.914 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 078 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.961 0.41 . . . . 0.0 111.177 . . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.505 HD23 ' H ' ' A' ' 156' ' ' LEU . 0.4 OUTLIER -75.28 158.14 33.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.121 -179.823 . . . . . . . . 3 3 . 1 . 078 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.63 ' HB2' HD22 ' A' ' 163' ' ' LEU . 0.9 OUTLIER -170.23 -92.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.484 179.842 . . . . . . . . 3 3 . 1 . 078 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 77.9 p -161.97 18.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.779 0.323 . . . . 0.0 111.388 179.537 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.451 ' HB3' ' HB2' ' A' ' 162' ' ' PHE . 6.5 t70 -168.9 -44.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.055 0.455 . . . . 0.0 110.176 179.683 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.444 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 87.09 -50.67 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.154 179.95 . . . . . . . . 3 3 . 1 . 078 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.444 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 1.5 m-85 -69.93 -30.42 67.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.226 0.536 . . . . 0.0 110.479 179.599 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.451 ' HB2' ' HB3' ' A' ' 159' ' ' ASP . 0.1 OUTLIER -71.55 -60.42 2.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.146 179.64 . . . . . . . . 3 3 . 1 . 078 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.63 HD22 ' HB2' ' A' ' 157' ' ' GLN . 27.9 tp -65.46 -7.07 12.43 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.721 179.044 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.435 ' CB ' ' O ' ' A' ' 160' ' ' VAL . 1.2 t80 -79.67 -37.71 35.25 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.444 -179.82 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.879 ' O ' HD22 ' A' ' 166' ' ' LEU . 0.5 OUTLIER -65.63 -42.13 91.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.841 179.631 . . . . . . . . 3 3 . 1 . 078 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.879 HD22 ' O ' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -158.6 119.21 1.85 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.7 -179.345 . . . . . . . . 3 3 . 1 . 078 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.543 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 10.3 Cg_endo -58.38 -32.01 95.24 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.446 2.098 . . . . 0.0 114.303 -179.363 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.551 ' HB2' ' HB2' ' A' ' 171' ' ' LEU . 26.4 Cg_endo -93.88 100.6 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.448 2.099 . . . . 0.0 112.448 -179.483 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.714 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 7.3 tt -73.98 -40.44 52.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.037 -179.305 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.411 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.4 mp -70.64 -43.34 77.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.029 -178.803 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 168' ' ' PRO . 0.4 OUTLIER -69.0 -2.97 11.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.983 0.421 . . . . 0.0 111.789 179.915 . . . . . . . . 3 3 . 1 . 078 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -145.88 17.28 1.43 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.354 179.978 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -80.81 -39.99 25.74 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.141 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.615 ' O ' ' N ' ' A' ' 176' ' ' PHE . . . -134.68 3.48 4.24 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 114.898 -1.047 . . . . 0.0 111.968 179.046 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.508 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER 54.97 -61.42 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 123.819 0.847 . . . . 0.0 112.147 179.799 . . . . . . . . 3 3 . 1 . 078 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.615 ' N ' ' O ' ' A' ' 174' ' ' GLY . 11.6 m-85 -97.05 23.3 7.42 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.056 -179.953 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.534 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 14.1 mt -92.67 -49.63 0.29 Allowed Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.378 -179.968 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.534 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 40.7 Cg_exo -57.53 -157.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.374 2.049 . . . . 0.0 112.361 179.921 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 178' ' ' PRO . 2.0 mm? 71.13 68.34 0.17 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.16 0.505 . . . . 0.0 110.732 -179.831 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 63.82 56.11 1.54 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.77 179.872 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 079 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.497 ' O ' HD23 ' A' ' 156' ' ' LEU . 37.8 m-85 . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.683 0.278 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 155' ' ' PHE . 97.3 mt -161.18 75.94 0.52 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.524 -179.967 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -170.55 -37.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.357 179.981 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.24 62.12 0.92 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.055 0.455 . . . . 0.0 110.405 179.787 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.536 ' O ' HG12 ' A' ' 160' ' ' VAL . 2.5 t0 75.88 -60.23 0.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.798 -179.651 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.3 OUTLIER 89.04 -40.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.547 179.748 . . . . . . . . 3 3 . 1 . 079 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.615 ' CE2' HD12 ' A' ' 165' ' ' LEU . 48.8 t80 -65.19 -26.1 68.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.109 0.48 . . . . 0.0 110.657 -179.978 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.78 -63.37 1.07 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.052 179.567 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.753 ' O ' HD13 ' A' ' 163' ' ' LEU . 2.4 tm? -63.09 -20.11 65.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.877 0.846 . . . . 0.0 109.385 178.888 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.464 ' CB ' ' O ' ' A' ' 160' ' ' VAL . 10.1 t80 -73.65 -60.98 2.0 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.892 -179.488 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.615 HD12 ' CE2' ' A' ' 161' ' ' PHE . 1.0 OUTLIER -63.99 -63.41 1.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.991 0.424 . . . . 0.0 110.761 179.803 . . . . . . . . 3 3 . 1 . 079 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -161.64 135.86 5.11 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.719 -179.862 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.1 110.26 2.38 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.44 2.093 . . . . 0.0 111.975 179.806 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.82 ' O ' HD12 ' A' ' 170' ' ' ILE . 54.3 Cg_endo -67.65 -94.94 0.0 OUTLIER 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.248 1.965 . . . . 0.0 112.442 -179.638 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.769 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 1.3 tt 80.23 -35.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.816 0.341 . . . . 0.0 111.757 179.986 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.967 ' O ' HD12 ' A' ' 177' ' ' LEU . 4.2 mp -73.63 -34.98 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.136 -179.582 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.478 HD23 ' HB3' ' A' ' 177' ' ' LEU . 43.6 mt -65.59 -59.46 3.93 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.941 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.54 4.09 8.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.868 178.472 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.769 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.31 -53.94 12.52 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.746 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -98.53 -18.39 25.93 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 177.887 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 13.5 t80 75.47 -13.38 0.87 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.81 0.444 . . . . 0.0 111.723 179.787 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -99.23 -9.51 23.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.656 0.265 . . . . 0.0 110.644 179.527 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.967 HD12 ' O ' ' A' ' 170' ' ' ILE . 11.1 mt -65.58 -48.46 65.2 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.357 -179.764 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 85.9 Cg_exo -47.39 93.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.613 2.209 . . . . 0.0 112.627 -179.926 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.13 -47.29 4.2 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.107 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.424 ' HD2' ' N ' ' A' ' 180' ' ' ARG . 0.0 OUTLIER -89.63 7.12 38.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.953 179.024 . . . . . . . . 3 3 . 1 . 079 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 080 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.432 ' HB3' HD11 ' A' ' 169' ' ' ILE . 32.3 p90 . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.853 0.359 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.781 ' HA ' HD22 ' A' ' 163' ' ' LEU . 0.6 OUTLIER -72.37 176.46 5.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.711 -179.864 . . . . . . . . 3 3 . 1 . 080 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -169.25 -38.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.413 179.939 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.46 37.71 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.975 0.417 . . . . 0.0 111.554 179.835 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.684 ' O ' ' N ' ' A' ' 161' ' ' PHE . 1.7 m-20 -163.76 -57.15 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.353 179.189 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.561 HG12 ' O ' ' A' ' 159' ' ' ASP . 11.1 p 52.14 -52.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 O-C-N 124.17 0.918 . . . . 0.0 112.131 -179.291 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.684 ' N ' ' O ' ' A' ' 159' ' ' ASP . 2.3 t80 -73.79 -2.33 23.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.814 -0.176 . . . . 0.0 111.26 179.071 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.444 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 7.8 m-85 -164.84 14.79 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.988 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.781 HD22 ' HA ' ' A' ' 156' ' ' LEU . 5.6 tp -69.81 -30.63 68.2 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.176 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 4.4 t80 67.23 5.03 3.95 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.509 178.957 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.778 ' HB2' HD23 ' A' ' 163' ' ' LEU . 3.0 mm? -69.21 -64.72 0.82 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.01 0.433 . . . . 0.0 110.93 179.564 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.759 HD23 ' HD2' ' A' ' 168' ' ' PRO . 0.2 OUTLIER -160.8 92.36 1.56 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.303 -179.546 . . . . . . . . 3 3 . 1 . 080 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.448 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 3.3 Cg_exo -38.89 -45.12 2.55 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.407 2.738 . . . . 0.0 114.018 -179.482 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.759 ' HD2' HD23 ' A' ' 166' ' ' LEU . 75.5 Cg_endo -86.73 -93.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.979 1.786 . . . . 0.0 113.819 -178.276 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.851 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.2 OUTLIER 88.12 -39.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 122.758 0.423 . . . . 0.0 111.179 -179.049 . . . . . . . . 3 3 . 1 . 080 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.57 ' H ' HD12 ' A' ' 170' ' ' ILE . 2.9 mp -78.24 -56.13 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.019 0.438 . . . . 0.0 110.507 179.44 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 171' ' ' LEU . 3.5 mm? -67.83 -45.32 75.01 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.964 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -73.82 -0.64 16.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.325 179.214 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.851 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.26 -45.63 54.66 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.29 0.567 . . . . 0.0 109.84 179.731 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.61 ' H ' ' HG2' ' A' ' 178' ' ' PRO . . . -126.62 -28.25 0.99 Allowed Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.261 179.054 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 35.7 t80 78.75 -12.66 1.06 Allowed 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 122.97 0.508 . . . . 0.0 112.134 179.525 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.442 ' HZ ' ' HG2' ' A' ' 181' ' ' HSL . 14.8 p90 -95.92 37.34 1.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.65 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.558 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 10.1 mt 64.81 46.44 0.56 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.885 -178.856 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.61 ' HG2' ' H ' ' A' ' 174' ' ' GLY . 42.1 Cg_exo -39.87 -69.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.161 2.574 . . . . 0.0 113.021 179.555 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 179' ' ' LEU . 3.8 mm? 56.85 52.49 9.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.029 0.442 . . . . 0.0 110.824 179.966 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.405 ' CZ ' ' HA ' ' A' ' 180' ' ' ARG . 0.2 OUTLIER 65.88 44.95 2.64 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.867 179.965 . . . . . . . . 3 3 . 1 . 080 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . 0.442 ' HG2' ' HZ ' ' A' ' 176' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.869 0.366 . . . . 0.0 111.459 . . . . . . . . . 0 0 . 1 . 081 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 72.2 mt -73.27 73.29 1.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.758 179.85 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -168.21 34.55 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.272 0.558 . . . . 0.0 110.54 179.835 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 159' ' ' ASP . 4.1 t -164.48 88.06 0.49 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.367 179.728 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 158' ' ' SER . 0.7 OUTLIER 74.38 -60.67 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.234 -178.641 . . . . . . . . 3 3 . 1 . 081 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.5 t 68.61 -54.4 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.665 179.593 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.47 ' HB3' ' CE1' ' A' ' 162' ' ' PHE . 0.4 OUTLIER -71.59 5.88 2.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.493 179.789 . . . . . . . . 3 3 . 1 . 081 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.47 ' CE1' ' HB3' ' A' ' 161' ' ' PHE . 0.1 OUTLIER -160.72 1.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.378 179.728 . . . . . . . . 3 3 . 1 . 081 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 14.3 tp -69.57 -2.84 12.55 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.29 0.567 . . . . 0.0 110.021 177.971 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -68.89 -11.25 60.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.591 -178.985 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.475 ' O ' HD22 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -65.31 -33.02 75.0 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.224 0.535 . . . . 0.0 109.908 178.636 . . . . . . . . 3 3 . 1 . 081 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.475 HD22 ' O ' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -160.27 67.97 2.76 Favored Pre-proline 0 N--CA 1.45 -0.461 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.683 -178.902 . . . . . . . . 3 3 . 1 . 081 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.512 ' HG2' ' HD3' ' A' ' 168' ' ' PRO . 4.3 Cg_endo -52.4 -37.68 72.55 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 123.085 2.523 . . . . 0.0 114.293 -179.107 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.512 ' HD3' ' HG2' ' A' ' 167' ' ' PRO . 40.1 Cg_endo -90.17 78.27 0.78 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 121.947 1.765 . . . . 0.0 113.241 -178.732 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.79 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 23.6 mm -78.01 -76.71 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.141 179.652 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.418 ' N ' HG22 ' A' ' 169' ' ' ILE . 3.8 mp -73.26 -29.77 29.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.592 -179.202 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 22.5 tp -64.81 -64.78 0.78 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 179.339 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 168' ' ' PRO . 21.5 t70 -77.68 8.43 4.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.181 178.627 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.79 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.26 -51.23 25.68 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.403 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.714 ' H ' ' HG2' ' A' ' 178' ' ' PRO . . . -121.69 -28.32 1.6 Allowed Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 178.046 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 77.8 -24.62 0.21 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.404 0.682 . . . . 0.0 112.192 179.202 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -92.76 50.16 1.54 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.954 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.549 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 5.7 mt 55.23 62.05 8.05 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.449 -178.627 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.714 ' HG2' ' H ' ' A' ' 174' ' ' GLY . 23.6 Cg_exo -67.66 -8.72 23.19 Favored 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 123.68 2.92 . . . . 0.0 112.793 -179.741 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.3 tt -62.27 -57.76 10.21 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.031 0.443 . . . . 0.0 110.963 -179.956 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.414 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -87.55 34.79 0.71 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.853 -179.865 . . . . . . . . 3 3 . 1 . 081 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 082 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.551 ' HB3' HD23 ' A' ' 163' ' ' LEU . 2.4 t80 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.847 0.356 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.801 ' HA ' HG23 ' A' ' 160' ' ' VAL . 0.4 OUTLIER -74.09 145.53 44.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.09 -179.838 . . . . . . . . 3 3 . 1 . 082 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.416 ' HB2' HD22 ' A' ' 163' ' ' LEU . 2.2 tp60 -170.04 52.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.713 -179.967 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.9 p 76.46 0.52 3.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.676 -179.777 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.521 ' O ' HG12 ' A' ' 160' ' ' VAL . 9.9 p30 -161.36 -38.75 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.41 -179.978 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.801 HG23 ' HA ' ' A' ' 156' ' ' LEU . 0.4 OUTLIER 85.27 -42.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.043 179.434 . . . . . . . . 3 3 . 1 . 082 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.411 ' HA ' ' HB2' ' A' ' 164' ' ' PHE . 60.4 m-85 -67.45 -30.82 70.64 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.071 0.462 . . . . 0.0 110.855 -179.939 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.431 ' CD1' ' HB3' ' A' ' 167' ' ' PRO . 2.4 t80 -67.71 -61.79 1.72 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.474 179.465 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.551 HD23 ' HB3' ' A' ' 155' ' ' PHE . 16.1 tp -67.25 -3.47 7.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.212 178.809 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.521 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.1 OUTLIER -76.39 -36.73 57.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.848 -178.762 . . . . . . . . 3 3 . 1 . 082 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.9 mt -174.8 -44.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.809 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.796 HD13 ' HD2' ' A' ' 167' ' ' PRO . 0.2 OUTLIER -158.83 131.08 4.25 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.706 0.289 . . . . 0.0 111.18 -179.084 . . . . . . . . 3 3 . 1 . 082 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.796 ' HD2' HD13 ' A' ' 166' ' ' LEU . 18.6 Cg_endo -58.27 116.66 3.4 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.727 2.285 . . . . 0.0 112.441 -179.969 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.79 83.67 0.31 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.457 2.104 . . . . 0.0 111.604 179.522 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.927 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 2.3 pt -69.4 -32.85 54.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.621 -179.326 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.495 HD12 HG13 ' A' ' 169' ' ' ILE . 3.8 mp -76.6 -54.29 13.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.293 -179.77 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 25.7 mt -67.37 -53.04 32.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.031 0.444 . . . . 0.0 110.488 179.974 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -74.46 5.27 4.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.727 179.764 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.927 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -69.75 -56.86 6.02 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.068 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.576 ' O ' ' HD2' ' A' ' 178' ' ' PRO . . . -132.85 30.9 3.02 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 177.394 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.443 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 18.4 t80 68.5 -69.22 0.15 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.366 0.603 . . . . 0.0 109.432 -178.371 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.798 ' O ' HD23 ' A' ' 177' ' ' LEU . 15.6 t80 -151.69 0.28 0.35 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.961 178.963 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.798 HD23 ' O ' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -150.97 -68.31 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -178.724 . . . . . . . . 3 3 . 1 . 082 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.576 ' HD2' ' O ' ' A' ' 174' ' ' GLY . 67.6 Cg_exo -34.67 173.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 123.559 2.839 . . . . 0.0 114.308 -179.365 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.654 ' HG ' ' HB1' ' A' ' 173' ' ' ALA . 0.2 OUTLIER 86.94 -24.27 0.12 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.369 179.884 . . . . . . . . 3 3 . 1 . 082 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.44 46.68 0.89 Allowed 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.883 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 083 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.879 0.371 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 083 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.474 HD23 ' N ' ' A' ' 156' ' ' LEU . 2.5 pt? -165.42 127.06 2.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.944 -179.787 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 43.4 tp60 -170.33 26.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.036 -179.876 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.519 ' O ' ' HB2' ' A' ' 162' ' ' PHE . 0.3 OUTLIER -167.65 33.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.865 179.95 . . . . . . . . 3 3 . 1 . 083 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.517 ' O ' HG12 ' A' ' 160' ' ' VAL . 0.5 OUTLIER 77.06 -6.59 1.99 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.918 -179.915 . . . . . . . . 3 3 . 1 . 083 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 89.31 -44.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 122.644 0.378 . . . . 0.0 111.56 179.702 . . . . . . . . 3 3 . 1 . 083 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.439 ' O ' ' HB2' ' A' ' 164' ' ' PHE . 46.1 m-85 -68.13 -38.05 81.78 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.203 0.525 . . . . 0.0 110.381 179.806 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.519 ' HB2' ' O ' ' A' ' 158' ' ' SER . 0.1 OUTLIER -72.59 -50.31 26.29 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.643 179.397 . . . . . . . . 3 3 . 1 . 083 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.667 HD23 ' O ' ' A' ' 163' ' ' LEU . 1.4 tt -64.9 -3.47 3.47 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 121.833 0.825 . . . . 0.0 109.856 178.424 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.586 ' HB3' HD13 ' A' ' 165' ' ' LEU . 0.4 OUTLIER -75.46 -72.41 0.31 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.162 -1.381 . . . . 0.0 111.036 -179.343 . . . . . . . . 3 3 . 1 . 083 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.711 ' N ' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -67.11 -68.21 0.4 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.052 0.453 . . . . 0.0 110.684 179.56 . . . . . . . . 3 3 . 1 . 083 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.2 mt -162.28 97.14 1.17 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.692 -179.032 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.478 ' HB2' HD12 ' A' ' 170' ' ' ILE . 43.0 Cg_endo -68.35 109.75 2.09 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.467 2.111 . . . . 0.0 112.756 -179.703 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.13 -11.55 19.47 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.583 2.189 . . . . 0.0 112.534 179.663 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.909 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.5 OUTLIER -70.6 -107.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 CA-C-O 118.943 -0.551 . . . . 0.0 109.526 -179.915 . . . . . . . . 3 3 . 1 . 083 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.71 ' H ' HG23 ' A' ' 169' ' ' ILE . 4.2 mt 21.03 -61.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 178.481 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.909 ' N ' ' O ' ' A' ' 169' ' ' ILE . 0.2 OUTLIER -64.72 -52.38 57.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.57 -179.248 . . . . . . . . 3 3 . 1 . 083 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -73.69 -11.2 60.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.725 0.298 . . . . 0.0 111.094 179.855 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.424 ' HB2' HG13 ' A' ' 169' ' ' ILE . . . -77.01 -56.12 4.86 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.914 0.388 . . . . 0.0 110.638 179.98 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -99.32 -24.8 9.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.855 179.371 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 27.6 t80 77.3 -40.76 0.35 Allowed 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 122.385 0.274 . . . . 0.0 111.681 179.976 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -94.13 -7.87 41.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.688 0.28 . . . . 0.0 111.277 -179.979 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.703 HD12 ' O ' ' A' ' 170' ' ' ILE . 28.4 mt -56.61 -44.19 99.65 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.343 179.709 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 78.8 Cg_exo -48.22 93.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.496 2.131 . . . . 0.0 112.779 -179.76 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.1 mt -99.1 -71.14 0.7 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.63 179.612 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.26 21.61 4.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.609 179.417 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 084 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 120.909 0.385 . . . . 0.0 111.341 . . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.48 ' O ' HD12 ' A' ' 156' ' ' LEU . 3.7 pp -165.74 128.92 2.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.771 -179.265 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.671 ' HB3' HD22 ' A' ' 163' ' ' LEU . 9.2 tt0 -70.05 -46.61 64.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.187 0.518 . . . . 0.0 110.524 179.805 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.529 ' HB3' ' HA ' ' A' ' 163' ' ' LEU . 2.7 t -164.9 51.17 0.11 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.436 179.359 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.461 ' CB ' ' O ' ' A' ' 158' ' ' SER . 0.4 OUTLIER 86.91 -23.91 0.13 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.388 -179.401 . . . . . . . . 3 3 . 1 . 084 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 96.9 t 68.85 -55.16 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.829 0.347 . . . . 0.0 111.614 179.562 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.417 ' O ' ' CD1' ' A' ' 162' ' ' PHE . 96.0 m-85 -72.29 2.33 6.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.018 179.542 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.417 ' CD1' ' O ' ' A' ' 161' ' ' PHE . 0.1 OUTLIER -166.39 16.38 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.847 179.785 . . . . . . . . 3 3 . 1 . 084 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.671 HD22 ' HB3' ' A' ' 157' ' ' GLN . 0.3 OUTLIER -67.31 -17.98 64.99 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.645 . . . . . . . . 3 3 . 1 . 084 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.584 ' CD2' ' O ' ' A' ' 164' ' ' PHE . 45.1 p90 47.46 57.43 5.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.538 179.784 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -170.6 -19.78 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.961 -179.264 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.497 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 4.3 tp -156.39 94.76 2.35 Favored Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-O 120.833 0.349 . . . . 0.0 111.045 -178.303 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.586 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 20.9 Cg_endo -63.88 -26.12 67.28 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.778 2.319 . . . . 0.0 114.656 -179.414 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 27.4 Cg_endo -93.17 -165.35 0.13 Allowed 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 121.918 1.746 . . . . 0.0 112.582 -179.467 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.746 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 12.6 tt -167.44 -42.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.822 -179.851 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.966 HG22 HD21 ' A' ' 177' ' ' LEU . 1.6 mp -70.35 -45.25 75.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.046 -179.684 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.438 ' HA ' ' HG3' ' A' ' 178' ' ' PRO . 3.6 mp -64.56 -52.22 58.76 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.235 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -76.21 1.54 15.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.153 178.529 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.746 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.41 -61.94 1.62 Allowed 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.142 0.496 . . . . 0.0 109.672 179.818 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -102.48 -21.39 10.64 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 178.332 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 1.6 t80 75.13 -38.86 0.39 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.569 0.347 . . . . 0.0 111.464 179.896 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -92.68 1.72 57.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.809 0.337 . . . . 0.0 110.74 179.546 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.966 HD21 HG22 ' A' ' 170' ' ' ILE . 0.3 OUTLIER -78.57 -46.0 1.97 Allowed Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.149 179.801 . . . . . . . . 3 3 . 1 . 084 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 99.1 Cg_exo -42.55 -68.76 0.09 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.543 2.162 . . . . 0.0 113.0 -179.477 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 8.8 mt 61.01 59.65 1.99 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.023 0.44 . . . . 0.0 110.19 -179.674 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 7.9 mtt-85 68.74 47.17 0.86 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.644 -179.358 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 085 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.43 ' O ' HD23 ' A' ' 156' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.654 0.264 . . . . 0.0 111.275 . . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.735 ' CD2' HG23 ' A' ' 160' ' ' VAL . 27.0 mt -162.92 96.28 0.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.577 -179.979 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.79 25.39 0.35 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.986 179.431 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.4 p 72.97 47.23 0.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.157 0.503 . . . . 0.0 110.982 -179.866 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.581 ' O ' HG12 ' A' ' 160' ' ' VAL . 1.8 m-20 -162.18 -61.74 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.309 179.566 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.735 HG23 ' CD2' ' A' ' 156' ' ' LEU . 0.3 OUTLIER 86.1 -38.61 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.703 179.663 . . . . . . . . 3 3 . 1 . 085 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.701 ' CE2' HD11 ' A' ' 165' ' ' LEU . 61.7 t80 -66.07 -27.51 68.13 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.976 0.417 . . . . 0.0 110.599 179.901 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' A' ' 168' ' ' PRO . 0.2 OUTLIER -69.31 -61.45 1.79 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.61 179.324 . . . . . . . . 3 3 . 1 . 085 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.0 tp -66.68 -5.31 11.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.046 178.773 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 0.2 OUTLIER -77.81 -60.45 2.36 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.288 -179.21 . . . . . . . . 3 3 . 1 . 085 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.701 HD11 ' CE2' ' A' ' 161' ' ' PHE . 0.3 OUTLIER -64.82 -51.37 62.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.19 0.519 . . . . 0.0 110.619 179.711 . . . . . . . . 3 3 . 1 . 085 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.784 ' O ' HD13 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -161.9 120.88 1.43 Allowed Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.494 -178.956 . . . . . . . . 3 3 . 1 . 085 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.653 ' CD ' HD22 ' A' ' 166' ' ' LEU . 9.9 Cg_endo -53.0 115.55 2.34 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.361 2.041 . . . . 0.0 111.981 179.863 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.436 ' HB3' ' CE1' ' A' ' 162' ' ' PHE . 58.6 Cg_endo -72.38 -3.3 13.14 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.291 1.994 . . . . 0.0 112.979 -179.639 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.883 ' O ' ' N ' ' A' ' 171' ' ' LEU . 0.5 OUTLIER -72.11 -107.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 118.911 -0.566 . . . . 0.0 109.703 179.648 . . . . . . . . 3 3 . 1 . 085 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.673 ' H ' HG23 ' A' ' 169' ' ' ILE . 2.2 mp 21.98 -63.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 178.595 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.883 ' N ' ' O ' ' A' ' 169' ' ' ILE . 4.0 pp -66.37 -50.32 63.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.181 -179.635 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.748 ' N ' HD12 ' A' ' 171' ' ' LEU . 0.4 OUTLIER -69.7 -11.68 61.04 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.607 179.611 . . . . . . . . 3 3 . 1 . 085 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -78.22 -62.0 1.82 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.812 179.87 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -113.15 -24.69 4.72 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.348 179.748 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 1.0 OUTLIER 76.66 -11.82 1.13 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.561 0.22 . . . . 0.0 111.455 -179.792 . . . . . . . . 3 3 . 1 . 085 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.448 ' CD1' HD11 ' A' ' 179' ' ' LEU . 27.8 t80 -122.99 3.94 9.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.684 0.278 . . . . 0.0 110.702 179.377 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.595 HD12 ' O ' ' A' ' 170' ' ' ILE . 22.4 mt -75.98 -45.38 3.87 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.209 179.975 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 3.2 Cg_exo -74.0 -85.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.514 2.143 . . . . 0.0 112.055 -179.785 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.448 HD11 ' CD1' ' A' ' 176' ' ' PHE . 4.6 mt 48.88 49.94 18.4 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 121.181 0.515 . . . . 0.0 110.663 -179.911 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 68.87 46.16 0.91 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.628 -179.552 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . 0.485 ' HB2' ' O ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.782 0.325 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 086 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 156' ' ' LEU . 20.1 mt 56.56 70.28 0.66 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.845 179.957 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -78.39 20.54 0.41 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.474 179.572 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 75.57 45.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.098 0.475 . . . . 0.0 110.643 -179.61 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.526 ' O ' HG12 ' A' ' 160' ' ' VAL . 44.4 m-20 -158.73 -61.34 0.08 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.199 179.894 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 88.37 -41.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.837 179.388 . . . . . . . . 3 3 . 1 . 086 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.428 ' HB3' ' HD2' ' A' ' 168' ' ' PRO . 1.6 m-85 -70.23 -34.5 72.95 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.124 0.488 . . . . 0.0 110.865 -179.843 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -68.71 -53.13 23.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.209 -179.848 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 12.8 tp -67.59 -5.44 15.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.329 178.709 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.44 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER -76.83 -4.57 44.29 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.862 179.805 . . . . . . . . 3 3 . 1 . 086 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.44 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.1 OUTLIER 84.2 -20.26 0.32 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.182 -179.643 . . . . . . . . 3 3 . 1 . 086 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 166' ' ' LEU . 4.9 tp -168.24 141.57 2.6 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.881 -178.484 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -74.12 109.22 2.84 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.32 2.013 . . . . 0.0 112.345 179.61 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.88 ' O ' ' N ' ' A' ' 170' ' ' ILE . 58.6 Cg_endo -71.72 -17.58 29.32 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.574 2.183 . . . . 0.0 112.508 179.93 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.793 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 5.2 tt 32.0 -62.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.177 0.991 . . . . 0.0 112.647 179.663 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.88 ' N ' ' O ' ' A' ' 168' ' ' PRO . 0.4 OUTLIER -67.03 -47.86 80.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.992 -179.899 . . . . . . . . 3 3 . 1 . 086 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 175' ' ' TYR . 0.1 OUTLIER -64.85 -50.92 64.73 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.419 . . . . . . . . 3 3 . 1 . 086 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.42 ' HB2' ' HG2' ' A' ' 168' ' ' PRO . 0.8 OUTLIER -73.82 -5.86 43.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.547 178.445 . . . . . . . . 3 3 . 1 . 086 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.793 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.71 -73.71 0.21 Allowed 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.571 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.453 ' H ' HD12 ' A' ' 177' ' ' LEU . . . -113.95 -19.86 6.25 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.44 178.585 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.402 ' HA ' HD13 ' A' ' 171' ' ' LEU . 35.0 t80 73.03 -44.86 0.61 Allowed 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 122.45 0.3 . . . . 0.0 111.59 179.87 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -94.08 -13.07 27.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.349 -179.729 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.53 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 8.0 mt -48.55 -43.51 62.23 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 120.522 0.201 . . . . 0.0 111.289 179.797 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 21.6 Cg_exo -65.98 -28.19 50.0 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.565 2.177 . . . . 0.0 112.13 -179.946 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 8.9 mp -77.91 -7.94 57.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.475 -179.913 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.88 62.5 0.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.222 0.534 . . . . 0.0 109.673 179.566 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 087 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.779 0.323 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 087 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.589 ' O ' HD12 ' A' ' 156' ' ' LEU . 1.0 OUTLIER -165.72 60.3 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.043 -179.929 . . . . . . . . 3 3 . 1 . 087 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -169.52 -41.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.962 179.975 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.4 p -75.96 57.92 1.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.911 179.873 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.578 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.5 OUTLIER 70.97 -48.6 0.67 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.887 179.871 . . . . . . . . 3 3 . 1 . 087 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.578 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 98.2 t 85.75 -53.38 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 C-N-CA 123.02 0.528 . . . . 0.0 110.719 -179.568 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.419 ' O ' ' CB ' ' A' ' 164' ' ' PHE . 0.1 OUTLIER -68.22 -24.2 64.9 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.104 0.478 . . . . 0.0 109.868 179.012 . . . . . . . . 3 3 . 1 . 087 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.419 ' C ' ' H ' ' A' ' 164' ' ' PHE . 0.3 OUTLIER -70.93 -51.13 27.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.447 179.152 . . . . . . . . 3 3 . 1 . 087 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.476 HD23 ' O ' ' A' ' 163' ' ' LEU . 0.7 OUTLIER -65.16 -5.89 7.89 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.794 0.807 . . . . 0.0 109.281 178.129 . . . . . . . . 3 3 . 1 . 087 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.419 ' H ' ' C ' ' A' ' 162' ' ' PHE . 0.1 OUTLIER -77.83 -63.46 1.38 Allowed 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.781 -179.733 . . . . . . . . 3 3 . 1 . 087 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.08 -45.84 79.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.175 0.512 . . . . 0.0 110.372 179.403 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.73 HD13 ' O ' ' A' ' 166' ' ' LEU . 0.2 OUTLIER -160.97 122.05 1.65 Allowed Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.323 -178.617 . . . . . . . . 3 3 . 1 . 087 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.675 ' CD ' HD22 ' A' ' 166' ' ' LEU . 11.8 Cg_endo -55.54 119.76 7.09 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.582 2.188 . . . . 0.0 112.86 -179.426 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.98 92.94 0.87 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.818 2.345 . . . . 0.0 111.463 179.312 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.89 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 2.9 tp -68.91 -40.67 81.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.408 -179.268 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.424 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.8 mp -71.33 -47.93 56.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.016 -179.904 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.48 -50.67 64.48 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.13 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.88 -4.66 39.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.998 178.869 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.89 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.37 -69.48 0.42 Allowed 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.368 0.604 . . . . 0.0 109.552 179.632 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.841 ' H ' ' HG2' ' A' ' 178' ' ' PRO . . . -122.36 -20.71 2.91 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.213 178.674 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.438 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 11.8 t80 76.35 -31.68 0.19 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.313 0.645 . . . . 0.0 112.349 179.549 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -91.63 61.9 4.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.332 0.587 . . . . 0.0 109.694 179.525 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.68 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 2.3 mt 44.16 56.03 13.09 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.029 -178.997 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.841 ' HG2' ' H ' ' A' ' 174' ' ' GLY . 12.5 Cg_exo -73.62 162.79 38.98 Favored 'Trans proline' 0 CA--C 1.528 0.18 0 C-N-CA 123.787 2.992 . . . . 0.0 112.587 -179.652 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.9 mt 167.8 -33.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.041 179.706 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.48 35.47 0.87 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.036 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 088 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.439 ' CE2' ' NE2' ' A' ' 157' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.782 0.325 . . . . 0.0 111.224 . . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 158' ' ' SER . 3.5 pp -165.62 -42.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.201 -179.976 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.465 ' CB ' ' HB2' ' A' ' 163' ' ' LEU . 12.4 mm-40 74.38 67.15 0.09 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.017 0.436 . . . . 0.0 111.188 179.623 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.557 ' N ' HD12 ' A' ' 156' ' ' LEU . 0.4 OUTLIER 72.41 -61.22 0.5 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.845 179.943 . . . . . . . . 3 3 . 1 . 088 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.411 ' O ' ' CB ' ' A' ' 160' ' ' VAL . 8.3 m-20 -159.44 12.87 0.14 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.015 -0.538 . . . . 0.0 112.281 179.926 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.411 ' CB ' ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 83.49 -46.1 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 111.819 0.304 . . . . 0.0 111.819 179.542 . . . . . . . . 3 3 . 1 . 088 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.482 ' HA ' ' HB2' ' A' ' 164' ' ' PHE . 37.8 m-85 -65.0 -24.73 67.6 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.843 0.354 . . . . 0.0 110.876 -179.585 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -68.23 -59.81 2.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.634 179.48 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.715 ' O ' HD13 ' A' ' 163' ' ' LEU . 1.5 tm? -62.8 -16.21 57.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.872 0.844 . . . . 0.0 109.499 178.356 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.482 ' HB2' ' HA ' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -69.08 -12.6 61.83 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.371 -179.472 . . . . . . . . 3 3 . 1 . 088 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 165' ' ' LEU . 5.1 tp -64.38 -32.08 73.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.214 0.53 . . . . 0.0 110.058 178.935 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.667 HD23 ' O ' ' A' ' 166' ' ' LEU . 0.1 OUTLIER -160.29 78.1 2.6 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.044 -178.544 . . . . . . . . 3 3 . 1 . 088 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.579 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 36.0 Cg_endo -69.38 -25.9 29.92 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.819 2.346 . . . . 0.0 115.302 -178.563 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 33.8 Cg_endo -88.3 49.85 1.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.56 1.507 . . . . 0.0 112.912 -179.294 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.829 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 7.5 tt -77.49 -41.23 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.952 179.585 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.859 HG22 ' CD1' ' A' ' 177' ' ' LEU . 1.3 mp -76.13 -51.85 19.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.92 -179.282 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.735 HD23 ' N ' ' A' ' 172' ' ' ASP . 0.0 OUTLIER -64.75 -53.13 52.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.981 0.42 . . . . 0.0 110.002 -179.756 . . . . . . . . 3 3 . 1 . 088 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.735 ' N ' HD23 ' A' ' 171' ' ' LEU . 1.1 t70 -74.84 4.73 5.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.384 179.053 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.829 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -70.44 -60.57 2.19 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.694 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -109.36 -17.18 10.2 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 178.085 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 29.7 t80 72.33 -12.39 0.72 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.565 0.346 . . . . 0.0 111.316 -179.777 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.605 ' CD1' HD21 ' A' ' 179' ' ' LEU . 76.4 t80 -97.88 19.17 14.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.937 0.399 . . . . 0.0 110.193 179.506 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.859 ' CD1' HG22 ' A' ' 170' ' ' ILE . 2.4 mt -81.05 -53.44 0.78 Allowed Pre-proline 0 C--O 1.232 0.155 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.918 -179.886 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 74.5 Cg_exo -50.46 -71.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.637 2.225 . . . . 0.0 112.498 -179.764 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.605 HD21 ' CD1' ' A' ' 176' ' ' PHE . 50.3 mt 61.28 57.17 2.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.062 0.458 . . . . 0.0 110.779 -179.981 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 9.4 mmp_? 62.09 46.67 6.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.812 179.926 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 089 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.451 ' O ' HD23 ' A' ' 156' ' ' LEU . 82.8 m-85 . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.68 0.276 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 155' ' ' PHE . 84.0 mt -161.97 79.36 0.54 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.787 -179.999 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -169.82 -40.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.413 179.715 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.82 60.78 0.74 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.229 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.461 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.3 OUTLIER 72.41 -58.88 0.58 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.383 -179.053 . . . . . . . . 3 3 . 1 . 089 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 57.6 t 74.25 -65.23 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.831 -179.842 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.427 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 22.8 m-85 -79.89 35.33 0.31 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.03 178.841 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.427 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 7.4 m-85 -170.06 -26.65 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.809 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.44 ' HA ' HD22 ' A' ' 163' ' ' LEU . 0.6 OUTLIER -57.13 -48.84 77.67 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.593 . . . . . . . . 3 3 . 1 . 089 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.585 ' HB2' HD11 ' A' ' 169' ' ' ILE . 0.5 OUTLIER 43.37 38.53 1.76 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.721 177.352 . . . . . . . . 3 3 . 1 . 089 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.491 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.7 OUTLIER 88.08 -29.69 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.068 -179.43 . . . . . . . . 3 3 . 1 . 089 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.533 HD22 ' HD2' ' A' ' 167' ' ' PRO . 0.1 OUTLIER -158.99 132.78 4.99 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.156 -178.859 . . . . . . . . 3 3 . 1 . 089 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.533 ' HD2' HD22 ' A' ' 166' ' ' LEU . 4.0 Cg_exo -38.4 -46.0 2.32 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.572 2.848 . . . . 0.0 114.355 -178.98 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.503 ' HD2' ' CD1' ' A' ' 166' ' ' LEU . 52.3 Cg_endo -88.78 101.04 0.38 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.74 2.293 . . . . 0.0 112.227 -179.336 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.86 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.0 OUTLIER -71.22 -46.5 65.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.248 -179.455 . . . . . . . . 3 3 . 1 . 089 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.612 HG23 HG22 ' A' ' 169' ' ' ILE . 0.6 OUTLIER -74.54 -43.67 48.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.361 -177.95 . . . . . . . . 3 3 . 1 . 089 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.445 ' HA ' ' HG2' ' A' ' 178' ' ' PRO . 0.2 OUTLIER -65.35 -56.55 12.01 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.227 . . . . . . . . 3 3 . 1 . 089 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.7 4.41 7.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.4 179.023 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.86 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.16 -75.34 0.13 Allowed 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.796 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.45 ' HA3' HD12 ' A' ' 177' ' ' LEU . . . -95.12 -13.03 54.11 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 177.924 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 69.76 -59.59 0.5 Allowed 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 120.862 0.363 . . . . 0.0 110.955 179.875 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -96.94 -5.5 37.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.194 179.708 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.525 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 62.7 mt -71.61 -45.21 12.81 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.161 179.685 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.525 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 27.5 Cg_exo -62.11 -149.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.466 2.111 . . . . 0.0 111.984 179.812 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.464 HD12 ' HA ' ' A' ' 179' ' ' LEU . 2.6 tp 81.02 74.1 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.135 0 CA-C-O 121.071 0.462 . . . . 0.0 110.763 -179.894 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 67.17 57.35 0.6 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.832 179.862 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 090 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.619 ' O ' ' O ' ' A' ' 156' ' ' LEU . 9.8 m-85 . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 120.79 0.329 . . . . 0.0 111.392 . . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.855 ' O ' HD12 ' A' ' 156' ' ' LEU . 3.3 pp 45.15 142.74 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.393 -0.822 . . . . 0.0 112.934 179.29 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.549 ' HB2' HD12 ' A' ' 163' ' ' LEU . 3.1 tp-100 -171.13 -80.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.225 179.881 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.7 m -170.1 -40.85 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.374 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.404 ' O ' HG12 ' A' ' 160' ' ' VAL . 74.6 m-20 -84.31 -52.45 6.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.066 178.819 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.447 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 80.0 -52.39 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.171 179.839 . . . . . . . . 3 3 . 1 . 090 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.447 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 72.6 t80 -69.57 -28.7 66.2 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.051 0.453 . . . . 0.0 110.259 179.393 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.422 ' HB3' ' HG3' ' A' ' 168' ' ' PRO . 0.2 OUTLIER -68.49 -60.05 2.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.782 179.46 . . . . . . . . 3 3 . 1 . 090 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.58 HD23 ' HA ' ' A' ' 167' ' ' PRO . 13.5 mt -65.93 -5.22 8.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.93 178.791 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.95 -63.69 1.25 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.869 -179.457 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -55.21 18.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.993 0.425 . . . . 0.0 110.667 179.607 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 166' ' ' LEU . 3.9 tp -161.37 141.56 8.09 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.587 -179.658 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.58 ' HA ' HD23 ' A' ' 163' ' ' LEU . 13.6 Cg_endo -57.06 110.17 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.478 2.118 . . . . 0.0 112.901 -179.672 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.422 ' HG3' ' HB3' ' A' ' 162' ' ' PHE . 81.8 Cg_endo -80.94 87.02 1.54 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.102 2.535 . . . . 0.0 112.093 179.45 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.948 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER -72.07 -38.17 62.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.313 -179.825 . . . . . . . . 3 3 . 1 . 090 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 6.0 mm -80.84 -44.09 21.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.61 -179.869 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.483 HD13 ' HG2' ' A' ' 178' ' ' PRO . 0.7 OUTLIER -64.38 -57.85 8.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.159 0.504 . . . . 0.0 109.792 179.95 . . . . . . . . 3 3 . 1 . 090 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.9 2.81 7.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.066 178.74 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.948 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.02 -54.79 8.8 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.432 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.468 ' HA3' HD21 ' A' ' 177' ' ' LEU . . . -126.39 -10.64 4.04 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.928 178.692 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.422 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 2.6 t80 68.55 -52.67 0.56 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.62 0.368 . . . . 0.0 111.708 179.59 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -92.49 10.01 31.98 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.403 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.491 ' O ' ' HB2' ' A' ' 181' ' ' HSL . 13.2 mt -71.85 -46.74 12.07 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.509 0.195 . . . . 0.0 110.806 179.352 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.483 ' HG2' HD13 ' A' ' 171' ' ' LEU . 90.2 Cg_exo -44.25 -28.78 2.58 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.512 2.142 . . . . 0.0 112.408 179.718 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.1 mp -81.5 -55.1 4.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.122 179.329 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.76 37.57 0.8 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.424 179.44 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . 0.491 ' HB2' ' O ' ' A' ' 177' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.4 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 41.9 m-85 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.517 0.199 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.409 ' HA ' HD23 ' A' ' 156' ' ' LEU . 7.0 mt -167.48 42.08 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.957 0.408 . . . . 0.0 110.683 -179.716 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -168.61 52.0 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.373 0.606 . . . . 0.0 110.731 179.804 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.529 ' O ' HD23 ' A' ' 163' ' ' LEU . 1.8 m -164.72 64.38 0.13 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.306 179.684 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.422 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.4 OUTLIER 76.69 -59.51 0.49 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.243 -178.746 . . . . . . . . 3 3 . 1 . 091 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.422 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 92.7 t 70.62 -59.23 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.678 179.917 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.47 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 36.0 t80 -74.85 20.56 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.541 179.351 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.47 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 35.4 m-85 -166.87 -17.14 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 179.978 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 158' ' ' SER . 0.3 OUTLIER -60.46 -41.97 95.25 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.53 . . . . . . . . 3 3 . 1 . 091 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.45 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 0.6 OUTLIER 48.73 30.25 2.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.358 178.212 . . . . . . . . 3 3 . 1 . 091 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.45 ' CB ' ' O ' ' A' ' 164' ' ' PHE . 0.1 OUTLIER 85.38 -22.85 0.18 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.436 -179.754 . . . . . . . . 3 3 . 1 . 091 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.556 HD23 ' O ' ' A' ' 166' ' ' LEU . 0.5 OUTLIER -161.59 115.01 1.25 Allowed Pre-proline 0 N--CA 1.447 -0.595 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.048 -178.357 . . . . . . . . 3 3 . 1 . 091 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.512 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 1.7 Cg_endo -49.35 -40.04 43.94 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.442 2.095 . . . . 0.0 113.415 -179.474 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.512 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 34.7 Cg_endo -92.25 81.94 0.28 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.452 2.102 . . . . 0.0 113.074 -179.008 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.699 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.4 OUTLIER -77.49 -45.93 28.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.227 179.904 . . . . . . . . 3 3 . 1 . 091 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.447 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.6 mp -72.65 -39.56 60.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.367 -179.633 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 171' ' ' LEU . 4.0 tt -68.82 -2.51 9.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.684 179.922 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -148.14 15.96 1.05 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.064 179.902 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -81.46 -46.42 14.58 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.015 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.588 ' O ' ' CG ' ' A' ' 175' ' ' TYR . . . -141.61 0.52 1.69 Allowed Glycine 0 CA--C 1.522 0.531 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.818 179.229 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.588 ' CG ' ' O ' ' A' ' 174' ' ' GLY . 45.2 p90 56.61 -52.72 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.904 0.881 . . . . 0.0 113.02 179.926 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.562 ' N ' ' O ' ' A' ' 174' ' ' GLY . 0.0 OUTLIER -92.11 12.72 21.15 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.312 . . . . . . . . 3 3 . 1 . 091 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.555 HD11 ' N ' ' A' ' 174' ' ' GLY . 11.8 mt -72.08 -48.12 10.77 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-O 120.635 0.255 . . . . 0.0 110.415 179.332 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.517 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 85.5 Cg_exo -48.52 -25.86 8.2 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.714 2.276 . . . . 0.0 112.395 179.479 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.413 ' N ' HD22 ' A' ' 179' ' ' LEU . 3.6 mm? -68.36 -60.54 2.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.909 -179.853 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.99 44.87 1.21 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.969 -179.881 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 092 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 120.813 0.34 . . . . 0.0 111.293 . . . . . . . . . 0 0 . 1 . 092 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.65 ' CD1' HG23 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -73.25 -21.71 60.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.011 -179.88 . . . . . . . . 3 3 . 1 . 092 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.19 18.65 6.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.51 179.817 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.4 p 74.91 -10.86 1.14 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.529 -179.925 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.772 ' O ' HG12 ' A' ' 160' ' ' VAL . 1.2 m-20 -78.62 -63.79 1.32 Allowed 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.452 0.168 . . . . 0.0 110.668 179.741 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.772 HG12 ' O ' ' A' ' 159' ' ' ASP . 9.9 p 58.39 -44.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 123.978 0.799 . . . . 0.0 112.634 -179.567 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.508 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 0.3 OUTLIER -71.13 -16.47 62.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.406 0.146 . . . . 0.0 111.273 179.929 . . . . . . . . 3 3 . 1 . 092 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.508 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 56.2 m-85 -161.85 20.65 0.11 Allowed 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 179.777 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.784 ' O ' HD13 ' A' ' 163' ' ' LEU . 2.1 tm? -65.97 -18.68 65.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.916 0.865 . . . . 0.0 109.289 177.811 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -70.95 -67.76 0.48 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.354 -1.294 . . . . 0.0 112.022 -178.796 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.718 ' N ' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -63.4 -72.76 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.333 -178.952 . . . . . . . . 3 3 . 1 . 092 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.461 HD12 ' HD2' ' A' ' 168' ' ' PRO . 0.3 OUTLIER -160.61 120.22 1.59 Allowed Pre-proline 0 N--CA 1.451 -0.395 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.16 -178.348 . . . . . . . . 3 3 . 1 . 092 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.436 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 6.4 Cg_exo -37.7 -48.55 1.99 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.796 2.33 . . . . 0.0 112.587 179.9 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.461 ' HD2' HD12 ' A' ' 166' ' ' LEU . 33.2 Cg_endo -92.41 74.16 0.51 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.092 2.528 . . . . 0.0 112.288 179.96 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.906 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 1.2 tp -74.2 -44.25 49.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.224 -179.659 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.551 ' O ' HD12 ' A' ' 177' ' ' LEU . 2.5 mp -72.45 -42.71 64.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.312 -179.684 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.413 ' HA ' ' HG3' ' A' ' 178' ' ' PRO . 3.7 tt -65.02 -56.21 14.43 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.443 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.1 1.0 14.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.118 178.711 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.906 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.95 -57.66 3.89 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-O 121.201 0.524 . . . . 0.0 109.833 179.723 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -119.98 -3.45 12.05 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.878 178.983 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.457 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 92.6 t80 71.03 -43.51 0.56 Allowed 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.587 0.355 . . . . 0.0 111.719 -179.964 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.9 14.11 22.66 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.791 0.329 . . . . 0.0 111.01 179.937 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.676 HD12 ' HB3' ' A' ' 173' ' ' ALA . 54.4 mt -82.98 -38.61 0.76 Allowed Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.76 179.995 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 86.8 Cg_exo -44.16 -26.34 1.48 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.555 2.17 . . . . 0.0 113.001 -179.771 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 179' ' ' LEU . 0.9 OUTLIER -60.8 -15.62 31.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.13 179.661 . . . . . . . . 3 3 . 1 . 092 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -145.58 46.32 1.29 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.029 0.442 . . . . 0.0 110.133 179.728 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . 0.518 ' HB2' ' HA ' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.536 ' O ' ' HB2' ' A' ' 156' ' ' LEU . 16.1 m-85 . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 . . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.566 HD23 HG22 ' A' ' 160' ' ' VAL . 6.5 mt 75.93 -43.97 0.49 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.843 179.952 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -71.46 -14.64 62.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.879 0.371 . . . . 0.0 110.535 179.556 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.7 ' OG ' HD13 ' A' ' 163' ' ' LEU . 1.2 p -79.7 28.4 0.27 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.978 -179.697 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.542 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 0.2 OUTLIER 79.59 -25.44 0.18 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.921 . . . . . . . . 3 3 . 1 . 093 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.566 HG22 HD23 ' A' ' 156' ' ' LEU . 58.0 t 81.62 -54.46 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.115 0 C-N-CA 122.613 0.365 . . . . 0.0 111.233 179.946 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.593 ' O ' ' HB2' ' A' ' 164' ' ' PHE . 31.0 t80 -67.36 -35.51 79.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.14 0.495 . . . . 0.0 110.403 179.626 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.495 ' C ' ' H ' ' A' ' 164' ' ' PHE . 0.2 OUTLIER -77.49 -44.88 27.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.413 179.698 . . . . . . . . 3 3 . 1 . 093 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.7 HD13 ' OG ' ' A' ' 158' ' ' SER . 3.4 tp -62.66 -4.24 1.92 Allowed 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 121.894 0.854 . . . . 0.0 109.293 178.783 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.593 ' HB2' ' O ' ' A' ' 161' ' ' PHE . 0.1 OUTLIER -75.6 -67.68 0.64 Allowed 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.41 -179.998 . . . . . . . . 3 3 . 1 . 093 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.38 -70.99 0.22 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.977 0.418 . . . . 0.0 111.246 179.407 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.446 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 5.7 tp -160.48 95.39 1.5 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.694 -178.309 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.586 ' HG3' HD12 ' A' ' 163' ' ' LEU . 21.7 Cg_endo -66.19 -28.55 48.1 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.746 2.297 . . . . 0.0 115.021 -179.126 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.58 ' CB ' HD13 ' A' ' 171' ' ' LEU . 33.2 Cg_endo -89.49 59.44 2.08 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.789 1.659 . . . . 0.0 113.083 -178.923 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.802 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -76.82 -33.75 21.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.134 179.711 . . . . . . . . 3 3 . 1 . 093 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 3.4 mp -69.07 -38.71 78.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.618 -179.004 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.58 HD13 ' CB ' ' A' ' 168' ' ' PRO . 2.6 mp -65.17 -60.09 3.38 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.258 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -74.36 3.31 7.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.263 178.55 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.802 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.15 -59.31 2.84 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.973 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -104.52 -20.4 10.22 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 178.309 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 36.7 t80 72.91 -11.64 0.85 Allowed 'General case' 0 C--O 1.232 0.157 0 C-N-CA 122.704 0.402 . . . . 0.0 111.845 179.83 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.406 ' HA ' HD12 ' A' ' 179' ' ' LEU . 23.3 p90 -95.41 -3.08 47.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.821 0.343 . . . . 0.0 110.495 179.348 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.443 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 1.3 mm? -53.51 -51.86 72.13 Favored Pre-proline 0 C--N 1.333 -0.139 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.592 179.649 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.443 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 35.4 Cg_exo -58.7 -41.08 67.19 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.681 2.254 . . . . 0.0 112.223 179.649 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 176' ' ' PHE . 2.6 mt -63.36 -56.08 19.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.839 -179.9 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -87.44 49.1 1.75 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.943 179.982 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 094 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.494 ' O ' HG12 ' A' ' 160' ' ' VAL . 32.3 m-85 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.814 0.34 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.538 ' HB3' HD12 ' A' ' 163' ' ' LEU . 17.7 mt 51.55 57.4 6.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.177 179.962 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 72.28 27.22 2.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.987 179.952 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 53.35 44.03 30.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.056 179.957 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.737 ' O ' HG13 ' A' ' 160' ' ' VAL . 15.7 m-20 -162.28 -57.29 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.598 179.872 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.737 HG13 ' O ' ' A' ' 159' ' ' ASP . 1.5 m 67.46 -58.48 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 123.134 0.574 . . . . 0.0 110.072 -179.72 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.512 ' CE1' ' CE2' ' A' ' 162' ' ' PHE . 0.0 OUTLIER -73.6 49.12 0.29 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.438 . . . . . . . . 3 3 . 1 . 094 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.512 ' CE2' ' CE1' ' A' ' 161' ' ' PHE . 5.5 m-85 -166.42 -30.53 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.68 -179.385 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.538 HD12 ' HB3' ' A' ' 156' ' ' LEU . 12.8 mt -58.43 -34.77 71.16 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.204 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.471 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 1.4 t80 46.38 40.6 8.1 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.719 177.649 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.531 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.2 OUTLIER 86.47 -30.08 0.05 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.067 -179.738 . . . . . . . . 3 3 . 1 . 094 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -161.24 133.97 4.49 Favored Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.422 -178.941 . . . . . . . . 3 3 . 1 . 094 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.409 ' HA ' ' HD2' ' A' ' 168' ' ' PRO . 9.9 Cg_endo -51.98 108.64 0.26 Allowed 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.533 2.155 . . . . 0.0 112.395 -179.703 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 167' ' ' PRO . 61.5 Cg_endo -71.9 82.11 1.29 Allowed 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.646 2.231 . . . . 0.0 112.042 179.75 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.929 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER -74.48 -45.24 46.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.283 0.563 . . . . 0.0 110.853 -179.911 . . . . . . . . 3 3 . 1 . 094 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.722 ' O ' HD23 ' A' ' 177' ' ' LEU . 0.7 OUTLIER -79.36 -45.34 23.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 114.92 -1.036 . . . . 0.0 112.074 -178.798 . . . . . . . . 3 3 . 1 . 094 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.437 HD23 HG13 ' A' ' 170' ' ' ILE . 13.2 mt -66.93 -55.69 13.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.089 0.471 . . . . 0.0 109.891 179.532 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.05 5.84 4.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.276 179.032 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.929 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.32 -47.75 40.04 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.26 0.552 . . . . 0.0 109.712 179.639 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.51 ' C ' ' CG ' ' A' ' 175' ' ' TYR . . . -120.75 -1.59 11.8 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.841 178.841 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.51 ' CG ' ' C ' ' A' ' 174' ' ' GLY . 0.1 OUTLIER 57.25 -50.07 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.963 0.905 . . . . 0.0 113.088 179.732 . . . . . . . . 3 3 . 1 . 094 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.49 ' N ' ' O ' ' A' ' 174' ' ' GLY . 26.6 p90 -90.57 9.88 27.76 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 122.217 -0.302 . . . . 0.0 111.152 -179.935 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.722 HD23 ' O ' ' A' ' 170' ' ' ILE . 0.1 OUTLIER -69.52 -51.35 16.66 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.651 179.663 . . . . . . . . 3 3 . 1 . 094 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 38.4 Cg_exo -61.22 78.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.627 2.218 . . . . 0.0 112.18 179.923 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.94 -63.85 1.17 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.21 -179.919 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.38 16.02 4.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.836 -179.891 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 095 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.906 0.384 . . . . 0.0 111.881 . . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.405 ' N ' HD13 ' A' ' 163' ' ' LEU . 9.3 mt 65.38 108.79 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.993 179.873 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.814 ' CB ' HD11 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -168.62 -73.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.244 0.545 . . . . 0.0 111.105 -179.963 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 20.6 t -171.06 -35.17 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.505 179.727 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 161' ' ' PHE . 2.1 m-20 -76.85 -57.8 3.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.151 179.321 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 161' ' ' PHE . 0.4 OUTLIER 63.4 -51.93 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.184 179.623 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.461 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 10.1 m-85 -72.73 -0.05 12.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.679 0.276 . . . . 0.0 111.082 179.643 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.444 ' CG ' ' C ' ' A' ' 161' ' ' PHE . 0.0 OUTLIER -160.58 14.02 0.11 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.151 -179.956 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.814 HD11 ' CB ' ' A' ' 157' ' ' GLN . 3.4 mt -67.56 -10.87 55.84 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.343 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -78.45 -84.03 0.08 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.38 -179.475 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.537 ' HB2' HD11 ' A' ' 169' ' ' ILE . 0.1 OUTLIER -67.83 -66.0 0.62 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.951 0.405 . . . . 0.0 111.307 -179.702 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.613 ' HB3' ' HD2' ' A' ' 168' ' ' PRO . 0.0 OUTLIER -160.19 153.06 17.91 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.538 -179.53 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.447 ' CB ' ' HD3' ' A' ' 168' ' ' PRO . 3.0 Cg_exo -37.35 -52.45 1.48 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.517 2.811 . . . . 0.0 113.875 -179.189 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.807 ' O ' HD12 ' A' ' 170' ' ' ILE . 85.6 Cg_endo -83.64 -62.41 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.836 1.69 . . . . 0.0 113.209 -179.198 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.877 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.0 OUTLIER 80.33 -38.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 179.4 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.807 HD12 ' O ' ' A' ' 168' ' ' PRO . 4.0 mp -71.64 -39.69 69.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.673 -179.022 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.928 HD13 ' HG3' ' A' ' 178' ' ' PRO . 2.0 mm? -64.54 -60.52 3.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.357 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -75.14 4.41 6.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.501 178.973 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.877 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.82 -69.66 0.38 Allowed 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.59 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 175' ' ' TYR . . . -108.25 -16.41 12.31 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.091 178.211 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.427 ' HB3' ' O ' ' A' ' 174' ' ' GLY . 53.1 t80 74.51 -15.78 0.6 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.868 0.467 . . . . 0.0 111.898 179.953 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -107.67 -22.41 12.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.781 0.324 . . . . 0.0 111.02 -179.964 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.522 ' N ' ' CD ' ' A' ' 178' ' ' PRO . 47.6 mt -48.29 -42.75 54.84 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.742 -179.946 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.928 ' HG3' HD13 ' A' ' 171' ' ' LEU . 26.0 Cg_exo -63.14 71.67 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.562 2.174 . . . . 0.0 112.408 -179.777 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 177' ' ' LEU . 0.4 OUTLIER -77.39 -66.1 0.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.572 179.675 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.37 40.57 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.578 179.58 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 096 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 1.3 p90 . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.836 0.351 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 096 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.423 ' HB2' ' CG2' ' A' ' 160' ' ' VAL . 1.3 pt? -165.43 170.29 14.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.051 -179.968 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -169.18 -85.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.888 179.904 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.631 ' HB3' HD13 ' A' ' 163' ' ' LEU . 8.5 t -78.18 53.6 1.25 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.742 0.306 . . . . 0.0 111.204 179.928 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.538 ' O ' ' HB ' ' A' ' 160' ' ' VAL . 6.7 t0 75.87 -34.88 0.25 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 179.913 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.538 ' HB ' ' O ' ' A' ' 159' ' ' ASP . 75.8 t 80.45 -57.02 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 C-N-CA 122.549 0.339 . . . . 0.0 110.486 -179.613 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.518 ' O ' ' CG ' ' A' ' 162' ' ' PHE . 7.3 m-85 -73.71 36.84 0.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.771 179.01 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.518 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 93.0 m-85 -165.88 -25.71 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.129 179.845 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.631 HD13 ' HB3' ' A' ' 158' ' ' SER . 6.0 tp -63.53 -1.89 1.4 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.769 0.795 . . . . 0.0 109.283 178.062 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.514 ' H ' ' C ' ' A' ' 162' ' ' PHE . 10.1 t80 -68.5 -10.03 52.89 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.347 -179.662 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.5 tp -64.44 -31.67 72.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.082 0.468 . . . . 0.0 110.136 178.971 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 1.8 tp -160.61 66.57 2.45 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.588 -179.463 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.67 108.24 0.52 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.954 2.436 . . . . 0.0 113.827 -178.505 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.453 ' HG2' ' HB2' ' A' ' 172' ' ' ASP . 92.5 Cg_endo -79.14 86.1 1.75 Allowed 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.937 2.425 . . . . 0.0 110.932 178.293 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.946 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 5.7 tp -71.45 -63.4 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.414 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.746 ' H ' HG23 ' A' ' 169' ' ' ILE . 1.9 mp -73.35 -39.98 56.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.812 -179.015 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 175' ' ' TYR . 4.7 tp -64.13 -60.89 2.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.274 0.559 . . . . 0.0 109.762 179.754 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.453 ' HB2' ' HG2' ' A' ' 168' ' ' PRO . 4.6 t70 -74.12 -0.0 15.24 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.128 179.014 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.946 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -70.11 -71.0 0.26 Allowed 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.203 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.486 ' HA3' ' CG ' ' A' ' 177' ' ' LEU . . . -125.87 -8.48 5.16 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.119 177.815 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 12.9 t80 70.59 -55.66 0.62 Allowed 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.605 0.362 . . . . 0.0 111.851 179.558 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -94.99 16.8 15.27 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.187 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.486 ' CG ' ' HA3' ' A' ' 174' ' ' GLY . 6.2 mt -81.56 -47.89 1.03 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.57 0.224 . . . . 0.0 110.826 179.434 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.674 ' HG3' HG22 ' A' ' 170' ' ' ILE . 73.6 Cg_exo -50.32 166.24 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.418 2.079 . . . . 0.0 112.069 179.718 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.405 ' CB ' ' O ' ' A' ' 178' ' ' PRO . 1.4 tp 81.49 -10.83 1.14 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.557 -179.824 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 180' ' ' ARG . 0.6 OUTLIER -151.66 32.06 0.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.445 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 097 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.455 ' O ' HD23 ' A' ' 156' ' ' LEU . 1.9 t80 . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.796 0.331 . . . . 0.0 111.551 . . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 156' ' ' LEU . 0.2 OUTLIER 62.59 132.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.477 179.782 . . . . . . . . 3 3 . 1 . 097 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.416 ' HG2' ' N ' ' A' ' 158' ' ' SER . 4.6 pm0 -172.06 -41.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.98 -179.832 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.416 ' N ' ' HG2' ' A' ' 157' ' ' GLN . 37.6 t -78.13 52.19 1.07 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.556 -179.764 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.569 ' O ' HG12 ' A' ' 160' ' ' VAL . 0.4 OUTLIER 75.37 -29.03 0.19 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.576 . . . . . . . . 3 3 . 1 . 097 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.569 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.3 OUTLIER 92.29 -41.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 122.929 0.492 . . . . 0.0 111.209 -179.806 . . . . . . . . 3 3 . 1 . 097 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -69.37 -29.27 67.01 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.078 0.466 . . . . 0.0 110.55 179.53 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.422 ' C ' ' H ' ' A' ' 164' ' ' PHE . 1.2 t80 -67.48 -60.1 2.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.942 179.784 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.888 HD22 ' HD2' ' A' ' 168' ' ' PRO . 18.6 mt -66.58 -1.92 4.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.206 178.761 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.422 ' H ' ' C ' ' A' ' 162' ' ' PHE . 1.5 t80 -73.41 -33.63 65.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.274 -179.038 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.552 ' O ' HD22 ' A' ' 166' ' ' LEU . 2.5 mt -66.0 -46.1 79.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.036 0.446 . . . . 0.0 110.58 179.5 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.552 HD22 ' O ' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -160.61 86.13 1.87 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.125 -179.162 . . . . . . . . 3 3 . 1 . 097 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.84 110.31 1.66 Allowed 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.645 2.23 . . . . 0.0 113.187 -179.017 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.888 ' HD2' HD22 ' A' ' 163' ' ' LEU . 92.0 Cg_endo -76.12 -146.88 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.873 2.382 . . . . 0.0 111.037 178.912 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.839 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.4 OUTLIER 86.79 -39.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.53 . . . . . . . . 3 3 . 1 . 097 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.46 HG12 ' H ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -69.92 -39.41 77.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.65 -176.899 . . . . . . . . 3 3 . 1 . 097 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.46 ' H ' HG12 ' A' ' 170' ' ' ILE . 46.5 mt -66.08 -55.79 14.76 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.798 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.34 0.4 19.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.307 178.5 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.839 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -72.22 -75.35 0.14 Allowed 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.777 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -86.5 -17.5 60.25 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 178.334 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 12.0 t80 68.99 -57.21 0.52 Allowed 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 122.607 0.363 . . . . 0.0 111.112 179.872 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.435 ' CD1' ' C ' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -93.1 15.98 13.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.12 179.803 . . . . . . . . 3 3 . 1 . 097 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.641 ' O ' HD22 ' A' ' 179' ' ' LEU . 13.9 mt -83.01 -47.05 0.84 Allowed Pre-proline 0 CA--C 1.529 0.158 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.74 179.732 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.508 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 8.1 Cg_exo -72.49 96.77 0.83 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.614 2.209 . . . . 0.0 111.982 179.648 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.641 HD22 ' O ' ' A' ' 177' ' ' LEU . 3.2 mm? -82.72 -72.91 0.42 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.952 0.406 . . . . 0.0 110.463 179.814 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.56 21.9 3.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.588 179.648 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . 0.406 ' HG2' ' HB3' ' A' ' 178' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.65 0.262 . . . . 0.0 111.327 . . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.2 mt -170.38 80.66 0.1 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.783 -179.828 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -169.27 71.42 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.252 0.549 . . . . 0.0 111.124 179.842 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.503 ' HB2' HD12 ' A' ' 163' ' ' LEU . 13.7 m -166.14 47.66 0.08 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.574 179.666 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.418 ' O ' HG12 ' A' ' 160' ' ' VAL . 0.5 OUTLIER 76.67 -57.66 0.53 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.56 -178.975 . . . . . . . . 3 3 . 1 . 098 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 71.29 -47.97 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.641 179.722 . . . . . . . . 3 3 . 1 . 098 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.418 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 1.2 m-85 -73.3 -0.0 13.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.933 -179.807 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -166.53 13.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.926 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.67 HD22 ' HB2' ' A' ' 165' ' ' LEU . 0.7 OUTLIER -66.75 -38.0 85.76 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.487 . . . . . . . . 3 3 . 1 . 098 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 8.6 t80 70.49 2.7 4.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.585 -1.189 . . . . 0.0 112.055 179.245 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.67 ' HB2' HD22 ' A' ' 163' ' ' LEU . 0.2 OUTLIER -68.12 -56.33 9.2 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.122 0.487 . . . . 0.0 110.406 179.208 . . . . . . . . 3 3 . 1 . 098 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.651 HD12 ' O ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER -159.34 51.7 0.44 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.944 -179.981 . . . . . . . . 3 3 . 1 . 098 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.613 ' HD3' ' N ' ' A' ' 166' ' ' LEU . 25.3 Cg_exo -60.35 -48.39 11.78 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.296 1.997 . . . . 0.0 112.922 -179.867 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.444 ' HD3' ' HB2' ' A' ' 167' ' ' PRO . 58.8 Cg_endo -88.04 -97.41 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.383 2.055 . . . . 0.0 113.127 -179.072 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.878 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 1.1 tp 80.65 -55.39 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-O 120.89 0.376 . . . . 0.0 110.984 -179.539 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.609 HG13 HG22 ' A' ' 169' ' ' ILE . 0.8 OUTLIER -81.27 -32.29 12.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.757 -179.622 . . . . . . . . 3 3 . 1 . 098 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.868 ' HA ' HD23 ' A' ' 177' ' ' LEU . 2.1 tm? -66.75 -62.46 1.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.939 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -76.4 7.84 4.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.135 178.613 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.878 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -71.08 -60.1 2.42 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.679 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.429 ' C ' ' H ' ' A' ' 176' ' ' PHE . . . -102.24 -17.09 21.19 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 177.884 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.429 ' HB2' ' O ' ' A' ' 174' ' ' GLY . 2.0 m-85 69.7 -12.27 0.47 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.827 0.451 . . . . 0.0 111.846 179.913 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.429 ' H ' ' C ' ' A' ' 174' ' ' GLY . 0.6 OUTLIER -94.91 -10.95 29.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.892 0.377 . . . . 0.0 110.186 179.196 . . . . . . . . 3 3 . 1 . 098 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.868 HD23 ' HA ' ' A' ' 171' ' ' LEU . 0.8 OUTLIER -54.01 -42.0 91.05 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.992 179.371 . . . . . . . . 3 3 . 1 . 098 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 177' ' ' LEU . 47.5 Cg_exo -57.06 73.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.804 2.336 . . . . 0.0 112.737 -179.922 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 177' ' ' LEU . 16.6 mt -96.86 -49.79 4.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.102 0.477 . . . . 0.0 109.791 179.233 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.53 23.64 1.59 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.961 179.122 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 099 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 2.7 t80 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.815 0.34 . . . . 0.0 111.869 . . . . . . . . . 0 0 . 1 . 099 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.529 HD21 ' CG2' ' A' ' 160' ' ' VAL . 11.2 mt 64.47 156.51 0.08 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.92 179.84 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.95 -64.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.888 -179.926 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 162' ' ' PHE . 0.6 OUTLIER -79.96 23.31 0.46 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.899 179.976 . . . . . . . . 3 3 . 1 . 099 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.8 t70 76.62 -1.58 2.85 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 179.886 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.529 ' CG2' HD21 ' A' ' 156' ' ' LEU . 0.4 OUTLIER 82.01 -53.91 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.768 0.318 . . . . 0.0 110.514 -179.912 . . . . . . . . 3 3 . 1 . 099 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.474 ' N ' ' CG1' ' A' ' 160' ' ' VAL . 27.1 m-85 -77.25 33.49 0.15 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.9 179.094 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.413 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 5.3 m-85 -168.54 -17.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.802 -179.634 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.401 HD11 ' HD3' ' A' ' 167' ' ' PRO . 27.0 tp -59.94 -34.06 72.73 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.23 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.45 ' O ' ' CB ' ' A' ' 165' ' ' LEU . 31.2 t80 45.76 37.81 3.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.84 178.001 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 165' ' ' LEU . 4.3 tp 84.6 -26.05 0.12 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.354 -179.577 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.895 ' O ' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -158.49 132.9 5.26 Favored Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.172 -178.437 . . . . . . . . 3 3 . 1 . 099 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.401 ' HD3' HD11 ' A' ' 163' ' ' LEU . 11.2 Cg_endo -55.41 120.32 8.02 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.146 1.897 . . . . 0.0 112.748 -178.915 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.523 ' HB2' ' HB3' ' A' ' 171' ' ' LEU . 41.9 Cg_endo -90.84 106.24 0.3 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 123.582 2.855 . . . . 0.0 111.477 179.437 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.852 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER -69.04 -42.53 82.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.326 -179.366 . . . . . . . . 3 3 . 1 . 099 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.498 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 0.7 OUTLIER -73.95 -46.67 45.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.422 -178.076 . . . . . . . . 3 3 . 1 . 099 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 168' ' ' PRO . 41.0 tp -66.91 -49.26 66.13 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.726 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -73.25 -5.33 38.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.6 178.357 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.852 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.2 -70.45 0.36 Allowed 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.607 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -117.24 -15.77 6.42 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.78 178.902 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 171' ' ' LEU . 23.4 t80 77.52 -37.16 0.24 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 122.501 0.32 . . . . 0.0 111.638 -179.923 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.41 ' HB2' ' HD3' ' A' ' 180' ' ' ARG . 11.3 p90 -97.39 28.63 3.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.849 0.357 . . . . 0.0 110.978 -179.975 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.582 ' HB2' ' HD3' ' A' ' 178' ' ' PRO . 12.1 mt -101.91 -52.81 0.15 Allowed Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.471 -179.88 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' A' ' 177' ' ' LEU . 4.6 Cg_exo -78.32 -28.63 4.47 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.741 2.294 . . . . 0.0 112.571 -179.639 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -66.72 -60.58 2.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.85 -179.741 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.41 ' HD3' ' HB2' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -90.99 49.92 1.71 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.763 179.815 . . . . . . . . 3 3 . 1 . 099 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 100 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.46 ' HA ' ' CG2' ' A' ' 160' ' ' VAL . 1.8 m-85 . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.665 0.269 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.694 ' HB2' HD12 ' A' ' 163' ' ' LEU . 14.9 mt -163.89 172.16 14.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.136 179.983 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.419 ' HB2' ' HG ' ' A' ' 163' ' ' LEU . 44.3 tp60 48.53 27.5 1.47 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.779 -179.523 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.4 p 43.72 46.44 6.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.615 -179.933 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.806 ' O ' HG12 ' A' ' 160' ' ' VAL . 1.1 t0 -164.74 -64.16 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.034 179.436 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.806 HG12 ' O ' ' A' ' 159' ' ' ASP . 0.4 OUTLIER 71.8 -36.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.355 -179.764 . . . . . . . . 3 3 . 1 . 100 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.449 ' H ' ' C ' ' A' ' 159' ' ' ASP . 0.2 OUTLIER -76.3 16.36 0.47 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.81 178.644 . . . . . . . . 3 3 . 1 . 100 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.405 ' CG ' ' O ' ' A' ' 161' ' ' PHE . 43.2 m-85 -162.99 1.15 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.841 -179.758 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.718 HD22 ' HB2' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -65.51 -44.09 88.06 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.56 . . . . . . . . 3 3 . 1 . 100 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 62.44 7.86 2.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.847 178.873 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.718 ' HB2' HD22 ' A' ' 163' ' ' LEU . 0.2 OUTLIER -69.02 -26.92 65.24 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 120.888 0.375 . . . . 0.0 111.04 179.529 . . . . . . . . 3 3 . 1 . 100 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.443 ' C ' ' HD2' ' A' ' 168' ' ' PRO . 0.2 OUTLIER -159.73 76.94 2.91 Favored Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.018 -178.639 . . . . . . . . 3 3 . 1 . 100 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.455 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 2.7 Cg_exo -40.16 -47.37 4.08 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.113 2.542 . . . . 0.0 112.928 179.903 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 167' ' ' PRO . 42.8 Cg_endo -88.61 58.76 2.57 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.539 2.159 . . . . 0.0 112.643 -179.424 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.798 ' O ' ' HB2' ' A' ' 173' ' ' ALA . 0.2 OUTLIER -77.31 -32.94 19.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.971 179.726 . . . . . . . . 3 3 . 1 . 100 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.785 HG23 ' O ' ' A' ' 178' ' ' PRO . 20.4 mm -68.54 -48.09 73.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.586 -178.898 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.6 mt -65.25 -48.2 74.08 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.224 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -76.11 -5.16 45.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.844 178.609 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.798 ' HB2' ' O ' ' A' ' 169' ' ' ILE . . . -73.97 -70.19 0.4 Allowed 'General case' 0 CA--C 1.522 -0.134 0 CA-C-O 121.205 0.526 . . . . 0.0 109.788 179.849 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.804 ' H ' ' HG2' ' A' ' 178' ' ' PRO . . . -121.06 -20.64 3.33 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.027 178.637 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 9.9 t80 75.6 -12.44 0.98 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.053 0.541 . . . . 0.0 111.971 179.659 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -94.3 45.79 1.14 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.794 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.678 ' N ' ' HD3' ' A' ' 178' ' ' PRO . 5.0 mt 54.02 52.41 9.4 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.037 -178.687 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.804 ' HG2' ' H ' ' A' ' 174' ' ' GLY . 24.0 Cg_exo -67.29 56.58 0.6 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.154 2.57 . . . . 0.0 112.578 179.848 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.78 ' HG ' HG21 ' A' ' 170' ' ' ILE . 11.6 mt -101.28 -66.33 0.92 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.921 0.391 . . . . 0.0 110.545 179.8 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 42.84 1.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.607 179.66 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 181' ' ' HSL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_